Citrus Sinensis ID: 036754

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-----
Protein Sequence
LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNSLLLGIVLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF
Secondary Structure (PSIPRED)
ccccccccccccccEEEccccccccccccccHHcHHccccEEEEcccEEEEEcccccccccccccEEcccccccccccHHHHHcccccccEEcccccccccHHHHHccccccccccccccHHHcccccccEEEcccccccccccHHHHcccccccccccccccccccHHHHHcccccccccccccccccccccccccccccHHHHcccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHccccccHHHHHHHHcccccccEEEcccccEEEEEEEccccEEEEEEEccccccccccHHHHHHHHHcccccccccEEEEEcccccEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
ccccHHHccccccEEEEcccccccccccHHHHcccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHHHHHHcccEEEccccccccccHHHcccccccEEEcccccHHccccccccEEEcccccccEEccccccccccccEEEccccccccccHHHHcccccccEEEccccEEEEEccccccHHHccHHHcccccEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHccccccccccHHHHHHHHHcccHHcEEEcccccEEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHEcccccccEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
lsflsslsnckcltfidlsnnpldsvlpktfvgnvsHSLEFFVMSYCNISGGILEEITNLTKLTTIIlggnklngsISITLGSNLASLRKlsldsneltsipltfwNLKDILYLnfsvipieigglpnleYLFLGYnrlqgsipdsfgdlislkslnlsknnlsgaipaSLEKLLYLKDLNLSFnklegeiprggsfgnfsaesfegnellcgspnlqvqpcktgihhtssknSLLLGIVLPLSTTFMIVVILLILRYRQrgkrlsndanmpIVATWRMFSYLELCRATYkfsennliskggfgsvykarlgdGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEymphgslekylyssnCILDIFQRLNIMIDVASALEYLHF
Flexible Loop (DISEMBL)
lsflsslsncKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNSLLLGIVLPLSTTFMIVVILLILRYrqrgkrlsndanmpiVATWRMFSYLELCRATYKFsennliskggFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF
Low Complexity Region (SEG)
LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGileeitnltklttiilggnKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLIslkslnlsknnlsGAIPASlekllylkdlnlSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNSLLLGIVLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF
Disordered region (IsUnstruct)
******LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNSLLLGIVLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL**
Disordered Region (DISOPRED)
LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN********************LGIVLPLSTTFMIVVILLILR********************RMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF
Disordered Region (DISEMBL)
LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNSLLLGIVLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF
Disordered Region (DISPRO)
LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNSLLLGIVLPLSTTFMIVVILLILRYRQRGKR****AN*PIVATWRMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNSLLLGIVLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	405	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.930	0.373	0.368	8e-57
C0LGT6	1031	LRR receptor-like serine/	no	no	0.987	0.387	0.322	5e-53
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.967	0.4	0.355	7e-49
Q8VZG8	1045	Probable LRR receptor-lik	no	no	0.960	0.372	0.326	6e-47
Q9SD62	1025	Putative receptor-like pr	no	no	0.992	0.392	0.335	4e-46
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.962	0.312	0.330	1e-42
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.965	0.312	0.324	1e-42
Q9LJF3	1164	Receptor-like protein kin	no	no	0.938	0.326	0.310	2e-41
Q9LP24	1120	Probable leucine-rich rep	no	no	0.940	0.340	0.322	1e-40
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.972	0.357	0.319	1e-39

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  221 bits (563), Expect = 8e-57,   Method: Compositional matrix adjust.
 Identities = 155/421 (36%), Positives = 229/421 (54%), Gaps = 44/421 (10%)

Query: 7   LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTI 66
           + N   L  +DLSNN  + ++P T +GN SH LE ++     ++G I  EI  + +L  +
Sbjct: 429 IGNMTMLETLDLSNNGFEGIVP-TSLGNCSHLLELWIGDN-KLNGTIPLEIMKIQQLLRL 486

Query: 67  ILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGL 126
            + GN L GS+   +G+ L +L  LSL  N+L+                   +P  +G  
Sbjct: 487 DMSGNSLIGSLPQDIGA-LQNLGTLSLGDNKLSG-----------------KLPQTLGNC 528

Query: 127 PNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNK 186
             +E LFL  N   G IPD  G L+ +K ++LS N+LSG+IP        L+ LNLSFN 
Sbjct: 529 LTMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNN 587

Query: 187 LEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVQPCKTGI-----HHTSSKNSLLLGIV 240
           LEG++P  G F N +  S  GN  LCG     Q++PC +        H+S    +++G+ 
Sbjct: 588 LEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVS 647

Query: 241 LPLS---TTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMFSYLELCRATYKFSENNL 297
           + ++     FM  V L+ LR R++ K  +N     +       SY +L  AT  FS +N+
Sbjct: 648 VGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNM 707

Query: 298 ISKGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCS 356
           +  G FG+VYKA  L +   VAVKV N+Q R A KSF  ECE +K IRH+NL+K++++CS
Sbjct: 708 VGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACS 767

Query: 357 N-----EEFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYL 403
           +      EF+AL+ E+MP+GSL+ +L+             L + +RLNI IDVAS L+YL
Sbjct: 768 SIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYL 827

Query: 404 H 404
           H
Sbjct: 828 H 828

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  208 bits (530), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 163/505 (32%), Positives = 241/505 (47%), Gaps = 105/505 (20%)

Query: 3   FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTK 62
           F+ +++NC  L ++D+  N L   LP + + N+S +L    +    ISG I  +I NL  
Sbjct: 336 FIGAVANCTQLEYLDVGYNRLGGELPAS-IANLSTTLTSLFLGQNLISGTIPHDIGNLVS 394

Query: 63  LTTIILGGNKLNGSISITLG-----------------------SNLASLRKLSLDSNELT 99
           L  + L  N L+G + ++ G                        N+  L+KL L+SN   
Sbjct: 395 LQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFH 454

Query: 100 -------------------------SIPLTFWNLKDILYLNFS----------------- 117
                                    +IP     +  + Y++ S                 
Sbjct: 455 GRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLEL 514

Query: 118 -------------VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLS 164
                         +P  IGG  ++E+LF+  N   G+IPD    L+SLK+++ S NNLS
Sbjct: 515 LVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLS 573

Query: 165 GAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVQPCK 223
           G IP  L  L  L++LNLS NK EG +P  G F N +A S  GN  +CG    +Q++PC 
Sbjct: 574 GRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCI 633

Query: 224 TGIHHT-----SSKNSLLLGIVLPLSTTFMIVVILLILRYRQRGKR-LSNDANMPIVATW 277
                      S +  ++ GI + +++  +I+++  +  + +R K+  ++D N     T 
Sbjct: 634 VQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTL 693

Query: 278 RMF----SYLELCRATYKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKS 332
            MF    SY EL  AT +FS  NLI  G FG+V+K  LG +   VAVKV NL    A KS
Sbjct: 694 GMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKS 753

Query: 333 FDIECEMMKSIRHQNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLY--------S 379
           F  ECE  K IRH+NL+K+I+ CS+      +F+ALV E+MP GSL+ +L          
Sbjct: 754 FMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVND 813

Query: 380 SNCILDIFQRLNIMIDVASALEYLH 404
            +  L   ++LNI IDVASALEYLH
Sbjct: 814 HSRSLTPAEKLNIAIDVASALEYLH 838

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  194 bits (494), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 149/419 (35%), Positives = 224/419 (53%), Gaps = 27/419 (6%)

Query: 7   LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTI 66
           L +   L  +D+S N L   +P +F GN+S  L   ++   ++SG + + +     L  +
Sbjct: 365 LGDIPRLGLLDVSRNNLSGSIPDSF-GNLSQ-LRRLLLYGNHLSGTVPQSLGKCINLEIL 422

Query: 67  ILGGNKLNGSISITLGSNLASLR-KLSLDSNELTS-IPLTFWNLKDILYLNFSV------ 118
            L  N L G+I + + SNL +L+  L+L SN L+  IPL    +  +L ++ S       
Sbjct: 423 DLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGK 482

Query: 119 IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLK 178
           IP ++G    LE+L L  N    ++P S G L  LK L++S N L+GAIP S ++   LK
Sbjct: 483 IPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLK 542

Query: 179 DLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNSLLLG 238
            LN SFN L G +   GSF   + ESF G+ LLCGS    +Q CK    + S    +LL 
Sbjct: 543 HLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACKKKHKYPSVLLPVLLS 601

Query: 239 IVLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIV---------ATWRMFSYLELCRAT 289
           ++   +T  + V    +++  + GK L+  A   +            +   SY +L  AT
Sbjct: 602 LI---ATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAAT 658

Query: 290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK-SFDIECEMMKSIRHQNL 348
             F+ ++LI  G FG VYK  L +  +VAVKV + +    F  SF  EC+++K  RH+NL
Sbjct: 659 GGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNL 718

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLH 404
           I++I++CS   F ALVL  MP+GSLE++LY    S+  LD+ Q +NI  DVA  + YLH
Sbjct: 719 IRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLH 777

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  188 bits (478), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 145/444 (32%), Positives = 223/444 (50%), Gaps = 55/444 (12%)

Query: 12  CLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGN 71
            L FIDLSNN     L   +    S  L  F++S  +I+G I  EI N+T+L+ + L  N
Sbjct: 455 TLNFIDLSNNNFHGQLSANW--EQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSN 512

Query: 72  KLNGSISITLGSNLASLRKLSLDSNELT-------------------------SIPLTFW 106
           ++ G +  ++ SN+  + KL L+ N L+                          IP T  
Sbjct: 513 RITGELPESI-SNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLN 571

Query: 107 NLKDILYLNFS------VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSK 160
           NL  + Y+N S       IP  +  L  L+ L L YN+L G I   F  L +L+ L+LS 
Sbjct: 572 NLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSH 631

Query: 161 NNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQ-- 218
           NNLSG IP S + +L L  +++S N L+G IP   +F N   ++FEGN+ LCGS N    
Sbjct: 632 NNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQG 691

Query: 219 VQPCKTGIHHTSSKN-SLLLGIVLPLSTTFMIVVIL--LILRYRQRGKRLSNDANMPIVA 275
           ++PC       S K+ +L++ I++P+    +I+ +   + + +R+R K++    +     
Sbjct: 692 LKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGG 751

Query: 276 -TWRMFS------YLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRR 328
            T  +FS      Y E+ +AT +F    LI  GG G VYKA+L + + +AVK  N     
Sbjct: 752 ETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNAI-MAVKKLNETTDS 810

Query: 329 AF------KSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC 382
           +       + F  E   +  IRH+N++K+   CS+     LV EYM  GSL K L + + 
Sbjct: 811 SISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDE 870

Query: 383 I--LDIFQRLNIMIDVASALEYLH 404
              LD  +R+N++  VA AL Y+H
Sbjct: 871 AKKLDWGKRINVVKGVAHALSYMH 894

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  186 bits (471), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 170/506 (33%), Positives = 245/506 (48%), Gaps = 104/506 (20%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L FL +L+NC  L ++++  N L   LP  F+ N+S  L    +    ISG I   I NL
Sbjct: 342 LDFLGALTNCSQLQYLNVGFNKLGGQLP-VFIANLSTQLTELSLGGNLISGSIPHGIGNL 400

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRK------------------------------ 90
             L T+ LG N L G +  +LG  L+ LRK                              
Sbjct: 401 VSLQTLDLGENLLTGKLPPSLGE-LSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNN 459

Query: 91  ------------------LSLDSNELT-SIPLTFWNLKDILYLNFS----VIPI--EIGG 125
                             L+L +N+L  SIP     L  ++ LN S    V P+  +IG 
Sbjct: 460 SFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGK 519

Query: 126 LPNLEYLFLGYNRLQGSIPDSFGDLISL-----------------------KSLNLSKNN 162
           L  L  L + YN+L G IP +  + +SL                       + L+LSKNN
Sbjct: 520 LKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRGLTGLRFLDLSKNN 579

Query: 163 LSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVQP 221
           LSG IP  +     L++LNLS N  +G +P  G F N SA S  GN  LCG  P+LQ+QP
Sbjct: 580 LSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQP 639

Query: 222 CKTGI--HHTSSKNSLLLGIVLPLSTTFMIVVILLILRY---RQRGKRLSNDAN----MP 272
           C   +   H+S +  + + +   ++   ++ + ++ L +   R +  R +N+ N     P
Sbjct: 640 CSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSP 699

Query: 273 IVATWRMFSYLELCRATYKFSENNLISKGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFK 331
           + + +   SY EL + T  FS +NLI  G FG+V+K  LG     VA+KV NL  R A K
Sbjct: 700 VKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAK 759

Query: 332 SFDIECEMMKSIRHQNLIKVISSCSNE-----EFKALVLEYMPHGSLEKYLYSSNC---- 382
           SF  ECE +  IRH+NL+K+++ CS+      +F+ALV E+MP+G+L+ +L+        
Sbjct: 760 SFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETG 819

Query: 383 ----ILDIFQRLNIMIDVASALEYLH 404
                L +F RLNI IDVASAL YLH
Sbjct: 820 NPSRTLGLFARLNIAIDVASALVYLH 845

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  174 bits (440), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 143/433 (33%), Positives = 217/433 (50%), Gaps = 43/433 (9%)

Query: 10   CKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILG 69
            CK LT IDL+NN L   +P  ++G +S  L    +S       +  E+ N TKL  + L 
Sbjct: 646  CKKLTHIDLNNNFLSGPIPP-WLGKLSQ-LGELKLSSNQFVESLPTELFNCTKLLVLSLD 703

Query: 70   GNKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFSV------IPIE 122
            GN LNGSI   +G NL +L  L+LD N+ + S+P     L  +  L  S       IP+E
Sbjct: 704  GNSLNGSIPQEIG-NLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVE 762

Query: 123  IGGLPNLE-YLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLN 181
            IG L +L+  L L YN   G IP + G L  L++L+LS N L+G +P S+  +  L  LN
Sbjct: 763  IGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLN 822

Query: 182  LSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHT--SSKNSLLLGI 239
            +SFN L G++ +   F  + A+SF GN  LCGSP  +    ++       S+++ +++  
Sbjct: 823  VSFNNLGGKLKK--QFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISA 880

Query: 240  VLPLSTT-FMIVVILLILRYRQ-------RGKRLSNDANMPIVATWRMF----------S 281
            +  L+    MI+VI L  + R         G      ++    AT +             
Sbjct: 881  ISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIR 940

Query: 282  YLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAV-KVFNLQCRRAFKSFDIECEMM 340
            + ++  AT+  SE  +I  GG G VYKA L +G  VAV K+       + KSF  E + +
Sbjct: 941  WEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTL 1000

Query: 341  KSIRHQNLIKVISSCS--NEEFKALVLEYMPHGSLEKYLYSSNCI-------LDIFQRLN 391
              IRH++L+K++  CS  +E    L+ EYM +GS+  +L+    +       LD   RL 
Sbjct: 1001 GRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLR 1060

Query: 392  IMIDVASALEYLH 404
            I + +A  +EYLH
Sbjct: 1061 IAVGLAQGVEYLH 1073

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  174 bits (440), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 139/428 (32%), Positives = 224/428 (52%), Gaps = 37/428 (8%)

Query: 10   CKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILG 69
            CK LT IDL+NN L  V+P T++G +   L    +S     G +  EI +LT + T+ L 
Sbjct: 647  CKKLTHIDLNNNYLSGVIP-TWLGKLPL-LGELKLSSNKFVGSLPTEIFSLTNILTLFLD 704

Query: 70   GNKLNGSISITLGSNLASLRKLSLDSNELTS-IPLTFWNLKDILYLNFSV------IPIE 122
            GN LNGSI   +G NL +L  L+L+ N+L+  +P T   L  +  L  S       IP+E
Sbjct: 705  GNSLNGSIPQEIG-NLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVE 763

Query: 123  IGGLPNLE-YLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLN 181
            IG L +L+  L L YN   G IP +   L  L+SL+LS N L G +P  +  +  L  LN
Sbjct: 764  IGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLN 823

Query: 182  LSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNSLLLGIVL 241
            LS+N LEG++ +   F  + A++F GN  LCGSP        +    + S  ++++   +
Sbjct: 824  LSYNNLEGKLKK--QFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAI 881

Query: 242  PLSTTFMIVVILLILRYRQ--------RG-----KRLSNDANMPIVATWRMFS---YLEL 285
                   ++V+++IL ++Q        RG        S+ +  P+ +     S   + ++
Sbjct: 882  SSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDI 941

Query: 286  CRATYKFSENNLISKGGFGSVYKARLGDGMEVAV-KVFNLQCRRAFKSFDIECEMMKSIR 344
              AT+  +E  +I  GG G VYKA L +G  +AV K+       + KSF+ E + + +IR
Sbjct: 942  MEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIR 1001

Query: 345  HQNLIKVISSCSNEE--FKALVLEYMPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVA 397
            H++L+K++  CS++      L+ EYM +GS+  +L+++       +L    RL I + +A
Sbjct: 1002 HRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLA 1061

Query: 398  SALEYLHF 405
              +EYLH+
Sbjct: 1062 QGVEYLHY 1069

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  170 bits (430), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 141/454 (31%), Positives = 209/454 (46%), Gaps = 74/454 (16%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFV--------GNVSHSLEFFVM----SYCNISGG 52
           S L NCK L ++DL++N L   LP            G+VS     FV     + C  +GG
Sbjct: 541 SELGNCKNLIWLDLNSNNLTGNLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGG 600

Query: 53  ILE-EITNLTKLTTIIL----GGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWN 107
           ++E E     +L    +       ++   +++ + S+  S+  L L  N ++        
Sbjct: 601 LVEFEGIRAERLEHFPMVHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYNAVS-------- 652

Query: 108 LKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAI 167
                      IP+  G +  L+ L LG+N L G+IPDSFG L ++  L+LS N+L G +
Sbjct: 653 ---------GSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFL 703

Query: 168 PASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIH 227
           P SL  L +L DL++S N L G IP GG    F    +  N  LCG P   + PC +G  
Sbjct: 704 PGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVP---LPPCSSGSR 760

Query: 228 HTSS-----KNSLLLGIVLPLSTTFMIVVILLILRYRQR------GKRLSNDANMPI--- 273
            T S     K S+  G+   +  +FM +V+L++  YR R       +R     ++P    
Sbjct: 761 PTRSHAHPKKQSIATGMSAGIVFSFMCIVMLIMALYRARKVQKKEKQREKYIESLPTSGS 820

Query: 274 ---------------VATW----RMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDG 314
                          VAT+    R  ++  L  AT  FS +++I  GGFG VYKA+L DG
Sbjct: 821 SSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADG 880

Query: 315 MEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLE 374
             VA+K       +  + F  E E +  I+H+NL+ ++  C   E + LV EYM +GSLE
Sbjct: 881 SVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLE 940

Query: 375 KYLYS----SNCILDIFQRLNIMIDVASALEYLH 404
             L+         LD   R  I I  A  L +LH
Sbjct: 941 TVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLH 974

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  167 bits (423), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 133/412 (32%), Positives = 211/412 (51%), Gaps = 31/412 (7%)

Query: 18  LSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSI 77
           +SNN +   +P T + N++  +E   +S  N+ G + E I NLT L+ + L GN+L+G +
Sbjct: 565 MSNNNITGAIP-TEIWNMTQLVEL-DLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRV 622

Query: 78  SITLGSNLASLRKLSLDSNELTS-IPLTFWNLKDILYLNFS------VIPIEIGGLPNLE 130
              L S L +L  L L SN  +S IP TF +   +  +N S       IP  +  L  L 
Sbjct: 623 PAGL-SFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLT 680

Query: 131 YLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGE 190
            L L +N+L G IP     L SL  L+LS NNLSG IP + E ++ L ++++S NKLEG 
Sbjct: 681 QLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGP 740

Query: 191 IPRGGSFGNFSAESFEGNELLCGS-PNLQVQPCKTGIHHTSSKNSLLLGIVLPLSTTFMI 249
           +P   +F   +A++ E N  LC + P  +++PC+  +       +L++ I++P+    +I
Sbjct: 741 LPDTPTFRKATADALEENIGLCSNIPKQRLKPCRE-LKKPKKNGNLVVWILVPILGVLVI 799

Query: 250 VVILL-ILRYRQRGKRLSN--------DANMPIVATWRMFSYLELCRATYKFSENNLISK 300
           + I      Y  R ++L N          NM I +    F Y ++  +T +F   +LI  
Sbjct: 800 LSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGT 859

Query: 301 GGFGSVYKARLGDGMEVAVKVFNLQCRRAF------KSFDIECEMMKSIRHQNLIKVISS 354
           GG+  VY+A L D + +AVK  +             + F  E + +  IRH+N++K+   
Sbjct: 860 GGYSKVYRANLQDTI-IAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGF 918

Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNIMIDVASALEYLH 404
           CS+     L+ EYM  GSL K L +      L   +R+N++  VA AL Y+H
Sbjct: 919 CSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMH 970

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  164 bits (416), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 137/429 (31%), Positives = 206/429 (48%), Gaps = 35/429 (8%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
           + L   K L  + L+NN     +P   +GN++  + F + S   ++G I +E+ +   + 
Sbjct: 493 ADLGKLKNLERLRLANNNFTGEIPPE-IGNLTKIVGFNISSN-QLTGHIPKELGSCVTIQ 550

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFSV----- 118
            + L GNK +G I+  LG  L  L  L L  N LT  IP +F +L  ++ L         
Sbjct: 551 RLDLSGNKFSGYIAQELGQ-LVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSE 609

Query: 119 -IPIEIGGLPNLEY-LFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
            IP+E+G L +L+  L + +N L G+IPDS G+L  L+ L L+ N LSG IPAS+  L+ 
Sbjct: 610 NIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMS 669

Query: 177 LKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSK---- 232
           L   N+S N L G +P    F    + +F GN  LC S     QP    + H+ SK    
Sbjct: 670 LLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPL---VPHSDSKLNWL 726

Query: 233 ------NSLLLGIVLPLSTTFMIVVILLILRYRQRGKRLS--NDANMPIVAT-----WRM 279
                   +L    + + + F+I  + L    ++R        D   P V        + 
Sbjct: 727 INGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKG 786

Query: 280 FSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAF--KSFDIEC 337
           F+Y  L  AT  FSE+ ++ +G  G+VYKA +  G  +AVK  N +   A    SF  E 
Sbjct: 787 FTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEI 846

Query: 338 EMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY--SSNCILDIFQRLNIMID 395
             +  IRH+N++K+   C ++    L+ EYM  GSL + L     NC+LD   R  I + 
Sbjct: 847 STLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALG 906

Query: 396 VASALEYLH 404
            A  L YLH
Sbjct: 907 AAEGLCYLH 915

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	405
255585401	843	serine-threonine protein kinase, plant-t	0.992	0.476	0.462	3e-98
255572272	1089	serine-threonine protein kinase, plant-t	0.995	0.370	0.448	6e-96
224139658	1019	predicted protein [Populus trichocarpa]	0.995	0.395	0.444	3e-94
224116832	1061	predicted protein [Populus trichocarpa]	0.975	0.372	0.439	2e-93
359483675	1250	PREDICTED: LRR receptor-like serine/thre	0.995	0.322	0.438	2e-93
359483685	1046	PREDICTED: LRR receptor-like serine/thre	0.995	0.385	0.431	3e-92
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.995	0.327	0.429	7e-92
359483683	1228	PREDICTED: LRR receptor-like serine/thre	0.995	0.328	0.431	1e-91
147852480	1229	hypothetical protein VITISV_039533 [Viti	0.995	0.327	0.431	3e-91
147776333	1205	hypothetical protein VITISV_000078 [Viti	0.995	0.334	0.431	4e-91

>gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  365 bits (936), Expect = 3e-98,   Method: Compositional matrix adjust.
 Identities = 223/482 (46%), Positives = 281/482 (58%), Gaps = 80/482 (16%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L FL+SL+ CK L  + L  NPL+S LP T +GN+S S+E+F +  CNI G I  EI  L
Sbjct: 188 LGFLASLARCKELRRLVLIGNPLNSTLP-TSIGNLS-SIEYFNVQSCNIKGNIPSEIGVL 245

Query: 61  TKLTTIILGGNKLNGSISITLGS------------------------------------- 83
           + L T+ L  N+L GSI +T+G                                      
Sbjct: 246 SNLITLHLQNNELVGSIPVTIGGLQKLQRLYLHGNLLYGSIPTDICHLSNLGELFLSNNS 305

Query: 84  ----------NLASLRKLSLDSNELTS-IPLTFWNLKDILYLNFS--------------- 117
                     +L SLR L L SN  TS IP + W+LKD+L LN S               
Sbjct: 306 LFGPLPACFGDLISLRILHLHSNNFTSGIPFSLWSLKDVLELNLSSNSLSGHIPLSIGNL 365

Query: 118 ---------------VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN 162
                          +IP  IG L NL  L L +NR +G IP+ FG+LISL+SL+LS NN
Sbjct: 366 KVLTQVDFSYNSLSGIIPNAIGSLRNLMSLSLTHNRFEGPIPEPFGELISLESLDLSSNN 425

Query: 163 LSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPC 222
           LSG IP SLE+L YLK LN+SFN L+GE+P  G+F NFSA SF GN  LCGS  L + PC
Sbjct: 426 LSGKIPKSLEQLKYLKYLNVSFNNLDGEVPNKGAFANFSASSFLGNLALCGSRLLPLMPC 485

Query: 223 KTGIHHTSSKNSLLLGIVLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMFSY 282
           K   H  S  ++ LL I +  ++   I  IL+ LR ++    L N  ++  V TWR  S+
Sbjct: 486 KNNTHGGSKTSTKLLLIYVLPASILTIAFILVFLRCQKVKLELENVMDIITVGTWRRISF 545

Query: 283 LELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKS 342
            EL +AT  F  +NL+  GG+GSVYK RL DG  VA+KVFNL    AFK FD ECE+M S
Sbjct: 546 QELEQATDGFCASNLLGAGGYGSVYKGRLEDGTNVAIKVFNLGVEGAFKIFDTECEVMSS 605

Query: 343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 402
           IRH+NL+K+IS CSN++FKA+VLEYMP+GSLEK+LYS N  L+I QRL +MIDVASALEY
Sbjct: 606 IRHRNLVKIISCCSNQDFKAIVLEYMPNGSLEKWLYSHNYCLNIQQRLEVMIDVASALEY 665

Query: 403 LH 404
           LH
Sbjct: 666 LH 667

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  357 bits (916), Expect = 6e-96,   Method: Compositional matrix adjust.
 Identities = 218/486 (44%), Positives = 276/486 (56%), Gaps = 83/486 (17%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L+  SSL NC+ L ++ LS NPLD  LP + VGN+S+SLE F+ S   I G + E I NL
Sbjct: 430 LTIFSSLKNCQNLKYLWLSYNPLDGYLPHS-VGNLSNSLESFLASDGLIKGSVHESIGNL 488

Query: 61  TKLTTIILGGNKLNGSISITLG-------------------------------------- 82
           + LT + LG N L G I  T+G                                      
Sbjct: 489 SSLTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNK 548

Query: 83  ---------SNLASLRKLSLDSNELTS-IPLTFWNLKDILYLNFSV-------------- 118
                    SNL SLR L L SN   S I  T W LKDIL +N +               
Sbjct: 549 LSGSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENL 608

Query: 119 ----------------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN 162
                           IPI IGGL +L  L+L  N+LQG IP S GD+ SL+ L+LS NN
Sbjct: 609 RAVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNN 668

Query: 163 LSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPC 222
           LSG IP SL+ LLYLK  N+SFN L+GEIP GGSF NFSA+SF GNE LCGS  LQV PC
Sbjct: 669 LSGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPC 728

Query: 223 KTGIHHTSSK--NSLLLGIVLP--LSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWR 278
           K      +    + ++L  VLP  +   F++  ++++ RY +R  + S + +   + T R
Sbjct: 729 KDDNSRATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIR 788

Query: 279 MFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECE 338
             SY EL  AT  F E+N +  G FGSVYK  L DG  +A KVFNLQ  RAFKSFD ECE
Sbjct: 789 RISYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECE 848

Query: 339 MMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 398
           +++++RH+NL+K+I+SCS   FKALVLE+MP+ SLEK+LYS +  L+  QRLNIM+DVAS
Sbjct: 849 VLRNLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVAS 908

Query: 399 ALEYLH 404
            LEYLH
Sbjct: 909 VLEYLH 914

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  351 bits (901), Expect = 3e-94,   Method: Compositional matrix adjust.
 Identities = 215/484 (44%), Positives = 274/484 (56%), Gaps = 81/484 (16%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L+F++SL+N + L  + + +NPLD +LP + VGN+S  L  F +    + G I  EI NL
Sbjct: 361 LNFITSLTNSRQLKELHIGDNPLDGMLPNS-VGNLSSFLTKFYVYASKLKGNIPGEIGNL 419

Query: 61  TKLTTIILGGNKLNGSISITLGS------------------------------------- 83
           + L  + L  N L G I  T+G                                      
Sbjct: 420 SNLIVLSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNV 479

Query: 84  ----------NLASLRKLSLDSNELTS-IPLTFWNLKDILYLNFSV-------------- 118
                     NL SLR L L  N L+S IP+  W+LKD+L LN                 
Sbjct: 480 LSGEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEM 539

Query: 119 ----------------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN 162
                           IP  IG L NL    L  N  QGSIP++FG L+SL+ L+LS+NN
Sbjct: 540 EAAIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNN 599

Query: 163 LSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPC 222
           LSG IP SLE L YL+  ++SFN L+GEIPRGG F NF+A SF  N+ LCG   LQV PC
Sbjct: 600 LSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPC 659

Query: 223 KTGIHHTSSKNSLLLGIVLPLSTTFMIVV--ILLILRYRQRGKRLSNDANMPIVATWRMF 280
                  S   S LL   LP   + ++VV  I L++  R+R ++      +P+ A  R  
Sbjct: 660 SIESRKDSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRI 719

Query: 281 SYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMM 340
           SYLEL  AT +F E+NL+  G FGSVY+ RL DG+ VAVK+FNLQ +RAF+SFD ECE+M
Sbjct: 720 SYLELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIM 779

Query: 341 KSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 400
           ++IRH+NL+K+I SCSN +FKALVLEYMP GSLEK+LYS N  LDI QR+NIMIDVASAL
Sbjct: 780 RNIRHRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASAL 839

Query: 401 EYLH 404
           EYLH
Sbjct: 840 EYLH 843

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  348 bits (894), Expect = 2e-93,   Method: Compositional matrix adjust.
 Identities = 209/476 (43%), Positives = 271/476 (56%), Gaps = 81/476 (17%)

Query: 9   NCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIIL 68
           NC+ L ++  + NPL   LP + +GN+S SLE      C I G I   I NL+ L  +IL
Sbjct: 409 NCRSLAYLRFNGNPLRGRLPVS-IGNLSASLEELYAFDCRIIGNIPRGIGNLSNLIGLIL 467

Query: 69  GGNKLNGSISITLG---------------------------------------------- 82
             N+L G+I   +G                                              
Sbjct: 468 QQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYLLENGFSGSLPAC 527

Query: 83  -SNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS------VIPIEIGGLP-------- 127
            SN+ SLR+L L SN  TSIP TFW+LKD+L +N S       +P+EIG L         
Sbjct: 528 LSNITSLRELYLGSNRFTSIPTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKVVTVIDFS 587

Query: 128 ----------------NLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASL 171
                           NL +  L  NR+QG IP SFGDL+SL+ L+LS+N+LSGAIP SL
Sbjct: 588 SNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAIPKSL 647

Query: 172 EKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSS 231
           EKL++LK  N+SFN+L+GEI  GG F NFS  SF  NE LCG   +QV PCK+   H  S
Sbjct: 648 EKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQS 707

Query: 232 KN--SLLLGIVLPLSTTFMIVVILLILRYRQRGKR-LSNDANMPIVATWRMFSYLELCRA 288
           K     ++  ++P     ++V+ L ++ +R+  KR LS   +    ATWR  SY EL RA
Sbjct: 708 KRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRKLSTQEDPLPPATWRKISYHELYRA 767

Query: 289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNL 348
           T  F+E NL+  G  GSVYK  L DG+ +AVKVF+LQ       FD ECE+++ +RH+NL
Sbjct: 768 TEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNL 827

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +K+ISSC N +FKAL+LE++PHGSLEK+LYS N  LDI QRLNIMIDVASALEYLH
Sbjct: 828 VKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLH 883

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483675|ref|XP_003632999.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  348 bits (894), Expect = 2e-93,   Method: Compositional matrix adjust.
 Identities = 212/484 (43%), Positives = 277/484 (57%), Gaps = 81/484 (16%)

Query: 1    LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
            + FL+SL+NCK L  + +  NPL   LP + +GN+S +LE F  S C+  G I   I NL
Sbjct: 578  VGFLTSLTNCKFLRTLWIDYNPLKGTLPNS-LGNLSVALESFTASACHFRGTIPTGIGNL 636

Query: 61   TKLTTIILGGNKLNGSISITLGS------------------------------------- 83
            T L  + LG N L GSI  TLG                                      
Sbjct: 637  TNLIWLDLGANDLTGSIPTTLGQLQKLQRLYIAGNRIQGSIPNDLFHLKNLGYLHLSSNK 696

Query: 84   ----------NLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFS--------------- 117
                      +L +LR+LSLDSN L  +IP++FW+L+D+L L+ S               
Sbjct: 697  LSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLLVLSLSSNFLTGNLPPEVGNM 756

Query: 118  ---------------VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN 162
                            IP  +G L NL  L L  N+LQGSIP  FGDL+SL+S++LS+NN
Sbjct: 757  KSITTLDLSKNLISGYIPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNN 816

Query: 163  LSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPC 222
            LSG IP SLE L+YLK LN+SFNKL+GEIP GG F NF+AESF  NE LCG+P+ QV  C
Sbjct: 817  LSGTIPKSLEALIYLKHLNVSFNKLQGEIPDGGPFVNFTAESFIFNEALCGAPHFQVIAC 876

Query: 223  KTGIHHTS--SKNSLLLGIVLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMF 280
                H  S  +K+ +L  I+LP+ +   +V  +++   RQ    +    +  +       
Sbjct: 877  DKNNHTQSWKTKSFILKYILLPVGSIVTLVAFIVLWIRRQDNTEIPAPIDSWLPGAHEKI 936

Query: 281  SYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMM 340
            S  +L  AT  F E+NLI KG  G VYK  L +G+ VA+KVFNL+ + A +SFD ECE+M
Sbjct: 937  SQQQLLYATNDFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVM 996

Query: 341  KSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 400
            + I H+NLI++I+ CSN +FKALVLEYMP GSL+K+LYS N  LD+FQRLNIMIDVA AL
Sbjct: 997  QGICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVALAL 1056

Query: 401  EYLH 404
            EYLH
Sbjct: 1057 EYLH 1060

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera]

 Score =  345 bits (884), Expect = 3e-92,   Method: Compositional matrix adjust.
 Identities = 209/484 (43%), Positives = 277/484 (57%), Gaps = 81/484 (16%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           + FL+SL+NCK L  + +  NPL   LP + +GN+  +LE F+ S C   G I   I NL
Sbjct: 396 VGFLTSLTNCKFLRNLWIGYNPLTGTLPNS-LGNLPIALEIFIASACQFRGTIPTGIGNL 454

Query: 61  TKLTTIILGGNKLNGSISITLGS------------------------------------- 83
           T L  + LG N L GSI  TLG                                      
Sbjct: 455 TNLIWLDLGANDLTGSIPTTLGQLQKLQALSIVGNRIRGSIPNDLCHLKNLGYLRLSYNK 514

Query: 84  ----------NLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFS--------------- 117
                     +L +LR+LSLDSN L  +IP++FW+L+D+L LN S               
Sbjct: 515 LSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLLVLNLSSNFLTGNLPPEVGNM 574

Query: 118 ---------------VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN 162
                           IP  +G L NL  L L  N+LQG IP  FGDL+SL+SL+LS+NN
Sbjct: 575 KSITTLDLSKNLVSGYIPSRMGKLQNLITLSLSQNKLQGPIPVEFGDLVSLESLDLSQNN 634

Query: 163 LSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPC 222
           LSG IP +LE L+YLK LN+SFNKL+GEIP GG F  F+AESF  NE LCG+P+ QV  C
Sbjct: 635 LSGTIPKTLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMAC 694

Query: 223 KTGIHHTS--SKNSLLLGIVLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMF 280
                  S  +K+ +L  I+LP+ +T  +VV +++   R+    +    +  +  T    
Sbjct: 695 DKNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPTPIDSWLPGTHEKI 754

Query: 281 SYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMM 340
           S+ +L  AT  F E+NLI KG  G VYK  L +G+ VA+KVFNL+ + A +SF+ ECE+M
Sbjct: 755 SHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFNSECEVM 814

Query: 341 KSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 400
           + IRH+NL+++I+ CSN +FKALVL+YMP+GSLEK LYS    LD+ QRLNIMIDVASAL
Sbjct: 815 QGIRHRNLVRIITCCSNLDFKALVLKYMPNGSLEKLLYSHYYFLDLIQRLNIMIDVASAL 874

Query: 401 EYLH 404
           EYLH
Sbjct: 875 EYLH 878

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  343 bits (881), Expect = 7e-92,   Method: Compositional matrix adjust.
 Identities = 208/484 (42%), Positives = 275/484 (56%), Gaps = 81/484 (16%)

Query: 1    LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
            + FL+SL+NCK L  + + NNP    LP + +GN+  +LE F+ S C   G I   I NL
Sbjct: 579  VGFLTSLTNCKFLKNLWIGNNPFKGTLPNS-LGNLPIALESFIASACQFRGTIPTRIGNL 637

Query: 61   TKLTTIILGGNKLNGSISITLG-------------------------------------- 82
            T L  + LG N L GSI  TLG                                      
Sbjct: 638  TNLIWLDLGANDLTGSIPTTLGRLKKLQKLHIVGNRLRGSIPNDLCHLKNLGYLHLSSNK 697

Query: 83   ---------SNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFSV-------------- 118
                      +L +L++L LDSN L  +IP + W+L+D+L LN S               
Sbjct: 698  LSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNM 757

Query: 119  ----------------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN 162
                            IP ++G   NL  L L  N+LQG IP  FGDL+SL+SL+LS+NN
Sbjct: 758  KSITTLDLSKNLVSGHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNN 817

Query: 163  LSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPC 222
            LSG IP SLE L+YLK LN+S NKL+GEIP GG F NF+AESF  NE LCG+P+ QV  C
Sbjct: 818  LSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMAC 877

Query: 223  KTGIHHTS--SKNSLLLGIVLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMF 280
                   S  +K+ +L  I+LP+ +   +VV +++   R+    +    +  +  T    
Sbjct: 878  DKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLPGTHEKI 937

Query: 281  SYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMM 340
            S+ +L  AT  F E+NLI KG  G VYK  L +G+ VA+KVFNL+ + A +SFD ECE+M
Sbjct: 938  SHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVM 997

Query: 341  KSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 400
            + IRH+NL+++I+ CSN +FKALVLEYMP+GSLEK+LYS N  LD+ QRLNIMIDVASAL
Sbjct: 998  QGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASAL 1057

Query: 401  EYLH 404
            EYLH
Sbjct: 1058 EYLH 1061

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  343 bits (879), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 209/484 (43%), Positives = 276/484 (57%), Gaps = 81/484 (16%)

Query: 1    LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
            + FL+SL+NCK L  + +  NPL   LP + +GN+S +LE F  S C+  G I   I NL
Sbjct: 578  VGFLTSLTNCKFLRTLWIDYNPLKGTLPNS-LGNLSVALESFTASACHFRGTIPTGIGNL 636

Query: 61   TKLTTIILGGNKLNGSISITLG-------------------------------------- 82
            T L  + LG N L GSI  TLG                                      
Sbjct: 637  TNLIWLDLGANDLTGSIPTTLGHLQKLQRLYIAGNRIQGSIPNDLCHLKNLGYLHLSSNK 696

Query: 83   ---------SNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFS--------------- 117
                      +L +LR+LSLDSN L  +IP++FW+L+D++ L+ S               
Sbjct: 697  LSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLMVLSLSSNFLTGNLPPEVGNM 756

Query: 118  ---------------VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN 162
                            IP  +G L NL  L L  N+LQGSIP  FGDL+SL+S++LS+NN
Sbjct: 757  KSITTLDLSKNLISGYIPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNN 816

Query: 163  LSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPC 222
            L G IP SLE L+YLK LN+SFNKL+GEIP GG F NF+AESF  NE LCG+P+ QV  C
Sbjct: 817  LFGTIPKSLEALIYLKHLNVSFNKLQGEIPNGGPFVNFTAESFIFNEALCGAPHFQVIAC 876

Query: 223  KTGIHHTS--SKNSLLLGIVLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMF 280
                   S  +K+ +L  I+LP+ +   +V  +++   R+    +    +  +       
Sbjct: 877  DKNNRTQSWKTKSFILKYILLPVGSAVTLVAFIVLWIRRRDNTEIPAPIDSWLPGAHEKI 936

Query: 281  SYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMM 340
            S  +L  AT  F E+NLI KG  G VYK  L +G+ VA+KVFNL+ + A +SFD ECE+M
Sbjct: 937  SQQQLLYATNGFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVM 996

Query: 341  KSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 400
            + I H+NLI++I+ CSN +FKALVLEYMP GSL+K+LYS N  LD+FQRLNIMIDVASAL
Sbjct: 997  QGICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVASAL 1056

Query: 401  EYLH 404
            EYLH
Sbjct: 1057 EYLH 1060

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147852480|emb|CAN78527.1| hypothetical protein VITISV_039533 [Vitis vinifera]

 Score =  341 bits (875), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 209/484 (43%), Positives = 274/484 (56%), Gaps = 81/484 (16%)

Query: 1    LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
            +SFL+SL+NCK L  + + NNP    LP + +GN+  +LE F+ S C   G I   I NL
Sbjct: 579  VSFLTSLTNCKFLKNLWIGNNPFKGTLPNS-LGNLPIALESFIASACQFRGTIPTGIGNL 637

Query: 61   TKLTTIILGGNKLNGSISITLG-------------------------------------- 82
            T L  + LG N L GSI   LG                                      
Sbjct: 638  TNLIWLDLGANDLTGSIPTILGRLKKLQRLHIAGNRLRGSIPNDLCHLKNLGYLHLSSNK 697

Query: 83   ---------SNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFS--------------- 117
                      +L +L++L LDSN L  +IP + W+L+D+L LN S               
Sbjct: 698  LSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNM 757

Query: 118  ---------------VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN 162
                            IP  +G   NL  L L  NRLQG IP  FGDL+SL+SL+LS+NN
Sbjct: 758  KSITTLDLSKNLVSGYIPRRMGEQQNLAKLSLSQNRLQGPIPVEFGDLVSLESLDLSQNN 817

Query: 163  LSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPC 222
            LSG IP SLE L+YLK LN+S NKL+GEIP GG F NF+AESF  NE LCG+P+ QV  C
Sbjct: 818  LSGTIPKSLEALIYLKYLNVSSNKLQGEIPNGGPFVNFTAESFMFNEALCGAPHFQVMAC 877

Query: 223  KTGIHHTS--SKNSLLLGIVLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMF 280
                   S  +K+ +L  I+LP+ +T  +VV +++   R+    +    +  +  T    
Sbjct: 878  DKNNRTQSWKTKSFILKYILLPVGSTITLVVFIVLWIRRRDNMEIPTPIDSWLPGTHEKI 937

Query: 281  SYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMM 340
            S+  L  AT  F E+NLI KG  G VYK  L +G+ VA+KVFNL+ + A +SFD ECE+M
Sbjct: 938  SHQRLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFDSECEVM 997

Query: 341  KSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 400
            + IRH+NL+++I+ CSN +FKALVL+YMP+GSLEK+LYS N  LD+ QRLNIMIDVASAL
Sbjct: 998  QGIRHRNLVRIITCCSNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASAL 1057

Query: 401  EYLH 404
            EYLH
Sbjct: 1058 EYLH 1061

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera]

 Score =  341 bits (874), Expect = 4e-91,   Method: Compositional matrix adjust.
 Identities = 209/484 (43%), Positives = 277/484 (57%), Gaps = 81/484 (16%)

Query: 1    LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
            + FL+SL+NCK L ++ +  NPL   LP + +GN+  +LE F    C   G I   I NL
Sbjct: 555  VGFLTSLTNCKFLRYLWIGYNPLKGTLPNS-LGNLPIALESFTAYACQFRGTIPTGIGNL 613

Query: 61   TKLTTIILGGNKLNGSISITLG-------------------------------------- 82
            T L  + LG N L GSI  TLG                                      
Sbjct: 614  TNLIWLDLGANDLTGSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLGLSSNK 673

Query: 83   ---------SNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFSV------IPIEIGGL 126
                      +L +LR+L LDSN L  +IP + W+L+D+L LN S       +P E+G +
Sbjct: 674  LSGSTPSCFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNM 733

Query: 127  PN---------------------LEYLF---LGYNRLQGSIPDSFGDLISLKSLNLSKNN 162
             +                     L+YL    L  NRLQG I   FGDL+SL+SL+LS NN
Sbjct: 734  KSITTLDLSKNLVSGYIPSRMGKLQYLITLSLSQNRLQGPIXVEFGDLVSLESLDLSHNN 793

Query: 163  LSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPC 222
            LSG IP SLE L+YLK LN+SFNKL+GEIP GG F  F+AESF  NE LCG+P+ QV  C
Sbjct: 794  LSGTIPKSLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMAC 853

Query: 223  KTGIHHTS--SKNSLLLGIVLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMF 280
                   S  +K+ +L  I+LP+ +T  +VV +++   R+    +    +  ++ T    
Sbjct: 854  DKNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPTPIDSWLLGTHEKI 913

Query: 281  SYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMM 340
            S+ +L  AT  F E+NLI KG  G VYK  L +G+ VA+KVFNL+ + A +SFD ECE+M
Sbjct: 914  SHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLNVAIKVFNLEFQGALRSFDSECEVM 973

Query: 341  KSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 400
            + IRH+NL+++I+ CSN +FKALVLEYMP+GSLEK+LYS N  LD+ QRLNIMIDVASAL
Sbjct: 974  QGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASAL 1033

Query: 401  EYLH 404
            EYLH
Sbjct: 1034 EYLH 1037

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	405
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.930	0.373	0.332	1.1e-44
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.977	0.392	0.308	1.1e-41
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.950	0.392	0.340	1.7e-41
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.980	0.387	0.302	2.2e-40
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.977	0.391	0.295	4.6e-40
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.975	0.385	0.327	1.6e-39
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.703	0.276	0.363	1.1e-37
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.916	0.456	0.314	2.3e-35
TAIR|locus:2097310	1002	BAM2 "BARELY ANY MERISTEM 2" [	0.958	0.387	0.295	1.1e-32
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.814	0.281	0.289	1.9e-32

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 480 (174.0 bits), Expect = 1.1e-44, P = 1.1e-44
 Identities = 140/421 (33%), Positives = 203/421 (48%)

Query:     7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGXXXXXXXXXXXXXX 66
             + N   L  +DLSNN  + ++P T +GN SH LE ++     ++G               
Sbjct:   429 IGNMTMLETLDLSNNGFEGIVP-TSLGNCSHLLELWIGDN-KLNGTIPLEIMKIQQLLRL 486

Query:    67 XXXXXKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGL 126
                   L GS+   +G+ L +L  LSL  N+L+                   +P  +G  
Sbjct:   487 DMSGNSLIGSLPQDIGA-LQNLGTLSLGDNKLSG-----------------KLPQTLGNC 528

Query:   127 PNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIPASXXXXXXXXXXXXSFNK 186
               +E LFL  N   G IPD  G L+             G+IP              SFN 
Sbjct:   529 LTMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNN 587

Query:   187 LEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVQPCKTGI-----HHTSSKNSLLLGI- 239
             LEG++P  G F N +  S  GN  LCG     Q++PC +        H+S    +++G+ 
Sbjct:   588 LEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVS 647

Query:   240 --VLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMFSYLELCRATYKFSENNL 297
               +  L   FM  V L+ LR R++ K  +N     +       SY +L  AT  FS +N+
Sbjct:   648 VGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNM 707

Query:   298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCS 356
             +  G FG+VYKA L  +   VAVKV N+Q R A KSF  ECE +K IRH+NL+K++++CS
Sbjct:   708 VGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACS 767

Query:   357 N-----EEFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYL 403
             +      EF+AL+ E+MP+GSL+ +L+             L + +RLNI IDVAS L+YL
Sbjct:   768 SIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYL 827

Query:   404 H 404
             H
Sbjct:   828 H 828

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 452 (164.2 bits), Expect = 1.1e-41, P = 1.1e-41
 Identities = 132/428 (30%), Positives = 218/428 (50%)

Query:     5 SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGXXXXXXXXXXXX 64
             +SL N   L  + L +N     +P +F+GN++  ++ + +S  +  G             
Sbjct:   404 TSLGNLVGLGELILFSNRFSGEIP-SFIGNLTQLVKLY-LSNNSFEGIVPPSLGDCSHML 461

Query:    65 XXXXXXXKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYL-----NFSV 118
                    KLNG+I   +   + +L  L+++SN L+ S+P     L++++ L     N S 
Sbjct:   462 DLQIGYNKLNGTIPKEI-MQIPTLVHLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSG 520

Query:   119 -IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIPASXXXXXXX 177
              +P  +G   ++E ++L  N   G+IPD  G L+             G+I          
Sbjct:   521 HLPQTLGKCLSMEVIYLQENHFDGTIPDIKG-LMGVKNVDLSNNNLSGSISEYFENFSKL 579

Query:   178 XXXXXSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVQPCKTGIHHTSSKN-SL 235
                  S N  EG +P  G F N +  S  GN+ LCGS   L+++PC        +++ SL
Sbjct:   580 EYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSL 639

Query:   236 LLGIVLPLSTTFMIVVILLIL-----RYRQRGKRLSNDANMPIVATWRMFSYLELCRATY 290
             L  + + +S    ++++L I+     + R+  ++++N A   +       SY +L  AT 
Sbjct:   640 LKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATD 699

Query:   291 KFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLI 349
              FS +N++  G FG+V+KA L  +   VAVKV N+Q R A KSF  ECE +K IRH+NL+
Sbjct:   700 GFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLV 759

Query:   350 KVISSCSN-----EEFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLNIMIDV 396
             K++++C++      EF+AL+ E+MP+GSL+K+L+             L + +RLNI IDV
Sbjct:   760 KLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDV 819

Query:   397 ASALEYLH 404
             AS L+YLH
Sbjct:   820 ASVLDYLH 827

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 450 (163.5 bits), Expect = 1.7e-41, P = 1.7e-41
 Identities = 141/414 (34%), Positives = 201/414 (48%)

Query:    13 LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGXXXXXXXXXXXXXXXXXXXK 72
             L  +D+S N L   +P +F GN+S  L   ++   ++SG                     
Sbjct:   371 LGLLDVSRNNLSGSIPDSF-GNLSQ-LRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNN 428

Query:    73 LNGSISITLGSNLASLRK-LSLDSNELTS-IPLTFWNLKDILYLNFSV------IPIEIG 124
             L G+I + + SNL +L+  L+L SN L+  IPL    +  +L ++ S       IP ++G
Sbjct:   429 LTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLG 488

Query:   125 GLPNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIPASXXXXXXXXXXXXSF 184
                 LE+L L  N    ++P S G L              GAIP S            SF
Sbjct:   489 SCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSF 548

Query:   185 NKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNSLLLGIVLPLS 244
             N L G +   GSF   + ESF G+ LLCGS    +Q CK    H     S+LL ++L L 
Sbjct:   549 NLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACKK--KHKYP--SVLLPVLLSLI 603

Query:   245 TTFMIVVILLILRYRQR-GKRLSNDANMPIV---------ATWRMFSYLELCRATYKFSE 294
              T ++ V    L  R R GK L+  A   +            +   SY +L  AT  F+ 
Sbjct:   604 ATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNA 663

Query:   295 NNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK-SFDIECEMMKSIRHQNLIKVIS 353
             ++LI  G FG VYK  L +  +VAVKV + +    F  SF  EC+++K  RH+NLI++I+
Sbjct:   664 SSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIIT 723

Query:   354 SCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLH 404
             +CS   F ALVL  MP+GSLE++LY    S+  LD+ Q +NI  DVA  + YLH
Sbjct:   724 TCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLH 777

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 440 (159.9 bits), Expect = 2.2e-40, P = 2.2e-40
 Identities = 128/423 (30%), Positives = 200/423 (47%)

Query:     2 SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGXXXXXXXXX 61
             S  SSL   K L  +    N L   +P   +GN++  L   ++     SG          
Sbjct:   415 SLPSSLGRLKNLGILLAYENNLSGSIPLA-IGNLTE-LNILLLGTNKFSGWIPYTLSNLT 472

Query:    62 XXXXXXXXXXKLNGSISITLGSNLASLR-KLSLDSNELT-SIPLTFWNLKDILYLNFSV- 118
                        L+G I   L  N+ +L   +++  N L  SIP    +LK+++  +    
Sbjct:   473 NLLSLGLSTNNLSGPIPSEL-FNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESN 531

Query:   119 -----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIPASXXX 173
                  IP  +G    L YL+L  N L GSIP + G L              G IP S   
Sbjct:   532 RLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLAD 591

Query:   174 XXXXXXXXXSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVQPCKTGIHHTSSK 232
                      SFN   GE+P  G+F   S  S +GN  LCG  P+L +  C   + +    
Sbjct:   592 ITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHF 651

Query:   233 NSLLLGIVLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMFSYLELCRATYKF 292
               L + + L  +   +  + LLI  +++  K   +  +M       + SY +L +AT  F
Sbjct:   652 PVLPISVSLAAALAILSSLYLLITWHKRTKKGAPSRTSMK---GHPLVSYSQLVKATDGF 708

Query:   293 SENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVI 352
             +  NL+  G FGSVYK +L     VAVKV  L+  +A KSF  ECE ++++RH+NL+K++
Sbjct:   709 APTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIV 768

Query:   353 SSCSN-----EEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALE 401
             + CS+      +FKA+V ++MP+GSLE +++      +    L++ +R+ I++DVA AL+
Sbjct:   769 TICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALD 828

Query:   402 YLH 404
             YLH
Sbjct:   829 YLH 831

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 437 (158.9 bits), Expect = 4.6e-40, P = 4.6e-40
 Identities = 127/430 (29%), Positives = 215/430 (50%)

Query:     5 SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGXXXXXXXXXXXX 64
             +SL     L  + L +N +   +P +F+GN++  LE   +S  +  G             
Sbjct:   404 TSLGKLLRLGLLSLYSNRMSGEIP-SFIGNLTQ-LEILYLSNNSFEGIVPPSLGKCSHML 461

Query:    65 XXXXXXXKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLN-----FSV 118
                    KLNG+I   +   + +L  LS++ N L+ S+P    +L++++ L+     FS 
Sbjct:   462 DLRIGYNKLNGTIPKEI-MQIPTLVNLSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSG 520

Query:   119 -IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIPASXXXXXXX 177
              +P  +G    +E LFL  N   G+IP+  G L+             G+IP         
Sbjct:   521 HLPQTLGNCLAMEQLFLQGNSFDGAIPNIRG-LMGVRRVDLSNNDLSGSIPEYFANFSKL 579

Query:   178 XXXXXSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVQPC-----KTGIHHTSS 231
                  S N   G++P  G+F N +     GN+ LCG   +L+++PC          H+S 
Sbjct:   580 EYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSH 639

Query:   232 KNSLLLGIVLPLSTTFMIVVILLIL---RYRQRGKRLSNDANMPIVATWRMFSYLELCRA 288
                + + + + ++   ++V+  ++L   R R++ ++ +N     +       SY +L  A
Sbjct:   640 LKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNA 699

Query:   289 TYKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQN 347
             T  FS +N++  G FG+V+KA L  +   VAVKV N+Q R A KSF  ECE +K  RH+N
Sbjct:   700 TNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRN 759

Query:   348 LIKVISSCSN-----EEFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLNIMI 394
             L+K++++C++      EF+AL+ EY+P+GS++ +L+             L + +RLNI+I
Sbjct:   760 LVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVI 819

Query:   395 DVASALEYLH 404
             DVAS L+YLH
Sbjct:   820 DVASVLDYLH 829

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 432 (157.1 bits), Expect = 1.6e-39, P = 1.6e-39
 Identities = 141/430 (32%), Positives = 199/430 (46%)

Query:     6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGXXXXXXXXXXXXX 65
             SL     L  + L +N L   +P + +GN+S  L +  +   +  G              
Sbjct:   420 SLGELSELRKVLLYSNGLSGEIPSS-LGNIS-GLTYLYLLNNSFEGSIPSSLGSCSYLLD 477

Query:    66 XXXXXXKLNGSISITLGS--NLASLR-KLSLDSNELTSI--PLTFWNLKDILYLNFS-VI 119
                   KLNGSI   L    +L  L    +L    L      L F    D+ Y   S  I
Sbjct:   478 LNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQI 537

Query:   120 PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIPASXXXXXXXXX 179
             P  +    +LE+L L  N   G IPD  G L              G IP           
Sbjct:   538 PQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQN 596

Query:   180 XXXSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVQPCKTGI--HHTSSKNSLL 236
                S N  +G +P  G F N SA S  GN  LCG  P+LQ+QPC   +   H+S +  + 
Sbjct:   597 LNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIIT 656

Query:   237 LGIVLPLSTTFMI---VVILLILRYRQRGKRLSNDAN----MPIVATWRMFSYLELCRAT 289
             + +   ++   ++   VV L   + R +  R +N+ N     P+ + +   SY EL + T
Sbjct:   657 ICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTT 716

Query:   290 YKFSENNLISKGGFGSVYKARLGD-GMEVAVKVFNLQCRR-AFKSFDIECEMMKSIRHQN 347
               FS +NLI  G FG+V+K  LG     VA+KV NL C+R A KSF  ECE +  IRH+N
Sbjct:   717 GGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL-CKRGAAKSFIAECEALGGIRHRN 775

Query:   348 LIKVISSCSNEEF-----KALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLNIMI 394
             L+K+++ CS+ +F     +ALV E+MP+G+L+ +L+             L +F RLNI I
Sbjct:   776 LVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAI 835

Query:   395 DVASALEYLH 404
             DVASAL YLH
Sbjct:   836 DVASALVYLH 845

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 415 (151.1 bits), Expect = 1.1e-37, P = 1.1e-37
 Identities = 113/311 (36%), Positives = 159/311 (51%)

Query:   119 IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIPASXXXXXXXX 178
             +P  IGG  ++E+LF+  N   G+IPD    L+             G IP          
Sbjct:   529 MPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLR 587

Query:   179 XXXXSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN-LQVQPCKTGIHHTSSK----- 232
                 S NK EG +P  G F N +A S  GN  +CG    +Q++PC         K     
Sbjct:   588 NLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVR 647

Query:   233 NSLLLGIVLPLSTTFMIVVILLILRYRQRGKRLS-NDANMPIVATWRMF----SYLELCR 287
               ++ GI + +++  +I+++  +  + +R K+ + +D N     T  MF    SY EL  
Sbjct:   648 KKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHS 707

Query:   288 ATYKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQ 346
             AT +FS  NLI  G FG+V+K  LG +   VAVKV NL    A KSF  ECE  K IRH+
Sbjct:   708 ATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHR 767

Query:   347 NLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLNIM 393
             NL+K+I+ CS+      +F+ALV E+MP GSL+ +L   +          L   ++LNI 
Sbjct:   768 NLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIA 827

Query:   394 IDVASALEYLH 404
             IDVASALEYLH
Sbjct:   828 IDVASALEYLH 838

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 391 (142.7 bits), Expect = 2.3e-35, P = 2.3e-35
 Identities = 125/398 (31%), Positives = 181/398 (45%)

Query:     2 SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGXX-XXXXXX 60
             S  SS S  K L  + + NN L   LP T +GN++      V    N  GG         
Sbjct:   389 SLPSSFSKLKNLRRLTVDNNKLIGSLPLT-IGNLTQLTNMEVQF--NAFGGTIPSTLGNL 445

Query:    61 XXXXXXXXXXXKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDIL--YLNFS 117
                           G I I + S  A    L +  N L  SIP     LK+I+  + + +
Sbjct:   446 TKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHADSN 505

Query:   118 VI----PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIPASXXX 173
              +    P  IG    L++LFL  N L GSIP +   L              G IP S   
Sbjct:   506 KLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMSLGD 565

Query:   174 XXXXXXXXXSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVQPCKTGIHHTSSK 232
                      SFN   GE+P  G F N S    +GN  +CG  P L +  C          
Sbjct:   566 MPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKKKKH 625

Query:   233 NSLLLGIVLPLSTTFMIVVILLILR--YRQRGKRLSNDANMPIVATWRMFSYLELCRATY 290
               LLL +V+ L +T  +  +L +L   +++R K +    +M       M +Y +L +AT 
Sbjct:   626 QILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTSMQ---GHPMITYKQLVKATD 682

Query:   291 KFSENNLISKGGFGSVYKARLG--DG---MEVAVKVFNLQCRRAFKSFDIECEMMKSIRH 345
              FS ++L+  G FGSVYK      DG     VAV+V  L+  +A KSF  ECE +++ RH
Sbjct:   683 GFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRNTRH 742

Query:   346 QNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLY 378
             +NL+K+++ CS+      +FKA+V ++MP+GSLE +L+
Sbjct:   743 RNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLH 780

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 368 (134.6 bits), Expect = 1.1e-32, P = 1.1e-32
 Identities = 125/423 (29%), Positives = 186/423 (43%)

Query:     2 SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHS-LEF---FVMSYCNISGGXXXXX 57
             S   SL  C+ LT I +  N L+  +PK   G    S +E    ++     ISGG     
Sbjct:   398 SIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGD 457

Query:    58 XXXXXXXXXXXXXXKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNF 116
                           +L+GS+   +G NL+ ++KL LD N+ + SIP     L+ +  L+F
Sbjct:   458 LGQISLSNN-----QLSGSLPAAIG-NLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDF 511

Query:   117 S-------VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIPA 169
             S       + P EI     L ++ L  N L G IP+    +              G+IP 
Sbjct:   512 SHNLFSGRIAP-EISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPV 570

Query:   170 SXXXXXXXXXXXXSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHT 229
             +            S+N L G +P  G F  F+  SF GN  LCG P L   PC  G H +
Sbjct:   571 TIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCG-PYLG--PCGKGTHQS 627

Query:   230 SSKN-SLLLGIVLPLSTTFMIVVILLILRYRQRGKRLSNDANMPIVATWRMFSYLEL--- 285
               K  S    ++L L   F  +V  ++   + R  R +++A       WR+ ++  L   
Sbjct:   628 HVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAK-----AWRLTAFQRLDFT 682

Query:   286 CRATY-KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKS--FDIECEMMKS 342
             C        E+N+I KGG G VYK  +  G  VAVK        +     F+ E + +  
Sbjct:   683 CDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGR 742

Query:   343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALE 401
             IRH+++++++  CSN E   LV EYMP+GSL + L+      L    R  I ++ A  L 
Sbjct:   743 IRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGLC 802

Query:   402 YLH 404
             YLH
Sbjct:   803 YLH 805

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 367 (134.2 bits), Expect = 1.9e-32, P = 1.9e-32
 Identities = 102/352 (28%), Positives = 181/352 (51%)

Query:    73 LNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFSV------IPIEI-G 124
             L G+I   LG  L  ++++ L +N  + SIP +    K++  L+FS       IP E+  
Sbjct:   637 LTGTIPKELGK-LEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQ 695

Query:   125 GLPNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIPASXXXXXXXXXXXXSF 184
             G+  +  L L  N   G IP SFG++              G IP S            + 
Sbjct:   696 GMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLAS 755

Query:   185 NKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPC--KTGIHHTSSKNSLLLGIVLP 242
             N L+G +P  G F N +A    GN  LCGS    ++PC  K    H S +  ++L I+  
Sbjct:   756 NNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILIILGS 814

Query:   243 LSTTFMIVVILLILRY-RQRGKRLSN--DANMPIVAT---WRMFSYLELCRATYKFSENN 296
              +   ++++++LIL   +++ K++ N  ++++P + +    + F   EL +AT  F+  N
Sbjct:   815 AAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSAN 874

Query:   297 LISKGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVIS- 353
             +I      +VYK +L DG  +AVKV NL+     + K F  E + +  ++H+NL+K++  
Sbjct:   875 IIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGF 934

Query:   354 SCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLH 404
             +  + + KALVL +M +G+LE  ++ S   I  + +++++ + +AS ++YLH
Sbjct:   935 AWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLH 986

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	405
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-31
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-21
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-20
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-20
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-19
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-19
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-18
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-17
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-17
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-14
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-11
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-11
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-10
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-10
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-09
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-08
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-08
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-08
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-08
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-08
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-08
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-07
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-07
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-07
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-07
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-07
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-06
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-06
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-06
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-06
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-06
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-06
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-06
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-06
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-06
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-06
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-06
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-06
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-06
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-05
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-05
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-05
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-05
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-05
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-05
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-05
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-05
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-05
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-05
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-05
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-05
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-05
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-05
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-05
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-05
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-04
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-04
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-04
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-04
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-04
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-04
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-04
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-04
PRK15370	754	PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl	3e-04
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-04
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-04
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-04
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-04
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-04
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-04
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	0.001
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	0.001
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	0.001
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	0.001
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	0.002
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	0.002
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.002
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	0.002
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.003
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	0.003
COG5238	388	COG5238, RNA1, Ran GTPase-activating protein (RanG	0.003
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	0.003
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	0.003
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	0.003
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	0.003
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.004
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	0.004
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	0.004
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  126 bits (319), Expect = 2e-31
 Identities = 116/422 (27%), Positives = 184/422 (43%), Gaps = 46/422 (10%)

Query: 6   SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTT 65
           SL  C+ L  + L +N     LP  F       + F  +S  N+ G I     ++  L  
Sbjct: 399 SLGACRSLRRVRLQDNSFSGELPSEFTK--LPLVYFLDISNNNLQGRINSRKWDMPSLQM 456

Query: 66  IILGGNKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFS------V 118
           + L  NK  G +  + GS    L  L L  N+ + ++P    +L +++ L  S       
Sbjct: 457 LSLARNKFFGGLPDSFGSK--RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGE 514

Query: 119 IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLK 178
           IP E+     L  L L +N+L G IP SF ++  L  L+LS+N LSG IP +L  +  L 
Sbjct: 515 IPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLV 574

Query: 179 DLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQ-VQPCKTGIHHTSSKNSLLL 237
            +N+S N L G +P  G+F   +A +  GN  LCG      + PCK        K     
Sbjct: 575 QVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR-----KTPSWW 629

Query: 238 GIVLPLSTTFMIVVILLILRYRQRG------KRLSNDANMPIVATWRMFSYLELCRATY- 290
             +      F+++ ++       RG      KR+ N+       TW +  +      +  
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENED-----GTWELQFFDSKVSKSIT 684

Query: 291 ------KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSF-DIECEMMKS 342
                    E N+IS+G  G+ YK + + +GM+  VK  N        S    E   M  
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-----DVNSIPSSEIADMGK 739

Query: 343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 402
           ++H N++K+I  C +E+   L+ EY+   +L + L +    L   +R  I I +A AL +
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRF 795

Query: 403 LH 404
           LH
Sbjct: 796 LH 797

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 99.6 bits (249), Expect = 2e-24
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 2/109 (1%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQ-CRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           + +GGFG+VY AR    G +VA+K+   +      +    E E++K + H N++K+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +E    LV+EY   GSL+  L  +   L   + L I++ +   LEYLH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH 109

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  102 bits (256), Expect = 2e-23
 Identities = 69/183 (37%), Positives = 95/183 (51%), Gaps = 22/183 (12%)

Query: 10  CKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILG 69
              L +++LSNN     +P+  + N    LE   +S   +SG I  +I + + L  + LG
Sbjct: 117 SSSLRYLNLSNNNFTGSIPRGSIPN----LETLDLSNNMLSGEIPNDIGSFSSLKVLDLG 172

Query: 70  GNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNL 129
           GN L G I  +L  NL SL  L+L SN+L                    IP E+G + +L
Sbjct: 173 GNVLVGKIPNSLT-NLTSLEFLTLASNQLVG-----------------QIPRELGQMKSL 214

Query: 130 EYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEG 189
           ++++LGYN L G IP   G L SL  L+L  NNL+G IP+SL  L  L+ L L  NKL G
Sbjct: 215 KWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSG 274

Query: 190 EIP 192
            IP
Sbjct: 275 PIP 277

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 94.5 bits (235), Expect = 8e-21
 Identities = 75/196 (38%), Positives = 105/196 (53%), Gaps = 10/196 (5%)

Query: 6   SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTT 65
           SL+N   L F+ L++N L   +P+  +G +  SL++  + Y N+SG I  EI  LT L  
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRE-LGQMK-SLKWIYLGYNNLSGEIPYEIGGLTSLNH 240

Query: 66  IILGGNKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFS------V 118
           + L  N L G I  +LG NL +L+ L L  N+L+  IP + ++L+ ++ L+ S       
Sbjct: 241 LDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299

Query: 119 IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLK 178
           IP  +  L NLE L L  N   G IP +   L  L+ L L  N  SG IP +L K   L 
Sbjct: 300 IPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT 359

Query: 179 DLNLSFNKLEGEIPRG 194
            L+LS N L GEIP G
Sbjct: 360 VLDLSTNNLTGEIPEG 375

Length = 968

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 87.9 bits (219), Expect = 8e-20
 Identities = 35/114 (30%), Positives = 52/114 (45%), Gaps = 12/114 (10%)

Query: 300 KGGFGSVYKARL-----GDGMEVAVKVFNLQC----RRAFKSFDIECEMMKSIRHQNLIK 350
           +G FG VYK  L     G   +VAVK          R  F     E  +MK + H N+++
Sbjct: 9   EGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLE---EASIMKKLSHPNIVR 65

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           ++  C+  E   +V EYMP G L  +L      L +   L + + +A  +EYL 
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 88.0 bits (219), Expect = 8e-20
 Identities = 35/116 (30%), Positives = 57/116 (49%), Gaps = 6/116 (5%)

Query: 295 NNLISKGGFGSVYKARLGD-----GMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNL 348
              + +G FG VYK +L        +EVAVK        +  + F  E  +M+ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +K++  C+ EE   +V+EYM  G L  YL  +   L +   L+  + +A  +EYL 
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 86.4 bits (215), Expect = 2e-19
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 3/111 (2%)

Query: 296 NLISKGGFGSVYKAR-LGDGMEVAVKVFNLQ-CRRAFKSFDIECEMMKSIRHQNLIKVIS 353
             + +G FG VY AR    G  VA+KV   +  ++  +    E +++K ++H N++++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 354 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
              +E+   LV+EY   G L   L      L   +    +  + SALEYLH
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH 114

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 86.2 bits (214), Expect = 4e-19
 Identities = 35/112 (31%), Positives = 55/112 (49%), Gaps = 8/112 (7%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI----ECEMMKSIRHQNLIKVI 352
           +  G FG+VYKA+  G G  VAVK+     R      D     E  +++ + H N++++I
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKK--RSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  +++   LV+EY   G L  YL S    L   +   I + +   LEYLH
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLH 115

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 84.9 bits (211), Expect = 8e-19
 Identities = 36/117 (30%), Positives = 57/117 (48%), Gaps = 7/117 (5%)

Query: 295 NNLISKGGFGSVYKARLGDG-----MEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNL 348
              + +G FG VYK  L        +EVAVK        +  + F  E  +M+ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLH 404
           +K++  C+ EE   +V+EYMP G L  YL  +    L +   L+  + +A  +EYL 
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 86.4 bits (214), Expect = 4e-18
 Identities = 60/150 (40%), Positives = 83/150 (55%), Gaps = 5/150 (3%)

Query: 48  NISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFW 106
           NISG I   I  L  + TI L  N+L+G I   + +  +SLR L+L +N  T SIP    
Sbjct: 80  NISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSI 139

Query: 107 NLKDILYLNFSV----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN 162
              + L L+ ++    IP +IG   +L+ L LG N L G IP+S  +L SL+ L L+ N 
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199

Query: 163 LSGAIPASLEKLLYLKDLNLSFNKLEGEIP 192
           L G IP  L ++  LK + L +N L GEIP
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIP 229

Length = 968

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 81.0 bits (201), Expect = 2e-17
 Identities = 41/125 (32%), Positives = 59/125 (47%), Gaps = 19/125 (15%)

Query: 296 NLISKGGFGSVYKARL----GDGMEVAVKV----FNLQCRRAFKSFDIECEMMKSIRHQN 347
             + +G FG VYK +L    G   EVAVK      + + R+ F     E  +MK + H N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLK---EARVMKKLGHPN 57

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLNIMIDVASA 399
           +++++  C+ EE   LVLEYM  G L  YL  S           L +   L+  I +A  
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 400 LEYLH 404
           +EYL 
Sbjct: 118 MEYLA 122

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 82.9 bits (205), Expect = 4e-17
 Identities = 51/146 (34%), Positives = 82/146 (56%), Gaps = 9/146 (6%)

Query: 118 VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYL 177
            IP +I  L +L+ + L  N ++G+IP S G + SL+ L+LS N+ +G+IP SL +L  L
Sbjct: 433 FIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSL 492

Query: 178 KDLNLSFNKLEGEIPR--GGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNSL 235
           + LNL+ N L G +P   GG   + ++ +F  N  LCG P L  + C  G H +      
Sbjct: 493 RILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RAC--GPHLSVGAK-- 546

Query: 236 LLGIVLPLSTTFMIVVILLILRYRQR 261
            +GI   +S  F+ +VI  +  +++R
Sbjct: 547 -IGIAFGVSVAFLFLVICAMCWWKRR 571

Length = 623

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 9/112 (8%)

Query: 297 LISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAF-----KSFDIECEMMKSIRHQNLIKV 351
            I KG FG VYK  L    EVAVK     CR        + F  E E++K   H N++K+
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKT----CRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57

Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           I  C  ++   +V+E +P GSL  +L      L + + L + +D A+ +EYL
Sbjct: 58  IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL 109

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 71.8 bits (177), Expect = 3e-14
 Identities = 35/125 (28%), Positives = 55/125 (44%), Gaps = 18/125 (14%)

Query: 291 KFSENNLISKGGFGSVYKARLGD-GMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQN 347
           +++   L+ +G FGSVY A   D G  +AVK   L        ++ + E  ++ S++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 348 LIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNI------MIDVASA 399
           +++   S  +EE   L   LEY+  GSL   L         F +L           +   
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-------FGKLPEPVIRKYTRQILEG 113

Query: 400 LEYLH 404
           L YLH
Sbjct: 114 LAYLH 118

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 39/131 (29%), Positives = 58/131 (44%), Gaps = 23/131 (17%)

Query: 298 ISKGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIK 350
           + +G FG V+           D   VAVK         A K F+ E E++ + +H+N++K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYS------------SNCI-LDIFQRLNIMIDVA 397
               C+  +   +V EYM HG L K+L S            S    L + Q L I + +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 398 SALEYL---HF 405
           S + YL   HF
Sbjct: 133 SGMVYLASQHF 143

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 67.6 bits (165), Expect = 5e-12
 Identities = 66/209 (31%), Positives = 94/209 (44%), Gaps = 16/209 (7%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
           L  +DL  N L   +P +  GN+  +L++  +    +SG I   I +L KL ++ L  N 
Sbjct: 238 LNHLDLVYNNLTGPIPSSL-GNLK-NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNS 295

Query: 73  LNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYL-----NFS-VIPIEIGG 125
           L+G I   L   L +L  L L SN  T  IP+   +L  +  L      FS  IP  +G 
Sbjct: 296 LSGEIP-ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK 354

Query: 126 LPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFN 185
             NL  L L  N L G IP+      +L  L L  N+L G IP SL     L+ + L  N
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414

Query: 186 KLEGEIPRGGS------FGNFSAESFEGN 208
              GE+P   +      F + S  + +G 
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGR 443

Length = 968

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 31/117 (26%), Positives = 56/117 (47%), Gaps = 8/117 (6%)

Query: 296 NLISKGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKS-FDIECEMMKSIRHQNLI 349
             + +G FG V   R        G +VAVK  N       +S F+ E E+++++ H+N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 350 KVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           K    C     ++  L++EY+P GSL  YL      +++ + L     +   ++YL 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 63/195 (32%), Positives = 90/195 (46%), Gaps = 12/195 (6%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSH-SLEFFVMSYCNISGGILEEITNLTKL 63
           SSL N K L ++ L  N L   +P +        SL+    S  ++SG I E +  L  L
Sbjct: 254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL---SDNSLSGEIPELVIQLQNL 310

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFSV---- 118
             + L  N   G I + L S L  L+ L L SN+ +  IP       ++  L+ S     
Sbjct: 311 EILHLFSNNFTGKIPVALTS-LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT 369

Query: 119 --IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
             IP  +    NL  L L  N L+G IP S G   SL+ + L  N+ SG +P+   KL  
Sbjct: 370 GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL 429

Query: 177 LKDLNLSFNKLEGEI 191
           +  L++S N L+G I
Sbjct: 430 VYFLDISNNNLQGRI 444

Length = 968

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 62.6 bits (153), Expect = 3e-11
 Identities = 39/108 (36%), Positives = 59/108 (54%), Gaps = 1/108 (0%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCS 356
           I KGGFG VYKAR    G EVA+KV  L+ +   +    E +++K  +H N++K   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 357 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            ++   +V+E+   GSL+  L S+N  L   Q   +  ++   LEYLH
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 62.2 bits (152), Expect = 8e-11
 Identities = 33/108 (30%), Positives = 51/108 (47%), Gaps = 2/108 (1%)

Query: 298 ISKGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCS 356
           I +G  G VYKA     G EVA+K   L+ +   +    E  +MK  +H N++    S  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 357 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             +   +V+EYM  GSL   +  +   ++  Q   +  +V   LEYLH
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH 133

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 62.2 bits (151), Expect = 3e-10
 Identities = 59/194 (30%), Positives = 93/194 (47%), Gaps = 10/194 (5%)

Query: 6   SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTT 65
           S+ + + L  +DLS+N L   +P+  +     +LE   +   N +G I   +T+L +L  
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEIPELVIQ--LQNLEILHLFSNNFTGKIPVALTSLPRLQV 336

Query: 66  IILGGNKLNGSISITLGSNLASLRKLSLDSNELTS-IPLTFWN----LKDILYLNF--SV 118
           + L  NK +G I   LG +  +L  L L +N LT  IP    +     K IL+ N     
Sbjct: 337 LQLWSNKFSGEIPKNLGKH-NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGE 395

Query: 119 IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLK 178
           IP  +G   +L  + L  N   G +P  F  L  +  L++S NNL G I +    +  L+
Sbjct: 396 IPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ 455

Query: 179 DLNLSFNKLEGEIP 192
            L+L+ NK  G +P
Sbjct: 456 MLSLARNKFFGGLP 469

Length = 968

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 37/124 (29%), Positives = 58/124 (46%), Gaps = 17/124 (13%)

Query: 297 LISKGGFGSVYKARL----GDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIK 350
           ++ +G FGSV + +L    G  ++VAVK   L        + F  E   MK   H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 351 VISSC----SNEEFKA--LVLEYMPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASA 399
           +I  C    S ++     ++L +M HG L  +L  S        L +   L  M+D+A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 400 LEYL 403
           +EYL
Sbjct: 126 MEYL 129

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 40/111 (36%), Positives = 58/111 (52%), Gaps = 9/111 (8%)

Query: 297 LISKGGFGSVYKARLGD--GMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVIS 353
            I KG FG V    LGD  G +VAVK   L+    A ++F  E  +M ++RH NL++++ 
Sbjct: 13  TIGKGEFGDVM---LGDYRGQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 354 SCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYL 403
                    +V EYM  GSL  YL S    ++ + Q+L   +DV   +EYL
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 36/123 (29%), Positives = 59/123 (47%), Gaps = 16/123 (13%)

Query: 291 KFSENNLISKGGFGSVYKA-RLGDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQN 347
            +   +LI +G FG VYK   L  G  VA+K  +L+     A KS   E +++K+++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALE 401
           ++K I S    +   ++LEY  +GSL + +            + ++Q       V   L 
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------VLQGLA 113

Query: 402 YLH 404
           YLH
Sbjct: 114 YLH 116

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 8/107 (7%)

Query: 301 GGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF 360
           G FG V+        +VAVK        + ++F  E ++MK +RH  L+++ + CS EE 
Sbjct: 17  GQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP 75

Query: 361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID----VASALEYL 403
             +V EYM  GSL  +L S         RL  ++D    +A  + YL
Sbjct: 76  IYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYL 119

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 33/122 (27%), Positives = 59/122 (48%), Gaps = 5/122 (4%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKS 342
           E+ R     +  + +  G +G VY+       + VAVK          + F  E  +MK 
Sbjct: 2   EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKE 58

Query: 343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALE 401
           I+H NL++++  C+ E    ++ E+M +G+L  YL   N   ++    L +   ++SA+E
Sbjct: 59  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118

Query: 402 YL 403
           YL
Sbjct: 119 YL 120

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 33/108 (30%), Positives = 51/108 (47%), Gaps = 1/108 (0%)

Query: 297 LISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK-SFDIECEMMKSIRHQNLIKVISSC 355
           L+ KG FG V+K  L D   VAVK       +  K  F  E  ++K   H N++K+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           +  +   +V+E +P G    +L      L   Q +   +D A+ + YL
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL 109

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 56.7 bits (137), Expect = 3e-09
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 2/104 (1%)

Query: 301 GGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF 360
           G FG V++    +   VAVK          K F  E ++MK +RH  LI++ + C+ EE 
Sbjct: 17  GQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTLEEP 75

Query: 361 KALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYL 403
             +V E M +GSL +YL       L + Q +++   VAS + YL
Sbjct: 76  IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 38/131 (29%), Positives = 57/131 (43%), Gaps = 23/131 (17%)

Query: 298 ISKGGFGSVYKARLG------DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKV 351
           + +G FG V+ A         D M VAVK        A + F  E E++  ++HQ++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNC---ILD-----------IFQRLNIMIDVA 397
              C+      +V EYM HG L ++L S      IL            + Q L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 398 SALEY---LHF 405
           S + Y   LHF
Sbjct: 133 SGMVYLASLHF 143

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 38/132 (28%), Positives = 60/132 (45%), Gaps = 24/132 (18%)

Query: 298 ISKGGFGSVYKAR------LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKV 351
           + +G FG V+ A         D M VAVK        A K F  E E++ +++H++++K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYS---------------SNCILDIFQRLNIMIDV 396
              C + +   +V EYM HG L K+L +               +   L + Q L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 397 ASALEYL---HF 405
           AS + YL   HF
Sbjct: 133 ASGMVYLASQHF 144

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 31/118 (26%), Positives = 57/118 (48%), Gaps = 1/118 (0%)

Query: 287 RATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQ 346
           R   +F+    +  G FG V++    + + VA+K+         + F  E + +K +RH+
Sbjct: 3   RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHK 62

Query: 347 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYL 403
           +LI + + CS  E   ++ E M  GSL  +L S    +L +   +++   VA  + YL
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 9/186 (4%)

Query: 11  KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGG 70
             L  +DL +    S L  +        L    ++   +   I E +  LT LT++ L  
Sbjct: 67  SRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDN 125

Query: 71  NKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS-----VIPIEIGG 125
           N +   I   +G   ++L++L L  N++ S+P    NL ++  L+ S      +P  +  
Sbjct: 126 NNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSN 184

Query: 126 LPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFN 185
           L NL  L L  N++   +P     L +L+ L+LS N++   + +SL  L  L  L LS N
Sbjct: 185 LSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNN 242

Query: 186 KLEGEI 191
           KLE   
Sbjct: 243 KLEDLP 248

Length = 394

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 55.9 bits (133), Expect = 1e-08
 Identities = 38/114 (33%), Positives = 57/114 (50%), Gaps = 8/114 (7%)

Query: 297 LISKGGFGSVYKARLGDGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQ-NLIKVI 352
            + +G FG VY AR  D   VA+KV   +     +  + F  E +++ S+ H  N++K+ 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLH 404
               +E    LV+EY+  GSLE  L        L   + L I+  + SALEYLH
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Length = 384

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 35/120 (29%), Positives = 54/120 (45%), Gaps = 8/120 (6%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDIECEMMKSIRHQN 347
           Y+  E  +I  G    VY A  L +  +VA+K  +L +C+ +      E + M    H N
Sbjct: 3   YELIE--VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           ++K  +S    +   LV+ Y+  GSL    K  Y     LD      ++ +V   LEYLH
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRG-GLDEAIIATVLKEVLKGLEYLH 119

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 54.8 bits (133), Expect = 2e-08
 Identities = 34/124 (27%), Positives = 51/124 (41%), Gaps = 14/124 (11%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC------RRAFKSFDIECEMMKSI 343
           K+     I KG FG VY  R   DG    +K  +L          A      E +++K +
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKL 56

Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASAL 400
            H N+IK   S   +    +V+EY   G L + +         F   Q L+  + +  AL
Sbjct: 57  NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 401 EYLH 404
           +YLH
Sbjct: 117 KYLH 120

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 37/145 (25%), Positives = 67/145 (46%), Gaps = 30/145 (20%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARL-GDGME-----VAVKVF----NLQCRRAFKSF 333
           E+  +  +F E   + +G FG VYK  L G         VA+K        + ++ F+  
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ- 57

Query: 334 DIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 381
             E E+M  ++H N++ ++  C+ E+   ++ EY+ HG L ++L  ++            
Sbjct: 58  --EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115

Query: 382 ---CILDIFQRLNIMIDVASALEYL 403
                LD    L+I I +A+ +EYL
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYL 140

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 53.7 bits (130), Expect = 4e-08
 Identities = 34/116 (29%), Positives = 53/116 (45%), Gaps = 14/116 (12%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI----ECEMMKSIRHQNLIK-- 350
           I +G +G VYKAR    G  VA+K   ++  +  + F I    E ++++ +RH N+++  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 351 --VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             V S      +  +V EYM H  L   L S        Q    M  +   L+YLH
Sbjct: 65  EIVTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 29/109 (26%), Positives = 52/109 (47%), Gaps = 7/109 (6%)

Query: 301 GGFGSVYKAR---LGDG--MEVAVKVF-NLQCRRAFKSFDIECEMMKSIRHQNLIKVISS 354
           G FG+VYK      G+   + VA+KV       +A K    E  +M S+ H ++++++  
Sbjct: 18  GAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGI 77

Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           C + +   L+ + MP G L  Y+ +    +     LN  + +A  + YL
Sbjct: 78  CLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 10/112 (8%)

Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAF-----KSFDIECEMMKSIRHQNLIKV 351
           I +G FG V+  RL  D   VAVK     CR          F  E  ++K   H N++++
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 58

Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           I  C+ ++   +V+E +  G    +L +    L + + + ++ + A+ +EYL
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 9/115 (7%)

Query: 297 LISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIK- 350
            + KG FGSV   R   L D  G  VAVK          + F+ E E++KS++H N++K 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 351 --VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
             V  S      + LV+EY+P+GSL  YL      LD  + L     +   +EYL
Sbjct: 71  KGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 53.3 bits (128), Expect = 5e-08
 Identities = 38/127 (29%), Positives = 57/127 (44%), Gaps = 17/127 (13%)

Query: 296 NLISKGGFGSVYKAR----LGDGME---VAVKVFNL-QCRRAFKSFDIECEMMKSIRHQN 347
           N +  G FG VY+      LG G     VAVK        +  K F  E  +M +  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC------ILDIFQRLNIMIDVASALE 401
           ++K++  C   E + +++E M  G L  YL  +        +L + + L+I +DVA    
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 402 YL---HF 405
           YL   HF
Sbjct: 121 YLEQMHF 127

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 54.5 bits (131), Expect = 6e-08
 Identities = 41/100 (41%), Positives = 51/100 (51%), Gaps = 4/100 (4%)

Query: 119 IPIEIGGLPNLEYLFLGYNRLQGSIPDS-FGDLISLKSLNLSKNNLSGAIPASLEKLLYL 177
           I   I  LP ++ + L  N+L G IPD  F    SL+ LNLS NN +G+IP      L  
Sbjct: 85  ISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLE- 143

Query: 178 KDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSPN 216
             L+LS N L GEIP   GSF +       GN L+   PN
Sbjct: 144 -TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182

Length = 968

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 47.9 bits (115), Expect = 1e-07
 Identities = 25/60 (41%), Positives = 33/60 (55%)

Query: 128 NLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKL 187
           NL+ L L  NRL      +F  L +LK L+LS NNL+   P +   L  L+ L+LS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 40/110 (36%), Positives = 56/110 (50%), Gaps = 9/110 (8%)

Query: 298 ISKGGFGSVYKARLGD--GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           I KG FG V    LGD  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 14  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 356 SNEEFKA-LVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYL 403
             E+    +V EYM  GSL  YL S    +L     L   +DV  A+EYL
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 40/129 (31%), Positives = 60/129 (46%), Gaps = 17/129 (13%)

Query: 292 FSENNLISKGGFGSVYKARL----GDGMEVAVKVF--NLQCRRAFKSFDIECEMMKSIRH 345
           F+   ++ KG FGSV +A+L    G   +VAVK+   ++      + F  E   MK   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 346 QNLIKVISSCSNEEFKA------LVLEYMPHGSLEKYLYSSNC-----ILDIFQRLNIMI 394
            N+IK+I        K       ++L +M HG L  +L  S        L +   +  MI
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 395 DVASALEYL 403
           D+AS +EYL
Sbjct: 121 DIASGMEYL 129

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 46.8 bits (112), Expect = 3e-07
 Identities = 29/77 (37%), Positives = 37/77 (48%), Gaps = 17/77 (22%)

Query: 87  SLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDS 146
           +L+ L L +N LT IP                      GLPNL+ L L  N L    P++
Sbjct: 1   NLKSLDLSNNRLTVIPDGA-----------------FKGLPNLKVLDLSGNNLTSISPEA 43

Query: 147 FGDLISLKSLNLSKNNL 163
           F  L SL+SL+LS NNL
Sbjct: 44  FSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 51.0 bits (123), Expect = 3e-07
 Identities = 38/122 (31%), Positives = 59/122 (48%), Gaps = 12/122 (9%)

Query: 290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFN---LQCRRAFKSFDIECE-MMKSIR 344
           +KF +  +I +G F +V  A+      E A+K+ +   L   +  K   IE E + +   
Sbjct: 3   FKFGK--IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 345 HQNLIKVISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEY 402
           H  +IK+  +  +EE    VLEY P+G L +Y+  Y S   LD         ++  ALEY
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEY 117

Query: 403 LH 404
           LH
Sbjct: 118 LH 119

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 35/118 (29%), Positives = 50/118 (42%), Gaps = 21/118 (17%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCS 356
           I  G +G VYKAR +  G  VA+KV  L+    F+    E  M+K  RH N++    S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 357 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN----------IMIDVASALEYLH 404
             +   +V+EY   GSL+          DI+Q             +  +    L YLH
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 30/106 (28%), Positives = 52/106 (49%), Gaps = 1/106 (0%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           +  G FG V+  +    ++VA+K+   +   +   F  E ++M  + H NL+++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 358 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           +    +V EYM +G L  YL      L     L++  DV  A+EYL
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL 116

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 34/114 (29%), Positives = 54/114 (47%), Gaps = 7/114 (6%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVA---VKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVIS 353
           I KG F  VYKA  L DG  VA   V++F +   +A +    E +++K + H N+IK ++
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 354 SCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           S        +VLE    G L    K+      ++         + + SALE++H
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.9 bits (119), Expect = 8e-07
 Identities = 35/115 (30%), Positives = 55/115 (47%), Gaps = 10/115 (8%)

Query: 298 ISKGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKS-FDIECEMMKSIRHQNLIKV 351
           + +G FG V          G G  VAVK    +C +   S +  E  ++K++ H+N++K 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 352 ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
              CS +  K   L++EY+P GSL  YL      L++ Q L     +   + YLH
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH 124

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 6/86 (6%)

Query: 298 ISKGGFGSVYKARL------GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKV 351
           + +G FG V+ A         D + VAVK        A K F  E E++ +++H++++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYL 377
              C   +   +V EYM HG L K+L
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFL 98

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 28/89 (31%), Positives = 42/89 (47%), Gaps = 8/89 (8%)

Query: 297 LISKGGFGSVYKARLGD------GMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNL 348
            + +G FG V KA             VAVK+       +       E EMMK I +H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYL 377
           I ++  C+ E    +V+EY  HG+L  +L
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFL 107

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 7/114 (6%)

Query: 297 LISKGGFGSVYKARLGD-GMEVAVKVFNL-----QCRRAFKSFDIECEMMKSIRHQNLIK 350
           L+ +G FG VY     D G E+AVK         + ++   + + E +++K+++H+ +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
                 ++E  ++ +EYMP GS++  L +   + +   R      +   +EYLH
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH 121

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 33/114 (28%), Positives = 51/114 (44%), Gaps = 7/114 (6%)

Query: 297 LISKGGFGSVYKA-RLGDGMEVAVKVFNL-----QCRRAFKSFDIECEMMKSIRHQNLIK 350
           L+  G FGSVY+   L DG   AVK  +L       + A K  + E  ++  ++H N+++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            + +   E+   + LE +P GSL K L                  +   LEYLH
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH 119

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 30/115 (26%), Positives = 51/115 (44%), Gaps = 6/115 (5%)

Query: 295 NNLISKGGFGSVYKA----RLGDGMEVAVKVFNLQCRRAFKS-FDIECEMMKSIRHQNLI 349
              I +G FG VY+        + + VAVK        + +  F  E  +M+   H +++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           K+I   + E    +V+E  P G L  YL  +   LD+   +     +++AL YL 
Sbjct: 71  KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 34/128 (26%), Positives = 58/128 (45%), Gaps = 20/128 (15%)

Query: 296 NLISKGGFGSVYKARL---GDGMEVAVKVFN-LQCRRAFKSFDIECEMM-KSIRHQNLIK 350
           ++I +G FG V +A +   G  M  A+K+          + F  E E++ K   H N+I 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 395
           ++ +C N  +  + +EY P+G+L  +L  S  +               L   Q L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 396 VASALEYL 403
           VA+ ++YL
Sbjct: 128 VATGMQYL 135

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 32/107 (29%), Positives = 58/107 (54%), Gaps = 5/107 (4%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           I +G FG+V +     G +VAVK  N++C    ++F  E  +M  + H+NL++++    +
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 358 EEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYL 403
                +V+E M  G+L  +L +    ++ + Q L   +DVA  +EYL
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 30/109 (27%), Positives = 46/109 (42%), Gaps = 7/109 (6%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKS---FDIECEMMKSIRHQNLIKVISS 354
           I  G FG V+     +  +VA+K      R    S   F  E ++M  + H  L+++   
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           C+      LV E+M HG L  YL +          L + +DV   + YL
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL 116

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 35/116 (30%), Positives = 59/116 (50%), Gaps = 5/116 (4%)

Query: 291 KFSENNLISKGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDI-ECEMMKSIRHQNL 348
           K++    I +G  G+VY A  +  G EVA+K  NLQ ++  K   I E  +M+  +H N+
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNI 78

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +  + S    +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH 132

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 38/125 (30%), Positives = 56/125 (44%), Gaps = 22/125 (17%)

Query: 300 KGGFGSVYKA----RLGDG--MEVAVKVFNLQCRRAFKS-FDIECEMMKSIRHQNLIKVI 352
            G FG VY+     R GD   ++VAVK     C    +S F +E  +M    HQN++++I
Sbjct: 16  HGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLI 75

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYLY---------SSNCILDIFQRLNIMIDVASALEYL 403
                   + ++LE M  G L+ +L          SS  + D+   L    DVA   +YL
Sbjct: 76  GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL---LFCARDVAKGCKYL 132

Query: 404 ---HF 405
              HF
Sbjct: 133 EENHF 137

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 28/116 (24%), Positives = 59/116 (50%), Gaps = 5/116 (4%)

Query: 293 SENNLISKGGFGSVYKA--RLGDGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQN 347
           ++  +I  G FG V++   ++    EVAV +  L+     +  + F  E  +M    H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           +I++    +  +   ++ EYM +G+L+KYL   +     +Q + ++  +A+ ++YL
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 48.0 bits (115), Expect = 3e-06
 Identities = 31/113 (27%), Positives = 52/113 (46%), Gaps = 9/113 (7%)

Query: 298 ISKGGFGSVYKAR---LGDGMEVAVKVFN---LQCRRAFKSFDIECEMMKSIRHQNLIKV 351
           ISKG +G V+ A+    GD    A+KV     +  +        E +++   +   ++K+
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             S   ++   LV+EY+P G L   L +    LD       + ++  ALEYLH
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH 110

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 16/122 (13%)

Query: 298 ISKGGFGSVYKARLGDG---MEVAVKVFNLQ-CRRA-FKSFDIECEMMKSIRHQNLIKVI 352
           + +G FGSV + +L      ++VAVK   +  C R+  + F  E   MK   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 353 SSC----SNEEFKA--LVLEYMPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASALE 401
             C     +E + +  ++L +M HG L  +L  S        L     +  M D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 402 YL 403
           YL
Sbjct: 127 YL 128

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 30/117 (25%), Positives = 55/117 (47%), Gaps = 11/117 (9%)

Query: 295 NNLISKGGFGSVYKARLG----DGMEVAVKVFNLQC----RRAFKSFDIECEMMKSIRHQ 346
             +I  G FG V + RL       ++VA+K          R  F +   E  +M    H 
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLT---EASIMGQFDHP 65

Query: 347 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           N+I++    +      ++ EYM +GSL+K+L  ++    + Q + ++  +AS ++YL
Sbjct: 66  NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 37/128 (28%), Positives = 62/128 (48%), Gaps = 20/128 (15%)

Query: 296 NLISKGGFGSVYKARL-GDG--MEVAVK-VFNLQCRRAFKSFDIECEMMKSI-RHQNLIK 350
           ++I +G FG V KAR+  DG  M+ A+K +     +   + F  E E++  +  H N+I 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 395
           ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q L+   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 396 VASALEYL 403
           VA  ++YL
Sbjct: 133 VARGMDYL 140

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 21/92 (22%), Positives = 50/92 (54%), Gaps = 6/92 (6%)

Query: 292 FSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQ------CRRAFKSFDIECEMMKSIRH 345
           +++  ++ KG +G+VY      G  +AVK   L         + ++    E +++KS++H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 346 QNLIKVISSCSNEEFKALVLEYMPHGSLEKYL 377
            N+++ + +C ++   ++ +E++P GS+   L
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL 93

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 47.6 bits (114), Expect = 4e-06
 Identities = 31/113 (27%), Positives = 47/113 (41%), Gaps = 11/113 (9%)

Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAF-KSFDIECEMMKSIRHQNLIKVISSC 355
           + +G  G VYK R    G   A+K  ++     F K    E + ++S     ++K    C
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64

Query: 356 SNEEFK----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
               +K    ++VLEYM  GSL   L     I +      I   +   L+YLH
Sbjct: 65  YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLH 116

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 27/94 (28%), Positives = 48/94 (51%), Gaps = 4/94 (4%)

Query: 290 YKFSENN---LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH 345
           Y++ EN    ++ KG +G VY AR L   + +A+K    +  R  +    E  +   ++H
Sbjct: 5   YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKH 64

Query: 346 QNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 379
           +N+++ + S S   F  + +E +P GSL   L S
Sbjct: 65  RNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRS 98

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 46.8 bits (111), Expect = 8e-06
 Identities = 31/114 (27%), Positives = 55/114 (48%), Gaps = 8/114 (7%)

Query: 298 ISKGGFGSVYKA---RLGDG-----MEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLI 349
           + +G F  ++K     +GD       EV +KV +   R   +SF     MM  + H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
                C   +   +V EY+  GSL+ YL  +  +++I  +L +   +A AL +L
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL 116

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 26/87 (29%), Positives = 44/87 (50%), Gaps = 7/87 (8%)

Query: 298 ISKGGFGSVYKAR-LG-----DGMEVAVKVFNLQCRRAFKS-FDIECEMMKSIRHQNLIK 350
           I +G FG V++AR  G         VAVK+   +     ++ F  E  +M    H N++K
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYL 377
           ++  C+  +   L+ EYM +G L ++L
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFL 99

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 45.6 bits (109), Expect = 2e-05
 Identities = 29/121 (23%), Positives = 53/121 (43%), Gaps = 18/121 (14%)

Query: 296 NLISKGGFGSVYKAR-LGDGMEVAVKVFN------LQCRRAFKSFDIECEMMKSIRHQNL 348
             I  G +G V  A     G +VA+K  +      +  +R  +    E ++++ +RH+N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61

Query: 349 IK---VISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           I    ++   S E+F  +  V E M    L K + S   + D   +   +  +   L+YL
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119

Query: 404 H 404
           H
Sbjct: 120 H 120

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 30/114 (26%), Positives = 59/114 (51%), Gaps = 8/114 (7%)

Query: 298 ISKGGFGSVYKARL---GD--GMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKV 351
           + +G FG V   R    GD  G +VAVK    +           E E+++++ H+N++K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 352 ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
              C+ +      L++E++P GSL++YL  +   +++ Q+L   + +   ++YL
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 33/119 (27%), Positives = 48/119 (40%), Gaps = 16/119 (13%)

Query: 297 LISKGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDI--ECEMMKSIRHQNLIKVIS 353
            + KG +GSVYK  RL D    A+K  +L      +  D   E  ++ S+ H N+I    
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII---- 62

Query: 354 SCSNEEF-----KALVLEYMPHGSLEKYLYSSNCILDIFQR---LNIMIDVASALEYLH 404
               E F       +V+EY P G L K +        +        I I +   L+ LH
Sbjct: 63  -SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 23/108 (21%), Positives = 44/108 (40%), Gaps = 15/108 (13%)

Query: 278 RMFSYLELCRATYKFSENNLISKGGFGSVYK--ARLGDGMEVAVKVFNLQC---RRAFKS 332
             F  + LC A       +   K    +       L     VAVKV  L+      A + 
Sbjct: 16  GQFGEVHLCEA---DGLQDFSEKAFAENDNADAPVL-----VAVKV--LRPDASDNARED 65

Query: 333 FDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS 380
           F  E +++  +   N+ +++  C+ +    +++EYM +G L ++L   
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKH 113

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 24/105 (22%), Positives = 50/105 (47%), Gaps = 1/105 (0%)

Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G FG VYKA+  + G+  A K+  ++     + F +E +++   +H N++ +  +   E 
Sbjct: 16  GAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75

Query: 360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
              +++E+   G+L+  +      L   Q   +   +  AL +LH
Sbjct: 76  KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 35/121 (28%), Positives = 54/121 (44%), Gaps = 17/121 (14%)

Query: 297 LISKGGFGSVYKARLG----DGMEVAVKVFNL------QCRRAFKSFDI---ECEMMKSI 343
           LI  G FGSVY   LG     G  +AVK   L         R     D    E  ++K +
Sbjct: 7   LIGSGSFGSVY---LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           +H+N+++ + S  + +   + LEY+P GS+   L +     +   R N +  +   L YL
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYL 122

Query: 404 H 404
           H
Sbjct: 123 H 123

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 55/182 (30%), Positives = 80/182 (43%), Gaps = 26/182 (14%)

Query: 2   SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT 61
           S  S L N   L  +DLS N L  +     + +   +L    +S   IS  +  EI  L+
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLSDL---PKLLSNLSNLNNLDLSGNKISD-LPPEIELLS 209

Query: 62  KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPI 121
            L  + L  N +     ++  SNL +L  L L +N+L  +P +                 
Sbjct: 210 ALEELDLSNNSI--IELLSSLSNLKNLSGLELSNNKLEDLPES----------------- 250

Query: 122 EIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLN 181
            IG L NLE L L  N++  S   S G L +L+ L+LS N+LS A+P     LL L+ L 
Sbjct: 251 -IGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL 307

Query: 182 LS 183
             
Sbjct: 308 NL 309

Length = 394

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 44.0 bits (105), Expect = 5e-05
 Identities = 34/113 (30%), Positives = 51/113 (45%), Gaps = 9/113 (7%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEM-----MKSIRHQNLIKV 351
           + KG FG V   R    G   A+KV  L+ ++  K  ++E  +     +  I H  ++K+
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKV--LKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             +   EE   LVLEY P G L  +L       +   R     ++  ALEYLH
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH 110

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 37/118 (31%), Positives = 52/118 (44%), Gaps = 14/118 (11%)

Query: 298 ISKGGFGSV----YKARLGDGMEVAVKVFNLQCRRAFKS-FDIECEMMKSIRHQNLIKVI 352
           +  G FGSV    Y  + G  +EVAVK    +   A K  F  E  +M  + H  ++++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYL---HF 405
             C  E    LV+E  P G L KYL       + D+     +   VA  + YL   HF
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKHF 116

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 44.0 bits (104), Expect = 5e-05
 Identities = 32/116 (27%), Positives = 57/116 (49%), Gaps = 11/116 (9%)

Query: 298 ISKGGFGSVYKARL---------GDGMEVAVKVFNL-QCRRAFKSFDIECEMMKSIRHQN 347
           + +G F ++YK  L         G G EV+V +  L    R   +F     +M  + H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           L+K+   C  +E   +V EY+  G L+ +L+     + +  +L++   +ASAL YL
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 44.2 bits (105), Expect = 6e-05
 Identities = 29/114 (25%), Positives = 50/114 (43%), Gaps = 12/114 (10%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQ------CRRAFKSFDIECEMMKSIRHQNLIK 350
           I +G +G VYKAR    G  VA+K   L+       + A +    E +++K + H N+IK
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           ++    ++    LV E+M    L K +      L      + +  +   L + H
Sbjct: 63  LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (105), Expect = 6e-05
 Identities = 35/121 (28%), Positives = 49/121 (40%), Gaps = 14/121 (11%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKS----FDIECE--MMKSI 343
            F+    I KG FG VYKA        VA+KV +L+     ++     DI+ E   +   
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-----EAEDEIEDIQQEIQFLSQC 56

Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           R   + K   S        +++EY   GS    L      LD      I+ +V   LEYL
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYL 114

Query: 404 H 404
           H
Sbjct: 115 H 115

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 43.9 bits (103), Expect = 6e-05
 Identities = 30/107 (28%), Positives = 53/107 (49%), Gaps = 3/107 (2%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS- 71

Query: 358 EEFKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYL 403
           EE   +V EYM  GSL  +L       L + Q +++   +AS + Y+
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 44.8 bits (106), Expect = 7e-05
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 2/81 (2%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
           + +S  + L  I+LS N +   +P +  G+++ SLE   +SY + +G I E +  LT L 
Sbjct: 436 NDISKLRHLQSINLSGNSIRGNIPPSL-GSIT-SLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 65  TIILGGNKLNGSISITLGSNL 85
            + L GN L+G +   LG  L
Sbjct: 494 ILNLNGNSLSGRVPAALGGRL 514

Length = 623

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 43.8 bits (104), Expect = 7e-05
 Identities = 32/117 (27%), Positives = 55/117 (47%), Gaps = 5/117 (4%)

Query: 292 FSENNLISKGGFGSVYKARLGDGMEV-AVKVFNLQ-C--RRAFKSFDIECEMMKSIRHQN 347
           F    +I KG FG V   +  D  ++ A+K  N Q C  + + ++   E  +++ + H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           L+ +  S  +EE   LV++ +  G L +Y  S        Q    + ++  ALEYLH
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLH 117

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 27/129 (20%), Positives = 56/129 (43%), Gaps = 21/129 (16%)

Query: 293 SENNLISKGGFGSVYKARL------GDGMEVAVKVFNL----QCRRAFKSFDIECEMMKS 342
            E   + +G FG V+ A+       G    V VK          +  F+    E +M + 
Sbjct: 8   QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRR---ELDMFRK 64

Query: 343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--------LDIFQRLNIMI 394
           + H+N+++++  C   E   ++LEY   G L+++L ++           L   Q++ +  
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 395 DVASALEYL 403
            +A  +++L
Sbjct: 125 QIALGMDHL 133

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 29/126 (23%), Positives = 52/126 (41%), Gaps = 22/126 (17%)

Query: 298 ISKGGFGSVYK---ARLGDG---MEVAVKVFN----LQCRRAFKSFDIECEMMKSIRHQN 347
           + +G FG VY+     +  G     VA+K  N    ++ R  F     E  +MK     +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFL---NEASVMKEFNCHH 70

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCILDIFQRLNIM---IDVAS 398
           +++++   S  +   +V+E M  G L+ YL S      +N  L        +    ++A 
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 399 ALEYLH 404
            + YL 
Sbjct: 131 GMAYLA 136

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 43.9 bits (103), Expect = 7e-05
 Identities = 37/128 (28%), Positives = 60/128 (46%), Gaps = 20/128 (15%)

Query: 296 NLISKGGFGSVYKARL---GDGMEVAVKVFN-LQCRRAFKSFDIECEMM-KSIRHQNLIK 350
           ++I +G FG V KAR+   G  M+ A+K       +   + F  E E++ K   H N+I 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 395
           ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 396 VASALEYL 403
           VA  ++YL
Sbjct: 121 VARGMDYL 128

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 31/113 (27%), Positives = 56/113 (49%), Gaps = 7/113 (6%)

Query: 297 LISKGGFGSVYKARL---GDGMEVAVKVFNLQCRRAFKSF-DIECEM--MKSIRHQNLIK 350
           L+  G FG+V+K      GD +++ V +  +Q R   ++F +I   M  M S+ H  +++
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++  C     + LV +  P GSL  ++      LD  + LN  + +A  + YL
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL 125

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 43.9 bits (103), Expect = 8e-05
 Identities = 32/113 (28%), Positives = 57/113 (50%), Gaps = 7/113 (6%)

Query: 297 LISKGGFGSVYKA-RLGDG----MEVAVKVFN-LQCRRAFKSFDIECEMMKSIRHQNLIK 350
           ++  G FG+VYK   + +G    + VA+K+ N     +A   F  E  +M S+ H +L++
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++  C +   + LV + MPHG L  Y++     +     LN  + +A  + YL
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 27/103 (26%), Positives = 46/103 (44%), Gaps = 1/103 (0%)

Query: 301 GGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF 360
           G FG V   +     +VA+K+   +   +   F  E ++M  + H+ L+++   C+ +  
Sbjct: 15  GQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP 73

Query: 361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
             +V EYM +G L  YL          Q L +  DV   + YL
Sbjct: 74  IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL 116

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 24/82 (29%), Positives = 43/82 (52%), Gaps = 1/82 (1%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           +  G FG V+     +  +VAVK        + ++F  E  +MK+++H  L+++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 358 EEFKALVLEYMPHGSLEKYLYS 379
           EE   ++ EYM  GSL  +L S
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKS 94

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 43.3 bits (102), Expect = 9e-05
 Identities = 29/118 (24%), Positives = 60/118 (50%), Gaps = 4/118 (3%)

Query: 291 KFSENNLISKGGFGSVYKA-RLGDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQN 347
           K+ +  ++ +G FG V+   R  D   V +K   ++   +    +   EC+++K + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLH 404
           +I+   +   ++   +V+EY P G+L +Y+    N +LD    L+  + +  AL ++H
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 30/121 (24%), Positives = 60/121 (49%), Gaps = 5/121 (4%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  +   +  G FG V+        +VA+K    Q   + ++F  E  +MK +
Sbjct: 2   EVPRETLKLVKK--LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQL 58

Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +H  L+++ +  + E    ++ EYM +GSL  +L +   I L I + +++   +A  + +
Sbjct: 59  QHPRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117

Query: 403 L 403
           +
Sbjct: 118 I 118

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 32/108 (29%), Positives = 47/108 (43%), Gaps = 2/108 (1%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCS 356
           I  G +G VYKAR +  G   A+KV  L+    F     E  MMK  +H N++    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 357 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             +   + +E+   GSL+  +Y     L   Q   +  +    L YLH
Sbjct: 77  RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH 123

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 42.9 bits (102), Expect = 2e-04
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 7/110 (6%)

Query: 301 GGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFK---SFDI--ECEMMKSIRHQNLIKVISS 354
           G +  VYKAR    G  VA+K   L  R+  K   +F    E ++++ ++H N+I ++  
Sbjct: 11  GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDV 70

Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             ++    LV E+M    LEK +   + +L      + M+     LEYLH
Sbjct: 71  FGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 27/109 (24%), Positives = 42/109 (38%), Gaps = 2/109 (1%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRA-FKSFDIECEMMKSIRHQNLIKVISSC 355
           +  G  G V K      G  +AVK   L+   A  K    E +++       ++    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            N    ++ +EYM  GSL+K L      +       I + V   L YLH
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 35/117 (29%), Positives = 52/117 (44%), Gaps = 12/117 (10%)

Query: 298 ISKGGFGSVYKARLGDGMEVA-VKVFNLQCRRAFK---SFDIECEMMKSIRHQNLIKVIS 353
           I  G FG V       GM  A V V  L+          F  E +  + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 354 SCSNEEFKALVLEYMPHGSLEKYLYSSNCIL------DIFQRLNIMIDVASALEYLH 404
            C       LVLE+ P G L+ YL S+  ++      D+ QR+    +VAS L +LH
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH 117

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 32/115 (27%), Positives = 53/115 (46%), Gaps = 11/115 (9%)

Query: 297 LISKGGFGSVYKARLG--DGMEVAVKVFNLQC------RRAFKSFDIECEMMKSIRHQNL 348
           +I  G FG V   RL      E+ V +  L+       RR F S   E  +M    H N+
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS---EASIMGQFDHPNI 67

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           I +    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL 122

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 33/108 (30%), Positives = 48/108 (44%), Gaps = 2/108 (1%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCS 356
           +  G +G VYKAR L  G   AVK+  L+    F     E  M+K  +H N++    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 357 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           + E   + +EY   GSL+  +Y     L   Q   +  +    L YLH
Sbjct: 77  SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH 123

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 35/114 (30%), Positives = 50/114 (43%), Gaps = 6/114 (5%)

Query: 296 NLISKGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDIECEMMKSIRHQNLIK 350
            +I KG FG VY   L    G  +  AVK  N +      + F  E  +MK   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 351 VISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++  C   E   LV L YM HG L  ++ S      +   +   + VA  +EYL
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL 114

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 31/125 (24%), Positives = 47/125 (37%), Gaps = 23/125 (18%)

Query: 292 FSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIK 350
           F     + +G +GSVYKA     G  VA+KV  ++     +    E  ++K      ++K
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVK 62

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN----------IMIDVASAL 400
              S        +V+EY   GS          + DI +  N          I+      L
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 401 EYLHF 405
           EYLH 
Sbjct: 113 EYLHS 117

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 42.1 bits (100), Expect = 3e-04
 Identities = 34/119 (28%), Positives = 49/119 (41%), Gaps = 22/119 (18%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECE-----------MMKSIRH 345
           + +G +G VYKAR    G  VA+K   L         D E E           ++K ++H
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRL---------DNEEEGIPSTALREISLLKELKH 57

Query: 346 QNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            N++K++     E    LV EY     L+KYL      L      +IM  +   L Y H
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 38/136 (27%), Positives = 71/136 (52%), Gaps = 12/136 (8%)

Query: 62  KLTTIILGGNKLNGSISITLGSNL-ASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP 120
           ++TT+IL  N+L      +L  NL  +++ L  +SN+LTSIP T  +    + L+ + I 
Sbjct: 200 QITTLILDNNEL-----KSLPENLQGNIKTLYANSNQLTSIPATLPDTIQEMELSINRIT 254

Query: 121 IEIGGLPN-LEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASL-EKLLYLK 178
                LP+ L+ L L +N++   +P++  +   L+ L++  N++   +PA L   + +L 
Sbjct: 255 ELPERLPSALQSLDLFHNKIS-CLPENLPE--ELRYLSVYDNSIR-TLPAHLPSGITHLN 310

Query: 179 DLNLSFNKLEGEIPRG 194
             + S   L   +P G
Sbjct: 311 VQSNSLTALPETLPPG 326

Length = 754

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 28/106 (26%), Positives = 52/106 (49%), Gaps = 1/106 (0%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           +  G FG V+  +    ++VA+K  N +   + + F  E ++M  + H  L+++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 358 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++   +V E+M +G L  YL      L     L++  DV   +EYL
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL 116

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 28/115 (24%), Positives = 55/115 (47%), Gaps = 11/115 (9%)

Query: 297 LISKGGFGSVYKARLG----DGMEVAVKV----FNLQCRRAFKSFDIECEMMKSIRHQNL 348
           +I  G FG V + RL       + VA+K     +  + RR F S   E  +M    H N+
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS---EASIMGQFDHPNI 67

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           I +    +      ++ E+M +G+L+ +L  ++    + Q + ++  +A+ ++YL
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 38/146 (26%), Positives = 67/146 (45%), Gaps = 26/146 (17%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLG-DGME----VAVKVF-NLQCRRAFKSFDIEC 337
           EL  +  +F E   + +  FG +YK  L   GM+    VA+K   ++   + +  F  E 
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 338 EMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY----------SSN------ 381
            +M  + H N++ ++   + E+   ++ EY+  G L ++L           SS+      
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 382 CILDIFQRLNIMIDVASALEYL--HF 405
             LD    L+I I +A+ +EYL  HF
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF 144

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 41.6 bits (97), Expect = 5e-04
 Identities = 26/105 (24%), Positives = 52/105 (49%), Gaps = 1/105 (0%)

Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G FG VYKA+  + G   A KV   +     + + +E E++ +  H  ++K++ +   + 
Sbjct: 23  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82

Query: 360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
              +++E+ P G+++  +   +  L   Q   I   +  AL+YLH
Sbjct: 83  KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH 127

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 10/115 (8%)

Query: 297 LISKGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFD---IECE---MMKSIRHQNLI 349
           +I KG FG V  A R  DG   AVKV  LQ +   K  +   I  E   ++K+++H  L+
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  S    E    VL+Y+  G L  +L    C L+   R     +VASA+ YLH
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH 113

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 27/125 (21%), Positives = 50/125 (40%), Gaps = 17/125 (13%)

Query: 295 NNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI--------------ECEM 339
              + +G +G V KA     G  VA+K   +       + D               E ++
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 340 MKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 399
           M  I+H+N++ ++      +F  LV++ M    L+K +      L   Q   I++ + + 
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNG 131

Query: 400 LEYLH 404
           L  LH
Sbjct: 132 LNVLH 136

Length = 335

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 8/114 (7%)

Query: 296 NLISKGGFGSVYKA-RLGDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVI 352
           N I  G FG VY A  L  G  +AVK   +Q    +  K    E ++++ ++H NL+K  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD--IFQRLNIMIDVASALEYLH 404
               + E   + +EY   G+LE+ L     ILD  + +   + +     L YLH
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQL--LEGLAYLH 116

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 40.7 bits (95), Expect = 7e-04
 Identities = 32/120 (26%), Positives = 52/120 (43%), Gaps = 18/120 (15%)

Query: 298 ISKGGFGSVYKARLGDGM---EVAVKVF----NLQCRRAFKSFDIECEMMKSIRHQNLIK 350
           I  G FG V    +  G    +V VK      ++Q +  F     E +  +S++H NL++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLE---EAQPYRSLQHSNLLQ 59

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYLH 404
            +  C+      LV+E+ P G L+ YL S              QR+    ++A  L +LH
Sbjct: 60  CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLH 117

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 40.6 bits (96), Expect = 9e-04
 Identities = 34/116 (29%), Positives = 52/116 (44%), Gaps = 21/116 (18%)

Query: 301 GGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMM---KSIR----HQNLIK-- 350
           G FGSVY AR    G  VA+K      ++ F S++ EC  +   KS+R    H N++K  
Sbjct: 10  GTFGSVYLARNKETGELVAIKKM----KKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLK 64

Query: 351 -VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLH 404
            V     N+E    V EYM  G+L + +              +I+  +   L ++H
Sbjct: 65  EVFR--ENDELY-FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 18/47 (38%), Positives = 26/47 (55%), Gaps = 2/47 (4%)

Query: 156 LNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSA 202
           L L    L G IP  + KL +L+ +NLS N + G IP   S G+ ++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIP--PSLGSITS 467

Length = 623

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 25/90 (27%), Positives = 42/90 (46%), Gaps = 7/90 (7%)

Query: 298 ISKGGFGSVYKAR------LGDGMEVAVKVFNLQCRRA-FKSFDIECEMMKSIRHQNLIK 350
           + +G FG V KA             VAVK+       +  +    E  ++K + H ++IK
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSS 380
           +  +CS +    L++EY  +GSL  +L  S
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRES 97

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 28/103 (27%), Positives = 52/103 (50%), Gaps = 15/103 (14%)

Query: 290 YKFSENNL-----ISKGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDI 335
           ++FS + L     + +G FG V         K +  + + VAVK+  +    +       
Sbjct: 10  WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS 69

Query: 336 ECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYL 377
           E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL
Sbjct: 70  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 112

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 26/91 (28%), Positives = 40/91 (43%), Gaps = 3/91 (3%)

Query: 292 FSENNLISKGGFGSVYKA-RLGDGMEVAVKVFNLQ-CRRAFKSFDI-ECEMMKSIRHQNL 348
           F   N I KG FG V+K  R  D    A+K  +L    R  +   I E  ++  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYS 379
           I+   S  ++    +V+EY  +G L K L  
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKM 92

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 3/107 (2%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           +  G FG V+        +VAVK          +SF  E ++MK +RH  L+++ +  S 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 358 EEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYL 403
           E    +V EYM  GSL  +L       L +   +++   VA+ + Y+
Sbjct: 73  EPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 29/109 (26%), Positives = 49/109 (44%), Gaps = 5/109 (4%)

Query: 300 KGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDI-ECEMMKSIRHQNLIKVISSCSN 357
           +G + +VYK R     E VA+K  +L       S  I E  +MK ++H+N++++      
Sbjct: 10  EGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT 69

Query: 358 EEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLH 404
           E    LV EYM    L+KY+  +     LD     +    +   + + H
Sbjct: 70  ENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 51/208 (24%), Positives = 82/208 (39%), Gaps = 37/208 (17%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHS--LEFFVMSYCNISGGILEEI---- 57
           L  L+    L  +DLS+N L        + ++  S  L+   ++   +    L  +    
Sbjct: 74  LQGLTKGCGLQELDLSDNALGPDGC-GVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGL 132

Query: 58  -TNLTKLTTIILGGNKLNGSISITLGSNL---ASLRKLSLDSNELTS--IPLTFWNLKDI 111
                 L  ++LG N+L G+    L   L     L++L+L +N +    I      LK  
Sbjct: 133 KDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKA- 191

Query: 112 LYLNFSVIPIEIGGLPNLEYLFLGYNRL--QGS--IPDSFGDLISLKSLNLSKNNLSGAI 167
                           NLE L L  N L  +G+  + ++   L SL+ LNL  NNL+ A 
Sbjct: 192 --------------NCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAG 237

Query: 168 -----PASLEKLLYLKDLNLSFNKLEGE 190
                 A L   + L  L+LS N +  +
Sbjct: 238 AAALASALLSPNISLLTLSLSCNDITDD 265

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 34/120 (28%), Positives = 56/120 (46%), Gaps = 7/120 (5%)

Query: 292 FSENNLISKGGFGSVYKAR-LGDGMEVAVK---VFNLQCRRAFKSFDIECEMMKSIRHQN 347
           F     I +G F  VY+A  L DG+ VA+K   +F+L   +A      E +++K + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +IK  +S   +    +VLE    G L    K+      ++         + + SALE++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 39.3 bits (92), Expect = 0.003
 Identities = 26/111 (23%), Positives = 47/111 (42%), Gaps = 8/111 (7%)

Query: 299 SKGGFGSVYKARLGDGMEVAVKVFNL--QCRRAFKSFDIECEMMKSIRHQNLIKVISSCS 356
                  + K +  + + VAVK  NL    +   K    E    + ++H N++  ++S  
Sbjct: 11  EDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69

Query: 357 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL---NIMIDVASALEYLH 404
            +    +V   M +GS E  L +     +    L    I+ DV +AL+Y+H
Sbjct: 70  VDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIH 118

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 38.9 bits (91), Expect = 0.003
 Identities = 32/124 (25%), Positives = 57/124 (45%), Gaps = 18/124 (14%)

Query: 291 KFSENNLISKGGFGSVYKARLGD-GMEVAVKVF-----NLQCRR-AFKSFDIECEMMKSI 343
           K+    L+ +G +G V K +  + G  VA+K F     +   ++ A +    E  M+K +
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR----EIRMLKQL 57

Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPH---GSLEKYLYSSNCILDIFQRLNIMIDVASAL 400
           RH+NL+ +I     ++   LV E++ H     LEKY       LD  +    +  +   +
Sbjct: 58  RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGI 113

Query: 401 EYLH 404
           E+ H
Sbjct: 114 EFCH 117

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 44/163 (26%), Positives = 65/163 (39%), Gaps = 13/163 (7%)

Query: 52  GILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDI 111
           G++EE+  + +L  + L GN +       L + +A++R  +L     +         KD 
Sbjct: 21  GVVEELEMMDELVEVDLSGNTIGTEAMEELCNVIANVR--NLRVVNFSDAFTGR--DKDE 76

Query: 112 LYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLIS----LKSLNLSKNNL---- 163
           LY N  ++   +   P L+ + L  N      P+  GDLIS    L  L L+ N L    
Sbjct: 77  LYSNLVMLLKALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIA 136

Query: 164 SGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFE 206
            G I  +L  L Y K       KLE  I       N S E   
Sbjct: 137 GGRIGKALFHLAYNKKAA-DKPKLEVVICGRNRLENGSKELSA 178

Length = 388

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 27/96 (28%), Positives = 48/96 (50%), Gaps = 4/96 (4%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R + K  +   +  G FG V+ A      +VAVK        + ++F  E  +MK++
Sbjct: 2   EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTL 58

Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 379
           +H  L+K+ +  + E    ++ E+M  GSL  +L S
Sbjct: 59  QHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKS 93

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 38.7 bits (90), Expect = 0.003
 Identities = 28/120 (23%), Positives = 48/120 (40%), Gaps = 18/120 (15%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECE-------MMKSIRHQNL 348
            +  G F S Y+AR +  G  +AVK      R      +   E       +M  + H ++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVT-YVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 349 IKVISSCSNEEFKALVLEYMPHGS----LEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           I+++ +   +    L +E+M  GS    L KY      ++     +N    +   L YLH
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLH 120

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 38.8 bits (91), Expect = 0.003
 Identities = 30/118 (25%), Positives = 49/118 (41%), Gaps = 20/118 (16%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI----ECEMMKSIRHQNLIKVI 352
           I +G  G V+KA+    G  VA+K   L  RR           E + +++ +H  ++K++
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVAL--RRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 353 ------SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
                 S         LV+EYMP   L + L      L   Q  + M  +   + Y+H
Sbjct: 66  DVFPHGSGFV------LVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 22/91 (24%), Positives = 41/91 (45%), Gaps = 7/91 (7%)

Query: 317 VAVKVFNLQC----RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGS 372
           VA+      C    RR F +   E   +    H N++++    +      +V EYM +G+
Sbjct: 36  VAIHTLRAGCSDKQRRGFLA---EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGA 92

Query: 373 LEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           L+ +L      L   Q + ++  +AS ++YL
Sbjct: 93  LDSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 35.2 bits (82), Expect = 0.004
 Identities = 19/61 (31%), Positives = 29/61 (47%), Gaps = 2/61 (3%)

Query: 13 LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
          L  +DLSNN L  +    F G    +L+   +S  N++    E  + L  L ++ L GN 
Sbjct: 2  LKSLDLSNNRLTVIPDGAFKGL--PNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 73 L 73
          L
Sbjct: 60 L 60

Length = 60

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 38.5 bits (89), Expect = 0.004
 Identities = 27/116 (23%), Positives = 53/116 (45%), Gaps = 9/116 (7%)

Query: 297 LISKGGFGSVYKARLGD-GMEVAVKVFNL-----QCRRAFKSFDIECEMMKSIRHQNLIK 350
           L+ +G FG VY     D G E+A K         +  +   + + E +++K+++H+ +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 351 VISSCSNEEFKALV--LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
                 +   K L   +EYMP GS++  L +   + +   R      +   + YLH
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH 123

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 11/95 (11%)

Query: 290 YKFSENNLISKGGFGSVYKA-RLGDGMEVAVKVFNLQCRRA----------FKSFDIECE 338
           +K+ +  LI KG +G VY A  +  G  +AVK   L    A           K+   E E
Sbjct: 1   FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60

Query: 339 MMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL 373
            +K + H N+++ +   + EE+ ++ LEY+P GS+
Sbjct: 61  TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSI 95

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 27/112 (24%), Positives = 50/112 (44%), Gaps = 5/112 (4%)

Query: 297 LISKGGFGSVYKARLGDGME-VAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLIKVI 352
            +  G FG V+  R        A+KV  +      +  +    E  ++K + H  +I++ 
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  ++ F  +++EY+P G L  YL +S    +         ++  ALEYLH
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH 118

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	405
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.95
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.91
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.85
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.84
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.84
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.83
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.83
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.82
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.81
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.81
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.8
KOG3653	534	consensus Transforming growth factor beta/activin	99.8
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.8
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.79
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.78
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.78
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.78
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.77
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.76
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.75
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.72
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.71
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.71
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.71
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.71
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.71
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.7
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.7
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.69
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.69
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.69
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.67
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.67
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.67
KOG0198	313	consensus MEKK and related serine/threonine protei	99.66
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.66
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.65
PHA02988	283	hypothetical protein; Provisional	99.65
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.65
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.65
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.65
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.65
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.65
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.64
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.64
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.64
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.64
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.64
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.64
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.64
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.64
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.64
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.64
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.63
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.63
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.63
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.63
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.63
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.63
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.63
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.63
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.63
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.63
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.63
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.63
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.63
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.63
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.63
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.63
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.62
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.62
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.62
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.62
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.62
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.62
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.61
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.61
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.61
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.61
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.61
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.61
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.61
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.61
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.61
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.61
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.61
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.61
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.61
KOG0578	550	consensus p21-activated serine/threonine protein k	99.61
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.6
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.6
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.6
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.6
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.6
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.6
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.6
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.6
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.59
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.59
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.59
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.59
KOG0586	596	consensus Serine/threonine protein kinase [General	99.59
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.59
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.59
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.59
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.59
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.59
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.59
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.59
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.59
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.59
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.59
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.59
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.58
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.58
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.58
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.58
KOG0605	550	consensus NDR and related serine/threonine kinases	99.58
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.58
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.58
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.58
KOG0610	459	consensus Putative serine/threonine protein kinase	99.58
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.58
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.58
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.58
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.58
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.58
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.58
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.58
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.58
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.58
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.58
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.58
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.57
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.57
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.57
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.57
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.57
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.57
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.57
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.57
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.57
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.57
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.57
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.57
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.57
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.57
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.57
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.57
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.57
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.56
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.56
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.56
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.56
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.56
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.56
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.56
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.56
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.56
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.56
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.56
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.56
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.56
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.56
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.56
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.56
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.56
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.56
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.56
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.56
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.56
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.56
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.56
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.56
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.56
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.56
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.56
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.55
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.55
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.55
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.55
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.55
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.55
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.55
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.55
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.55
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.55
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.55
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.55
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.55
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.55
PTZ00267	478	NIMA-related protein kinase; Provisional	99.55
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.55
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.55
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.55
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.55
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.55
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.54
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.54
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.54
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.54
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.54
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.54
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.54
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.54
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.54
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.54
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.54
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.54
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.54
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.54
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.54
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.54
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.54
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.54
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.54
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.54
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.54
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.54
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.54
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.54
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.54
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.54
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.53
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.53
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.53
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.53
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.53
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.53
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.53
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.53
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.53
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.53
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.53
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.53
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.53
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.53
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.53
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.53
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.53
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.53
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.53
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.53
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.53
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.52
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.52
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.52
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.52
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.52
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.52
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.52
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.52
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.52
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.52
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.52
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.52
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.52
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.52
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.52
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.52
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.52
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.52
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.51
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.51
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.51
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.51
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.51
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.51
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.51
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.51
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.51
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.5
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.5
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.5
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.5
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.5
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.5
KOG0589	426	consensus Serine/threonine protein kinase [General	99.5
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.5
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.5
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.5
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.5
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.5
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.5
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.5
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.5
PHA03212	391	serine/threonine kinase US3; Provisional	99.5
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.5
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.5
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.5
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.5
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.49
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.49
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.49
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.49
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.49
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.49
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.48
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.48
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.48
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.48
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.48
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.48
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.48
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.48
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.48
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.48
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.48
PHA03211	461	serine/threonine kinase US3; Provisional	99.47
PHA03209	357	serine/threonine kinase US3; Provisional	99.47
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.47
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.47
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.47
PLN03150	623	hypothetical protein; Provisional	99.47
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.47
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.47
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.47
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.46
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.46
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.46
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.46
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.46
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.46
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.46
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.46
PTZ00283	496	serine/threonine protein kinase; Provisional	99.45
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.45
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.45
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.45
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.45
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.45
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.45
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.44
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.44
PLN00009	294	cyclin-dependent kinase A; Provisional	99.44
PTZ00036	440	glycogen synthase kinase; Provisional	99.44
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.43
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.43
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.43
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.43
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.43
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.43
KOG0584	632	consensus Serine/threonine protein kinase [General	99.42
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.42
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.42
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.42
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.41
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.41
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.41
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.41
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.4
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.4
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.4
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.4
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.4
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.4
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.4
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.4
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.4
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.39
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.39
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.39
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.39
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.39
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.39
PHA03207	392	serine/threonine kinase US3; Provisional	99.38
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.38
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.38
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.38
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.37
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.37
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.37
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.37
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.37
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.37
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.36
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.36
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.36
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.35
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.35
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.35
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.35
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.35
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.34
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.34
PTZ00284	467	protein kinase; Provisional	99.33
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.33
PRK09188	365	serine/threonine protein kinase; Provisional	99.32
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.3
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.28
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.28
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.27
KOG1152	772	consensus Signal transduction serine/threonine kin	99.27
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.27
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.26
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.26
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.25
PRK10345	210	hypothetical protein; Provisional	99.25
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.25
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.23
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.22
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.22
PLN03150	623	hypothetical protein; Provisional	99.21
PHA03210	501	serine/threonine kinase US3; Provisional	99.21
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.21
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.19
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.18
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.18
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.17
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.16
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.16
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.16
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.14
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.12
PRK14879	211	serine/threonine protein kinase; Provisional	99.11
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.1
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.09
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.09
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.06
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.06
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.04
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.04
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.03
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.02
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	98.97
smart00090	237	RIO RIO-like kinase.	98.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	98.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	98.94
PHA02882	294	putative serine/threonine kinase; Provisional	98.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	98.92
KOG0695	593	consensus Serine/threonine protein kinase [Signal	98.92
KOG0696	683	consensus Serine/threonine protein kinase [Signal	98.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	98.88
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	98.85
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	98.8
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	98.8
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	98.78
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.76
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.72
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.7
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	98.7
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	98.66
KOG1027	903	consensus Serine/threonine protein kinase and endo	98.66
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.65
KOG1167	418	consensus Serine/threonine protein kinase of the C	98.64
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	98.6
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	98.59
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	98.58
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.58
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.52
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.51
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	98.49
COG0515	384	SPS1 Serine/threonine protein kinase [General func	98.48
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.47
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.47
PRK15386	426	type III secretion protein GogB; Provisional	98.44
PRK12274	218	serine/threonine protein kinase; Provisional	98.43
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.42
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.39
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.38
KOG1644	233	consensus U2-associated snRNP A' protein [RNA proc	98.37
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.35
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	98.26
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.24
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.22
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.19
KOG2120	419	consensus SCF ubiquitin ligase, Skp2 component [Po	98.17
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.16
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.16
KOG1644	233	consensus U2-associated snRNP A' protein [RNA proc	97.98
KOG3665	699	consensus ZYG-1-like serine/threonine protein kina	97.91
PF13306	129	LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_	97.9
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	97.9
KOG3665	699	consensus ZYG-1-like serine/threonine protein kina	97.86
KOG2120	419	consensus SCF ubiquitin ligase, Skp2 component [Po	97.84
PF13306	129	LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_	97.79
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	97.78
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	97.75
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	97.74
PRK15386	426	type III secretion protein GogB; Provisional	97.63
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	97.54
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	97.45
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	97.41
KOG0590	601	consensus Checkpoint kinase and related serine/thr	97.33
KOG2739	260	consensus Leucine-rich acidic nuclear protein [Cel	97.22
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	97.21
KOG1243	690	consensus Protein kinase [General function predict	97.2
KOG1266	458	consensus Protein kinase [Signal transduction mech	97.19
KOG2739	260	consensus Leucine-rich acidic nuclear protein [Cel	97.18
KOG2123	388	consensus Uncharacterized conserved protein [Funct	97.13
PF00560	22	LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le	96.95
KOG2123	388	consensus Uncharacterized conserved protein [Funct	96.94
PLN00181	793	protein SPA1-RELATED; Provisional	96.8
PLN02876	822	acyl-CoA dehydrogenase	96.73

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.3e-47  Score=402.57  Aligned_cols=383  Identities=28%  Similarity=0.424  Sum_probs=284.2

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchh
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG   82 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   82 (405)
                      +|+.++++++|+.|+|++|++++..|.. +..++ +|+.|++++|.+++..|..+..+++|+.|+|++|++.+.+|..+ 
T Consensus       396 ~p~~~~~~~~L~~L~L~~n~l~~~~p~~-~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-  472 (968)
T PLN00113        396 IPKSLGACRSLRRVRLQDNSFSGELPSE-FTKLP-LVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-  472 (968)
T ss_pred             CCHHHhCCCCCCEEECcCCEeeeECChh-HhcCC-CCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-
Confidence            3455666777777777777777777766 45555 77777777777777777777777778888888887777776654 


Q ss_pred             cCCCCCCeeeCCCCCCC-CCchhhhccccCccccCCC------CChhccCCCCCCEEeccCCcccccCCcccccCCCCCe
Q 036754           83 SNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFSV------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKS  155 (405)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~l~l~~------~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  155 (405)
                       .+++|+.|+|++|+++ .+|..+.++++|+.|+++.      +|..+.++++|++|++++|.+++.+|..|..+++|+.
T Consensus       473 -~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  551 (968)
T PLN00113        473 -GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ  551 (968)
T ss_pred             -ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCE
Confidence             4678899999999988 6788888999999998875      7888999999999999999999999999999999999


Q ss_pred             eecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCccCCCC-CCCCCCCCccccccCCcc
Q 036754          156 LNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN-LQVQPCKTGIHHTSSKNS  234 (405)
Q Consensus       156 L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~-~~~~~c~~~~~~~~~~~~  234 (405)
                      |++++|++++.+|..+..+++|+.+++++|++.+.+|..+.+..+....+.||+..|+.+. ....+|.....    ...
T Consensus       552 L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~----~~~  627 (968)
T PLN00113        552 LDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK----TPS  627 (968)
T ss_pred             EECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc----cce
Confidence            9999999999999999999999999999999999999988888888889999999997542 22344532211    111


Q ss_pred             chhhhhhhhHHHHHHH-HHHHHHHhhhcCcccCCCCC-Cchhh--------hhhhhHHHHHHhhhccCCccCcccccCCC
Q 036754          235 LLLGIVLPLSTTFMIV-VILLILRYRQRGKRLSNDAN-MPIVA--------TWRMFSYLELCRATYKFSENNLISKGGFG  304 (405)
Q Consensus       235 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~--------~~~~~~~~~~~~~~~~~~~~~~lg~G~fg  304 (405)
                      +.++++++++++++++ +++++++++++++...+... ....+        ......++++   ...+...++||+|+||
T Consensus       628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g  704 (968)
T PLN00113        628 WWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKG  704 (968)
T ss_pred             eeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCe
Confidence            1222222222222222 22222222222211111000 00000        0112333333   2346677899999999


Q ss_pred             ceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCHHHHHhcCCCC
Q 036754          305 SVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI  383 (405)
Q Consensus       305 ~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~  383 (405)
                      .||+|+. .+|..||||++......    ...|++.+++++|||||+++|+|.+.+..++||||+++|+|.++++    .
T Consensus       705 ~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~  776 (968)
T PLN00113        705 ASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----N  776 (968)
T ss_pred             eEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----c
Confidence            9999995 67899999988643221    1346888999999999999999999999999999999999999995    3


Q ss_pred             CCHHHHHHHHHHHHHHHhhhc
Q 036754          384 LDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       384 l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      ++|.++.+|+.|||+||+|||
T Consensus       777 l~~~~~~~i~~~ia~~L~yLH  797 (968)
T PLN00113        777 LSWERRRKIAIGIAKALRFLH  797 (968)
T ss_pred             CCHHHHHHHHHHHHHHHHHhc
Confidence            899999999999999999999

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.2e-27  Score=220.34  Aligned_cols=130  Identities=45%  Similarity=0.665  Sum_probs=118.8

Q ss_pred             hhhhhHHHHHHhhhccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeee
Q 036754          276 TWRMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC  355 (405)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  355 (405)
                      ....|++.++..+|++|+..+.||+|+||.||+|.+.+|+.||||++........++|..|+.++++++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45679999999999999999999999999999999999999999988655432155699999999999999999999999


Q ss_pred             ecCC-eeEEEEecCCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHhhhcC
Q 036754          356 SNEE-FKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       356 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+.+ ...||||||++|+|.++|+.... .++|.+|++||.++|+||+|||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~  192 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHE  192 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHcc
Confidence            9988 59999999999999999998765 89999999999999999999996

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.91  E-value=3.2e-24  Score=228.78  Aligned_cols=210  Identities=31%  Similarity=0.474  Sum_probs=143.4

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchh
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG   82 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   82 (405)
                      +|+.++.+++|+.|+|++|++.+..|.. +..+. +|+.|++++|++.+..|..+..+++|+.|+|++|++++.+|..+.
T Consensus       348 ~p~~l~~~~~L~~L~Ls~n~l~~~~p~~-~~~~~-~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~  425 (968)
T PLN00113        348 IPKNLGKHNNLTVLDLSTNNLTGEIPEG-LCSSG-NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFT  425 (968)
T ss_pred             CChHHhCCCCCcEEECCCCeeEeeCChh-HhCcC-CCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHh
Confidence            3455666667777777777776666655 23332 455555555555555555555555555555555555444444332


Q ss_pred             -----------------------cCCCCCCeeeCCCCCCC-CCchhhhccccCccccCCC------CChhccCCCCCCEE
Q 036754           83 -----------------------SNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFSV------IPIEIGGLPNLEYL  132 (405)
Q Consensus        83 -----------------------~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~l~l~~------~p~~~~~l~~L~~L  132 (405)
                                             ..+++|++|+|++|++. .+|.. ....+|+.|+++.      +|..+.++++|++|
T Consensus       426 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~-~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L  504 (968)
T PLN00113        426 KLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS-FGSKRLENLDLSRNQFSGAVPRKLGSLSELMQL  504 (968)
T ss_pred             cCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcc-cccccceEEECcCCccCCccChhhhhhhccCEE
Confidence                                   24445555555555444 23322 2334555565543      56677888999999


Q ss_pred             eccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCC-CccCCCCcccccCCCCc
Q 036754          133 FLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELL  211 (405)
Q Consensus       133 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~-~~~~~~~~~~~~~n~~~  211 (405)
                      ++++|.+.+.+|+.+..+++|++|++++|.+++.+|..+..+++|+.|++++|.+.+.+|.. ..+.+++.+++.+|++.
T Consensus       505 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~  584 (968)
T PLN00113        505 KLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLH  584 (968)
T ss_pred             ECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcce
Confidence            99999999999999999999999999999999999999999999999999999999888763 55778889999999987


Q ss_pred             cCCC
Q 036754          212 CGSP  215 (405)
Q Consensus       212 c~~~  215 (405)
                      +..|
T Consensus       585 ~~~p  588 (968)
T PLN00113        585 GSLP  588 (968)
T ss_pred             eeCC
Confidence            6444

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.85  E-value=5e-21  Score=172.41  Aligned_cols=115  Identities=28%  Similarity=0.482  Sum_probs=102.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeecc--ccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      .+|...+.||+|+||+||+|.. .++..||||.+.+.  .++..+....|+.+++.++|||||++++++...+.+|+|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            4566667799999999999995 56799999999765  34556677899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||.+|||.+|++.++ .+++.....++.|+|.||+|||+
T Consensus        90 yC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~  127 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHE  127 (429)
T ss_pred             eCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999998765 79999999999999999999995

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.84  E-value=2.2e-22  Score=188.16  Aligned_cols=206  Identities=24%  Similarity=0.272  Sum_probs=163.2

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      +|.++++|+.|.|..|+|+....+.|.+ + .+++.|+|+.|+++..-.+.+-+|+.|+.|+||.|.|. .+..+..+..
T Consensus       240 tFqgL~Sl~nlklqrN~I~kL~DG~Fy~-l-~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~-rih~d~Wsft  316 (873)
T KOG4194|consen  240 TFQGLPSLQNLKLQRNDISKLDDGAFYG-L-EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQ-RIHIDSWSFT  316 (873)
T ss_pred             hhcCchhhhhhhhhhcCcccccCcceee-e-cccceeecccchhhhhhcccccccchhhhhccchhhhh-eeecchhhhc
Confidence            4666777777777777777777777554 3 37888888888888777778888888888888888887 5544444678


Q ss_pred             CCCCeeeCCCCCCCCCch-hhhccccCccccCCCC------ChhccCCCCCCEEeccCCcccccCCc---ccccCCCCCe
Q 036754           86 ASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSVI------PIEIGGLPNLEYLFLGYNRLQGSIPD---SFGDLISLKS  155 (405)
Q Consensus        86 ~~L~~L~Ls~N~l~~lp~-~~~~l~~L~~l~l~~~------p~~~~~l~~L~~L~l~~n~l~~~~p~---~~~~l~~L~~  155 (405)
                      ++|++|+|++|+|+++|+ +|..|..|+.|++++.      -..|.++.+|+.|||++|.+++.+-+   .|.+|++|+.
T Consensus       317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk  396 (873)
T KOG4194|consen  317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK  396 (873)
T ss_pred             ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence            899999999999998865 5667888888888762      23577899999999999999876654   3788999999


Q ss_pred             eecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCccCC
Q 036754          156 LNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS  214 (405)
Q Consensus       156 L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~~  214 (405)
                      |++.+|++.......|.++..|++|++.+|.|...-|.......+..+-+....+.|.|
T Consensus       397 L~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDC  455 (873)
T KOG4194|consen  397 LRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDC  455 (873)
T ss_pred             eeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEec
Confidence            99999999988889999999999999999999876666544447777777777777776

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.84  E-value=2.1e-20  Score=174.11  Aligned_cols=110  Identities=33%  Similarity=0.544  Sum_probs=97.6

Q ss_pred             CcccccCCCceEEEeeCCCcEEEEEEeeccccc--hhHHHHHHHHHhhcCCCCCcceEEeeeecCC-eeEEEEecCCCCC
Q 036754          296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCRR--AFKSFDIECEMMKSIRHQNLIKVISSCSNEE-FKALVLEYMPHGS  372 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~g~  372 (405)
                      +.+|+|+||+||+|.+.....||||++......  ..+.|.+|+.++.+++|||||+++|+|.+.. ..+|||||+++|+
T Consensus        47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs  126 (362)
T KOG0192|consen   47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS  126 (362)
T ss_pred             hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence            459999999999999955445999999765422  2568999999999999999999999999887 7999999999999


Q ss_pred             HHHHHhc-CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          373 LEKYLYS-SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       373 L~~~l~~-~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |.++++. .+..+++..++++|.|||+||.|||+
T Consensus       127 L~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~  160 (362)
T KOG0192|consen  127 LSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS  160 (362)
T ss_pred             HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            9999987 35689999999999999999999995

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.83  E-value=1.2e-21  Score=183.26  Aligned_cols=178  Identities=26%  Similarity=0.320  Sum_probs=103.9

Q ss_pred             CCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCC
Q 036754            8 SNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLAS   87 (405)
Q Consensus         8 ~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~   87 (405)
                      +-++.|+.||||.|.|+.+.-.+|-..  .+++.|+|++|+|+....+.|.++.+|.+|.|++|+++ .+|...|.+|++
T Consensus       146 ~~l~alrslDLSrN~is~i~~~sfp~~--~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-tLp~r~Fk~L~~  222 (873)
T KOG4194|consen  146 SALPALRSLDLSRNLISEIPKPSFPAK--VNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-TLPQRSFKRLPK  222 (873)
T ss_pred             HhHhhhhhhhhhhchhhcccCCCCCCC--CCceEEeeccccccccccccccccchheeeecccCccc-ccCHHHhhhcch
Confidence            334555555555555555444443221  14555555555555555555555555555555555555 555555544555


Q ss_pred             CCeeeCCCCCCC------------------------CCch-hhhccccCccccCCC------CChhccCCCCCCEEeccC
Q 036754           88 LRKLSLDSNELT------------------------SIPL-TFWNLKDILYLNFSV------IPIEIGGLPNLEYLFLGY  136 (405)
Q Consensus        88 L~~L~Ls~N~l~------------------------~lp~-~~~~l~~L~~l~l~~------~p~~~~~l~~L~~L~l~~  136 (405)
                      |+.|+|..|+|.                        .+.+ .|+.+.+++.|+++.      ....+.++++|+.|++|+
T Consensus       223 L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~  302 (873)
T KOG4194|consen  223 LESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSY  302 (873)
T ss_pred             hhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccch
Confidence            555555555544                        3322 233344444444432      223455677777777777


Q ss_pred             CcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCccc
Q 036754          137 NRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       137 n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~  188 (405)
                      |.+..+.+++|+-+++|+.|+|++|+++...+.+|..+..|++|++++|.++
T Consensus       303 NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~  354 (873)
T KOG4194|consen  303 NAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID  354 (873)
T ss_pred             hhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH
Confidence            7777777777777777777777777777777777776666666666666654

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.83  E-value=4.8e-22  Score=187.30  Aligned_cols=177  Identities=25%  Similarity=0.304  Sum_probs=108.4

Q ss_pred             CCCCCcCCeeeCcCCcC--cccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcC
Q 036754            7 LSNCKCLTFIDLSNNPL--DSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSN   84 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l--~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~   84 (405)
                      ++.++.|+.+++..|++  +|++++. + .+. .|..||||+|++.. .|..+..-+++-+|+||+|+|. +||..+|-+
T Consensus        74 Ls~Lp~LRsv~~R~N~LKnsGiP~di-F-~l~-dLt~lDLShNqL~E-vP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfin  148 (1255)
T KOG0444|consen   74 LSDLPRLRSVIVRDNNLKNSGIPTDI-F-RLK-DLTILDLSHNQLRE-VPTNLEYAKNSIVLNLSYNNIE-TIPNSLFIN  148 (1255)
T ss_pred             hccchhhHHHhhhccccccCCCCchh-c-ccc-cceeeecchhhhhh-cchhhhhhcCcEEEEcccCccc-cCCchHHHh
Confidence            34444455555555444  2223332 2 222 56666666666654 5566666666666666666665 666666666


Q ss_pred             CCCCCeeeCCCCCCCCCchhhhccccCccccCCC-------------------------------CChhccCCCCCCEEe
Q 036754           85 LASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-------------------------------IPIEIGGLPNLEYLF  133 (405)
Q Consensus        85 l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-------------------------------~p~~~~~l~~L~~L~  133 (405)
                      |+.|-.||||+|++..+|+.+..|..|+.|.+++                               +|.++..+.+|..+|
T Consensus       149 LtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvD  228 (1255)
T KOG0444|consen  149 LTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVD  228 (1255)
T ss_pred             hHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhcc
Confidence            6666667777777666666665555555554432                               666677777778888


Q ss_pred             ccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCc
Q 036754          134 LGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGE  190 (405)
Q Consensus       134 l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~  190 (405)
                      +|.|.+. ..|+.+..+.+|+.|+||+|.++. +......+.+|+.|+++.|+++..
T Consensus       229 lS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt~L  283 (1255)
T KOG0444|consen  229 LSENNLP-IVPECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLTVL  283 (1255)
T ss_pred             ccccCCC-cchHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhccc
Confidence            8888877 677777777777777777777763 334445555566666666665533

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.82  E-value=2.6e-20  Score=182.20  Aligned_cols=115  Identities=29%  Similarity=0.494  Sum_probs=100.5

Q ss_pred             ccCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccccc-hhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQCRR-AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  362 (405)
                      .++...+.||+|+||+||+|+..      +...||||.++..+.. ..++|.+|++++..++|||||+++|.|..++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            34555678999999999999853      2467999999877655 7889999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhcCC---------CC----CCHHHHHHHHHHHHHHHhhhc
Q 036754          363 LVLEYMPHGSLEKYLYSSN---------CI----LDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~---------~~----l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      ||+|||.+|||.+||+.+.         ..    ++..+.+.||.|||.||+||-
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs  620 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS  620 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999998532         22    888999999999999999983

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.81  E-value=1.6e-21  Score=155.76  Aligned_cols=179  Identities=30%  Similarity=0.474  Sum_probs=133.2

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      .+.++++++.|.||+|+++...|.  +.++. +|+.|++++|++.. +|.++.++++|+.|+++-|++. .+|.+++ .+
T Consensus        28 gLf~~s~ITrLtLSHNKl~~vppn--ia~l~-nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~-~lprgfg-s~  101 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLTVVPPN--IAELK-NLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLN-ILPRGFG-SF  101 (264)
T ss_pred             cccchhhhhhhhcccCceeecCCc--HHHhh-hhhhhhcccchhhh-cChhhhhchhhhheecchhhhh-cCccccC-CC
Confidence            455677778888888888877666  45665 78888888888865 7777888888888888888887 7777764 78


Q ss_pred             CCCCeeeCCCCCCC--CCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccc
Q 036754           86 ASLRKLSLDSNELT--SIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNL  163 (405)
Q Consensus        86 ~~L~~L~Ls~N~l~--~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l  163 (405)
                      +.|+.|||+.|++.  .+|..|+.                  +..|+.|+++.|.+. .+|..++.+++|+.|.+.+|.+
T Consensus       102 p~levldltynnl~e~~lpgnff~------------------m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndl  162 (264)
T KOG0617|consen  102 PALEVLDLTYNNLNENSLPGNFFY------------------MTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDL  162 (264)
T ss_pred             chhhhhhccccccccccCCcchhH------------------HHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCch
Confidence            88888888888887  56666554                  455667778888887 6777788888888888888888


Q ss_pred             cCccchhHHhcccCCccccccCcccCcCCCCCcc---CCCCcccccCCCC
Q 036754          164 SGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSF---GNFSAESFEGNEL  210 (405)
Q Consensus       164 ~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~---~~~~~~~~~~n~~  210 (405)
                      . .+|..+..++.|++|.+.+|.++-.+|+.+.+   .+-+......|||
T Consensus       163 l-~lpkeig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPw  211 (264)
T KOG0617|consen  163 L-SLPKEIGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPW  211 (264)
T ss_pred             h-hCcHHHHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCC
Confidence            7 56888888888888888888888777665432   2333444555665

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.81  E-value=3.6e-21  Score=172.70  Aligned_cols=201  Identities=27%  Similarity=0.431  Sum_probs=155.8

Q ss_pred             cccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCcc-ccCccCCCeeecCCcccccccCcc
Q 036754            2 SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEE-ITNLTKLTTIILGGNKLNGSISIT   80 (405)
Q Consensus         2 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~   80 (405)
                      ++|+.++.+.+|.-|+|..|+|... | . |+.+. .|++|+++.|.+.. +|.+ ..++.+|.+|||++|++. ++|.+
T Consensus       197 tlP~~lg~l~~L~~LyL~~Nki~~l-P-e-f~gcs-~L~Elh~g~N~i~~-lpae~~~~L~~l~vLDLRdNklk-e~Pde  270 (565)
T KOG0472|consen  197 TLPPELGGLESLELLYLRRNKIRFL-P-E-FPGCS-LLKELHVGENQIEM-LPAEHLKHLNSLLVLDLRDNKLK-EVPDE  270 (565)
T ss_pred             cCChhhcchhhhHHHHhhhcccccC-C-C-CCccH-HHHHHHhcccHHHh-hHHHHhcccccceeeeccccccc-cCchH
Confidence            4688888899999999999998764 4 3 55665 78889999888876 4554 458899999999999998 88988


Q ss_pred             hhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCC------------------------------------------
Q 036754           81 LGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV------------------------------------------  118 (405)
Q Consensus        81 ~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~------------------------------------------  118 (405)
                      +. -+.+|++||+|+|.|+.+|.+++++ .|+.|-+.+                                          
T Consensus       271 ~c-lLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~  348 (565)
T KOG0472|consen  271 IC-LLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAM  348 (565)
T ss_pred             HH-HhhhhhhhcccCCccccCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccC
Confidence            86 7889999999999999999888877 554442211                                          


Q ss_pred             ------------------------------------------------------------------------------CC
Q 036754          119 ------------------------------------------------------------------------------IP  120 (405)
Q Consensus       119 ------------------------------------------------------------------------------~p  120 (405)
                                                                                                    +|
T Consensus       349 t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~  428 (565)
T KOG0472|consen  349 TLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVP  428 (565)
T ss_pred             CCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccch
Confidence                                                                                          22


Q ss_pred             hhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccC-----------------------ccchhHHhcccC
Q 036754          121 IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG-----------------------AIPASLEKLLYL  177 (405)
Q Consensus       121 ~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-----------------------~~~~~~~~l~~L  177 (405)
                      ..++.+++|..|++++|.+. .+|..++.+..|+.|+++.|++..                       ..|..+.++.+|
T Consensus       429 ~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL  507 (565)
T KOG0472|consen  429 LELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNL  507 (565)
T ss_pred             HHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhc
Confidence            23456888899999988887 788888888889999888776642                       233446677888


Q ss_pred             CccccccCcccCcCCCCCccCCCCcccccCCCCc
Q 036754          178 KDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL  211 (405)
Q Consensus       178 ~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~  211 (405)
                      ..|++.+|.+...+|..+.+.++..+.+.|||+-
T Consensus       508 ~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  508 TTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            8888888888877777888888888888888763

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.8e-19  Score=170.59  Aligned_cols=116  Identities=31%  Similarity=0.469  Sum_probs=101.2

Q ss_pred             ccCCccCcccccCCCceEEEeeCC--C--cE-EEEEEeecc---ccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCee
Q 036754          290 YKFSENNLISKGGFGSVYKARLGD--G--ME-VAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  361 (405)
                      ++....++||+|+||.||+|++..  +  .. ||||..+..   ......+|.+|.++|++++|||||+++|++..+.++
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            344455889999999999999633  2  23 899998752   245678999999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|||+|+||+|.++|++.+..++..++++++.|+|.||+|||.
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~  280 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS  280 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH
Confidence            99999999999999998876679999999999999999999994

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.80  E-value=3.3e-19  Score=163.32  Aligned_cols=108  Identities=33%  Similarity=0.451  Sum_probs=90.7

Q ss_pred             CCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHH--HHHhhcCCCCCcceEEeeeecCC----eeEEEE
Q 036754          292 FSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIE--CEMMKSIRHQNLIKVISSCSNEE----FKALVL  365 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e--~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  365 (405)
                      +...+++|+|+||.||+|++ +++.||||++..+..   +.|..|  |.-+..++|+||++++++-....    +.+||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhc-cCceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            34457899999999999998 458999999976543   344444  55566789999999999876654    788999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||.+.|+|.+||..+  .++|.+..+|+..+|+||+|||+
T Consensus       288 ~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHe  325 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHE  325 (534)
T ss_pred             eeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcc
Confidence            999999999999764  59999999999999999999996

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.80  E-value=1.9e-19  Score=167.93  Aligned_cols=110  Identities=31%  Similarity=0.522  Sum_probs=98.8

Q ss_pred             cCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCHH
Q 036754          295 NNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLE  374 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  374 (405)
                      .+.||+|.||.||.|.+.....||+|.++.. .-....|.+|+.+|.+++|++||+++|+|..++.+|||||||+.|+|.
T Consensus       211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl  289 (468)
T KOG0197|consen  211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL  289 (468)
T ss_pred             HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence            4569999999999999977779999999765 233467889999999999999999999999989999999999999999


Q ss_pred             HHHhc-CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          375 KYLYS-SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       375 ~~l~~-~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||+. .+..+.-.+.+.+|.|||+||+||++
T Consensus       290 ~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes  321 (468)
T KOG0197|consen  290 DYLRTREGGLLNLPQLLDFAAQIAEGMAYLES  321 (468)
T ss_pred             HHhhhcCCCccchHHHHHHHHHHHHHHHHHHh
Confidence            99997 44678999999999999999999963

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.79  E-value=3.4e-19  Score=171.90  Aligned_cols=114  Identities=25%  Similarity=0.450  Sum_probs=102.8

Q ss_pred             CCccCcccccCCCceEEEeeC----CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          292 FSENNLISKGGFGSVYKARLG----DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +...++||.|.||.||+|.+.    +...||||.++... .+.+.+|+.|..+|.+.+||||+++.|..+....++||+|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            345689999999999999863    24679999998765 4567899999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||++|+|..||+.+.+.+++.+.+.+.++||.||.||-+
T Consensus       711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd  749 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD  749 (996)
T ss_pred             hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh
Confidence            999999999999888889999999999999999999853

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.78  E-value=6.3e-19  Score=165.07  Aligned_cols=112  Identities=23%  Similarity=0.463  Sum_probs=99.4

Q ss_pred             CccCcccccCCCceEEEeeCCCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCC
Q 036754          293 SENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHG  371 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  371 (405)
                      ...++||+|.||.|..++...+..||||.++..+. ..+.+|..|+++|++++|||||+++|.|..++.+++++|||++|
T Consensus       541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG  620 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG  620 (807)
T ss_pred             ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence            34578999999999999998889999999998764 45689999999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhc
Q 036754          372 SLEKYLYSSN-CILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       372 ~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      ||.+|+..+. ...+-..-++||.|||.||+||-
T Consensus       621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe  654 (807)
T KOG1094|consen  621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLE  654 (807)
T ss_pred             cHHHHHHhccCcccccchhHHHHHHHHHHHHHHH
Confidence            9999998764 22355567889999999999984

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.78  E-value=3.4e-21  Score=172.83  Aligned_cols=200  Identities=26%  Similarity=0.376  Sum_probs=133.9

Q ss_pred             cccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcch
Q 036754            2 SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITL   81 (405)
Q Consensus         2 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~   81 (405)
                      ++|++++.+..++.|+.|+|+++.+++.  ++... +|..++.++|++.. +|+.++.+..|+.|+..+|+++ ++|.++
T Consensus        82 ~lp~aig~l~~l~~l~vs~n~ls~lp~~--i~s~~-~l~~l~~s~n~~~e-l~~~i~~~~~l~dl~~~~N~i~-slp~~~  156 (565)
T KOG0472|consen   82 QLPAAIGELEALKSLNVSHNKLSELPEQ--IGSLI-SLVKLDCSSNELKE-LPDSIGRLLDLEDLDATNNQIS-SLPEDM  156 (565)
T ss_pred             hCCHHHHHHHHHHHhhcccchHhhccHH--Hhhhh-hhhhhhccccceee-cCchHHHHhhhhhhhccccccc-cCchHH
Confidence            4566677777777777777777654333  44444 66666666666654 5555666666666666666665 555555


Q ss_pred             hcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChh----------------------ccCCCCCCEEec
Q 036754           82 GSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIE----------------------IGGLPNLEYLFL  134 (405)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~----------------------~~~l~~L~~L~l  134 (405)
                      + ++.+|..|++.+|.++.+|+..-+++.|++++...     +|+.                      |.++..|.+|++
T Consensus       157 ~-~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~~lPef~gcs~L~Elh~  235 (565)
T KOG0472|consen  157 V-NLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIRFLPEFPGCSLLKELHV  235 (565)
T ss_pred             H-HHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccccCCCCCccHHHHHHHh
Confidence            4 45555555555555555555444455555554322     4444                      444445555555


Q ss_pred             cCCcccccCCccc-ccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCC
Q 036754          135 GYNRLQGSIPDSF-GDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL  210 (405)
Q Consensus       135 ~~n~l~~~~p~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~  210 (405)
                      +.|.++ .+|... .+++++..||+.+|+++ ..|+.+.-+.+|+.||+++|.+++.+++.+.+ .+..+.+.|||.
T Consensus       236 g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl  309 (565)
T KOG0472|consen  236 GENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL  309 (565)
T ss_pred             cccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence            555554 334333 36788999999999999 67999999999999999999999999988888 888999999996

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.78  E-value=6.6e-21  Score=170.67  Aligned_cols=206  Identities=27%  Similarity=0.326  Sum_probs=148.1

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEE-cccCcccccCCccccCccCCCeeecCCcccccccCcchhcC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFV-MSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSN   84 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~-L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~   84 (405)
                      +|+.+++|+.||||+|.|+.+.|++|.| +. +|.+|. +++|+|+....+.|++|..|+.|.+.-|++. -++.+.+..
T Consensus        86 aF~~l~~LRrLdLS~N~Is~I~p~AF~G-L~-~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~-Cir~~al~d  162 (498)
T KOG4237|consen   86 AFKTLHRLRRLDLSKNNISFIAPDAFKG-LA-SLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHIN-CIRQDALRD  162 (498)
T ss_pred             hccchhhhceecccccchhhcChHhhhh-hH-hhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhc-chhHHHHHH
Confidence            4666777777777777777777776443 33 443333 3336666655566666666666666666665 555555566


Q ss_pred             CCCCCeeeCCCCCCCCCch-hhhccccCccccCCC---------------------------------------------
Q 036754           85 LASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSV---------------------------------------------  118 (405)
Q Consensus        85 l~~L~~L~Ls~N~l~~lp~-~~~~l~~L~~l~l~~---------------------------------------------  118 (405)
                      |++|..|.+..|.+..++. ++..+..++.+.++.                                             
T Consensus       163 L~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~  242 (498)
T KOG4237|consen  163 LPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDAR  242 (498)
T ss_pred             hhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchh
Confidence            7777777777777766654 444444433332211                                             


Q ss_pred             ----------------------CC-hhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcc
Q 036754          119 ----------------------IP-IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLL  175 (405)
Q Consensus       119 ----------------------~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  175 (405)
                                            .| ..|..+++|+.|++++|.++++-+.+|.+...++.|.|..|++.......|.++.
T Consensus       243 kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls  322 (498)
T KOG4237|consen  243 KFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLS  322 (498)
T ss_pred             hhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccc
Confidence                                  11 1367899999999999999999999999999999999999999988889999999


Q ss_pred             cCCccccccCcccCcCCCC-CccCCCCcccccCCCCccCC
Q 036754          176 YLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGS  214 (405)
Q Consensus       176 ~L~~l~l~~n~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~  214 (405)
                      .|+.|++.+|+|+..-|.. .....+..+.+-+|||.|.|
T Consensus       323 ~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC  362 (498)
T KOG4237|consen  323 GLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNC  362 (498)
T ss_pred             cceeeeecCCeeEEEecccccccceeeeeehccCcccCcc
Confidence            9999999999999766643 34567788889999999975

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=4.2e-21  Score=153.37  Aligned_cols=153  Identities=29%  Similarity=0.473  Sum_probs=111.4

Q ss_pred             ccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCC-----CCChhccCCCCCCEEec
Q 036754           60 LTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS-----VIPIEIGGLPNLEYLFL  134 (405)
Q Consensus        60 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~-----~~p~~~~~l~~L~~L~l  134 (405)
                      +.+++.|.||+|+++ .+|+.+. .+.+|+.|++++|+|+++|.++.++++|+.|++.     .+|..|+.+|.|+.||+
T Consensus        32 ~s~ITrLtLSHNKl~-~vppnia-~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldl  109 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPPNIA-ELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDL  109 (264)
T ss_pred             hhhhhhhhcccCcee-ecCCcHH-HhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhc
Confidence            344444555555554 4444443 4555555555555555555555555555555433     25566778899999999


Q ss_pred             cCCccc-ccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCccC
Q 036754          135 GYNRLQ-GSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCG  213 (405)
Q Consensus       135 ~~n~l~-~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~  213 (405)
                      +.|.+. ..+|..|..|+.|+.|++++|.+. .+|..+.++++|+.|.+..|.+-..+.+.+.+..+..+..+||.+..-
T Consensus       110 tynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~vl  188 (264)
T KOG0617|consen  110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLTVL  188 (264)
T ss_pred             cccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceeeec
Confidence            999885 478999999999999999999998 778889999999999999999987776778888888999999987654


Q ss_pred             CC
Q 036754          214 SP  215 (405)
Q Consensus       214 ~~  215 (405)
                      .|
T Consensus       189 pp  190 (264)
T KOG0617|consen  189 PP  190 (264)
T ss_pred             Ch
Confidence            44

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.78  E-value=3.2e-20  Score=175.08  Aligned_cols=132  Identities=27%  Similarity=0.428  Sum_probs=86.5

Q ss_pred             CCCCCCeeeCCCCCCCCCchhhhccccCccccCCC----------------------------CChhccCCCCCCEEecc
Q 036754           84 NLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV----------------------------IPIEIGGLPNLEYLFLG  135 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~----------------------------~p~~~~~l~~L~~L~l~  135 (405)
                      .|.+|..+|||.|++..+|+.+.++++|..|+++.                            +|..++.+++|+.|++.
T Consensus       220 ~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n  299 (1255)
T KOG0444|consen  220 DLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYAN  299 (1255)
T ss_pred             hhhhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhc
Confidence            45666666777777777777776666666666654                            45555555555555555


Q ss_pred             CCccc-ccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCccCC
Q 036754          136 YNRLQ-GSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS  214 (405)
Q Consensus       136 ~n~l~-~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~~  214 (405)
                      +|++. .-+|..++.+.+|+.+..++|.+. ..|..+..+..|+.|.+++|.+...+....-++.+..+++..||.+--.
T Consensus       300 ~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMP  378 (1255)
T KOG0444|consen  300 NNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMP  378 (1255)
T ss_pred             cCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCC
Confidence            55542 124555666666666666666665 6777777778888888888877654444555677788888888876654


Q ss_pred             CC
Q 036754          215 PN  216 (405)
Q Consensus       215 ~~  216 (405)
                      |.
T Consensus       379 PK  380 (1255)
T KOG0444|consen  379 PK  380 (1255)
T ss_pred             CC
Confidence            43

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=2.1e-18  Score=162.91  Aligned_cols=114  Identities=26%  Similarity=0.371  Sum_probs=103.8

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeecc---ccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      .|...+.||+|+|+++|+++. ..|+.||+|++.+.   .....+...+||++-+.++|||||+++++|++.+.+|||.|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            466788999999999999995 89999999999763   34567788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|++|+|..+++ +++.+++.++..+..||+.||.|||+
T Consensus        99 LC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~  136 (592)
T KOG0575|consen   99 LCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHS  136 (592)
T ss_pred             ecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHh
Confidence            999999999987 44589999999999999999999995

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=1.9e-18  Score=159.60  Aligned_cols=113  Identities=30%  Similarity=0.373  Sum_probs=100.2

Q ss_pred             CCccCcccccCCCceEEEe-eCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecC--CeeEEEEe
Q 036754          292 FSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE--EFKALVLE  366 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  366 (405)
                      |...++||+|.||.||+|. ..+|+.||+|+++.+.  .+......+||.++++++||||+++.+.....  ..+|||+|
T Consensus       119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe  198 (560)
T KOG0600|consen  119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE  198 (560)
T ss_pred             HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence            3445679999999999998 6789999999998765  34456678999999999999999999988765  68999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||++ ||..++...+..+++.+...++.|+++||+|||+
T Consensus       199 YMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~  236 (560)
T KOG0600|consen  199 YMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS  236 (560)
T ss_pred             cccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh
Confidence            9999 9999998877789999999999999999999995

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=5.6e-18  Score=152.87  Aligned_cols=114  Identities=23%  Similarity=0.329  Sum_probs=98.2

Q ss_pred             cCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccccc-------hhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeE
Q 036754          291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRR-------AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  362 (405)
                      .|...+.+|+|+||.|-.|. ..+|+.||||++.++...       ......+|+++|.+++|||||+++++++.+++.|
T Consensus       173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y  252 (475)
T KOG0615|consen  173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY  252 (475)
T ss_pred             eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence            34556889999999999998 568999999999764311       1234578999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||||+++|+|.+++...+ .+.+..-..++.|++.|+.|||+
T Consensus       253 mVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~  294 (475)
T KOG0615|consen  253 MVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHS  294 (475)
T ss_pred             EEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHH
Confidence            9999999999999998765 67777778899999999999995

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.72  E-value=4.3e-18  Score=165.14  Aligned_cols=113  Identities=27%  Similarity=0.423  Sum_probs=99.1

Q ss_pred             CCccCcccccCCCceEEEee-CCC----cEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          292 FSENNLISKGGFGSVYKARL-GDG----MEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      +..+++||+|+||+||+|.+ +.|    .+||+|++.... .+...++..|+..|++++|||+++++|+|.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34568899999999999985 554    468999987543 455788999999999999999999999997655 88999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|||.|+|.+|++.++..+.-...+.|++|||+||.|||+
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~  816 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE  816 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999988889999999999999999999984

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.71  E-value=9.4e-18  Score=158.18  Aligned_cols=113  Identities=27%  Similarity=0.486  Sum_probs=100.2

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +++.....||+|+||+||+|.+.  ..||||.+....  .+..+.|..|+.++++-+|.||+=++|||..... .||+.+
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw  468 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW  468 (678)
T ss_pred             HHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence            34455678999999999999985  379999998654  3456789999999999999999999999988777 899999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |++-+|+.+++..+..++..+...||.|||+||.|||.
T Consensus       469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA  506 (678)
T KOG0193|consen  469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA  506 (678)
T ss_pred             ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh
Confidence            99999999999877789999999999999999999994

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.71  E-value=9.8e-18  Score=150.90  Aligned_cols=111  Identities=25%  Similarity=0.368  Sum_probs=99.4

Q ss_pred             ccCcccccCCCceEEEee-CCCcEEEEEEeecccc---chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          294 ENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR---RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      ..+.+|+|.||+|-+|.- ..|+.||||.+++..-   ++.-.+.+||++|+.++||||++++..|+..+.+.|||||..
T Consensus        57 ~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS  136 (668)
T KOG0611|consen   57 ITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYAS  136 (668)
T ss_pred             HHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecC
Confidence            345799999999999984 6799999999987653   344457889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|++|+..++ .+++.++.++++||..|+.|+|.
T Consensus       137 ~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHk  171 (668)
T KOG0611|consen  137 GGELYDYISERG-SLSEREARHFFRQIVSAVHYCHK  171 (668)
T ss_pred             CccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhh
Confidence            999999998765 79999999999999999999994

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.71  E-value=2.9e-17  Score=140.31  Aligned_cols=113  Identities=27%  Similarity=0.429  Sum_probs=101.1

Q ss_pred             CCccCcccccCCCceEEEe-eCCCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |...+++|+|.||.||+|+ ..+|+.||||+++....  .......+||..++.++|+||+.+++++...+...||+|||
T Consensus         4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm   83 (318)
T KOG0659|consen    4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM   83 (318)
T ss_pred             hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence            3445789999999999999 57899999999986542  23456789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +. ||+..+++....++..+...++.++.+|++|||.
T Consensus        84 ~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~  119 (318)
T KOG0659|consen   84 PT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS  119 (318)
T ss_pred             cc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh
Confidence            98 9999999888889999999999999999999994

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.71  E-value=6.5e-17  Score=144.65  Aligned_cols=112  Identities=25%  Similarity=0.267  Sum_probs=98.9

Q ss_pred             CccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC-eeEEEEecCC
Q 036754          293 SENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE-FKALVLEYMP  369 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~  369 (405)
                      ...+.||+|..|+||++.. ++++.+|+|++.... ....+...+|++++.+.+||+||++||+|.... .++|+||||.
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD  161 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD  161 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence            4457799999999999994 678999999996554 345678899999999999999999999998888 5999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+.+... +.+++...-+|+.+|++||.|||+
T Consensus       162 gGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~  196 (364)
T KOG0581|consen  162 GGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE  196 (364)
T ss_pred             CCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Confidence            99999998765 478999999999999999999994

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.71  E-value=3.3e-17  Score=166.23  Aligned_cols=115  Identities=30%  Similarity=0.507  Sum_probs=101.3

Q ss_pred             cCCccCcccccCCCceEEEeeCC--C----cEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          291 KFSENNLISKGGFGSVYKARLGD--G----MEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~--~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      .....+.||+|+||.||+|++.+  |    ..||||.+++.. .+...+|..|..+|++++|||||+++|.|.+....+|
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            44556789999999999999643  3    348999997754 4567899999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~------~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|||++|||..||++.      ...++..+.+.+|.|||+|+.||++
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~  820 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES  820 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh
Confidence            99999999999999987      4679999999999999999999974

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.8e-17  Score=139.49  Aligned_cols=118  Identities=28%  Similarity=0.367  Sum_probs=102.6

Q ss_pred             hhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      +.++|...+.+|+|.||.||.|.. .++-.||+|++-+..   .+....+.+|+++-+.++||||.++++++.+....|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            345778889999999999999984 567899999986543   2334568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||++.|++...|+..+ ..+++...-.++.|+|.|+.|+|.
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~  142 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL  142 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc
Confidence            999999999999998544 468899999999999999999994

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.70  E-value=9.6e-17  Score=145.89  Aligned_cols=116  Identities=21%  Similarity=0.383  Sum_probs=100.6

Q ss_pred             ccCCccCcccccCCCceEEEeeC----CCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG----DGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      .+|...+.||+|+||.||+|...    .+..||+|.++.... .....+.+|+..+.+++||||++++|++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            34666788999999999999752    356899999876532 3345788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++......++|.++..++.|++.||+|||+
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~  125 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE  125 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999998755578999999999999999999995

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.69  E-value=1e-16  Score=145.13  Aligned_cols=111  Identities=38%  Similarity=0.578  Sum_probs=95.3

Q ss_pred             cCcccccCCCceEEEeeC-----CCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          295 NNLISKGGFGSVYKARLG-----DGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      .+.||.|+||.||+|.+.     .+..|+||.++.... .....|.+|++.+.+++||||++++|+|...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            357999999999999975     257899999965433 34678999999999999999999999999888899999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.++|... ...+++.++..|+.|||+||+|||+
T Consensus        84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~  121 (259)
T PF07714_consen   84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS  121 (259)
T ss_dssp             TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccc
Confidence            999999999887 4679999999999999999999994

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.69  E-value=5.9e-17  Score=142.65  Aligned_cols=119  Identities=23%  Similarity=0.306  Sum_probs=101.7

Q ss_pred             HhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeec--CCe
Q 036754          286 CRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSN--EEF  360 (405)
Q Consensus       286 ~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~  360 (405)
                      |+..++|...+.|++|.||.||+|+. .+++.||+|+++....  .....-.+||.++.+++|||||.+......  -+.
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            44455677778899999999999994 6789999999976542  233456899999999999999999988765  467


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|||||||++ ||...+..-++.+...+...+..|+++|++|||+
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~  195 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD  195 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh
Confidence            9999999999 9999998777789999999999999999999995

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.69  E-value=2e-16  Score=144.48  Aligned_cols=109  Identities=24%  Similarity=0.358  Sum_probs=94.2

Q ss_pred             cccccCCCceEEEeeCC-------------------------CcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceE
Q 036754          297 LISKGGFGSVYKARLGD-------------------------GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKV  351 (405)
Q Consensus       297 ~lg~G~fg~v~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  351 (405)
                      .||+|+||.||+|....                         ...||+|.+..........+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997421                         13588998876544455678889999999999999999


Q ss_pred             EeeeecCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       352 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|......++||||+++|+|..+++..+..+++..++.++.||++||+|||+
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~  135 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED  135 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc
Confidence            999999999999999999999999997655678999999999999999999995

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.67  E-value=2.1e-16  Score=141.38  Aligned_cols=116  Identities=28%  Similarity=0.385  Sum_probs=103.7

Q ss_pred             hccCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          289 TYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      .++|...++||+|+||+||.++ ..+++.+|+|++++..   ..+.....+|..++.+++||.||+++..+.+.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4678889999999999999988 4578999999998753   33456678899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||+.||+|..+|.+.+ .+++..+.-++..|+.||.|||+
T Consensus       104 ld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~  143 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHS  143 (357)
T ss_pred             EeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHh
Confidence            99999999999998654 78999899999999999999995

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.67  E-value=2.3e-16  Score=136.79  Aligned_cols=115  Identities=27%  Similarity=0.362  Sum_probs=101.8

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc---chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR---RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.+|.|+||+|...+. .+|..+|+|++.++.-   +..+....|..+++.+.||.++++++.+.+.+.+||||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            4566778899999999999884 5688999999987642   33445667999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|.|+.++++.+ .+++..+.-+|.||+.|++|||+
T Consensus       124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~  162 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHS  162 (355)
T ss_pred             eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHh
Confidence            9999999999999765 79999999999999999999995

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.67  E-value=3.7e-16  Score=148.69  Aligned_cols=114  Identities=18%  Similarity=0.324  Sum_probs=100.4

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||.||+|.. .+|+.||||++....   ......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            567778999999999999985 568999999997542   2334567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+ .+++..+..++.|++.||+|||+
T Consensus        82 ~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~  119 (364)
T cd05599          82 YLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHK  119 (364)
T ss_pred             CCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999997654 68999999999999999999995

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.66  E-value=4.3e-16  Score=141.15  Aligned_cols=115  Identities=28%  Similarity=0.399  Sum_probs=98.5

Q ss_pred             cCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCC--eeEEEEec
Q 036754          291 KFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE--FKALVLEY  367 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~  367 (405)
                      ++...+.||+|+||+||.+... +|...|||..........+...+|+.++++++|||||+.+|.....+  ..++.|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            3455678999999999999964 48999999987654333566889999999999999999999855544  68899999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++.+.+..+++....++.+||++||+|||+
T Consensus        98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs  135 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS  135 (313)
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999998765579999999999999999999994

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.66  E-value=7.5e-16  Score=139.09  Aligned_cols=114  Identities=25%  Similarity=0.373  Sum_probs=99.9

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +|...+.||+|+||.||++...++..+|+|.+.... .....+..|+.++.+++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            456667899999999999998777889999876432 2345788899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.++++.....++|..+..++.|+++||+|||+
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  118 (256)
T cd05114          84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER  118 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999997655568999999999999999999995

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.65  E-value=8.7e-16  Score=139.66  Aligned_cols=120  Identities=24%  Similarity=0.319  Sum_probs=103.8

Q ss_pred             HhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          286 CRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       286 ~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      ..+++++.....||+|+||.||+|.. .++..||+|.+........+.+.+|+.++.+++|+||+++++++...+..+++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            34566677778899999999999984 46788999998765555567889999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCC--CHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCIL--DIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l--~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||+++++|.++++.....+  ++..+..++.||++||+|||+
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~  126 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD  126 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999998654445  788889999999999999994

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PHA02988 hypothetical protein; Provisional

Probab=99.65  E-value=1.2e-15  Score=139.89  Aligned_cols=109  Identities=23%  Similarity=0.315  Sum_probs=94.8

Q ss_pred             cCcccccCCCceEEEeeCCCcEEEEEEeeccccch---hHHHHHHHHHhhcCCCCCcceEEeeeec----CCeeEEEEec
Q 036754          295 NNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRA---FKSFDIECEMMKSIRHQNLIKVISSCSN----EEFKALVLEY  367 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  367 (405)
                      ...+|+|++|.||+|.. +|+.||||+++......   .+.|.+|+.++.+++|||||+++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36789999999999998 78899999997543222   4678899999999999999999999876    3567899999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++...+ .++|..+.+++.|++.||+|||.
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~  140 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYK  140 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHh
Confidence            99999999997654 78999999999999999999994

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.65  E-value=9.5e-16  Score=144.24  Aligned_cols=116  Identities=22%  Similarity=0.340  Sum_probs=100.2

Q ss_pred             hccCCccCcccccCCCceEEEe-eCCCcEEEEEEeecc----cc-chhHHHHHHHHHhhcCC-CCCcceEEeeeecCCee
Q 036754          289 TYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQ----CR-RAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEFK  361 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~  361 (405)
                      ...|...+.||+|+||+|+.|. ..++..||+|.+...    .. ...+...+|+.++++++ ||||++++.++......
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            3456677889999999999998 457899999977553    11 23445668999999999 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+||||+.+|+|.+++.+ .+.+.+.++..++.|++.|++|||.
T Consensus        96 ~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~  138 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS  138 (370)
T ss_pred             EEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh
Confidence            999999999999999988 4578999999999999999999994

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.65  E-value=6e-16  Score=147.72  Aligned_cols=89  Identities=22%  Similarity=0.389  Sum_probs=75.4

Q ss_pred             cCCccCcccccCCCceEEEee------CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeE
Q 036754          291 KFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  362 (405)
                      +|...+.||+|+||.||+|+.      ..+..||||+++... ......+.+|+.++..+ +||||++++++|...+..+
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~  115 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL  115 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence            456678899999999999973      235689999987543 33456788999999999 8999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhc
Q 036754          363 LVLEYMPHGSLEKYLYS  379 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~  379 (405)
                      +||||+++|+|.++++.
T Consensus       116 lv~E~~~~g~L~~~l~~  132 (375)
T cd05104         116 VITEYCCYGDLLNFLRR  132 (375)
T ss_pred             eeehhccCCcHHHHHHh
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.65  E-value=1.2e-15  Score=145.98  Aligned_cols=114  Identities=19%  Similarity=0.284  Sum_probs=99.3

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||.||++.. .+|+.||+|++....   ......+.+|++++.+++|||||++++++.+.+..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            566678899999999999984 578999999986532   2334567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+ .+++..+..++.|++.||+|||+
T Consensus        82 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~  119 (377)
T cd05629          82 FLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHK  119 (377)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999997543 68898999999999999999995

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.65  E-value=1.2e-15  Score=145.09  Aligned_cols=114  Identities=18%  Similarity=0.294  Sum_probs=100.0

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||+||++.. .+++.||+|+++...   ......+.+|+.++.+++|+||+++++.+.+....|+|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            567778999999999999984 568899999997543   2334567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+ .+++.++..++.|++.||+|||+
T Consensus        82 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~  119 (363)
T cd05628          82 FLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQ  119 (363)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999997654 78999999999999999999995

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.65  E-value=6.6e-16  Score=142.29  Aligned_cols=114  Identities=25%  Similarity=0.345  Sum_probs=99.5

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||.||+|.. .+|+.||+|++....   ......+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            466678899999999999985 468999999986532   2334567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+ .+++..+..++.|+++||+|||+
T Consensus        82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~  119 (291)
T cd05612          82 YVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHS  119 (291)
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999997654 68999999999999999999995

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.64  E-value=1.4e-15  Score=141.10  Aligned_cols=115  Identities=23%  Similarity=0.452  Sum_probs=96.7

Q ss_pred             cCCccCcccccCCCceEEEeeC-----------------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEE
Q 036754          291 KFSENNLISKGGFGSVYKARLG-----------------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVI  352 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~  352 (405)
                      +|...+.||+|+||.||++...                 ++..||+|.++... ......|.+|+.++.+++||||++++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   85 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL   85 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence            4556688999999999999743                 23479999987643 23456789999999999999999999


Q ss_pred             eeeecCCeeEEEEecCCCCCHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          353 SSCSNEEFKALVLEYMPHGSLEKYLYSSN------------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       353 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++...+..++||||+++|+|.+++....                  ..++|....+++.||+.||+|||+
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~  156 (304)
T cd05096          86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS  156 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999986431                  246888999999999999999995

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.64  E-value=1.3e-15  Score=145.90  Aligned_cols=114  Identities=18%  Similarity=0.265  Sum_probs=99.4

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      .|...+.||+|+||+||+|.. .+++.||+|++....   ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            356678899999999999984 568899999997542   2345578899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+ .+++..+..++.|++.||+|||.
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~  119 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHK  119 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999997654 68899999999999999999994

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.64  E-value=3e-16  Score=146.90  Aligned_cols=113  Identities=28%  Similarity=0.395  Sum_probs=99.3

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +|...+.||+|+||+||||+. .+...||+|.+.+..  .++.+...+|++++++++|||||.++++|++....++|+||
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~   82 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY   82 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence            345556799999999999984 467889999996653  34567789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +.+ +|+.+|...+ .+.+.+...|+.|...||.|||+
T Consensus        83 a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs  118 (808)
T KOG0597|consen   83 AVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHS  118 (808)
T ss_pred             hhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            987 9999997644 79999999999999999999995

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.64  E-value=1.7e-15  Score=141.61  Aligned_cols=109  Identities=25%  Similarity=0.318  Sum_probs=95.5

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHG  371 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  371 (405)
                      +.||+|+||.||++.. .+|..||+|+++...   ......+.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3689999999999984 578999999997542   234456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          372 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       372 ~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|..++...+ .+++..+..++.|+++||+|||+
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~  113 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHS  113 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999887543 68999999999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.64  E-value=2e-15  Score=137.07  Aligned_cols=116  Identities=25%  Similarity=0.430  Sum_probs=101.1

Q ss_pred             ccCCccCcccccCCCceEEEeeC----CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG----DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      ++|+..+.||+|+||+||+|...    +...||+|.++... ......|.+|+..+.+++|+||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            45777889999999999999863    23579999987543 33456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++......+++.++.+++.|++.|++|||+
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~  124 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE  124 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999997765678999999999999999999995

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.64  E-value=2e-15  Score=141.24  Aligned_cols=109  Identities=25%  Similarity=0.306  Sum_probs=95.8

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHG  371 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  371 (405)
                      +.||+|+||.||++.. .+|+.||+|+++...   ......+.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999985 578999999997542   233456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          372 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       372 ~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|.+++...+ .+++.++..++.||+.||+|||+
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~  113 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLHS  113 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999987644 68999999999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.64  E-value=2.7e-16  Score=148.58  Aligned_cols=116  Identities=27%  Similarity=0.452  Sum_probs=100.4

Q ss_pred             hhccCCccCcccccCCCceEEEeeCC-CcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          288 ATYKFSENNLISKGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ...++....++|-|.||.||.|.|.. ...||||.++.+ .-...+|+.|..+|..++|||+|+++|.|+.+...|||+|
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            34456667889999999999999754 568999999754 3457899999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhc
Q 036754          367 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      ||.+|+|.+||+.+. ..++---.+.+|.||+.||+||.
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE  382 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE  382 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH
Confidence            999999999999875 34666677899999999999984

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.64  E-value=1.4e-15  Score=145.80  Aligned_cols=91  Identities=23%  Similarity=0.384  Sum_probs=76.0

Q ss_pred             hccCCccCcccccCCCceEEEeeC------CCcEEEEEEeecccc-chhHHHHHHHHHhhcCC-CCCcceEEeeeecCCe
Q 036754          289 TYKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEF  360 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  360 (405)
                      .++|...+.||+|+||.||+|+..      .+..||||+++.... ...+.+.+|+.++.+++ |||||+++++|.....
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            345666788999999999999842      235799999975432 33567899999999996 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhc
Q 036754          361 KALVLEYMPHGSLEKYLYS  379 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~  379 (405)
                      .+|||||+++|+|.++++.
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~  134 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHK  134 (400)
T ss_pred             eEEEEEecCCCcHHHHHHH
Confidence            9999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.64  E-value=3.4e-16  Score=136.18  Aligned_cols=112  Identities=23%  Similarity=0.262  Sum_probs=95.2

Q ss_pred             CccCcccccCCCceEEEe-eCCCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          293 SENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      ....++|+|+||+||+++ -.+|+.||||++.....  ...+-.++||+++++++|+|+|.++.+|......++|+|||+
T Consensus         5 E~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~d   84 (396)
T KOG0593|consen    5 EKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCD   84 (396)
T ss_pred             hhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecc
Confidence            344678999999999999 45799999999976533  234557899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      . ++.+-|......++.....+++.|+++|++|+|.
T Consensus        85 h-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk  119 (396)
T KOG0593|consen   85 H-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK  119 (396)
T ss_pred             h-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh
Confidence            8 5555565555578999999999999999999994

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.64  E-value=1.7e-15  Score=136.79  Aligned_cols=114  Identities=24%  Similarity=0.368  Sum_probs=99.3

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +|...+.||+|+||.||.|...++..+|+|.+.... .....+.+|+.++.+++||||+++++++...+..+++|||+++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            455567899999999999987666779999886432 2345688999999999999999999999988889999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++......+++.++..++.||++||+|||+
T Consensus        84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~  118 (256)
T cd05113          84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES  118 (256)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999997655578999999999999999999995

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.63  E-value=1.9e-15  Score=141.80  Aligned_cols=115  Identities=20%  Similarity=0.236  Sum_probs=100.0

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||.||++.. .+++.||+|++.+..   ....+.+.+|+.++..++|+||+++++++...+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            466678899999999999985 468899999997532   2234567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++......+++..+..++.||+.||+|||+
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~  120 (331)
T cd05597          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ  120 (331)
T ss_pred             cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999997655578999999999999999999995

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.63  E-value=1.8e-15  Score=141.95  Aligned_cols=115  Identities=21%  Similarity=0.287  Sum_probs=100.1

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      .+|...+.||+|+||.||+|.. .+|+.||+|.+....   ......+.+|+.++.+++||||+++++++...+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            4566678899999999999995 468899999997542   233456889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+ .+++..+..++.|+++||+|||+
T Consensus        98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~  136 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHS  136 (329)
T ss_pred             cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997654 68888999999999999999995

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.63  E-value=2.1e-15  Score=144.11  Aligned_cols=114  Identities=19%  Similarity=0.277  Sum_probs=99.2

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||.||++.. .+++.||+|.+....   ......+.+|++++.+++|+||+++++.+...+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            466778899999999999984 568999999986532   2334567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+ .+++.....++.||+.||+|||+
T Consensus        82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~  119 (376)
T cd05598          82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHK  119 (376)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999997654 68888889999999999999995

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.63  E-value=2.3e-15  Score=141.45  Aligned_cols=114  Identities=22%  Similarity=0.375  Sum_probs=99.7

Q ss_pred             cCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||.||+|... +++.||+|++....   ......+..|+.++..++||||+++++++...+..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            4666788999999999999964 58899999997543   2334567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+ .+++.++..++.|++.||+|||+
T Consensus        82 ~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~  119 (333)
T cd05600          82 YVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHE  119 (333)
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999997544 68999999999999999999994

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.63  E-value=3.1e-15  Score=134.66  Aligned_cols=109  Identities=26%  Similarity=0.452  Sum_probs=96.3

Q ss_pred             cccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCHH
Q 036754          297 LISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLE  374 (405)
Q Consensus       297 ~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  374 (405)
                      .||+|+||.||+|+. .+++.||+|...... ......+.+|++++.+++|+||+++++++...+..++||||+++|+|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            589999999999985 578899999876433 234467889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          375 KYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       375 ~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++......+++.++..++.|+++||+|||+
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~  112 (252)
T cd05084          82 TFLRTEGPRLKVKELIQMVENAAAGMEYLES  112 (252)
T ss_pred             HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9997655568999999999999999999994

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.63  E-value=1.1e-15  Score=143.94  Aligned_cols=116  Identities=21%  Similarity=0.371  Sum_probs=95.2

Q ss_pred             ccCCccCcccccCCCceEEEee------CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecC-Ce
Q 036754          290 YKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNE-EF  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~  360 (405)
                      ++|...+.||+|+||.||+|..      ..++.||||+++... ......+.+|+.++.++ +||||++++++|... ..
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            4566678899999999999973      235689999987543 23346788999999999 899999999988764 45


Q ss_pred             eEEEEecCCCCCHHHHHhcCC-----------------------------------------------------------
Q 036754          361 KALVLEYMPHGSLEKYLYSSN-----------------------------------------------------------  381 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  381 (405)
                      .++||||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            789999999999999987431                                                           


Q ss_pred             --CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          382 --CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       382 --~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                        ..+++.++..++.||++||+|||+
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~  192 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLAS  192 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence              247788899999999999999995

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.63  E-value=3e-15  Score=140.28  Aligned_cols=109  Identities=26%  Similarity=0.336  Sum_probs=95.8

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHG  371 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  371 (405)
                      +.||+|+||.||++.. .+|+.||+|++....   ......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999984 578999999997542   334567788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          372 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       372 ~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|..++...+ .+++.++..++.|+++||+|||.
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~  113 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHS  113 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999887543 68999999999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.63  E-value=2.9e-15  Score=137.47  Aligned_cols=115  Identities=32%  Similarity=0.477  Sum_probs=98.8

Q ss_pred             cCCccCcccccCCCceEEEee-----CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeec--CCeeEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN--EEFKAL  363 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  363 (405)
                      +|...+.||+|+||.||++..     .++..||+|.+........+.+.+|++++.+++|+||+++++++..  ....++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   84 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL   84 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence            456678899999999999874     2578899999876655556788999999999999999999998754  346889


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++...+..++|..+..++.|+++||+|||+
T Consensus        85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~  126 (284)
T cd05081          85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS  126 (284)
T ss_pred             EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999997655568999999999999999999995

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.63  E-value=2.9e-15  Score=140.76  Aligned_cols=115  Identities=18%  Similarity=0.228  Sum_probs=100.6

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||.||++.. .++..+|+|.+..... .....+.+|++++.+++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            5677788999999999999985 4678899998875432 3346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++...+ .+++.....++.|+++||+|||+
T Consensus        85 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~  121 (333)
T cd06650          85 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE  121 (333)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999997644 68899999999999999999994

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.63  E-value=2.3e-15  Score=144.26  Aligned_cols=114  Identities=18%  Similarity=0.276  Sum_probs=99.3

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      .|...+.||+|+||.||+|.. .+++.||+|++....   ......+.+|+.++.+++|+|||++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            356678899999999999984 568899999997543   2334568889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+ .+++.....++.||+.||+|||+
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~  119 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHK  119 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999987643 68888899999999999999995

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.63  E-value=2.8e-15  Score=140.70  Aligned_cols=115  Identities=18%  Similarity=0.207  Sum_probs=101.0

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||.||+++. .+|..||+|.+..... .....+.+|++++.+++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            4677778999999999999995 4688899999875432 3356789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++.... .+++..+..++.|+++||+|||+
T Consensus        85 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~  121 (331)
T cd06649          85 MDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLRE  121 (331)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhh
Confidence            99999999997644 68899999999999999999994

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.63  E-value=3.6e-15  Score=135.50  Aligned_cols=115  Identities=27%  Similarity=0.352  Sum_probs=100.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      .+|...+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++.+++|+||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            3566778899999999999995 578899999987554445566788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++.... .+++.++..++.|+++||+|||+
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~  124 (267)
T cd06646          89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHS  124 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999987543 68999999999999999999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.63  E-value=1.4e-16  Score=146.42  Aligned_cols=112  Identities=23%  Similarity=0.356  Sum_probs=97.1

Q ss_pred             CCccCcccccCCCceEEEe-eCCCcEEEEEEeeccccchhHH--HHHHHHHhhcCC-CCCcceEEeeeecCC-eeEEEEe
Q 036754          292 FSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKS--FDIECEMMKSIR-HQNLIKVISSCSNEE-FKALVLE  366 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~lv~e  366 (405)
                      |...+.+|.|.||.||+|+ ..+|+.||||+++..- ..+++  =+||+..++++. |||||++.+.+.+.+ .+|+|||
T Consensus        12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE   90 (538)
T KOG0661|consen   12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE   90 (538)
T ss_pred             HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-ccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence            3445679999999999999 6788999999986532 12333  267999999998 999999999998877 8999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+. +|++.+++++..+++.++..|+.||.+||+|+|.
T Consensus        91 ~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk  128 (538)
T KOG0661|consen   91 FMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK  128 (538)
T ss_pred             hhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh
Confidence            9988 9999999888899999999999999999999994

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.63  E-value=2.8e-15  Score=135.97  Aligned_cols=109  Identities=21%  Similarity=0.371  Sum_probs=94.3

Q ss_pred             cccccCCCceEEEeeCC-------------CcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          297 LISKGGFGSVYKARLGD-------------GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       297 ~lg~G~fg~v~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      .||+|+||.||+|+...             +..||+|.+..........+..|+..+..++||||+++++++......++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            58999999999998532             23588898866555555678889999999999999999999999889999


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|..++......+++..+..++.||++||+|||+
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  123 (262)
T cd05077          82 VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED  123 (262)
T ss_pred             EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh
Confidence            999999999999987655578999999999999999999995

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.63  E-value=1.8e-15  Score=137.00  Aligned_cols=117  Identities=26%  Similarity=0.427  Sum_probs=103.6

Q ss_pred             hccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ..+|...+.||+|+||.||+|...++..+|+|.+..........+..|+.++.+++|+||+++++++...+..++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            34566678899999999999998778999999997665545667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++.+.. ..+++.++..++.|+++|++|||+
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~  122 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE  122 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999997643 468999999999999999999995

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.63  E-value=2.6e-15  Score=141.36  Aligned_cols=115  Identities=21%  Similarity=0.250  Sum_probs=99.1

Q ss_pred             ccCCccCcccccCCCceEEEeeCC--CcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLGD--GMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      ++|...+.||+|+||.||+|....  +..||+|.+....   ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            456677889999999999998532  3689999986532   23455688899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++...+ .+++..+..++.|++.||+|||+
T Consensus       110 ~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~  149 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQS  149 (340)
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999997654 68999999999999999999995

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.62  E-value=3.3e-15  Score=138.80  Aligned_cols=114  Identities=19%  Similarity=0.201  Sum_probs=99.4

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +|...+.||+|+||.||++.. .++..+|+|.+..... .....+.+|++++.+++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            567778899999999999984 5678899998865432 23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++... ..+++..+..++.|+++||+|||+
T Consensus        82 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~  117 (308)
T cd06615          82 DGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLRE  117 (308)
T ss_pred             CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999765 368899999999999999999994

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.62  E-value=2.9e-15  Score=137.61  Aligned_cols=114  Identities=20%  Similarity=0.284  Sum_probs=98.1

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      |...+.||+|+||.||++.. .+|+.||+|.+....   ......+.+|+.++.+++|++++++.+++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            45667899999999999985 678999999986543   22334678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++.... ..+++..+..++.|++.||+|||+
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  120 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR  120 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999998886533 368999999999999999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.62  E-value=3.4e-15  Score=138.96  Aligned_cols=107  Identities=23%  Similarity=0.243  Sum_probs=94.2

Q ss_pred             ccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCH
Q 036754          298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL  373 (405)
Q Consensus       298 lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  373 (405)
                      ||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999985 467899999987532   33445678899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          374 EKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       374 ~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+++...+ .+++..+..++.|+++||+|||+
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~  111 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLHK  111 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            99997643 68999999999999999999995

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.62  E-value=2.7e-15  Score=137.29  Aligned_cols=116  Identities=21%  Similarity=0.348  Sum_probs=102.6

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ++|...+.||+|+||.||++.. .++..||+|............+.+|+.++++++|+|++++++.+......++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            3455667799999999999986 468899999987665555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++...+..+++..+..++.|++.||+|||+
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~  121 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS  121 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999997765679999999999999999999994

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.62  E-value=3.7e-15  Score=139.87  Aligned_cols=115  Identities=20%  Similarity=0.216  Sum_probs=99.5

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++..++|++|+++++++...+..|+|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            566678899999999999985 467889999986532   2234557788999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++......+++..+..++.|++.||+|||+
T Consensus        82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~  120 (331)
T cd05624          82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ  120 (331)
T ss_pred             CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999998655578999999999999999999994

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.62  E-value=9.4e-16  Score=155.32  Aligned_cols=159  Identities=23%  Similarity=0.288  Sum_probs=75.3

Q ss_pred             cccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCC
Q 036754           38 SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS  117 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~  117 (405)
                      +|+.|+|++|++.. +|..+.  .+|+.|+|++|+++ .+|..++   ++|+.|+|++|+|+.+|..+.  ..|+.|+++
T Consensus       242 ~L~~L~Ls~N~L~~-LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~---~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls  312 (754)
T PRK15370        242 TIQEMELSINRITE-LPERLP--SALQSLDLFHNKIS-CLPENLP---EELRYLSVYDNSIRTLPAHLP--SGITHLNVQ  312 (754)
T ss_pred             cccEEECcCCccCc-CChhHh--CCCCEEECcCCccC-ccccccC---CCCcEEECCCCccccCcccch--hhHHHHHhc
Confidence            44555555555442 333332  35666666666665 5555442   366777777777766654332  123333222


Q ss_pred             C-----CChhcc-------------------CCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHh
Q 036754          118 V-----IPIEIG-------------------GLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEK  173 (405)
Q Consensus       118 ~-----~p~~~~-------------------~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  173 (405)
                      .     +|..+.                   -.++|+.|++++|++. .+|..+.  ++|+.|++++|.++. +|..+. 
T Consensus       313 ~N~Lt~LP~~l~~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~-  387 (754)
T PRK15370        313 SNSLTALPETLPPGLKTLEAGENALTSLPASLPPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLP-  387 (754)
T ss_pred             CCccccCCccccccceeccccCCccccCChhhcCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-CCHhHH-
Confidence            1     222111                   0134555555555554 3343332  355555555555553 233332 


Q ss_pred             cccCCccccccCcccCcCCCC----CccCCCCcccccCCCCc
Q 036754          174 LLYLKDLNLSFNKLEGEIPRG----GSFGNFSAESFEGNELL  211 (405)
Q Consensus       174 l~~L~~l~l~~n~l~~~~p~~----~~~~~~~~~~~~~n~~~  211 (405)
                       ..|+.|++++|++.+.+...    ...+++..+.+.+|++.
T Consensus       388 -~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        388 -AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             -HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCcc
Confidence             24555566666655322111    11234455666677654

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=2.3e-15  Score=137.33  Aligned_cols=108  Identities=32%  Similarity=0.509  Sum_probs=88.8

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhh--cCCCCCcceEEeeeecC----CeeEEE
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMK--SIRHQNLIKVISSCSNE----EFKALV  364 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~----~~~~lv  364 (405)
                      ++...+.||+|.||.||+|.+ .|+.||||++...+   ...|.+|.++..  -++|+||..+++.=...    .+++||
T Consensus       212 qI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             eeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            455668899999999999999 68899999996443   334555555554  46999999998864432    368899


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhc
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      ++|.++|+|+|||..  ..++-...++++..+|.||++||
T Consensus       288 TdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH  325 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLH  325 (513)
T ss_pred             eecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHH
Confidence            999999999999976  46899999999999999999999

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.61  E-value=3.7e-15  Score=136.85  Aligned_cols=114  Identities=21%  Similarity=0.301  Sum_probs=97.8

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      |...++||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++.+++|+||+++++++...+..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            45667899999999999985 568999999996542   12234577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++.... ..+++..+..++.|++.||+|||+
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  120 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR  120 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999886543 468999999999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.61  E-value=5.4e-15  Score=138.43  Aligned_cols=109  Identities=24%  Similarity=0.301  Sum_probs=95.0

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHG  371 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  371 (405)
                      +.||+|+||.||++.. .+|+.||+|.+....   ......+..|++++..++|+||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3589999999999984 578999999997542   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          372 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       372 ~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|..++...+ .+++.++..++.|+++||+|||+
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~  113 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHS  113 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999886544 68999999999999999999993

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.61  E-value=2.9e-15  Score=142.75  Aligned_cols=117  Identities=21%  Similarity=0.256  Sum_probs=100.1

Q ss_pred             hhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeE
Q 036754          287 RATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       287 ~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  362 (405)
                      ...++|...+.||+|+||.||+++. .+++.||+|++....   ......+..|+.++..++||||+++++++.+.+..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            3445677788999999999999985 468899999996532   223445778999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++...  .+++..+..++.|+++||+|||+
T Consensus       120 lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~  160 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHS  160 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999998754  47888888999999999999995

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.61  E-value=5.2e-15  Score=134.51  Aligned_cols=116  Identities=25%  Similarity=0.421  Sum_probs=99.2

Q ss_pred             ccCCccCcccccCCCceEEEeeC----CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG----DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      .+|...+.||+|+||.||+|...    .+..+|+|.++... ......+..|+.++.+++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            34566788999999999999853    23479999886543 33456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++......+++.++..++.|++.|++|||+
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~  124 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD  124 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999998665568999999999999999999994

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.61  E-value=5.1e-15  Score=138.18  Aligned_cols=109  Identities=22%  Similarity=0.314  Sum_probs=94.5

Q ss_pred             CcccccCCCceEEEee----CCCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          296 NLISKGGFGSVYKARL----GDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      +.||+|+||.||++..    .+|+.||+|++.....  .....+..|++++.+++||||+++++++...+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4689999999999874    3578999999975432  234456789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++.... .+++..+..++.||++||+|||+
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~  116 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHS  116 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999996543 68999999999999999999995

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.61  E-value=4.1e-15  Score=139.59  Aligned_cols=115  Identities=21%  Similarity=0.279  Sum_probs=100.7

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||.||++.. .+|+.||+|+++...   ......+.+|+.++..++|+||+++++++...+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            466678899999999999985 578899999997543   2344567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++......+++..+..++.|+++||+|||+
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~  120 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ  120 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999998765579999999999999999999994

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.61  E-value=6.2e-15  Score=138.27  Aligned_cols=109  Identities=19%  Similarity=0.231  Sum_probs=94.5

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      ++||+|+||.||++.. .+++.||+|+++...   ......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3689999999999985 568899999997542   23345577899999888 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++...+ .+++..+..++.|++.||+|||.
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~  114 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHE  114 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999886543 69999999999999999999994

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.61  E-value=4.8e-15  Score=134.19  Aligned_cols=115  Identities=23%  Similarity=0.387  Sum_probs=100.4

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      ++|...+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++.+++|+||+++++++...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            4566778899999999999998788889999876432 235678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++... ...+++.++..++.|+++||+|||+
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~  121 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER  121 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999753 3468899999999999999999995

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.61  E-value=4.4e-15  Score=138.51  Aligned_cols=115  Identities=24%  Similarity=0.386  Sum_probs=97.5

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCc----EEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGM----EVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      .+|...+.||+|+||.||+|++. ++.    .||+|.++... ....+++..|+.++..++|+||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            35777889999999999999853 343    38999986543 34456788999999999999999999998764 5679


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||+++|+|.+++......+++....+++.||++||+|||+
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~  127 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE  127 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999998766678999999999999999999995

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.61  E-value=4.6e-15  Score=141.23  Aligned_cols=120  Identities=20%  Similarity=0.249  Sum_probs=102.1

Q ss_pred             HHHhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC
Q 036754          284 ELCRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE  359 (405)
Q Consensus       284 ~~~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  359 (405)
                      ++....++|...+.||+|+||.||++.. .+++.||+|.+.+..   ......+.+|+.++..++||||+++++++..++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            3344456788888999999999999985 467899999986532   223456778999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++||||+++|+|.+++...  .+++..+..++.||+.||+|||+
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~  160 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHS  160 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999654  47888999999999999999995

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.61  E-value=6e-15  Score=133.21  Aligned_cols=114  Identities=26%  Similarity=0.396  Sum_probs=99.4

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +|...+.||+|+||.||++....+..+|+|.+.... .....+.+|+.++.+++|+||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            355667899999999999998777789999886432 2335688899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|.++++.....++|.....++.|+++|++|||+
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~  118 (256)
T cd05059          84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES  118 (256)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999998655578999999999999999999994

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.61  E-value=6.1e-15  Score=135.64  Aligned_cols=115  Identities=22%  Similarity=0.349  Sum_probs=98.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||.||+|.. .++..||+|+++... ......+.+|+.++.+++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            3566678899999999999985 468899999986543 22345677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++ +|.+++...+..+++..+..++.||++||+|||+
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~  121 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK  121 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            985 9999987666568899999999999999999995

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=1.4e-15  Score=142.98  Aligned_cols=113  Identities=27%  Similarity=0.377  Sum_probs=102.3

Q ss_pred             cCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      .|.....||+|+-|.||.|. ..++..||||++........+-...|+.+|+..+|+|||.++..|...+.+|+|||||+
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~  353 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME  353 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence            45566789999999999998 67889999999988777777788999999999999999999998888899999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+.+...  .+++.+...||+++++||+|||.
T Consensus       354 ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~  387 (550)
T KOG0578|consen  354 GGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHA  387 (550)
T ss_pred             CCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHh
Confidence            99999998654  59999999999999999999994

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.60  E-value=1.2e-15  Score=154.65  Aligned_cols=160  Identities=23%  Similarity=0.356  Sum_probs=104.3

Q ss_pred             cCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhc--------
Q 036754           12 CLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGS--------   83 (405)
Q Consensus        12 ~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--------   83 (405)
                      +|+.|+|++|.+.. +|.. +   +.+|+.|+|++|+++. +|..+.  ++|+.|+|++|+|+ .+|..+..        
T Consensus       242 ~L~~L~Ls~N~L~~-LP~~-l---~s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp~sL~~L~Ls  312 (754)
T PRK15370        242 TIQEMELSINRITE-LPER-L---PSALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIR-TLPAHLPSGITHLNVQ  312 (754)
T ss_pred             cccEEECcCCccCc-CChh-H---hCCCCEEECcCCccCc-cccccC--CCCcEEECCCCccc-cCcccchhhHHHHHhc
Confidence            34445555555442 2322 1   2367777777777764 455443  36777777777766 44433210        


Q ss_pred             ----------CCCCCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccc
Q 036754           84 ----------NLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFG  148 (405)
Q Consensus        84 ----------~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~  148 (405)
                                -.++|+.|++++|.++.+|..+.  ++|+.|+++.     +|..+  .++|++|++++|.++ .+|..+.
T Consensus       313 ~N~Lt~LP~~l~~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~~LP~~l--p~~L~~LdLs~N~Lt-~LP~~l~  387 (754)
T PRK15370        313 SNSLTALPETLPPGLKTLEAGENALTSLPASLP--PELQVLDVSKNQITVLPETL--PPTITTLDVSRNALT-NLPENLP  387 (754)
T ss_pred             CCccccCCccccccceeccccCCccccCChhhc--CcccEEECCCCCCCcCChhh--cCCcCEEECCCCcCC-CCCHhHH
Confidence                      12456777777777776665543  4677776654     55544  368999999999999 4666554


Q ss_pred             cCCCCCeeecccccccCccchhHHh----cccCCccccccCccc
Q 036754          149 DLISLKSLNLSKNNLSGAIPASLEK----LLYLKDLNLSFNKLE  188 (405)
Q Consensus       149 ~l~~L~~L~l~~n~l~~~~~~~~~~----l~~L~~l~l~~n~l~  188 (405)
                        ..|+.|++++|++. .+|..+..    ++.+..+++.+|++.
T Consensus       388 --~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        388 --AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             --HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence              37999999999998 45655544    477899999999986

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.60  E-value=9.7e-15  Score=131.26  Aligned_cols=110  Identities=29%  Similarity=0.466  Sum_probs=97.2

Q ss_pred             CcccccCCCceEEEeeCCCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCHH
Q 036754          296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLE  374 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  374 (405)
                      ++||+|+||.||+|...++..+|+|.+..... .....+.+|++++.+++|+||+++++++...+..++||||+++|+|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999987888999999865432 33456889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          375 KYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       375 ~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++......+++..+..++.|++.||.|+|.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  111 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLES  111 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9997655568999999999999999999994

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.60  E-value=6.3e-15  Score=141.35  Aligned_cols=89  Identities=24%  Similarity=0.411  Sum_probs=75.1

Q ss_pred             cCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCC-CCCcceEEeeeecCCeeE
Q 036754          291 KFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  362 (405)
                      ++...+.||+|+||.||+|...      .++.||+|+++... ......+.+|+.++.++. |||||+++++|......+
T Consensus        38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~  117 (401)
T cd05107          38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY  117 (401)
T ss_pred             HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence            4556688999999999999853      24679999997543 233457889999999997 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhc
Q 036754          363 LVLEYMPHGSLEKYLYS  379 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~  379 (405)
                      +||||+++|+|.++++.
T Consensus       118 iv~E~~~~g~L~~~l~~  134 (401)
T cd05107         118 IITEYCRYGDLVDYLHR  134 (401)
T ss_pred             EEEeccCCCcHHHHHHh
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.60  E-value=7.3e-15  Score=139.60  Aligned_cols=114  Identities=18%  Similarity=0.298  Sum_probs=99.6

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||.||++.. .+++.||+|+++...   ......+.+|+.++..++|++|+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            566778899999999999985 468899999997532   2334567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+ .+++..+..++.|++.||+|||+
T Consensus        82 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~  119 (360)
T cd05627          82 FLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQ  119 (360)
T ss_pred             CCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999997644 68999999999999999999995

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.60  E-value=8.5e-15  Score=135.73  Aligned_cols=115  Identities=23%  Similarity=0.323  Sum_probs=99.0

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            5677788999999999999995 4788999999875432 2334567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++ |++.+++......+++..+..++.|+++||+|||+
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~  121 (303)
T cd07869          85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ  121 (303)
T ss_pred             CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            96 58988887665678999999999999999999995

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.60  E-value=7.4e-15  Score=133.63  Aligned_cols=114  Identities=23%  Similarity=0.444  Sum_probs=98.7

Q ss_pred             CCccCcccccCCCceEEEeeC-CC---cEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          292 FSENNLISKGGFGSVYKARLG-DG---MEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +...+.||+|+||.||+|... ++   ..||+|.+.... ......|..|+..+.+++||||+++.+++......++|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   85 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE   85 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence            455678999999999999853 33   369999986542 3345689999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++......+++.++..++.|++.|++|||+
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~  124 (269)
T cd05065          86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE  124 (269)
T ss_pred             cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999998665678999999999999999999995

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.60  E-value=4.2e-15  Score=141.82  Aligned_cols=116  Identities=21%  Similarity=0.372  Sum_probs=96.7

Q ss_pred             ccCCccCcccccCCCceEEEee------CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCee
Q 036754          290 YKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  361 (405)
                      ++|...+.||+|+||.||+|..      .++..||+|.++... ......+.+|+.++..+ +|+|||+++++|......
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            3566778999999999999873      123579999997543 23345688999999999 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCC------------------------------------------------------------
Q 036754          362 ALVLEYMPHGSLEKYLYSSN------------------------------------------------------------  381 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~------------------------------------------------------------  381 (405)
                      ++||||+++|+|.++++...                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999986421                                                            


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          382 ---------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       382 ---------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                               ..+++.+..+++.||++||+|||+
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~  230 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS  230 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence                     237888899999999999999994

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.60  E-value=1.5e-15  Score=142.38  Aligned_cols=101  Identities=21%  Similarity=0.391  Sum_probs=89.9

Q ss_pred             cCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCHH
Q 036754          295 NNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLE  374 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  374 (405)
                      .+-+|.|+-|.||.|++ .++.||||+++...       ..+|..+++++|+||+.+.|+|......+||||||+.|-|.
T Consensus       129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            45589999999999998 46789999875432       24788999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHhhhc
Q 036754          375 KYLYSSNCILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       375 ~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      ..|+..+ .++....+.+..|||.||.|||
T Consensus       201 ~VLka~~-~itp~llv~Wsk~IA~GM~YLH  229 (904)
T KOG4721|consen  201 EVLKAGR-PITPSLLVDWSKGIAGGMNYLH  229 (904)
T ss_pred             HHHhccC-ccCHHHHHHHHHHhhhhhHHHH
Confidence            9998765 7888899999999999999999

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.59  E-value=9.9e-15  Score=133.70  Aligned_cols=108  Identities=22%  Similarity=0.322  Sum_probs=92.8

Q ss_pred             ccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCH
Q 036754          298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL  373 (405)
Q Consensus       298 lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  373 (405)
                      ||+|+||+||++.. .+|+.||+|.+....   ......+..|++++.+++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999985 578899999986542   22335677899999999999999999999999999999999999999


Q ss_pred             HHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          374 EKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       374 ~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++..   ....+++..+..++.||++||+|||+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~  115 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ  115 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            988753   22468999999999999999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.59  E-value=2.7e-15  Score=135.70  Aligned_cols=109  Identities=27%  Similarity=0.424  Sum_probs=94.5

Q ss_pred             cccccCCCceEEEeeCC--------CcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          297 LISKGGFGSVYKARLGD--------GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       297 ~lg~G~fg~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      .||+|+||.||+|....        ...||+|.+........+.+..|+.++..++|||++++++++...+..++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            58999999999997532        2348888876555555667888999999999999999999999988999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.++++..+..+++..+..++.||+.||+|||+
T Consensus        82 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~  118 (258)
T cd05078          82 KFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED  118 (258)
T ss_pred             CCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999998766578999999999999999999995

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.59  E-value=2.5e-15  Score=140.32  Aligned_cols=119  Identities=26%  Similarity=0.387  Sum_probs=101.9

Q ss_pred             HhhhccCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCe
Q 036754          286 CRATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEF  360 (405)
Q Consensus       286 ~~~~~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  360 (405)
                      .....+|...+.||+|+|++|++|+ ...++.||||++.+..   ....+=+.+|-.+|.+| .||.|++|+..|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            3345678888999999999999998 5678999999996542   12223355677888888 89999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|+||+++|+|.++|++-+ .+++..+..++.+|+.|++|||+
T Consensus       149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~  192 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHS  192 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999999998654 89999999999999999999995

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.59  E-value=7.8e-15  Score=138.08  Aligned_cols=113  Identities=23%  Similarity=0.349  Sum_probs=99.9

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc---chhHHHHHHHHHhhcCC-CCCcceEEeeeecCCeeEEEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR---RAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  365 (405)
                      .|...+.+|+|.||.||+++. .+|+.+|+|.+.+...   .....+.+|+.+|.++. |||||++++.+++....++||
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm  115 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM  115 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence            344557899999999999995 4599999999976543   23468899999999998 999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |++.+|+|.+.+...  .+++.++..++.||++|++|||.
T Consensus       116 EL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~  153 (382)
T KOG0032|consen  116 ELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS  153 (382)
T ss_pred             EecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999765  39999999999999999999995

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.59  E-value=4.9e-15  Score=140.47  Aligned_cols=117  Identities=29%  Similarity=0.378  Sum_probs=102.3

Q ss_pred             hhccCCccCcccccCCCceEEEe-eCCCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          288 ATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      ....|.....||+|.|++|..|+ ..+|..||+|.+.+..-  ...+.+.+|+++|..++|||||+++.+..++..+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            34566777899999999999998 45789999999976542  3345689999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+.+|++++++.+++ .+.+..+..++.|+.+|++|||.
T Consensus       134 ~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~  173 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHS  173 (596)
T ss_pred             EEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhh
Confidence            99999999999998876 56668888899999999999995

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.59  E-value=1.2e-15  Score=133.56  Aligned_cols=109  Identities=26%  Similarity=0.344  Sum_probs=102.0

Q ss_pred             CcccccCCCceEEEe-eCCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEecCCCCCH
Q 036754          296 NLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPHGSL  373 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  373 (405)
                      +++|+|+|+.|..+. +.+|.+||||++.++..+.+.++.+|++++... .|+||++++++++++...|+|||-|.||.|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            579999999999988 778999999999988888889999999999988 599999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          374 EKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       374 ~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++.+++ .+++.++.+++.+||.||+|||+
T Consensus       164 LshI~~~~-~F~E~EAs~vvkdia~aLdFlH~  194 (463)
T KOG0607|consen  164 LSHIQKRK-HFNEREASRVVKDIASALDFLHT  194 (463)
T ss_pred             HHHHHHhh-hccHHHHHHHHHHHHHHHHHHhh
Confidence            99998765 89999999999999999999995

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.59  E-value=5.6e-15  Score=139.82  Aligned_cols=114  Identities=25%  Similarity=0.361  Sum_probs=100.5

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||+||+|.. .+|+.||+|++....   ......+..|+.++..++|+||+++++++...+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            466678899999999999995 468999999997542   2345678889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++... ..+++..+..++.||++||+|||.
T Consensus        82 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~  119 (350)
T cd05573          82 YMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK  119 (350)
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999765 478999999999999999999994

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.59  E-value=1e-14  Score=132.09  Aligned_cols=115  Identities=30%  Similarity=0.415  Sum_probs=100.9

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      .+|...+.||+|+||.||+|...+++.||+|.++... ...+.+.+|+.++.+++|+||+++++++...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            4566678999999999999998777889999986543 235678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++.... ..+++.+...++.|++.|++|||+
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  121 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA  121 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999997643 468999999999999999999995

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.59  E-value=1.4e-14  Score=131.38  Aligned_cols=113  Identities=22%  Similarity=0.486  Sum_probs=98.4

Q ss_pred             CCccCcccccCCCceEEEeeCCCcEEEEEEeeccc------cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          292 FSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC------RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      |...+.||+|+||.||+|...+|..+|+|.+....      ......+.+|++.+++++|+||+++++++...+..++++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            45667899999999999998888999999886432      122356888999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||+
T Consensus        82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~  120 (265)
T cd06631          82 EFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHN  120 (265)
T ss_pred             ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999997644 68899999999999999999995

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.59  E-value=9e-15  Score=132.11  Aligned_cols=108  Identities=26%  Similarity=0.450  Sum_probs=92.0

Q ss_pred             CcccccCCCceEEEeeCCC-----------cEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          296 NLISKGGFGSVYKARLGDG-----------MEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~~-----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      +.||+|+||.||+|.....           ..|++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            3589999999999996432           24777877544333 6778899999999999999999999888 778999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++......+++..++.++.|++.||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~  119 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED  119 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh
Confidence            99999999999998655578999999999999999999995

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.59  E-value=6.5e-17  Score=145.26  Aligned_cols=201  Identities=25%  Similarity=0.299  Sum_probs=162.4

Q ss_pred             cCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCC-cccccccCcchhcCCCCCCe
Q 036754           12 CLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGG-NKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        12 ~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~l~~L~~   90 (405)
                      .-..++|..|+|+.+.|++ |+.+. +|+.|||+.|+|+.+-|+.|.++.+|..|.+.+ |+|+ .+|.+.|.+|.+|+.
T Consensus        68 ~tveirLdqN~I~~iP~~a-F~~l~-~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqr  144 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGA-FKTLH-RLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQR  144 (498)
T ss_pred             cceEEEeccCCcccCChhh-ccchh-hhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHH
Confidence            4577999999999999999 67776 999999999999999999999999988876665 9998 899999999999999


Q ss_pred             eeCCCCCCCCC-chhhhccccCccccCCC-----CCh-hccCCCCCCEEeccCCccc-----------------------
Q 036754           91 LSLDSNELTSI-PLTFWNLKDILYLNFSV-----IPI-EIGGLPNLEYLFLGYNRLQ-----------------------  140 (405)
Q Consensus        91 L~Ls~N~l~~l-p~~~~~l~~L~~l~l~~-----~p~-~~~~l~~L~~L~l~~n~l~-----------------------  140 (405)
                      |.+.-|++.-+ ...++.|++|..|.+.+     ++. .|..+..++.+.+..|++-                       
T Consensus       145 LllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgar  224 (498)
T KOG4237|consen  145 LLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGAR  224 (498)
T ss_pred             HhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccce
Confidence            99999999955 55678888887766543     444 6677777777777777621                       


Q ss_pred             --------------------------------------ccCC-cccccCCCCCeeecccccccCccchhHHhcccCCccc
Q 036754          141 --------------------------------------GSIP-DSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLN  181 (405)
Q Consensus       141 --------------------------------------~~~p-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~  181 (405)
                                                            +..| ..|..+++|+.|++++|.+++..+.+|.....+++|+
T Consensus       225 c~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~  304 (498)
T KOG4237|consen  225 CVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELY  304 (498)
T ss_pred             ecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhh
Confidence                                                  0011 2366789999999999999999999999999999999


Q ss_pred             cccCcccCcCC-CCCccCCCCcccccCCCCccCCC
Q 036754          182 LSFNKLEGEIP-RGGSFGNFSAESFEGNELLCGSP  215 (405)
Q Consensus       182 l~~n~l~~~~p-~~~~~~~~~~~~~~~n~~~c~~~  215 (405)
                      +..|++.-.-. ....+..+..+++.+|...|-.|
T Consensus       305 L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~  339 (498)
T KOG4237|consen  305 LTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAP  339 (498)
T ss_pred             cCcchHHHHHHHhhhccccceeeeecCCeeEEEec
Confidence            99999863221 13456778889999999888654

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.59  E-value=1.3e-14  Score=135.27  Aligned_cols=109  Identities=22%  Similarity=0.348  Sum_probs=92.6

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhc-CCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKS-IRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.||+|+||.||+|.. .+++.||+|+++...   ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            3589999999999995 457899999997642   2334456677777776 4999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++.... .+++.++..++.|+++||+|||+
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~  114 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHS  114 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999997643 68999999999999999999995

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.59  E-value=1.2e-14  Score=135.94  Aligned_cols=109  Identities=24%  Similarity=0.366  Sum_probs=93.9

Q ss_pred             CcccccCCCceEEEee----CCCcEEEEEEeeccc----cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          296 NLISKGGFGSVYKARL----GDGMEVAVKVFNLQC----RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +.||+|+||.||++..    ..++.||+|+++...    ......+..|+.++..++||||+++++++...+..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5699999999999974    357889999997532    22344577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++...+ .+.+..+..++.|+++||+|||+
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~  118 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQ  118 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999987644 67888889999999999999995

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.59  E-value=7.7e-15  Score=134.06  Aligned_cols=116  Identities=26%  Similarity=0.332  Sum_probs=103.1

Q ss_pred             ccCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      .+|.....||.|..++||+|. .+.++.||||++.... ........+|+..|+.++||||++.+..|..+..+|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            456677889999999999998 6788999999997653 44567889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |.+|++.+.++..- ..+++..+..|.+++++||.|||.
T Consensus       106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~  144 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ  144 (516)
T ss_pred             hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh
Confidence            99999999997642 469999999999999999999995

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=2.7e-16  Score=135.43  Aligned_cols=115  Identities=22%  Similarity=0.324  Sum_probs=96.9

Q ss_pred             cCCccCcccccCCCceEEEe-eCCCcEEEEEEeecc--ccchhHHHHHHHHHhhcCCCCCcceEEee-eecCCe-eEEEE
Q 036754          291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVISS-CSNEEF-KALVL  365 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~-~~lv~  365 (405)
                      +|...++||+|.||.||++. +.+|..+|.|.++..  +.+..+....|+.++++++|||||+.+++ +.+.++ ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            34455779999999999998 689999999998744  34556778899999999999999999983 444444 89999


Q ss_pred             ecCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||..|||.+.+..   .++.+++...-+++.|.++||..+|.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~  142 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHS  142 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhc
Confidence            99999999998863   34679999999999999999999995

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.59  E-value=1.1e-14  Score=136.82  Aligned_cols=115  Identities=21%  Similarity=0.222  Sum_probs=99.1

Q ss_pred             cCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||.||++... .++.+|+|.+.+..   ......+..|+.++..++|++|+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            5667788999999999999854 57889999986532   2233457889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++......+++..+..++.|++.||+|||+
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~  120 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ  120 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999998655578999999999999999999995

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.58  E-value=1.4e-14  Score=135.40  Aligned_cols=109  Identities=24%  Similarity=0.288  Sum_probs=93.4

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      ++||+|+||.||+|+. .+++.||+|++....   ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            3689999999999985 457899999997542   23345567788888766 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|..++...+ .+++..+..++.|+++||+|||+
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~  114 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHR  114 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999887654 68999999999999999999995

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.58  E-value=1.2e-14  Score=138.59  Aligned_cols=122  Identities=20%  Similarity=0.232  Sum_probs=103.7

Q ss_pred             HHHHHhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeec
Q 036754          282 YLELCRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSN  357 (405)
Q Consensus       282 ~~~~~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  357 (405)
                      +.++....++|...+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++..++||||+++++++..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            445555667888889999999999999985 467899999986432   2234557789999999999999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          358 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       358 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+..++||||+++|+|.+++...  .+++..+..++.|++.||+|||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~  160 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHS  160 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999998754  47888889999999999999995

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.58  E-value=1.4e-14  Score=131.76  Aligned_cols=116  Identities=24%  Similarity=0.472  Sum_probs=100.3

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CC---cEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DG---MEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      .+|+..+.||+|+||.||+|... ++   ..+|+|..+... ....+.+..|++++.+++|+|++++.+++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46677889999999999999864 33   368999886543 33456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++......+++.++..++.|++.|++|||+
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~  125 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD  125 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999997655678999999999999999999995

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.58  E-value=1.1e-14  Score=132.26  Aligned_cols=113  Identities=22%  Similarity=0.368  Sum_probs=98.6

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc------cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC------RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      |+..+.||+|+||.||++.. .+++.||+|.+....      ......+.+|+..+++++|+||+++++++...+..++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            56678899999999999984 678899999986432      12346788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||+++|+|.+++...+ .+++.....++.|++.||+|||+
T Consensus        82 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~  121 (268)
T cd06630          82 VEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHE  121 (268)
T ss_pred             EeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999997644 68999999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.58  E-value=1e-14  Score=136.23  Aligned_cols=117  Identities=22%  Similarity=0.337  Sum_probs=103.9

Q ss_pred             hhccCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          288 ATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      ..++|.....||+|+||.||.|+ ..+|..+|+|++++..   ....+.+..|-.+|...+++.||+++..|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            44688888999999999999998 5679999999998753   4456677889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+||||+-.+|...+ .+++..+..++.+.+-|++-+|.
T Consensus       219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~  259 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQ  259 (550)
T ss_pred             EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHH
Confidence            999999999999997655 79999999999999999998884

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.58  E-value=1.6e-14  Score=135.53  Aligned_cols=109  Identities=22%  Similarity=0.251  Sum_probs=93.4

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.||+|+||.||++.. .+++.||+|+++...   ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            3689999999999985 467899999997542   23345577888888776 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|..++...+ .+++..+..++.|+++||+|||+
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~  114 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHE  114 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999886543 68999999999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.58  E-value=2.7e-15  Score=121.10  Aligned_cols=112  Identities=26%  Similarity=0.336  Sum_probs=98.9

Q ss_pred             CccCcccccCCCceEEEe-eCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          293 SENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      ...++||+|.||+|++|+ ..+++.||+|..+.++  ..-.....+||.+++.++|+|||++++....++...+|+|||.
T Consensus         5 dkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd   84 (292)
T KOG0662|consen    5 DKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_pred             HHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh
Confidence            345679999999999998 5678999999998654  3334677899999999999999999999999999999999998


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      . +|.++.....+.++......++.|..+|+.|+|.
T Consensus        85 q-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchs  119 (292)
T KOG0662|consen   85 Q-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS  119 (292)
T ss_pred             H-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh
Confidence            7 9999988777789999999999999999999994

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.58  E-value=2.1e-14  Score=129.52  Aligned_cols=113  Identities=28%  Similarity=0.385  Sum_probs=98.6

Q ss_pred             CCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc-----cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          292 FSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC-----RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      |...+.||+|+||.||+|... ++..||+|.+....     .+..+.+.+|+..+++++|+|++++++++......++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            445678999999999999965 78999999986533     224467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++++|.+++.... .+++..+..++.|+++|++|||.
T Consensus        82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~  120 (258)
T cd06632          82 ELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHD  120 (258)
T ss_pred             EecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997653 58999999999999999999994

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.58  E-value=6e-15  Score=133.62  Aligned_cols=113  Identities=27%  Similarity=0.374  Sum_probs=97.7

Q ss_pred             CCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          292 FSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      |...+.||.|.-|+||.+.+. .+..+|+|++.+..   .+...+...|-++++.++||-++.+|+.+++++..+++|||
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey  158 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY  158 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence            344567999999999999964 45899999997654   33345566788999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhc
Q 036754          368 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       368 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      |+||||....+.+. +.+++..+.-+|..|.-||+|||
T Consensus       159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH  196 (459)
T KOG0610|consen  159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH  196 (459)
T ss_pred             CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH
Confidence            99999999887543 67999999999999999999999

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.58  E-value=1.4e-14  Score=135.37  Aligned_cols=109  Identities=25%  Similarity=0.301  Sum_probs=93.6

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.||+|+||.||+|+. .+++.||+|+++...   ......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            3689999999999985 468899999997542   23345667788888776 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++...+ .+++..+..++.|++.||+|||.
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~  114 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLHD  114 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999987654 68999999999999999999994

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.58  E-value=1.1e-14  Score=132.28  Aligned_cols=114  Identities=28%  Similarity=0.360  Sum_probs=99.9

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      +|...+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.++..++||||+++++.+...+..++|+||++
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~   89 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG   89 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence            445556799999999999984 5688999999876655555667889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++...+ .+++.+...++.|++.|++|||+
T Consensus        90 ~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~  124 (267)
T cd06645          90 GGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHS  124 (267)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999987544 68999999999999999999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.58  E-value=6.4e-15  Score=139.50  Aligned_cols=113  Identities=32%  Similarity=0.518  Sum_probs=98.5

Q ss_pred             CCccCcccccCCCceEEEeeCC---C--cEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          292 FSENNLISKGGFGSVYKARLGD---G--MEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~~---~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      +...++||+|.||.||+|.+.+   |  ..||||.-+.++ ....+.|.+|..+|++++|||||+++|.|. +...+|||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEEE
Confidence            4455789999999999998532   3  358999988754 345788999999999999999999999996 46789999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |.++.|.|..||...+..++......++.||..||+|||+
T Consensus       470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS  509 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES  509 (974)
T ss_pred             ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999998877889999999999999999999984

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.58  E-value=1.3e-14  Score=135.93  Aligned_cols=111  Identities=22%  Similarity=0.270  Sum_probs=95.0

Q ss_pred             cCccccc--CCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          295 NNLISKG--GFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       295 ~~~lg~G--~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      .++||+|  +|++||++.. .+|+.||+|++....  ......+.+|+.+++.++||||+++++++...+..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            3578999  6889999985 678999999997542  2334556779999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++..+. ..+++..+..++.|+++||+|||+
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  119 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH  119 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999986532 458999999999999999999995

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.58  E-value=1.3e-14  Score=132.34  Aligned_cols=116  Identities=22%  Similarity=0.409  Sum_probs=99.2

Q ss_pred             ccCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccccc-hhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQCRR-AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  362 (405)
                      .+|.....+|+|+||.||+|+..      ....||+|.+...... ....+.+|++++.+++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            45667788999999999999853      2467999988654433 4567899999999999999999999999889999


Q ss_pred             EEEecCCCCCHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSN--------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++....        ..+++.++..++.|+++||+|||+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~  135 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN  135 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh
Confidence            9999999999999997543        158999999999999999999995

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.58  E-value=1.3e-14  Score=132.94  Aligned_cols=112  Identities=23%  Similarity=0.366  Sum_probs=98.5

Q ss_pred             ccCcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCC
Q 036754          294 ENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGS  372 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  372 (405)
                      ..+.||+|+||.||+|... ++..+|+|.+..........+.+|+.+++.++|+|++++++++...+..++|+||+++|+
T Consensus         9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~   88 (282)
T cd06643           9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA   88 (282)
T ss_pred             HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence            3467999999999999964 578889999866555556778899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          373 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       373 L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |..++......+++..+..++.|+++||+|||+
T Consensus        89 l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~  121 (282)
T cd06643          89 VDAVMLELERPLTEPQIRVVCKQTLEALNYLHE  121 (282)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999887655579999999999999999999995

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.58  E-value=1.4e-14  Score=135.57  Aligned_cols=111  Identities=23%  Similarity=0.300  Sum_probs=92.8

Q ss_pred             CccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHH---hhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          293 SENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEM---MKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ...+.||+|+||.||+|.. .+|+.||||.++...   ......+.+|+++   +.+++||||+++++++...+..|+||
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~   81 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM   81 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence            3457899999999999985 568999999997542   2233455666554   46778999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|..++..  ..+++.++..++.|++.||+|||+
T Consensus        82 E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~  119 (324)
T cd05589          82 EYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHE  119 (324)
T ss_pred             cCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999998864  368999999999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.58  E-value=1.8e-14  Score=132.77  Aligned_cols=115  Identities=23%  Similarity=0.362  Sum_probs=101.6

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      .|...+.||+|+||.||+|+. .++..||+|.+........+.+.+|+.++++++|+|++++++++......++||||++
T Consensus        13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   92 (292)
T cd06644          13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP   92 (292)
T ss_pred             hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence            455567899999999999985 4588999999976655566778899999999999999999999998899999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|..++......+++..+..++.|+++|++|||+
T Consensus        93 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~  128 (292)
T cd06644          93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS  128 (292)
T ss_pred             CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            999998887655578999999999999999999995

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.58  E-value=1.9e-14  Score=134.33  Aligned_cols=109  Identities=23%  Similarity=0.273  Sum_probs=93.8

Q ss_pred             CcccccCCCceEEEeeC-CCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.||+|+||+||++... ++..||+|+++...   ......+..|++++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999864 57899999997642   23345667888888877 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|..++...+ .+++.++..++.|+++||+|||+
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~  114 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHE  114 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999987653 68999999999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.58  E-value=1.7e-14  Score=135.00  Aligned_cols=114  Identities=19%  Similarity=0.218  Sum_probs=96.1

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCC-CcceEEeeeecCCeeEEEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQ-NLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  365 (405)
                      +|...+.||+|+||.||+|+. .+++.||+|++....   ......+..|++++..++|+ +|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            355678899999999999985 457899999997542   23455678899999999765 5888888998899999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++.... .+++..+..++.|+++||+|||.
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~  119 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHS  119 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999987644 68999999999999999999995

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.58  E-value=9.2e-16  Score=133.29  Aligned_cols=112  Identities=22%  Similarity=0.294  Sum_probs=101.1

Q ss_pred             CCccCcccccCCCceEEEe-eCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          292 FSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      |+...++|+|+||.||+|. ...|..+|+|+....  .+.++...|+.+|.+++.+++|+.||.|.....++||||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            4455789999999999998 467899999988543  4567888999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+..+.++.+++.+++.+...+..+.++||+|||.
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~  147 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD  147 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH
Confidence            99999999888899999999999999999999994

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.57  E-value=2.1e-14  Score=134.44  Aligned_cols=109  Identities=30%  Similarity=0.353  Sum_probs=91.5

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHH-HhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECE-MMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.||+|+||.||+|.. .+|+.||+|++....   ......+..|.. ++..++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3689999999999984 578999999997542   223345555655 46778999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|..++...+ .+++.++..++.||++||+|||+
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~  114 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHS  114 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999887543 68999999999999999999995

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.57  E-value=2.2e-14  Score=129.46  Aligned_cols=114  Identities=32%  Similarity=0.496  Sum_probs=100.2

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      .+|...+.+|+|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.++.+++|+|++++++++...+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            3566678899999999999986 478899999975533 45678899999999999999999999998899999999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++.... ..+++..+..++.|++.|++|||+
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~  120 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE  120 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999997543 368999999999999999999995

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.57  E-value=1.7e-14  Score=130.03  Aligned_cols=114  Identities=27%  Similarity=0.308  Sum_probs=99.8

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeecc--ccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |...+.||+|+||.||+|.. .+++.||+|.+...  .......+.+|++++++++|||++++++++...+..++||||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            55567899999999999985 46889999998643  2345567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++|.+++... ...+++.++..++.|+++||+|||+
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~  119 (256)
T cd08529          82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS  119 (256)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999764 3578999999999999999999994

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.57  E-value=1.9e-14  Score=132.22  Aligned_cols=114  Identities=22%  Similarity=0.304  Sum_probs=97.7

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      |...+.||+|+||+||+|.. .+++.||+|.+....   ......+.+|++++.+++|++++++.+++...+..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            44567899999999999985 578899999986542   22334577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++...+ ..+++..+..++.|++.||+|||+
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~  120 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR  120 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999886543 469999999999999999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.57  E-value=1.6e-16  Score=156.44  Aligned_cols=184  Identities=32%  Similarity=0.379  Sum_probs=118.8

Q ss_pred             ccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcC
Q 036754            5 SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSN   84 (405)
Q Consensus         5 ~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~   84 (405)
                      +...+++.|+.|||..|+|.. .|+.|+.-...+|..|+.+.|++....--.=..+..|+.|.+.+|.++...=+- +.+
T Consensus       304 ~~le~~~sL~tLdL~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~-l~~  381 (1081)
T KOG0618|consen  304 PFLEGLKSLRTLDLQSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPV-LVN  381 (1081)
T ss_pred             Ccccccceeeeeeehhccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhh-hcc
Confidence            344556666666666666654 333434433333556666666655422111223556777777778776442222 247


Q ss_pred             CCCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccccccc
Q 036754           85 LASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLS  164 (405)
Q Consensus        85 l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~  164 (405)
                      ..+|+.|+|++|+|+++|++                 .+.+++.|++|+||+|+++ .+|+++..+..|++|...+|++.
T Consensus       382 ~~hLKVLhLsyNrL~~fpas-----------------~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~  443 (1081)
T KOG0618|consen  382 FKHLKVLHLSYNRLNSFPAS-----------------KLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL  443 (1081)
T ss_pred             ccceeeeeecccccccCCHH-----------------HHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee
Confidence            77888888888888888776                 3456677778888888877 56777777888888888888777


Q ss_pred             CccchhHHhcccCCccccccCcccC-cCCCCCccCCCCcccccCCCC
Q 036754          165 GAIPASLEKLLYLKDLNLSFNKLEG-EIPRGGSFGNFSAESFEGNEL  210 (405)
Q Consensus       165 ~~~~~~~~~l~~L~~l~l~~n~l~~-~~p~~~~~~~~~~~~~~~n~~  210 (405)
                       ..| .+.+++.|+.+|++.|+++- .+|.....++++.+++.||++
T Consensus       444 -~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  444 -SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             -ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence             445 67777888888888887764 344444447777788888875

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.57  E-value=2.3e-14  Score=129.56  Aligned_cols=107  Identities=24%  Similarity=0.423  Sum_probs=92.0

Q ss_pred             ccccCCCceEEEeeC---CCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCH
Q 036754          298 ISKGGFGSVYKARLG---DGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL  373 (405)
Q Consensus       298 lg~G~fg~v~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  373 (405)
                      ||+|+||.||+|.+.   .+..||+|++..... ...+.+.+|+.++.+++|+||+++++++. .+..++||||+++|+|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            799999999999753   355799999865533 33467889999999999999999999875 4578999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          374 EKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       374 ~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+++......+++.++.+++.|+++||+|||+
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~  113 (257)
T cd05115          82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEG  113 (257)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99997655679999999999999999999995

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.57  E-value=1.6e-14  Score=132.48  Aligned_cols=114  Identities=22%  Similarity=0.267  Sum_probs=98.9

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +|...+.||+|+||+||++.. .+|..||+|++.... ......+.+|++++..++|+||+++++++...+..++||||+
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM   85 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence            445567899999999999985 468899999886543 334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++...+ .+++.....++.|+++||+|||+
T Consensus        86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~  121 (284)
T cd06620          86 DCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN  121 (284)
T ss_pred             CCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999887643 68999999999999999999994

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.57  E-value=1.7e-14  Score=132.64  Aligned_cols=116  Identities=29%  Similarity=0.476  Sum_probs=99.9

Q ss_pred             ccCCccCcccccCCCceEEEee------CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      ++|...+.+|+|+||.||++..      .++..+|+|.+..........+.+|++++.+++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            4566778899999999999974      2345689999876555556778999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSN------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++...+            ..+++.++..++.|++.||+|||+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~  138 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS  138 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999997432            248999999999999999999995

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.57  E-value=2.1e-14  Score=131.69  Aligned_cols=115  Identities=24%  Similarity=0.433  Sum_probs=96.7

Q ss_pred             cCCccCcccccCCCceEEEee-----CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-----GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      +|+..+.||+|+||.||+|..     ..+..||+|.+.... ......+.+|+.++++++|+||+++++++...+..++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   85 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML   85 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence            455567899999999999974     245789999986433 33446788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSN----------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++....                ..+++.+...++.|++.||+|||+
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~  142 (283)
T cd05090          86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS  142 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999985321                247889999999999999999995

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.57  E-value=2.1e-14  Score=130.56  Aligned_cols=109  Identities=27%  Similarity=0.346  Sum_probs=91.0

Q ss_pred             cccccCCCceEEEeeCC---CcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCC
Q 036754          297 LISKGGFGSVYKARLGD---GMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGS  372 (405)
Q Consensus       297 ~lg~G~fg~v~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  372 (405)
                      .||+|+||.||+|+..+   ...+|+|.+.... ......+.+|+..++.++|+||+++++++......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997533   3568888775443 2334568899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCC----CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          373 LEKYLYSSN----CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       373 L~~~l~~~~----~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |.+++....    ...++.....++.|++.|++|||+
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  118 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ  118 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence            999997643    234677889999999999999995

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.57  E-value=2.1e-14  Score=133.83  Aligned_cols=109  Identities=23%  Similarity=0.327  Sum_probs=91.0

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhc-CCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKS-IRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.||+|+||.||+|.. .+++.||+|+++...   ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3689999999999985 467899999997542   2233445566666664 4899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|..++.... .+++.+...++.|++.||+|||+
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~  114 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHK  114 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999987644 68999999999999999999995

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.57  E-value=1.8e-14  Score=133.13  Aligned_cols=113  Identities=27%  Similarity=0.398  Sum_probs=97.4

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccccc-----hhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRR-----AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      |...+.||+|+||.||+|.. .+|+.||+|.+......     ....+..|+.++.+++|+||+++++++.+.+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            45567899999999999995 46899999999754322     2345678999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+ +|+|.+++......+++..+..++.||++||+|||+
T Consensus        82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~  120 (298)
T cd07841          82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS  120 (298)
T ss_pred             ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999 899999997654469999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.57  E-value=2.4e-14  Score=133.95  Aligned_cols=109  Identities=29%  Similarity=0.371  Sum_probs=91.3

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHH-HhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECE-MMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.||+|+||+||+|.. .+|+.||+|++....   ......+..|.. ++..++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            3689999999999995 478999999997542   222344555554 46789999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|..++...+ .+++..+..++.||++||+|||+
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~  114 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHS  114 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999987643 68899999999999999999995

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.57  E-value=2.1e-14  Score=130.63  Aligned_cols=109  Identities=27%  Similarity=0.382  Sum_probs=91.8

Q ss_pred             cccccCCCceEEEeeC---CCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCC
Q 036754          297 LISKGGFGSVYKARLG---DGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGS  372 (405)
Q Consensus       297 ~lg~G~fg~v~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  372 (405)
                      .||+|+||.||+|...   .+..+|+|.++.... .....+.+|+.++.+++||||+++++++......++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            5899999999999853   345789998865432 334578889999999999999999999998889999999999999


Q ss_pred             HHHHHhcCC----CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          373 LEKYLYSSN----CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       373 L~~~l~~~~----~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |.++++...    ...++..+..++.|+++|++|||+
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~  118 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK  118 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence            999997532    246777888999999999999994

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.57  E-value=1.9e-14  Score=134.59  Aligned_cols=113  Identities=19%  Similarity=0.219  Sum_probs=95.3

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCC-CCCcceEEeeeecCCeeEEEEe
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      |...+.||+|+||.||+|.. .+|+.||+|++....   ......+..|..++..+. |++|+++.+++...+..|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            55668899999999999985 568899999997542   233456777888888875 5778889999998999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++.... .+++.++..++.|++.||+|||+
T Consensus        82 y~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~  119 (323)
T cd05615          82 YVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHR  119 (323)
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999987644 68999999999999999999994

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.57  E-value=2.1e-14  Score=130.15  Aligned_cols=114  Identities=27%  Similarity=0.455  Sum_probs=99.0

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      +|...+.||+|+||.||+|.. ..++.||+|.+... .....++.+|++.+.+++|+||+++++++...+..+++|||++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            455667899999999999985 45789999998643 3345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++.... ..+++..+..++.|+++||+|||.
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~  122 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK  122 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999997543 468999999999999999999994

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.57  E-value=2.7e-14  Score=131.87  Aligned_cols=114  Identities=27%  Similarity=0.346  Sum_probs=100.4

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ..|...+.+|+|+||.||+|.. .++..||+|.+..........+.+|+.++..++|+|++++++++......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            3556677899999999999984 578899999997665555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++...  .+++.++..++.|+++||+|||+
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~  134 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS  134 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999998643  58999999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.56  E-value=2.9e-14  Score=131.71  Aligned_cols=114  Identities=27%  Similarity=0.342  Sum_probs=101.0

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ..|...+.||+|+||.||++.. .++..||+|.+..........+.+|+.+++.++|+|++++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            4567778899999999999984 578999999997655555567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++.+.  .+++.++..++.|+++||+|||+
T Consensus        99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~  133 (297)
T cd06656          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHS  133 (297)
T ss_pred             CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999998653  58999999999999999999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.56  E-value=2.7e-14  Score=133.55  Aligned_cols=109  Identities=29%  Similarity=0.350  Sum_probs=90.9

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHH-HhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECE-MMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      ++||+|+||.||+|+. .+|+.||+|++....   ......+..|.. ++..++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3689999999999995 468899999987532   223344555654 57789999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|..++.... .+++.++..++.||++||+|||+
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~  114 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLHS  114 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999887543 68888899999999999999995

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.56  E-value=2.7e-14  Score=128.73  Aligned_cols=114  Identities=26%  Similarity=0.329  Sum_probs=101.5

Q ss_pred             ccCCccCcccccCCCceEEEeeCC-CcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ++|...+.+|+|+||.||+|.... +..+|+|.+.....  ...+.+|++.+++++|+|++++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            456777889999999999999654 78999999865432  678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++|.+++...+..+++..+..++.|+++||+|||+
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~  117 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS  117 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999997666678999999999999999999995

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.56  E-value=1.6e-14  Score=132.77  Aligned_cols=114  Identities=19%  Similarity=0.243  Sum_probs=96.2

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +|...+.||+|+||.||++.. .++..||+|++....  ......+.+|+.++.+++|+||+++++++...+..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            456678899999999999996 467899999987543  23345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++.+..+.. ....+++..+..++.|++.||+|||.
T Consensus        82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~  118 (287)
T cd07848          82 VEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHK  118 (287)
T ss_pred             CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99877665543 33468999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PLN03210 Resistant to P

Probab=99.56  E-value=2.5e-14  Score=154.04  Aligned_cols=89  Identities=21%  Similarity=0.249  Sum_probs=63.0

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchh
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG   82 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   82 (405)
                      ++..+..+++|+.|+|++|.....+|.  ++.++ +|+.|+|++|.....+|..+..+++|+.|++++|...+.+|..+ 
T Consensus       626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~-~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-  701 (1153)
T PLN03210        626 LWDGVHSLTGLRNIDLRGSKNLKEIPD--LSMAT-NLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-  701 (1153)
T ss_pred             cccccccCCCCCEEECCCCCCcCcCCc--cccCC-cccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-
Confidence            355677888888888888765555664  44555 88888888887667788888888888888888875444677654 


Q ss_pred             cCCCCCCeeeCCCC
Q 036754           83 SNLASLRKLSLDSN   96 (405)
Q Consensus        83 ~~l~~L~~L~Ls~N   96 (405)
                       ++++|+.|+|++|
T Consensus       702 -~l~sL~~L~Lsgc  714 (1153)
T PLN03210        702 -NLKSLYRLNLSGC  714 (1153)
T ss_pred             -CCCCCCEEeCCCC
Confidence             4555555555554

syringae 6; Provisional

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.56  E-value=3.5e-15  Score=142.92  Aligned_cols=109  Identities=27%  Similarity=0.408  Sum_probs=95.6

Q ss_pred             cCcccccCCCceEEEee--CCCc--EEEEEEeeccccc-hhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          295 NNLISKGGFGSVYKARL--GDGM--EVAVKVFNLQCRR-AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~--~~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      .+.||+|.||.|++|.|  +.|+  .||||.++..... ...+|.+|+.+|.+++|+|++++||...+ ....||+|.++
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap  193 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP  193 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence            46799999999999986  3454  5899999876533 67899999999999999999999999887 77889999999


Q ss_pred             CCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHhhhc
Q 036754          370 HGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       370 ~g~L~~~l~~-~~~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      .|+|.+.|++ .+..+-......++.|||.||+||.
T Consensus       194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe  229 (1039)
T KOG0199|consen  194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE  229 (1039)
T ss_pred             cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh
Confidence            9999999987 4567888899999999999999984

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.56  E-value=7.1e-15  Score=144.96  Aligned_cols=115  Identities=27%  Similarity=0.416  Sum_probs=98.3

Q ss_pred             cCCccCcccccCCCceEEEeeCCC-cEEEEEEeeccccchhHHHHHHHHHhhcCC-CCCcceEEe-eeec------CCee
Q 036754          291 KFSENNLISKGGFGSVYKARLGDG-MEVAVKVFNLQCRRAFKSFDIECEMMKSIR-HQNLIKVIS-SCSN------EEFK  361 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~-~~~~------~~~~  361 (405)
                      ..+..+.|.+|||+.||.|+...+ ..||+|++-..+....+.+.+||++|++++ |+|||.+++ ....      .-++
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            445668899999999999997665 999999997777777888999999999997 999999999 3322      1357


Q ss_pred             EEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|.||||++|.|-+++..+. ..+++.+.++|+.|+++|+++||.
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~  162 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY  162 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc
Confidence            79999999999999997542 459999999999999999999994

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.56  E-value=2.5e-14  Score=131.31  Aligned_cols=114  Identities=25%  Similarity=0.495  Sum_probs=97.0

Q ss_pred             CCccCcccccCCCceEEEee-----CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecC--CeeEE
Q 036754          292 FSENNLISKGGFGSVYKARL-----GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE--EFKAL  363 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  363 (405)
                      |...+.||+|+||.||.+..     ..+..||+|.++... ......+.+|+.++++++|+|++++.+++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL   85 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence            45567899999999999874     356789999987543 33346788999999999999999999988764  56889


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++......++|..+..++.|++.||+|||+
T Consensus        86 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~  127 (284)
T cd05079          86 IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS  127 (284)
T ss_pred             EEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999997654568999999999999999999995

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.56  E-value=2.4e-14  Score=130.41  Aligned_cols=113  Identities=29%  Similarity=0.432  Sum_probs=96.5

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeecccc----------chhHHHHHHHHHhhcCCCCCcceEEeeeecCCe
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR----------RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF  360 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  360 (405)
                      |...+.||+|+||.||+|.. .+|..||+|.++....          ...+.+.+|+.++.+++|+|++++++++...+.
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            44567899999999999984 4688999998854211          112457789999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++||||+++|+|.++++... .+++..+..++.|+++||+|||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~  126 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHS  126 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh
Confidence            999999999999999997653 68999999999999999999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.56  E-value=2.9e-14  Score=133.00  Aligned_cols=109  Identities=21%  Similarity=0.358  Sum_probs=92.5

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhc-CCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKS-IRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.||+|+||.||+|.. .+|+.||+|.++...   .........|..++.. .+|+||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            3689999999999985 468899999997642   2334456677777765 4899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++.... .+++.++..++.|+++||+|||+
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~  114 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHS  114 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999987643 68999999999999999999995

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.56  E-value=2.9e-14  Score=133.62  Aligned_cols=109  Identities=20%  Similarity=0.234  Sum_probs=94.1

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.||+|+||.||++.. .+++.||+|+++...   ......+..|+.++.++ +|+||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3689999999999985 467899999997642   23345677899988888 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++...+ .+++..+..++.|+++||+|||+
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~  114 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHE  114 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999886543 69999999999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.56  E-value=2.6e-14  Score=132.81  Aligned_cols=115  Identities=20%  Similarity=0.335  Sum_probs=98.5

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+.++.+++|+||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            3466678899999999999985 467889999987543 22344677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++ ++.+++...+..+++.++..++.|+++||+|||+
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~  122 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR  122 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            985 8999887666678999999999999999999995

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.56  E-value=3.6e-14  Score=128.90  Aligned_cols=115  Identities=24%  Similarity=0.342  Sum_probs=98.2

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||.||+|+. .+++.||+|.+....   ......+.+|++++++++|||++++++++...+..++++|
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            566778899999999999984 578999999876422   2334568889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++..   ....+++.....++.|+++||+|||+
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~  124 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS  124 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            9999999988853   22457889999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.56  E-value=2.1e-14  Score=132.60  Aligned_cols=115  Identities=23%  Similarity=0.446  Sum_probs=96.0

Q ss_pred             cCCccCcccccCCCceEEEeeCC---------------CcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEee
Q 036754          291 KFSENNLISKGGFGSVYKARLGD---------------GMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISS  354 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~  354 (405)
                      +|...+.||+|+||.||++....               ...||+|.++... ......|.+|++++.+++|+|+++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   85 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV   85 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            45666789999999999987432               2358999987543 2334578899999999999999999999


Q ss_pred             eecCCeeEEEEecCCCCCHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          355 CSNEEFKALVLEYMPHGSLEKYLYSSN-----------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       355 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +...+..++||||+++|+|.+++....           ..++|..+..++.|+++||+|||+
T Consensus        86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~  147 (295)
T cd05097          86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS  147 (295)
T ss_pred             EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999999999999986432           236889999999999999999995

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.56  E-value=3.1e-14  Score=128.79  Aligned_cols=114  Identities=21%  Similarity=0.382  Sum_probs=97.6

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      ++|...++||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++|+|++++++++ ..+..+++|||++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCC
Confidence            3456678899999999999998888999999986543 2345788999999999999999999876 4567899999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++.... ..+++.++..++.|++.||+|||+
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~  120 (260)
T cd05067          84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER  120 (260)
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            999999987533 468999999999999999999995

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.56  E-value=2.9e-14  Score=130.63  Aligned_cols=115  Identities=26%  Similarity=0.463  Sum_probs=98.7

Q ss_pred             cCCccCcccccCCCceEEEeeC-----CCcEEEEEEeeccccc-hhHHHHHHHHHhhcCCCCCcceEEeeeec--CCeeE
Q 036754          291 KFSENNLISKGGFGSVYKARLG-----DGMEVAVKVFNLQCRR-AFKSFDIECEMMKSIRHQNLIKVISSCSN--EEFKA  362 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  362 (405)
                      +|...+.||+|+||.||++...     .+..||+|.+...... ....|.+|+..+.+++|+||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            3455578999999999999853     3678999999755433 46788999999999999999999998877  56789


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|||+++|+|.+++......+++..+..++.|+++||+|||+
T Consensus        85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~  127 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS  127 (284)
T ss_pred             EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999998765569999999999999999999995

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.56  E-value=2.4e-14  Score=132.67  Aligned_cols=116  Identities=22%  Similarity=0.366  Sum_probs=98.7

Q ss_pred             ccCCccCcccccCCCceEEEee------CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCee
Q 036754          290 YKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  361 (405)
                      ++|...+.||+|+||.||+++.      ..+..||+|.++... ......+.+|+.+++++ +|+||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            4577788999999999999873      134579999887543 33356788999999999 799999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|||+++|+|.++++... ..+++.++..++.|++.||+|||+
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~  159 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS  159 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999997543 348999999999999999999994

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=9.2e-15  Score=139.53  Aligned_cols=113  Identities=25%  Similarity=0.373  Sum_probs=100.6

Q ss_pred             CCccCcccccCCCceEEEe-eCCCcEEEEEEeecccc---chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          292 FSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCR---RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      |...+.+|.|+-|.|-.|+ ..+|+.+|||++.++.+   .....+.+||.+|+-+.|||++++++.|++...+|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            4456789999999999998 67899999999976532   2345678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|.|++++..++ .+.+.++.+++.||..|+.|+|.
T Consensus        94 v~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~  130 (786)
T KOG0588|consen   94 VPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHA  130 (786)
T ss_pred             cCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhh
Confidence            99999999998765 78999999999999999999995

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.56  E-value=3.2e-14  Score=128.71  Aligned_cols=115  Identities=29%  Similarity=0.447  Sum_probs=100.9

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      ++|...+.||+|+||.||+|...++..||+|.+.... ....++.+|+..+++++|+|++++++++......++||||++
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS   84 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence            4566778899999999999998777889999987542 234678899999999999999999999998899999999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++.... ..+++.++..++.|++.|++|||+
T Consensus        85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~  121 (261)
T cd05034          85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES  121 (261)
T ss_pred             CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999997643 468999999999999999999995

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.56  E-value=3.1e-14  Score=130.39  Aligned_cols=116  Identities=30%  Similarity=0.468  Sum_probs=99.8

Q ss_pred             ccCCccCcccccCCCceEEEee------CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      .++...+.+|+|+||.||++..      .++..+|+|.+..........+.+|++++.+++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            3456678899999999999863      2456899998876655556789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSN--------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|||+++|+|.++++..+              ..+++..+..++.|++.|++|||+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~  140 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS  140 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999997643              247899999999999999999994

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.56  E-value=4.2e-14  Score=127.56  Aligned_cols=114  Identities=20%  Similarity=0.276  Sum_probs=99.2

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |+..+.||+|+||.||.++. .++..+++|.+....  ......+.+|++++++++|+||+++++++...+..+++|||+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            55678899999999998884 568899999986542  344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++... ...+++.++..++.|+++|++|||+
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  119 (256)
T cd08221          82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK  119 (256)
T ss_pred             CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999764 3468999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.56  E-value=1.6e-14  Score=136.95  Aligned_cols=108  Identities=27%  Similarity=0.321  Sum_probs=91.9

Q ss_pred             CccCcccccCCCceEEEee-CCCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          293 SENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      ...+.||+|+||.||+|+. .+|+.||+|++..... .....+.+|++++.+++|+||+++++++...+..++||||+++
T Consensus        77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  156 (353)
T PLN00034         77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG  156 (353)
T ss_pred             hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence            3456799999999999985 4689999999865432 3346788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|....     ..++.....++.||++||+|||+
T Consensus       157 ~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~  186 (353)
T PLN00034        157 GSLEGTH-----IADEQFLADVARQILSGIAYLHR  186 (353)
T ss_pred             Ccccccc-----cCCHHHHHHHHHHHHHHHHHHHH
Confidence            9986532     35677888999999999999994

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.56  E-value=2.7e-14  Score=130.53  Aligned_cols=117  Identities=26%  Similarity=0.386  Sum_probs=99.5

Q ss_pred             hccCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCee
Q 036754          289 TYKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  361 (405)
                      .++|...+.||+|+||.||+|...      .+..||+|...... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            356777789999999999999864      35678999886543 23345789999999999999999999999888899


Q ss_pred             EEEEecCCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+++|+|.+++...+      ..++|.++.+++.||++|++|||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~  134 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE  134 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999997543      258999999999999999999994

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.56  E-value=3.8e-14  Score=129.69  Aligned_cols=114  Identities=25%  Similarity=0.436  Sum_probs=97.1

Q ss_pred             cCCccCcccccCCCceEEEeeC-CC----cEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          291 KFSENNLISKGGFGSVYKARLG-DG----MEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      +|...+.||+|+||.||+|... +|    ..+|+|...... .....++.+|+..+.+++|+|++++++++.. ...++|
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v   86 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI   86 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence            4556678999999999999853 33    258999886553 2345678899999999999999999999887 788999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++......+++..+..++.|+++|++|||+
T Consensus        87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~  127 (279)
T cd05057          87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE  127 (279)
T ss_pred             EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999998765579999999999999999999995

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.56  E-value=3.6e-14  Score=129.77  Aligned_cols=108  Identities=19%  Similarity=0.318  Sum_probs=91.9

Q ss_pred             ccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCH
Q 036754          298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL  373 (405)
Q Consensus       298 lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  373 (405)
                      ||+|+||.||++.. .+|+.||+|.+....   ......+..|++++.+++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999985 568999999986432   12234456799999999999999999999999999999999999999


Q ss_pred             HHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          374 EKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       374 ~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+++.... ..+++..+..++.|++.||+|||+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~  113 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS  113 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            98886533 468999999999999999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.56  E-value=4.1e-14  Score=128.02  Aligned_cols=116  Identities=29%  Similarity=0.391  Sum_probs=102.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ++|...+.+|+|+||.||+|.. .+++.+|+|.+........+.+.+|+.++++++||||+++++++......+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            3566678899999999999985 467889999997665556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++|.+++......+++.++..++.|++.||+|||+
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~  119 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE  119 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999987654578999999999999999999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.56  E-value=3.5e-14  Score=130.44  Aligned_cols=114  Identities=19%  Similarity=0.285  Sum_probs=97.2

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeecccc---chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR---RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      |...+.||+|+||.||++.. .+++.||+|.+.....   .....+.+|+.++.+++|++++++++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            45567899999999999985 5688999999865421   2234567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++.... ..+++.++..++.|++.||+|||+
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~  120 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ  120 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999986533 358999999999999999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.55  E-value=3.5e-14  Score=129.99  Aligned_cols=114  Identities=25%  Similarity=0.370  Sum_probs=93.7

Q ss_pred             cCCccCcccccCCCceEEEee-CCCc----EEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGM----EVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      +|...+.||+|+||.||+|.. .++.    .+|+|...... .....++..|+..+.+++|+||+++++++. ....+++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i   86 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLV   86 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEE
Confidence            456678899999999999985 3444    47777775332 233456778888999999999999999875 4557899


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||+++|+|.+++......++|..+..++.||++||+|||+
T Consensus        87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~  127 (279)
T cd05111          87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE  127 (279)
T ss_pred             EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999998766679999999999999999999995

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.55  E-value=3.7e-14  Score=128.04  Aligned_cols=109  Identities=26%  Similarity=0.363  Sum_probs=95.1

Q ss_pred             CcccccCCCceEEEeeCC--C--cEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARLGD--G--MEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.||+|++|.||+|.+..  +  ..||+|.+..... ...+.+.+|+..+++++|+||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            358999999999998633  3  3689999976554 556789999999999999999999999888 889999999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++.+.. ..++|.....++.|+++||+|||+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~  115 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES  115 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh
Confidence            99999997654 468999999999999999999995

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.55  E-value=4.7e-14  Score=127.77  Aligned_cols=115  Identities=23%  Similarity=0.453  Sum_probs=99.6

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-----cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-----RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      ++|...+.||+|++|.||++.. .++..||+|.+....     ......+.+|+.++.+++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4577788999999999999985 468899999986432     1234568889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+||+++|+|.+++...+ .+++..+..++.|++.||+|||+
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~  122 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHS  122 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999987644 68899999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.55  E-value=3.2e-14  Score=130.02  Aligned_cols=117  Identities=22%  Similarity=0.359  Sum_probs=97.9

Q ss_pred             hccCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCee
Q 036754          289 TYKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  361 (405)
                      .++|+..+.||+|+||.||+|...      .+..||+|.+.... .....++.+|+.++..++|+||+++++++......
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~   84 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   84 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence            456777889999999999998742      35679999886432 23445788999999999999999999999988999


Q ss_pred             EEEEecCCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+++|+|.+++...+         ..+++..+..++.|+++||+|||.
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~  137 (277)
T cd05062          85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA  137 (277)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999987532         236788999999999999999994

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.55  E-value=3.3e-14  Score=130.72  Aligned_cols=117  Identities=27%  Similarity=0.422  Sum_probs=99.3

Q ss_pred             hccCCccCcccccCCCceEEEeeC------CCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCee
Q 036754          289 TYKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  361 (405)
                      .++|...+.||+|+||.||++...      ++..||+|.+..... .....+.+|+.++++++|+||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            456777889999999999999853      467899999875432 3356788999999999999999999999998999


Q ss_pred             EEEEecCCCCCHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN---------------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~---------------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|||+++|+|.+++....                     ..+++.+++.++.|++.||+|||+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~  148 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE  148 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999999997421                     247788899999999999999995

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.55  E-value=4.2e-14  Score=130.92  Aligned_cols=115  Identities=22%  Similarity=0.338  Sum_probs=98.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||.||+|.. .++..||+|.++... ......+.+|+..+.+++|+||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            3466678899999999999985 467899999986543 23345677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++ ++|.+++......+++.....++.|+++||+|||+
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~  122 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR  122 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            98 59999987665678999999999999999999995

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.55  E-value=4.1e-14  Score=132.90  Aligned_cols=113  Identities=20%  Similarity=0.292  Sum_probs=96.4

Q ss_pred             CCccCcccccCCCceEEEee----CCCcEEEEEEeeccc----cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeE
Q 036754          292 FSENNLISKGGFGSVYKARL----GDGMEVAVKVFNLQC----RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  362 (405)
                      |...+.||+|+||.||++..    .+++.||+|++....    ......+..|+.++..+ +|++|+++++++...+..+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            55667899999999999874    357899999997532    22345677899999999 5999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++..++ .+++.++..++.||++||+|||+
T Consensus        82 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~  123 (332)
T cd05614          82 LILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHK  123 (332)
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999997654 68999999999999999999995

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.55  E-value=2.4e-14  Score=131.51  Aligned_cols=115  Identities=22%  Similarity=0.298  Sum_probs=99.2

Q ss_pred             cCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +|...+.||+|+||.||++... .|..||+|.+.... ......+.+|+.++.+++|+||+++++++...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            3455678999999999999864 78999999886542 233467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~--~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++|..++...  ...+++..+..++.|+++||+|||+
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~  120 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE  120 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999998764  2368999999999999999999994

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.55  E-value=3.1e-14  Score=129.58  Aligned_cols=114  Identities=25%  Similarity=0.375  Sum_probs=96.2

Q ss_pred             cCCccCcccccCCCceEEEeeCC----CcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          291 KFSENNLISKGGFGSVYKARLGD----GMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      +|...+.||+|+||.||+|...+    ...||+|...... ....+.+.+|+.++.+++|+||+++++++.. +..++||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~   85 (270)
T cd05056           7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM   85 (270)
T ss_pred             hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence            45667889999999999998533    2468999886543 3445678899999999999999999998865 5678999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++......+++..+..++.|+++||+|||+
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~  125 (270)
T cd05056          86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES  125 (270)
T ss_pred             EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999997655568999999999999999999995

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.55  E-value=4.7e-14  Score=129.42  Aligned_cols=113  Identities=23%  Similarity=0.264  Sum_probs=99.3

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |...+.||+|+||.||+|.. .+|..||+|++....  ......+.+|+.++++++|+|++++++++......++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            44567899999999999995 568999999987543  334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       +++|.+++......+++.++..++.||++||+|||+
T Consensus        82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  117 (286)
T cd07832          82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA  117 (286)
T ss_pred             -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence             999999997655679999999999999999999995

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.55  E-value=3e-14  Score=130.29  Aligned_cols=115  Identities=31%  Similarity=0.507  Sum_probs=98.4

Q ss_pred             cCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccccc-hhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          291 KFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQCRR-AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      +|...+.||+|+||.||+|...      ++..||+|.++..... ....+.+|++++.+++|+|++++++++......++
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   85 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM   85 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence            3555678999999999999853      2478999998755433 45688999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSN-------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++...+             ..+++.+...++.|++.|++|||+
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~  140 (280)
T cd05049          86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS  140 (280)
T ss_pred             EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence            999999999999997532             347899999999999999999995

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.55  E-value=5.6e-14  Score=126.38  Aligned_cols=110  Identities=34%  Similarity=0.513  Sum_probs=97.7

Q ss_pred             CcccccCCCceEEEeeCCCcEEEEEEeeccccc-hhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCHH
Q 036754          296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCRR-AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLE  374 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  374 (405)
                      ++||+|+||.||++...+++.||+|........ ....+..|+.++.+++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            368999999999999766999999988754333 4567889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          375 KYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       375 ~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++......+++.....++.|+++|++|||+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~  111 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES  111 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9997655568999999999999999999995

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.55  E-value=9.8e-16  Score=143.03  Aligned_cols=202  Identities=25%  Similarity=0.262  Sum_probs=110.6

Q ss_pred             cCCCCCcCCeeeCcCCcCcc------cCCchhhhcccccccEEEcccCcccccCCccccCccC---CCeeecCCccccc-
Q 036754            6 SLSNCKCLTFIDLSNNPLDS------VLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTK---LTTIILGGNKLNG-   75 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~------~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~N~l~~-   75 (405)
                      .+...++|+.|+++++.+.+      ..+.. +..++ +|+.|++++|.+....+..+..+.+   |+.|++++|++++ 
T Consensus        46 ~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~-l~~~~-~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~  123 (319)
T cd00116          46 ALRPQPSLKELCLSLNETGRIPRGLQSLLQG-LTKGC-GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDR  123 (319)
T ss_pred             HHhhCCCceEEeccccccCCcchHHHHHHHH-HHhcC-ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchH
Confidence            44555667777777766652      11112 33333 6777777777766544555544444   7777777776652 


Q ss_pred             ---ccCcchhcCC-CCCCeeeCCCCCCC-----CCchhhhccccCccccCCC----------CChhccCCCCCCEEeccC
Q 036754           76 ---SISITLGSNL-ASLRKLSLDSNELT-----SIPLTFWNLKDILYLNFSV----------IPIEIGGLPNLEYLFLGY  136 (405)
Q Consensus        76 ---~~~~~~~~~l-~~L~~L~Ls~N~l~-----~lp~~~~~l~~L~~l~l~~----------~p~~~~~l~~L~~L~l~~  136 (405)
                         .+...+ ..+ ++|+.|++++|.++     .++..+..+..|+.|+++.          ++..+..+++|++|++++
T Consensus       124 ~~~~l~~~l-~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~  202 (319)
T cd00116         124 GLRLLAKGL-KDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN  202 (319)
T ss_pred             HHHHHHHHH-HhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccC
Confidence               111122 234 66677777777666     2233344455666666554          122334456777777777


Q ss_pred             CcccccC----CcccccCCCCCeeecccccccCccchhHHh-----cccCCccccccCcccCc----C-CCCCccCCCCc
Q 036754          137 NRLQGSI----PDSFGDLISLKSLNLSKNNLSGAIPASLEK-----LLYLKDLNLSFNKLEGE----I-PRGGSFGNFSA  202 (405)
Q Consensus       137 n~l~~~~----p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-----l~~L~~l~l~~n~l~~~----~-p~~~~~~~~~~  202 (405)
                      |.+.+..    +..+..+++|+.|++++|.+++.....+..     .+.|+.|++++|.++..    + .....+.++..
T Consensus       203 n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~  282 (319)
T cd00116         203 NGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLE  282 (319)
T ss_pred             CccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccE
Confidence            7765322    233455667777777777776433333322     25777777777776521    0 11122355666


Q ss_pred             ccccCCCC
Q 036754          203 ESFEGNEL  210 (405)
Q Consensus       203 ~~~~~n~~  210 (405)
                      +++++|..
T Consensus       283 l~l~~N~l  290 (319)
T cd00116         283 LDLRGNKF  290 (319)
T ss_pred             EECCCCCC
Confidence            66666654

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.55  E-value=4.6e-14  Score=128.11  Aligned_cols=115  Identities=22%  Similarity=0.375  Sum_probs=96.6

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-----cchhHHHHHHHHHhhcCCCCCcceEEeeeecC--Cee
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-----RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE--EFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  361 (405)
                      .+|...+.||+|+||.||+|.. .+|..||+|.+....     ......+.+|+..+.+++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            3567778999999999999985 568899999886422     12345778899999999999999999988653  567


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|||+++|+|.+++.... .+++....+++.|++.||+|||+
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~  124 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHS  124 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            89999999999999987654 57888999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.55  E-value=3e-14  Score=140.24  Aligned_cols=114  Identities=17%  Similarity=0.225  Sum_probs=97.0

Q ss_pred             CCccCcccccCCCceEEEee-CC-CcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          292 FSENNLISKGGFGSVYKARL-GD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      |...+.+|+|+||.||+|.. .+ +..||+|............+.+|+.++..++|||||++++++...+..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            56678899999999999984 33 57788887755544445567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.++++..   ...+++.++..++.||+.||+|||+
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~  187 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS  187 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999988642   2468899999999999999999995

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.55  E-value=4.2e-14  Score=132.31  Aligned_cols=114  Identities=19%  Similarity=0.227  Sum_probs=95.2

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      +|...+.||+|+||.||+|.. .+++.||+|.+....   ......+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            356678899999999999985 467899999997542   22334566777877776 5899999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+ .+++.++..++.|++.||+|||+
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~  119 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHS  119 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999987544 68999999999999999999994

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.55  E-value=2.5e-14  Score=135.01  Aligned_cols=116  Identities=22%  Similarity=0.397  Sum_probs=94.8

Q ss_pred             ccCCccCcccccCCCceEEEee------CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecC-Ce
Q 036754          290 YKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNE-EF  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~  360 (405)
                      ++|...+.||+|+||.||+|..      ..++.||||.++... ......+.+|+.++.++ +|+||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            3566778999999999999973      346789999997543 23345688899999999 689999999988654 56


Q ss_pred             eEEEEecCCCCCHHHHHhcCC-----------------------------------------------------------
Q 036754          361 KALVLEYMPHGSLEKYLYSSN-----------------------------------------------------------  381 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  381 (405)
                      .+++|||+++|+|.++++...                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            789999999999999986421                                                           


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          382 -------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       382 -------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                             ..++|.++..++.|+++||+|||+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~  197 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS  197 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh
Confidence                   236888899999999999999995

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.55  E-value=2.4e-14  Score=127.99  Aligned_cols=112  Identities=25%  Similarity=0.327  Sum_probs=95.9

Q ss_pred             CccCcccccCCCceEEEe-eCCCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCC-cceEEeeeecCC------eeE
Q 036754          293 SENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQN-LIKVISSCSNEE------FKA  362 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------~~~  362 (405)
                      ...+++|+|+||+||+|. ..+|..||+|+++....  .......+|+.++.+++|+| ||++++++.+.+      ..+
T Consensus        14 ~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~   93 (323)
T KOG0594|consen   14 EKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLY   93 (323)
T ss_pred             HHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEE
Confidence            344569999999999998 56889999999986543  23455688999999999999 999999998876      789


Q ss_pred             EEEecCCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+||+.. ||.+++....   ..++......++.|+.+||+|||+
T Consensus        94 lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~  138 (323)
T KOG0594|consen   94 LVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS  138 (323)
T ss_pred             EEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999987 9999998755   467888899999999999999995

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.55  E-value=4.8e-14  Score=127.56  Aligned_cols=113  Identities=27%  Similarity=0.422  Sum_probs=96.6

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +|...+.||+|+||.||+|....+..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++|||+++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~   84 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK   84 (260)
T ss_pred             HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence            4555678999999999999987888899999875432 3456889999999999999999999875 4568999999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++.... ..+++.++..++.|++.||+|||+
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~  120 (260)
T cd05070          85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER  120 (260)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999997543 458999999999999999999995

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.55  E-value=4.5e-14  Score=129.97  Aligned_cols=114  Identities=29%  Similarity=0.350  Sum_probs=99.3

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||.||++.. .+++.||+|++....   ......+.+|++++.+++||||+++++++...+..++|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            456678899999999999985 468899999986542   2334568889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+ .+++..+..++.|+++||+|||+
T Consensus        82 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~  119 (290)
T cd05580          82 YVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHS  119 (290)
T ss_pred             cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999997653 68999999999999999999995

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.54  E-value=2e-14  Score=145.12  Aligned_cols=187  Identities=21%  Similarity=0.196  Sum_probs=111.6

Q ss_pred             CCcCCeeeCcCCcCcccCCch--h------------hhcccccccEEEcccCcccccCCccccCccCCCeeecCCccccc
Q 036754           10 CKCLTFIDLSNNPLDSVLPKT--F------------VGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNG   75 (405)
Q Consensus        10 l~~L~~L~Ls~N~l~~~~~~~--f------------~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~   75 (405)
                      +++|++|+|++|+|+.+.+..  .            +..++.+|+.|++++|+++. +|.   .+++|+.|+|++|+++ 
T Consensus       241 p~~Lk~LdLs~N~LtsLP~lp~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~-  315 (788)
T PRK15387        241 PPELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLA-  315 (788)
T ss_pred             CCCCcEEEecCCccCcccCcccccceeeccCCchhhhhhchhhcCEEECcCCcccc-ccc---cccccceeECCCCccc-
Confidence            466777777777666554211  0            00112356666666666654 232   2356777777777766 


Q ss_pred             ccCcchh----------------cCCCCCCeeeCCCCCCCCCchhhhccccCcc--ccCCCCChhccCCCCCCEEeccCC
Q 036754           76 SISITLG----------------SNLASLRKLSLDSNELTSIPLTFWNLKDILY--LNFSVIPIEIGGLPNLEYLFLGYN  137 (405)
Q Consensus        76 ~~~~~~~----------------~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~--l~l~~~p~~~~~l~~L~~L~l~~n  137 (405)
                      .+|....                ....+|++|+|++|+|+.+|....++..|..  ..+..+|..   ..+|+.|++++|
T Consensus       316 ~Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~LP~lp~~L~~L~Ls~N~L~~LP~l---~~~L~~LdLs~N  392 (788)
T PRK15387        316 SLPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLPAL---PSGLKELIVSGN  392 (788)
T ss_pred             cCCCCcccccccccccCccccccccccccceEecCCCccCCCCCCCcccceehhhccccccCccc---ccccceEEecCC
Confidence            3432110                0113678888888888877764433333211  112234432   246888888888


Q ss_pred             cccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCcc
Q 036754          138 RLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC  212 (405)
Q Consensus       138 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c  212 (405)
                      ++.+ +|..   .++|+.|++++|.+++ +|...   .+|+.|++++|+++..+.....+.++..+++.+|++..
T Consensus       393 ~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~  459 (788)
T PRK15387        393 RLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSE  459 (788)
T ss_pred             cccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCc
Confidence            8884 5543   3578888888888885 45432   35777888888887544345567778888888888754

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.54  E-value=6.3e-14  Score=127.16  Aligned_cols=116  Identities=28%  Similarity=0.334  Sum_probs=100.1

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.||+|+||.||+|... +|+.||+|.++...   ......+.+|++++.+++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            35667788999999999999964 78999999886422   233567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|..++...   +..+++.++..++.|+++||+|||+
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  124 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS  124 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999988642   3458999999999999999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.54  E-value=5.9e-14  Score=126.72  Aligned_cols=110  Identities=36%  Similarity=0.581  Sum_probs=97.3

Q ss_pred             CcccccCCCceEEEeeCC----CcEEEEEEeeccccc-hhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARLGD----GMEVAVKVFNLQCRR-AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.||+|+||.||+|....    +..||+|.++..... ....+.+|++.+..++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            368999999999999643    788999999765433 367788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~--------~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++...        ...+++.++..++.|+++||+|||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~  123 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS  123 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc
Confidence            9999999875        3578999999999999999999995

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.54  E-value=6.2e-14  Score=128.14  Aligned_cols=112  Identities=25%  Similarity=0.354  Sum_probs=97.4

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      |+..+.||+|+||.||+|.. .++..||+|...... ......+.+|+..+.+++|+||+++++++......++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            44567899999999999985 468899999886433 3345678889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++...  .+++.....++.|++.|++|||+
T Consensus        86 ~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~  119 (277)
T cd06641          86 GGSALDLLEPG--PLDETQIATILREILKGLDYLHS  119 (277)
T ss_pred             CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHcc
Confidence            99999998653  58999999999999999999995

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.54  E-value=5.3e-14  Score=128.72  Aligned_cols=115  Identities=25%  Similarity=0.390  Sum_probs=97.0

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCc----EEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGM----EVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      .+|...+.||+|+||+||+|+. .+|.    .||+|.++... ......+..|+..+..++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            4566778999999999999984 4554    48999986543 3345678899999999999999999999875 45779


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||+++|+|.++++.....+++..++.++.||++||+|||+
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~  127 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE  127 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999998755579999999999999999999995

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.54  E-value=2.7e-14  Score=131.45  Aligned_cols=117  Identities=26%  Similarity=0.353  Sum_probs=94.8

Q ss_pred             hhccCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccc---------cc-----hhHHHHHHHHHhhcCCCCCcceEE
Q 036754          288 ATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC---------RR-----AFKSFDIECEMMKSIRHQNLIKVI  352 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~---------~~-----~~~~~~~e~~~l~~l~h~niv~l~  352 (405)
                      ..++|.....||+|.||.|-+|. ..+++.||+|++.+..         ..     ..+.+.+||.+|++++|+|||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            34567778889999999999998 4678999999995421         01     124688999999999999999999


Q ss_pred             eeeec--CCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          353 SSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       353 ~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+..+  .+.+|||+|||..|.+...=.+ +..++..++.+|.+++..||+|||.
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~  228 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHY  228 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHh
Confidence            99876  4679999999999886553222 2238999999999999999999994

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.54  E-value=3.5e-14  Score=128.93  Aligned_cols=115  Identities=26%  Similarity=0.369  Sum_probs=98.6

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||.||++.. .++..+|||.+....   .....++.+|+.++..++|+||+++++++...+..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            455667899999999999994 678999999886432   2334678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++..   ....+++..+..++.|+++||+|||+
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~  124 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS  124 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999998863   23468999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.54  E-value=5.6e-14  Score=130.38  Aligned_cols=114  Identities=25%  Similarity=0.362  Sum_probs=99.2

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.+|+|+||.||++.. ..++.||+|.+....   ......+.+|+.++..++|+||+++++.+...+..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            466678899999999999985 467899999987653   2334567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+ .+++..+..++.|+++||+|||+
T Consensus        82 ~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~  119 (305)
T cd05609          82 YVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHN  119 (305)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999997654 68999999999999999999995

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.54  E-value=1.5e-14  Score=134.29  Aligned_cols=114  Identities=23%  Similarity=0.279  Sum_probs=101.7

Q ss_pred             CCccCcccccCCCceEEEe-eCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |+..+.||+|-|+.|-.|. ..+|..||||++.+..  ........+|++.|+-++|||||++|....+...+|+|.|.-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            4456789999999999887 5689999999997654  334456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+|||++|+.++...+.+.-+.+++.||+.|+.|+|.
T Consensus       100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq  136 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ  136 (864)
T ss_pred             CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh
Confidence            9999999999888889999999999999999999993

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.54  E-value=5.5e-14  Score=127.41  Aligned_cols=113  Identities=27%  Similarity=0.405  Sum_probs=95.6

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      .|...+.||+|+||.||+|+..+...||+|.+.... .....+.+|++++.+++|+||+++++++. .+..++||||+++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~   84 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK   84 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence            456678899999999999987666679999987532 23457889999999999999999998874 4568999999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++.... ..+++..+..++.|+++||+|||+
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~  120 (262)
T cd05071          85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER  120 (262)
T ss_pred             CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999997533 458999999999999999999995

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.54  E-value=4.9e-14  Score=129.63  Aligned_cols=117  Identities=25%  Similarity=0.373  Sum_probs=96.5

Q ss_pred             hccCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCee
Q 036754          289 TYKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  361 (405)
                      .++|...+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+..+.+++|+||+++++++...+..
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            345677789999999999998742      24579999886443 22345678899999999999999999999988999


Q ss_pred             EEEEecCCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+++|+|.++++..+         ...++.....++.|++.||+|||+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~  137 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA  137 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999999997422         235677889999999999999995

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.54  E-value=7.9e-15  Score=141.13  Aligned_cols=114  Identities=33%  Similarity=0.486  Sum_probs=97.8

Q ss_pred             CCccCcccccCCCceEEEe-eCCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecC------CeeEE
Q 036754          292 FSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE------EFKAL  363 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l  363 (405)
                      +...+.+|+|+||.||+|. -..|+.||||.++... ...+..+.+|++++++++|+|||++.+.-++.      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            3445779999999999999 6789999999997643 45567788999999999999999998865543      35679


Q ss_pred             EEecCCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||||++|||...|.+..  ..+++.+.+.+..+++.||.|||+
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE  138 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE  138 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999998654  579999999999999999999995

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.54  E-value=4.1e-14  Score=130.47  Aligned_cols=114  Identities=29%  Similarity=0.359  Sum_probs=99.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ..|...+.+|+|+||.||++.. .++..||+|.+..........+.+|+.++.+++|||++++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            3556678899999999999984 567899999986554455567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++...  .+++.++..++.|+++||+|||+
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~  133 (293)
T cd06647          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS  133 (293)
T ss_pred             CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999998753  47899999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.54  E-value=3.9e-14  Score=128.83  Aligned_cols=109  Identities=20%  Similarity=0.337  Sum_probs=90.0

Q ss_pred             cccccCCCceEEEeeCCC---cEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCC
Q 036754          297 LISKGGFGSVYKARLGDG---MEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGS  372 (405)
Q Consensus       297 ~lg~G~fg~v~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  372 (405)
                      .||+|+||.||+|...++   ..+++|.+.... ......+.+|+.++..++||||++++++|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975433   345677665433 2345678999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCC---CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          373 LEKYLYSSN---CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       373 L~~~l~~~~---~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |.++++...   ...++.....++.||++||+|||+
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~  117 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK  117 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence            999997542   345677788999999999999995

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.54  E-value=4.8e-14  Score=130.70  Aligned_cols=116  Identities=31%  Similarity=0.575  Sum_probs=96.2

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCc--EEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGM--EVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  364 (405)
                      ++|...+.||+|+||.||+|... ++.  .+|+|.++... ......+.+|+.++.++ +|+||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            35666788999999999999853 454  45777765432 33456788899999999 899999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.++++..+               ..+++.++..++.|+++|++|||+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~  142 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ  142 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999997432               257899999999999999999995

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.54  E-value=7.6e-14  Score=125.84  Aligned_cols=114  Identities=16%  Similarity=0.262  Sum_probs=98.0

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      |...+.+|+|+||.||+++. .++..+|+|.++... ....+.+..|+.++.+++|+|++++.+++.+.+..+++|||++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD   81 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence            45567899999999999984 468899999986432 3345677889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++... ...+++.....++.|+++||+|||+
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~  118 (255)
T cd08219          82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE  118 (255)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            99999988653 3457899999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.54  E-value=2.3e-14  Score=131.02  Aligned_cols=110  Identities=23%  Similarity=0.307  Sum_probs=95.9

Q ss_pred             ccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCC
Q 036754          294 ENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHG  371 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  371 (405)
                      ..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+..+++++|+||+++++++...+..++||||+++|
T Consensus         8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06642           8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCC
Confidence            346689999999999985 467889999986443 344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          372 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       372 ~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|.+++..  ..+++..+..++.|+++|++|||+
T Consensus        88 ~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~  119 (277)
T cd06642          88 SALDLLKP--GPLEETYIATILREILKGLDYLHS  119 (277)
T ss_pred             cHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhc
Confidence            99999864  358999999999999999999995

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.54  E-value=7.2e-14  Score=126.55  Aligned_cols=113  Identities=29%  Similarity=0.412  Sum_probs=99.5

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |...+.||+|+||.||+|.. .++..||+|.++....  .....+.+|+.++.+++|+||+++++.+...+..++|+||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            45567899999999999985 4688999999876543  35678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++|.+++.... .+++..+..++.|+++||+|||+
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~  117 (264)
T cd06626          82 SGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHS  117 (264)
T ss_pred             CCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHH
Confidence            9999999997653 58899999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.54  E-value=5.4e-14  Score=129.56  Aligned_cols=115  Identities=31%  Similarity=0.492  Sum_probs=98.1

Q ss_pred             cCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          291 KFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      +|...+.||+|+||.||+|+..      ++..+|+|.+........+.+.+|++.+++++|+||+++++++...+..++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV   85 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence            4555678999999999999742      3456889988655555556788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++....               ..++|..+..++.|++.|++|||+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~  141 (291)
T cd05094          86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS  141 (291)
T ss_pred             EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999997532               348999999999999999999995

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.54  E-value=7.3e-14  Score=128.28  Aligned_cols=117  Identities=28%  Similarity=0.320  Sum_probs=103.0

Q ss_pred             hhccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          288 ATYKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      .+..|...+.+|+|+||.||+|... ++..||+|++..... ....+.+|++.+.+++|+|++++++++...+..++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4455666788999999999999965 688999999976544 45678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++++|.+++......+++..+..++.|+++||+|||.
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~  134 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS  134 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999998764479999999999999999999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.54  E-value=5.7e-14  Score=129.28  Aligned_cols=115  Identities=22%  Similarity=0.362  Sum_probs=98.5

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            45666788999999999999964 678999999865432 2234567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++ +|.+++......+++.....++.|+++||+|||+
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~  121 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ  121 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            985 9999987655578999999999999999999995

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.54  E-value=6.5e-14  Score=126.34  Aligned_cols=114  Identities=25%  Similarity=0.400  Sum_probs=99.3

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +|+..+.||+|+||.||++....+..+|+|.+.... .....+.+|++++.+++|||++++++++......++||||+++
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            455567899999999999987678889999886432 2245688999999999999999999999988999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++......+++..+..++.|++.|++|||+
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~  118 (256)
T cd05112          84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES  118 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999998655568999999999999999999994

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.54  E-value=7.6e-14  Score=125.91  Aligned_cols=114  Identities=19%  Similarity=0.324  Sum_probs=98.5

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |+..+.+|+|+||.+|++.. .+|+.||+|.+....  .....++.+|+.++++++|+||+++.+++...+..++|+||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            45667899999999999984 568899999986432  334467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++.... ..+++.+...++.|++.|++|||+
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  119 (256)
T cd08218          82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD  119 (256)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999987543 357899999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.54  E-value=4.9e-14  Score=128.97  Aligned_cols=117  Identities=24%  Similarity=0.389  Sum_probs=98.3

Q ss_pred             hccCCccCcccccCCCceEEEeeCC-----CcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeec-CCee
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGD-----GMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSN-EEFK  361 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  361 (405)
                      .++|...++||+|+||.||+|....     +..||+|.+.... ......+.+|+.++.+++|+|++++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            3456677899999999999998654     6789999886543 3345678899999999999999999998776 4678


Q ss_pred             EEEEecCCCCCHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN-------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++||+++|+|.+++....       ..+++.++..++.|+++||+|||+
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~  135 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK  135 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            89999999999999986532       358999999999999999999995

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.54  E-value=5.1e-14  Score=130.73  Aligned_cols=116  Identities=27%  Similarity=0.429  Sum_probs=97.4

Q ss_pred             ccCCccCcccccCCCceEEEeeC--------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLG--------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEE  359 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  359 (405)
                      ++|...+.||+|+||.||++...        .+..+|+|.++... ......+.+|+.++.++ +|+||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            34666788999999999998742        23469999987543 33456788899999999 7999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++||||+++|+|.+++...+               ..++|.++++++.|++.||+|||+
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~  158 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS  158 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999997532               248899999999999999999995

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.54  E-value=9.5e-14  Score=125.71  Aligned_cols=114  Identities=25%  Similarity=0.295  Sum_probs=101.1

Q ss_pred             cCCccCcccccCCCceEEEeeC-CCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +|...+.||+|++|.||+++.. +++.||+|.+..... .....+.+|+..+.+++|+|++++++++...+..++||||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            4566788999999999999964 589999999876543 44577899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++|.+++... ..+++..+..++.|+++|++|||+
T Consensus        82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~  117 (264)
T cd06623          82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHT  117 (264)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhc
Confidence            999999999765 468999999999999999999995

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.53  E-value=5.6e-14  Score=127.94  Aligned_cols=117  Identities=23%  Similarity=0.313  Sum_probs=97.0

Q ss_pred             hhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeecC------C
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNE------E  359 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~  359 (405)
                      +++.|...+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.++.++ +|+|++++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            344566677899999999999985 467899999986543 3345678899999998 799999999998653      4


Q ss_pred             eeEEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..+++|||+++|+|.+++.... ..++|..+..++.|++.|++|||+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~  129 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ  129 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            5789999999999999987643 468999999999999999999995

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.53  E-value=7.6e-14  Score=127.58  Aligned_cols=112  Identities=24%  Similarity=0.367  Sum_probs=97.8

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      |+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++|+||+++++++.+....++||||++
T Consensus         6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06640           6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence            44557799999999999985 468899999987543 3445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++...  .+++.+...++.|+++||+|||+
T Consensus        86 ~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~  119 (277)
T cd06640          86 GGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHS  119 (277)
T ss_pred             CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999998653  58899999999999999999995

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.53  E-value=7.3e-14  Score=128.02  Aligned_cols=115  Identities=29%  Similarity=0.560  Sum_probs=97.1

Q ss_pred             cCCccCcccccCCCceEEEeeCC------CcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          291 KFSENNLISKGGFGSVYKARLGD------GMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      +|...+.||+|+||.||+|....      ...||+|.++.... .....|.+|+..+.+++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            45667889999999999998532      25799999865432 334578899999999999999999999999899999


Q ss_pred             EEecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|||+++|+|.+++....               ..+++.+...++.|+++||+|||+
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~  142 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS  142 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999997531               357889999999999999999995

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.53  E-value=6.1e-14  Score=126.95  Aligned_cols=114  Identities=22%  Similarity=0.383  Sum_probs=97.6

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      +.+...+.||+|+||.||++....+..+|+|.+... ......+.+|++++.+++|+|++++.+.+.. ...+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            345667889999999999999777788999988643 2234678889999999999999999998877 77899999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++.... ..+++.++..++.|++.||+|||+
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~  120 (260)
T cd05073          84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ  120 (260)
T ss_pred             CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh
Confidence            999999997643 457899999999999999999995

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.53  E-value=5.4e-14  Score=129.60  Aligned_cols=117  Identities=28%  Similarity=0.459  Sum_probs=98.2

Q ss_pred             hccCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCe
Q 036754          289 TYKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEF  360 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  360 (405)
                      .++|...+.||+|+||.||++...      ....+|+|.+.... .+....+.+|+.++.++ +|+||+++++++...+.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            345667788999999999999853      23679999987543 23445688999999999 89999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+++|||+++|+|.+++...               ...+++..++.++.|++.|++|||+
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~  150 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS  150 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999998642               2468999999999999999999994

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.53  E-value=1.1e-13  Score=125.80  Aligned_cols=114  Identities=22%  Similarity=0.432  Sum_probs=96.7

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-----cchhHHHHHHHHHhhcCCCCCcceEEeeeec--CCeeE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-----RRAFKSFDIECEMMKSIRHQNLIKVISSCSN--EEFKA  362 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  362 (405)
                      +|...+.+|+|+||.||+|.. .++..||+|.+....     .+....+.+|+.++++++|+||+++++++..  ....+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            577788999999999999985 468899999886432     1234567889999999999999999998765  35788


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++||+++++|.+++.... .+++.....++.|+++||+|||+
T Consensus        83 l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~  124 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHS  124 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999997644 58999999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=4.4e-15  Score=139.78  Aligned_cols=113  Identities=27%  Similarity=0.341  Sum_probs=98.2

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeecc---ccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      |.+.+-||.|+||.||-|.. .+...||||++.-.   ..+.++++..|++.+.+++|||++...|||..+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            44556799999999999984 56788999998643   345578889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |-| +-.+.+.-+++.+.+-+...|+.|+++||+|||+
T Consensus       108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS  144 (948)
T KOG0577|consen  108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS  144 (948)
T ss_pred             Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH
Confidence            975 7788776666789999999999999999999995

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.53  E-value=4.9e-14  Score=144.10  Aligned_cols=115  Identities=25%  Similarity=0.315  Sum_probs=97.9

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||.||+|.. .+|+.||+|+++...   ....++|.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            466678899999999999985 468999999986532   2234678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSS----------NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~----------~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...          ....++..+++++.||++||+|||+
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs  131 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS  131 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999988631          1246678889999999999999995

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.53  E-value=8.6e-14  Score=127.39  Aligned_cols=110  Identities=25%  Similarity=0.253  Sum_probs=94.6

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +|...++||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++.+++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            455667899999999999984 578899999986542 334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|..+.     .+++.....++.|++.||+|||+
T Consensus        82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~  113 (279)
T cd06619          82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS  113 (279)
T ss_pred             CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH
Confidence            999987652     46788889999999999999995

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.53  E-value=6.4e-14  Score=129.40  Aligned_cols=114  Identities=28%  Similarity=0.373  Sum_probs=100.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ..|...+.||.|+||.||+|.. .+|+.||+|.+..........+.+|+..++.++|+|++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            3466778899999999999984 678999999987655555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++...  .+++.++..++.|+++|++|||+
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~  133 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHA  133 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999988653  58999999999999999999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.53  E-value=7.9e-14  Score=128.34  Aligned_cols=114  Identities=25%  Similarity=0.396  Sum_probs=95.5

Q ss_pred             CCccCcccccCCCceEEEeeC------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          292 FSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      |...+.||+|+||.||+|+..      ....+|+|.+.... ......+.+|+.++.+++||||+++++.+...+..+++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI   81 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence            456678999999999999842      23578898886543 23456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||+++|+|.+++....                       ..+++.....++.|++.|++|||+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~  145 (290)
T cd05045          82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE  145 (290)
T ss_pred             EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999986421                       247899999999999999999995

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.53  E-value=9.8e-14  Score=125.11  Aligned_cols=112  Identities=31%  Similarity=0.553  Sum_probs=97.7

Q ss_pred             ccCcccccCCCceEEEeeCC-----CcEEEEEEeeccccc-hhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          294 ENNLISKGGFGSVYKARLGD-----GMEVAVKVFNLQCRR-AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ..+.+|+|+||.||++....     +..||+|.+...... ..+.+..|++.+..++|+||+++++++...+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            45779999999999998643     378999999765433 567888999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~-l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++...... +++.++..++.|++.|++|||+
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~  121 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES  121 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc
Confidence            9999999999765433 8999999999999999999995

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.53  E-value=9e-14  Score=125.87  Aligned_cols=110  Identities=30%  Similarity=0.462  Sum_probs=91.6

Q ss_pred             CcccccCCCceEEEeeC----CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeec-CCeeEEEEecCC
Q 036754          296 NLISKGGFGSVYKARLG----DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSN-EEFKALVLEYMP  369 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  369 (405)
                      +.||+|+||.||+|...    .+..||+|.+.... ......+.+|+.+++.++|||++++++++.. +...++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36899999999999853    23579999885432 3345678899999999999999999997764 556889999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++.......++..++.++.|+++|++|||+
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  116 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS  116 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999997655567888899999999999999995

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.53  E-value=9.4e-14  Score=126.12  Aligned_cols=113  Identities=27%  Similarity=0.455  Sum_probs=96.3

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeecccc---------chhHHHHHHHHHhhcCCCCCcceEEeeeecCCee
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR---------RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  361 (405)
                      |.....||+|+||.||+|.. .+++.||+|.+.....         ...+.+.+|+.++.+++||||+++++++...+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            34457899999999999985 4678999998864321         1224678899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|||+++++|.+++...+ .+++..+..++.|++.||+|||+
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~  124 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHN  124 (267)
T ss_pred             EEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999999997653 68899999999999999999994

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.53  E-value=7.4e-14  Score=128.01  Aligned_cols=114  Identities=25%  Similarity=0.387  Sum_probs=97.7

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +|+..+.||+|++|.||+|+. .+|..||+|.++.... .....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            356678899999999999996 4688999999876533 23456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++ +|.+++....  ..+++.++..++.|+++||+|||+
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  118 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE  118 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence            85 8999886543  468999999999999999999995

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.53  E-value=2.8e-14  Score=130.96  Aligned_cols=114  Identities=25%  Similarity=0.353  Sum_probs=97.5

Q ss_pred             cCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          291 KFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +|...+.||+|+||.||+|... .++.||+|.+....  ....+.+.+|++++..++|+||+++++++...+..++|+||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            4556688999999999999964 58899999886432  22345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++++..+.... ..++|.++..++.||++||+|||+
T Consensus        82 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~  118 (286)
T cd07846          82 VDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHS  118 (286)
T ss_pred             CCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999888876543 358999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.53  E-value=6.2e-14  Score=129.99  Aligned_cols=116  Identities=27%  Similarity=0.453  Sum_probs=97.1

Q ss_pred             ccCCccCcccccCCCceEEEeeC--------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLG--------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEE  359 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  359 (405)
                      .+|...+.||+|+||.||+|+..        ++..||+|...... ......+.+|+..+..+ +|+||+++++++....
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            44566788999999999999731        24579999886442 33456788999999999 8999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..+++|||+++|+|.+++....               ..+++.++..++.||++||+|||+
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~  155 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS  155 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999997532               247888999999999999999995

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.53  E-value=5.7e-14  Score=132.21  Aligned_cols=112  Identities=21%  Similarity=0.285  Sum_probs=93.1

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecC-----CeeEE
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE-----EFKAL  363 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~l  363 (405)
                      |...+.||+|+||.||+|.. .+|..||+|++....  ......+.+|+.++++++||||+++++++...     ...|+
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            44567899999999999984 578999999986432  23345688999999999999999999987543     34799


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||++ ++|.+++.... .+++..+..++.|+++||+|||+
T Consensus        82 v~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~  121 (338)
T cd07859          82 VFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHT  121 (338)
T ss_pred             EEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHH
Confidence            999996 69999887543 68999999999999999999995

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.53  E-value=7.1e-14  Score=129.07  Aligned_cols=116  Identities=22%  Similarity=0.411  Sum_probs=97.2

Q ss_pred             ccCCccCcccccCCCceEEEeeC-----------------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-----------------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKV  351 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l  351 (405)
                      ++|+..+.||+|+||.||++...                 ++..||+|.++... ......+.+|+.++.+++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            34666788999999999987521                 23568999987543 3345678899999999999999999


Q ss_pred             EeeeecCCeeEEEEecCCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       352 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++...+..+++|||+++|+|.+++....          ..+++.+...++.|++.|++|||+
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~  148 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS  148 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999987532          247788999999999999999995

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.53  E-value=3.8e-14  Score=128.05  Aligned_cols=113  Identities=26%  Similarity=0.294  Sum_probs=99.4

Q ss_pred             CCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          292 FSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      |...+.||+|+||.||++... ++..||+|.+....   ....+.+.+|++.+++++||||+++++++...+..++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            556678999999999999964 68899999997543   23456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++++|.+++... ..+++..+..++.|+++||+|||+
T Consensus        82 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~  118 (258)
T cd05578          82 LLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS  118 (258)
T ss_pred             CCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999765 368999999999999999999995

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.53  E-value=5.3e-14  Score=134.29  Aligned_cols=113  Identities=23%  Similarity=0.250  Sum_probs=95.8

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeecc--ccchhHHHHHHHHHhhcCCCCCcceEEeeeecCC-----eeE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE-----FKA  362 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  362 (405)
                      +|...+.||+|+||.||++.. .+|+.||+|.+...  .....+.+.+|++++..++|+||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            366778999999999999985 57899999998643  2234467889999999999999999999988766     789


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+||++ ++|.+++... ..+++..+..++.||++||+|||+
T Consensus        81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~  121 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHS  121 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999997 5888888654 368999999999999999999995

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.52  E-value=9.7e-16  Score=151.06  Aligned_cols=193  Identities=27%  Similarity=0.362  Sum_probs=127.0

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchh--------
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG--------   82 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--------   82 (405)
                      ++|+.|+.++|.+....+..    .+.+|++++++.|++++ +|+.++.+.+|+.|+..+|+++ .+|..++        
T Consensus       219 ~~l~~L~a~~n~l~~~~~~p----~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l  292 (1081)
T KOG0618|consen  219 PSLTALYADHNPLTTLDVHP----VPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSL  292 (1081)
T ss_pred             cchheeeeccCcceeecccc----ccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHH
Confidence            34444555555554333321    12355555555555554 3355555555555555555554 3333332        


Q ss_pred             --------------cCCCCCCeeeCCCCCCCCCchhhhcccc--------------------------CccccCCC----
Q 036754           83 --------------SNLASLRKLSLDSNELTSIPLTFWNLKD--------------------------ILYLNFSV----  118 (405)
Q Consensus        83 --------------~~l~~L~~L~Ls~N~l~~lp~~~~~l~~--------------------------L~~l~l~~----  118 (405)
                                    .++++|++|+|..|+|.++|+.+....+                          |+.|++.+    
T Consensus       293 ~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Lt  372 (1081)
T KOG0618|consen  293 SAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLT  372 (1081)
T ss_pred             HhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccc
Confidence                          3578888888888888888775432211                          12222221    


Q ss_pred             --CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCc
Q 036754          119 --IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGS  196 (405)
Q Consensus       119 --~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~  196 (405)
                        .-+.+.++++|+.|+|++|++...+...+.++..|+.|+||+|.++ .+|+.+..+..|+.|....|++. ..|+...
T Consensus       373 d~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~  450 (1081)
T KOG0618|consen  373 DSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQ  450 (1081)
T ss_pred             ccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhh
Confidence              1224567899999999999998555555788999999999999999 67899999999999999999998 4558788


Q ss_pred             cCCCCcccccCCCCc
Q 036754          197 FGNFSAESFEGNELL  211 (405)
Q Consensus       197 ~~~~~~~~~~~n~~~  211 (405)
                      .+++..++++.|.+.
T Consensus       451 l~qL~~lDlS~N~L~  465 (1081)
T KOG0618|consen  451 LPQLKVLDLSCNNLS  465 (1081)
T ss_pred             cCcceEEecccchhh
Confidence            888888888888653

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.52  E-value=6.9e-15  Score=131.50  Aligned_cols=110  Identities=29%  Similarity=0.463  Sum_probs=88.0

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecC--C---eeEEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNE--E---FKALV  364 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~---~~~lv  364 (405)
                      .+...+++|.|+||.||+|.+ .+++.||||+...+.+.    -.+|..+|++++|||||++..++...  .   ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            345568899999999999995 45789999998654322    13589999999999999999887542  2   34589


Q ss_pred             EecCCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||||. +|.++++.-   +..++.-...-+..|+.+||+|||.
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~  143 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS  143 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh
Confidence            999998 999999741   3467777788899999999999995

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.52  E-value=9.6e-14  Score=127.33  Aligned_cols=113  Identities=23%  Similarity=0.332  Sum_probs=96.4

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |...+.||+|+||.||+|+. .++..||+|.++...  ......+.+|+.++.+++|+|++++++++..++..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            55567899999999999985 468899999986532  223456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      + |+|.+++....  ..+++.++..++.|+++||+|||+
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~  119 (285)
T cd07861          82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS  119 (285)
T ss_pred             C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh
Confidence            8 68988886432  468999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.52  E-value=7.6e-14  Score=128.97  Aligned_cols=115  Identities=30%  Similarity=0.539  Sum_probs=96.2

Q ss_pred             cCCccCcccccCCCceEEEeeC-CC--cEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEE
Q 036754          291 KFSENNLISKGGFGSVYKARLG-DG--MEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      +|...+.||+|+||.||+|... ++  ..+|+|.++... ....+.+.+|+.++.++ +||||+++++++...+..++++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~   82 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI   82 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence            5667788999999999999864 33  347888876432 33456788999999999 7999999999999989999999


Q ss_pred             ecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.++++...               ..+++..+..++.|++.|++|||+
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~  137 (297)
T cd05089          83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE  137 (297)
T ss_pred             EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999996532               248899999999999999999995

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.52  E-value=8.8e-14  Score=127.61  Aligned_cols=114  Identities=25%  Similarity=0.305  Sum_probs=97.3

Q ss_pred             cCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          291 KFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +|.....+|+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++.+++|+|++++++++...+..++||||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            3556678999999999999964 68899999986432  22345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++.+..+.... ..+++..+..++.|+++||+|||+
T Consensus        82 ~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~  118 (286)
T cd07847          82 CDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHK  118 (286)
T ss_pred             cCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9998888877543 368999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.52  E-value=1.1e-13  Score=129.68  Aligned_cols=109  Identities=28%  Similarity=0.337  Sum_probs=89.5

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHH-HhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECE-MMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.||+|+||+||+|.. .+++.||+|++....   ......+..|.. ++..++|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            3689999999999985 467889999997532   222334444444 46778999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++...+ .+.+.....++.||++||+|||+
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~  114 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLHS  114 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999997644 57888888899999999999995

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.52  E-value=1.2e-13  Score=125.87  Aligned_cols=110  Identities=32%  Similarity=0.603  Sum_probs=92.5

Q ss_pred             CcccccCCCceEEEeeCC-Cc--EEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARLGD-GM--EVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      ++||+|+||.||+|...+ +.  .+|+|.++... ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998643 43  46888886432 34456788999999999 899999999999999999999999999


Q ss_pred             CCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++...+               ..+++.++..++.|++.|++|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~  130 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ  130 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999997532               247899999999999999999995

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.52  E-value=1.1e-13  Score=127.58  Aligned_cols=116  Identities=22%  Similarity=0.376  Sum_probs=98.4

Q ss_pred             ccCCccCcccccCCCceEEEeeCC-----------------CcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceE
Q 036754          290 YKFSENNLISKGGFGSVYKARLGD-----------------GMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKV  351 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l  351 (405)
                      .+|...+.||+|+||.||++....                 +..||+|.+.... ......+.+|++++.+++|+|++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            356667889999999999987432                 2468999987553 3345678899999999999999999


Q ss_pred             EeeeecCCeeEEEEecCCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       352 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++...+..++++||+++|+|.+++....          ..+++.....++.|+++||+|||+
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~  148 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES  148 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999899999999999999999997543          258999999999999999999995

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=2.4e-14  Score=137.38  Aligned_cols=116  Identities=24%  Similarity=0.328  Sum_probs=98.1

Q ss_pred             hhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeE
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  362 (405)
                      ..++|...+++|+|.||+|+.+.. .+++.+|||+++++.   +.+.+....|.+++.-. +||-++.++.++.+.+.+|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            346788889999999999999995 567899999998864   34556666777776655 6999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .||||+.|||+..+.+  ...+++.++.-||+.|+.||+|||+
T Consensus       446 fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~  486 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHE  486 (694)
T ss_pred             EEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999555443  2469999999999999999999995

>PLN03210 Resistant to P

Probab=99.52  E-value=1e-13  Score=149.38  Aligned_cols=198  Identities=19%  Similarity=0.219  Sum_probs=135.4

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchh
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG   82 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   82 (405)
                      +|+.| ...+|+.|+|++|++..+.. . +..++ +|+.|+|++|.....+|. ++.+++|+.|+|++|.....+|..+ 
T Consensus       604 lP~~f-~~~~L~~L~L~~s~l~~L~~-~-~~~l~-~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si-  677 (1153)
T PLN03210        604 MPSNF-RPENLVKLQMQGSKLEKLWD-G-VHSLT-GLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSI-  677 (1153)
T ss_pred             CCCcC-CccCCcEEECcCcccccccc-c-cccCC-CCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhh-
Confidence            44445 56889999999999876544 3 45565 899999998875555664 7889999999999987666888887 


Q ss_pred             cCCCCCCeeeCCCC-CCCCCchhhhccccCccccCCCCC--hhc-cCCCCCCEEeccCCcccccCCccc-----------
Q 036754           83 SNLASLRKLSLDSN-ELTSIPLTFWNLKDILYLNFSVIP--IEI-GGLPNLEYLFLGYNRLQGSIPDSF-----------  147 (405)
Q Consensus        83 ~~l~~L~~L~Ls~N-~l~~lp~~~~~l~~L~~l~l~~~p--~~~-~~l~~L~~L~l~~n~l~~~~p~~~-----------  147 (405)
                      .++++|+.|++++| .++.+|..+ ++++|+.|++++..  ..+ ...++|++|++++|.+. .+|..+           
T Consensus       678 ~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~  755 (1153)
T PLN03210        678 QYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE-EFPSNLRLENLDELILC  755 (1153)
T ss_pred             hccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCccc-ccccccccccccccccc
Confidence            48999999999986 677888765 67788888776521  011 11346677777777665 334321           


Q ss_pred             -------------------ccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCC
Q 036754          148 -------------------GDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGN  208 (405)
Q Consensus       148 -------------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n  208 (405)
                                         ...++|+.|++++|...+.+|..+.++++|+.|++++|..-+.+|....+.++..+.++++
T Consensus       756 ~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c  835 (1153)
T PLN03210        756 EMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGC  835 (1153)
T ss_pred             ccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCC
Confidence                               1124566777777766666777777777777777777644344555444555555555554

syringae 6; Provisional

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.52  E-value=2.4e-14  Score=144.52  Aligned_cols=117  Identities=29%  Similarity=0.313  Sum_probs=94.2

Q ss_pred             cCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEecc
Q 036754           61 TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLG  135 (405)
Q Consensus        61 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~  135 (405)
                      .+|+.|+|++|+|+ .+|..    ..+|+.|++++|+|+.+|...   .+|+.|+++.     +|..   .++|+.|+++
T Consensus       342 ~~Lq~LdLS~N~Ls-~LP~l----p~~L~~L~Ls~N~L~~LP~l~---~~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS  410 (788)
T PRK15387        342 SGLQELSVSDNQLA-SLPTL----PSELYKLWAYNNRLTSLPALP---SGLKELIVSGNRLTSLPVL---PSELKELMVS  410 (788)
T ss_pred             cccceEecCCCccC-CCCCC----CcccceehhhccccccCcccc---cccceEEecCCcccCCCCc---ccCCCEEEcc
Confidence            37999999999998 67753    357889999999999998654   3566666654     4432   3579999999


Q ss_pred             CCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCC
Q 036754          136 YNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPR  193 (405)
Q Consensus       136 ~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~  193 (405)
                      +|++++ +|..+   .+|+.|++++|+++ .+|..+.++++|+.+++++|++++.++.
T Consensus       411 ~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        411 GNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             CCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            999985 66543   57889999999998 6788999999999999999999987654

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.52  E-value=7.2e-14  Score=128.27  Aligned_cols=124  Identities=21%  Similarity=0.274  Sum_probs=100.9

Q ss_pred             HHHHHHhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeee--
Q 036754          281 SYLELCRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCS--  356 (405)
Q Consensus       281 ~~~~~~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~--  356 (405)
                      .++.+..+.++|...+.||+|+||.||++.. .+++.+|+|.+... ......+.+|+.++.++ +|+||+++++++.  
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            3455566777888889999999999999985 56789999987643 22235677899999998 6999999999874  


Q ss_pred             ---cCCeeEEEEecCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          357 ---NEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       357 ---~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                         ..+..++||||+++|+|.++++.   ....+++..+..++.|+++||+|||.
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  142 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV  142 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh
Confidence               34568999999999999998763   22468899999999999999999994

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.52  E-value=1.2e-13  Score=125.78  Aligned_cols=113  Identities=31%  Similarity=0.530  Sum_probs=93.4

Q ss_pred             CccCcccccCCCceEEEeeCC----CcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCe------
Q 036754          293 SENNLISKGGFGSVYKARLGD----GMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF------  360 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------  360 (405)
                      ...+.||+|+||.||+|+...    +..||+|.++...  ......+.+|+..+..++|+||+++++++...+.      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            446789999999999998532    3679999987543  2334678899999999999999999998866443      


Q ss_pred             eEEEEecCCCCCHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSN-----CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++++||+++|+|..++....     ..+++.....++.|++.||+|||+
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~  131 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN  131 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh
Confidence            789999999999999885431     368999999999999999999995

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.52  E-value=1.2e-13  Score=125.90  Aligned_cols=112  Identities=29%  Similarity=0.338  Sum_probs=98.3

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      |...+.+|.|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++|+|++++++++.+....++|+||++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG   82 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence            45567899999999999985 468899999986543 3445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++...  .+++.....++.|++.|++|||+
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~  116 (274)
T cd06609          83 GGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHE  116 (274)
T ss_pred             CCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999998754  68999999999999999999995

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.52  E-value=8e-14  Score=125.73  Aligned_cols=114  Identities=20%  Similarity=0.342  Sum_probs=98.0

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |...+.+|+|+||.||++.. .+|..||+|.+....  ......+.+|+.++++++|+|++++++.+...+..++|+||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            45567899999999999995 467889999986542  233456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++|.+++.... ..+++..+..++.|+++||+|||+
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  119 (257)
T cd08225          82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD  119 (257)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999987543 358999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.52  E-value=1.4e-13  Score=124.44  Aligned_cols=107  Identities=22%  Similarity=0.341  Sum_probs=91.2

Q ss_pred             cccccCCCceEEEee---CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCC
Q 036754          297 LISKGGFGSVYKARL---GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHG  371 (405)
Q Consensus       297 ~lg~G~fg~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  371 (405)
                      .||+|+||.||+|.+   .++..+|+|+++...  .....++..|+.++.+++|+||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999974   356889999986443  234567889999999999999999999885 45678999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          372 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       372 ~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|.+++...+ .+++..+..++.|++.||+|||+
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~  113 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEE  113 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999997544 68999999999999999999995

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.52  E-value=9e-14  Score=128.13  Aligned_cols=115  Identities=22%  Similarity=0.290  Sum_probs=97.4

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecC--CeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNE--EFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  364 (405)
                      ++|...+.||+|+||.||+|+.. +++.+|+|.++....  .....+.+|+.++.+++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            35666788999999999999964 688999999975432  2234567899999999999999999998877  889999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++ +|.+++......+++..+..++.||++||+|||+
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  124 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD  124 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999985 9999887655568999999999999999999995

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.52  E-value=1.3e-13  Score=124.35  Aligned_cols=114  Identities=24%  Similarity=0.423  Sum_probs=98.8

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |...+.||+|+||.||++.. .++..+|+|.+....  ......+.+|++++++++|+|++++++.+...+..++||||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            45567899999999999985 567899999986542  334567889999999999999999999998889999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++.... ..+++..+..++.|+++|++|||+
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~  119 (256)
T cd08220          82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT  119 (256)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999997643 458999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.51  E-value=9e-14  Score=141.86  Aligned_cols=115  Identities=25%  Similarity=0.319  Sum_probs=99.8

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.||+|+||.||+|... +++.||+|+++...   ......+..|+..+..++|+||+++++++...+..|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            45667788999999999999964 68899999997542   223466788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+ .+++..+..|+.||+.||+|||.
T Consensus        84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~  122 (669)
T cd05610          84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHR  122 (669)
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999997544 68899999999999999999994

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.51  E-value=1.2e-13  Score=127.11  Aligned_cols=116  Identities=22%  Similarity=0.339  Sum_probs=97.8

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +.+|...+.||+|+||.||+|.. .+|..||+|.+..... .....+.+|+..+.+++|+||+++++++...+..++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            45677788999999999999985 5688999999865432 223466789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |++ +++.+++......+.+.++..++.|+++||+|||+
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~  121 (291)
T cd07870          84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG  121 (291)
T ss_pred             ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            996 68888776544568888999999999999999995

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.51  E-value=1.4e-13  Score=124.57  Aligned_cols=113  Identities=25%  Similarity=0.399  Sum_probs=95.1

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      .|.....||+|+||.||++....+..+|+|.+.... .....+.+|+.++++++|+|++++++++. .+..+++|||+++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK   84 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence            355567899999999999997776779999876432 23456888999999999999999998875 4668899999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.++++... ..++|..+..++.|+++||+|||+
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~  120 (260)
T cd05069          85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER  120 (260)
T ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999997543 358999999999999999999995

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.51  E-value=8.9e-14  Score=128.52  Aligned_cols=109  Identities=28%  Similarity=0.310  Sum_probs=96.1

Q ss_pred             cCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCH
Q 036754          295 NNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL  373 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  373 (405)
                      ...||+|+||.||++.. .++..||+|.+..........+.+|+..+..++|||++++++++...+..++++||+++|+|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            34689999999999985 46889999998765545556788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          374 EKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       374 ~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++..  ..+++.++..++.|++.||+|||+
T Consensus       106 ~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~  135 (297)
T cd06659         106 TDIVSQ--TRLNEEQIATVCESVLQALCYLHS  135 (297)
T ss_pred             HHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh
Confidence            998754  358999999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.51  E-value=6.4e-14  Score=127.37  Aligned_cols=110  Identities=31%  Similarity=0.518  Sum_probs=93.3

Q ss_pred             CcccccCCCceEEEeeCC-------CcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          296 NLISKGGFGSVYKARLGD-------GMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +.||+|+||.||+|+..+       +..+|+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            358999999999998532       2578999886543 23456788999999999999999999999998999999999


Q ss_pred             CCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++....      ..+++.+++.++.|+++|++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~  124 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ  124 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh
Confidence            99999999997531      347899999999999999999995

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.51  E-value=6.8e-14  Score=143.77  Aligned_cols=118  Identities=19%  Similarity=0.310  Sum_probs=98.9

Q ss_pred             hhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeec--CCeeE
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSN--EEFKA  362 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  362 (405)
                      ...+|...+.||+|+||+||++.. ..+..||+|.+....  ......+..|+.++.+++|||||++++++..  ....|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            345677788999999999999985 467789999986532  3345678899999999999999999998754  45689


Q ss_pred             EEEecCCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||||+++|+|.++|...   ...+++..+..|+.||+.||+|||.
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs  136 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN  136 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999998652   2468999999999999999999994

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.51  E-value=1.4e-13  Score=126.13  Aligned_cols=111  Identities=30%  Similarity=0.528  Sum_probs=93.6

Q ss_pred             CccCcccccCCCceEEEee-----CCCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecC--CeeEEE
Q 036754          293 SENNLISKGGFGSVYKARL-----GDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNE--EFKALV  364 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  364 (405)
                      ...+.||+|+||+||.+..     .++..||+|.++.... .....+.+|++++++++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            4567899999999987652     3577899999875432 3456788999999999999999999987653  468899


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++...  .+++.++..++.|+++|++|||+
T Consensus        87 ~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~  125 (283)
T cd05080          87 MEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHS  125 (283)
T ss_pred             ecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999754  48999999999999999999994

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.51  E-value=1.5e-13  Score=126.40  Aligned_cols=115  Identities=27%  Similarity=0.275  Sum_probs=96.4

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecC--CeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNE--EFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  366 (405)
                      +|...+.||.|++|.||++.. .+++.+|+|.+..... .....+.+|++++++++|+||+++++++...  +..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            456678899999999999996 4678999999875432 3456788999999999999999999988653  46899999


Q ss_pred             cCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++..   ....+++.....++.|+++||+|||+
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~  123 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS  123 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999988653   23468899999999999999999994

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.51  E-value=7e-14  Score=128.88  Aligned_cols=109  Identities=25%  Similarity=0.300  Sum_probs=96.2

Q ss_pred             cCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCH
Q 036754          295 NNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL  373 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  373 (405)
                      ...||+|+||.||++.. .++..||+|.+..........+.+|+..+..++|+||+++++.+...+..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            35689999999999985 56889999998765555566788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          374 EKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       374 ~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+++...  .+++.+...++.||+.||+|||+
T Consensus       107 ~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~  136 (292)
T cd06658         107 TDIVTHT--RMNEEQIATVCLSVLRALSYLHN  136 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9988543  58999999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.50  E-value=1.5e-13  Score=128.04  Aligned_cols=115  Identities=30%  Similarity=0.403  Sum_probs=99.7

Q ss_pred             cCCccCcccccCCCceEEEeeC-CCcEEEEEEeecccc---chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCR---RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +|...+.||+|+||.||++... +++.||+|.+.....   ...+.+..|++++..++|+||+++++.+......++|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            4666788999999999999864 589999999975432   245678889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++.... ..+++..+..++.|+++||+|||.
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~  121 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL  121 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999987532 468999999999999999999994

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.50  E-value=1.5e-13  Score=128.94  Aligned_cols=107  Identities=23%  Similarity=0.222  Sum_probs=89.1

Q ss_pred             ccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC---CCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI---RHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       298 lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      ||+|+||+||+|.. .+++.||+|++....   ......+..|..++.+.   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999985 568999999986532   12233445566666655   699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++...+ .+++..+..++.||++||+|||+
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~  114 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHK  114 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999987543 68999999999999999999995

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.50  E-value=1.7e-13  Score=127.08  Aligned_cols=115  Identities=28%  Similarity=0.452  Sum_probs=94.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCc----EEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGM----EVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      .+|...+.||+|+||.||+|.. .+|.    .||+|.+..... ....++.+|+.++.+++|+||++++|+|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            3566678899999999999985 3443    478888765432 2334688899999999999999999998654 4679


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||+++|+|.+++..+...+++..+..++.|+++||+|||+
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~  127 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE  127 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh
Confidence            999999999999998765578999999999999999999995

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.50  E-value=9.8e-14  Score=125.58  Aligned_cols=107  Identities=28%  Similarity=0.369  Sum_probs=94.8

Q ss_pred             ccccCCCceEEEeeC-CCcEEEEEEeecccc---chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCH
Q 036754          298 ISKGGFGSVYKARLG-DGMEVAVKVFNLQCR---RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL  373 (405)
Q Consensus       298 lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  373 (405)
                      +|+|+||.||+++.. +|+.+|+|.+.....   .....+.+|++.+.+++|+|++++++.+......+++|||+++|+|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            589999999999975 489999999865432   3456788899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          374 EKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       374 ~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+++...+ .+++..+..++.|+++||+|||+
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~  111 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHS  111 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99997654 68999999999999999999995

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.50  E-value=1.3e-13  Score=128.00  Aligned_cols=114  Identities=27%  Similarity=0.335  Sum_probs=97.1

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      .|...+.+|+|+||.||+|.. .+|..||+|.+....   ....+.+.+|+.++..++|||++++.+++...+..++|+|
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   95 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME   95 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence            456668899999999999985 468899999986432   2334578899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |++ |++.+++......+++..+..++.|++.||.|||+
T Consensus        96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~  133 (307)
T cd06607          96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS  133 (307)
T ss_pred             hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            997 57877776555579999999999999999999995

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.50  E-value=2.2e-13  Score=124.57  Aligned_cols=108  Identities=19%  Similarity=0.282  Sum_probs=93.5

Q ss_pred             ccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCH
Q 036754          298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL  373 (405)
Q Consensus       298 lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  373 (405)
                      ||+|+||+||++.. .+|+.||+|.+....   ......+..|++++.+++|||++++++.+...+..++||||+++|+|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999984 568899999986532   22345567899999999999999999999999999999999999999


Q ss_pred             HHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          374 EKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       374 ~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+++.... ..+++.++..++.|++.|+.|||+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~  113 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ  113 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99997644 368999999999999999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.50  E-value=6.3e-14  Score=130.67  Aligned_cols=115  Identities=21%  Similarity=0.338  Sum_probs=97.9

Q ss_pred             cCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCe-eEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF-KALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e  366 (405)
                      +|...+.+|+|+||.++... -.++..+++|.+....  .........|+.++++++|||||...+.|...+. .+|||+
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~   84 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME   84 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence            44556789999999998776 3467789999987543  3344567889999999999999999999988877 999999


Q ss_pred             cCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |++|||+.+.+...+ ..+++.+...++.|++.|+.|||+
T Consensus        85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~  124 (426)
T KOG0589|consen   85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE  124 (426)
T ss_pred             ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh
Confidence            999999999997655 678899999999999999999994

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.50  E-value=1.8e-13  Score=127.74  Aligned_cols=113  Identities=27%  Similarity=0.343  Sum_probs=96.4

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      |...+.||+|+||.||++.. .++..||+|.+....   ......+..|++.+++++|+|++++++++...+..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            45567899999999999985 468899999986432   23345688899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++ |++.+.+......++|.++..++.|++.||.|||+
T Consensus       107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~  143 (317)
T cd06635         107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS  143 (317)
T ss_pred             CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            97 48888776555679999999999999999999995

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.50  E-value=2e-13  Score=123.25  Aligned_cols=108  Identities=30%  Similarity=0.417  Sum_probs=91.9

Q ss_pred             CcccccCCCceEEEeeC--C--CcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARLG--D--GMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.||+|+||.||+|...  +  +..+|+|.+..... .....+.+|+.++++++|+|++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            36899999999999742  2  26899999875543 34567889999999999999999999875 4567999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++.... .+++..+..++.|+++||+|||+
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~  113 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLES  113 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhh
Confidence            99999997654 68999999999999999999995

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.50  E-value=1.5e-13  Score=124.65  Aligned_cols=115  Identities=23%  Similarity=0.233  Sum_probs=100.4

Q ss_pred             cCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +|...+.||+|+||.||++... ++..+|+|.+.... ......+.+|+..+++++|+||+++++.+......++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            3555678999999999999864 68899999987653 344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++|.+++......+++....+++.|+++||+|||.
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~  118 (265)
T cd06605          82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE  118 (265)
T ss_pred             CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC
Confidence            9999999998654578999999999999999999995

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.50  E-value=2.3e-13  Score=123.43  Aligned_cols=115  Identities=23%  Similarity=0.416  Sum_probs=96.8

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-----cchhHHHHHHHHHhhcCCCCCcceEEeeeecC--Cee
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-----RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE--EFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  361 (405)
                      .+|...+.||+|+||.||+|.. .++..||+|.+....     ......+.+|+.++++++|+||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            3567778999999999999985 568999999875321     23345788899999999999999999988664  457


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++||+++++|.+++.... .+++....+++.|+++||+|||+
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~  124 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHS  124 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            89999999999999987644 58899999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.50  E-value=1.8e-13  Score=124.95  Aligned_cols=116  Identities=23%  Similarity=0.354  Sum_probs=97.8

Q ss_pred             ccCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  362 (405)
                      ++|...+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.++..++|+||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            35666788999999999999853      23689999986543 234567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++....         ..++|..+..++.|++.|++|||+
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  137 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA  137 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999996432         247889999999999999999995

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.50  E-value=2.5e-13  Score=122.26  Aligned_cols=113  Identities=27%  Similarity=0.407  Sum_probs=99.8

Q ss_pred             CCccCcccccCCCceEEEeeC-CCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecC--CeeEEEEe
Q 036754          292 FSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNE--EFKALVLE  366 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  366 (405)
                      |...+.||+|++|.||+|... +++.|++|++.....  .....+.+|+..+++++|+||+++++.+...  ...++++|
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            456678999999999999965 688999999875542  4456788999999999999999999999887  88999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++++|.+++.... .+++.++..++.|+++||+|||+
T Consensus        82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~  119 (260)
T cd06606          82 YVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS  119 (260)
T ss_pred             ecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999997654 78999999999999999999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.50  E-value=1.1e-13  Score=126.86  Aligned_cols=114  Identities=25%  Similarity=0.365  Sum_probs=97.1

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +|...+.||+|+||.||+|.. .+|..||+|.+....  ......+..|++++++++|+||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            356678899999999999985 468899999886543  22335788899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++ ++|..++.... ..+++..+..++.|+++||+|||+
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~  118 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS  118 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            96 58999886533 468999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.50  E-value=2.1e-13  Score=124.51  Aligned_cols=112  Identities=24%  Similarity=0.396  Sum_probs=97.1

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCC---CCCcceEEeeeecCCeeEEEEe
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIR---HQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      |+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++   |+|++++++++......++|||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            44567899999999999995 578999999986543 334567888999998886   9999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++++|.+++...  .+++.....++.|+++||+|||+
T Consensus        83 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~  119 (277)
T cd06917          83 YAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHK  119 (277)
T ss_pred             cCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999998653  68999999999999999999995

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.50  E-value=1.3e-13  Score=132.05  Aligned_cols=108  Identities=22%  Similarity=0.279  Sum_probs=94.0

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      .+|...+.||+|+||.||++.. .+++.||+|...      ...+.+|++++++++|||||++++++......++|+||+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            4577788999999999999985 568899999653      234678999999999999999999999999999999998


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      . ++|..++.... .+++.++..++.||++||+|||+
T Consensus       166 ~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~  200 (391)
T PHA03212        166 K-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHE  200 (391)
T ss_pred             C-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            6 68999886543 68999999999999999999995

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.50  E-value=3.5e-13  Score=120.85  Aligned_cols=114  Identities=35%  Similarity=0.487  Sum_probs=101.7

Q ss_pred             CCccCcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          292 FSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      |...+.+|+|++|.||++... ++..+++|++..........+.+|++.+.+++|+|++++++++......++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            455678999999999999964 6889999999766555667889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|.+++......+++..+..++.|+++|++|||+
T Consensus        82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~  116 (253)
T cd05122          82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS  116 (253)
T ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc
Confidence            99999997764578999999999999999999995

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.50  E-value=2.4e-13  Score=123.78  Aligned_cols=112  Identities=30%  Similarity=0.507  Sum_probs=90.8

Q ss_pred             ccCcccccCCCceEEEeeCC-Cc--EEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecC------CeeE
Q 036754          294 ENNLISKGGFGSVYKARLGD-GM--EVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE------EFKA  362 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~  362 (405)
                      ..+.||+|+||.||+|+... +.  .||+|.++...  ......+.+|+.++.+++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            45789999999999998643 32  58999886532  33456788999999999999999999987532      2468


Q ss_pred             EEEecCCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|||+++|+|.+++...     ...+++.....++.|+++||+|||+
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  130 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS  130 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999987422     2358899999999999999999995

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.50  E-value=4.5e-15  Score=138.58  Aligned_cols=201  Identities=21%  Similarity=0.236  Sum_probs=124.2

Q ss_pred             CCCCcCCeeeCcCCcCcccCCch---hhhcccccccEEEcccCcccc------cCCccccCccCCCeeecCCcccccccC
Q 036754            8 SNCKCLTFIDLSNNPLDSVLPKT---FVGNVSHSLEFFVMSYCNISG------GILEEITNLTKLTTIILGGNKLNGSIS   78 (405)
Q Consensus         8 ~~l~~L~~L~Ls~N~l~~~~~~~---f~~~~~~~L~~L~L~~n~l~~------~~~~~~~~l~~L~~L~L~~N~l~~~~~   78 (405)
                      ..++.|+.|+++++.++......   .....+ +|+.|+++.+.+.+      .++..+..+++|+.|++++|.+.+..+
T Consensus        20 ~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~-~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~   98 (319)
T cd00116          20 PKLLCLQVLRLEGNTLGEEAAKALASALRPQP-SLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGC   98 (319)
T ss_pred             HHHhhccEEeecCCCCcHHHHHHHHHHHhhCC-CceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHH
Confidence            44556888888888875432111   122333 58888888887752      233456667788888888888864344


Q ss_pred             cchhcCCCC---CCeeeCCCCCCCC-----Cchhhhcc-ccCccccCCC----------CChhccCCCCCCEEeccCCcc
Q 036754           79 ITLGSNLAS---LRKLSLDSNELTS-----IPLTFWNL-KDILYLNFSV----------IPIEIGGLPNLEYLFLGYNRL  139 (405)
Q Consensus        79 ~~~~~~l~~---L~~L~Ls~N~l~~-----lp~~~~~l-~~L~~l~l~~----------~p~~~~~l~~L~~L~l~~n~l  139 (405)
                      ..+ ..+.+   |++|++++|+++.     +...+..+ ++|+.|+++.          ++..+..+++|++|++++|.+
T Consensus        99 ~~~-~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l  177 (319)
T cd00116          99 GVL-ESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGI  177 (319)
T ss_pred             HHH-HHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCC
Confidence            333 23444   8888888888772     23344455 6777777764          223455667788888888887


Q ss_pred             ccc----CCcccccCCCCCeeecccccccCcc----chhHHhcccCCccccccCcccCcCCC-C-C----ccCCCCcccc
Q 036754          140 QGS----IPDSFGDLISLKSLNLSKNNLSGAI----PASLEKLLYLKDLNLSFNKLEGEIPR-G-G----SFGNFSAESF  205 (405)
Q Consensus       140 ~~~----~p~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~l~l~~n~l~~~~p~-~-~----~~~~~~~~~~  205 (405)
                      .+.    ++..+..+++|+.|++++|.+++..    ...+..+++|+.|++++|.+++.... . .    ...++..+++
T Consensus       178 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l  257 (319)
T cd00116         178 GDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSL  257 (319)
T ss_pred             chHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEc
Confidence            742    2334455568888888888876432    23445566788888888877642111 0 0    1256677777


Q ss_pred             cCCCC
Q 036754          206 EGNEL  210 (405)
Q Consensus       206 ~~n~~  210 (405)
                      .+|..
T Consensus       258 ~~n~i  262 (319)
T cd00116         258 SCNDI  262 (319)
T ss_pred             cCCCC
Confidence            77654

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.50  E-value=2.5e-13  Score=125.02  Aligned_cols=113  Identities=20%  Similarity=0.268  Sum_probs=96.3

Q ss_pred             CCccCcccccCCCceEEEee----CCCcEEEEEEeeccc----cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeE
Q 036754          292 FSENNLISKGGFGSVYKARL----GDGMEVAVKVFNLQC----RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  362 (405)
                      |+..+.||+|+||.||.+..    .+|..||+|.++...    ....+.+..|+.++.++ +|+||+++++++......+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            45567899999999999885    368899999987532    22345678899999999 5999999999999888999


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++.... .+++.....++.|+++||+|||+
T Consensus        82 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~  123 (290)
T cd05613          82 LILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHK  123 (290)
T ss_pred             EEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999997654 68899999999999999999995

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.49  E-value=1.8e-13  Score=127.49  Aligned_cols=116  Identities=26%  Similarity=0.431  Sum_probs=96.5

Q ss_pred             ccCCccCcccccCCCceEEEeeC--------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLG--------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEE  359 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  359 (405)
                      .+|...+.||+|+||.||+++..        ....+|+|.++... ......+..|+.++.++ +|+||+++++++....
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            34566788999999999998731        24578999887543 33456788899999999 6999999999999888


Q ss_pred             eeEEEEecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..+++|||+++|+|.+++....               ..++|.+.++++.|++.||+|||+
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~  152 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES  152 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999996532               358899999999999999999995

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.49  E-value=2.7e-13  Score=122.32  Aligned_cols=112  Identities=32%  Similarity=0.446  Sum_probs=95.2

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeee-cCCeeEEEEecCC
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCS-NEEFKALVLEYMP  369 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  369 (405)
                      +|...+.+|+|+||.||++.. .|..||+|..+..  ...+.+.+|+.++++++|+|++++++++. ..+..+++|||++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            556678899999999999976 4778999988643  23457889999999999999999999764 4567899999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++...+ ..+++..+..++.|++.||+|||+
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  120 (256)
T cd05082          84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA  120 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999997654 358899999999999999999995

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.49  E-value=2e-13  Score=126.36  Aligned_cols=117  Identities=26%  Similarity=0.325  Sum_probs=97.4

Q ss_pred             hhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC-----
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE-----  359 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  359 (405)
                      ..++|+..+.+|+|+||.||+|.. .+|+.||+|.++...  ......+.+|++++++++|||++++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            345677778999999999999996 468899999987543  223456778999999999999999999887654     


Q ss_pred             -----eeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 -----FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 -----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                           ..++|+||+++ ++...+......+++.++..++.|++.||+|||+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  134 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK  134 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence                 78999999986 7878776655578999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.49  E-value=3.1e-13  Score=122.59  Aligned_cols=115  Identities=27%  Similarity=0.325  Sum_probs=100.0

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +|+..+.+|.|+||+||+|.. .++..+|+|++.... ......+.+|+..++.++|+|++++++.+...+..++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   81 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL   81 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence            566778899999999999984 467889999986533 335567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++|.+++....  ..+++.....++.|++.||+|||+
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~  120 (267)
T cd06610          82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS  120 (267)
T ss_pred             CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999997542  468999999999999999999995

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.49  E-value=2.2e-13  Score=124.86  Aligned_cols=114  Identities=22%  Similarity=0.271  Sum_probs=92.9

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHH-hhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEM-MKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +|...+.||+|+||.||++.. .+|+.||+|+++... ......+..|+.. ++..+|+|++++++++...+..+++|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~   81 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV   81 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence            466678899999999999985 468999999987543 2233455566665 5567899999999999999999999999


Q ss_pred             CCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++ |+|.+++..   .+..+++..+..++.||+.||+|||+
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  121 (283)
T cd06617          82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS  121 (283)
T ss_pred             hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            97 588887754   23468999999999999999999994

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.49  E-value=2.9e-13  Score=122.56  Aligned_cols=107  Identities=21%  Similarity=0.337  Sum_probs=94.1

Q ss_pred             ccccCCCceEEEeeC-CCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCH
Q 036754          298 ISKGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL  373 (405)
Q Consensus       298 lg~G~fg~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  373 (405)
                      ||+|+||.||++... ++..||+|.+....   ....+.+.+|+.++.+++|+||+++++.+.+.+..++++||+++|+|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999964 58899999986532   23446788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          374 EKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       374 ~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+++.... .+++..+..++.|+++||+|||+
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~  111 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHN  111 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh
Confidence            99997654 58999999999999999999995

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.48  E-value=2.9e-14  Score=120.93  Aligned_cols=116  Identities=22%  Similarity=0.274  Sum_probs=102.5

Q ss_pred             ccCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecC-----CeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNE-----EFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~l  363 (405)
                      ..|...+.+|+|||+.||.++ ..++..||+|++.....++.+...+|++.-++++|||++++++++..+     ...||
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            345667889999999999999 788999999999887777788899999999999999999999987543     45899


Q ss_pred             EEecCCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|...|+|.+.+...   +..+++.+.+.|+.||.+||++||+
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~  145 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE  145 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc
Confidence            99999999999998753   3579999999999999999999996

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.48  E-value=1.7e-13  Score=128.98  Aligned_cols=115  Identities=23%  Similarity=0.425  Sum_probs=93.9

Q ss_pred             cCCccCcccccCCCceEEEee------CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeec-CCee
Q 036754          291 KFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSN-EEFK  361 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-~~~~  361 (405)
                      .|...+.||+|+||.||+|..      .+++.||+|+++... ....+.+..|+.++.++ +|+||++++++|.. ....
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~   87 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL   87 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence            456678899999999999963      234789999987543 23345678899999999 89999999998765 4568


Q ss_pred             EEEEecCCCCCHHHHHhcCC------------------------------------------------------------
Q 036754          362 ALVLEYMPHGSLEKYLYSSN------------------------------------------------------------  381 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~------------------------------------------------------------  381 (405)
                      +++|||+++|+|.+++....                                                            
T Consensus        88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (337)
T cd05054          88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK  167 (337)
T ss_pred             EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence            89999999999999886421                                                            


Q ss_pred             CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          382 CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       382 ~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++|..+..++.||++||+|||+
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH~  191 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLAS  191 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHh
Confidence            257899999999999999999995

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.48  E-value=1.1e-13  Score=126.90  Aligned_cols=113  Identities=25%  Similarity=0.344  Sum_probs=96.1

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |...+.||+|+||.||+|.. .+|+.||+|.++...  ......+.+|++++++++|+|++++++++.+....++++||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            44557799999999999985 468899999986532  222356778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      + |+|.+++......+++..+..++.||++||+|||+
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~  117 (284)
T cd07839          82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS  117 (284)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            7 48888887655578999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.48  E-value=4.4e-13  Score=121.87  Aligned_cols=114  Identities=22%  Similarity=0.364  Sum_probs=94.4

Q ss_pred             CCccCcccccCCCceEEEeeCC--CcEEEEEEeeccc----------cchhHHHHHHHHHhhc-CCCCCcceEEeeeecC
Q 036754          292 FSENNLISKGGFGSVYKARLGD--GMEVAVKVFNLQC----------RRAFKSFDIECEMMKS-IRHQNLIKVISSCSNE  358 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~  358 (405)
                      |+..+.||+|+||.||+|....  ++.+|+|.+....          .....++.+|+.++.+ ++|+||+++++++...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            5566789999999999999654  6889999885321          1233457778888875 7999999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 EFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 ~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +..+++|||+++++|.+++..   ....+++..+..++.|++.||+|||+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  131 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK  131 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc
Confidence            999999999999999988743   33568999999999999999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.48  E-value=8.8e-14  Score=125.63  Aligned_cols=111  Identities=31%  Similarity=0.521  Sum_probs=95.2

Q ss_pred             ccCcccccCCCceEEEeeC-CCcEEEEEEeeccccch--hHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          294 ENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRA--FKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      ..+.||+|+||+||++... +++.||+|.+.......  .....+|+..+.+++|+||+++++++......++||||+++
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~   82 (260)
T PF00069_consen    3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG   82 (260)
T ss_dssp             EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred             EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence            4568999999999999954 56789999997654332  23345699999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++... ..+++..+..++.|+++||+|||+
T Consensus        83 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~  116 (260)
T PF00069_consen   83 GSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHS  116 (260)
T ss_dssp             EBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccc-cccccccccccccccccccccccc
Confidence            9999999732 368999999999999999999994

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.48  E-value=2.2e-13  Score=125.37  Aligned_cols=126  Identities=25%  Similarity=0.290  Sum_probs=103.4

Q ss_pred             hhHHHHHHhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeee
Q 036754          279 MFSYLELCRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCS  356 (405)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  356 (405)
                      .+...++..++++|...+.+|+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|+|++++++++.
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            344556666778898889999999999999985 568899999986432 2235667889999988 8999999999886


Q ss_pred             cC-----CeeEEEEecCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          357 NE-----EFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       357 ~~-----~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..     ...++||||+++|+|.++++.   ....+++..+..++.|++.||+|||+
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~  146 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN  146 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            53     358999999999999998863   23468999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.48  E-value=2.5e-13  Score=127.71  Aligned_cols=115  Identities=27%  Similarity=0.448  Sum_probs=95.7

Q ss_pred             cCCccCcccccCCCceEEEeeC--------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCe
Q 036754          291 KFSENNLISKGGFGSVYKARLG--------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEF  360 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  360 (405)
                      .|...+.||+|+||.||++...        .+..||+|.++... ......+.+|+.++.++ +|+||+++++++...+.
T Consensus        13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (334)
T cd05100          13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP   92 (334)
T ss_pred             HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence            3456688999999999999732        12368999886543 33456788999999999 89999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++++||+++|+|.+++....               ..++|.+++.++.|+++||+|||+
T Consensus        93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~  152 (334)
T cd05100          93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS  152 (334)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999986421               247899999999999999999994

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.48  E-value=3.1e-13  Score=124.55  Aligned_cols=108  Identities=24%  Similarity=0.296  Sum_probs=95.5

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCHH
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLE  374 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  374 (405)
                      .+||+|+||.||++.. .++..||+|.+..........+.+|+.++++++|+|++++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            4689999999999985 578999999986544445567889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          375 KYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       375 ~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++...  .+++.....++.|++.|++|||+
T Consensus       106 ~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~  134 (292)
T cd06657         106 DIVTHT--RMNEEQIAAVCLAVLKALSVLHA  134 (292)
T ss_pred             HHHhcC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            987543  58999999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.48  E-value=3.3e-13  Score=122.13  Aligned_cols=113  Identities=20%  Similarity=0.319  Sum_probs=95.0

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeec--CCeeEEEEe
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSN--EEFKALVLE  366 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  366 (405)
                      |...+.+|.|+||.||++.. .++..||+|.+....  ......+..|+.++++++|+|++++++++..  ....+++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            45567899999999999984 567899999986432  2334568889999999999999999997754  456789999


Q ss_pred             cCCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHhhhc
Q 036754          367 YMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       367 ~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      |+++|+|.+++...   ...+++..+..++.|+++||+|||
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH  122 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH  122 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh
Confidence            99999999998653   357899999999999999999999

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.48  E-value=3.1e-13  Score=123.08  Aligned_cols=117  Identities=24%  Similarity=0.296  Sum_probs=98.7

Q ss_pred             hhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeecCC------
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEE------  359 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------  359 (405)
                      ++++|...+.+|+|+||.||+|.. .++..+|+|.+..... ....+.+|+.++.++ .|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            456778889999999999999996 4578899999865432 345688999999998 7999999999987644      


Q ss_pred             eeEEEEecCCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++||||+++++|.+++...   +..+++..+..++.|+++||+|||.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~  131 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE  131 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            489999999999999988642   2578999999999999999999995

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.48  E-value=4.5e-13  Score=123.05  Aligned_cols=112  Identities=24%  Similarity=0.298  Sum_probs=98.1

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +...+.||+|++|.||++.. .++..+|+|++........+.+.+|+.++.+++|+|++++++++...+..++++||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            34457899999999999984 57889999998655444456688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|.+++..  ..+++.++..++.|++.||+|||+
T Consensus       101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~  133 (285)
T cd06648         101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLHA  133 (285)
T ss_pred             CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999876  358999999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.47  E-value=2.5e-13  Score=132.11  Aligned_cols=109  Identities=20%  Similarity=0.255  Sum_probs=94.2

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      .+|...+.||+|+||.||++... .+..||||...      ...+.+|++++++++|+|||++++++...+..++||||+
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            45777789999999999999954 57889999532      234568999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      . |+|..++......++|.++..++.|+++||+|||+
T Consensus       243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~  278 (461)
T PHA03211        243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG  278 (461)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            5 69999987655579999999999999999999995

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.47  E-value=1.8e-13  Score=129.83  Aligned_cols=109  Identities=23%  Similarity=0.310  Sum_probs=94.0

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      .+|...+.||+|+||.||+|.. ..+..||+|.....      ....|+.++.+++|+||+++++++......++|+||+
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            4677788999999999999995 45678999975332      2346899999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      . |+|.+++......+++..+..++.||++||+|||+
T Consensus       140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  175 (357)
T PHA03209        140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA  175 (357)
T ss_pred             C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            5 59999987666679999999999999999999995

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.47  E-value=3.4e-13  Score=121.57  Aligned_cols=111  Identities=28%  Similarity=0.505  Sum_probs=94.3

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +|...+.||+|+||.||++.. .++.||+|..+...  ....+.+|+.++.+++|+|++++++++.. +..+++|||+++
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~   82 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSK   82 (254)
T ss_pred             HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCC
Confidence            456678899999999999875 67889999886432  34578899999999999999999998865 457999999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++.... ..+++..+..++.|+++|++|||+
T Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~  118 (254)
T cd05083          83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES  118 (254)
T ss_pred             CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999997643 358999999999999999999995

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.47  E-value=5.2e-13  Score=120.24  Aligned_cols=114  Identities=27%  Similarity=0.375  Sum_probs=99.7

Q ss_pred             CCccCcccccCCCceEEEeeC-CCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |...+.||+|+||.||++... ++..||+|++.....  .....+.+|++.+.+++|+|++++.+.+...+..++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            455678999999999999964 688999999875432  45567889999999999999999999998889999999999


Q ss_pred             CCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++|.+++...   ...+++.++..++.++++||+|||+
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~  121 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS  121 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999764   2579999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.47  E-value=6.9e-13  Score=119.27  Aligned_cols=113  Identities=30%  Similarity=0.423  Sum_probs=99.2

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |...+.||+|++|.||+++. .++..||+|.+.....  .....+.+|++++.+++|+|++++++++...+..+++|||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            45567899999999999985 4678999999976543  34567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++|.+++... ..+++..+..++.|++.|++|||+
T Consensus        82 ~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~  117 (254)
T cd06627          82 ENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHE  117 (254)
T ss_pred             CCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhh
Confidence            999999998765 468999999999999999999995

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PLN03150 hypothetical protein; Provisional

Probab=99.47  E-value=1.3e-13  Score=139.06  Aligned_cols=98  Identities=39%  Similarity=0.596  Sum_probs=85.9

Q ss_pred             CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCC--c
Q 036754          119 IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGG--S  196 (405)
Q Consensus       119 ~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~--~  196 (405)
                      +|..++.+++|+.|+|++|.+.|.+|..++.+++|+.|+|++|.+++.+|..+.++++|+.|++++|.++|.+|...  .
T Consensus       434 ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~  513 (623)
T PLN03150        434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR  513 (623)
T ss_pred             CCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhc
Confidence            44456778899999999999999999999999999999999999999999999999999999999999999988642  2


Q ss_pred             cCCCCcccccCCCCccCCCC
Q 036754          197 FGNFSAESFEGNELLCGSPN  216 (405)
Q Consensus       197 ~~~~~~~~~~~n~~~c~~~~  216 (405)
                      ..++..+.+.+|+..|+.|.
T Consensus       514 ~~~~~~l~~~~N~~lc~~p~  533 (623)
T PLN03150        514 LLHRASFNFTDNAGLCGIPG  533 (623)
T ss_pred             cccCceEEecCCccccCCCC
Confidence            23556778999999998764

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.47  E-value=3.5e-13  Score=123.53  Aligned_cols=114  Identities=21%  Similarity=0.375  Sum_probs=94.9

Q ss_pred             CCccCcccccCCCceEEEeeC------CCcEEEEEEeeccccc-hhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          292 FSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQCRR-AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      |...+.||+|+||.||+|...      .+..||+|.++..... ....+.+|+.++.+++|+||+++++++...+..+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            334567999999999999852      2478999999754332 345688899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||+++++|.+++...               +..+++..+..++.|+++||+|||+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~  142 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS  142 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999998532               1347888999999999999999994

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.47  E-value=4.8e-13  Score=122.45  Aligned_cols=111  Identities=21%  Similarity=0.205  Sum_probs=92.5

Q ss_pred             ccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCC-CCCcceEEeeeecC--CeeEEEEecC
Q 036754          294 ENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIR-HQNLIKVISSCSNE--EFKALVLEYM  368 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~  368 (405)
                      ..+.+|+|+||.||+|.. .++..||+|.++... ........+|+..+.++. |+|++++++++.+.  +..++|+||+
T Consensus         3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~   82 (282)
T cd07831           3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM   82 (282)
T ss_pred             eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence            456799999999999985 568899999986542 222334457888898885 99999999999877  8899999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      + |++.+++......++|.++..++.|+++||+|||+
T Consensus        83 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~  118 (282)
T cd07831          83 D-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR  118 (282)
T ss_pred             C-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            7 58888887655578999999999999999999994

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.47  E-value=3.9e-13  Score=123.28  Aligned_cols=112  Identities=27%  Similarity=0.355  Sum_probs=96.5

Q ss_pred             CccCcccccCCCceEEEeeC-CCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecC--CeeEEEEec
Q 036754          293 SENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE--EFKALVLEY  367 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~  367 (405)
                      ...+.+|+|+||.||+|... +|+.+|+|.+....  ......+.+|++++.+++|+|++++++++...  +..++|+||
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   81 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY   81 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence            34567999999999999864 57899999997653  33456788999999999999999999999887  789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++ +|.+++......+++.++..++.||++||+|||+
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~  118 (287)
T cd07840          82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS  118 (287)
T ss_pred             ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            985 8999887654579999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.46  E-value=6.6e-13  Score=122.15  Aligned_cols=114  Identities=25%  Similarity=0.346  Sum_probs=89.5

Q ss_pred             cCCccCcccccCCCceEEEee-C-CCcEEEEEEeeccc--cchhHHHHHHHHHhhcC---CCCCcceEEeeeec-----C
Q 036754          291 KFSENNLISKGGFGSVYKARL-G-DGMEVAVKVFNLQC--RRAFKSFDIECEMMKSI---RHQNLIKVISSCSN-----E  358 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~  358 (405)
                      +|...+.||+|+||.||+|.. . +|..||+|.++...  ......+.+|+.++..+   +||||++++++|..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            455667899999999999985 3 46789999986543  22234556677766655   79999999998852     4


Q ss_pred             CeeEEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 EFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 ~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ...++||||++ |+|.+++.... ..+++..+..++.||++||+|||+
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~  128 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS  128 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            56889999997 59999986533 458999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.46  E-value=4.2e-13  Score=124.70  Aligned_cols=117  Identities=26%  Similarity=0.336  Sum_probs=97.3

Q ss_pred             hhccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecC--CeeE
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNE--EFKA  362 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  362 (405)
                      ..++|...+.||+|+||.||+|.. .+|+.||+|.++....  .....+.+|+.++.+++|+|++++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            345677888999999999999995 5689999999865432  2233566899999999999999999998654  5689


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++ +|.+++......+++.++..++.|+++||+|||+
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~  126 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE  126 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999975 8988887655578999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.46  E-value=2.1e-13  Score=124.61  Aligned_cols=114  Identities=30%  Similarity=0.435  Sum_probs=99.1

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCC-CCCcceEEeeeecCCeeEEEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  365 (405)
                      +|...+.||+|+||.||++.. .+|..||+|++....   ......+.+|..++.+++ |+||+++++++...+..++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            456677899999999999995 478999999986532   233456788999999998 999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||+
T Consensus        82 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~  120 (280)
T cd05581          82 EYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHS  120 (280)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997654 69999999999999999999995

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.46  E-value=4.8e-13  Score=122.54  Aligned_cols=124  Identities=22%  Similarity=0.299  Sum_probs=100.4

Q ss_pred             HHHHHHhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeec-
Q 036754          281 SYLELCRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSN-  357 (405)
Q Consensus       281 ~~~~~~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-  357 (405)
                      +..++..+...|...+.+|+|+||.||+|.. ..+..+|+|...... .....+..|+.++.++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            3445555566777778999999999999995 567899999886442 2335677889999988 79999999998853 


Q ss_pred             -----CCeeEEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          358 -----EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       358 -----~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                           .+..+++|||+++|+|.+++.... ..+++..+..++.|+++||+|||+
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~  139 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA  139 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                 457899999999999999987543 458888899999999999999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.46  E-value=4.2e-13  Score=122.97  Aligned_cols=112  Identities=27%  Similarity=0.352  Sum_probs=96.0

Q ss_pred             CccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          293 SENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      +..+.||+|++|.||+|.. .+|..||+|++....  ......+.+|++.+++++|+|++++++++...+..+++|||++
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~   81 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD   81 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence            4457899999999999985 578999999987543  2234568889999999999999999999999999999999995


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       ++|.+++.... ..+++..+..++.|+++||+|||+
T Consensus        82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~  117 (283)
T cd07835          82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS  117 (283)
T ss_pred             -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence             68999886543 368999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.46  E-value=7.4e-13  Score=123.32  Aligned_cols=113  Identities=27%  Similarity=0.318  Sum_probs=95.6

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      |...+.+|+|+||+||+|+. .+|..||+|.+....   ......+..|++.+.+++|+|++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            33456799999999999985 468899999986432   22345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++ |++.+++......+++.++..++.|++.|++|||+
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~  139 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS  139 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            96 58888886655578999999999999999999995

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.46  E-value=3.6e-15  Score=126.15  Aligned_cols=113  Identities=22%  Similarity=0.421  Sum_probs=97.6

Q ss_pred             CCccCcccccCCCceEEEe-eCCCcEEEEEEeecc--ccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |+..+.||+|.|+.||++. .++|..+|+|.+...  .....++..+|+++...++|||||++...+.+....|||+|+|
T Consensus        13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m   92 (355)
T KOG0033|consen   13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV   92 (355)
T ss_pred             hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence            4445679999999999987 578888898887543  2446788899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .||+|..-+..+. ..++..+-.++.||++||+|+|.
T Consensus        93 ~G~dl~~eIV~R~-~ySEa~aSH~~rQiLeal~yCH~  128 (355)
T KOG0033|consen   93 TGGELFEDIVARE-FYSEADASHCIQQILEALAYCHS  128 (355)
T ss_pred             cchHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHh
Confidence            9999988776553 67888999999999999999995

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.46  E-value=3e-13  Score=124.14  Aligned_cols=114  Identities=24%  Similarity=0.288  Sum_probs=96.7

Q ss_pred             cCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          291 KFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +|...+.||+|+||.||+|... +++.||+|.++...  ......+.+|++++++++|+||+++++++...+..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            3556678999999999999864 57899999986532  33456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++.+..+... ...+++.++..++.||++|++|||+
T Consensus        82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~  118 (288)
T cd07833          82 VERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHS  118 (288)
T ss_pred             CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            998777666544 3468999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.45  E-value=3.1e-13  Score=133.34  Aligned_cols=117  Identities=21%  Similarity=0.287  Sum_probs=96.7

Q ss_pred             hccCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC------
Q 036754          289 TYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE------  359 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  359 (405)
                      ..+|...+.||+|+||+||+|. ..+|+.||||.+....  ......+.+|+..+..++|+|++++++.+...+      
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~  110 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN  110 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence            3567778899999999999998 4578999999986542  334556788999999999999999887664322      


Q ss_pred             --eeEEEEecCCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 --FKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 --~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                        ..++||||+++|+|.+++....   ..+++..+..++.|++.||+|||+
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~  161 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS  161 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence              3679999999999999987532   468899999999999999999994

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.45  E-value=6.4e-13  Score=124.60  Aligned_cols=109  Identities=24%  Similarity=0.313  Sum_probs=93.1

Q ss_pred             ccccc--CCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCC
Q 036754          297 LISKG--GFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHG  371 (405)
Q Consensus       297 ~lg~G--~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  371 (405)
                      .||+|  +||+||+++. .+|+.||+|......  ....+.+.+|+.++..++||||+++++++...+..++|+||+++|
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            35665  8999999985 578999999986543  223467888999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          372 SLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       372 ~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++.+++.... ..+++..+..++.|+++||+|||+
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~  119 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ  119 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999987543 358899999999999999999995

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.45  E-value=1.2e-13  Score=132.38  Aligned_cols=109  Identities=27%  Similarity=0.412  Sum_probs=97.0

Q ss_pred             cccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCHHH
Q 036754          297 LISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEK  375 (405)
Q Consensus       297 ~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  375 (405)
                      ++|+|.||+||.|.. .+...+|||.+...+....+....||..-+.++|+|||+.+|.|.+....-|.||-+|||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            689999999999984 4566789999988777778888889999999999999999999998888899999999999999


Q ss_pred             HHhcCCCCC--CHHHHHHHHHHHHHHHhhhcC
Q 036754          376 YLYSSNCIL--DIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       376 ~l~~~~~~l--~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .|+..=+.+  ++...-.+..||++||.|||+
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHe  693 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHE  693 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhh
Confidence            998765566  677777899999999999996

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.45  E-value=8.9e-13  Score=120.68  Aligned_cols=108  Identities=19%  Similarity=0.221  Sum_probs=87.1

Q ss_pred             cccccCCCceEEEee-CCCcEEEEEEeecccc---chhHHHHHHHH---HhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          297 LISKGGFGSVYKARL-GDGMEVAVKVFNLQCR---RAFKSFDIECE---MMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       297 ~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      +||+|+||.||++.. .+++.+|+|.+.....   .....+.+|..   .+...+|+|++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999985 4688999999865321   11222334433   3334579999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++...+ .+++..+..++.|++.||+|||+
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~  115 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHN  115 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999987654 69999999999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.45  E-value=7.6e-13  Score=119.38  Aligned_cols=114  Identities=25%  Similarity=0.420  Sum_probs=95.7

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeec-CCeeEEEEec
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSN-EEFKALVLEY  367 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  367 (405)
                      |...+.+|+|++|.||++.. .+++.||+|.+....  ......+.+|+.++++++|+|++++.+.+.. ....+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            55668899999999999985 457889999986532  2344568889999999999999999988764 4467899999


Q ss_pred             CCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++.... ..+++.++..++.|++.|++|||+
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~  120 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE  120 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999997643 468999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.45  E-value=5.1e-13  Score=122.80  Aligned_cols=113  Identities=20%  Similarity=0.318  Sum_probs=95.7

Q ss_pred             CCccCcccccCCCceEEEee----CCCcEEEEEEeeccc----cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeE
Q 036754          292 FSENNLISKGGFGSVYKARL----GDGMEVAVKVFNLQC----RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  362 (405)
                      |...+.||+|+||.||+++.    .+++.||||+++...    ......+.+|+.++.++ +|+||+++++.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            44567899999999999874    356889999987532    22345678899999999 5999999999998889999


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++.... .+++.....++.|+++||+|||+
T Consensus        82 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~  123 (288)
T cd05583          82 LILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQ  123 (288)
T ss_pred             EEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999987543 68899999999999999999994

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.45  E-value=2.2e-13  Score=121.80  Aligned_cols=113  Identities=22%  Similarity=0.293  Sum_probs=96.1

Q ss_pred             cCCccCcccccCCCceEEEe-eCCCcEEEEEEee--ccccchhHHHHHHHHHhhcCCCCCcceEEeeeec-----CCeeE
Q 036754          291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN--LQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN-----EEFKA  362 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~~  362 (405)
                      .|...+.||+|+||.|+.+. ..+|+.||+|++.  .......++-.+|+..++.++|+||+.+.+.+..     -+.+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            34445789999999999998 4678999999986  4445566788999999999999999999998765     35789


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|+|+. ||.+.++..+ .++.....-+.+|+++||.|+|+
T Consensus       103 iV~elMet-DL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHS  143 (359)
T KOG0660|consen  103 LVFELMET-DLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHS  143 (359)
T ss_pred             EehhHHhh-HHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhc
Confidence            99999965 9999997644 68999999999999999999995

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.44  E-value=6.5e-13  Score=123.30  Aligned_cols=115  Identities=24%  Similarity=0.353  Sum_probs=94.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC-------
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE-------  359 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------  359 (405)
                      ++|...+.||+|+||.||+|.. .++..||+|.+....  ......+.+|+.++++++||||+++++++...+       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            4566778899999999999985 468899999986432  222345678999999999999999999887644       


Q ss_pred             -eeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 -FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 -~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       ..++||||+++ ++.+++......+++.+...++.|+++||+|||+
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~  137 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR  137 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence             35999999975 8888887655568999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.44  E-value=9.6e-13  Score=119.00  Aligned_cols=109  Identities=26%  Similarity=0.306  Sum_probs=88.9

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHh-hcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMM-KSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.+|+|+||.||+|.. .+|+.||+|.++...   ......+..|...+ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4589999999999985 468899999986532   12223344554443 455899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++...+ .+++..+..++.|+++||+|||.
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~  115 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQ  115 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999997644 68899999999999999999995

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.44  E-value=7.3e-13  Score=122.16  Aligned_cols=114  Identities=23%  Similarity=0.306  Sum_probs=95.1

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +|...+.||+|++|.||+|.. .+|+.||+|.+....  ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY   82 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence            466678899999999999985 478899999986532  22345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++ +++.+++.... ..+++.....++.||+.||+|||+
T Consensus        83 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~  120 (294)
T PLN00009         83 LD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS  120 (294)
T ss_pred             cc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh
Confidence            96 58888876543 236788888999999999999995

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.44  E-value=6.1e-13  Score=129.56  Aligned_cols=111  Identities=28%  Similarity=0.421  Sum_probs=89.2

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecC--------Ce
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNE--------EF  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~~  360 (405)
                      .+|...+.||+|+||.||+|.. .+++.||||++....    ....+|+.++.+++|+|||++++++...        ..
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence            4577788999999999999985 568899999885432    2234699999999999999999876431        24


Q ss_pred             eEEEEecCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++||||+++ ++.+++..   ....+++.....++.|+++||+|||+
T Consensus       142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~  188 (440)
T PTZ00036        142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS  188 (440)
T ss_pred             EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            6799999985 77777643   23568999999999999999999995

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.43  E-value=7.6e-13  Score=122.02  Aligned_cols=114  Identities=23%  Similarity=0.285  Sum_probs=93.8

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCC-CCCcceEEeeeecCCe-----e
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEF-----K  361 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----~  361 (405)
                      +|+..+.||+|+||.||+|.. .+|+.||+|..+...  ......+.+|+.++.+++ |+||+++++++...+.     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            466678899999999999995 468999999886542  223456788999999995 6999999998876555     8


Q ss_pred             EEEEecCCCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+||||+++ ++.+++....    ..+++..+..++.||++||+|||+
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~  128 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK  128 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999985 8988886432    358999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.43  E-value=5.3e-13  Score=124.41  Aligned_cols=111  Identities=23%  Similarity=0.355  Sum_probs=94.3

Q ss_pred             ccCcccccCCCceEEEe-eCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          294 ENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      .++++|+|.||+||-|+ ..+|+.||||++.+..  .+.......|+.++.+++||.||.+.--|++.+.+++|||-+.+
T Consensus       568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            35789999999999998 5689999999997643  33346678899999999999999999999999999999998854


Q ss_pred             CCHHHH-HhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKY-LYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~-l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       |+.+. |...++.+++.....++.||+.||.|||+
T Consensus       648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~  682 (888)
T KOG4236|consen  648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF  682 (888)
T ss_pred             -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh
Confidence             76554 44555789998889999999999999995

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.43  E-value=1.4e-12  Score=119.26  Aligned_cols=108  Identities=19%  Similarity=0.224  Sum_probs=87.2

Q ss_pred             cccccCCCceEEEee-CCCcEEEEEEeecccc---chhHHHHHHH---HHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          297 LISKGGFGSVYKARL-GDGMEVAVKVFNLQCR---RAFKSFDIEC---EMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       297 ~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      +||+|+||.||++.. .+++.||+|.+.....   .....+..|.   ..++...|++|+++.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            479999999999985 5688999999865321   1112233333   34455689999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++... ..+++.++..++.|+++||+|||+
T Consensus        81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~  115 (278)
T cd05606          81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHN  115 (278)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999988654 379999999999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.43  E-value=2.1e-12  Score=117.42  Aligned_cols=109  Identities=20%  Similarity=0.208  Sum_probs=86.4

Q ss_pred             cCCccCc--ccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhc-CCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNL--ISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKS-IRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~--lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ++...+.  +|+|+||.||++.. .++..+|+|..........     |+..... .+|+|++++++++...+..++|||
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            3444444  59999999999984 5678899999865422111     2221111 279999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++.... .++|.++..++.|+++|++|||+
T Consensus        90 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~  127 (267)
T PHA03390         90 YIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHK  127 (267)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999997654 78999999999999999999995

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.43  E-value=6.9e-13  Score=119.47  Aligned_cols=114  Identities=25%  Similarity=0.376  Sum_probs=97.8

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |+..+.+|+|+||.||+++. .++..+|+|.+....  .....++.+|++++++++|+||+++++++......++|+||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            45567899999999999984 567899999987542  334557788999999999999999999998889999999999


Q ss_pred             CCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++|.+++...   +..+++..+..++.|+++||+|||+
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~  121 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE  121 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            999999998652   2468999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.43  E-value=1.4e-12  Score=118.84  Aligned_cols=113  Identities=33%  Similarity=0.506  Sum_probs=91.4

Q ss_pred             CccCcccccCCCceEEEeeC----CCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC------e
Q 036754          293 SENNLISKGGFGSVYKARLG----DGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE------F  360 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~  360 (405)
                      ...++||+|+||.||+|...    .+..||+|.+....  ......+.+|+.++++++||||+++++++...+      .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            34578999999999999853    36789999986542  234567889999999999999999999876532      3


Q ss_pred             eEEEEecCCCCCHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSN-----CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++++||+++|+|.+++....     ..+++.....++.|++.|++|||+
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~  131 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS  131 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            478999999999998875321     247888999999999999999995

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.42  E-value=1.7e-13  Score=130.33  Aligned_cols=112  Identities=23%  Similarity=0.396  Sum_probs=94.4

Q ss_pred             CccCcccccCCCceEEEee-CCCcEEEEEEeecc----ccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCe--eEEEE
Q 036754          293 SENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ----CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF--KALVL  365 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  365 (405)
                      ....+||+|+|=+||+|.. .+|..||.-.++..    .....++|..|+.+++.++|+|||+++.+|.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            3456899999999999985 46777876544332    23445789999999999999999999999987655  67899


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |.+..|+|..|..+++ .++......+|+||++||.|||.
T Consensus       123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs  161 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHS  161 (632)
T ss_pred             ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhc
Confidence            9999999999998776 68888999999999999999995

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.42  E-value=1.2e-12  Score=123.00  Aligned_cols=109  Identities=24%  Similarity=0.296  Sum_probs=92.3

Q ss_pred             cCcccccCCCceEEEee-CCCcEEEEEEeeccccch--------------hHHHHHHHHHhhcCCCCCcceEEeeeecCC
Q 036754          295 NNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRA--------------FKSFDIECEMMKSIRHQNLIKVISSCSNEE  359 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  359 (405)
                      .+.||+|+||+||+|.. ..++.||+|.++......              ...+.+|+.++.+++|+||+++++++...+
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            46799999999999985 468899999986432111              124678999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++||||++ |+|.+++.... .+++.....++.|+++||+|||+
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~  137 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHK  137 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999997 59999986543 68999999999999999999995

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.42  E-value=1.4e-12  Score=121.41  Aligned_cols=113  Identities=21%  Similarity=0.363  Sum_probs=93.6

Q ss_pred             CCccCcccccCCCceEEEeeC---CCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecC--CeeEE
Q 036754          292 FSENNLISKGGFGSVYKARLG---DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE--EFKAL  363 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  363 (405)
                      |...+.||+|+||.||+|...   .+..||+|.+....   ......+.+|+.++.+++||||+++++++...  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            445677999999999999953   57899999997633   33456678899999999999999999999887  78999


Q ss_pred             EEecCCCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++ ++.+++....    ..+++.....++.|++.||+|||+
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  126 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS  126 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh
Confidence            9999985 7777664322    267888999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.42  E-value=1.5e-12  Score=120.98  Aligned_cols=113  Identities=27%  Similarity=0.359  Sum_probs=95.3

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeecc---ccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      |+..+.+|+|+||.||+|.. .++..+|+|.+...   .......+.+|+++++.++|+|++++.+++......++||||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            44456799999999999995 46788999988643   223345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +. |++.+.+......+++.++..++.|++.|++|||+
T Consensus        97 ~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~  133 (308)
T cd06634          97 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS  133 (308)
T ss_pred             cC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            97 68888776555568999999999999999999995

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.41  E-value=6.8e-13  Score=119.98  Aligned_cols=114  Identities=19%  Similarity=0.259  Sum_probs=92.0

Q ss_pred             CCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc-----cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          292 FSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC-----RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      |...+.||+|+||.||++... .+..+++|..+...     ......+.+|+.++.+++||||+++++++...+..++||
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            445578999999999999853 34455666654321     223345677899999999999999999999888999999


Q ss_pred             ecCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++++|.+++..   ....+++.++..++.|+++|++|||+
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~  124 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ  124 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999998864   23468999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.41  E-value=7.3e-13  Score=121.17  Aligned_cols=112  Identities=29%  Similarity=0.351  Sum_probs=96.8

Q ss_pred             CccCcccccCCCceEEEeeC-CCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          293 SENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      +..+.||+|+||.||+|+.. +++.||+|.+....  ....+.+..|+.++++++|+|++++++++...+..++|+||++
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD   81 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence            34567999999999999954 58999999997653  3334667889999999999999999999999999999999998


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       ++|.+++......+++..+..++.|+++||+|||+
T Consensus        82 -~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~  116 (282)
T cd07829          82 -MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS  116 (282)
T ss_pred             -cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH
Confidence             59999998764479999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.41  E-value=1.6e-12  Score=122.72  Aligned_cols=114  Identities=20%  Similarity=0.276  Sum_probs=94.2

Q ss_pred             hccCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC------
Q 036754          289 TYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE------  359 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  359 (405)
                      .+.|...+.||+|+||.||++. ..+|..||||++....  ......+.+|+.++.+++|+||+++++++....      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            4567778899999999999998 4578999999985432  223456788999999999999999999886543      


Q ss_pred             eeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++||||+ +++|.+++..  ..+++..+..++.|+++||+|||.
T Consensus        94 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~  136 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHA  136 (343)
T ss_pred             eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            358999998 6799888864  358999999999999999999995

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.41  E-value=1.1e-12  Score=123.88  Aligned_cols=114  Identities=19%  Similarity=0.229  Sum_probs=93.3

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecC------C
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE------E  359 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  359 (405)
                      .+.|...+.||+|+||.||+|.. .++..||||.+....  ......+.+|+.++.+++|+||+++++++...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            35677778999999999999984 567899999986532  22345677899999999999999999887542      4


Q ss_pred             eeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++++|++ +++|.+++...  .+++..+..++.|+++||+|||+
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~  136 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHS  136 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            568999987 67998887543  58999999999999999999994

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.40  E-value=1.2e-12  Score=117.41  Aligned_cols=107  Identities=29%  Similarity=0.342  Sum_probs=93.9

Q ss_pred             ccccCCCceEEEeeC-CCcEEEEEEeecccc---chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCH
Q 036754          298 ISKGGFGSVYKARLG-DGMEVAVKVFNLQCR---RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL  373 (405)
Q Consensus       298 lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  373 (405)
                      ||+|+||.||++... +++.+|+|.+.....   .....+..|+.++.+++|+|++++++.+...+..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999854 588999999875432   2345788899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          374 EKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       374 ~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+++.... .+++.....++.|+++|++|||+
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~  111 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHS  111 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99997654 68999999999999999999995

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.40  E-value=2.7e-12  Score=119.73  Aligned_cols=108  Identities=20%  Similarity=0.288  Sum_probs=87.5

Q ss_pred             cCcccccCCCceEEEeeC---CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeec--CCeeEEEEecCC
Q 036754          295 NNLISKGGFGSVYKARLG---DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN--EEFKALVLEYMP  369 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  369 (405)
                      ..+||+|+||.||+|...   +++.||+|.+...  .....+.+|+.++++++||||+++++++..  ....+++|||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            357999999999999853   4578999988643  223456789999999999999999998754  456889999987


Q ss_pred             CCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~--------~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      + +|.+++...        ...+++..+..++.||+.||+|||+
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~  126 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA  126 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh
Confidence            5 888877532        1258888999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.40  E-value=9e-13  Score=120.72  Aligned_cols=112  Identities=22%  Similarity=0.262  Sum_probs=94.3

Q ss_pred             CccCcccccCCCceEEEeeC-CCcEEEEEEeecccc-chhHHHHHHHHHhhcCC-CCCcceEEeeeecCCeeEEEEecCC
Q 036754          293 SENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      ...+.||+|+||.||+|... +++.||+|++..... .......+|+..+.+++ |+|++++++++...+..++||||+ 
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   80 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-   80 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence            34577999999999999975 578899999865432 22234457899999999 999999999999999999999999 


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|++.+++.... ..+++.++..++.|+++||+|||+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~  117 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK  117 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH
Confidence            789999887653 468999999999999999999995

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.40  E-value=1.7e-12  Score=123.37  Aligned_cols=112  Identities=22%  Similarity=0.244  Sum_probs=92.0

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecC------Ce
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE------EF  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  360 (405)
                      .+|...+.||+|+||.||++.. .+|..||+|.+....  ......+.+|+.++..++||||+++++++...      ..
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            4667778999999999999985 568899999986432  23456778899999999999999999988643      34


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++||||+++ ++.+.+..   .+++..+..++.|+++||+|||+
T Consensus       101 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~  141 (359)
T cd07876         101 VYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHS  141 (359)
T ss_pred             eEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHh
Confidence            7899999976 67776642   47888899999999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.40  E-value=1.3e-12  Score=131.47  Aligned_cols=114  Identities=25%  Similarity=0.434  Sum_probs=97.8

Q ss_pred             CCccCcccccCCCceEEEeeC----C----CcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCee
Q 036754          292 FSENNLISKGGFGSVYKARLG----D----GMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  361 (405)
                      +...+.+|+|+||.|++|...    .    ...||||.++... ..+.+.+..|+.+|..+ +|+||+.++|+|......
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~  377 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL  377 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence            334458999999999999742    1    3579999998654 34567889999999998 699999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+||+.+|+|..+++..+               ..++..+.+.++.|||.||+||++
T Consensus       378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~  436 (609)
T KOG0200|consen  378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS  436 (609)
T ss_pred             EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh
Confidence            99999999999999998766               348899999999999999999974

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.40  E-value=2.1e-12  Score=122.02  Aligned_cols=121  Identities=20%  Similarity=0.246  Sum_probs=98.3

Q ss_pred             HHHHHhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecC
Q 036754          282 YLELCRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE  358 (405)
Q Consensus       282 ~~~~~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  358 (405)
                      -.++...+++|...+.||+|+||.||+|.. .+|..||+|++....  ......+.+|+.++.+++|+||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            345566778888889999999999999984 578899999986532  22345678899999999999999999987542


Q ss_pred             ------CeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 ------EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 ------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                            ...+++++++ +++|.+++...  .+++..+..++.|+++||+|||+
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~  138 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHS  138 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence                  3467888876 77998887643  58999999999999999999995

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.40  E-value=1.6e-12  Score=121.94  Aligned_cols=117  Identities=24%  Similarity=0.261  Sum_probs=96.6

Q ss_pred             HhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeec-CCee
Q 036754          286 CRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSN-EEFK  361 (405)
Q Consensus       286 ~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  361 (405)
                      ...+++|...+.||+|+||.||++.. .+++.||+|.+....  ....+.+.+|++++.+++|||++++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            34566788889999999999999984 578999999885432  2334667889999999999999999998865 5678


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++||+. ++|.+++...  .+++.....++.|+++||+|||+
T Consensus        86 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~  126 (328)
T cd07856          86 YFVTELLG-TDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHS  126 (328)
T ss_pred             EEEeehhc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999984 5899888643  47888888999999999999995

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.40  E-value=1.5e-12  Score=122.61  Aligned_cols=113  Identities=26%  Similarity=0.321  Sum_probs=93.4

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeecc--ccchhHHHHHHHHHhhcC-CCCCcceEEeeeecC--CeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNE--EFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~l  363 (405)
                      ++|...+.||+|+||.||+|... +|+.+|+|++...  .......+.+|+.++.++ +|+||+++++++...  ...++
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            34556678999999999999864 6789999988542  223345677899999999 999999999988653  46899


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||++ ++|..++...  .++|..+..++.||+.||+|||+
T Consensus        87 v~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~  125 (337)
T cd07852          87 VFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHS  125 (337)
T ss_pred             Eecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999998 5999988654  68999999999999999999995

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=8.6e-14  Score=127.09  Aligned_cols=114  Identities=29%  Similarity=0.421  Sum_probs=99.9

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      .|+..+.||+|+||.||+|.. ..++.||+|++.... ..+..+..+|+.+++.++++||.+.+|.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            355567899999999999994 578999999998654 445678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+|++.+.+.... .+++....-|.+++..|+.|||.
T Consensus        94 ~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~  129 (467)
T KOG0201|consen   94 GGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHS  129 (467)
T ss_pred             cCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhh
Confidence            9999999997654 55888888899999999999995

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.39  E-value=2e-12  Score=119.39  Aligned_cols=115  Identities=19%  Similarity=0.219  Sum_probs=94.9

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCC-CCCcceEEeeeecCCeeEEEEe
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ++|...+.+|+|+||.||+|... ++..||||.++... .....++..|+..+.+.. |+||+++++++......+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            45566788999999999999975 48899999997543 233456677887777775 9999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++ ++..+.......+++..+..++.|+++||+|||+
T Consensus        95 ~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~  132 (296)
T cd06618          95 LMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE  132 (296)
T ss_pred             ccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9864 7777766544578999999999999999999994

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.39  E-value=1.4e-12  Score=121.53  Aligned_cols=106  Identities=25%  Similarity=0.236  Sum_probs=87.6

Q ss_pred             cccCCCceEEEeeCCCcEEEEEEeecc--ccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCHHHH
Q 036754          299 SKGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKY  376 (405)
Q Consensus       299 g~G~fg~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  376 (405)
                      |.|+++.||++.. +++.||+|++...  .......+..|+..+++++|+||+++++++...+..+++|||+++|++.++
T Consensus        11 ~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~   89 (314)
T cd08216          11 EDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDL   89 (314)
T ss_pred             cCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence            3444444444444 7899999998754  234456788999999999999999999999999999999999999999999


Q ss_pred             HhcC-CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          377 LYSS-NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       377 l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +... ...+++.....++.|+++||+|||+
T Consensus        90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~  119 (314)
T cd08216          90 LKTHFPEGLPELAIAFILKDVLNALDYIHS  119 (314)
T ss_pred             HHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9754 2458899999999999999999995

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.39  E-value=2.6e-12  Score=118.01  Aligned_cols=113  Identities=27%  Similarity=0.381  Sum_probs=88.7

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeecccc--chhHHHHHHHHHhhcC---CCCCcceEEeeeec-----CCe
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSI---RHQNLIKVISSCSN-----EEF  360 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~~  360 (405)
                      |...+.||+|+||.||+|.. .+|+.||+|.++....  .....+.+|+..+..+   +|+||+++++++..     ...
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            45567899999999999985 4688999999865422  2223455677666554   79999999998764     345


Q ss_pred             eEEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+++|||+++ +|.+++.... ..+++..+..++.|++.||+|||+
T Consensus        82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~  126 (288)
T cd07863          82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA  126 (288)
T ss_pred             EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            7899999985 8988886543 358999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.39  E-value=1.5e-12  Score=122.89  Aligned_cols=113  Identities=23%  Similarity=0.259  Sum_probs=94.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecC----------
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNE----------  358 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----------  358 (405)
                      ..|...+.||+|+||.||+|.. .+|..||+|.+........+.+.+|++++.+++|+||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            3466678899999999999985 56899999998765555567788899999999999999999766543          


Q ss_pred             ----CeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 ----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 ----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                          ...++||||++ ++|.+++...  .+++.....++.||++||+|||+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~  132 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHS  132 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh
Confidence                35789999997 5999888643  58899999999999999999995

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.39  E-value=9.1e-14  Score=131.98  Aligned_cols=110  Identities=23%  Similarity=0.349  Sum_probs=98.0

Q ss_pred             CcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCHH
Q 036754          296 NLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLE  374 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  374 (405)
                      .-+|.|+||+||+|.-. .+...|.|++.....+...+|.-||++++.++||+||++++.|..++.++|..|||+||...
T Consensus        38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD  117 (1187)
T KOG0579|consen   38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD  117 (1187)
T ss_pred             hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence            45799999999999854 44556788887777778889999999999999999999999998899999999999999999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          375 KYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       375 ~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..+-.-+..+++.+..-+|+|++.||.|||+
T Consensus       118 aimlEL~r~LtE~QIqvvc~q~ldALn~LHs  148 (1187)
T KOG0579|consen  118 AIMLELGRVLTEDQIQVVCYQVLDALNWLHS  148 (1187)
T ss_pred             HHHHHhccccchHHHHHHHHHHHHHHHHHhh
Confidence            8887766789999999999999999999995

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.39  E-value=2e-12  Score=118.34  Aligned_cols=111  Identities=26%  Similarity=0.304  Sum_probs=95.9

Q ss_pred             ccCcccccCCCceEEEee-CCCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          294 ENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      ..+.||+|++|.||+|.. .+|+.+|+|.+.....  .....+.+|+..+++++|+||+++++++...+..++|+||+++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (283)
T cd05118           3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT   82 (283)
T ss_pred             cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence            446799999999999985 4688999999865432  2456788899999999999999999999999999999999985


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       ++.+++......+++.++..++.|+++||+|||+
T Consensus        83 -~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~  116 (283)
T cd05118          83 -DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS  116 (283)
T ss_pred             -CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH
Confidence             8998887755578999999999999999999994

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.38  E-value=2e-12  Score=124.25  Aligned_cols=108  Identities=23%  Similarity=0.282  Sum_probs=91.7

Q ss_pred             cCCccCcccccCCCceEEEeeC---CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          291 KFSENNLISKGGFGSVYKARLG---DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      .|...+.||+|+||.||++...   .+..||+|.+...     ....+|++++.+++|+|||++++++......+++|||
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~  167 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK  167 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence            4666788999999999998743   3577999987543     2345799999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +. ++|.+++... ..+++.++..++.|++.||+|||+
T Consensus       168 ~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~  203 (392)
T PHA03207        168 YK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHG  203 (392)
T ss_pred             cC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            86 5899988543 479999999999999999999995

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.38  E-value=3.9e-12  Score=118.55  Aligned_cols=107  Identities=21%  Similarity=0.290  Sum_probs=86.8

Q ss_pred             CcccccCCCceEEEeeC---CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeec--CCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARLG---DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN--EEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  370 (405)
                      .+||+|+||.||+|+..   ++..||+|.+....  ....+.+|+.++++++||||+++++++..  ....++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            57999999999999854   45789999886432  23457789999999999999999998854  5678899999875


Q ss_pred             CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~--------~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       +|.+++...        ...+++..+..++.|+++||+|||+
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~  126 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA  126 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh
Confidence             788777421        1247888999999999999999995

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.38  E-value=1.6e-12  Score=126.77  Aligned_cols=118  Identities=18%  Similarity=0.198  Sum_probs=88.3

Q ss_pred             hhccCCccCcccccCCCceEEEee-----------------CCCcEEEEEEeeccccchhHH--------------HHHH
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL-----------------GDGMEVAVKVFNLQCRRAFKS--------------FDIE  336 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e  336 (405)
                      ..++|...++||+|+||+||+|..                 ..++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            456888899999999999999963                 234679999986543322222              3446


Q ss_pred             HHHhhcCCCCCc-----ceEEeeeec--------CCeeEEEEecCCCCCHHHHHhcCC----------------------
Q 036754          337 CEMMKSIRHQNL-----IKVISSCSN--------EEFKALVLEYMPHGSLEKYLYSSN----------------------  381 (405)
Q Consensus       337 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------  381 (405)
                      +..+.+++|.++     ++++++|..        ....++||||+++|+|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777778877655     667777653        356899999999999999886421                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          382 -CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       382 -~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       ..++|..+..++.|+++||+|||+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~  327 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR  327 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH
Confidence             124677888999999999999994

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.38  E-value=1.5e-12  Score=122.33  Aligned_cols=114  Identities=19%  Similarity=0.237  Sum_probs=95.2

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeec----CCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSN----EEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  362 (405)
                      .+|...+.||+|+||.||+|.. .+|..||+|++....  ......+.+|+.++.+++|+||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            5667778899999999999984 568999999986542  2345667789999999999999999987753    35689


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+. |+|.+++.... .+++.....++.||++||+|||+
T Consensus        85 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~  125 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHS  125 (334)
T ss_pred             EEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999996 69999986544 58999999999999999999995

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.37  E-value=4.6e-13  Score=111.60  Aligned_cols=122  Identities=28%  Similarity=0.340  Sum_probs=31.2

Q ss_pred             cccEEEcccCcccccCCcccc-CccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccC
Q 036754           38 SLEFFVMSYCNISGGILEEIT-NLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNF  116 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l  116 (405)
                      .++.|+|++|+|+.+  +.++ .+.+|+.|+|++|.|+ .++. + ..+++|+.|++++|+|++++..+.          
T Consensus        20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~~-l-~~L~~L~~L~L~~N~I~~i~~~l~----------   84 (175)
T PF14580_consen   20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLEG-L-PGLPRLKTLDLSNNRISSISEGLD----------   84 (175)
T ss_dssp             ------------------S--TT-TT--EEE-TTS--S---TT------TT--EEE--SS---S-CHHHH----------
T ss_pred             ccccccccccccccc--cchhhhhcCCCEEECCCCCCc-cccC-c-cChhhhhhcccCCCCCCccccchH----------
Confidence            344455555554432  1222 3445555555555554 3331 1 245555555555555554432211          


Q ss_pred             CCCChhccCCCCCCEEeccCCcccccC-CcccccCCCCCeeecccccccCcc---chhHHhcccCCccc
Q 036754          117 SVIPIEIGGLPNLEYLFLGYNRLQGSI-PDSFGDLISLKSLNLSKNNLSGAI---PASLEKLLYLKDLN  181 (405)
Q Consensus       117 ~~~p~~~~~l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~n~l~~~~---~~~~~~l~~L~~l~  181 (405)
                             ..+|+|++|++++|++...- -..+..+++|+.|++.+|+++...   ...+..+++|+.||
T Consensus        85 -------~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   85 -------KNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             -------HH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred             -------HhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence                   11344555555555543211 123445555555555555554221   12455666666666

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.37  E-value=2.4e-12  Score=121.17  Aligned_cols=113  Identities=22%  Similarity=0.263  Sum_probs=94.1

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeecc--ccchhHHHHHHHHHhhcCCCCCcceEEeeeecC-----CeeE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNE-----EFKA  362 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~  362 (405)
                      .|...+.||+|+||+||+|.. .+++.||+|.+...  .......+.+|+.++..++|+||+++++++...     ...+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            466678899999999999984 57899999998653  233345677899999999999999999987653     3479


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+||+. ++|.+++... ..+++.....++.|+++||+|||+
T Consensus        86 lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~  126 (337)
T cd07858          86 IVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHS  126 (337)
T ss_pred             EEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999996 6899988754 368999999999999999999995

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.37  E-value=3.9e-14  Score=133.07  Aligned_cols=167  Identities=32%  Similarity=0.424  Sum_probs=84.3

Q ss_pred             cCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCee
Q 036754           12 CLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKL   91 (405)
Q Consensus        12 ~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L   91 (405)
                      --...||+.|++..+ |.. +..+- .|+.+.|..|.+.. +|..++++..|++|||+.|+++ .+|..++ .| -|+.|
T Consensus        76 dt~~aDlsrNR~~el-p~~-~~~f~-~Le~liLy~n~~r~-ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC-~l-pLkvl  148 (722)
T KOG0532|consen   76 DTVFADLSRNRFSEL-PEE-ACAFV-SLESLILYHNCIRT-IPEAICNLEALTFLDLSSNQLS-HLPDGLC-DL-PLKVL  148 (722)
T ss_pred             chhhhhccccccccC-chH-HHHHH-HHHHHHHHhcccee-cchhhhhhhHHHHhhhccchhh-cCChhhh-cC-cceeE
Confidence            344556666666543 322 22222 45555555555543 4555555555555555555555 5555554 33 25555


Q ss_pred             eCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCc
Q 036754           92 SLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGA  166 (405)
Q Consensus        92 ~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~  166 (405)
                      -+++|+++.+|+.++.+..|..|+.+.     +|..++++.+|+.|.+..|++. .+|..+..+ .|..||++.|++. .
T Consensus       149 i~sNNkl~~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~  225 (722)
T KOG0532|consen  149 IVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-Y  225 (722)
T ss_pred             EEecCccccCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-e
Confidence            555555555555555444444444332     4555555555555555555554 333334322 3455555555555 4


Q ss_pred             cchhHHhcccCCccccccCccc
Q 036754          167 IPASLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       167 ~~~~~~~l~~L~~l~l~~n~l~  188 (405)
                      +|-.|.+|+.|+.|.|.+|.+.
T Consensus       226 iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  226 LPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             cchhhhhhhhheeeeeccCCCC
Confidence            4555555555555555555554

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.37  E-value=3.7e-12  Score=121.21  Aligned_cols=113  Identities=20%  Similarity=0.200  Sum_probs=92.8

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecC------C
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE------E  359 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  359 (405)
                      ..+|...+.||+|+||.||++.. ..++.||||++....  ......+.+|+.++..++|+||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            34677778999999999999984 468899999986432  33456778899999999999999999987543      3


Q ss_pred             eeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..|+||||+++ ++.+++..   .+++.++..++.|+++||+|||+
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~  144 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS  144 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhh
Confidence            57999999976 78777743   47889999999999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.37  E-value=2.6e-13  Score=119.44  Aligned_cols=115  Identities=23%  Similarity=0.286  Sum_probs=100.2

Q ss_pred             ccCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+++|+|.||+|..++ -..|+.+|+|++++.-   +.+...-..|-+++...+||-+..+...+.+.+.++.||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            567788999999999999987 5689999999998753   333444566889999999999999998899999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+-||+|+-+|...+ .+++.+..-+...|..||.|||+
T Consensus       248 eyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs  286 (516)
T KOG0690|consen  248 EYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHS  286 (516)
T ss_pred             EEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhh
Confidence            9999999999997654 78998888999999999999996

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.37  E-value=3.2e-14  Score=133.70  Aligned_cols=173  Identities=25%  Similarity=0.364  Sum_probs=138.1

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchh
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG   82 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   82 (405)
                      +|..++.+-.|+.+.|..|.+..+.+ . +.++. .|..|+|+.|+++. +|..++.|+ |+.|.+++|+++ .+|.++.
T Consensus        90 lp~~~~~f~~Le~liLy~n~~r~ip~-~-i~~L~-~lt~l~ls~NqlS~-lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig  163 (722)
T KOG0532|consen   90 LPEEACAFVSLESLILYHNCIRTIPE-A-ICNLE-ALTFLDLSSNQLSH-LPDGLCDLP-LKVLIVSNNKLT-SLPEEIG  163 (722)
T ss_pred             CchHHHHHHHHHHHHHHhccceecch-h-hhhhh-HHHHhhhccchhhc-CChhhhcCc-ceeEEEecCccc-cCCcccc
Confidence            44556666778888899999976544 4 56665 88999999999876 666666654 888999999997 8898886


Q ss_pred             cCCCCCCeeeCCCCCCCCCchhhhccccCccccCC-----CCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeee
Q 036754           83 SNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS-----VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLN  157 (405)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~-----~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  157 (405)
                       .+..|..||.+.|++.++|..++.+..|..|++.     .+|..+..|+ |..||+|.|++. .+|-.|.+|..|++|-
T Consensus       164 -~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~  240 (722)
T KOG0532|consen  164 -LLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQ  240 (722)
T ss_pred             -cchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeee
Confidence             8889999999999999999999888888877654     4888888654 889999999999 7899999999999999


Q ss_pred             cccccccCccchhHHhcc---cCCccccccC
Q 036754          158 LSKNNLSGAIPASLEKLL---YLKDLNLSFN  185 (405)
Q Consensus       158 l~~n~l~~~~~~~~~~l~---~L~~l~l~~n  185 (405)
                      |.+|++. .+|..+...-   -.++|+...+
T Consensus       241 LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~  270 (722)
T KOG0532|consen  241 LENNPLQ-SPPAQICEKGKVHIFKYLSTQAC  270 (722)
T ss_pred             eccCCCC-CChHHHHhccceeeeeeecchhc
Confidence            9999998 6676665332   2455555555

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.36  E-value=2.9e-12  Score=121.57  Aligned_cols=113  Identities=21%  Similarity=0.214  Sum_probs=92.5

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecC------C
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE------E  359 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  359 (405)
                      .++|...+.||+|+||.||++.. ..++.||+|.+....  ......+.+|+.++..++|+||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            35677778999999999999984 468899999986532  23346778899999999999999999987643      3


Q ss_pred             eeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++||||+++ ++.+.+..   .+++.++..++.|+++||+|||+
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~  137 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS  137 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHh
Confidence            57899999976 67777643   47899999999999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.36  E-value=3.3e-12  Score=120.16  Aligned_cols=113  Identities=19%  Similarity=0.274  Sum_probs=94.0

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecC-----CeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE-----EFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~  362 (405)
                      ++|...+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.++.+++|+||+++++++...     ...+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            4677788999999999999984 578999999986432 33445678899999999999999999887543     3579


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++||+++ ++.+.+..  ..+++..+..++.|+++||+|||+
T Consensus        85 lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~  124 (336)
T cd07849          85 IVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHS  124 (336)
T ss_pred             EEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999975 88888754  358999999999999999999995

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.36  E-value=5.7e-12  Score=115.54  Aligned_cols=112  Identities=26%  Similarity=0.345  Sum_probs=90.2

Q ss_pred             CccCcccccCCCceEEEeeC-CCcEEEEEEeeccc--cchhHHHHHHHHHhhcC---CCCCcceEEeeeecCCe-----e
Q 036754          293 SENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDIECEMMKSI---RHQNLIKVISSCSNEEF-----K  361 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----~  361 (405)
                      +..+.||+|+||.||+|+.. ++..||+|.++...  ......+.+|+.++.++   +|+|++++++++...+.     .
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            44578999999999999965 48999999996432  22234566677766554   69999999999987766     8


Q ss_pred             EEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|||+++ +|.+++.... ..+++.++..++.|+++||+|||+
T Consensus        82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~  125 (287)
T cd07838          82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS  125 (287)
T ss_pred             EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999975 8999887543 368999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.35  E-value=3.4e-12  Score=117.28  Aligned_cols=113  Identities=21%  Similarity=0.270  Sum_probs=91.4

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCC-CCCcceEEeeeecCCeeEEEEecC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      |...+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+..+.++. |+||+++++++..+...+++|||+
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~   85 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM   85 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence            34456799999999999985 568999999987543 234557888999999996 999999999999889999999998


Q ss_pred             CCCCHHHH---Hhc-CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKY---LYS-SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~---l~~-~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +. ++.++   +.. ....+++.....++.|+++||+|||+
T Consensus        86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~  125 (288)
T cd06616          86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE  125 (288)
T ss_pred             cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            75 55443   322 22468999999999999999999984

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.35  E-value=8.9e-12  Score=109.72  Aligned_cols=113  Identities=31%  Similarity=0.403  Sum_probs=98.8

Q ss_pred             CccCcccccCCCceEEEeeCC-CcEEEEEEeeccccc-hhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          293 SENNLISKGGFGSVYKARLGD-GMEVAVKVFNLQCRR-AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      ...+.||+|++|.||++.... +..+|+|.+...... ....+.+|++.+.+++|+|++++++++......++++||+++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            345679999999999999764 789999999765444 567888999999999999999999999988999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|.+++......+++.....++.+++++++|||.
T Consensus        82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  116 (225)
T smart00221       82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS  116 (225)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999997654238999999999999999999994

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.35  E-value=3.2e-12  Score=118.72  Aligned_cols=116  Identities=25%  Similarity=0.323  Sum_probs=94.9

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecC-------
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNE-------  358 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  358 (405)
                      .++|...+.||+|+||.||+|.. .++..+|+|.+.....  .....+.+|++.+.+++|+||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            45677788999999999999985 4688999999865432  2234567899999999999999999876543       


Q ss_pred             -CeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 -EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       ...++|+||+++ ++...+......+++.++..++.|+++||+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~  133 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE  133 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence             346899999975 7888776555579999999999999999999995

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.35  E-value=7e-13  Score=127.54  Aligned_cols=173  Identities=31%  Similarity=0.440  Sum_probs=82.0

Q ss_pred             CCCcCCeeeCcCCcCcccCCchhhhcccc-cccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCC
Q 036754            9 NCKCLTFIDLSNNPLDSVLPKTFVGNVSH-SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLAS   87 (405)
Q Consensus         9 ~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~   87 (405)
                      .++.++.|++.+|.++.+.+..  + ... +|+.|++++|.+.. +|..+..+++|+.|++++|+++ .+|.... .++.
T Consensus       114 ~~~~l~~L~l~~n~i~~i~~~~--~-~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~-~~~~  187 (394)
T COG4886         114 ELTNLTSLDLDNNNITDIPPLI--G-LLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLS-NLSN  187 (394)
T ss_pred             cccceeEEecCCcccccCcccc--c-cchhhcccccccccchhh-hhhhhhccccccccccCCchhh-hhhhhhh-hhhh
Confidence            3445555555555555544432  1 111 45556666655544 3344555555666666666555 4444432 4555


Q ss_pred             CCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccccc
Q 036754           88 LRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN  162 (405)
Q Consensus        88 L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~  162 (405)
                      |+.|++++|+++.+|.....+..|..+.++.     .+..+.++.++..+.+.+|++. .++..++.++.++.|++++|.
T Consensus       188 L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~  266 (394)
T COG4886         188 LNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ  266 (394)
T ss_pred             hhheeccCCccccCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchhccccccceecccccc
Confidence            5556666666555555433333333333322     2333444444444444444443 223444444444555555554


Q ss_pred             ccCccchhHHhcccCCccccccCcccCc
Q 036754          163 LSGAIPASLEKLLYLKDLNLSFNKLEGE  190 (405)
Q Consensus       163 l~~~~~~~~~~l~~L~~l~l~~n~l~~~  190 (405)
                      ++...+  +..+.+++.++++.|.+...
T Consensus       267 i~~i~~--~~~~~~l~~L~~s~n~~~~~  292 (394)
T COG4886         267 ISSISS--LGSLTNLRELDLSGNSLSNA  292 (394)
T ss_pred             cccccc--ccccCccCEEeccCcccccc
Confidence            442221  44444444444444444433

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.35  E-value=3.2e-12  Score=119.96  Aligned_cols=112  Identities=23%  Similarity=0.266  Sum_probs=95.9

Q ss_pred             CCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC-----eeEE
Q 036754          292 FSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE-----FKAL  363 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l  363 (405)
                      |...+.||+|+||.||+|+.. .+..||+|.+....  ....+.+.+|+..+..++|+||+++.+++...+     ..|+
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            455678999999999999964 58899999986543  344567889999999999999999999987765     7899


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|||+++ +|.+++.... .+++..+..++.|+++||+|||+
T Consensus        82 v~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~  121 (330)
T cd07834          82 VTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHS  121 (330)
T ss_pred             Eecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999984 8999887644 79999999999999999999995

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.34  E-value=5.6e-13  Score=116.73  Aligned_cols=114  Identities=23%  Similarity=0.308  Sum_probs=93.5

Q ss_pred             cCCccCcccccCCCceEEEeeC---C--CcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeec-CCeeE
Q 036754          291 KFSENNLISKGGFGSVYKARLG---D--GMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSN-EEFKA  362 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~---~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~  362 (405)
                      .|.....||+|.||.||+|...   +  .+.+|+|+++...  ........+|+..++.++||||+.+...+.+ +..++
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~  104 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW  104 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence            3455677999999999999632   2  2479999997543  3345677899999999999999999998776 78899


Q ss_pred             EEEecCCCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++||+++ ||.+.++.++    ..+.......|.-||+.|++|||+
T Consensus       105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~  150 (438)
T KOG0666|consen  105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS  150 (438)
T ss_pred             EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh
Confidence            99999998 9999887543    457777888999999999999995

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.34  E-value=4.2e-12  Score=108.82  Aligned_cols=106  Identities=17%  Similarity=0.160  Sum_probs=79.2

Q ss_pred             CcccccCCCceEEEeeCCCcEEEEEEeeccccc--h-------hHH-----------------HHHHHHHhhcCCCCCcc
Q 036754          296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCRR--A-------FKS-----------------FDIECEMMKSIRHQNLI  349 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~e~~~l~~l~h~niv  349 (405)
                      ..||+|+||.||+|...+|+.||||+++.....  .       ...                 ...|++.+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            579999999999999878999999999754211  0       111                 23488999999888775


Q ss_pred             eEEeeeecCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhc
Q 036754          350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       350 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      ....+..  ...+|||||++++++....... ..+++.+...++.|++++|+|+|
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~  134 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILY  134 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence            4433322  2338999999998776553322 36889999999999999999994

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PTZ00284 protein kinase; Provisional

Probab=99.33  E-value=5.2e-12  Score=124.23  Aligned_cols=117  Identities=22%  Similarity=0.277  Sum_probs=90.2

Q ss_pred             HhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCC------CCCcceEEeeeecC
Q 036754          286 CRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR------HQNLIKVISSCSNE  358 (405)
Q Consensus       286 ~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~  358 (405)
                      ...+.+|...+.||+|+||+||+|.. ..++.||||+++... .....+..|+.++.+++      |.+++++++++...
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            34456788888999999999999985 467889999986432 12233455666666554      45588888888754


Q ss_pred             -CeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 -EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       ...++|||++ +++|.+++...+ .+++..+..|+.||+.||+|||+
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~  249 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHT  249 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence             5688999987 668999887654 68999999999999999999994

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.33  E-value=9.5e-12  Score=117.89  Aligned_cols=112  Identities=22%  Similarity=0.226  Sum_probs=92.6

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeecc--ccchhHHHHHHHHHhhcCCCCCcceEEeeeecC------Ce
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNE------EF  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  360 (405)
                      ..|...+.||+|+||.||+|.. .+|+.||+|.+...  .......+.+|+.++.+++|+||+++++++...      ..
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            4577778899999999999984 57899999998643  223345677899999999999999999987643      35


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++||||+++ +|.+.+..   .+++.++..++.|++.||+|||.
T Consensus        96 ~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~  136 (353)
T cd07850          96 VYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHS  136 (353)
T ss_pred             EEEEEeccCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHh
Confidence            7999999965 88888754   28889999999999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.32  E-value=7.7e-12  Score=116.95  Aligned_cols=106  Identities=17%  Similarity=0.140  Sum_probs=80.2

Q ss_pred             hccCCccCcccccCCCceEEEeeC--CCcEEEEEEeecc-----ccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCee
Q 036754          289 TYKFSENNLISKGGFGSVYKARLG--DGMEVAVKVFNLQ-----CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  361 (405)
                      ..+|...+.||+|+||+||+|...  ++..||||++...     .......|.+|++++.+++|+|+++.+..+   ...
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~   93 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKD   93 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCc
Confidence            356778899999999999999853  5777899987532     122345689999999999999999643322   457


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+||||+++++|... .. .   .   ...++.|+++||+|||+
T Consensus        94 ~LVmE~~~G~~L~~~-~~-~---~---~~~~~~~i~~aL~~lH~  129 (365)
T PRK09188         94 GLVRGWTEGVPLHLA-RP-H---G---DPAWFRSAHRALRDLHR  129 (365)
T ss_pred             EEEEEccCCCCHHHh-Cc-c---c---hHHHHHHHHHHHHHHHH
Confidence            999999999999732 11 1   1   14678899999999995

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.30  E-value=4e-11  Score=104.00  Aligned_cols=108  Identities=32%  Similarity=0.525  Sum_probs=94.8

Q ss_pred             ccccCCCceEEEeeCC-CcEEEEEEeeccccc-hhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCHHH
Q 036754          298 ISKGGFGSVYKARLGD-GMEVAVKVFNLQCRR-AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEK  375 (405)
Q Consensus       298 lg~G~fg~v~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  375 (405)
                      ||+|.+|.||++.... +..+++|.+...... ....+.+|++.+.+++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            5899999999999754 889999998755332 34678899999999999999999999998899999999999999999


Q ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          376 YLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       376 ~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++......+++..+..++.+++++++|||+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  110 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHS  110 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            997653468999999999999999999995

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.28  E-value=2e-11  Score=115.20  Aligned_cols=112  Identities=22%  Similarity=0.305  Sum_probs=91.4

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecC------Ce
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE------EF  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  360 (405)
                      .+|...+.||+|+||.||+|.. .+|..||+|++....  ......+.+|+.++.+++|+||+++++++...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            4677778999999999999984 578999999986432  22345678899999999999999999988654      24


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++|+||++. ++..+..   ..+++..+..++.|+++||+|||.
T Consensus        95 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~  135 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHS  135 (342)
T ss_pred             EEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            5899999975 7777652   258899999999999999999994

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.28  E-value=9e-12  Score=117.58  Aligned_cols=114  Identities=19%  Similarity=0.241  Sum_probs=94.5

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeecc--ccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCe-----
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF-----  360 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  360 (405)
                      .++|.....||+|+||.||+|.. .++..||+|++...  .......+.+|+.++++++|+|++++.+++...+.     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            34567778899999999999996 46789999998643  22334567789999999999999999987766554     


Q ss_pred             -eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 -KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 -~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       .++|+||+ +++|.+++..  ..+++.++..++.|+++||+|||+
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~  136 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHS  136 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence             89999998 5699998865  358999999999999999999995

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.27  E-value=5.4e-12  Score=121.40  Aligned_cols=195  Identities=32%  Similarity=0.406  Sum_probs=152.1

Q ss_pred             CCCCcCC---eeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCcc-CCCeeecCCcccccccCcchhc
Q 036754            8 SNCKCLT---FIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT-KLTTIILGGNKLNGSISITLGS   83 (405)
Q Consensus         8 ~~l~~L~---~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~   83 (405)
                      ..+..+.   .|+++.|.+......  ...+. .++.|++.+|.++. ++.....+. +|+.|++++|.+. .+|..+ .
T Consensus        87 ~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~-~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~-~  160 (394)
T COG4886          87 ENLLNLLPLPSLDLNLNRLRSNISE--LLELT-NLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPL-R  160 (394)
T ss_pred             ccccCCCCCceeeccccccccCchh--hhccc-ceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhh-h
Confidence            3344444   588888887443333  23333 79999999999987 556666664 9999999999998 776566 4


Q ss_pred             CCCCCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeec
Q 036754           84 NLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNL  158 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l  158 (405)
                      .+++|+.|++++|+++++|.....+..|..|+++.     +|........|++|++++|++. ..+..+..+..+..+.+
T Consensus       161 ~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l  239 (394)
T COG4886         161 NLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLEL  239 (394)
T ss_pred             ccccccccccCCchhhhhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhccccccccc
Confidence            89999999999999999998877888888887765     6666555666999999999654 46677888899999999


Q ss_pred             ccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCc
Q 036754          159 SKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL  211 (405)
Q Consensus       159 ~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~  211 (405)
                      .+|++. ..+..+..+++++.|++++|.++...+ .+...+++.+++++|...
T Consensus       240 ~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~  290 (394)
T COG4886         240 SNNKLE-DLPESIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLS  290 (394)
T ss_pred             CCceee-eccchhccccccceecccccccccccc-ccccCccCEEeccCcccc
Confidence            999987 347788888999999999999985444 667778888888888653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.27  E-value=6.3e-12  Score=118.59  Aligned_cols=114  Identities=18%  Similarity=0.267  Sum_probs=95.0

Q ss_pred             cCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc--------cchhHHHHHHHHHhhcCC---CCCcceEEeeeecC
Q 036754          291 KFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC--------RRAFKSFDIECEMMKSIR---HQNLIKVISSCSNE  358 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  358 (405)
                      +|+..+.+|+|+||.|+.|... +...|++|.+.+..        .........||++|+.++   |+||+++++++++.
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            5677789999999999999864 45678999886532        112234567999999997   99999999999999


Q ss_pred             CeeEEEEecC-CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 EFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 ~~~~lv~e~~-~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +..||+||-. ++-||++++..+ ..+++.++.-|+.||+.|+++||+
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~  688 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHD  688 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccc
Confidence            9999999953 456899999755 479999999999999999999996

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.27  E-value=2.3e-11  Score=108.49  Aligned_cols=99  Identities=15%  Similarity=0.020  Sum_probs=84.0

Q ss_pred             cCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCHHHHHhc
Q 036754          301 GGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS  379 (405)
Q Consensus       301 G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  379 (405)
                      |.||.||++.. .+++.||+|++....     .+.+|...+....|||++++++++...+..+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999984 578899999986543     223455555566799999999999999999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          380 SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       380 ~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .. .+++.....++.|+++||+|||+
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH~  103 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALHR  103 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            44 68999999999999999999995

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.26  E-value=2.5e-11  Score=119.80  Aligned_cols=124  Identities=22%  Similarity=0.298  Sum_probs=99.9

Q ss_pred             HHHHHHhhhccCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeec-
Q 036754          281 SYLELCRATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSN-  357 (405)
Q Consensus       281 ~~~~~~~~~~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-  357 (405)
                      .++.+...+.-|....++|.|.+|.||+++ ..+++.+|+|++...... ..+...|..++... .|||++.++|++.. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            344444555667778899999999999998 678899999998765332 33445666776665 79999999998854 


Q ss_pred             ----CCeeEEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          358 ----EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       358 ----~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                          ++++|+|||||.+|+..+.+.+.. ..+.|.....|++.++.|+++||.
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~  141 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN  141 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh
Confidence                678999999999999999987643 579999999999999999999994

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.26  E-value=3e-12  Score=129.19  Aligned_cols=123  Identities=24%  Similarity=0.263  Sum_probs=104.8

Q ss_pred             HHHHHhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeec
Q 036754          282 YLELCRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSN  357 (405)
Q Consensus       282 ~~~~~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  357 (405)
                      ..++....++|...++||+|+||.|...+. .+++.||+|++.++.   .....-|+.|-.+|..-+.+.||+++.+|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            445666678899999999999999999884 578999999998753   4455678889999999999999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          358 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       358 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++|+||||||||||-..+.+.. .+++.-+..+...|.-||+-+|.
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~  193 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHS  193 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999999999997665 67777777788888888887773

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.25  E-value=4.6e-11  Score=112.21  Aligned_cols=112  Identities=19%  Similarity=0.185  Sum_probs=89.9

Q ss_pred             CCccCcccccCCCceEEEeeC-C--CcEEEEEEeeccc--cchhHHHHHHHHHhhcC-CCCCcceEEeeeec----CCee
Q 036754          292 FSENNLISKGGFGSVYKARLG-D--GMEVAVKVFNLQC--RRAFKSFDIECEMMKSI-RHQNLIKVISSCSN----EEFK  361 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~  361 (405)
                      |...+.||+|+||.||++... .  +..||+|.+....  ....+.+.+|+.++.++ +|+||+++++++..    ....
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            455678999999999999953 4  7789999986432  22345678899999999 59999999987543    2457


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++||++ ++|.+++.... .+++..+..++.||+.||+|||+
T Consensus        82 ~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~  123 (332)
T cd07857          82 YLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIHS  123 (332)
T ss_pred             EEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            88999986 58999886543 68999999999999999999995

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PRK10345 hypothetical protein; Provisional

Probab=99.25  E-value=5.8e-11  Score=102.85  Aligned_cols=108  Identities=11%  Similarity=0.180  Sum_probs=82.1

Q ss_pred             CCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcC-----CCCCcceEEeeeecCC---eeE-
Q 036754          292 FSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-----RHQNLIKVISSCSNEE---FKA-  362 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~-  362 (405)
                      +...+.||+|+||.||.  .+.....+||+...........+.+|+.++..+     .||||++++|++.+..   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34567899999999996  332233478888765444566789999999999     6799999999998763   334 


Q ss_pred             EEEec--CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHH-hhhcC
Q 036754          363 LVLEY--MPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL-EYLHF  405 (405)
Q Consensus       363 lv~e~--~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl-~yLH~  405 (405)
                      +|+||  +++|+|.+++.+.  .+++.  ..++.|++.++ +|||+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~  123 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLD  123 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHH
Confidence            78999  6689999999653  35555  35678888887 99995

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.25  E-value=1.1e-12  Score=125.56  Aligned_cols=115  Identities=27%  Similarity=0.376  Sum_probs=102.5

Q ss_pred             ccCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ++|...+.+|.|.||-|||++ ...++..|+|.++.......+...+|+-++...+|+|||.++|.+...+..++.||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            456667889999999999998 5678999999998877777777888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+|+|.+.-+-. ..+++.+...+++...+|++|||.
T Consensus        95 gggslQdiy~~T-gplselqiayvcRetl~gl~ylhs  130 (829)
T KOG0576|consen   95 GGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHS  130 (829)
T ss_pred             CCCcccceeeec-ccchhHHHHHHHhhhhccchhhhc
Confidence            999999965443 479999999999999999999995

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.23  E-value=2.8e-12  Score=131.11  Aligned_cols=116  Identities=29%  Similarity=0.438  Sum_probs=99.1

Q ss_pred             hccCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          289 TYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      +..+.....||.|.||.||.|. ..+|...|+|.++.+.  ......+.+|+.++..++|||+|+.+|.-...+..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            3456667899999999999998 6789999999986554  334566788999999999999999999998899999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||++|+|.+.+...+ ..++.-...+..|++.|++|||+
T Consensus      1314 EyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~ 1352 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHE 1352 (1509)
T ss_pred             HHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHh
Confidence            9999999999987544 56777677788999999999995

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.22  E-value=1.3e-11  Score=106.46  Aligned_cols=114  Identities=25%  Similarity=0.400  Sum_probs=95.8

Q ss_pred             cCCccCcccccCCCceEEEe-eCCCcEEEEEEeecccc--------chhHHHHHHHHHhhcC-CCCCcceEEeeeecCCe
Q 036754          291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCR--------RAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEF  360 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  360 (405)
                      .+...+++|+|..++|-++. -.+|..+|+|++.....        +..+.-.+|+.+++++ .||+|+++.++|++...
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF   97 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF   97 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence            34566789999999998887 46788999999864321        1233456799999987 79999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++|+|.|+.|.|+++|.+.- .+++.+..+|++|+.+|++|||.
T Consensus        98 ~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa  141 (411)
T KOG0599|consen   98 VFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHA  141 (411)
T ss_pred             hhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999998654 78999999999999999999993

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=7.8e-12  Score=114.47  Aligned_cols=110  Identities=30%  Similarity=0.438  Sum_probs=91.1

Q ss_pred             cCcccccCCCceEEEe-eCCCcEEEEEEeeccc--cc-----hhHHHHHHHHHhhcCCCCCcceEEeeee-cCCeeEEEE
Q 036754          295 NNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC--RR-----AFKSFDIECEMMKSIRHQNLIKVISSCS-NEEFKALVL  365 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~--~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~  365 (405)
                      ..++|+|+|+.||+|. +...+.||||+-....  +.     ..+...+|-++-..++||.||++|+|+. +.+..+-|.
T Consensus       468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL  547 (775)
T KOG1151|consen  468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL  547 (775)
T ss_pred             HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence            4679999999999998 5667889999864321  11     1234567889999999999999999886 456778999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+|-||.-||..++ .+++.++..|+.||+.||.||.+
T Consensus       548 EYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNE  586 (775)
T KOG1151|consen  548 EYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNE  586 (775)
T ss_pred             eecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhc
Confidence            9999999999998765 79999999999999999999853

>PLN03150 hypothetical protein; Provisional

Probab=99.21  E-value=3.1e-11  Score=121.85  Aligned_cols=112  Identities=37%  Similarity=0.553  Sum_probs=93.9

Q ss_pred             CCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCC-CCchhhhccccCccccCCCCChhccCCCCCCEEeccCCccc
Q 036754           62 KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQ  140 (405)
Q Consensus        62 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~  140 (405)
                      .++.|+|++|.+.|.+|..+. .+++|+.|+|++|+++ .+|..                  ++.+++|+.|+|++|.+.
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~-~L~~L~~L~Ls~N~l~g~iP~~------------------~~~l~~L~~LdLs~N~ls  479 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPS------------------LGSITSLEVLDLSYNSFN  479 (623)
T ss_pred             EEEEEECCCCCccccCCHHHh-CCCCCCEEECCCCcccCcCChH------------------HhCCCCCCEEECCCCCCC
Confidence            478899999999999998874 8999999999999987 56654                  455778899999999999


Q ss_pred             ccCCcccccCCCCCeeecccccccCccchhHHhc-ccCCccccccCcccCcCC
Q 036754          141 GSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKL-LYLKDLNLSFNKLEGEIP  192 (405)
Q Consensus       141 ~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~l~l~~n~l~~~~p  192 (405)
                      +.+|+.++.+++|+.|+|++|.+++.+|..+... .++..+++.+|...+..|
T Consensus       480 g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            9999999999999999999999999999888764 456788888886554333

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.21  E-value=3.8e-11  Score=118.81  Aligned_cols=115  Identities=19%  Similarity=0.228  Sum_probs=84.7

Q ss_pred             ccCCccCcccccCCCceEEEeeCC--CcEEEEEEe--------------ec---cccchhHHHHHHHHHhhcCCCCCcce
Q 036754          290 YKFSENNLISKGGFGSVYKARLGD--GMEVAVKVF--------------NL---QCRRAFKSFDIECEMMKSIRHQNLIK  350 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~--~~~vavK~~--------------~~---~~~~~~~~~~~e~~~l~~l~h~niv~  350 (405)
                      .+|...+.||+|+||+||++....  +..++.|..              .+   ........+.+|+.++.+++|+|||+
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            467778899999999999987432  222222211              00   11123456788999999999999999


Q ss_pred             EEeeeecCCeeEEEEecCCCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       351 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++++...+..|+|+|++. +++.+++....    ......+...++.|++.||+|||+
T Consensus       228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~  285 (501)
T PHA03210        228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD  285 (501)
T ss_pred             EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999999985 48888775432    123355677899999999999995

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.21  E-value=1e-10  Score=100.50  Aligned_cols=106  Identities=23%  Similarity=0.240  Sum_probs=80.3

Q ss_pred             CcccccCCCceEEEeeCCCcEEEEEEeeccccc--h------------------------hHHHHHHHHHhhcCCCCCcc
Q 036754          296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCRR--A------------------------FKSFDIECEMMKSIRHQNLI  349 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~niv  349 (405)
                      ..||+|+||.||+|...+|+.||||+++.....  .                        ...+.+|.+.+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            569999999999999778999999999764211  0                        11235688999999999986


Q ss_pred             eEEeeeecCCeeEEEEecCCCCCHHHH-HhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          350 KVISSCSNEEFKALVLEYMPHGSLEKY-LYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       350 ~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ....+...  ..++||||++++++... +..  ..++..+...++.|+++++.|+|+
T Consensus        83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~  135 (190)
T cd05145          83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ  135 (190)
T ss_pred             CceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH
Confidence            55554433  24899999998865443 432  357788899999999999999994

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.19  E-value=1.2e-10  Score=103.61  Aligned_cols=103  Identities=30%  Similarity=0.374  Sum_probs=91.0

Q ss_pred             CCCceEEEeeC-CCcEEEEEEeeccccch-hHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCHHHHHhc
Q 036754          302 GFGSVYKARLG-DGMEVAVKVFNLQCRRA-FKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS  379 (405)
Q Consensus       302 ~fg~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  379 (405)
                      +||.||+|... +|..+|+|++....... ...+.+|++.+++++|+|++++.+++......++++||+++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999965 58899999997654433 67889999999999999999999999998999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          380 SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       380 ~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .. .+++..+..++.++++|++|||.
T Consensus        81 ~~-~~~~~~~~~~~~~l~~~l~~lh~  105 (244)
T smart00220       81 RG-RLSEDEARFYARQILSALEYLHS  105 (244)
T ss_pred             cc-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            44 38999999999999999999994

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.18  E-value=1.7e-11  Score=102.17  Aligned_cols=111  Identities=33%  Similarity=0.465  Sum_probs=39.8

Q ss_pred             ccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccC
Q 036754           57 ITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGY  136 (405)
Q Consensus        57 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~  136 (405)
                      +.+..+++.|+|++|.|+ .+. .+...+.+|+.|+|++|.|+.++.                   +..++.|+.|++++
T Consensus        15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l~~-------------------l~~L~~L~~L~L~~   73 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKLEG-------------------LPGLPRLKTLDLSN   73 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S--TT-----------------------TT--EEE--S
T ss_pred             cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccccC-------------------ccChhhhhhcccCC
Confidence            445567899999999997 554 343357899999999999987752                   34567889999999


Q ss_pred             CcccccCCccc-ccCCCCCeeecccccccCccc-hhHHhcccCCccccccCcccC
Q 036754          137 NRLQGSIPDSF-GDLISLKSLNLSKNNLSGAIP-ASLEKLLYLKDLNLSFNKLEG  189 (405)
Q Consensus       137 n~l~~~~p~~~-~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~l~l~~n~l~~  189 (405)
                      |+++. +++.+ ..+++|++|++++|++...-. ..+..+++|+.|++.+|+++.
T Consensus        74 N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~  127 (175)
T PF14580_consen   74 NRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE  127 (175)
T ss_dssp             S---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred             CCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence            99984 44444 468899999999999864322 456677778888888787763

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.18  E-value=4.2e-12  Score=116.08  Aligned_cols=178  Identities=23%  Similarity=0.236  Sum_probs=91.2

Q ss_pred             CCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccC--CccccCccCCCeeecCCcccccccCcchhcCCC
Q 036754            9 NCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGI--LEEITNLTKLTTIILGGNKLNGSISITLGSNLA   86 (405)
Q Consensus         9 ~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~   86 (405)
                      ++++|+...|.+.......-......++ +++.|||+.|-+..-.  -.....|++|+.|+|+.|++.-......-..++
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~-~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILP-NVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCC-cceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            3445555555555443322212233344 5555555555544311  112334555555555555554222222222345


Q ss_pred             CCCeeeCCCCCCC--CCchhhhccccCccccCCCCC------hhccCCCCCCEEeccCCcccccCC--cccccCCCCCee
Q 036754           87 SLRKLSLDSNELT--SIPLTFWNLKDILYLNFSVIP------IEIGGLPNLEYLFLGYNRLQGSIP--DSFGDLISLKSL  156 (405)
Q Consensus        87 ~L~~L~Ls~N~l~--~lp~~~~~l~~L~~l~l~~~p------~~~~~l~~L~~L~l~~n~l~~~~p--~~~~~l~~L~~L  156 (405)
                      +|+.|.|+.|.|+  ++-......+.|..|++....      .....+..|+.|||++|++.. .+  ...+.++.|+.|
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~L  276 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQL  276 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhh
Confidence            5555555555555  222222333444444443210      011234567888888888763 33  335677888888


Q ss_pred             ecccccccCcc-chh-----HHhcccCCccccccCccc
Q 036754          157 NLSKNNLSGAI-PAS-----LEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       157 ~l~~n~l~~~~-~~~-----~~~l~~L~~l~l~~n~l~  188 (405)
                      +++.+.+...- |+.     ...+++|+.|++..|++.
T Consensus       277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             hccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence            88888775331 222     345678888888888875

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.17  E-value=2.2e-11  Score=111.95  Aligned_cols=122  Identities=22%  Similarity=0.285  Sum_probs=103.5

Q ss_pred             HHHhhh-ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecC
Q 036754          284 ELCRAT-YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE  358 (405)
Q Consensus       284 ~~~~~~-~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  358 (405)
                      |.+..+ +.|..-++||+|+||.||-++. .+|+.+|.|.+.+..   ++.....+.|-.++.+++.+-||.+-.+|++.
T Consensus       178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk  257 (591)
T KOG0986|consen  178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK  257 (591)
T ss_pred             HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence            334333 4578889999999999999884 579999999885432   23334567788999999999999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 EFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 ~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +.+++|+..|-||||.-+|.+.+ ..+++.+++-+|.+|+-||++||.
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~  305 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR  305 (591)
T ss_pred             CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh
Confidence            99999999999999999998765 579999999999999999999994

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.16  E-value=1e-10  Score=112.41  Aligned_cols=113  Identities=22%  Similarity=0.338  Sum_probs=95.4

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCC-C-----CCcceEEeeeecCCeeEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-H-----QNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  363 (405)
                      .|...++||+|.||.|.+|.. .+++.||||+++... .....-..|+.++..++ |     -|+|++++|+...+..+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            455678999999999999995 568999999997553 23334466888888886 3     489999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+.. +|.++++..+ ..++......|+.||+.||.+||+
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~  307 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE  307 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999877 9999998654 678999999999999999999984

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.16  E-value=8.2e-12  Score=107.55  Aligned_cols=109  Identities=23%  Similarity=0.505  Sum_probs=91.4

Q ss_pred             CcccccCCCceEEEeeCCCcEEEEEEeecc--ccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCH
Q 036754          296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL  373 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  373 (405)
                      .++.+...|..|+|++. |..+++|++...  .....++|..|...++-..||||+.++|+|.....+.++..|||.|+|
T Consensus       196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl  274 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL  274 (448)
T ss_pred             hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence            35778888999999984 445566776543  234456788888888899999999999999999999999999999999


Q ss_pred             HHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          374 EKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       374 ~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +..|+... ..++-.++++++.+||+||+|||+
T Consensus       275 ynvlhe~t~vvvd~sqav~faldiargmaflhs  307 (448)
T KOG0195|consen  275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS  307 (448)
T ss_pred             HHHHhcCccEEEecchHHHHHHHHHhhHHHHhh
Confidence            99998754 357888999999999999999995

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.16  E-value=3.5e-12  Score=111.38  Aligned_cols=130  Identities=28%  Similarity=0.330  Sum_probs=79.5

Q ss_pred             cccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCC
Q 036754           38 SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS  117 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~  117 (405)
                      .|+.+|||+|.++. +.++..-++.++.|++|.|.|. .+.. + ..|++|+.||||+|.++++..+-.+          
T Consensus       285 ~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~-~v~n-L-a~L~~L~~LDLS~N~Ls~~~Gwh~K----------  350 (490)
T KOG1259|consen  285 ELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIR-TVQN-L-AELPQLQLLDLSGNLLAECVGWHLK----------  350 (490)
T ss_pred             hhhhccccccchhh-hhhhhhhccceeEEecccccee-eehh-h-hhcccceEeecccchhHhhhhhHhh----------
Confidence            57777777777765 4455666677777777777776 4443 2 4677777777777777765443222          


Q ss_pred             CCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCcc-chhHHhcccCCccccccCcccCcC
Q 036754          118 VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAI-PASLEKLLYLKDLNLSFNKLEGEI  191 (405)
Q Consensus       118 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~l~l~~n~l~~~~  191 (405)
                              +.+.+.|.|++|.+.. + ..+..+-+|..||+++|++.... -..+++++.|+.+.+.+|++.+.+
T Consensus       351 --------LGNIKtL~La~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  351 --------LGNIKTLKLAQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             --------hcCEeeeehhhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence                    3345566666666542 1 23455566666666666664221 134556666777777777776543

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.14  E-value=3.5e-11  Score=105.10  Aligned_cols=105  Identities=21%  Similarity=0.249  Sum_probs=87.5

Q ss_pred             CcccccCCCceEEEe-eCCCcEEEEEEeeccccchhHHHHHHHHH-hhcCCCCCcceEEeeeec----CCeeEEEEecCC
Q 036754          296 NLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEM-MKSIRHQNLIKVISSCSN----EEFKALVLEYMP  369 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~  369 (405)
                      ++||-|-.|+|-.+. .++|+.+|+|++...     ....+|++. +..-.|+|||++++.|..    ...+.+|||.|+
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me  142 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME  142 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence            689999999999887 567888999988533     233567765 444579999999998764    467889999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+|+..+.+++ ..+++.++-+|+.||+.|++|||+
T Consensus       143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~  179 (400)
T KOG0604|consen  143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS  179 (400)
T ss_pred             chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh
Confidence            999999998765 579999999999999999999995

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.12  E-value=5.4e-11  Score=81.74  Aligned_cols=60  Identities=35%  Similarity=0.384  Sum_probs=43.2

Q ss_pred             cccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCC
Q 036754           38 SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNEL   98 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l   98 (405)
                      +|+.|++++|+++...++.|..+++|++|++++|+++ .++++.|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~-~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLT-SIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSES-EEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccC-ccCHHHHcCCCCCCEEeCcCCcC
Confidence            5677777777777666667777777777777777776 66666666777777777777764

...

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.11  E-value=3.7e-10  Score=98.77  Aligned_cols=104  Identities=17%  Similarity=0.228  Sum_probs=85.0

Q ss_pred             CcccccCCCceEEEeeCCCcEEEEEEeecccc--------chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCR--------RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +.||+|++|.||+|.. .|..+++|.......        .....+.+|+..+..+.|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4689999999999987 677899997653221        1124577899999999999998888887777888999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++++|.+++....    + ++..++.+++.+|+++|.
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~  113 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS  113 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh
Confidence            99999999986432    2 788999999999999994

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.10  E-value=8e-11  Score=120.00  Aligned_cols=67  Identities=33%  Similarity=0.531  Sum_probs=56.4

Q ss_pred             hccCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeee
Q 036754          289 TYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSC  355 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~  355 (405)
                      ..+|.+..++|+||||.||+++ --+|+.||||++.... ........+|+..+++++|||||+.+..|
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAW  546 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAW  546 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence            3567778899999999999998 4589999999996543 44456788999999999999999988655

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.09  E-value=2.2e-11  Score=111.50  Aligned_cols=181  Identities=25%  Similarity=0.245  Sum_probs=127.0

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCch-hhhcccccccEEEcccCcccccCCccc-cCccCCCeeecCCcccccccCcchhcC
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKT-FVGNVSHSLEFFVMSYCNISGGILEEI-TNLTKLTTIILGGNKLNGSISITLGSN   84 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~-f~~~~~~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~~   84 (405)
                      ...|++++.||||.|-+....|.. +...++ +|+.|+|++|++........ ..++.|+.|.|+.|.++..--..+.-.
T Consensus       142 ~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp-~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~  220 (505)
T KOG3207|consen  142 SKILPNVRDLDLSRNLFHNWFPVLKIAEQLP-SLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT  220 (505)
T ss_pred             hhhCCcceeecchhhhHHhHHHHHHHHHhcc-cchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence            457899999999999998887754 344555 99999999999875333332 357789999999999984333334457


Q ss_pred             CCCCCeeeCCCCC-CCCCchhhhccccCccccCCCC-----C--hhccCCCCCCEEeccCCcccccC-Ccc-----cccC
Q 036754           85 LASLRKLSLDSNE-LTSIPLTFWNLKDILYLNFSVI-----P--IEIGGLPNLEYLFLGYNRLQGSI-PDS-----FGDL  150 (405)
Q Consensus        85 l~~L~~L~Ls~N~-l~~lp~~~~~l~~L~~l~l~~~-----p--~~~~~l~~L~~L~l~~n~l~~~~-p~~-----~~~l  150 (405)
                      +++|+.|+|+.|+ +..-..+...++.|+.|+++..     +  ...+.+|.|..|+++.+.+...- |+.     ...+
T Consensus       221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f  300 (505)
T KOG3207|consen  221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTF  300 (505)
T ss_pred             CCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhccc
Confidence            8999999999994 3322333445667888888762     2  35678899999999999876421 222     2456


Q ss_pred             CCCCeeecccccccCcc-chhHHhcccCCccccccCccc
Q 036754          151 ISLKSLNLSKNNLSGAI-PASLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       151 ~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~l~l~~n~l~  188 (405)
                      ++|+.|+++.|++.... -..+..+.+|+.|.+..|.++
T Consensus       301 ~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  301 PKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             ccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence            89999999999996331 133444556666666666654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.09  E-value=3.2e-10  Score=102.59  Aligned_cols=123  Identities=20%  Similarity=0.268  Sum_probs=97.0

Q ss_pred             HHHHhhhccCCccCcccccCCCceEEEeeCCC------cEEEEEEeeccccc-hhHHHHHHHHHhhcCCCCCcceEEeee
Q 036754          283 LELCRATYKFSENNLISKGGFGSVYKARLGDG------MEVAVKVFNLQCRR-AFKSFDIECEMMKSIRHQNLIKVISSC  355 (405)
Q Consensus       283 ~~~~~~~~~~~~~~~lg~G~fg~v~~~~~~~~------~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~  355 (405)
                      .++......+....++.+|.||.||+|.++++      +.|-||.++.++.+ ....+..|.-.+..+.|||+.++.+.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            34444455566777889999999999976543      44566766555433 356788899999999999999999987


Q ss_pred             ec-CCeeEEEEecCCCCCHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          356 SN-EEFKALVLEYMPHGSLEKYLYSSN-------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       356 ~~-~~~~~lv~e~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .. ...++.+|.++..|+|+.||..++       +.++-.+.+.++.|++.||+|||.
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~  414 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN  414 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh
Confidence            65 567889999999999999998322       467888999999999999999994

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.06  E-value=6.2e-10  Score=103.39  Aligned_cols=113  Identities=20%  Similarity=0.269  Sum_probs=91.1

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCC--------CCCcceEEeeeec----
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR--------HQNLIKVISSCSN----  357 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~~----  357 (405)
                      .|...++||-|-|++||.+.. .+.+.||+|+.+. +++..+....||.++++++        -..||+++++|..    
T Consensus        79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             eEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            345668899999999999985 4567899998864 3455566778999988763        2469999998864    


Q ss_pred             CCeeEEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          358 EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       358 ~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +..++||+|+... +|..+|.... +.+......+||.||+.||+|||.
T Consensus       158 G~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~  205 (590)
T KOG1290|consen  158 GQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR  205 (590)
T ss_pred             CcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH
Confidence            4678999999854 8999887654 578999999999999999999994

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.06  E-value=3.5e-10  Score=108.12  Aligned_cols=125  Identities=20%  Similarity=0.313  Sum_probs=102.9

Q ss_pred             hHHHHHHhhhc---cCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEE
Q 036754          280 FSYLELCRATY---KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVI  352 (405)
Q Consensus       280 ~~~~~~~~~~~---~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~  352 (405)
                      ..|-.++++..   -|...+.||=|+||.|..+. ..+...||.|.+++.+   +.....+..|-.++...+.+.||+++
T Consensus       616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy  695 (1034)
T KOG0608|consen  616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY  695 (1034)
T ss_pred             hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence            44555665554   37778899999999999887 4456789999998765   23344567789999999999999999


Q ss_pred             eeeecCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          353 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       353 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..|.+.+.+|+||||++|||+-.+|...+ .+.+.-+..++..++-|++|.|.
T Consensus       696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHk  747 (1034)
T KOG0608|consen  696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHK  747 (1034)
T ss_pred             EEeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999887554 78888888888999999999983

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.04  E-value=1.7e-10  Score=79.28  Aligned_cols=61  Identities=31%  Similarity=0.411  Sum_probs=56.0

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCccc
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKL   73 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l   73 (405)
                      ++|+.|++++|+|+.+.+.. +..++ +|++|++++|+++...|+.|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~-f~~l~-~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDS-FSNLP-NLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTT-TTTGT-TESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHH-HcCCC-CCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            57999999999999887777 66676 999999999999999999999999999999999985

...

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.04  E-value=2.2e-09  Score=107.15  Aligned_cols=104  Identities=18%  Similarity=0.166  Sum_probs=81.4

Q ss_pred             CCccCcccccCCCceEEEeeCCCcEEEEEEe-ecc-c------cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          292 FSENNLISKGGFGSVYKARLGDGMEVAVKVF-NLQ-C------RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~-~~~-~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      +...+.||+|+||.||+|.+.... +++|+. .+. .      ......+.+|++++.+++|++++....++......++
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l  413 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI  413 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence            345688999999999999875443 344432 211 1      1123567889999999999999998888877778899


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++++|.+++.         .+..++.|++++|+|||+
T Consensus       414 v~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~  446 (535)
T PRK09605        414 VMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHK  446 (535)
T ss_pred             EEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh
Confidence            999999999999875         356789999999999995

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.03  E-value=7.3e-10  Score=95.99  Aligned_cols=100  Identities=18%  Similarity=0.263  Sum_probs=78.7

Q ss_pred             cccccCCCceEEEeeCCCcEEEEEEeeccc-c-------chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          297 LISKGGFGSVYKARLGDGMEVAVKVFNLQC-R-------RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       297 ~lg~G~fg~v~~~~~~~~~~vavK~~~~~~-~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      .||+|+||.||+|.. +|..|++|...... .       .....+.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            379999999999985 67889999864321 1       11345778999999999988776666666677789999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++|.+++.....        .++.+++++|+++|.
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~  108 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHK  108 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHHH
Confidence            99999998754321        789999999999994

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.02  E-value=1.3e-11  Score=105.24  Aligned_cols=111  Identities=23%  Similarity=0.379  Sum_probs=90.9

Q ss_pred             ccCcccccCCCceEEEee-CCCcEEEEEEeecc--ccchhHHHHHHHHHhhcCCCCCcceEEeeeec--------CCeeE
Q 036754          294 ENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVISSCSN--------EEFKA  362 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~~~~  362 (405)
                      ...++|+|.||.|++|.. ..|+.||+|+.-..  .........+|+.++..++|+|++.++..|.+        ....|
T Consensus        21 k~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~y  100 (376)
T KOG0669|consen   21 KLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFY  100 (376)
T ss_pred             HHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceee
Confidence            346799999999999985 45677888765322  22334566889999999999999999988854        23489


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+++|++ ||...|.+....++..+..+++.+...||.|+|.
T Consensus       101 lVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr  142 (376)
T KOG0669|consen  101 LVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR  142 (376)
T ss_pred             eeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH
Confidence            99999998 9999998876789999999999999999999994

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.00  E-value=4.2e-11  Score=104.72  Aligned_cols=131  Identities=28%  Similarity=0.387  Sum_probs=94.3

Q ss_pred             ccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccC
Q 036754           57 ITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGY  136 (405)
Q Consensus        57 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~  136 (405)
                      ......|+.||||+|.|+ .+..+.- -++.++.|++|+|.|..+.                   .+..+++|+.||||+
T Consensus       280 ~dTWq~LtelDLS~N~I~-~iDESvK-L~Pkir~L~lS~N~i~~v~-------------------nLa~L~~L~~LDLS~  338 (490)
T KOG1259|consen  280 ADTWQELTELDLSGNLIT-QIDESVK-LAPKLRRLILSQNRIRTVQ-------------------NLAELPQLQLLDLSG  338 (490)
T ss_pred             cchHhhhhhccccccchh-hhhhhhh-hccceeEEeccccceeeeh-------------------hhhhcccceEeeccc
Confidence            334567888899999887 7776653 6788889999999887653                   234467888889999


Q ss_pred             CcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccC--cCCCCCccCCCCcccccCCCCc
Q 036754          137 NRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEG--EIPRGGSFGNFSAESFEGNELL  211 (405)
Q Consensus       137 n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~--~~p~~~~~~~~~~~~~~~n~~~  211 (405)
                      |.+. .+...-..+-++++|.|++|.+...  ..+..+-+|..|+++.|+|..  .....+.++-+..+.+.+||+.
T Consensus       339 N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~  412 (490)
T KOG1259|consen  339 NLLA-ECVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA  412 (490)
T ss_pred             chhH-hhhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence            8887 4555566778888888998888632  345667778888888888863  2333455566666778888763

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.97  E-value=4.9e-11  Score=102.88  Aligned_cols=113  Identities=24%  Similarity=0.300  Sum_probs=91.8

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeec--cccchhHHHHHHHHHhhcCCCCCcceEEeeeecC-----CeeE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNL--QCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNE-----EFKA  362 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~  362 (405)
                      ++..++.||-|+||.||..+. ++|+.||.|++..  +.-...+.+.+|+.++.-.+|.|+...++.....     +++|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            445678899999999999886 5789999998843  2233457788999999999999999988766543     4578


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|.|+. ||.+.+...+ .++-....-+.+||++||.|||+
T Consensus       134 V~TELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHs  174 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHT  174 (449)
T ss_pred             HHHHHHHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHHhh
Confidence            89999876 8999887654 67777788899999999999995

>smart00090 RIO RIO-like kinase

Probab=98.97  E-value=4e-09  Score=93.63  Aligned_cols=109  Identities=19%  Similarity=0.169  Sum_probs=79.8

Q ss_pred             CCccCcccccCCCceEEEe--eCCCcEEEEEEeeccccc------------------------hhHHHHHHHHHhhcCCC
Q 036754          292 FSENNLISKGGFGSVYKAR--LGDGMEVAVKVFNLQCRR------------------------AFKSFDIECEMMKSIRH  345 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h  345 (405)
                      |...+.||+|+||.||+|.  ..+|+.||+|+++.....                        ....+.+|++.+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            4556789999999999998  578999999998753210                        01235679999999976


Q ss_pred             CC--cceEEeeeecCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          346 QN--LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       346 ~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..  +.+++++    ...++||||++++++....... ...+..+...++.|++++++|||+
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~  166 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYK  166 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHh
Confidence            43  3344432    2358999999998887754332 245666678899999999999995

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=98.96  E-value=1.6e-09  Score=102.23  Aligned_cols=114  Identities=18%  Similarity=0.204  Sum_probs=96.0

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeec--cccchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEec
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNL--QCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      .|...+.||+||.+.||++...+...||+|....  .+.+....|..|+.++.++ .|.+||++++|-..++.+||||||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~  441 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC  441 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence            4666788999999999999988888899887754  3455667899999999999 599999999999999999999997


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      =+. ||.++|......+....+..+-.|++.|+.|+|.
T Consensus       442 Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~  478 (677)
T KOG0596|consen  442 GDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ  478 (677)
T ss_pred             ccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH
Confidence            655 9999998766555533677788999999999994

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=98.94  E-value=1.1e-09  Score=94.74  Aligned_cols=113  Identities=18%  Similarity=0.284  Sum_probs=90.4

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEee-eecCCeeEEEEe
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISS-CSNEEFKALVLE  366 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~e  366 (405)
                      +.|...+.+|+|.||.+..+.. ...+.+++|.+... ....++|.+|...--.+ .|.||+.-++. +.+.+....++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            3456678899999999999985 45678999988543 23456888888775555 58999988764 566677779999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.|||..-+...  .+.+..-.+++.|+++|++|||+
T Consensus       103 ~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHs  139 (378)
T KOG1345|consen  103 FAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHS  139 (378)
T ss_pred             cCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhc
Confidence            99999999987653  47888889999999999999996

>PHA02882 putative serine/threonine kinase; Provisional

Probab=98.94  E-value=7.8e-09  Score=95.34  Aligned_cols=114  Identities=22%  Similarity=0.285  Sum_probs=78.0

Q ss_pred             ccCCccCcccccCCCceEEEeeCC----CcEEEEEEeeccccchh-----------HHHHHHHHHhhcCCCCCcceEEee
Q 036754          290 YKFSENNLISKGGFGSVYKARLGD----GMEVAVKVFNLQCRRAF-----------KSFDIECEMMKSIRHQNLIKVISS  354 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~~  354 (405)
                      ..|...+.||+|+||+||+|...+    +..+|+|..........           .....+...+..+.|+++++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            356677899999999999998643    34566765432221110           112233445667899999999997


Q ss_pred             eecCC----eeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          355 CSNEE----FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       355 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +....    ..++++|++.. ++.+.+... ...++..+..++.|+++||+|||+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~  144 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHE  144 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHh
Confidence            65543    34678887654 566655432 246788889999999999999995

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=98.92  E-value=4.9e-10  Score=94.45  Aligned_cols=109  Identities=16%  Similarity=0.343  Sum_probs=89.3

Q ss_pred             ccCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccccchhHHHHHHHHHhhcCC-CCCcceEEeeeecC--CeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-HQNLIKVISSCSNE--EFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  365 (405)
                      ++|...+++|+|.++.|+.|. ..+.+.++||++++-.   .+...+|+.++..++ ||||+++++...+.  ....+++
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            445556789999999999998 5667889999997643   346778999999997 99999999988764  4567999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+.+.|....-    ..++..+...++.+++.||+|+|+
T Consensus       115 E~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS  150 (338)
T KOG0668|consen  115 EYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHS  150 (338)
T ss_pred             hhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHh
Confidence            999997766543    257788888899999999999995

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=8.4e-10  Score=97.95  Aligned_cols=115  Identities=20%  Similarity=0.221  Sum_probs=93.6

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  364 (405)
                      .+|....+||+|+|++|..+.+ .+.+.+|+|++++.-   .++..-...|-.+.... +||-+|.++.++.++..++.|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            4678889999999999999884 567889999987642   23333344555555554 799999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .||+++|||--++...+ .+.+..+.-+...|.-||.|||+
T Consensus       330 ieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~  369 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHE  369 (593)
T ss_pred             EEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhh
Confidence            99999999988876544 68888888899999999999995

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.91  E-value=3.7e-10  Score=102.78  Aligned_cols=114  Identities=19%  Similarity=0.227  Sum_probs=91.5

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      +|....+||+|+||+|..|.. .+.+.+|||+++++-   ..+.+--..|-++++-- +-|-+++++.++.+-+.+|.||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            566678999999999999984 456789999998753   11222223455555544 6789999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+.+|||--++..-+ .+.++.++-+|..||-||=|||+
T Consensus       430 EyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~  468 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHS  468 (683)
T ss_pred             EEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhc
Confidence            9999999988887544 68889999999999999999995

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=98.88  E-value=6.6e-09  Score=90.55  Aligned_cols=107  Identities=16%  Similarity=0.172  Sum_probs=82.3

Q ss_pred             hccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchh---HH------HHHHHHHhhcCCCCCcceEEeeeecC-
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KS------FDIECEMMKSIRHQNLIKVISSCSNE-  358 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~---~~------~~~e~~~l~~l~h~niv~l~~~~~~~-  358 (405)
                      ...|...+++|+|+||.||.... ++..+|+|.+++......   ..      +.+|+..+.++.|++|..+..++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            35678889999999999999766 567899999975432221   22      57899999999999999999885532 


Q ss_pred             -------CeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 -------EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 -------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                             ...+|+|||++|.+|.++..     .+.    ....+++++++.+|+
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~  153 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQ  153 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHH
Confidence                   35789999999999988732     222    245688999999984

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=98.85  E-value=6.4e-09  Score=104.02  Aligned_cols=114  Identities=20%  Similarity=0.167  Sum_probs=74.0

Q ss_pred             hhccCCccCcccccCCCceEEEeeC-C----CcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEee------ee
Q 036754          288 ATYKFSENNLISKGGFGSVYKARLG-D----GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISS------CS  356 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~  356 (405)
                      ..++|...+.||+|+||.||+|+.. +    +..||+|++.....  .+.+..|  .+....+.+++.+...      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4567888899999999999999964 4    68999998754221  1111111  1111222222222111      24


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhcCCCC-------------------CCHHHHHHHHHHHHHHHhhhcC
Q 036754          357 NEEFKALVLEYMPHGSLEKYLYSSNCI-------------------LDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       357 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .....++||||+++|+|.+++......                   ..+.....++.|+++||+|||+
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~  273 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS  273 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH
Confidence            567789999999999999998754211                   1122345799999999999995

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=98.80  E-value=1.2e-09  Score=94.21  Aligned_cols=109  Identities=25%  Similarity=0.269  Sum_probs=85.9

Q ss_pred             cCcccccCCCceEEEe-eCCCcEEEEEEeeccc-cchhHHHHHHHHHhhc-CCCCCcceEEeeeecCCeeEEEEecCCCC
Q 036754          295 NNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC-RRAFKSFDIECEMMKS-IRHQNLIKVISSCSNEEFKALVLEYMPHG  371 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~g  371 (405)
                      ...||.|+||+|++-. -+.|+..|||+++... ..+.++++.|.++..+ -+.||||+++|++..+...||.||.|.- 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            3468999999999987 4679999999998654 3566778888876544 5799999999999999999999999965 


Q ss_pred             CHHHH---HhcC-CCCCCHHHHHHHHHHHHHHHhhhc
Q 036754          372 SLEKY---LYSS-NCILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       372 ~L~~~---l~~~-~~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      ++..+   .+.. +..+.+.-.-.|...+.+||.||.
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK  184 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLK  184 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHH
Confidence            55443   2222 246777777788888899999984

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=98.80  E-value=3.7e-09  Score=91.55  Aligned_cols=109  Identities=17%  Similarity=0.200  Sum_probs=92.2

Q ss_pred             cCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCC-CCCcceEEeeeecCCeeEEEEecCCCC
Q 036754          295 NNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEFKALVLEYMPHG  371 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  371 (405)
                      ...+|.|..|.|+++.. ..|..+|||+++... +++.++++.+++++.+.+ .|.||+.+||+.....++|.||.|.. 
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence            34589999999999985 568999999997654 456678888999888775 89999999999999999999998865 


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhc
Q 036754          372 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       372 ~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      .+++.++.-++.+.+.-+-++.+.+..||.||.
T Consensus       176 C~ekLlkrik~piPE~ilGk~tva~v~AL~YLK  208 (391)
T KOG0983|consen  176 CAEKLLKRIKGPIPERILGKMTVAIVKALYYLK  208 (391)
T ss_pred             HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHH
Confidence            567777665667888888899999999999985

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=98.78  E-value=1.4e-08  Score=84.58  Aligned_cols=111  Identities=21%  Similarity=0.261  Sum_probs=90.4

Q ss_pred             ccCcccccCCCceEEEe-eCCCcEEEEEEeeccc-cchhHHHHHHHHHhhc-CCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          294 ENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC-RRAFKSFDIECEMMKS-IRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      ....||+|++|.|-+-+ ..+|...|+|.++..- .+..++.++|+.+..+ ..+|.+|.++|.+.++...+|.||.|..
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t  129 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT  129 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence            34568999999988776 4679999999997543 4455667888887555 5799999999999999999999999976


Q ss_pred             CCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~---~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       +|..+-+   +++..+.+.-.-+||..|.+||.|||+
T Consensus       130 -Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~  166 (282)
T KOG0984|consen  130 -SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS  166 (282)
T ss_pred             -hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH
Confidence             7766543   345678899999999999999999995

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.76  E-value=1.4e-10  Score=112.39  Aligned_cols=128  Identities=32%  Similarity=0.385  Sum_probs=79.6

Q ss_pred             CCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccc
Q 036754           62 KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQG  141 (405)
Q Consensus        62 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~  141 (405)
                      .|.+.+.+.|.+. .++..+ .-++.|+.|||++|+++.+.                   .+..+++|++|||+.|.+..
T Consensus       165 ~L~~a~fsyN~L~-~mD~SL-qll~ale~LnLshNk~~~v~-------------------~Lr~l~~LkhLDlsyN~L~~  223 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESL-QLLPALESLNLSHNKFTKVD-------------------NLRRLPKLKHLDLSYNCLRH  223 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHH-HHHHHhhhhccchhhhhhhH-------------------HHHhcccccccccccchhcc
Confidence            4555556666665 344333 34566666666666665433                   23456778888888888873


Q ss_pred             cCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCc--CCCCCccCCCCcccccCCCCccC
Q 036754          142 SIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGE--IPRGGSFGNFSAESFEGNELLCG  213 (405)
Q Consensus       142 ~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~--~p~~~~~~~~~~~~~~~n~~~c~  213 (405)
                      ..--.-..+. |..|.+++|.++..  ..+.++.+|+.||+++|.|.+.  .-..+.+..+..+.+.|||+.|.
T Consensus       224 vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  224 VPQLSMVGCK-LQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             ccccchhhhh-heeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            3222233443 88888888887743  3567788888888888877642  22234456667778888888774

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.75  E-value=2e-09  Score=104.05  Aligned_cols=171  Identities=28%  Similarity=0.335  Sum_probs=81.8

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCC
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLA   86 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~   86 (405)
                      +..+++|+.|++.+|+|..+...  +..+. +|++|+|++|.|+...  .+..++.|+.|++++|.|+ .++..  ..+.
T Consensus        91 l~~~~~l~~l~l~~n~i~~i~~~--l~~~~-~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~-~~~~~--~~l~  162 (414)
T KOG0531|consen   91 LSKLKSLEALDLYDNKIEKIENL--LSSLV-NLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLIS-DISGL--ESLK  162 (414)
T ss_pred             cccccceeeeeccccchhhcccc--hhhhh-cchheecccccccccc--chhhccchhhheeccCcch-hccCC--ccch
Confidence            45566666666666666655441  12233 6666666666665532  3444555666666666665 33322  2366


Q ss_pred             CCCeeeCCCCCCCCCchh-hhccccCccccCCCC----ChhccCCCCCCEEeccCCcccccCCcccccCC--CCCeeecc
Q 036754           87 SLRKLSLDSNELTSIPLT-FWNLKDILYLNFSVI----PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLI--SLKSLNLS  159 (405)
Q Consensus        87 ~L~~L~Ls~N~l~~lp~~-~~~l~~L~~l~l~~~----p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~--~L~~L~l~  159 (405)
                      .|+.+++++|+++.++.. ...+..+..+.+...    ...+..+..+..+++..|.+...-+  +..+.  +|+.++++
T Consensus       163 ~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~  240 (414)
T KOG0531|consen  163 SLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLS  240 (414)
T ss_pred             hhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhcccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcc
Confidence            666666666666655442 233334444333321    1111122223333444444432111  11112  25555555


Q ss_pred             cccccCccchhHHhcccCCccccccCccc
Q 036754          160 KNNLSGAIPASLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       160 ~n~l~~~~~~~~~~l~~L~~l~l~~n~l~  188 (405)
                      +|++. ..+..+..+..+..+++.+|.+.
T Consensus       241 ~n~i~-~~~~~~~~~~~l~~l~~~~n~~~  268 (414)
T KOG0531|consen  241 GNRIS-RSPEGLENLKNLPVLDLSSNRIS  268 (414)
T ss_pred             cCccc-cccccccccccccccchhhcccc
Confidence            55554 22233444455555555555543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.72  E-value=7e-08  Score=79.09  Aligned_cols=100  Identities=18%  Similarity=0.226  Sum_probs=81.6

Q ss_pred             cCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCC--CCcceEEeeeecCCeeEEEEecCCCCC
Q 036754          295 NNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH--QNLIKVISSCSNEEFKALVLEYMPHGS  372 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  372 (405)
                      .+.+|+|.++.||++...+ ..+++|.......  ...+.+|+..+..++|  ..+.+++++....+..++++||+++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            3568999999999999744 7889998865432  4568889999999977  589999988887788999999999877


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          373 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       373 L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +..+        ++.....++.+++++++++|.
T Consensus        80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~  104 (155)
T cd05120          80 LDEV--------SEEEKEDIAEQLAELLAKLHQ  104 (155)
T ss_pred             cccC--------CHHHHHHHHHHHHHHHHHHhC
Confidence            6553        556677889999999999994

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.72  E-value=5.8e-08  Score=84.02  Aligned_cols=103  Identities=21%  Similarity=0.138  Sum_probs=75.5

Q ss_pred             CCccCcccccCCCceEEEeeCCCcEEEEEEeeccccc----------------------hhHHHHHHHHHhhcCCCCC--
Q 036754          292 FSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRR----------------------AFKSFDIECEMMKSIRHQN--  347 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~n--  347 (405)
                      +...+.||+|+||.||++...+|+.||||+.+.....                      ....+.+|...+.++.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            4556889999999999999878999999987643200                      0113567888888888874  


Q ss_pred             cceEEeeeecCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       348 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +.+.++    ....++||||+++++|.+....       .....++.++++++.++|+
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~  143 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYK  143 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHH
Confidence            444443    2455899999999998775421       2355688999999999984

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.70  E-value=3.6e-09  Score=94.59  Aligned_cols=192  Identities=20%  Similarity=0.255  Sum_probs=117.5

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchh---hhcccccccEEEcccCcccccC-------------CccccCccCCCeee
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTF---VGNVSHSLEFFVMSYCNISGGI-------------LEEITNLTKLTTII   67 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f---~~~~~~~L~~L~L~~n~l~~~~-------------~~~~~~l~~L~~L~   67 (405)
                      .+++-.+++|++||||+|-+....+..|   +..+. +|+.|.|.+|.+...-             ..-.++-++|+++.
T Consensus        85 ~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~-~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i  163 (382)
T KOG1909|consen   85 SKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCT-DLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFI  163 (382)
T ss_pred             HHHHhcCCceeEeeccccccCccchHHHHHHHHhcc-CHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEE
Confidence            3456677888899999988866555442   33433 7888888888774211             11233456788888


Q ss_pred             cCCcccccccC----cchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccc--
Q 036754           68 LGGNKLNGSIS----ITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQG--  141 (405)
Q Consensus        68 L~~N~l~~~~~----~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~--  141 (405)
                      .++|++. .-+    ...+...+.|+.+.++.|.|..=....             +-..+..+++|+.|||..|-++.  
T Consensus       164 ~~rNrle-n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~a-------------l~eal~~~~~LevLdl~DNtft~eg  229 (382)
T KOG1909|consen  164 CGRNRLE-NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTA-------------LAEALEHCPHLEVLDLRDNTFTLEG  229 (382)
T ss_pred             eeccccc-cccHHHHHHHHHhccccceEEEecccccCchhHH-------------HHHHHHhCCcceeeecccchhhhHH
Confidence            8888875 222    233455678888888888775211100             11135567778888888887653  


Q ss_pred             --cCCcccccCCCCCeeecccccccCccchhH-----HhcccCCccccccCcccCcCC-----CCCccCCCCcccccCCC
Q 036754          142 --SIPDSFGDLISLKSLNLSKNNLSGAIPASL-----EKLLYLKDLNLSFNKLEGEIP-----RGGSFGNFSAESFEGNE  209 (405)
Q Consensus       142 --~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~l~l~~n~l~~~~p-----~~~~~~~~~~~~~~~n~  209 (405)
                        .+...+..+++|+.|+++++.+...--..+     ...++|+.+.+.+|.++..-.     .....+.+..+.+++|.
T Consensus       230 s~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~  309 (382)
T KOG1909|consen  230 SVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNR  309 (382)
T ss_pred             HHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccc
Confidence              223445667778888888877753222111     135678888888887763211     01224566777778886


Q ss_pred             C
Q 036754          210 L  210 (405)
Q Consensus       210 ~  210 (405)
                      +
T Consensus       310 l  310 (382)
T KOG1909|consen  310 L  310 (382)
T ss_pred             c
Confidence            5

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=98.70  E-value=2e-09  Score=100.50  Aligned_cols=115  Identities=18%  Similarity=0.267  Sum_probs=96.3

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCc-EEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGM-EVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~-~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      .++.....+|-|+||.|=........ .+|+|.+++..   ....+.+..|-.+|...+.+.||++|-.|.+...+|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34555667999999999888764433 47888886542   334455677899999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |-|-||++...|++++ .++...+.-++..|.+|++|||.
T Consensus       500 EaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~  538 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHR  538 (732)
T ss_pred             HhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHh
Confidence            9999999999998765 78999999999999999999994

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=98.66  E-value=1.6e-07  Score=87.76  Aligned_cols=114  Identities=25%  Similarity=0.322  Sum_probs=89.4

Q ss_pred             cCCccCcccccCCCceEEEeeCC--CcEEEEEEeeccccchhHHHHHHHHHhhcCC----CCCcceEEeee-ecCCeeEE
Q 036754          291 KFSENNLISKGGFGSVYKARLGD--GMEVAVKVFNLQCRRAFKSFDIECEMMKSIR----HQNLIKVISSC-SNEEFKAL  363 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~l~~~~-~~~~~~~l  363 (405)
                      .|...+.||+|+||.||.+....  ...+|+|............+..|+.++..+.    .+++.++++.. ......+|
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            57778899999999999999544  3578888876543332225667888887776    26888888888 47778999


Q ss_pred             EEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+.+ +.+|.+...... +.++....++|+.|++.+|+|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~  140 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS  140 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh
Confidence            99976 559999775443 679999999999999999999995

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=98.66  E-value=2.8e-08  Score=98.21  Aligned_cols=109  Identities=27%  Similarity=0.419  Sum_probs=83.9

Q ss_pred             CCccCcccccCCC-ceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEecCC
Q 036754          292 FSENNLISKGGFG-SVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       292 ~~~~~~lg~G~fg-~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      |...+++|.|+-| .||+|.+ +|+.||||++-...   .....+||..+..- .|||||+.++.-.+....||..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            4455778899887 4688988 67899999875332   23446799988877 69999999888888889999999998


Q ss_pred             CCCHHHHHhcCCCCCCH---HHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDI---FQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~---~~~~~i~~~ia~gl~yLH~  405 (405)
                      . +|.+++..+......   -....+..|+++||++||.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs  624 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS  624 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh
Confidence            7 999999864211111   3456788999999999995

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.65  E-value=5e-09  Score=101.24  Aligned_cols=86  Identities=23%  Similarity=0.291  Sum_probs=48.3

Q ss_pred             CCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCC
Q 036754           10 CKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLR   89 (405)
Q Consensus        10 l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~   89 (405)
                      +..++.+++..|.|......  .+.+. +|+.|++..|++..+. ..+..+++|++|+|++|.|+ .+..-  ..++.|+
T Consensus        71 l~~l~~l~l~~n~i~~~~~~--l~~~~-~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~-~i~~l--~~l~~L~  143 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIAKILNH--LSKLK-SLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKIT-KLEGL--STLTLLK  143 (414)
T ss_pred             hHhHHhhccchhhhhhhhcc--ccccc-ceeeeeccccchhhcc-cchhhhhcchheeccccccc-cccch--hhccchh
Confidence            45555666666666552221  12223 6677777777766532 22556667777777777766 33221  2455577


Q ss_pred             eeeCCCCCCCCCc
Q 036754           90 KLSLDSNELTSIP  102 (405)
Q Consensus        90 ~L~Ls~N~l~~lp  102 (405)
                      .|++++|.|+.++
T Consensus       144 ~L~l~~N~i~~~~  156 (414)
T KOG0531|consen  144 ELNLSGNLISDIS  156 (414)
T ss_pred             hheeccCcchhcc
Confidence            7777777766554

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=98.64  E-value=7.5e-08  Score=88.29  Aligned_cols=111  Identities=27%  Similarity=0.297  Sum_probs=93.7

Q ss_pred             hccCCccCcccccCCCceEEEeeC----CCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARLG----DGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  363 (405)
                      ...|...++||+|.|++||++++.    ..+.||+|.+....  .......|++.+..+ .+.||+++.+++...+...+
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i  112 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI  112 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence            345677889999999999999853    46789999986543  234577899999998 59999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+||.++-+..++.++    ++..+...+......||+|+|.
T Consensus       113 vlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~  150 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHK  150 (418)
T ss_pred             EecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhc
Confidence            9999999888887753    6678888899999999999995

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=98.60  E-value=6.7e-08  Score=87.55  Aligned_cols=113  Identities=18%  Similarity=0.216  Sum_probs=88.5

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCC------CcceEEeeeecCCeeEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQ------NLIKVISSCSNEEFKAL  363 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~~~~l  363 (405)
                      .|.....+|+|.||.|-.+.. ..+..||+|+++.-. ...+.-.-|++++.++.+.      -+|++.+++.-.+..+|
T Consensus        90 Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCi  168 (415)
T KOG0671|consen   90 RYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICI  168 (415)
T ss_pred             ceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEE
Confidence            445567899999999999884 347899999986432 2233445689999988322      36777788888999999


Q ss_pred             EEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+. -+++++|.... ..+.......|+.|+.++++|||+
T Consensus       169 vfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~  210 (415)
T KOG0671|consen  169 VFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD  210 (415)
T ss_pred             EEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh
Confidence            999773 38999998643 568888999999999999999996

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=98.59  E-value=6.1e-08  Score=93.39  Aligned_cols=109  Identities=20%  Similarity=0.244  Sum_probs=86.3

Q ss_pred             cCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ++.....+|.|+|+.|-++. .+++...|||++.....    +-..|+.++... +|+|++++.+.+.+....|+|||++
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l  398 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL  398 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence            34444569999999999888 46778899999865421    123456555544 7999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+|-+.+.++..+ ... .++..|+++++.|++|||+
T Consensus       399 ~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~  433 (612)
T KOG0603|consen  399 DGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHE  433 (612)
T ss_pred             cccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHh
Confidence            9999988887644 233 7788899999999999995

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=98.58  E-value=1.8e-07  Score=79.82  Aligned_cols=113  Identities=19%  Similarity=0.339  Sum_probs=91.2

Q ss_pred             ccCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCC-CCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH-QNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ..|...++||.|+||.+|.|. ...|+.||+|.-.....+.  ....|..+...+++ ..|..+..|..+...-.+|||.
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp--qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL   92 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP--QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL   92 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc--chhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence            356677899999999999998 6789999999876544432  34567777777765 5677777777888888999998


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      . +-+|++...-+...++....+..|-|+..-++|+|.
T Consensus        93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~  129 (341)
T KOG1163|consen   93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL  129 (341)
T ss_pred             c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh
Confidence            7 459999887666679999999999999999999993

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.58  E-value=4.1e-08  Score=101.85  Aligned_cols=123  Identities=24%  Similarity=0.333  Sum_probs=85.3

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCc--ccccCCccccCccCCCeeecCCcccccccCcchhcCCCCC
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCN--ISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASL   88 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L   88 (405)
                      ...+.+.+-+|.+..+....   ..+ .|++|-+..|.  +..+.++.|..++.|++|||++|.=-+.+|..+. +|.+|
T Consensus       523 ~~~rr~s~~~~~~~~~~~~~---~~~-~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~-~Li~L  597 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIEHIAGSS---ENP-KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIG-ELVHL  597 (889)
T ss_pred             hheeEEEEeccchhhccCCC---CCC-ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHh-hhhhh
Confidence            45566666677665433321   223 68888888886  5555555677888888888888765567888874 78888


Q ss_pred             CeeeCCCCCCCCCchhhhccccCccccCCC------CChhccCCCCCCEEeccCCc
Q 036754           89 RKLSLDSNELTSIPLTFWNLKDILYLNFSV------IPIEIGGLPNLEYLFLGYNR  138 (405)
Q Consensus        89 ~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~------~p~~~~~l~~L~~L~l~~n~  138 (405)
                      ++|+|++..++.+|..+.+|+.|.+|++..      +|.....+++|++|.+-.-.
T Consensus       598 ryL~L~~t~I~~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  598 RYLDLSDTGISHLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             hcccccCCCccccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            888888888888888888888887777653      34444557777777666543

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.52  E-value=1.7e-07  Score=97.32  Aligned_cols=104  Identities=21%  Similarity=0.215  Sum_probs=64.7

Q ss_pred             CCcCCeeeCcCCcC-cccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCC
Q 036754           10 CKCLTFIDLSNNPL-DSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASL   88 (405)
Q Consensus        10 l~~L~~L~Ls~N~l-~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L   88 (405)
                      +++|++|-+..|.. ....+..|+..++ .|+.|||++|.--+.+|..++.|-+|++|+|++..+. .+|.++. +|..|
T Consensus       544 ~~~L~tLll~~n~~~l~~is~~ff~~m~-~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~-~Lk~L  620 (889)
T KOG4658|consen  544 NPKLRTLLLQRNSDWLLEISGEFFRSLP-LLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLG-NLKKL  620 (889)
T ss_pred             CCccceEEEeecchhhhhcCHHHHhhCc-ceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHH-HHHhh
Confidence            44677777777652 2334445555555 6777777776655667777777777777777777776 6776663 67777


Q ss_pred             CeeeCCCCCC-CCCchhhhccccCccccC
Q 036754           89 RKLSLDSNEL-TSIPLTFWNLKDILYLNF  116 (405)
Q Consensus        89 ~~L~Ls~N~l-~~lp~~~~~l~~L~~l~l  116 (405)
                      .+|++..+.- ..+|.....|.+|++|.+
T Consensus       621 ~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l  649 (889)
T KOG4658|consen  621 IYLNLEVTGRLESIPGILLELQSLRVLRL  649 (889)
T ss_pred             heeccccccccccccchhhhcccccEEEe
Confidence            7777776643 244444444666665543

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.51  E-value=1.2e-08  Score=79.35  Aligned_cols=98  Identities=23%  Similarity=0.222  Sum_probs=66.1

Q ss_pred             cCCeeeCcCCcCcccCCchhhhccc--ccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCC
Q 036754           12 CLTFIDLSNNPLDSVLPKTFVGNVS--HSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLR   89 (405)
Q Consensus        12 ~L~~L~Ls~N~l~~~~~~~f~~~~~--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~   89 (405)
                      .+..+|||+++|-. +++. ...+.  ..|+..+|++|.+....+..-..++.++.|+|++|.|+ .+|.++ ..++.|+
T Consensus        28 E~h~ldLssc~lm~-i~da-vy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~-Aam~aLr  103 (177)
T KOG4579|consen   28 ELHFLDLSSCQLMY-IADA-VYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEEL-AAMPALR  103 (177)
T ss_pred             HhhhcccccchhhH-HHHH-HHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHH-hhhHHhh
Confidence            46678888887743 3332 11111  25677888888887744444445568888888888887 788885 4788888


Q ss_pred             eeeCCCCCCCCCchhhhccccCcc
Q 036754           90 KLSLDSNELTSIPLTFWNLKDILY  113 (405)
Q Consensus        90 ~L~Ls~N~l~~lp~~~~~l~~L~~  113 (405)
                      .|+++.|.+...|..+..|.++-+
T Consensus       104 ~lNl~~N~l~~~p~vi~~L~~l~~  127 (177)
T KOG4579|consen  104 SLNLRFNPLNAEPRVIAPLIKLDM  127 (177)
T ss_pred             hcccccCccccchHHHHHHHhHHH
Confidence            888888888877776655444333

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=98.49  E-value=5e-07  Score=80.70  Aligned_cols=112  Identities=18%  Similarity=0.254  Sum_probs=88.1

Q ss_pred             cCCccCcccccCCCceEEEe-eCCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +|...++||+|.||.++.|+ +-+++.||||.-....+  .-....|-+..+.+ ..++|..++.+-..+..-.||+|..
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            46678899999999999998 67899999997543221  12233455555555 5689998887776677778999987


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       |-+|++...-++..++....+.+|.|+..-++|+|+
T Consensus       107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~  142 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE  142 (449)
T ss_pred             -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh
Confidence             448999887777789999999999999999999995

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=98.48  E-value=1.8e-06  Score=80.09  Aligned_cols=111  Identities=33%  Similarity=0.423  Sum_probs=93.6

Q ss_pred             CccCcccccCCCceEEEeeCCCcEEEEEEeeccccc---hhHHHHHHHHHhhcCCCC-CcceEEeeeecCCeeEEEEecC
Q 036754          293 SENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRR---AFKSFDIECEMMKSIRHQ-NLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ...+.+|.|+||.||++...  ..+|+|.+......   ....+.+|+..+..+.|+ +++++.+++......+++++|+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            34567899999999999876  78899998765432   367889999999999988 7999999997777789999999


Q ss_pred             CCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++++.+++....  ..+.......+..|++.+++|+|.
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~  119 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS  119 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999997776543  268889999999999999999994

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.47  E-value=2.2e-08  Score=77.90  Aligned_cols=106  Identities=28%  Similarity=0.335  Sum_probs=68.7

Q ss_pred             CCeeecCCcccccccCcchh--cCCCCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCccc
Q 036754           63 LTTIILGGNKLNGSISITLG--SNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQ  140 (405)
Q Consensus        63 L~~L~L~~N~l~~~~~~~~~--~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~  140 (405)
                      +..++|++|.+- .+++...  ....+|...+|++|.+..+|..|..                 .++.++.|++++|.++
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~-----------------kf~t~t~lNl~~neis   90 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTI-----------------KFPTATTLNLANNEIS   90 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhh-----------------ccchhhhhhcchhhhh
Confidence            445666666653 3333221  2445566667777777777766532                 2445677777777777


Q ss_pred             ccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCccc
Q 036754          141 GSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       141 ~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~  188 (405)
                       .+|..+..++.|+.|+++.|++. ..|..+..+.+|..|+..+|.+.
T Consensus        91 -dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen   91 -DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             -hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence             56667777778888888888777 45666666777777777777665

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.47  E-value=6.7e-07  Score=76.48  Aligned_cols=103  Identities=22%  Similarity=0.235  Sum_probs=66.8

Q ss_pred             CcccccCCCceEEEeeCCCcEEEEEEeeccccc--hhHHH----------------------HHHHHHhhcCCCCC--cc
Q 036754          296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCRR--AFKSF----------------------DIECEMMKSIRHQN--LI  349 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~e~~~l~~l~h~n--iv  349 (405)
                      +.||+|+||+||+|...+|+.||||+++.....  ....+                      ..|.+.+.++.+..  +.
T Consensus         3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~   82 (187)
T cd05119           3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP   82 (187)
T ss_pred             cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence            579999999999999878999999998753211  11111                      23555555554433  34


Q ss_pred             eEEeeeecCCeeEEEEecCCCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          350 KVISSCSNEEFKALVLEYMPHGSLEK-YLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       350 ~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +.+++    ...++||||+++|++.. .+....  .. .+...++.+++.++.++|.
T Consensus        83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~  132 (187)
T cd05119          83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR  132 (187)
T ss_pred             ceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh
Confidence            44432    24589999999965432 121111  11 5677899999999999994

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK15386 type III secretion protein GogB; Provisional

Probab=98.44  E-value=4.6e-07  Score=84.94  Aligned_cols=134  Identities=17%  Similarity=0.229  Sum_probs=84.7

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCc-ccccccCcchhcCC
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGN-KLNGSISITLGSNL   85 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~l   85 (405)
                      +..+++++.|++++|.|..+ |.     +|.+|+.|.+++|.--..+|+.+.  ++|+.|++++| .+. .+|       
T Consensus        48 ~~~~~~l~~L~Is~c~L~sL-P~-----LP~sLtsL~Lsnc~nLtsLP~~LP--~nLe~L~Ls~Cs~L~-sLP-------  111 (426)
T PRK15386         48 IEEARASGRLYIKDCDIESL-PV-----LPNELTEITIENCNNLTTLPGSIP--EGLEKLTVCHCPEIS-GLP-------  111 (426)
T ss_pred             HHHhcCCCEEEeCCCCCccc-CC-----CCCCCcEEEccCCCCcccCCchhh--hhhhheEccCccccc-ccc-------
Confidence            34468899999999988764 42     356899999998665455666553  58999999998 554 455       


Q ss_pred             CCCCeeeCCCCCC---CCCchhhhcccc--CccccCCCCChhccCC-CCCCEEeccCCcccccCCcccccCCCCCeeecc
Q 036754           86 ASLRKLSLDSNEL---TSIPLTFWNLKD--ILYLNFSVIPIEIGGL-PNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLS  159 (405)
Q Consensus        86 ~~L~~L~Ls~N~l---~~lp~~~~~l~~--L~~l~l~~~p~~~~~l-~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~  159 (405)
                      .+|+.|+++.|.+   ..+|.++..|.-  ........+|.   .+ ++|++|++++|... .+|..+.  .+|+.|+++
T Consensus       112 ~sLe~L~L~~n~~~~L~~LPssLk~L~I~~~n~~~~~~lp~---~LPsSLk~L~Is~c~~i-~LP~~LP--~SLk~L~ls  185 (426)
T PRK15386        112 ESVRSLEIKGSATDSIKNVPNGLTSLSINSYNPENQARIDN---LISPSLKTLSLTGCSNI-ILPEKLP--ESLQSITLH  185 (426)
T ss_pred             cccceEEeCCCCCcccccCcchHhheecccccccccccccc---ccCCcccEEEecCCCcc-cCccccc--ccCcEEEec
Confidence            3477788887764   456655432210  00000011111   12 47888999888765 3444443  478888887


Q ss_pred             ccc
Q 036754          160 KNN  162 (405)
Q Consensus       160 ~n~  162 (405)
                      .+.
T Consensus       186 ~n~  188 (426)
T PRK15386        186 IEQ  188 (426)
T ss_pred             ccc
Confidence            763

>PRK12274 serine/threonine protein kinase; Provisional

Probab=98.43  E-value=1.6e-06  Score=74.26  Aligned_cols=99  Identities=12%  Similarity=0.085  Sum_probs=72.6

Q ss_pred             ccCcccccCCCceEEEeeCCCcEEEEEEeecccc----chhHHHHHHHHHhhcCC-CCCcceEEeeeecCCeeEEEEecC
Q 036754          294 ENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCR----RAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ....+++|+||+||.+.. .+..++.+.+.....    -....+.+|++++.++. |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            346799999999996655 566677666643321    11235788999999995 5889999886    4569999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++.+|.+.+..        ....++.|++++++|+|.
T Consensus        81 ~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~  109 (218)
T PRK12274         81 AGAAMYQRPPR--------GDLAYFRAARRLLQQLHR  109 (218)
T ss_pred             cCccHHhhhhh--------hhHHHHHHHHHHHHHHHH
Confidence            99998764321        123577899999999994

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.42  E-value=2.3e-07  Score=58.44  Aligned_cols=40  Identities=30%  Similarity=0.506  Sum_probs=24.9

Q ss_pred             cCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCc
Q 036754           61 TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP  102 (405)
Q Consensus        61 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp  102 (405)
                      ++|++|++++|+|+ .+|..+ .+|++|++|++++|+|+++|
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l-~~l~~L~~L~l~~N~i~~i~   40 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPEL-SNLPNLETLNLSNNPISDIS   40 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHG-TTCTTSSEEEETSSCCSBEG
T ss_pred             CcceEEEccCCCCc-ccCchH-hCCCCCCEEEecCCCCCCCc
Confidence            35677777777776 566554 36777777777777776554

...

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.39  E-value=1.4e-06  Score=76.49  Aligned_cols=108  Identities=18%  Similarity=0.183  Sum_probs=83.6

Q ss_pred             CcccccCCCceEEEeeCCCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCC--CcceEEeeeecC---CeeEEEEecCC
Q 036754          296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQ--NLIKVISSCSNE---EFKALVLEYMP  369 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~  369 (405)
                      +.++.|..+.+|++...+|+.+++|....... .....+.+|..++..+++.  .+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            45899999999999887678999998754432 2345678899999988764  456777776553   25689999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++.+.+..  ..++..++..++.+++++|++||.
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~  117 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHS  117 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhC
Confidence            9888775532  247888889999999999999995

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.38  E-value=1.1e-07  Score=83.42  Aligned_cols=178  Identities=21%  Similarity=0.201  Sum_probs=76.1

Q ss_pred             CCcCCeeeCcCCcCcccCCc-hhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCC
Q 036754           10 CKCLTFIDLSNNPLDSVLPK-TFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASL   88 (405)
Q Consensus        10 l~~L~~L~Ls~N~l~~~~~~-~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L   88 (405)
                      ++.++.|||.+|.|+....- +...++| .|+.|+|+.|.+...+...-..+.+|++|.|.+..+...-.......++.+
T Consensus        70 ~~~v~elDL~~N~iSdWseI~~ile~lP-~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v  148 (418)
T KOG2982|consen   70 VTDVKELDLTGNLISDWSEIGAILEQLP-ALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV  148 (418)
T ss_pred             hhhhhhhhcccchhccHHHHHHHHhcCc-cceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence            44555566666655543221 1133444 556666666655442222213344555555555555433233333455555


Q ss_pred             CeeeCCCCCCCCC--chhh-h-ccccCccccCCCCCh--------hccCCCCCCEEeccCCcccccC-CcccccCCCCCe
Q 036754           89 RKLSLDSNELTSI--PLTF-W-NLKDILYLNFSVIPI--------EIGGLPNLEYLFLGYNRLQGSI-PDSFGDLISLKS  155 (405)
Q Consensus        89 ~~L~Ls~N~l~~l--p~~~-~-~l~~L~~l~l~~~p~--------~~~~l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~  155 (405)
                      ++|++|.|++..+  .+.. . .-+.+..+.+...|.        --.-+|++..+.+..|+++..- -..+..++.+..
T Consensus       149 telHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~  228 (418)
T KOG2982|consen  149 TELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSC  228 (418)
T ss_pred             hhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchh
Confidence            5565555543311  1000 0 000111111111000        0112455555555555554211 122334455555


Q ss_pred             eecccccccCcc-chhHHhcccCCccccccCccc
Q 036754          156 LNLSKNNLSGAI-PASLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       156 L~l~~n~l~~~~-~~~~~~l~~L~~l~l~~n~l~  188 (405)
                      |+|+.|++...- -+.+..++.|..|.+++|++.
T Consensus       229 LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~  262 (418)
T KOG2982|consen  229 LNLGANNIDSWASVDALNGFPQLVDLRVSENPLS  262 (418)
T ss_pred             hhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence            666666554221 134445555555555555554

>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]

Probab=98.37  E-value=6.3e-07  Score=74.57  Aligned_cols=127  Identities=22%  Similarity=0.316  Sum_probs=83.9

Q ss_pred             CCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeee
Q 036754           13 LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLS   92 (405)
Q Consensus        13 L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~   92 (405)
                      =+.+||-+.++..+..   .|....+...+||++|++..  .+.|..+++|.+|.|++|+|+ .|...+..-++.|+.|.
T Consensus        21 e~e~~LR~lkip~ien---lg~~~d~~d~iDLtdNdl~~--l~~lp~l~rL~tLll~nNrIt-~I~p~L~~~~p~l~~L~   94 (233)
T KOG1644|consen   21 ERELDLRGLKIPVIEN---LGATLDQFDAIDLTDNDLRK--LDNLPHLPRLHTLLLNNNRIT-RIDPDLDTFLPNLKTLI   94 (233)
T ss_pred             ccccccccccccchhh---ccccccccceecccccchhh--cccCCCccccceEEecCCcce-eeccchhhhccccceEE
Confidence            4567777777655433   33334467788888888754  345677888888888888888 77777766777888888


Q ss_pred             CCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCC---cccccCCCCCeeecccc
Q 036754           93 LDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIP---DSFGDLISLKSLNLSKN  161 (405)
Q Consensus        93 Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~l~~L~~L~l~~n  161 (405)
                      |.+|+|.++.+--                .+..+|+|++|.+-+|++...-.   .-+..+++|+.||...=
T Consensus        95 LtnNsi~~l~dl~----------------pLa~~p~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~kV  150 (233)
T KOG1644|consen   95 LTNNSIQELGDLD----------------PLASCPKLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQKV  150 (233)
T ss_pred             ecCcchhhhhhcc----------------hhccCCccceeeecCCchhcccCceeEEEEecCcceEeehhhh
Confidence            8888877543210                23456778888888887763221   11345677777765543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.35  E-value=9e-09  Score=100.19  Aligned_cols=127  Identities=31%  Similarity=0.273  Sum_probs=67.5

Q ss_pred             cccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCC
Q 036754           38 SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS  117 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~  117 (405)
                      .|...+.+.|.+.- ....+.-++.|+.|||++|+++ .+. .+ ..|++|++|||+.|.+..+|.--.           
T Consensus       165 ~L~~a~fsyN~L~~-mD~SLqll~ale~LnLshNk~~-~v~-~L-r~l~~LkhLDlsyN~L~~vp~l~~-----------  229 (1096)
T KOG1859|consen  165 KLATASFSYNRLVL-MDESLQLLPALESLNLSHNKFT-KVD-NL-RRLPKLKHLDLSYNCLRHVPQLSM-----------  229 (1096)
T ss_pred             hHhhhhcchhhHHh-HHHHHHHHHHhhhhccchhhhh-hhH-HH-Hhcccccccccccchhccccccch-----------
Confidence            46666677777653 4455666677777777777776 333 22 467777777777777776653210           


Q ss_pred             CCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCcc-chhHHhcccCCccccccCccc
Q 036754          118 VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAI-PASLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       118 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~l~l~~n~l~  188 (405)
                            .++ +|..|.+++|.++..  ..+.++.+|+.||+++|-+.+-- -..+..+..|..|++.+|++.
T Consensus       230 ------~gc-~L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  230 ------VGC-KLQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ------hhh-hheeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence                  111 145555555554421  12445555555555555443211 112233444555555555554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=98.26  E-value=8.9e-07  Score=91.27  Aligned_cols=111  Identities=27%  Similarity=0.385  Sum_probs=83.7

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCC---CCCcceEEeeeecCCeeEEEEec
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR---HQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      .|.....+|+|+||+||+|+-.+|+.||+|+-++...=   +|.--.+++.+++   -+.|..+..++...+..++|+||
T Consensus       699 ~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey  775 (974)
T KOG1166|consen  699 KFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY  775 (974)
T ss_pred             eEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence            34555779999999999999878999999987653211   1222234455555   23444445555667888899999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+.|+|.+++.. .+.++|.-.+.++.|+++-++.||.
T Consensus       776 ~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~  812 (974)
T KOG1166|consen  776 SPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHA  812 (974)
T ss_pred             cccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHh
Confidence            999999999974 4589999999999999999999994

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.24  E-value=1e-05  Score=71.99  Aligned_cols=104  Identities=11%  Similarity=0.101  Sum_probs=74.8

Q ss_pred             cCccc-ccCCCceEEEeeCCCcEEEEEEeeccc-------------cchhHHHHHHHHHhhcCCCCCc--ceEEeeeecC
Q 036754          295 NNLIS-KGGFGSVYKARLGDGMEVAVKVFNLQC-------------RRAFKSFDIECEMMKSIRHQNL--IKVISSCSNE  358 (405)
Q Consensus       295 ~~~lg-~G~fg~v~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~  358 (405)
                      ..++| .|+.|+||..+.. +..++||.+....             ......+.+|++++.+++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8999999998874 6788998875311             0123457889999999999885  6677764432


Q ss_pred             -C---eeEEEEecCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 -E---FKALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 -~---~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       .   ..++||||+++ ++|.+++...  .++..    .+.++++++++||+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~  160 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHD  160 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHH
Confidence             2   23599999997 6899888643  34443    35789999999995

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.22  E-value=1.7e-07  Score=82.34  Aligned_cols=60  Identities=18%  Similarity=0.191  Sum_probs=31.0

Q ss_pred             CCCCeeecccccccCc-cchhHHhcccCCccccccCcccC--cCCCCCccCCCCcccccCCCC
Q 036754          151 ISLKSLNLSKNNLSGA-IPASLEKLLYLKDLNLSFNKLEG--EIPRGGSFGNFSAESFEGNEL  210 (405)
Q Consensus       151 ~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~l~l~~n~l~~--~~p~~~~~~~~~~~~~~~n~~  210 (405)
                      +++..+.+..|++... -...+..++.+..|+++.|+|..  .+.....|+++..+....||+
T Consensus       199 pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl  261 (418)
T KOG2982|consen  199 PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPL  261 (418)
T ss_pred             ccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcc
Confidence            4555555555655321 12234445556666666666642  222334456666666666654

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.19  E-value=1.5e-07  Score=84.43  Aligned_cols=167  Identities=23%  Similarity=0.261  Sum_probs=116.4

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhc------------ccccccEEEcccCcccc----cCCccccCccCCCeeecCC
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGN------------VSHSLEFFVMSYCNISG----GILEEITNLTKLTTIILGG   70 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~------------~~~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~   70 (405)
                      +.++..|+.|.|.+|.+...-... ++.            -++.|+++...+|++..    .+-..|...+.|+.+.++.
T Consensus       116 l~s~~~L~eL~L~N~Glg~~ag~~-l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~q  194 (382)
T KOG1909|consen  116 LSSCTDLEELYLNNCGLGPEAGGR-LGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQ  194 (382)
T ss_pred             HHhccCHHHHhhhcCCCChhHHHH-HHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEec
Confidence            567899999999999985432222 111            13489999999999864    2334577789999999999


Q ss_pred             cccccc---cCcchhcCCCCCCeeeCCCCCCCCCc-hhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcc
Q 036754           71 NKLNGS---ISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDS  146 (405)
Q Consensus        71 N~l~~~---~~~~~~~~l~~L~~L~Ls~N~l~~lp-~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~  146 (405)
                      |.|...   +-..-+..+++|+.|||..|-++.-- ..+.              ..+..++.|+.|++++|.++..-...
T Consensus       195 N~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La--------------kaL~s~~~L~El~l~dcll~~~Ga~a  260 (382)
T KOG1909|consen  195 NGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA--------------KALSSWPHLRELNLGDCLLENEGAIA  260 (382)
T ss_pred             ccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH--------------HHhcccchheeecccccccccccHHH
Confidence            998511   11222458999999999999998321 1221              13445678889999998887544333


Q ss_pred             c-----ccCCCCCeeecccccccCc----cchhHHhcccCCccccccCccc
Q 036754          147 F-----GDLISLKSLNLSKNNLSGA----IPASLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       147 ~-----~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~l~l~~n~l~  188 (405)
                      |     ...++|+.|.+.+|.++..    +-..+...+.|+.|+++.|.+.
T Consensus       261 ~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  261 FVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            3     2467899999999988622    2234455778999999999883

>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]

Probab=98.17  E-value=4.9e-08  Score=85.73  Aligned_cols=86  Identities=20%  Similarity=0.181  Sum_probs=42.8

Q ss_pred             CCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcc-cccccCcchhcCCCCCCee
Q 036754           13 LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK-LNGSISITLGSNLASLRKL   91 (405)
Q Consensus        13 L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~l~~L~~L   91 (405)
                      |+.||||+-.|+..--...+..+. .|+.|.|.++++...+-..++.-.+|+.|+|+.+. ++..--..+++++++|.+|
T Consensus       187 lq~lDLS~s~it~stl~~iLs~C~-kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L  265 (419)
T KOG2120|consen  187 LQHLDLSNSVITVSTLHGILSQCS-KLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL  265 (419)
T ss_pred             hHHhhcchhheeHHHHHHHHHHHH-hhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence            555666655554332222233443 55666666666555444555555566666665543 2211112234455566666


Q ss_pred             eCCCCCCC
Q 036754           92 SLDSNELT   99 (405)
Q Consensus        92 ~Ls~N~l~   99 (405)
                      +|+-+.++
T Consensus       266 NlsWc~l~  273 (419)
T KOG2120|consen  266 NLSWCFLF  273 (419)
T ss_pred             CchHhhcc
Confidence            66655544

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.16  E-value=4e-06  Score=81.31  Aligned_cols=107  Identities=20%  Similarity=0.228  Sum_probs=65.5

Q ss_pred             cCcccccCCCceEEEeeCCCcEEEEEEeeccccchh----------------------------------------HHHH
Q 036754          295 NNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAF----------------------------------------KSFD  334 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  334 (405)
                      .+.+|.|++|.||+|++.+|+.||||+.++......                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999876421100                                        0234


Q ss_pred             HHHHHhhcC----C-CCCcceEEeeeecCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHH-Hhhhc
Q 036754          335 IECEMMKSI----R-HQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA-LEYLH  404 (405)
Q Consensus       335 ~e~~~l~~l----~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~g-l~yLH  404 (405)
                      +|.+.+.++    + ++++.-..-+.......+|||||++|+++.+.........+   +.+++.+++++ +..+|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence            455555544    2 34433222232334457899999999999887653221222   33455555542 34443

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.16  E-value=1.7e-06  Score=54.49  Aligned_cols=36  Identities=31%  Similarity=0.432  Sum_probs=26.4

Q ss_pred             cccEEEcccCcccccCCccccCccCCCeeecCCcccc
Q 036754           38 SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLN   74 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~   74 (405)
                      +|++|++++|+++. +|..+++|++|+.|++++|+++
T Consensus         2 ~L~~L~l~~N~i~~-l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    2 NLEELDLSNNQITD-LPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             T-SEEEETSSS-SS-HGGHGTTCTTSSEEEETSSCCS
T ss_pred             cceEEEccCCCCcc-cCchHhCCCCCCEEEecCCCCC
Confidence            67788888888875 4556788888888888888876

...

>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]

Probab=97.98  E-value=7.9e-06  Score=68.14  Aligned_cols=86  Identities=21%  Similarity=0.210  Sum_probs=68.5

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCccccc--ccCcchhcCCCCC
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNG--SISITLGSNLASL   88 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~~l~~L   88 (405)
                      .....+||++|.+.....   +..++ .|.+|.|++|+|+.+.|.--.-+++|..|.|.+|+|..  .+..  ...++.|
T Consensus        42 d~~d~iDLtdNdl~~l~~---lp~l~-rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~p--La~~p~L  115 (233)
T KOG1644|consen   42 DQFDAIDLTDNDLRKLDN---LPHLP-RLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDP--LASCPKL  115 (233)
T ss_pred             cccceecccccchhhccc---CCCcc-ccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcch--hccCCcc
Confidence            356789999999976433   33444 89999999999999888877888999999999999862  2222  2478999


Q ss_pred             CeeeCCCCCCCCCc
Q 036754           89 RKLSLDSNELTSIP  102 (405)
Q Consensus        89 ~~L~Ls~N~l~~lp  102 (405)
                      ++|.+-+|..+.-+
T Consensus       116 ~~Ltll~Npv~~k~  129 (233)
T KOG1644|consen  116 EYLTLLGNPVEHKK  129 (233)
T ss_pred             ceeeecCCchhccc
Confidence            99999999988554

>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only]

Probab=97.91  E-value=6.7e-06  Score=83.52  Aligned_cols=128  Identities=18%  Similarity=0.281  Sum_probs=85.5

Q ss_pred             cccEEEcccCcc-cccCCcccc-CccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCcccc
Q 036754           38 SLEFFVMSYCNI-SGGILEEIT-NLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLN  115 (405)
Q Consensus        38 ~L~~L~L~~n~l-~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~  115 (405)
                      +|+.|++++... +...|..++ -||+|+.|.+++=.+...-=..++.++++|..||+|+.+++.+ ..+++|++|+.|.
T Consensus       123 nL~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl-~GIS~LknLq~L~  201 (699)
T KOG3665|consen  123 NLQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL-SGISRLKNLQVLS  201 (699)
T ss_pred             hhhhcCccccchhhccHHHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc-HHHhccccHHHHh
Confidence            678888877653 233444443 4788888888876664221123456788888888888888877 5677888888877


Q ss_pred             CCCCC-------hhccCCCCCCEEeccCCcccccC--C----cccccCCCCCeeecccccccCc
Q 036754          116 FSVIP-------IEIGGLPNLEYLFLGYNRLQGSI--P----DSFGDLISLKSLNLSKNNLSGA  166 (405)
Q Consensus       116 l~~~p-------~~~~~l~~L~~L~l~~n~l~~~~--p----~~~~~l~~L~~L~l~~n~l~~~  166 (405)
                      +.+++       ..+.+|++|+.||+|........  .    +.-..+|.|+.||.|++.+.+.
T Consensus       202 mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~~~  265 (699)
T KOG3665|consen  202 MRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDINEE  265 (699)
T ss_pred             ccCCCCCchhhHHHHhcccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcchhHH
Confidence            66532       24677899999999987654221  1    1123478888898888777644

>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A

Probab=97.90  E-value=2.9e-05  Score=61.87  Aligned_cols=84  Identities=21%  Similarity=0.271  Sum_probs=35.3

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      +|.++++|+.+.+.. .+..+...+ +.++. +|+.+++..+ +.......|.++++|+.+.+.+ .+. .++...|.++
T Consensus         7 ~F~~~~~l~~i~~~~-~~~~I~~~~-F~~~~-~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~-~i~~~~F~~~   80 (129)
T PF13306_consen    7 AFYNCSNLESITFPN-TIKKIGENA-FSNCT-SLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLK-SIGDNAFSNC   80 (129)
T ss_dssp             TTTT-TT--EEEETS-T--EE-TTT-TTT-T-T-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT--EE-TTTTTT-
T ss_pred             HHhCCCCCCEEEECC-CeeEeChhh-ccccc-cccccccccc-ccccceeeeecccccccccccc-ccc-cccccccccc
Confidence            355566666666553 455544444 33333 4555555553 4444444455555555555544 332 3444445445


Q ss_pred             CCCCeeeCCC
Q 036754           86 ASLRKLSLDS   95 (405)
Q Consensus        86 ~~L~~L~Ls~   95 (405)
                      ++|+.+++..
T Consensus        81 ~~l~~i~~~~   90 (129)
T PF13306_consen   81 TNLKNIDIPS   90 (129)
T ss_dssp             TTECEEEETT
T ss_pred             ccccccccCc
Confidence            5555555544

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=97.90  E-value=1.9e-05  Score=76.08  Aligned_cols=66  Identities=30%  Similarity=0.479  Sum_probs=61.6

Q ss_pred             hhcCCCCCcceEEeeeecCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          340 MKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       340 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |..+.|.|+.+++|.+..+...++|.+||+.|+|.+.+......++|.-...+.++|+.||+|+|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~   66 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN   66 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc
Confidence            356789999999999999999999999999999999998877789999999999999999999995

>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only]

Probab=97.86  E-value=7e-06  Score=83.35  Aligned_cols=129  Identities=24%  Similarity=0.315  Sum_probs=95.5

Q ss_pred             CcCCeeeCcCCcCcc-cCCchhhhcccccccEEEcccCccccc-CCccccCccCCCeeecCCcccccccCcchhcCCCCC
Q 036754           11 KCLTFIDLSNNPLDS-VLPKTFVGNVSHSLEFFVMSYCNISGG-ILEEITNLTKLTTIILGGNKLNGSISITLGSNLASL   88 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~-~~~~~f~~~~~~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L   88 (405)
                      .+|+.||+++...-. ..|.. +|...++|+.|.+++-.+... ......+++||..||+|+.+++ .+ .++ ++|++|
T Consensus       122 ~nL~~LdI~G~~~~s~~W~~k-ig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~-nl-~GI-S~LknL  197 (699)
T KOG3665|consen  122 QNLQHLDISGSELFSNGWPKK-IGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNIS-NL-SGI-SRLKNL  197 (699)
T ss_pred             HhhhhcCccccchhhccHHHH-HhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCcc-Cc-HHH-hccccH
Confidence            579999999976533 23334 555555999999998777542 2344578999999999999997 44 444 689999


Q ss_pred             CeeeCCCCCCCCCc--hhhhccccCccccCCCCCh------------hccCCCCCCEEeccCCcccccC
Q 036754           89 RKLSLDSNELTSIP--LTFWNLKDILYLNFSVIPI------------EIGGLPNLEYLFLGYNRLQGSI  143 (405)
Q Consensus        89 ~~L~Ls~N~l~~lp--~~~~~l~~L~~l~l~~~p~------------~~~~l~~L~~L~l~~n~l~~~~  143 (405)
                      +.|.+.+=.+..-+  ..+++|++|+.||++.-..            .-..+|+|+.||.|+..+.+..
T Consensus       198 q~L~mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~~~~  266 (699)
T KOG3665|consen  198 QVLSMRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDINEEI  266 (699)
T ss_pred             HHHhccCCCCCchhhHHHHhcccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcchhHHH
Confidence            99999987777543  3578999999999986211            2235899999999998876533

>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]

Probab=97.84  E-value=9.8e-07  Score=77.71  Aligned_cols=151  Identities=19%  Similarity=0.169  Sum_probs=94.2

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCc-ccc-cCCccccCccCCCeeecCCcccccccCcchh-c
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCN-ISG-GILEEITNLTKLTTIILGGNKLNGSISITLG-S   83 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~-l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~   83 (405)
                      ++.|.+|+.|.|.++++...+... +..-. +|+.|+|+.+. ++. ...-.+.+++.|..|+|+.|.++...-..+. .
T Consensus       206 Ls~C~kLk~lSlEg~~LdD~I~~~-iAkN~-~L~~lnlsm~sG~t~n~~~ll~~scs~L~~LNlsWc~l~~~~Vtv~V~h  283 (419)
T KOG2120|consen  206 LSQCSKLKNLSLEGLRLDDPIVNT-IAKNS-NLVRLNLSMCSGFTENALQLLLSSCSRLDELNLSWCFLFTEKVTVAVAH  283 (419)
T ss_pred             HHHHHhhhhccccccccCcHHHHH-Hhccc-cceeeccccccccchhHHHHHHHhhhhHhhcCchHhhccchhhhHHHhh
Confidence            467899999999999999888777 44444 89999999876 322 1122367889999999999987643322111 1


Q ss_pred             CCCCCCeeeCCCCCC--C--CCchhhhccccCccccCCC-------CChhccCCCCCCEEeccCCcccccCCcc---ccc
Q 036754           84 NLASLRKLSLDSNEL--T--SIPLTFWNLKDILYLNFSV-------IPIEIGGLPNLEYLFLGYNRLQGSIPDS---FGD  149 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l--~--~lp~~~~~l~~L~~l~l~~-------~p~~~~~l~~L~~L~l~~n~l~~~~p~~---~~~  149 (405)
                      --+.|+.|+|++..-  .  .+..-..+.++|.+|+++.       .-..|..++.|++|.++.|..  ++|..   +..
T Consensus       284 ise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSlsRCY~--i~p~~~~~l~s  361 (419)
T KOG2120|consen  284 ISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSLSRCYD--IIPETLLELNS  361 (419)
T ss_pred             hchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeehhhhcC--CChHHeeeecc
Confidence            235778888888632  1  2222223455666666654       112345566677777776652  34544   345


Q ss_pred             CCCCCeeecccc
Q 036754          150 LISLKSLNLSKN  161 (405)
Q Consensus       150 l~~L~~L~l~~n  161 (405)
                      .++|.+|++.+.
T Consensus       362 ~psl~yLdv~g~  373 (419)
T KOG2120|consen  362 KPSLVYLDVFGC  373 (419)
T ss_pred             CcceEEEEeccc
Confidence            566666665443

>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A

Probab=97.79  E-value=5.2e-05  Score=60.40  Aligned_cols=121  Identities=25%  Similarity=0.241  Sum_probs=55.8

Q ss_pred             hhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccC
Q 036754           32 VGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDI  111 (405)
Q Consensus        32 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L  111 (405)
                      +.++. +|+.+.+.. .+..+....|.++++|+.+.+.++ +. .++...|.++++|+.+.+.+ .+..++..       
T Consensus         8 F~~~~-~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~-~i~~~~F~~~~~l~~i~~~~-~~~~i~~~-------   75 (129)
T PF13306_consen    8 FYNCS-NLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LT-SIGDNAFSNCKSLESITFPN-NLKSIGDN-------   75 (129)
T ss_dssp             TTT-T-T--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TS-CE-TTTTTT-TT-EEEEETS-TT-EE-TT-------
T ss_pred             HhCCC-CCCEEEECC-CeeEeChhhccccccccccccccc-cc-ccceeeeecccccccccccc-cccccccc-------
Confidence            33443 677777764 465656666777777777777765 54 66666666776777777754 44444433       


Q ss_pred             ccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccC
Q 036754          112 LYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYL  177 (405)
Q Consensus       112 ~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  177 (405)
                                .|..+++|+.+++..+ +.......|.++ .|+.+.+.. .+.......|.+.++|
T Consensus        76 ----------~F~~~~~l~~i~~~~~-~~~i~~~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l  128 (129)
T PF13306_consen   76 ----------AFSNCTNLKNIDIPSN-ITEIGSSSFSNC-NLKEINIPS-NITKIEENAFKNCTKL  128 (129)
T ss_dssp             ----------TTTT-TTECEEEETTT--BEEHTTTTTT--T--EEE-TT-B-SS----GGG-----
T ss_pred             ----------cccccccccccccCcc-ccEEchhhhcCC-CceEEEECC-CccEECCccccccccC
Confidence                      2344566777777655 444445556665 777777665 3333445555555444

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=97.78  E-value=1.5e-05  Score=71.02  Aligned_cols=106  Identities=25%  Similarity=0.227  Sum_probs=80.5

Q ss_pred             cCcccccCCCceEEEe-eCCCcEEEEEEeec--cccchhHHHHHHHHHhhcCCCCCcceEEeeeecC------CeeEEEE
Q 036754          295 NNLISKGGFGSVYKAR-LGDGMEVAVKVFNL--QCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNE------EFKALVL  365 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~  365 (405)
                      ...+|.|+- .|..+. .-.+..||+|....  ......++..+|...+..+.|+|+++++.+++..      ...|+||
T Consensus        22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~  100 (369)
T KOG0665|consen   22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM  100 (369)
T ss_pred             ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence            445666666 455454 23578899988743  2234456778899999999999999999998753      4578999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||.. +|...+..   .++-.....|..|+..|++|||.
T Consensus       101 e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs  136 (369)
T KOG0665|consen  101 ELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHS  136 (369)
T ss_pred             Hhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHh
Confidence            99976 89888863   35666777899999999999994

>cd05151 ChoK Choline Kinase (ChoK)

Probab=97.75  E-value=8e-05  Score=62.37  Aligned_cols=97  Identities=15%  Similarity=0.135  Sum_probs=66.7

Q ss_pred             CcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcc-eEEeeeecCCeeEEEEecCCCCCHH
Q 036754          296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLI-KVISSCSNEEFKALVLEYMPHGSLE  374 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L~  374 (405)
                      +.++.|.++.||+++.. +..|++|....... ....+..|...+..+.+.+++ +++++.  ....++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            46789999999998864 77899998754422 223456788888888665554 444433  33457999999998765


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          375 KYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       375 ~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..    .  .   ....+..+++++++.||.
T Consensus        80 ~~----~--~---~~~~~~~~l~~~l~~LH~  101 (170)
T cd05151          80 TE----D--F---SDPENLEKIAKLLKKLHS  101 (170)
T ss_pred             cc----c--c---cCHHHHHHHHHHHHHHhC
Confidence            43    0  1   112356789999999984

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=97.74  E-value=3.1e-05  Score=76.38  Aligned_cols=34  Identities=35%  Similarity=0.451  Sum_probs=29.4

Q ss_pred             cCCccCcccccCCCceEEEeeCC-CcEEEEEEeecc
Q 036754          291 KFSENNLISKGGFGSVYKARLGD-GMEVAVKVFNLQ  325 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~-~~~vavK~~~~~  325 (405)
                      +|+. +.+|.|++|.||+|++.+ |+.||||+.+++
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~  155 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPD  155 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcc
Confidence            4554 689999999999999877 999999999754

>PRK15386 type III secretion protein GogB; Provisional

Probab=97.63  E-value=0.00015  Score=68.45  Aligned_cols=132  Identities=18%  Similarity=0.236  Sum_probs=81.6

Q ss_pred             ccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCC-CCCCCchhhhccccCcccc
Q 036754           37 HSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSN-ELTSIPLTFWNLKDILYLN  115 (405)
Q Consensus        37 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N-~l~~lp~~~~~l~~L~~l~  115 (405)
                      .+++.|++++|.++. +|. +  -.+|+.|.++++.--..+|..+   .++|++|++++| .+..+|..+..|.      
T Consensus        52 ~~l~~L~Is~c~L~s-LP~-L--P~sLtsL~Lsnc~nLtsLP~~L---P~nLe~L~Ls~Cs~L~sLP~sLe~L~------  118 (426)
T PRK15386         52 RASGRLYIKDCDIES-LPV-L--PNELTEITIENCNNLTTLPGSI---PEGLEKLTVCHCPEISGLPESVRSLE------  118 (426)
T ss_pred             cCCCEEEeCCCCCcc-cCC-C--CCCCcEEEccCCCCcccCCchh---hhhhhheEccCcccccccccccceEE------
Confidence            389999999998876 342 1  2369999998844323677654   368999999998 7888887654433      


Q ss_pred             CCC-CChhccCC-CCCCEEeccCCc-cc-ccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCc
Q 036754          116 FSV-IPIEIGGL-PNLEYLFLGYNR-LQ-GSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNK  186 (405)
Q Consensus       116 l~~-~p~~~~~l-~~L~~L~l~~n~-l~-~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~  186 (405)
                      +.. .-..+..+ ++|+.|.+.+++ .. ..+|..+  .++|++|++++|... ..|..+.  .+|+.|+++.+.
T Consensus       119 L~~n~~~~L~~LPssLk~L~I~~~n~~~~~~lp~~L--PsSLk~L~Is~c~~i-~LP~~LP--~SLk~L~ls~n~  188 (426)
T PRK15386        119 IKGSATDSIKNVPNGLTSLSINSYNPENQARIDNLI--SPSLKTLSLTGCSNI-ILPEKLP--ESLQSITLHIEQ  188 (426)
T ss_pred             eCCCCCcccccCcchHhheecccccccccccccccc--CCcccEEEecCCCcc-cCccccc--ccCcEEEecccc
Confidence            211 00112333 357777775433 11 1112111  158999999998866 3344333  478888887763

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=97.54  E-value=8.1e-05  Score=65.07  Aligned_cols=46  Identities=24%  Similarity=0.455  Sum_probs=30.9

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCch---hhhcccccccEEEcccCccc
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKT---FVGNVSHSLEFFVMSYCNIS   50 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~---f~~~~~~~L~~L~L~~n~l~   50 (405)
                      .+++-+|++|+..+||.|.+....|..   |+..- ..|+.|.|++|.+.
T Consensus        85 l~aLlkcp~l~~v~LSDNAfg~~~~e~L~d~is~~-t~l~HL~l~NnGlG  133 (388)
T COG5238          85 LKALLKCPRLQKVDLSDNAFGSEFPEELGDLISSS-TDLVHLKLNNNGLG  133 (388)
T ss_pred             HHHHhcCCcceeeeccccccCcccchHHHHHHhcC-CCceeEEeecCCCC
Confidence            456677888888888888887766654   22222 36777777777663

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=97.45  E-value=0.0001  Score=64.41  Aligned_cols=174  Identities=22%  Similarity=0.232  Sum_probs=109.2

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhccc---ccccEEEcccCccc---ccCCc-------cccCccCCCeeecCCccc
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVS---HSLEFFVMSYCNIS---GGILE-------EITNLTKLTTIILGGNKL   73 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~---~~L~~L~L~~n~l~---~~~~~-------~~~~l~~L~~L~L~~N~l   73 (405)
                      +..+..++.+|||+|-|...-... +.++.   .+|+..+++.--..   ..+++       .+..++.|+..+||+|.+
T Consensus        26 l~~~d~~~evdLSGNtigtEA~e~-l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAf  104 (388)
T COG5238          26 LEMMDELVEVDLSGNTIGTEAMEE-LCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAF  104 (388)
T ss_pred             HHhhcceeEEeccCCcccHHHHHH-HHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeecccccc
Confidence            445778999999999987654333 32221   26666666643211   12222       345789999999999999


Q ss_pred             ccccCcch---hcCCCCCCeeeCCCCCCCCCch-hhhc-cccCccccCCCCChhccCCCCCCEEeccCCcccccCCcc--
Q 036754           74 NGSISITL---GSNLASLRKLSLDSNELTSIPL-TFWN-LKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDS--  146 (405)
Q Consensus        74 ~~~~~~~~---~~~l~~L~~L~Ls~N~l~~lp~-~~~~-l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~--  146 (405)
                      ....|..+   .+.-+.|++|.|++|.+..+.. .+++ |..|-+..      ...+-|.|+......|++.. .|..  
T Consensus       105 g~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nK------Kaa~kp~Le~vicgrNRlen-gs~~~~  177 (388)
T COG5238         105 GSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNK------KAADKPKLEVVICGRNRLEN-GSKELS  177 (388)
T ss_pred             CcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHh------hhccCCCceEEEeccchhcc-CcHHHH
Confidence            76666543   3567899999999999985532 2221 11111111      22345788999999998863 2321  


Q ss_pred             ---cccCCCCCeeecccccccCc-----cchhHHhcccCCccccccCccc
Q 036754          147 ---FGDLISLKSLNLSKNNLSGA-----IPASLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       147 ---~~~l~~L~~L~l~~n~l~~~-----~~~~~~~l~~L~~l~l~~n~l~  188 (405)
                         +..-..|+++.+..|.|...     .-..+..+.+|+.|++..|-++
T Consensus       178 a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft  227 (388)
T COG5238         178 AALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFT  227 (388)
T ss_pred             HHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchh
Confidence               23335788888888877521     1113345678888888888776

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=97.41  E-value=0.00067  Score=64.86  Aligned_cols=104  Identities=18%  Similarity=0.131  Sum_probs=75.3

Q ss_pred             CCCceEEEe-eCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeec----CCeeEEEEecCCC-CCHHH
Q 036754          302 GFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN----EEFKALVLEYMPH-GSLEK  375 (405)
Q Consensus       302 ~fg~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~  375 (405)
                      .-.+.|++. -.+|..|++|+++............-++.++++.|.|+|++...+.+    ...+.+||+|.|+ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            345778888 46899999999954333323233345678899999999999987763    4578899999986 56766


Q ss_pred             HHhcC--------------CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          376 YLYSS--------------NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       376 ~l~~~--------------~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +-...              +....+...-.++.|++.||.|+|+
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs  411 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS  411 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh
Confidence            54321              1235566677889999999999996

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=97.33  E-value=9.8e-05  Score=74.24  Aligned_cols=110  Identities=20%  Similarity=0.237  Sum_probs=77.1

Q ss_pred             ccCcccccCCCceEEEee-CCCcEEEEEEee----ccc-c-chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          294 ENNLISKGGFGSVYKARL-GDGMEVAVKVFN----LQC-R-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~----~~~-~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ...++|.|++|.|+..+. ...+..+.|..+    ... . .....+..|..+-..++|+|++.....+.+....+-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            457789999997776663 233333444332    111 1 111225557777788999999887776665555444599


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||++ ||+..+... ..++..++..++.|+..|++|+|+
T Consensus       402 ~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~  438 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHS  438 (601)
T ss_pred             cccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHh
Confidence            9999 999999764 258888999999999999999995

>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only]

Probab=97.22  E-value=0.00019  Score=62.54  Aligned_cols=96  Identities=21%  Similarity=0.342  Sum_probs=57.3

Q ss_pred             cccEEEcccCcccccCCccccCccCCCeeecCCc--ccccccCcchhcCCCCCCeeeCCCCCCCCCc--hhhhccccCcc
Q 036754           38 SLEFFVMSYCNISGGILEEITNLTKLTTIILGGN--KLNGSISITLGSNLASLRKLSLDSNELTSIP--LTFWNLKDILY  113 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N--~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp--~~~~~l~~L~~  113 (405)
                      .|+.|.+.+..++.  -..|..|++|+.|.++.|  ++++.++.-+ ..+++|++|+|++|+|..+.  ..+..+.+|..
T Consensus        44 ~le~ls~~n~gltt--~~~~P~Lp~LkkL~lsdn~~~~~~~l~vl~-e~~P~l~~l~ls~Nki~~lstl~pl~~l~nL~~  120 (260)
T KOG2739|consen   44 ELELLSVINVGLTT--LTNFPKLPKLKKLELSDNYRRVSGGLEVLA-EKAPNLKVLNLSGNKIKDLSTLRPLKELENLKS  120 (260)
T ss_pred             chhhhhhhccceee--cccCCCcchhhhhcccCCcccccccceehh-hhCCceeEEeecCCccccccccchhhhhcchhh
Confidence            56666666666653  234556778888888888  5555555443 35688888888888776321  12335556666


Q ss_pred             ccCCCCCh---------hccCCCCCCEEeccC
Q 036754          114 LNFSVIPI---------EIGGLPNLEYLFLGY  136 (405)
Q Consensus       114 l~l~~~p~---------~~~~l~~L~~L~l~~  136 (405)
                      |++...+.         .|.-+++|++||--.
T Consensus       121 Ldl~n~~~~~l~dyre~vf~ll~~L~~LD~~d  152 (260)
T KOG2739|consen  121 LDLFNCSVTNLDDYREKVFLLLPSLKYLDGCD  152 (260)
T ss_pred             hhcccCCccccccHHHHHHHHhhhhccccccc
Confidence            66654322         234466777665443

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=97.21  E-value=0.00043  Score=65.87  Aligned_cols=109  Identities=23%  Similarity=0.252  Sum_probs=81.1

Q ss_pred             CccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCC------CCcceEEeeeecCCeeEEEE
Q 036754          293 SENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH------QNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~~~~~lv~  365 (405)
                      ......|+|-|++|.+|.. ..|..||||+++.+ ..+.+.=+.|++++.++..      -+.++++-.|...+.++||+
T Consensus       435 ~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVF  513 (752)
T KOG0670|consen  435 EVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVF  513 (752)
T ss_pred             EEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEe
Confidence            3344579999999999984 56789999999754 2333444678999998842      36788888888889999999


Q ss_pred             ecCCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHhhh
Q 036754          366 EYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYL  403 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yL  403 (405)
                      |-+.- +|.+.|..-+  ..+.......++.|+.-||..|
T Consensus       514 E~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklL  552 (752)
T KOG0670|consen  514 EPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLL  552 (752)
T ss_pred             hhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHH
Confidence            97654 8888887533  3466666677888887777665

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=97.20  E-value=0.0012  Score=64.92  Aligned_cols=89  Identities=21%  Similarity=0.217  Sum_probs=67.4

Q ss_pred             eCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHH
Q 036754          311 LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL  390 (405)
Q Consensus       311 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~  390 (405)
                      ..++.+|.|...+...........+.+..++.++||||++++..+..+...|||+|-+.-  |..++...    ......
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l----~~~~v~  107 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKEL----GKEEVC  107 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHh----HHHHHH
Confidence            456788888887654443334456778889999999999999999999999999998753  66666542    234444


Q ss_pred             HHHHHHHHHHhhhcC
Q 036754          391 NIMIDVASALEYLHF  405 (405)
Q Consensus       391 ~i~~~ia~gl~yLH~  405 (405)
                      -.+.||+.||.|||+
T Consensus       108 ~Gl~qIl~AL~FL~~  122 (690)
T KOG1243|consen  108 LGLFQILAALSFLND  122 (690)
T ss_pred             HHHHHHHHHHHHHhc
Confidence            567899999999984

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.19  E-value=0.00016  Score=64.97  Aligned_cols=67  Identities=27%  Similarity=0.352  Sum_probs=54.7

Q ss_pred             HhhcCCCCCcceEEeeeecCC-----eeEEEEecCCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          339 MMKSIRHQNLIKVISSCSNEE-----FKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       339 ~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      -+-.+.|.|||+++.|+.+.+     +..++.|||..|++..+|+..+   ..+......+++.||..||.|||.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs  194 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS  194 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc
Confidence            355667999999999987643     4678899999999999998643   456666778899999999999995

>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only]

Probab=97.18  E-value=0.00021  Score=62.23  Aligned_cols=104  Identities=23%  Similarity=0.260  Sum_probs=72.6

Q ss_pred             CCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccC--cccccCCccccCccCCCeeecCCcccccccCcch--hcC
Q 036754            9 NCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYC--NISGGILEEITNLTKLTTIILGGNKLNGSISITL--GSN   84 (405)
Q Consensus         9 ~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~--~~~   84 (405)
                      .+..|+.|.+.+..+++...   +-.++ +|+.|.++.|  .+.+.++-....+++|++|+|++|+|.  ++.++  ...
T Consensus        41 ~~~~le~ls~~n~gltt~~~---~P~Lp-~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~--~lstl~pl~~  114 (260)
T KOG2739|consen   41 EFVELELLSVINVGLTTLTN---FPKLP-KLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIK--DLSTLRPLKE  114 (260)
T ss_pred             cccchhhhhhhccceeeccc---CCCcc-hhhhhcccCCcccccccceehhhhCCceeEEeecCCccc--cccccchhhh
Confidence            34567777777777765432   22334 8999999999  666666666667799999999999986  12222  136


Q ss_pred             CCCCCeeeCCCCCCCCCch----hhhccccCccccCCC
Q 036754           85 LASLRKLSLDSNELTSIPL----TFWNLKDILYLNFSV  118 (405)
Q Consensus        85 l~~L~~L~Ls~N~l~~lp~----~~~~l~~L~~l~l~~  118 (405)
                      +.+|..|++.+|..+.+..    .|.-+++|++|+-..
T Consensus       115 l~nL~~Ldl~n~~~~~l~dyre~vf~ll~~L~~LD~~d  152 (260)
T KOG2739|consen  115 LENLKSLDLFNCSVTNLDDYREKVFLLLPSLKYLDGCD  152 (260)
T ss_pred             hcchhhhhcccCCccccccHHHHHHHHhhhhccccccc
Confidence            7889999999998876532    244567888887543

>KOG2123 consensus Uncharacterized conserved protein [Function unknown]

Probab=97.13  E-value=4e-05  Score=67.13  Aligned_cols=87  Identities=21%  Similarity=0.222  Sum_probs=51.6

Q ss_pred             cccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCC
Q 036754           38 SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS  117 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~  117 (405)
                      +.+.|++-+|.+..+  .....|+.|++|.||-|+|+ ++..  +..+++|++|+|..|.|.++.+-.            
T Consensus        20 ~vkKLNcwg~~L~DI--sic~kMp~lEVLsLSvNkIs-sL~p--l~rCtrLkElYLRkN~I~sldEL~------------   82 (388)
T KOG2123|consen   20 NVKKLNCWGCGLDDI--SICEKMPLLEVLSLSVNKIS-SLAP--LQRCTRLKELYLRKNCIESLDELE------------   82 (388)
T ss_pred             HhhhhcccCCCccHH--HHHHhcccceeEEeeccccc-cchh--HHHHHHHHHHHHHhcccccHHHHH------------
Confidence            556666667766542  23456677777777777776 4332  246677777777777766543221            


Q ss_pred             CCChhccCCCCCCEEeccCCcccccCCc
Q 036754          118 VIPIEIGGLPNLEYLFLGYNRLQGSIPD  145 (405)
Q Consensus       118 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~  145 (405)
                          .+.++|+|+.|.|..|+-.|.-+.
T Consensus        83 ----YLknlpsLr~LWL~ENPCc~~ag~  106 (388)
T KOG2123|consen   83 ----YLKNLPSLRTLWLDENPCCGEAGQ  106 (388)
T ss_pred             ----HHhcCchhhhHhhccCCcccccch
Confidence                234456666666766666554443

>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=96.95  E-value=0.00024  Score=37.27  Aligned_cols=17  Identities=41%  Similarity=0.538  Sum_probs=8.9

Q ss_pred             CCeeecCCcccccccCcc
Q 036754           63 LTTIILGGNKLNGSISIT   80 (405)
Q Consensus        63 L~~L~L~~N~l~~~~~~~   80 (405)
                      |++|||++|+|+ .+|.+
T Consensus         2 L~~Ldls~n~l~-~ip~~   18 (22)
T PF00560_consen    2 LEYLDLSGNNLT-SIPSS   18 (22)
T ss_dssp             ESEEEETSSEES-EEGTT
T ss_pred             ccEEECCCCcCE-eCChh
Confidence            455555555555 45544

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....

>KOG2123 consensus Uncharacterized conserved protein [Function unknown]

Probab=96.94  E-value=5.9e-05  Score=66.13  Aligned_cols=82  Identities=26%  Similarity=0.280  Sum_probs=42.9

Q ss_pred             CCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccC-cchhcCCCCC
Q 036754           10 CKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSIS-ITLGSNLASL   88 (405)
Q Consensus        10 l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~l~~L   88 (405)
                      +.+.+.|++.++.|+.+--   ...++ .|+.|.|+-|+|+..  ..|..+++|+.|+|..|.|. .+. -....++++|
T Consensus        18 l~~vkKLNcwg~~L~DIsi---c~kMp-~lEVLsLSvNkIssL--~pl~rCtrLkElYLRkN~I~-sldEL~YLknlpsL   90 (388)
T KOG2123|consen   18 LENVKKLNCWGCGLDDISI---CEKMP-LLEVLSLSVNKISSL--APLQRCTRLKELYLRKNCIE-SLDELEYLKNLPSL   90 (388)
T ss_pred             HHHhhhhcccCCCccHHHH---HHhcc-cceeEEeeccccccc--hhHHHHHHHHHHHHHhcccc-cHHHHHHHhcCchh
Confidence            3445556666666554311   22333 566666666666542  33455666666666666665 222 1223456666


Q ss_pred             CeeeCCCCCC
Q 036754           89 RKLSLDSNEL   98 (405)
Q Consensus        89 ~~L~Ls~N~l   98 (405)
                      +.|.|..|.-
T Consensus        91 r~LWL~ENPC  100 (388)
T KOG2123|consen   91 RTLWLDENPC  100 (388)
T ss_pred             hhHhhccCCc
Confidence            6666666543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=96.80  E-value=0.00062  Score=71.73  Aligned_cols=63  Identities=17%  Similarity=0.294  Sum_probs=49.2

Q ss_pred             cCCC-CCcceEEeeee-------cCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          342 SIRH-QNLIKVISSCS-------NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       342 ~l~h-~niv~l~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++| +||+++++++.       ..+..+.++||+ +++|.++|......+++.++..++.||++||+|||+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~   98 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS   98 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh
Confidence            3445 57777888762       224566778887 459999997655579999999999999999999995

>PLN02876 acyl-CoA dehydrogenase

Probab=96.73  E-value=0.0081  Score=63.46  Aligned_cols=108  Identities=15%  Similarity=0.194  Sum_probs=75.9

Q ss_pred             cCcccccCCCceEEEeeCCC---cEEEEEEeecccc-chhHHHHHHHHHhhcCC-CCCc--ceEEeeeecC---CeeEEE
Q 036754          295 NNLISKGGFGSVYKARLGDG---MEVAVKVFNLQCR-RAFKSFDIECEMMKSIR-HQNL--IKVISSCSNE---EFKALV  364 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  364 (405)
                      ...++.|.+..+|+.....+   ..+++|+...... .....+.+|.+++..+. |.++  .+++++|.+.   ...|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            35578899999998876543   3567776543321 23346788999999885 6665  7778887664   467899


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++..+.+.   .-..++..++..++.+++++|+.||.
T Consensus       123 ME~v~G~~~~~~---~~~~~~~~~r~~l~~~l~~~La~LH~  160 (822)
T PLN02876        123 MEYLEGRIFVDP---KLPGVAPERRRAIYRATAKVLAALHS  160 (822)
T ss_pred             EEecCCcccCCc---cCCCCCHHHHHHHHHHHHHHHHHHhC
Confidence            999997543321   11235667788899999999999995

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	405
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-13
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-12
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		9e-11
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-10
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		6e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-06
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-06
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-06
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-06
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-06
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-06
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-06
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-05
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-05
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-05
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-05
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-05
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-05
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-05
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-05
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-05
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-05
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-05
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-05
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-05
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-05
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-05
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-05
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-05
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-05
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-05
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-05
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-05
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-05
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-05
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-05
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-05
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-05
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-05
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-05
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-05
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-05
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-05
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-05
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-05
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-05
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-05
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-05
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-05
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-05
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-05
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-05
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-05
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-05
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-05
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-05
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-05
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-05
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-05
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-05
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-05
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-05
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-05
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-05
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-05
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-04
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-04
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-04
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-04
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-04
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-04
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-04
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-04
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-04
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-04
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-04
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-04
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-04
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-04
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-04
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-04
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-04
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-04
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-04
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-04
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-04
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-04
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-04
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-04
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-04
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-04
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-04
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-04
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-04
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-04
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-04
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-04
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-04
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-04
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-04
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-04
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-04
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-04
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-04
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-04
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-04
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-04
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-04
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-04
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-04
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-04
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-04
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-04
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-04
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-04
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-04
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-04
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-04
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-04
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-04
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-04
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-04
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-04
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-04
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-04
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-04
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-04
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-04
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-04
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-04
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-04
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-04
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-04
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-04
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-04
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-04
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-04
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-04
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-04
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-04
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-04
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-04
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-04
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/131 (36%), Positives = 66/131 (50%), Gaps = 4/131 (3%)
Query: 278 RMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK-SFDIE 336
           + FS  EL  A+  FS  N++ +GGFG VYK RL DG  VAVK    +  +  +  F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 337 CEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---SSNCILDIFQRLNIM 393
            EM+    H+NL+++   C     + LV  YM +GS+   L     S   LD  +R  I 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 394 IDVASALEYLH 404
           +  A  L YLH
Sbjct: 146 LGSARGLAYLH 156

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/131 (35%), Positives = 65/131 (49%), Gaps = 4/131 (3%)
Query: 278 RMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK-SFDIE 336
           + FS  EL  A+  F   N++ +GGFG VYK RL DG  VAVK    +  +  +  F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 337 CEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---SSNCILDIFQRLNIM 393
            EM+    H+NL+++   C     + LV  YM +GS+   L     S   LD  +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 394 IDVASALEYLH 404
           +  A  L YLH
Sbjct: 138 LGSARGLAYLH 148

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 65/125 (52%), Gaps = 3/125 (2%)
Query: 283 LELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKS 342
           ++L  AT  F    LI  G FG VYK  L DG +VA+K    +  +  + F+ E E +  
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASA 399
            RH +L+ +I  C       L+ +YM +G+L+++LY S+     +   QRL I I  A  
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 400 LEYLH 404
           L YLH
Sbjct: 152 LHYLH 156

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 65/125 (52%), Gaps = 3/125 (2%)
Query: 283 LELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKS 342
           ++L  AT  F    LI  G FG VYK  L DG +VA+K    +  +  + F+ E E +  
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASA 399
            RH +L+ +I  C       L+ +YM +G+L+++LY S+     +   QRL I I  A  
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 400 LEYLH 404
           L YLH
Sbjct: 152 LHYLH 156

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/136 (33%), Positives = 55/136 (40%), Gaps = 8/136 (5%)
Query: 104 TFWNLKDILYLNFSV------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLIXXXXXX 157
           TF N   +++L+ S       IP EIG +P L  L LG+N + GSIPD  GDL       
Sbjct: 624 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILD 683
Query: 158 XXXXXXXGAIPASXXXXXXXXXXXXSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNL 217
                  G IP +            S N L G IP  G F  F    F  N  LCG P  
Sbjct: 684 LSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP 743
Query: 218 QVQPCKTG--IHHTSS 231
           +  P       HH  S
Sbjct: 744 RCDPSNADGYAHHQRS 759

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/124 (34%), Positives = 52/124 (41%), Gaps = 6/124 (4%)
Query: 104 TFWNLKDILYLNFSV------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLIXXXXXX 157
           TF N   +++L+ S       IP EIG +P L  L LG+N + GSIPD  GDL       
Sbjct: 627 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILD 686
Query: 158 XXXXXXXGAIPASXXXXXXXXXXXXSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNL 217
                  G IP +            S N L G IP  G F  F    F  N  LCG P  
Sbjct: 687 LSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP 746
Query: 218 QVQP 221
           +  P
Sbjct: 747 RCDP 750

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 62/129 (48%), Gaps = 12/129 (9%)
Query: 287 RATYKFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIE 336
           R   +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E
Sbjct: 33  RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 92
Query: 337 CEMMKSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 394
            E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 395 DVASALEYL 403
            +   +EYL
Sbjct: 153 QICKGMEYL 161

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 62/129 (48%), Gaps = 12/129 (9%)
Query: 287 RATYKFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIE 336
           R   +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 337 CEMMKSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 394
            E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 124
Query: 395 DVASALEYL 403
            +   +EYL
Sbjct: 125 QICKGMEYL 133

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 62/129 (48%), Gaps = 12/129 (9%)
Query: 287 RATYKFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIE 336
           R   +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E
Sbjct: 9   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 68
Query: 337 CEMMKSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 394
            E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 69  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 128
Query: 395 DVASALEYL 403
            +   +EYL
Sbjct: 129 QICKGMEYL 137

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 62/129 (48%), Gaps = 12/129 (9%)
Query: 287 RATYKFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIE 336
           R   +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E
Sbjct: 6   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 65
Query: 337 CEMMKSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 394
            E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 66  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 125
Query: 395 DVASALEYL 403
            +   +EYL
Sbjct: 126 QICKGMEYL 134

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 62/129 (48%), Gaps = 12/129 (9%)
Query: 287 RATYKFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIE 336
           R   +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E
Sbjct: 2   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 61
Query: 337 CEMMKSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 394
            E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 395 DVASALEYL 403
            +   +EYL
Sbjct: 122 QICKGMEYL 130

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 62/129 (48%), Gaps = 12/129 (9%)
Query: 287 RATYKFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIE 336
           R   +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E
Sbjct: 7   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 66
Query: 337 CEMMKSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 394
            E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 67  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 126
Query: 395 DVASALEYL 403
            +   +EYL
Sbjct: 127 QICKGMEYL 135

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 62/129 (48%), Gaps = 12/129 (9%)
Query: 287 RATYKFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIE 336
           R   +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E
Sbjct: 8   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 67
Query: 337 CEMMKSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 394
            E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 68  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 127
Query: 395 DVASALEYL 403
            +   +EYL
Sbjct: 128 QICKGMEYL 136

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 62/129 (48%), Gaps = 12/129 (9%)
Query: 287 RATYKFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIE 336
           R   +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E
Sbjct: 1   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 60
Query: 337 CEMMKSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 394
            E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 61  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 120
Query: 395 DVASALEYL 403
            +   +EYL
Sbjct: 121 QICKGMEYL 129

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 62/129 (48%), Gaps = 12/129 (9%)
Query: 287 RATYKFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIE 336
           R   +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E
Sbjct: 3   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 62
Query: 337 CEMMKSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 394
            E++KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 63  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 122
Query: 395 DVASALEYL 403
            +   +EYL
Sbjct: 123 QICKGMEYL 131

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 60/111 (54%), Gaps = 5/111 (4%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK--SFDIECEMMKSIRHQNLIKVISSC 355
           I  G FG+V++A    G +VAVK+   Q   A +   F  E  +MK +RH N++  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLH 404
           +     ++V EY+  GSL + L+ S     LD  +RL++  DVA  + YLH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 63/129 (48%), Gaps = 12/129 (9%)
Query: 287 RATYKFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIE 336
           R   +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 337 CEMMKSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 394
            E++KS++H N++K    C +   +   L++EY+P+GSL  YL +    +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS 124
Query: 395 DVASALEYL 403
            +   +EYL
Sbjct: 125 QICKGMEYL 133

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 60/111 (54%), Gaps = 5/111 (4%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK--SFDIECEMMKSIRHQNLIKVISSC 355
           I  G FG+V++A    G +VAVK+   Q   A +   F  E  +MK +RH N++  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLH 404
           +     ++V EY+  GSL + L+ S     LD  +RL++  DVA  + YLH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 61/125 (48%), Gaps = 12/125 (9%)
Query: 291 KFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIECEMM 340
           +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E E++
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 341 KSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 398
           KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 399 ALEYL 403
            +EYL
Sbjct: 144 GMEYL 148

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 61/125 (48%), Gaps = 12/125 (9%)
Query: 291 KFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIECEMM 340
           +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E E++
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 341 KSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 398
           KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 399 ALEYL 403
            +EYL
Sbjct: 144 GMEYL 148

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 61/125 (48%), Gaps = 12/125 (9%)
Query: 291 KFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIECEMM 340
           +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E E++
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 341 KSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 398
           KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 399 ALEYL 403
            +EYL
Sbjct: 126 GMEYL 130

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 61/125 (48%), Gaps = 12/125 (9%)
Query: 291 KFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIECEMM 340
           +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E E++
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 341 KSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 398
           KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 399 ALEYL 403
            +EYL
Sbjct: 126 GMEYL 130

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 61/125 (48%), Gaps = 12/125 (9%)
Query: 291 KFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIECEMM 340
           +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E E++
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 63
Query: 341 KSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 398
           KS++H N++K    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 123
Query: 399 ALEYL 403
            +EYL
Sbjct: 124 GMEYL 128

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 63/129 (48%), Gaps = 12/129 (9%)
Query: 287 RATYKFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIE 336
           R   +F E +L     + KG FGSV   R   L D  G  VAVK          + F+ E
Sbjct: 5   RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 337 CEMMKSIRHQNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 394
            E++KS++H N++K    C +   +   L++E++P+GSL +YL      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS 124
Query: 395 DVASALEYL 403
            +   +EYL
Sbjct: 125 QICKGMEYL 133

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 56/106 (52%), Gaps = 6/106 (5%)
Query: 304 GSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNE--E 359
           G ++K R   G ++ VKV  ++    R  + F+ EC  ++   H N++ V+ +C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 360 FKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLH 404
              L+  +MP+GSL   L+  +N ++D  Q +   +D+A  + +LH
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 280 FSYLELCRATYKFSEN------NLISKGGFGSVYKARLGDGMEVAVK----VFNLQCRRA 329
           FS+ EL   T  F E       N + +GGFG VYK  + +   VAVK    + ++     
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 330 FKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----L 384
            + FD E ++M   +H+NL++++   S+ +   LV  YMP+GSL   L   +C+     L
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGTPPL 130
Query: 385 DIFQRLNIMIDVASALEYLH 404
               R  I    A+ + +LH
Sbjct: 131 SWHMRCKIAQGAANGINFLH 150

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 280 FSYLELCRATYKFSEN------NLISKGGFGSVYKARLGDGMEVAVK----VFNLQCRRA 329
           FS+ EL   T  F E       N + +GGFG VYK  + +   VAVK    + ++     
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 330 FKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----L 384
            + FD E ++M   +H+NL++++   S+ +   LV  YMP+GSL   L   +C+     L
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGTPPL 124
Query: 385 DIFQRLNIMIDVASALEYLH 404
               R  I    A+ + +LH
Sbjct: 125 SWHMRCKIAQGAANGINFLH 144

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 280 FSYLELCRATYKFSEN------NLISKGGFGSVYKARLGDGMEVAVK----VFNLQCRRA 329
           FS+ EL   T  F E       N + +GGFG VYK  + +   VAVK    + ++     
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 330 FKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----L 384
            + FD E ++M   +H+NL++++   S+ +   LV  YMP+GSL   L   +C+     L
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGTPPL 130
Query: 385 DIFQRLNIMIDVASALEYLH 404
               R  I    A+ + +LH
Sbjct: 131 SWHMRCKIAQGAANGINFLH 150

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 60/132 (45%), Gaps = 24/132 (18%)
Query: 298 ISKGGFGSVYKAR------LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKV 351
           + +G FG V+ A         D M VAVK        A K F  E E++ +++H++++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYS---------------SNCILDIFQRLNIMIDV 396
              C + +   +V EYM HG L K+L +               +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 397 ASALEYL---HF 405
           AS + YL   HF
Sbjct: 143 ASGMVYLASQHF 154

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNL--QCRRAFKSFDIECEMMKSIRHQNLIKVISS 354
           I  G FG+VYK +  GD   VAVK+  +       F++F  E  +++  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            + +   A+V ++    SL K+L+       +FQ ++I    A  ++YLH
Sbjct: 101 MTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH 149

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 6/88 (6%)
Query: 298 ISKGGFGSVYKARL------GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKV 351
           + +G FG V+ A         D M VAVK        A + F  E E++  ++HQ++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYS 379
              C+      +V EYM HG L ++L S
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRS 107

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 6/88 (6%)
Query: 298 ISKGGFGSVYKARL------GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKV 351
           + +G FG V+ A         D M VAVK        A + F  E E++  ++HQ++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYS 379
              C+      +V EYM HG L ++L S
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRS 113

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/106 (26%), Positives = 53/106 (50%), Gaps = 6/106 (5%)
Query: 304 GSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNE--E 359
           G ++K R   G ++ VKV  ++    R  + F+ EC  ++   H N++ V+ +C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 360 FKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLH 404
              L+  + P+GSL   L+  +N ++D  Q +   +D A    +LH
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH 128

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 6/88 (6%)
Query: 298 ISKGGFGSVYKARL------GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKV 351
           + +G FG V+ A         D M VAVK        A + F  E E++  ++HQ++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYS 379
              C+      +V EYM HG L ++L S
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRS 136

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 10/115 (8%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNL-------QCRRAFKSFDIECEMMKSIRHQNLI 349
           I KGGFG V+K RL  D   VA+K   L       +    F+ F  E  +M ++ H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           K+     N     +V+E++P G L   L      +    +L +M+D+A  +EY+ 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 10/115 (8%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNL-------QCRRAFKSFDIECEMMKSIRHQNLI 349
           I KGGFG V+K RL  D   VA+K   L       +    F+ F  E  +M ++ H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           K+     N     +V+E++P G L   L      +    +L +M+D+A  +EY+ 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 10/115 (8%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNL-------QCRRAFKSFDIECEMMKSIRHQNLI 349
           I KGGFG V+K RL  D   VA+K   L       +    F+ F  E  +M ++ H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           K+     N     +V+E++P G L   L      +    +L +M+D+A  +EY+ 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 20/129 (15%)
Query: 295 NNLISKGGFGSVYKARLG-DG--MEVAVKVFN-LQCRRAFKSFDIECEMM-KSIRHQNLI 349
            ++I +G FG V KAR+  DG  M+ A+K       +   + F  E E++ K   H N+I
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMI 394
            ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q L+   
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 395 DVASALEYL 403
           DVA  ++YL
Sbjct: 147 DVARGMDYL 155

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/112 (28%), Positives = 53/112 (47%), Gaps = 10/112 (8%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAF-----KSFDIECEMMKSIRHQNLIKV 351
           I +G FG V+  RL  D   VAVK     CR          F  E  ++K   H N++++
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           I  C+ ++   +V+E +  G    +L +    L +   L ++ D A+ +EYL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 20/129 (15%)
Query: 295 NNLISKGGFGSVYKARLG-DG--MEVAVKVFN-LQCRRAFKSFDIECEMM-KSIRHQNLI 349
            ++I +G FG V KAR+  DG  M+ A+K       +   + F  E E++ K   H N+I
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMI 394
            ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q L+   
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 395 DVASALEYL 403
           DVA  ++YL
Sbjct: 140 DVARGMDYL 148

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/112 (28%), Positives = 53/112 (47%), Gaps = 10/112 (8%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAF-----KSFDIECEMMKSIRHQNLIKV 351
           I +G FG V+  RL  D   VAVK     CR          F  E  ++K   H N++++
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           I  C+ ++   +V+E +  G    +L +    L +   L ++ D A+ +EYL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 20/129 (15%)
Query: 295 NNLISKGGFGSVYKARLG-DG--MEVAVKVFN-LQCRRAFKSFDIECEMM-KSIRHQNLI 349
            ++I +G FG V KAR+  DG  M+ A+K       +   + F  E E++ K   H N+I
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMI 394
            ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q L+   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 395 DVASALEYL 403
           DVA  ++YL
Sbjct: 150 DVARGMDYL 158

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 298 ISKGGFGSVYKARL------GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKV 351
           + +G FG V+ A         D + VAVK        A K F  E E++ +++H++++K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYL 377
              C   +   +V EYM HG L K+L
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFL 106

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 54/115 (46%), Gaps = 9/115 (7%)
Query: 295 NNLISKGGFGSVYKA-RLGDGMEVAVKVF----NLQCRRAFKSFDIECEMMKSIRHQNLI 349
             +I  GGFG VY+A  +GD  EVAVK      +    +  ++   E ++   ++H N+I
Sbjct: 12  EEIIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +   C  E    LV+E+   G L + L       DI   +N  + +A  + YLH
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLH 122

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/117 (26%), Positives = 55/117 (47%), Gaps = 6/117 (5%)
Query: 293 SENNLISKGGFGSVYKARLGDG---MEVAVKVFNLQCRRAFKS---FDIECEMMKSIRHQ 346
           +   +I  G FG VYK  L       EV V +  L+     K    F  E  +M    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 347 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           N+I++    S  +   ++ EYM +G+L+K+L   +    + Q + ++  +A+ ++YL
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 19/143 (13%)
Query: 277 WRMFSYLELCRATYKFSEN------NLISKGGFGSVYKARLGDGMEVAVK----VFNLQC 326
           +  FS+ EL   T  F E       N   +GGFG VYK  + +   VAVK    + ++  
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 61
Query: 327 RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--- 383
               + FD E ++    +H+NL++++   S+ +   LV  Y P+GSL   L   +C+   
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL---SCLDGT 118
Query: 384 --LDIFQRLNIMIDVASALEYLH 404
             L    R  I    A+ + +LH
Sbjct: 119 PPLSWHXRCKIAQGAANGINFLH 141

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 3/105 (2%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY        + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 43  GQYGEVYVGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTLEP 101
Query: 360 FKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYL 403
              +V EYMP+G+L  YL   N   +     L +   ++SA+EYL
Sbjct: 102 PFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYL 146

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  E   +  G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 5   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 61
Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +HQ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + +
Sbjct: 62  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 120
Query: 403 LH 404
           + 
Sbjct: 121 IE 122

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 58/110 (52%), Gaps = 7/110 (6%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISS 354
           I  G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  +  A+V ++    SL  +L++S    ++ + ++I    A  ++YLH
Sbjct: 89  STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  E   +  G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 18  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 74
Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +HQ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + +
Sbjct: 75  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 133
Query: 403 LH 404
           + 
Sbjct: 134 IE 135

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 58/110 (52%), Gaps = 7/110 (6%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISS 354
           I  G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  +  A+V ++    SL  +L++S    ++ + ++I    A  ++YLH
Sbjct: 77  STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 125

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 54/111 (48%), Gaps = 5/111 (4%)
Query: 298 ISKGGFGSVYKARLGDG-MEVAVKV-FNLQCRRAFKSFDI--ECEMMKSIRHQNLIKVIS 353
           + KG FG+VY AR       VA+KV F  Q  +      +  E E+   + H N++++ +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 354 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
              +     L+LEY P G L K L  S C  D  +   IM ++A AL Y H
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKS-CTFDEQRTATIMEELADALMYCH 140

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  E   +  G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 17  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 73
Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +HQ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + +
Sbjct: 74  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 132
Query: 403 LH 404
           + 
Sbjct: 133 IE 134

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  E   +  G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 11  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 67
Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +HQ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + +
Sbjct: 68  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 126
Query: 403 LH 404
           + 
Sbjct: 127 IE 128

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  E   +  G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 65
Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +HQ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + +
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 403 LH 404
           + 
Sbjct: 125 IE 126

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  E   +  G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 65
Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +HQ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + +
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 403 LH 404
           + 
Sbjct: 125 IE 126

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  E   +  G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 10  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 66
Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +HQ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + +
Sbjct: 67  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 125
Query: 403 LH 404
           + 
Sbjct: 126 IE 127

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  E   +  G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 15  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 71
Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +HQ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + +
Sbjct: 72  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 403 LH 404
           + 
Sbjct: 131 IE 132

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  E   +  G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 19  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 75
Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +HQ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + +
Sbjct: 76  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 134
Query: 403 LH 404
           + 
Sbjct: 135 IE 136

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  E   +  G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 65
Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +HQ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + +
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 403 LH 404
           + 
Sbjct: 125 IE 126

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/111 (24%), Positives = 52/111 (46%), Gaps = 4/111 (3%)
Query: 296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVIS 353
            LI KG FG VY  R     EVA+++ +++       K+F  E    +  RH+N++  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 354 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +C +    A++       +L   +  +  +LD+ +   I  ++   + YLH
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  E   +  G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 15  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 71
Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +HQ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + +
Sbjct: 72  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 403 LH 404
           + 
Sbjct: 131 IE 132

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  E   +  G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 14  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 70
Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +HQ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + +
Sbjct: 71  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 129
Query: 403 LH 404
           + 
Sbjct: 130 IE 131

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 12/114 (10%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI--RHQNLIKVISSC 355
           + KG +G V++     G  VAVK+F+    R  KS+  E E+  ++  RH+N++  I+S 
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 356 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 405
                 +    L+  Y   GSL  YL  +   LD    L I++ +AS L +LH 
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHI 152

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 5/122 (4%)
Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  E   +  G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 4   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 60
Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +HQ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + +
Sbjct: 61  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 119
Query: 403 LH 404
           + 
Sbjct: 120 IE 121

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 56/111 (50%), Gaps = 9/111 (8%)
Query: 298 ISKGGFGSVYKARLGD--GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           I KG FG V    LGD  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 20  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 356 SNEEFKA-LVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLH 404
             E+    +V EYM  GSL  YL S    +L     L   +DV  A+EYL 
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 125

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 5/114 (4%)
Query: 295 NNLISKGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLI 349
           + ++  G FG V   RL      E++V +  L+     +  + F  E  +M    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 5/114 (4%)
Query: 295 NNLISKGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLI 349
           + ++  G FG V   RL      E++V +  L+     +  + F  E  +M    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 284 ELCRATYKFSENN---LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEM 339
           +L    Y++ EN    ++ KG +G VY  R L + + +A+K    +  R  +    E  +
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 340 MKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI-DVA 397
            K ++H+N+++ + S S   F  + +E +P GSL   L S    + D  Q +      + 
Sbjct: 73  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 398 SALEYLH 404
             L+YLH
Sbjct: 133 EGLKYLH 139

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 58/110 (52%), Gaps = 7/110 (6%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISS 354
           I  G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  +  A+V ++    SL  +L++S    ++ + ++I    A  ++YLH
Sbjct: 89  STAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 5/114 (4%)
Query: 295 NNLISKGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLI 349
           + ++  G FG V   RL      E++V +  L+     +  + F  E  +M    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 55/111 (49%), Gaps = 13/111 (11%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 87
Query: 360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLH 404
              +++E+M +G+L  YL   N      Q +N ++       ++SA+EYL 
Sbjct: 88  PFYIIIEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE 133

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 5/114 (4%)
Query: 295 NNLISKGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLI 349
           + ++  G FG V   RL      E++V +  L+     +  + F  E  +M    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 5/114 (4%)
Query: 295 NNLISKGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLI 349
           + ++  G FG V   RL      E++V +  L+     +  + F  E  +M    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 5/114 (4%)
Query: 295 NNLISKGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLI 349
           + ++  G FG V   RL      E++V +  L+     +  + F  E  +M    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 59/114 (51%), Gaps = 8/114 (7%)
Query: 298 ISKGGFGSVYKARL---GD--GMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKV 351
           + +G FG V   R    GD  G +VAVK    +           E E+++++ H+N++K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 352 ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
              C+ +      L++E++P GSL++YL  +   +++ Q+L   + +   ++YL
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 130

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 312 GDGMEVAVKVFNLQCRRAFKS-FDIECEMMKSIRHQNLIKVISSCSNEEFKA--LVLEYM 368
           G G  VAVK     C    +S +  E E+++++ H++++K    C ++  K+  LV+EY+
Sbjct: 35  GTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 94
Query: 369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           P GSL  YL   +C+  + Q L     +   + YLH
Sbjct: 95  PLGSLRDYL-PRHCV-GLAQLLLFAQQICEGMAYLH 128

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 312 GDGMEVAVKVFNLQCRRAFKS-FDIECEMMKSIRHQNLIKVISSCSNEEFKA--LVLEYM 368
           G G  VAVK     C    +S +  E E+++++ H++++K    C ++  K+  LV+EY+
Sbjct: 36  GTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 95
Query: 369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           P GSL  YL   +C+  + Q L     +   + YLH
Sbjct: 96  PLGSLRDYL-PRHCV-GLAQLLLFAQQICEGMAYLH 129

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 59/114 (51%), Gaps = 8/114 (7%)
Query: 298 ISKGGFGSVYKARL---GD--GMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKV 351
           + +G FG V   R    GD  G +VAVK    +           E E+++++ H+N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 352 ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
              C+ +      L++E++P GSL++YL  +   +++ Q+L   + +   ++YL
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 5/114 (4%)
Query: 295 NNLISKGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLI 349
           + ++  G FG V   RL      E++V +  L+     +  + F  E  +M    H N+I
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 151

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 56/111 (50%), Gaps = 9/111 (8%)
Query: 298 ISKGGFGSVYKARLGD--GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           I KG FG V    LGD  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 29  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 356 SNEEFK-ALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLH 404
             E+    +V EYM  GSL  YL S    +L     L   +DV  A+EYL 
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 5/114 (4%)
Query: 295 NNLISKGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLI 349
           + ++  G FG V   RL      E++V +  L+     +  + F  E  +M    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 56/111 (50%), Gaps = 9/111 (8%)
Query: 298 ISKGGFGSVYKARLGD--GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           I KG FG V    LGD  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 14  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 356 SNEEFKA-LVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLH 404
             E+    +V EYM  GSL  YL S    +L     L   +DV  A+EYL 
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 5/114 (4%)
Query: 295 NNLISKGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLI 349
           + ++  G FG V   RL      E++V +  L+     +  + F  E  +M    H N+I
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL
Sbjct: 108 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 161

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 55/111 (49%), Gaps = 13/111 (11%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 83
Query: 360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLH 404
              +++E+M +G+L  YL   N      Q +N ++       ++SA+EYL 
Sbjct: 84  PFYIIIEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE 129

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 57/124 (45%), Gaps = 16/124 (12%)
Query: 296 NLISKGGFGSVYKARL----GDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLI 349
            ++ +G FGSV +  L    G  ++VAVK   L    +R  + F  E   MK   H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 350 KVISSCSNEEFKAL-----VLEYMPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASA 399
           +++  C     + +     +L +M +G L  YL  S        + +   L  M+D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 400 LEYL 403
           +EYL
Sbjct: 160 MEYL 163

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 55/115 (47%), Gaps = 13/115 (11%)
Query: 297 LISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCS 356
           LI +G +G+VYK  L D   VAVKVF+   R+ F + +     +  + H N+ + I    
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN-EKNIYRVPLMEHDNIARFI--VG 75
Query: 357 NEEFKA-------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +E   A       LV+EY P+GSL KYL  S    D      +   V   L YLH
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLAYLH 128

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 12/114 (10%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI--RHQNLIKVISSC 355
           + KG +G V++     G  VAVK+F+    R  KS+  E E+  ++  RH+N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 356 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 405
                 +    L+  Y   GSL  YL  +   LD    L I++ +AS L +LH 
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHI 123

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 56/111 (50%), Gaps = 9/111 (8%)
Query: 298 ISKGGFGSVYKARLGD--GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           I KG FG V    LGD  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 201 IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 356 SNEEFK-ALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLH 404
             E+    +V EYM  GSL  YL S    +L     L   +DV  A+EYL 
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 12/114 (10%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI--RHQNLIKVISSC 355
           + KG +G V++     G  VAVK+F+    R  KS+  E E+  ++  RH+N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 356 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 405
                 +    L+  Y   GSL  YL  +   LD    L I++ +AS L +LH 
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHI 123

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 265 LSNDANMPIVATWRMFSYLELCRATYKFSENNLISKGGFGSVYKA-RLGDG----MEVAV 319
           L+     P  A  R+    EL R         ++  G FG+VYK   + +G    + VA+
Sbjct: 20  LTPSGTAPNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAI 72
Query: 320 KVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY 378
           K+ N     +A   F  E  +M S+ H +L++++  C +   + LV + MPHG L +Y++
Sbjct: 73  KILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVH 131
Query: 379 SSNCILDIFQRLNIMIDVASALEYL 403
                +     LN  + +A  + YL
Sbjct: 132 EHKDNIGSQLLLNWCVQIAKGMMYL 156

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 5/114 (4%)
Query: 295 NNLISKGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLI 349
           + ++  G FG V   RL      E++V +  L+     +  + F  E  +M    H N+I
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 134

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 59/121 (48%), Gaps = 6/121 (4%)
Query: 290 YKFSENN---LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH 345
           Y++ EN    ++ KG +G VY  R L + + +A+K    +  R  +    E  + K ++H
Sbjct: 5   YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH 64
Query: 346 QNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI-DVASALEYL 403
           +N+++ + S S   F  + +E +P GSL   L S    + D  Q +      +   L+YL
Sbjct: 65  KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 124
Query: 404 H 404
           H
Sbjct: 125 H 125

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 3/106 (2%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 80
Query: 360 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLH 404
              +++E+M +G+L  YL   N   +     L +   ++SA+EYL 
Sbjct: 81  PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 87
Query: 360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLH 404
              ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL 
Sbjct: 88  PFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE 133

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 87
Query: 360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLH 404
              ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL 
Sbjct: 88  PFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE 133

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 3/106 (2%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 360 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLH 404
              +++E+M +G+L  YL   N   +     L +   ++SA+EYL 
Sbjct: 83  PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 312 GDGMEVAVKVFNLQCRRAFKS-FDIECEMMKSIRHQNLIKVISSCSNEEFKAL--VLEYM 368
           G G  VAVK     C    +S +  E ++++++ H+++IK    C ++  K+L  V+EY+
Sbjct: 41  GTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           P GSL  YL   +  + + Q L     +   + YLH
Sbjct: 101 PLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH 134

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 3/106 (2%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G FG VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 22  GQFGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 80
Query: 360 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLH 404
              ++ E+M +G+L  YL   N   +     L +   ++SA+EYL 
Sbjct: 81  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 312 GDGMEVAVKVFNLQCRRAFKS-FDIECEMMKSIRHQNLIKVISSCSNEEFKAL--VLEYM 368
           G G  VAVK     C    +S +  E ++++++ H+++IK    C ++  K+L  V+EY+
Sbjct: 41  GTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           P GSL  YL   +  + + Q L     +   + YLH
Sbjct: 101 PLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH 134

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 57/118 (48%), Gaps = 18/118 (15%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAF-----KSFDIECEMMKSIRHQNLIKV--- 351
           GGFG V +    D G +VA+K    QCR+       + + +E ++MK + H N++     
Sbjct: 25  GGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 352 ---ISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLH 404
              +   +  +   L +EY   G L KYL  + + C L       ++ D++SAL YLH
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLH 404
              ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL 
Sbjct: 83  PFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE 128

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 25  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 83
Query: 360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLH 404
              ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL 
Sbjct: 84  PFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE 129

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 53/105 (50%), Gaps = 3/105 (2%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 270 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 328
Query: 360 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYL 403
              ++ E+M +G+L  YL   N   ++    L +   ++SA+EYL
Sbjct: 329 PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 373

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 28  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 86
Query: 360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLH 404
              ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL 
Sbjct: 87  PFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE 132

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLH 404
              ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL 
Sbjct: 83  PFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE 128

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 57/118 (48%), Gaps = 18/118 (15%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAF-----KSFDIECEMMKSIRHQNLIKV--- 351
           GGFG V +    D G +VA+K    QCR+       + + +E ++MK + H N++     
Sbjct: 26  GGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 352 ---ISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLH 404
              +   +  +   L +EY   G L KYL  + + C L       ++ D++SAL YLH
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 139

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 84
Query: 360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLH 404
              ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL 
Sbjct: 85  PFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE 130

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 3/106 (2%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 360 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLH 404
              +++E+M +G+L  YL   N   +     L +   ++SA+EYL 
Sbjct: 83  PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 87
Query: 360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLH 404
              ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL 
Sbjct: 88  PFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE 133

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 37  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 95
Query: 360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLH 404
              ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL 
Sbjct: 96  PFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE 141

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 84
Query: 360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLH 404
              ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL 
Sbjct: 85  PFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE 130

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 26  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 84
Query: 360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLH 404
              ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL 
Sbjct: 85  PFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE 130

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 52/105 (49%), Gaps = 3/105 (2%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 289
Query: 360 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYL 403
              ++ E+M +G+L  YL   N   +     L +   ++SA+EYL
Sbjct: 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISS 354
           I  G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH
Sbjct: 73  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISS 354
           I  G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH
Sbjct: 78  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 126

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISS 354
           I  G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH
Sbjct: 78  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 126

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISS 354
           I  G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH
Sbjct: 73  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 53/113 (46%), Gaps = 7/113 (6%)
Query: 296 NLISKGGFGSVYKARLGDGMEVAVKV----FNLQCRRAFKSFDIECEMMKSIRHQNLIKV 351
            ++ KG FG   K    +  EV V      F+ + +R F     E ++M+ + H N++K 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRCLEHPNVLKF 72
Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           I     ++    + EY+  G+L   + S +      QR++   D+AS + YLH
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISS 354
           I  G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH
Sbjct: 75  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 123

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISS 354
           I  G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 149

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISS 354
           I  G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 149

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 3/106 (2%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 360 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLH 404
              ++ E+M +G+L  YL   N   +     L +   ++SA+EYL 
Sbjct: 83  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISS 354
           I  G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 43  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH
Sbjct: 100 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 148

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 3/106 (2%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 29  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 87
Query: 360 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLH 404
              ++ E+M +G+L  YL   N   +     L +   ++SA+EYL 
Sbjct: 88  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 133

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 3/106 (2%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 22  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 80
Query: 360 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLH 404
              ++ E+M +G+L  YL   N   +     L +   ++SA+EYL 
Sbjct: 81  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 3/106 (2%)
Query: 301 GGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE 359
           G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+ E 
Sbjct: 24  GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 360 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLH 404
              ++ E+M +G+L  YL   N   +     L +   ++SA+EYL 
Sbjct: 83  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 14/138 (10%)
Query: 272 PIVATWRMFSYLELCRATYKFSENNLISKGGFGSVYKA-RLGDG----MEVAVKVFNLQC 326
           P  A  R+    EL R         ++  G FG+VYK   + +G    + VA+K+ N   
Sbjct: 4   PNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT 56
Query: 327 -RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD 385
             +A   F  E  +M S+ H +L++++  C +   + LV + MPHG L +Y++     + 
Sbjct: 57  GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIG 115
Query: 386 IFQRLNIMIDVASALEYL 403
               LN  + +A  + YL
Sbjct: 116 SQLLLNWCVQIAKGMMYL 133

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISS 354
           I  G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 36  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH
Sbjct: 93  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 141

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISS 354
           I  G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +  +  A+V ++    SL  +L+      ++ + ++I    A  ++YLH
Sbjct: 73  STAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 60/122 (49%), Gaps = 5/122 (4%)
Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  E   +  G  G V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 9   EVPRETLKLVER--LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 65
Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +HQ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + +
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 403 LH 404
           + 
Sbjct: 125 IE 126

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 53/108 (49%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 358 EEFKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLH 404
           E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+ 
Sbjct: 75  EPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 121

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 61/130 (46%), Gaps = 17/130 (13%)
Query: 291 KFSENNLISKGGFGSVYKARL----GDGMEVAVKVF--NLQCRRAFKSFDIECEMMKSIR 344
           +F+   ++ KG FGSV +A+L    G  ++VAVK+   ++      + F  E   MK   
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 345 HQNLIKVISSCSNEEFKA------LVLEYMPHGSLEKYLYSSNCILDIFQ-----RLNIM 393
           H ++ K++        K       ++L +M HG L  +L +S    + F       +  M
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 394 IDVASALEYL 403
           +D+A  +EYL
Sbjct: 144 VDIACGMEYL 153

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 55/115 (47%), Gaps = 6/115 (5%)
Query: 295 NNLISKGGFGSVYKA----RLGDGMEVAVKVFNLQCRRAFKS-FDIECEMMKSIRHQNLI 349
           N ++ +G FG VY+       G+ + VAVK     C    K  F  E  +MK++ H +++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           K+I     EE   +++E  P+G L  YL  +   L +   +   + +  A+ YL 
Sbjct: 77  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 55/115 (47%), Gaps = 6/115 (5%)
Query: 295 NNLISKGGFGSVYKA----RLGDGMEVAVKVFNLQCRRAFKS-FDIECEMMKSIRHQNLI 349
           N ++ +G FG VY+       G+ + VAVK     C    K  F  E  +MK++ H +++
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           K+I     EE   +++E  P+G L  YL  +   L +   +   + +  A+ YL 
Sbjct: 89  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 142

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 54/108 (50%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K        + ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 358 EEFKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLH 404
           E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+ 
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 50/107 (46%), Gaps = 1/107 (0%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           +  G FG V   +     +VA+K+   +   +   F  E ++M ++ H+ L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 358 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +    ++ EYM +G L  YL          Q L +  DV  A+EYL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 50/107 (46%), Gaps = 1/107 (0%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           +  G FG V   +     +VA+K+   +   +   F  E ++M ++ H+ L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 358 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +    ++ EYM +G L  YL          Q L +  DV  A+EYL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 48/107 (44%), Gaps = 1/107 (0%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           I  G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 358 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +    LV E+M HG L  YL +   +      L + +DV   + YL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 48/107 (44%), Gaps = 1/107 (0%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           I  G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 358 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +    LV E+M HG L  YL +   +      L + +DV   + YL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 58/133 (43%), Gaps = 12/133 (9%)
Query: 283 LELCRATYKFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKS 332
           L  C+    F E +L     + KG FGSV   R   LGD  G  VAVK          + 
Sbjct: 11  LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 70
Query: 333 FDIECEMMKSIRHQNLIKV--ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 390
           F  E +++K++    ++K   +S     +   LV+EY+P G L  +L      LD  + L
Sbjct: 71  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 391 NIMIDVASALEYL 403
                +   +EYL
Sbjct: 131 LYSSQICKGMEYL 143

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 57/130 (43%), Gaps = 12/130 (9%)
Query: 286 CRATYKFSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDI 335
           C+    F E +L     + KG FGSV   R   LGD  G  VAVK          + F  
Sbjct: 1   CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 60
Query: 336 ECEMMKSIRHQNLIKV--ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 393
           E +++K++    ++K   +S     +   LV+EY+P G L  +L      LD  + L   
Sbjct: 61  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 120
Query: 394 IDVASALEYL 403
             +   +EYL
Sbjct: 121 SQICKGMEYL 130

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 48/107 (44%), Gaps = 1/107 (0%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           I  G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 358 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +    LV E+M HG L  YL +   +      L + +DV   + YL 
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 123

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK IRH+ L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 358 EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLH 404
           E    +V EYM  GSL  +L       L + Q +++   +AS + Y+ 
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 48/107 (44%), Gaps = 1/107 (0%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           I  G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 358 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +    LV E+M HG L  YL +   +      L + +DV   + YL 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 55/115 (47%), Gaps = 6/115 (5%)
Query: 295 NNLISKGGFGSVYKA----RLGDGMEVAVKVFNLQCRRAFKS-FDIECEMMKSIRHQNLI 349
           N ++ +G FG VY+       G+ + VAVK     C    K  F  E  +MK++ H +++
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           K+I     EE   +++E  P+G L  YL  +   L +   +   + +  A+ YL 
Sbjct: 73  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 126

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/112 (25%), Positives = 53/112 (47%), Gaps = 7/112 (6%)
Query: 295 NNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISS 354
             ++ +G FG V KA+     +VA+K    +  R  K+F +E   +  + H N++K+  +
Sbjct: 14  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 70
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNIMIDVASALEYLH 404
           C N     LV+EY   GSL   L+ +  +        ++  +  +  + YLH
Sbjct: 71  CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 120

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 47/107 (43%), Gaps = 1/107 (0%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           I  G FG V+     +  +VA+K    +   +   F  E E+M  + H  L+++   C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 358 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +    LV E+M HG L  YL +   +      L + +DV   + YL 
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 140

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 53/108 (49%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 358 EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLH 404
           E    +V+EYM  GSL  +L       L + Q +++   +AS + Y+ 
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 53/108 (49%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 358 EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLH 404
           E    +V+EYM  GSL  +L       L + Q +++   +AS + Y+ 
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/137 (24%), Positives = 56/137 (40%), Gaps = 14/137 (10%)
Query: 281 SYLELCRATYKFSEN---------NLISKGGFGSVYKARL----GDGMEVAVKVFNLQ-C 326
           +Y E  RA   F+            +I  G  G V   RL       + VA+K       
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 327 RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI 386
            R  + F  E  +M    H N+I++    +      +V EYM +GSL+ +L + +    I
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 387 FQRLNIMIDVASALEYL 403
            Q + ++  V + + YL
Sbjct: 151 MQLVGMLRGVGAGMRYL 167

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/112 (25%), Positives = 53/112 (47%), Gaps = 7/112 (6%)
Query: 295 NNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISS 354
             ++ +G FG V KA+     +VA+K    +  R  K+F +E   +  + H N++K+  +
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNIMIDVASALEYLH 404
           C N     LV+EY   GSL   L+ +  +        ++  +  +  + YLH
Sbjct: 70  CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 53/108 (49%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 358 EEFKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLH 404
           E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+ 
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 50/107 (46%), Gaps = 1/107 (0%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           +  G FG V   +     +VA+K+   +   +   F  E ++M ++ H+ L+++   C+ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 358 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +    ++ EYM +G L  YL          Q L +  DV  A+EYL 
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 128

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/114 (23%), Positives = 54/114 (47%), Gaps = 5/114 (4%)
Query: 295 NNLISKGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLI 349
           + ++  G FG V   RL      E++V +  L+     +  + F  E  +M    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++    +  +   +V E M +GSL+ +L   +    + Q + ++  +AS ++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 53/108 (49%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 358 EEFKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLH 404
           E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+ 
Sbjct: 78  EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 124

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 53/108 (49%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 358 EEFKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLH 404
           E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+ 
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 49/104 (47%), Gaps = 1/104 (0%)
Query: 301 GGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF 360
           G FG V   +     +VA+K+   +   +   F  E ++M ++ H+ L+++   C+ +  
Sbjct: 20  GQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 78
Query: 361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             ++ EYM +G L  YL          Q L +  DV  A+EYL 
Sbjct: 79  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 122

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/137 (24%), Positives = 56/137 (40%), Gaps = 14/137 (10%)
Query: 281 SYLELCRATYKFSEN---------NLISKGGFGSVYKARL----GDGMEVAVKVFNL-QC 326
           +Y E  RA   F+            +I  G  G V   RL       + VA+K       
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 327 RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI 386
            R  + F  E  +M    H N+I++    +      +V EYM +GSL+ +L + +    I
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 387 FQRLNIMIDVASALEYL 403
            Q + ++  V + + YL
Sbjct: 151 MQLVGMLRGVGAGMRYL 167

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 50/115 (43%), Gaps = 6/115 (5%)
Query: 295 NNLISKGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDIECEMMKSIRHQNLI 349
           N +I +G FG VY   L    G  +  AVK  N +        F  E  +MK   H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 350 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
            ++  C   E   LV L YM HG L  ++ +      +   +   + VA  ++YL
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 167

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 48/107 (44%), Gaps = 1/107 (0%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           I  G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 358 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +    LV E+M HG L  YL +   +      L + +DV   + YL 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 49/104 (47%), Gaps = 1/104 (0%)
Query: 301 GGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF 360
           G FG V   +     +VA+K+   +   +   F  E ++M ++ H+ L+++   C+ +  
Sbjct: 20  GQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 78
Query: 361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             ++ EYM +G L  YL          Q L +  DV  A+EYL 
Sbjct: 79  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 122

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/114 (23%), Positives = 54/114 (47%), Gaps = 5/114 (4%)
Query: 295 NNLISKGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLI 349
           + ++  G FG V   RL      E++V +  L+     +  + F  E  +M    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++    +  +   +V E M +GSL+ +L   +    + Q + ++  +AS ++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 49/104 (47%), Gaps = 1/104 (0%)
Query: 301 GGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF 360
           G FG V   +     +VA+K+   +   +   F  E ++M ++ H+ L+++   C+ +  
Sbjct: 19  GQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 77
Query: 361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             ++ EYM +G L  YL          Q L +  DV  A+EYL 
Sbjct: 78  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 121

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 50/115 (43%), Gaps = 6/115 (5%)
Query: 295 NNLISKGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDIECEMMKSIRHQNLI 349
           N +I +G FG VY   L    G  +  AVK  N +        F  E  +MK   H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 350 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
            ++  C   E   LV L YM HG L  ++ +      +   +   + VA  ++YL
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 168

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 50/115 (43%), Gaps = 6/115 (5%)
Query: 295 NNLISKGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDIECEMMKSIRHQNLI 349
           N +I +G FG VY   L    G  +  AVK  N +        F  E  +MK   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 350 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
            ++  C   E   LV L YM HG L  ++ +      +   +   + VA  ++YL
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 148

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 49/104 (47%), Gaps = 1/104 (0%)
Query: 301 GGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF 360
           G FG V   +     +VA+K+   +   +   F  E ++M ++ H+ L+++   C+ +  
Sbjct: 15  GQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 73
Query: 361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             ++ EYM +G L  YL          Q L +  DV  A+EYL 
Sbjct: 74  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 50/115 (43%), Gaps = 6/115 (5%)
Query: 295 NNLISKGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDIECEMMKSIRHQNLI 349
           N +I +G FG VY   L    G  +  AVK  N +        F  E  +MK   H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 350 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
            ++  C   E   LV L YM HG L  ++ +      +   +   + VA  ++YL
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 147

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 50/115 (43%), Gaps = 6/115 (5%)
Query: 295 NNLISKGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDIECEMMKSIRHQNLI 349
           N +I +G FG VY   L    G  +  AVK  N +        F  E  +MK   H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 350 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
            ++  C   E   LV L YM HG L  ++ +      +   +   + VA  ++YL
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 141

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/114 (23%), Positives = 54/114 (47%), Gaps = 5/114 (4%)
Query: 295 NNLISKGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLI 349
           + ++  G FG V   RL      E++V +  L+     +  + F  E  +M    H N+I
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++    +  +   +V E M +GSL+ +L   +    + Q + ++  +AS ++YL
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 134

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 50/115 (43%), Gaps = 6/115 (5%)
Query: 295 NNLISKGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDIECEMMKSIRHQNLI 349
           N +I +G FG VY   L    G  +  AVK  N +        F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 350 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
            ++  C   E   LV L YM HG L  ++ +      +   +   + VA  ++YL
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 149

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 50/115 (43%), Gaps = 6/115 (5%)
Query: 295 NNLISKGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDIECEMMKSIRHQNLI 349
           N +I +G FG VY   L    G  +  AVK  N +        F  E  +MK   H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 350 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
            ++  C   E   LV L YM HG L  ++ +      +   +   + VA  ++YL
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 53/108 (49%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K        + ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 358 EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLH 404
           E    +V EYM  GSL  +L       L + Q +++   +AS + Y+ 
Sbjct: 252 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 298

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 50/115 (43%), Gaps = 6/115 (5%)
Query: 295 NNLISKGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDIECEMMKSIRHQNLI 349
           N +I +G FG VY   L    G  +  AVK  N +        F  E  +MK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 350 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
            ++  C   E   LV L YM HG L  ++ +      +   +   + VA  ++YL
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 146

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/81 (29%), Positives = 42/81 (51%), Gaps = 1/81 (1%)
Query: 301 GGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF 360
           G FG V+     +  +VAVK        + ++F  E  +MK+++H  L+++ +  + EE 
Sbjct: 24  GQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEP 82
Query: 361 KALVLEYMPHGSLEKYLYSSN 381
             ++ EYM  GSL  +L S  
Sbjct: 83  IYIITEYMAKGSLLDFLKSDE 103

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 50/115 (43%), Gaps = 6/115 (5%)
Query: 295 NNLISKGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDIECEMMKSIRHQNLI 349
           N +I +G FG VY   L    G  +  AVK  N +        F  E  +MK   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 350 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
            ++  C   E   LV L YM HG L  ++ +      +   +   + VA  ++YL
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 148

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 52/111 (46%), Gaps = 6/111 (5%)
Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECEMMKSIRHQNLIKVIS 353
           I KG F  V  AR +  G EVAVK+ +   L      K F  E  +MK + H N++K+  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 73
Query: 354 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
               E+   LV+EY   G +  YL +   + +   R      + SA++Y H
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCH 123

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 50/115 (43%), Gaps = 6/115 (5%)
Query: 295 NNLISKGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDIECEMMKSIRHQNLI 349
           N +I +G FG VY   L    G  +  AVK  N +        F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 350 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
            ++  C   E   LV L YM HG L  ++ +      +   +   + VA  ++YL
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 149

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 52/108 (48%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 358 EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLH 404
           E    +V EYM  GSL  +L       L + Q +++   +AS + Y+ 
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/121 (23%), Positives = 58/121 (47%), Gaps = 12/121 (9%)
Query: 292 FSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC-------RRAFKSFDIECEMMKSI 343
           F   NL+ KG F  VY+A  +  G+EVA+K+ + +        +R      I C++    
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL---- 68
Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           +H +++++ +   +  +  LVLE   +G + +YL +        +  + M  + + + YL
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 404 H 404
           H
Sbjct: 129 H 129

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 52/108 (48%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 358 EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLH 404
           E    +V EYM  GSL  +L       L + Q +++   +AS + Y+ 
Sbjct: 74  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 120

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 55/124 (44%), Gaps = 12/124 (9%)
Query: 292 FSENNL-----ISKGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDIECEMMK 341
           F E +L     + KG FGSV   R   LGD  G  VAVK          + F  E +++K
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 342 SIRHQNLIKV--ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 399
           ++    ++K   +S     +   LV+EY+P G L  +L      LD  + L     +   
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 400 LEYL 403
           +EYL
Sbjct: 128 MEYL 131

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 52/108 (48%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 358 EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLH 404
           E    +V EYM  GSL  +L       L + Q +++   +AS + Y+ 
Sbjct: 76  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 122

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 52/108 (48%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 358 EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLH 404
           E    +V EYM  GSL  +L       L + Q +++   +AS + Y+ 
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 53/108 (49%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 358 EEFKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLH 404
           E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+ 
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE 128

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 64/131 (48%), Gaps = 17/131 (12%)
Query: 264 RLSNDANMPIVATWRMFSYLELCRATYKFSENNL-----ISKGGFGSVY--------KAR 310
           RLS+ A+ P++A    +   E     ++F  + L     + +G FG V         K +
Sbjct: 52  RLSSTADTPMLAGVSEYELPE--DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDK 109
Query: 311 LGDGMEVAVKVF-NLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYM 368
             + + VAVK+  +    +       E EMMK I +H+N+I ++ +C+ +    +++EY 
Sbjct: 110 PKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 169
Query: 369 PHGSLEKYLYS 379
             G+L +YL +
Sbjct: 170 SKGNLREYLRA 180

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 53/108 (49%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 358 EEFKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLH 404
           E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+ 
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE 128

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 53/108 (49%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 358 EEFKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLH 404
           E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+ 
Sbjct: 251 EPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 52/108 (48%), Gaps = 3/108 (2%)
Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V+         VA+K          ++F  E ++MK +RH+ L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 358 EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLH 404
           E    +V EYM  GSL  +L       L + Q +++   +AS + Y+ 
Sbjct: 85  EPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 49/85 (57%), Gaps = 10/85 (11%)
Query: 292 FSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKV 351
           ++   +I  G FG V++A+L +  EVA+K   LQ +R FK+   E ++M+ ++H N++ +
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKR-FKNR--ELQIMRIVKHPNVVDL 97
Query: 352 IS------SCSNEEFKALVLEYMPH 370
            +         +E F  LVLEY+P 
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPE 122

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 52/111 (46%), Gaps = 6/111 (5%)
Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECEMMKSIRHQNLIKVIS 353
           I KG F  V  AR +  G EVAVK+ +   L      K F  E  +MK + H N++K+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 354 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
               E+   LV+EY   G +  YL +   + +   R      + SA++Y H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH 130

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/137 (21%), Positives = 63/137 (45%), Gaps = 14/137 (10%)
Query: 281 SYLELCRATYKFSEN---------NLISKGGFGSVYKARLG--DGMEVAVKVFNLQC--- 326
           +Y +  RA ++F++           +I  G FG V   RL      +VAV +  L+    
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 327 RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI 386
            +  + F  E  +M    H N++ +    +  +   +V+E+M +G+L+ +L   +    +
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV 144
Query: 387 FQRLNIMIDVASALEYL 403
            Q + ++  +A+ + YL
Sbjct: 145 IQLVGMLRGIAAGMRYL 161

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 52/111 (46%), Gaps = 6/111 (5%)
Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECEMMKSIRHQNLIKVIS 353
           I KG F  V  AR +  G EVAVK+ +   L      K F  E  +MK + H N++K+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 354 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
               E+   LV+EY   G +  YL +   + +   R      + SA++Y H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH 130

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 52/111 (46%), Gaps = 6/111 (5%)
Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECEMMKSIRHQNLIKVIS 353
           I KG F  V  AR +  G EVAVK+ +   L      K F  E  +MK + H N++K+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 354 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
               E+   LV+EY   G +  YL +   + +   R      + SA++Y H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH 130

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 55/119 (46%), Gaps = 16/119 (13%)
Query: 288 ATYKFSEN----NLISKGGFGSVYK-ARLGDGMEVAVKVFNLQ--CRRAFKSFDIECEMM 340
           A+ KFS+N      + KG F  V +      G+E A K+ N +    R F+  + E  + 
Sbjct: 23  ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 82
Query: 341 KSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRL 390
           + ++H N++++  S   E F  LV + +  G L      +  YS    S+CI  I + +
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESI 141

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 19/51 (37%), Positives = 25/51 (49%)
Query: 165 GAIPASXXXXXXXXXXXXSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP 215
           G +P              SFN L GEIP+GG+   F   ++  N+ LCGSP
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	405
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-59
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-29
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-05
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-49
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-43
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-41
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-37
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-37
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-36
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-35
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-23
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-04
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-37
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-34
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-33
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-28
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-27
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-24
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-32
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-29
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-28
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-25
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-30
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-28
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-27
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-25
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-25
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-29
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-23
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-22
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-21
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-29
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-28
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-24
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-23
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-05
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-28
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-15
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-13
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-09
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-27
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-26
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-26
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-26
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-22
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-05
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-26
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-25
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-25
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-16
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-05
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-25
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-24
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-24
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-20
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-19
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-24
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-24
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-23
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-23
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-23
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-22
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-24
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-24
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-24
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-24
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-24
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-23
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-21
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-19
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-15
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-10
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-23
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-23
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-22
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-20
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-20
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-19
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-18
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-19
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-17
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-08
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-18
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-22
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-21
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-19
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-17
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-17
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-16
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-15
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-10
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-07
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-15
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-07
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-21
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-07
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-20
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-20
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-19
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-17
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-16
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-12
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-20
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-20
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-20
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-16
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-20
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-17
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-16
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-13
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-09
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-07
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-16
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-20
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-19
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-19
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-19
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-17
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-10
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-19
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-19
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-19
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-19
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-19
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-17
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-11
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-18
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-18
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-18
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-18
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-18
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-15
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-14
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-06
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-13
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-18
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-17
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-15
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-18
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-18
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-17
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-17
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-17
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-17
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-17
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-13
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-12
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-17
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-17
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-17
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-16
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-16
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-12
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-07
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-14
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-08
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-05
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-17
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-16
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-16
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-16
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-13
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-04
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-04
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-16
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-09
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-07
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-04
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-16
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-15
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-15
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-15
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-15
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-09
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	9e-06
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-14
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-14
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-10
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-13
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-13
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-04
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-10
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-13
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-13
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-12
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-12
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-12
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-12
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-12
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-12
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-09
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-12
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-12
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	8e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	9e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-07
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-11
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-11
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-11
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-11
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-11
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-11
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-11
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-11
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-11
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-11
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-11
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-10
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-10
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-10
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-05
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-06
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-09
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-09
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-09
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-09
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-09
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-09
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-09
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-09
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-09
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-09
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-07
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-05
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-09
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-08
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-08
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-07
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-08
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-08
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-04
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-08
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-08
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-08
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	8e-05
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-08
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-08
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-08
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-08
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-07
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-05
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-07
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-07
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-07
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-07
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-07
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-07
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-05
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-07
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-07
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-07
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-07
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-07
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-07
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-07
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-07
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	8e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-05
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-07
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-07
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-06
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-06
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-06
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-06
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-06
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-06
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-06
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-06
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-06
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-06
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-06
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-06
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-06
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-06
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-06
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-06
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-06
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-06
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-06
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	5e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	6e-06
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-06
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-06
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-06
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	8e-06
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	9e-06
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-05
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-05
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-05
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-05
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-05
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-04
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-05
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-05
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	6e-05
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-05
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-05
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-05
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-04
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-04
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	2e-04
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-04
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-04

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  193 bits (493), Expect = 7e-59
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 11/218 (5%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
            +++    L ++ +++  +   +P  F+  +  +L     SY  +SG +   I++L  L 
Sbjct: 95  PAIAKLTQLHYLYITHTNVSGAIP-DFLSQIK-TLVTLDFSYNALSGTLPPSISSLPNLV 152

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFS------ 117
            I   GN+++G+I  + GS       +++  N LT  IP TF NL  + +++ S      
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEG 211

Query: 118 VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYL 177
              +  G   N + + L  N L   +    G   +L  L+L  N + G +P  L +L +L
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270

Query: 178 KDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP 215
             LN+SFN L GEIP+GG+   F   ++  N+ LCGSP
Sbjct: 271 HSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  113 bits (285), Expect = 9e-29
 Identities = 42/159 (26%), Positives = 65/159 (40%), Gaps = 21/159 (13%)

Query: 45  SYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG-SNLASLRKLSL-DSNELTSIP 102
                 G + +  T   ++  + L G  L     I    +NL  L  L +   N L    
Sbjct: 34  CNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG-- 91

Query: 103 LTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN 162
                           IP  I  L  L YL++ +  + G+IPD    + +L +L+ S N 
Sbjct: 92  ---------------PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136

Query: 163 LSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFS 201
           LSG +P S+  L  L  +    N++ G IP   S+G+FS
Sbjct: 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPD--SYGSFS 173

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 44.1 bits (105), Expect = 4e-05
 Identities = 23/101 (22%), Positives = 34/101 (33%), Gaps = 29/101 (28%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           L  +   K L  +DL NN                           I G + + +T L  L
Sbjct: 237 LGKVGLSKNLNGLDLRNN--------------------------RIYGTLPQGLTQLKFL 270

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNE-LTSIPL 103
            ++ +  N L G I    G NL      +  +N+ L   PL
Sbjct: 271 HSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANNKCLCGSPL 309

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  177 bits (451), Expect = 2e-49
 Identities = 70/239 (29%), Positives = 103/239 (43%), Gaps = 19/239 (7%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
           + L +C+ L ++DL+ N  +  +P           +   ++   I+G     I N     
Sbjct: 532 AELGDCRSLIWLDLNTNLFNGTIPAAM------FKQSGKIAANFIAGKRYVYIKNDGMKK 585

Query: 65  TIILGGN--KLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFS---- 117
                GN  +  G  S  L   L++    ++ S         TF N   +++L+ S    
Sbjct: 586 ECHGAGNLLEFQGIRSEQLN-RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644

Query: 118 --VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLL 175
              IP EIG +P L  L LG+N + GSIPD  GDL  L  L+LS N L G IP ++  L 
Sbjct: 645 SGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALT 704

Query: 176 YLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNS 234
            L +++LS N L G IP  G F  F    F  N  LCG P   +  C        + + 
Sbjct: 705 MLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNADGYAHHQ 760

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  158 bits (403), Expect = 7e-43
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 12/206 (5%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT-KL 63
               +C  L  + LS+N     LP   +  +   L+   +S+   SG + E +TNL+  L
Sbjct: 312 PFFGSCSLLESLALSSNNFSGELPMDTLLKMR-GLKVLDLSFNEFSGELPESLTNLSASL 370

Query: 64  TTIILGGNKLNGSISITLGSN-LASLRKLSLDSNELT-SIPLTFWNLKDILYLNFS---- 117
            T+ L  N  +G I   L  N   +L++L L +N  T  IP T  N  +++ L+ S    
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430

Query: 118 --VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLL 175
              IP  +G L  L  L L  N L+G IP     + +L++L L  N+L+G IP+ L    
Sbjct: 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490

Query: 176 YLKDLNLSFNKLEGEIPRGGSFGNFS 201
            L  ++LS N+L GEIP+    G   
Sbjct: 491 NLNWISLSNNRLTGEIPK--WIGRLE 514

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  155 bits (394), Expect = 1e-41
 Identities = 68/264 (25%), Positives = 107/264 (40%), Gaps = 13/264 (4%)

Query: 5   SSLSNCKC-LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
            SL+N    L  +DLS+N     +      N  ++L+   +     +G I   ++N ++L
Sbjct: 361 ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSEL 420

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFS----- 117
            ++ L  N L+G+I  +LG +L+ LR L L  N L   IP     +K +  L        
Sbjct: 421 VSLHLSFNYLSGTIPSSLG-SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLT 479

Query: 118 -VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
             IP  +    NL ++ L  NRL G IP   G L +L  L LS N+ SG IPA L     
Sbjct: 480 GEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRS 539

Query: 177 LKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNSLL 236
           L  L+L+ N   G IP   +    S +       + G   + ++          + N L 
Sbjct: 540 LIWLDLNTNLFNGTIPA--AMFKQSGK--IAANFIAGKRYVYIKNDGMKKECHGAGNLLE 595

Query: 237 LGIVLPLSTTFMIVVILLILRYRQ 260
              +       +       +  R 
Sbjct: 596 FQGIRSEQLNRLSTRNPCNITSRV 619

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  142 bits (361), Expect = 3e-37
 Identities = 67/209 (32%), Positives = 97/209 (46%), Gaps = 19/209 (9%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
                 C  L  + +S N +   +    V     +LEF  +S  N S GI   + + + L
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVD---VSRCV-NLEFLDVSSNNFSTGI-PFLGDCSAL 225

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFS----- 117
             + + GNKL+G  S  +      L+ L++ SN+    IP     LK + YL+ +     
Sbjct: 226 QHLDISGNKLSGDFSRAIS-TCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFT 282

Query: 118 -VIPIEIGG-LPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPA-SLEKL 174
             IP  + G    L  L L  N   G++P  FG    L+SL LS NN SG +P  +L K+
Sbjct: 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM 342

Query: 175 LYLKDLNLSFNKLEGEIPRGGSFGNFSAE 203
             LK L+LSFN+  GE+P   S  N SA 
Sbjct: 343 RGLKVLDLSFNEFSGELPE--SLTNLSAS 369

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  141 bits (357), Expect = 9e-37
 Identities = 45/206 (21%), Positives = 78/206 (37%), Gaps = 10/206 (4%)

Query: 2   SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT 61
                L   K L  + L  N L   +P     N + +L +  +S   ++G I + I  L 
Sbjct: 457 EIPQELMYVKTLETLILDFNDLTGEIPSGL-SNCT-NLNWISLSNNRLTGEIPKWIGRLE 514

Query: 62  KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFSV-- 118
            L  + L  N  +G+I   LG +  SL  L L++N    +IP   +     +  NF    
Sbjct: 515 NLAILKLSNNSFSGNIPAELG-DCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGK 573

Query: 119 IPIEIGGLPNLEYLFLGYNRLQ--GSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
             + I      +      N L+  G   +    L +    N++     G    + +    
Sbjct: 574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633

Query: 177 LKDLNLSFNKLEGEIPRGGSFGNFSA 202
           +  L++S+N L G IP+    G+   
Sbjct: 634 MMFLDMSYNMLSGYIPK--EIGSMPY 657

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  138 bits (350), Expect = 7e-36
 Identities = 62/200 (31%), Positives = 86/200 (43%), Gaps = 22/200 (11%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGI-LEEITNLTKL 63
                C  LT +DLS N     +P  F G+ S  LE   +S  N SG + ++ +  +  L
Sbjct: 288 FLSGACDTLTGLDLSGNHFYGAVPPFF-GSCS-LLESLALSSNNFSGELPMDTLLKMRGL 345

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFSVIPIE 122
             + L  N+ +G +  +L +  ASL  L L SN  +  I                     
Sbjct: 346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNP------------- 392

Query: 123 IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNL 182
                 L+ L+L  N   G IP +  +   L SL+LS N LSG IP+SL  L  L+DL L
Sbjct: 393 ---KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449

Query: 183 SFNKLEGEIPRGGSFGNFSA 202
             N LEGEIP+         
Sbjct: 450 WLNMLEGEIPQ--ELMYVKT 467

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  137 bits (348), Expect = 1e-35
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 17/200 (8%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTF-VGNVSHSLEFFVMSYCNISGGI-LEEITNLT 61
           +S       LT +DLS N L   +     +G+ S  L+F  +S   +     +     L 
Sbjct: 93  VSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCS-GLKFLNVSSNTLDFPGKVSGGLKLN 151

Query: 62  KLTTIILGGNKLNGSI--SITLGSNLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFS- 117
            L  + L  N ++G+      L      L+ L++  N+++  + +      ++ +L+ S 
Sbjct: 152 SLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSS 209

Query: 118 -----VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLE 172
                 IP  +G    L++L +  N+L G    +      LK LN+S N   G IP    
Sbjct: 210 NNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL-- 266

Query: 173 KLLYLKDLNLSFNKLEGEIP 192
            L  L+ L+L+ NK  GEIP
Sbjct: 267 PLKSLQYLSLAENKFTGEIP 286

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  101 bits (255), Expect = 1e-23
 Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 20/165 (12%)

Query: 50  SGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELT-SIP--LTFW 106
              +   + +LT L ++ L  + +NGS+S       ASL  L L  N L+  +    +  
Sbjct: 66  FSAVSSSLLSLTGLESLFLSNSHINGSVSGF--KCSASLTSLDLSRNSLSGPVTTLTSLG 123

Query: 107 NLKDILYLNFS------VIPIEIG-GLPNLEYLFLGYNRLQGSIPDSF---GDLISLKSL 156
           +   + +LN S         +  G  L +LE L L  N + G+    +        LK L
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183

Query: 157 NLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFS 201
            +S N +SG +  S  + + L+ L++S N     IP     G+ S
Sbjct: 184 AISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGIP---FLGDCS 223

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 72.6 bits (179), Expect = 6e-14
 Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 7/101 (6%)

Query: 94  DSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISL 153
             +++TSI L+   L     + FS +   +  L  LE LFL  + + GS+   F    SL
Sbjct: 48  RDDKVTSIDLSSKPL----NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASL 102

Query: 154 KSLNLSKNNLSGAIPA--SLEKLLYLKDLNLSFNKLEGEIP 192
            SL+LS+N+LSG +    SL     LK LN+S N L+    
Sbjct: 103 TSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGK 143

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 60.7 bits (148), Expect = 4e-10
 Identities = 19/68 (27%), Positives = 32/68 (47%), Gaps = 1/68 (1%)

Query: 134 LGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPR 193
              N    ++  S   L  L+SL LS ++++G++    +    L  L+LS N L G +  
Sbjct: 60  KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTT 118

Query: 194 GGSFGNFS 201
             S G+ S
Sbjct: 119 LTSLGSCS 126

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 41.0 bits (97), Expect = 7e-04
 Identities = 13/51 (25%), Positives = 24/51 (47%), Gaps = 3/51 (5%)

Query: 152 SLKSLNLSKNNLS---GAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGN 199
            + S++LS   L+    A+ +SL  L  L+ L LS + + G +       +
Sbjct: 51  KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSAS 101

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  136 bits (346), Expect = 2e-37
 Identities = 44/130 (33%), Positives = 65/130 (50%), Gaps = 3/130 (2%)

Query: 278 RMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIEC 337
                ++L  AT  F    LI  G FG VYK  L DG +VA+K    +  +  + F+ E 
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 338 EMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMI 394
           E +   RH +L+ +I  C       L+ +YM +G+L+++LY S+     +   QRL I I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 395 DVASALEYLH 404
             A  L YLH
Sbjct: 147 GAARGLHYLH 156

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  128 bits (325), Expect = 2e-34
 Identities = 48/132 (36%), Positives = 66/132 (50%), Gaps = 4/132 (3%)

Query: 277 WRMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKS-FDI 335
            + FS  EL  A+  FS  N++ +GGFG VYK RL DG  VAVK    +  +  +  F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 336 ECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---SSNCILDIFQRLNI 392
           E EM+    H+NL+++   C     + LV  YM +GS+   L     S   LD  +R  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 393 MIDVASALEYLH 404
            +  A  L YLH
Sbjct: 137 ALGSARGLAYLH 148

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  129 bits (325), Expect = 9e-33
 Identities = 37/223 (16%), Positives = 71/223 (31%), Gaps = 26/223 (11%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
              L+     + +  I +  N L +   +T +  +   L      Y  + G  L    + 
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK-KLGMLECLYNQLEG-KLPAFGSE 352

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP--LTFWNLKDILYLN--- 115
            KL ++ L  N++   I          +  LS   N+L  IP      ++  +  ++   
Sbjct: 353 IKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSY 411

Query: 116 ----------FSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG 165
                     F  +        N+  + L  N++     + F     L S+NL  N L+ 
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471

Query: 166 -------AIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFS 201
                      + +    L  ++L FNKL   +          
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLP 513

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  114 bits (288), Expect = 6e-28
 Identities = 34/206 (16%), Positives = 64/206 (31%), Gaps = 24/206 (11%)

Query: 2   SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISG-------GIL 54
               +      ++ I+LSNN +     + F    S  L    +    ++           
Sbjct: 424 PLDPTPFKGINVSSINLSNNQISKFPKELF-STGS-PLSSINLMGNMLTEIPKNSLKDEN 481

Query: 55  EEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYL 114
           E   N   LT+I L  NKL         + L  L  + L  N  +  P    N   +   
Sbjct: 482 ENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGF 541

Query: 115 NFS------------VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN 162
                            P  I   P+L  L +G N ++  + +      ++  L++  N 
Sbjct: 542 GIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNP 598

Query: 163 LSGAIPASLEKLLYLKDLNLSFNKLE 188
                 + +   +      L ++K +
Sbjct: 599 NISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  112 bits (282), Expect = 4e-27
 Identities = 29/186 (15%), Positives = 62/186 (33%), Gaps = 19/186 (10%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
            ++     L    + N+P  +        N +         Y         +  NL  LT
Sbjct: 200 KAVMRLTKLRQFYMGNSPFVAENICEAWENEN-------SEYAQQYKTEDLKWDNLKDLT 252

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIG 124
            + +        +   L   L  ++ +++  N   S      + +            +  
Sbjct: 253 DVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQLKDDWQ---------ALADAP 302

Query: 125 GLPNLEYLFLGYNRLQ-GSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLS 183
               ++ +++GYN L+   +  S   +  L  L    N L G +P +    + L  LNL+
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLA 361

Query: 184 FNKLEG 189
           +N++  
Sbjct: 362 YNQITE 367

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  102 bits (257), Expect = 7e-24
 Identities = 23/202 (11%), Positives = 58/202 (28%), Gaps = 6/202 (2%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSH--SLEFFVMSYCNISGGILEEIT--NL 60
            ++     L  + L ++             +S   S E       +     ++     + 
Sbjct: 99  DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDF 158

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP 120
           + L    +  +    SI  +    L    ++   SN +T +      L  +        P
Sbjct: 159 SDLIKDCINSDPQQKSIKKSSRITL-KDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSP 217

Query: 121 IE-IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKD 179
                     E     Y +   +    + +L  L  + +        +P  L+ L  ++ 
Sbjct: 218 FVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277

Query: 180 LNLSFNKLEGEIPRGGSFGNFS 201
           +N++ N+          +   +
Sbjct: 278 INVACNRGISGEQLKDDWQALA 299

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 17/186 (9%), Positives = 43/186 (23%), Gaps = 34/186 (18%)

Query: 45  SYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-- 102
                SG + + I  LT+L  + LG +    +  +     +++                 
Sbjct: 89  EGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKT 148

Query: 103 ----LTFWNLKDILYLNFS------VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLIS 152
                   +  D++    +       I            +    N +   +  +   L  
Sbjct: 149 FVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTK 207

Query: 153 LKSLNLSKNNLSG-------------------AIPASLEKLLYLKDLNLSFNKLEGEIPR 193
           L+   +  +                             + L  L D+ +       ++P 
Sbjct: 208 LRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267

Query: 194 GGSFGN 199
                 
Sbjct: 268 --FLKA 271

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 23/164 (14%), Positives = 51/164 (31%), Gaps = 15/164 (9%)

Query: 42  FVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSI 101
           F              + +  ++T + L G   +G +   +G  L  L  L+L S+     
Sbjct: 62  FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIG-QLTELEVLALGSHGEKVN 120

Query: 102 PLTF--------WNLKDILYLNFSVIPIEIGGLP-----NLEYLFLGYNRLQGSIPDSFG 148
              F         + +    +        +   P     +L    +  +  Q SI  S  
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180

Query: 149 DLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIP 192
             +    +    NN++  +  ++ +L  L+   +  +    E  
Sbjct: 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI 223

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 19/145 (13%), Positives = 38/145 (26%), Gaps = 7/145 (4%)

Query: 81  LGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQ 140
           L     +L   +       + P   WN    L +  +   + +     +  L L      
Sbjct: 35  LKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGAS 94

Query: 141 GSIPDSFGDLISLKSLNLSKNNLSG----AIPASLEKLLYLKDLNLSFNKLEGEIPRGGS 196
           G +PD+ G L  L+ L L  +          P  +   +  +         +        
Sbjct: 95  GRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDP 154

Query: 197 FGNFS---AESFEGNELLCGSPNLQ 218
             +FS    +    +          
Sbjct: 155 REDFSDLIKDCINSDPQQKSIKKSS 179

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  127 bits (321), Expect = 3e-32
 Identities = 42/197 (21%), Positives = 73/197 (37%), Gaps = 9/197 (4%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
             S  +   L F+DLS N L      +     + SL++  +S+  +   +      L +L
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQL 398

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSI-PLTFWNLKDILYLNFS----- 117
             +    + L      ++  +L +L  L +            F  L  +  L  +     
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458

Query: 118 --VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLL 175
              +P     L NL +L L   +L+   P +F  L SL+ LN+S NN         + L 
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518

Query: 176 YLKDLNLSFNKLEGEIP 192
            L+ L+ S N +     
Sbjct: 519 SLQVLDYSLNHIMTSKK 535

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  118 bits (297), Expect = 5e-29
 Identities = 50/201 (24%), Positives = 78/201 (38%), Gaps = 17/201 (8%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
              +DLS NPL  +   +F       L+   +S C I         +L+ L+T+IL GN 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSF--PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTS-IPLTFWNLKDILYLNFS-------VIPIEIG 124
           +           L+SL+KL      L S       +LK +  LN +        +P    
Sbjct: 88  IQSLALGAFS-GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 125 GLPNLEYLFLGYNRLQGSIPDSFGDLISLK----SLNLSKNNLSGAIPASLEKLLYLKDL 180
            L NLE+L L  N++Q         L  +     SL+LS N ++   P +  K + L  L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKL 205

Query: 181 NLSFNKLEGEIPRGGSFGNFS 201
            L  N     + +       +
Sbjct: 206 TLRNNFDSLNVMK-TCIQGLA 225

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  115 bits (290), Expect = 3e-28
 Identities = 32/192 (16%), Positives = 68/192 (35%), Gaps = 19/192 (9%)

Query: 2   SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT 61
           +  S+    + L  +D  ++ L  +   +   ++  +L +  +S+ +           L+
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR-NLIYLDISHTHTRVAFNGIFNGLS 445

Query: 62  KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPI 121
            L  + + GN    +    + + L +L  L L   +L  +                  P 
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS-----------------PT 488

Query: 122 EIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY-LKDL 180
               L +L+ L + +N         +  L SL+ L+ S N++  +    L+     L  L
Sbjct: 489 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 548

Query: 181 NLSFNKLEGEIP 192
           NL+ N       
Sbjct: 549 NLTQNDFACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  106 bits (267), Expect = 3e-25
 Identities = 39/197 (19%), Positives = 70/197 (35%), Gaps = 20/197 (10%)

Query: 17  DLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGS 76
                    +       N+  S +   +S+  +         +  +L  + L   ++   
Sbjct: 13  QCMELNFYKIPD-----NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67

Query: 77  ISITLGSNLASLRKLSLDSNELTSI-PLTFWNLKDILYLNFS------VIPIEIGGLPNL 129
                  +L+ L  L L  N + S+    F  L  +  L         +    IG L  L
Sbjct: 68  EDGAYQ-SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126

Query: 130 EYLFLGYNRLQG-SIPDSFGDLISLKSLNLSKNNLSGAIPASLEKL----LYLKDLNLSF 184
           + L + +N +Q   +P+ F +L +L+ L+LS N +       L  L    L    L+LS 
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 185 NKLEGEIPRGGSFGNFS 201
           N +    P  G+F    
Sbjct: 187 NPMNFIQP--GAFKEIR 201

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 46/215 (21%), Positives = 73/215 (33%), Gaps = 20/215 (9%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
            +  +   L+ + L+ NP+ S+    F G    SL+  V    N++      I +L  L 
Sbjct: 70  GAYQSLSHLSTLILTGNPIQSLALGAFSGL--SSLQKLVAVETNLASLENFPIGHLKTLK 127

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP---------LTFWNLKDILYLN 115
            + +  N +         SNL +L  L L SN++ SI          +   NL   L LN
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187

Query: 116 F-SVIPIEIGGLPNLEYLFLGYNRLQGSIP-DSFGDLISLKSLNLSKN------NLSGAI 167
             + I         L  L L  N    ++       L  L+   L         NL    
Sbjct: 188 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247

Query: 168 PASLEKLLYLKDLNLSFNKLEGEIPRG-GSFGNFS 201
            ++LE L  L         L+  +      F   +
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 31/209 (14%), Positives = 56/209 (26%), Gaps = 21/209 (10%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVG--NVSHSLEFFVMSYCNISGGILEEIT 58
                  SN   L  +DLS+N + S+          +        +S   ++        
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198

Query: 59  NLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTS-------IPLTFWNLKDI 111
            + +L  + L  N  + ++  T    LA L    L   E  +              L ++
Sbjct: 199 EI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257

Query: 112 LYLNFS---------VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN 162
               F           I      L N+    L    ++     S+      + L L    
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCK 315

Query: 163 LSGAIPASLEKLLYLKDLNLSFNKLEGEI 191
                   L+ L  L   +        E+
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 46/224 (20%), Positives = 74/224 (33%), Gaps = 40/224 (17%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEE-ITN 59
           L  L  +        +DLS NP++ + P  F       L    +     S  +++  I  
Sbjct: 169 LRVLHQMPLL--NLSLDLSLNPMNFIQPGAFKEI---RLHKLTLRNNFDSLNVMKTCIQG 223

Query: 60  LTKLTTIILGGNKLNGSISITL--GSNLASLRKLSLDSNELTS-------IPLTFWNLKD 110
           L  L    L   +     ++     S L  L  L+++   L         I   F  L +
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283

Query: 111 ILYLNFS----VIPIEIGGLPNLEYLFLGYNRL-------------------QGSIPDSF 147
           +   +          +       ++L L   +                    +G    S 
Sbjct: 284 VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE 343

Query: 148 GDLISLKSLNLSKNNLS--GAIPASLEKLLYLKDLNLSFNKLEG 189
            DL SL+ L+LS+N LS  G    S      LK L+LSFN +  
Sbjct: 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  122 bits (307), Expect = 2e-30
 Identities = 48/234 (20%), Positives = 75/234 (32%), Gaps = 26/234 (11%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISG--GILEEITNLTK 62
                 + +  I LS N    +   +F      SL+  ++    +            L  
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALV--PSLQRLMLRRVALKNVDSSPSPFQPLRN 481

Query: 63  LTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSI---------PLTFWNLKDILY 113
           LT + L  N +       L   L  L  L L  N L  +               L  +  
Sbjct: 482 LTILDLSNNNIANINDDMLE-GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI 540

Query: 114 LNFS------VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAI 167
           LN        +       L  L+ + LG N L       F + +SLKSLNL KN ++   
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600

Query: 168 PASLEKLLY-LKDLNLSFNKLEGEIPRGGSFGNFSAES-----FEGNELLCGSP 215
                     L +L++ FN  +        F N+  E+        +  LC +P
Sbjct: 601 KKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  116 bits (292), Expect = 2e-28
 Identities = 40/207 (19%), Positives = 79/207 (38%), Gaps = 17/207 (8%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
           ++ +    LT +D+  N +  + P+         L+   + +  +S    +     T LT
Sbjct: 43  ANFTRYSQLTSLDVGFNTISKLEPELCQKL--PMLKVLNLQHNELSQLSDKTFAFCTNLT 100

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFS------ 117
            + L  N +    +        +L  L L  N L+S  L T   L+++  L  S      
Sbjct: 101 ELHLMSNSIQKIKNNPFV-KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159

Query: 118 --VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASL---E 172
                ++I    +L+ L L  N+++   P  F  +  L  L L+   L  ++   L    
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLEL 219

Query: 173 KLLYLKDLNLSFNKLEGEIPRGGSFGN 199
               +++L+LS ++L        +F  
Sbjct: 220 ANTSIRNLSLSNSQLSTTSN--TTFLG 244

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  112 bits (282), Expect = 5e-27
 Identities = 49/206 (23%), Positives = 78/206 (37%), Gaps = 20/206 (9%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
            +    + L  + LSNN + ++  +      + SL+   +S   I          + +L 
Sbjct: 139 GTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLF 198

Query: 65  TIILGGNKLNGSI--SITLGSNLASLRKLSLDSNELTSI-PLTFWNLKDILYLNFSVIPI 121
            + L   +L  S+   + L     S+R LSL +++L++    TF  LK            
Sbjct: 199 GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK------------ 246

Query: 122 EIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLN 181
                 NL  L L YN L     DSF  L  L+   L  NN+      SL  L  ++ LN
Sbjct: 247 ----WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302

Query: 182 LSFNKLEGEIPRGGSFGNFSAESFEG 207
           L  +  +  I    S       SF+ 
Sbjct: 303 LKRSFTKQSIS-LASLPKIDDFSFQW 327

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  110 bits (278), Expect = 2e-26
 Identities = 45/211 (21%), Positives = 78/211 (36%), Gaps = 19/211 (9%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
                   L  ++L +N L  +  KTF      +L    +   +I             L 
Sbjct: 67  ELCQKLPMLKVLNLQHNELSQLSDKTFAFC--TNLTELHLMSNSIQKIKNNPFVKQKNLI 124

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP---LTFWNLKDILYLNFS---- 117
           T+ L  N L+ +   T    L +L++L L +N++ ++    L  +    +  L  S    
Sbjct: 125 TLDLSHNGLSSTKLGTQV-QLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183

Query: 118 --VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGD---LISLKSLNLSKNNLSGAIPASLE 172
               P     +  L  LFL   +L  S+ +         S+++L+LS + LS     +  
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243

Query: 173 KLLY--LKDLNLSFNKLEGEIPRGGSFGNFS 201
            L +  L  L+LS+N L        SF    
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGN--DSFAWLP 272

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  110 bits (278), Expect = 2e-26
 Identities = 39/193 (20%), Positives = 70/193 (36%), Gaps = 24/193 (12%)

Query: 10  CKC-LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIIL 68
           C       D S+  L  V       ++  ++    +++  +        T  ++LT++ +
Sbjct: 2   CTVSHEVADCSHLKLTQVPD-----DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDV 56

Query: 69  GGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPN 128
           G N ++          L  L+ L+L  NEL+ +                          N
Sbjct: 57  GFNTISKLEPELCQ-KLPMLKVLNLQHNELSQLS-----------------DKTFAFCTN 98

Query: 129 LEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLE 188
           L  L L  N +Q    + F    +L +L+LS N LS     +  +L  L++L LS NK++
Sbjct: 99  LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158

Query: 189 GEIPRGGSFGNFS 201
                       S
Sbjct: 159 ALKSEELDIFANS 171

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  110 bits (276), Expect = 3e-26
 Identities = 43/219 (19%), Positives = 79/219 (36%), Gaps = 22/219 (10%)

Query: 6   SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEIT---NLTK 62
            +     L  ++LS+N +    P  F       L    ++   +   + E++      T 
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHA--IGRLFGLFLNNVQLGPSLTEKLCLELANTS 223

Query: 63  LTTIILGGNKLNGSISITL-GSNLASLRKLSLDSNELTSI-PLTFWNLKDILYLNFS--- 117
           +  + L  ++L+ + + T  G    +L  L L  N L  +   +F  L  + Y       
Sbjct: 224 IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNN 283

Query: 118 ---VIPIEIGGLPNLEYLFLGYN---------RLQGSIPDSFGDLISLKSLNLSKNNLSG 165
              +    + GL N+ YL L  +          L      SF  L  L+ LN+  N++ G
Sbjct: 284 IQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343

Query: 166 AIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAES 204
                   L+ LK L+LS +          +F + +   
Sbjct: 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  107 bits (269), Expect = 2e-25
 Identities = 46/214 (21%), Positives = 80/214 (37%), Gaps = 17/214 (7%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L  +  L+  +  T   +S   L  +   +F       LE   M   +I G      T L
Sbjct: 295 LFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL--KCLEHLNMEDNDIPGIKSNMFTGL 352

Query: 61  TKLTTIILGGNKLN-GSISITLGSNLA--SLRKLSLDSNELTSI-PLTFWNLKDILYLNF 116
             L  + L  +  +  +++     +LA   L  L+L  N+++ I    F  L  +  L+ 
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412

Query: 117 S-------VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG--AI 167
                   +   E  GL N+  ++L YN+      +SF  + SL+ L L +  L    + 
Sbjct: 413 GLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSS 472

Query: 168 PASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFS 201
           P+  + L  L  L+LS N +              
Sbjct: 473 PSPFQPLRNLTILDLSNNNIANIND--DMLEGLE 504

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  107 bits (268), Expect = 3e-25
 Identities = 47/202 (23%), Positives = 78/202 (38%), Gaps = 15/202 (7%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           L        +  + LSN+ L +    TF+G    +L    +SY N++    +    L +L
Sbjct: 215 LCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQL 274

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEI 123
               L  N +    S +L   L ++R L+L  +  T   ++  +L  I            
Sbjct: 275 EYFFLEYNNIQHLFSHSL-HGLFNVRYLNLKRS-FTKQSISLASLPKI-------DDFSF 325

Query: 124 GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLE----KLLYLKD 179
             L  LE+L +  N + G   + F  LI+LK L+LS +  S     +          L  
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385

Query: 180 LNLSFNKLEGEIPRGGSFGNFS 201
           LNL+ NK+        +F    
Sbjct: 386 LNLTKNKISKIES--DAFSWLG 405

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 18/117 (15%), Positives = 38/117 (32%), Gaps = 2/117 (1%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           +  L     L  ++L +N  D +  + F       L+   +   N++        N   L
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKD--LFELKIIDLGLNNLNTLPASVFNNQVSL 586

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP 120
            ++ L  N +        G    +L +L +  N       +     + +    + IP
Sbjct: 587 KSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIP 643

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  119 bits (301), Expect = 1e-29
 Identities = 40/200 (20%), Positives = 69/200 (34%), Gaps = 9/200 (4%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
            S          L+++DLS N L      ++    ++SL    +S+      +      L
Sbjct: 340 GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGL 398

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFS-- 117
            +L  +    + L      +   +L  L  L +            F  L  +  L  +  
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458

Query: 118 -----VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLE 172
                 +        NL +L L   +L+      F  L  L+ LN+S NNL     +   
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518

Query: 173 KLLYLKDLNLSFNKLEGEIP 192
           +L  L  L+ SFN++E    
Sbjct: 519 QLYSLSTLDCSFNRIETSKG 538

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  100 bits (251), Expect = 5e-23
 Identities = 47/194 (24%), Positives = 73/194 (37%), Gaps = 16/194 (8%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
              IDLS NPL  +   +F       L++  +S C I     +    L  L+ +IL GN 
Sbjct: 34  TKNIDLSFNPLKILKSYSFSN--FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLNFS-------VIPIEIG 124
           +      +  S L SL  L     +L S+       L  +  LN +        +P    
Sbjct: 92  IQSFSPGSF-SGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150

Query: 125 GLPNLEYLFLGYNRLQGSIPDSFGDL----ISLKSLNLSKNNLSGAIPASLEKLLYLKDL 180
            L NL ++ L YN +Q    +    L        SL++S N +   I     + + L +L
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHEL 209

Query: 181 NLSFNKLEGEIPRG 194
            L  N     I + 
Sbjct: 210 TLRGNFNSSNIMKT 223

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 96.6 bits (241), Expect = 8e-22
 Identities = 39/212 (18%), Positives = 74/212 (34%), Gaps = 23/212 (10%)

Query: 5   SSLSNCKCL---TFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT 61
            SL+ C  +         +  L  V       ++  S +   +S+  +        +N +
Sbjct: 2   GSLNPCIEVVPNITYQCMDQKLSKVPD-----DIPSSTKNIDLSFNPLKILKSYSFSNFS 56

Query: 62  KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSI-PLTFWNLKDILYLNFS--- 117
           +L  + L   ++           L  L  L L  N + S  P +F  L  +  L      
Sbjct: 57  ELQWLDLSRCEIETIEDKAW-HGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115

Query: 118 ---VIPIEIGGLPNLEYLFLGYNRLQG-SIPDSFGDLISLKSLNLSKNNLSGAIPASLEK 173
              +    IG L  L+ L + +N +    +P  F +L +L  ++LS N +       L+ 
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQF 175

Query: 174 L----LYLKDLNLSFNKLEGEIPRGGSFGNFS 201
           L         L++S N ++       +F    
Sbjct: 176 LRENPQVNLSLDMSLNPIDFIQD--QAFQGIK 205

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 42/202 (20%), Positives = 78/202 (38%), Gaps = 13/202 (6%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           L+ L   + +         L+   P    G    +++ F ++Y N     + +   L  +
Sbjct: 228 LAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANV 287

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS----VI 119
           + + L G  +     +         + LS+   +L   P    +L  +  L  +     I
Sbjct: 288 SAMSLAGVSIK---YLEDVPKHFKWQSLSIIRCQLKQFP--TLDLPFLKSLTLTMNKGSI 342

Query: 120 PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDL--ISLKSLNLSKNNLSGAIPASLEKLLYL 177
             +   LP+L YL L  N L  S   S+ DL   SL+ L+LS N     + A+   L  L
Sbjct: 343 SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEEL 401

Query: 178 KDLNLSFNKLEGEIPRGGSFGN 199
           + L+   + L+  +    +F +
Sbjct: 402 QHLDFQHSTLKR-VTEFSAFLS 422

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 37/214 (17%), Positives = 63/214 (29%), Gaps = 19/214 (8%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
            +      L+ + L+ NP+ S  P +F G    SLE  V     ++      I  L  L 
Sbjct: 74  KAWHGLHHLSNLILTGNPIQSFSPGSFSGL--TSLENLVAVETKLASLESFPIGQLITLK 131

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYL--------- 114
            + +  N ++        SNL +L  + L  N + +I       L++   +         
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191

Query: 115 NFSVIPIEIGGLPNLEYLFLGYNRLQGSIP-DSFGDLISLKSLNLSKNNLSGAI------ 167
               I  +      L  L L  N    +I      +L  L    L               
Sbjct: 192 PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251

Query: 168 PASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFS 201
           P+ +E L  +                   F   +
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLA 285

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 84.7 bits (210), Expect = 6e-18
 Identities = 43/212 (20%), Positives = 66/212 (31%), Gaps = 23/212 (10%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVG--NVSHSLEFFVMSYCNISGGILEEIT 58
               +  SN   L  +DLS N + ++                   MS   I   I ++  
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAF 201

Query: 59  NLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSI-------PLTFWNLKDI 111
              KL  + L GN  + +I  T   NLA L    L   E           P     L D+
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261

Query: 112 ----LYLN----FSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNL 163
                 L     FS   ++   L N+  + L    +     +        +SL++ +  L
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQL 319

Query: 164 SGAIPASLEKLLYLKDLNLSFNKLEGEIPRGG 195
                  L     LK L L+ NK      +  
Sbjct: 320 KQFPTLDLPF---LKSLTLTMNKGSISFKKVA 348

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 25/105 (23%), Positives = 42/105 (40%), Gaps = 3/105 (2%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
           +  +N   LTF+DLS   L+ +    F     H L+   MS+ N+          L  L+
Sbjct: 467 NVFANTTNLTFLDLSKCQLEQISWGVFDT--LHRLQLLNMSHNNLLFLDSSHYNQLYSLS 524

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLK 109
           T+    N++  +    L     SL   +L +N +  I      L+
Sbjct: 525 TLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQ 568

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  118 bits (296), Expect = 7e-29
 Identities = 40/241 (16%), Positives = 75/241 (31%), Gaps = 30/241 (12%)

Query: 6   SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSH---SLEFFVMSYCNISGGILEEITNLTK 62
           +  +   +  +D S N + S           +   +     +SY  I     E     + 
Sbjct: 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSP 698

Query: 63  LTTIILGGNKL------NGSISITLGSNLASLRKLSLDSNELTSIP--LTFWNLKDILYL 114
           ++TIIL  N +      +         N   L  + L  N+LTS+        L  +  +
Sbjct: 699 ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNM 758

Query: 115 N-----FSVIPIEIGGLPNLEYL------FLGYNRLQGSIPDSFGDLISLKSLNLSKNNL 163
           +     FS  P +      L+            NR+    P       SL  L +  N++
Sbjct: 759 DVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818

Query: 164 SGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAE----SFEGNELLCGSPNLQV 219
              +   L     L  L+++ N     I          A      ++  + + G   L +
Sbjct: 819 RK-VDEKL--TPQLYILDIADNPNI-SIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGI 874

Query: 220 Q 220
           +
Sbjct: 875 E 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  115 bits (290), Expect = 4e-28
 Identities = 34/217 (15%), Positives = 65/217 (29%), Gaps = 25/217 (11%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
                   +    +  N L+       +  +   L      +  +    LE      KLT
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEEFPASASLQKMV-KLGLLDCVHNKVR--HLEAFGTNVKLT 598

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP--LTFWNLKDILYLNFS----- 117
            + L  N++   I     +    +  L    N+L  IP      ++  +  ++FS     
Sbjct: 599 DLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIG 657

Query: 118 VIPIEIGG------LPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLS------- 164
                I          N   + L YN +Q    + F     + ++ LS N ++       
Sbjct: 658 SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSL 717

Query: 165 GAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFS 201
                + +    L  ++L FNKL   +          
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLP 753

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  105 bits (264), Expect = 1e-24
 Identities = 38/219 (17%), Positives = 76/219 (34%), Gaps = 28/219 (12%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISG---------GILE 55
            S SN K LT ++L N P  + LP     ++   L+   ++                + +
Sbjct: 485 LSWSNLKDLTDVELYNCPNMTQLPDFL-YDLP-ELQSLNIACNRGISAAQLKADWTRLAD 542

Query: 56  EITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLN 115
           +     K+    +G N L    +      +  L  L    N++  +   F     +  L 
Sbjct: 543 DEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLE-AFGTNVKLTDLK 601

Query: 116 -----FSVIPIEIG-GLPNLEYLFLGYNRLQGSIPD--SFGDLISLKSLNLSKNNLSG-- 165
                   IP +       +E L   +N+L+  IP+  +   +  + S++ S N +    
Sbjct: 602 LDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEG 660

Query: 166 ---AIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFS 201
              +      K +    + LS+N+++        F   S
Sbjct: 661 RNISCSMDDYKGINASTVTLSYNEIQKFPT--ELFATGS 697

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  102 bits (255), Expect = 2e-23
 Identities = 30/235 (12%), Positives = 65/235 (27%), Gaps = 32/235 (13%)

Query: 6   SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTT 65
            L N   +T + L+       +P    G ++  L+       + +               
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAI-GQLTE-LKVLSFGTHSETVSGRLFGDEELTPDM 375

Query: 66  IILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-------LTFWNLKDILYLNFS- 117
                +++              L    L  + +   P        +  +LKD    N + 
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTN 435

Query: 118 ---VIPIEIGGLPNLEYLFLGYNRLQG-------------------SIPDSFGDLISLKS 155
               I   I  L  L+ ++   +                       +   S+ +L  L  
Sbjct: 436 RITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495

Query: 156 LNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 210
           + L        +P  L  L  L+ LN++ N+          +   + +   G ++
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 15/95 (15%), Positives = 35/95 (36%)

Query: 99  TSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNL 158
            +I    WN    L +      +++     +  L L     +G +PD+ G L  LK L+ 
Sbjct: 295 NTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSF 354

Query: 159 SKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPR 193
             ++ + +     ++ L         +++     +
Sbjct: 355 GTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK 389

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 11/103 (10%), Positives = 31/103 (30%), Gaps = 1/103 (0%)

Query: 135 GYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG 194
             +           +   +  L+L+     G +P ++ +L  LK L+   +         
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366

Query: 195 GSFGNFSAESFE-GNELLCGSPNLQVQPCKTGIHHTSSKNSLL 236
           G        S E  + +      + +   +        ++++ 
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN 409

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  113 bits (284), Expect = 1e-28
 Identities = 29/129 (22%), Positives = 61/129 (47%), Gaps = 8/129 (6%)

Query: 280 FSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEM 339
                L   +       + ++G FG V+KA+L     VAVK+F +Q +++++  + E   
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYS 71

Query: 340 MKSIRHQNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 395
           +  ++H+N+++ I +            L+  +   GSL  +L ++  ++   +  +I   
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAET 129

Query: 396 VASALEYLH 404
           +A  L YLH
Sbjct: 130 MARGLAYLH 138

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  111 bits (281), Expect = 3e-28
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 13/139 (9%)

Query: 278 RMFSYLELCRATYKFSE------NNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRA-- 329
             FS+ EL   T  F E       N + +GGFG VYK  + +   VAVK           
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 330 --FKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY--SSNCILD 385
              + FD E ++M   +H+NL++++   S+ +   LV  YMP+GSL   L        L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 386 IFQRLNIMIDVASALEYLH 404
              R  I    A+ + +LH
Sbjct: 132 WHMRCKIAQGAANGINFLH 150

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  108 bits (273), Expect = 3e-27
 Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 10/122 (8%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC-------RRAFKSFDIECEMMKS 342
           +      I KGGFG V+K R + D   VA+K   L            F+ F  E  +M +
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79

Query: 343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 402
           + H N++K+     N     +V+E++P G L   L      +    +L +M+D+A  +EY
Sbjct: 80  LNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137

Query: 403 LH 404
           + 
Sbjct: 138 MQ 139

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  107 bits (269), Expect = 2e-26
 Identities = 39/132 (29%), Positives = 54/132 (40%), Gaps = 13/132 (9%)

Query: 280 FSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEM 339
            +  E            LI +G +G+VYK  L D   VAVKVF+   R+ F +   E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN---EKNI 58

Query: 340 MK--SIRHQNLIKVISSC-----SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 392
            +   + H N+ + I               LV+EY P+GSL KYL       D      +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRL 116

Query: 393 MIDVASALEYLH 404
              V   L YLH
Sbjct: 117 AHSVTRGLAYLH 128

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  105 bits (265), Expect = 4e-26
 Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 5/111 (4%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           I  G FG+V++A    G +VAVK+   Q         F  E  +MK +RH N++  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNIMIDVASALEYLH 404
           +     ++V EY+  GSL + L+ S     LD  +RL++  DVA  + YLH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  109 bits (274), Expect = 4e-26
 Identities = 46/221 (20%), Positives = 79/221 (35%), Gaps = 16/221 (7%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
             L N + L  +DLS++ +++             L+   +SY        E      +L 
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLNFS------ 117
            + L   +L    + +   NL  L+ L+L  + L       F  L  + +LN        
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463

Query: 118 ---VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKL 174
                   +  L  LE L L +  L      +F  L  +  ++LS N L+ +   +L  L
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL 523

Query: 175 LYLKDLNLSFNKLEGEIPRGGSFGNFSAES---FEGNELLC 212
             +  LNL+ N +   +P        S +       N L C
Sbjct: 524 KGIY-LNLASNHISIILP--SLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  103 bits (260), Expect = 3e-24
 Identities = 44/206 (21%), Positives = 75/206 (36%), Gaps = 14/206 (6%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITN--LT 61
           +SSL     L+ ++L+ N +  + P  F   V  SL F           I + + N  + 
Sbjct: 173 MSSLQQATNLS-LNLNGNDIAGIEPGAFDSAVFQSLNF---GGTQNLLVIFKGLKNSTIQ 228

Query: 62  KLTTIILGGNKLNGSISITL-GSNLASLRKLSLDSNELTSI-PLTFWNLKDILYLN---- 115
            L                   G    S+  ++L  +   +I   TF     +  L+    
Sbjct: 229 SLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTAT 288

Query: 116 -FSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAI-PASLEK 173
             S +P  + GL  L+ L L  N+ +     S  +  SL  L++  N     +    LE 
Sbjct: 289 HLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348

Query: 174 LLYLKDLNLSFNKLEGEIPRGGSFGN 199
           L  L++L+LS + +E          N
Sbjct: 349 LENLRELDLSHDDIETSDCCNLQLRN 374

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  102 bits (255), Expect = 1e-23
 Identities = 42/206 (20%), Positives = 69/206 (33%), Gaps = 22/206 (10%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
              ++ S N L ++   TF      +L F  ++ C I     +   +  +L T++L  N 
Sbjct: 35  TECLEFSFNVLPTIQNTTFSR--LINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYL 132
           L       L S   +L+ L      ++SI                   I +     LE L
Sbjct: 93  LIFMAETAL-SGPKALKHLFFIQTGISSID-----------------FIPLHNQKTLESL 134

Query: 133 FLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKL--LYLKDLNLSFNKLEGE 190
           +LG N +             LK L+   N +       +  L       LNL+ N + G 
Sbjct: 135 YLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGI 194

Query: 191 IPRGGSFGNFSAESFEGNELLCGSPN 216
            P       F + +F G + L     
Sbjct: 195 EPGAFDSAVFQSLNFGGTQNLLVIFK 220

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 99.7 bits (249), Expect = 6e-23
 Identities = 45/204 (22%), Positives = 68/204 (33%), Gaps = 23/204 (11%)

Query: 2   SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEE-ITNL 60
              S L     L  + LS N  +++   +       SL    +        +    + NL
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNF--PSLTHLSIKGNTKRLELGTGCLENL 349

Query: 61  TKLTTIILGGNKLNGS-ISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVI 119
             L  + L  + +  S        NL+ L+ L+L  NE  S+                  
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLK----------------- 392

Query: 120 PIEIGGLPNLEYLFLGYNRLQGSIPDS-FGDLISLKSLNLSKNNLSGAIPASLEKLLYLK 178
                  P LE L L + RL+     S F +L  LK LNLS + L  +     + L  L+
Sbjct: 393 TEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQ 452

Query: 179 DLNLSFNKLEGEIPRG-GSFGNFS 201
            LNL  N       +   S     
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLG 476

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 98.2 bits (245), Expect = 3e-22
 Identities = 39/201 (19%), Positives = 67/201 (33%), Gaps = 12/201 (5%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           L      + L  +D  NN +  +  +        +     ++  +I+ GI     +    
Sbjct: 146 LPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVF 204

Query: 64  TTIILGGNKLNGSISITL-GSNLASLRKLSLDSNELTSI-PLTFWNLKD----ILYLN-- 115
            ++  GG +    I   L  S + SL   + +  +   I P  F  L +     + L   
Sbjct: 205 QSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264

Query: 116 --FSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEK 173
             F++          L+ L L    L   +P     L +LK L LS N        S   
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323

Query: 174 LLYLKDLNLSFNKLEGEIPRG 194
              L  L++  N    E+  G
Sbjct: 324 FPSLTHLSIKGNTKRLELGTG 344

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 93.9 bits (234), Expect = 6e-21
 Identities = 39/208 (18%), Positives = 69/208 (33%), Gaps = 17/208 (8%)

Query: 6   SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTT 65
           +  +   L  + L+ NPL  +      G    +L+        IS      + N   L +
Sbjct: 76  TFQSQHRLDTLVLTANPLIFMAETALSGP--KALKHLFFIQTGISSIDFIPLHNQKTLES 133

Query: 66  IILGGNKLNGSISITLGSNLASLRKLSLDSNELTSI-PLTFWNLK--DILYLNFS----- 117
           + LG N ++ SI +  G     L+ L   +N +  +      +L+    L LN +     
Sbjct: 134 LYLGSNHIS-SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192

Query: 118 VIPIEIGGLPNLEYLFLGYNRLQGSIPD--SFGDLISLKSLNLSKNNLSGAIPASLEKL- 174
            I          + L  G  +    I        + SL        +     PA  E L 
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252

Query: 175 -LYLKDLNLSFNKLEGEIPRGGSFGNFS 201
            + ++ +NL  +          +F  FS
Sbjct: 253 EMSVESINLQKHYFFNISS--NTFHCFS 278

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 42/208 (20%), Positives = 76/208 (36%), Gaps = 16/208 (7%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
             L N K L  + L +N + S+         +  L+        I     E++++L + T
Sbjct: 123 IPLHNQKTLESLYLGSNHISSIKLPKGFP--TEKLKVLDFQNNAIHYLSKEDMSSLQQAT 180

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL------TFWNLK--DILYLNF 116
            + L  N  + +       + A  + L+    +   +        T  +L       ++ 
Sbjct: 181 NLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240

Query: 117 SVIP---IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEK 173
             I     E     ++E + L  +       ++F     L+ L+L+  +LS  +P+ L  
Sbjct: 241 EDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVG 299

Query: 174 LLYLKDLNLSFNKLEGEIPRGGSFGNFS 201
           L  LK L LS NK E       S  NF 
Sbjct: 300 LSTLKKLVLSANKFENLCQ--ISASNFP 325

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 23/122 (18%), Positives = 37/122 (30%), Gaps = 9/122 (7%)

Query: 87  SLRKLSLDSNELTSI-PLTFWNLKDILYLNFS------VIPIEIGGLPNLEYLFLGYNRL 139
           S   L    N L +I   TF  L ++ +L+ +      +          L+ L L  N L
Sbjct: 34  STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93

Query: 140 QGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGN 199
                 +     +LK L   +  +S      L     L+ L L  N +            
Sbjct: 94  IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKL--PKGFP 151

Query: 200 FS 201
             
Sbjct: 152 TE 153

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 75.1 bits (185), Expect = 8e-15
 Identities = 23/116 (19%), Positives = 40/116 (34%), Gaps = 8/116 (6%)

Query: 89  RKLSLDSNELTSIPLT-FWNLKDILYLNF----SVIPIEIGGLPNLEYLFLGYNRLQGSI 143
           +  + ++  L  IP T   + +  L  +F    ++       L NL +L L   ++    
Sbjct: 15  KTYNCENLGLNEIPGTLPNSTE-CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 144 PDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGN 199
            D+F     L +L L+ N L      +L     LK L      +           N
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF--IPLHN 127

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 69.3 bits (170), Expect = 7e-13
 Identities = 35/189 (18%), Positives = 70/189 (37%), Gaps = 32/189 (16%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEE---ITNLT 61
           S   N   L  ++LS++ LD    + F G    +L+   +   +   G +++   +  L 
Sbjct: 419 SPFQNLHLLKVLNLSHSLLDISSEQLFDGL--PALQHLNLQGNHFPKGNIQKTNSLQTLG 476

Query: 62  KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS---- 117
           +L  ++L    L+        ++L  +  + L  N LTS  +   +    +YLN +    
Sbjct: 477 RLEILVLSFCDLSSIDQHAF-TSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHI 535

Query: 118 --VIPIEIGGLPNLEYLFLGYNRLQGS----------------IPDS----FGDLISLKS 155
             ++P  +  L     + L  N L  +                + D+      +   L+ 
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRG 595

Query: 156 LNLSKNNLS 164
           + LS   LS
Sbjct: 596 VRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 35/185 (18%), Positives = 53/185 (28%), Gaps = 51/185 (27%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
            +SL     L  + LS   L S+    F                          T+L  +
Sbjct: 469 TNSLQTLGRLEILVLSFCDLSSIDQHAF--------------------------TSLKMM 502

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEI 123
             + L  N+L  S SI   S+L  +  L+L SN ++ I                  P  +
Sbjct: 503 NHVDLSHNRLT-SSSIEALSHLKGIY-LNLASNHISIIL-----------------PSLL 543

Query: 124 GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKS-LNLSKNNLSGAIPASLEKLLYLKDLNL 182
             L     + L  N L  +        I        +   L        E    L+ + L
Sbjct: 544 PILSQQRTINLRQNPLDCTC-----SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRL 598

Query: 183 SFNKL 187
           S   L
Sbjct: 599 SDVTL 603

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  104 bits (262), Expect = 6e-26
 Identities = 28/112 (25%), Positives = 56/112 (50%), Gaps = 6/112 (5%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           +++   G ++K R   G ++ VKV  ++    R  + F+ EC  ++   H N++ V+ +C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 356 SNEEFK--ALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLH 404
            +       L+  +MP+GSL   L+      +D  Q +   +D+A  + +LH
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  104 bits (261), Expect = 2e-25
 Identities = 27/111 (24%), Positives = 52/111 (46%), Gaps = 4/111 (3%)

Query: 296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVIS 353
            LI KG FG VY  R     EVA+++ +++       K+F  E    +  RH+N++  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 354 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +C +    A++       +L   +  +  +LD+ +   I  ++   + YLH
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  104 bits (262), Expect = 2e-25
 Identities = 41/201 (20%), Positives = 71/201 (35%), Gaps = 17/201 (8%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
                   L  + +    L   LP T     +  LE   ++   +   +   I +L +L 
Sbjct: 98  DQAFRLSHLQHMTIDAAGLME-LPDTM-QQFA-GLETLTLARNPLRA-LPASIASLNRLR 153

Query: 65  TIILGGNKLNGSISITLGS--------NLASLRKLSLDSNELTSIPLTFWNLKDILYLNF 116
            + +        +   L S         L +L+ L L+   + S+P +  NL+++  L  
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKI 213

Query: 117 S-----VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASL 171
                  +   I  LP LE L L       + P  FG    LK L L   +    +P  +
Sbjct: 214 RNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDI 273

Query: 172 EKLLYLKDLNLSFNKLEGEIP 192
            +L  L+ L+L        +P
Sbjct: 274 HRLTQLEKLDLRGCVNLSRLP 294

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 92.3 bits (230), Expect = 4e-21
 Identities = 31/208 (14%), Positives = 56/208 (26%), Gaps = 24/208 (11%)

Query: 6   SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTT 65
              +      +    +               H                     N      
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYN------ADRNRWHSAWRQANSNNPQI 60

Query: 66  IILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS-----VIP 120
               G  L  +  +   +       L L S  L   P   + L  + ++         +P
Sbjct: 61  ETRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLMELP 120

Query: 121 IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASL--------- 171
             +     LE L L  N L+ ++P S   L  L+ L++        +P  L         
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179

Query: 172 EKLLYLKDLNLSFNKLEGEIPRGGSFGN 199
           + L+ L+ L L +  +   +P   S  N
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPA--SIAN 204

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 76.9 bits (190), Expect = 7e-16
 Identities = 29/190 (15%), Positives = 55/190 (28%), Gaps = 50/190 (26%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
                       L  + L    + S LP                            I NL
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIRS-LP--------------------------ASIANL 205

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSL-DSNELTSIPLTFWNLKDILYLNFSVI 119
             L ++ +  + L+ ++   +  +L  L +L L     L +                   
Sbjct: 206 QNLKSLKIRNSPLS-ALGPAIH-HLPKLEELDLRGCTALRN------------------Y 245

Query: 120 PIEIGGLPNLEYLFL-GYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLK 178
           P   GG   L+ L L   + L  ++P     L  L+ L+L        +P+ + +L    
Sbjct: 246 PPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC 304

Query: 179 DLNLSFNKLE 188
            + +  +   
Sbjct: 305 IILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 15/101 (14%), Positives = 36/101 (35%), Gaps = 3/101 (2%)

Query: 2   SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT 61
           +   ++ +   L  +DL         P  F G  +  L+  ++  C+    +  +I  LT
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIF-GGRA-PLKRLILKDCSNLLTLPLDIHRLT 277

Query: 62  KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP 102
           +L  + L G      +   +   L +   + +  +    + 
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIA-QLPANCIILVPPHLQAQLD 317

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  102 bits (257), Expect = 3e-25
 Identities = 31/111 (27%), Positives = 49/111 (44%), Gaps = 7/111 (6%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQC----RRAFKSFDIECEMMKSIRHQNLIKVIS 353
           I  GGFG VY+A    G EVAVK           +  ++   E ++   ++H N+I +  
Sbjct: 15  IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 354 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            C  E    LV+E+   G L + L      +     +N  + +A  + YLH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLH 122

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  102 bits (256), Expect = 1e-24
 Identities = 32/113 (28%), Positives = 51/113 (45%), Gaps = 8/113 (7%)

Query: 296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
             I KG +G V+  +   G +VAVKVF      ++   + E      +RH+N++  I++ 
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIAAD 100

Query: 356 SNEEFK----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
                      L+ +Y  +GSL  YL S+   LD    L +     S L +LH
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLH 151

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  104 bits (261), Expect = 1e-24
 Identities = 44/197 (22%), Positives = 75/197 (38%), Gaps = 11/197 (5%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
              ++   L  ++L+ N + +V P  F      +L    +    +    L   T L+ LT
Sbjct: 50  DEFASFPHLEELELNENIVSAVEPGAFNNL--FNLRTLGLRSNRLKLIPLGVFTGLSNLT 107

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKD--ILYL---NFSV 118
            + +  NK+   +   +  +L +L+ L +  N+L  I    F  L     L L   N + 
Sbjct: 108 KLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS 166

Query: 119 IPIEI-GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYL 177
           IP E    L  L  L L +  +      SF  L  LK L +S       +  +    L L
Sbjct: 167 IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226

Query: 178 KDLNLSFNKLEGEIPRG 194
             L+++   L   +P  
Sbjct: 227 TSLSITHCNLT-AVPYL 242

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 90.9 bits (226), Expect = 4e-20
 Identities = 44/195 (22%), Positives = 76/195 (38%), Gaps = 14/195 (7%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEIT--NLTKLTTIILGG 70
              +DL  N + ++    F       LE   ++   +S   +E     NL  L T+ L  
Sbjct: 34  TRLLDLGKNRIKTLNQDEFASF--PHLEELELNENIVS--AVEPGAFNNLFNLRTLGLRS 89

Query: 71  NKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLN-----FSVIPIEI- 123
           N+L   I + + + L++L KL +  N++  +    F +L ++  L         I     
Sbjct: 90  NRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAF 148

Query: 124 GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLS 183
            GL +LE L L    L     ++   L  L  L L   N++     S ++L  LK L +S
Sbjct: 149 SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208

Query: 184 FNKLEGEIPRGGSFG 198
                  +     +G
Sbjct: 209 HWPYLDTMTPNCLYG 223

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 87.9 bits (218), Expect = 4e-19
 Identities = 48/209 (22%), Positives = 86/209 (41%), Gaps = 13/209 (6%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
           L  +++ +N L  +  + F G   +SLE   +  CN++    E +++L  L  + L    
Sbjct: 130 LKSLEVGDNDLVYISHRAFSGL--NSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLN 187

Query: 73  LNGSISITLGSNLASLRKLSLDSNE-LTSIPLTFWNLKDILYL-----NFSVIPIE-IGG 125
           +N +I       L  L+ L +     L ++        ++  L     N + +P   +  
Sbjct: 188 IN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRH 246

Query: 126 LPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFN 185
           L  L +L L YN +         +L+ L+ + L    L+   P +   L YL+ LN+S N
Sbjct: 247 LVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306

Query: 186 KLEGEIPRG--GSFGNFSAESFEGNELLC 212
           +L   +      S GN      + N L C
Sbjct: 307 QLT-TLEESVFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 27/116 (23%), Positives = 43/116 (37%), Gaps = 8/116 (6%)

Query: 86  ASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSVIPIEI------GGLPNLEYLFLGYNR 138
              R L L  N + ++    F +   +  L  +   +          L NL  L L  NR
Sbjct: 32  TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91

Query: 139 LQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG 194
           L+      F  L +L  L++S+N +   +    + L  LK L +  N L   I   
Sbjct: 92  LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHR 146

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 25/82 (30%), Positives = 36/82 (43%), Gaps = 3/82 (3%)

Query: 113 YLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLE 172
              F  +P  I        L LG NR++    D F     L+ L L++N +S   P +  
Sbjct: 20  RKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFN 77

Query: 173 KLLYLKDLNLSFNKLEGEIPRG 194
            L  L+ L L  N+L+  IP G
Sbjct: 78  NLFNLRTLGLRSNRLK-LIPLG 98

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  101 bits (255), Expect = 2e-24
 Identities = 41/192 (21%), Positives = 89/192 (46%), Gaps = 16/192 (8%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           +  ++ ++N   L  + L+ N ++ + P   + +++ SL +F      I+   +  + N+
Sbjct: 167 VKDVTPIANLTDLYSLSLNYNQIEDISP---LASLT-SLHYFTAYVNQITD--ITPVANM 220

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS--- 117
           T+L ++ +G NK+     +   +NL+ L  L + +N+++ I     +L  +  LN     
Sbjct: 221 TRLNSLKIGNNKITDLSPL---ANLSQLTWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQ 276

Query: 118 -VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
                 +  L  L  LFL  N+L     +  G L +L +L LS+N+++   P  L  L  
Sbjct: 277 ISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334

Query: 177 LKDLNLSFNKLE 188
           +   + +   ++
Sbjct: 335 MDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  100 bits (252), Expect = 5e-24
 Identities = 39/196 (19%), Positives = 77/196 (39%), Gaps = 17/196 (8%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           ++ +  +     L +++L+ N +  + P   + N+   L    +    I+   +  + NL
Sbjct: 56  VASIQGIEYLTNLEYLNLNGNQITDISP---LSNLV-KLTNLYIGTNKIT--DISALQNL 109

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS--- 117
           T L  + L  + ++    +   +NL  +  L+L +N   S      N+  + YL  +   
Sbjct: 110 TNLRELYLNEDNISDISPL---ANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESK 166

Query: 118 -VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
                 I  L +L  L L YN+++   P     L SL       N ++   P  +  +  
Sbjct: 167 VKDVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222

Query: 177 LKDLNLSFNKLEGEIP 192
           L  L +  NK+    P
Sbjct: 223 LNSLKIGNNKITDLSP 238

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 98.4 bits (246), Expect = 4e-23
 Identities = 41/197 (20%), Positives = 87/197 (44%), Gaps = 19/197 (9%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           ++ + +    + +T + ++   + S+     +  ++ +LE+  ++   I+   +  ++NL
Sbjct: 34  VTDVVTQEELESITKLVVAGEKVASI---QGIEYLT-NLEYLNLNGNQITD--ISPLSNL 87

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS--- 117
            KLT + +G NK+     I+   NL +LR+L L+ + ++ I     NL  +  LN     
Sbjct: 88  VKLTNLYIGTNKIT---DISALQNLTNLRELYLNEDNISDIS-PLANLTKMYSLNLGANH 143

Query: 118 --VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLL 175
                  +  +  L YL +  ++++   P    +L  L SL+L+ N +    P  L  L 
Sbjct: 144 NLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLT 199

Query: 176 YLKDLNLSFNKLEGEIP 192
            L       N++    P
Sbjct: 200 SLHYFTAYVNQITDITP 216

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 98.4 bits (246), Expect = 4e-23
 Identities = 46/197 (23%), Positives = 84/197 (42%), Gaps = 17/197 (8%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           +S +S L+N   +  ++L  N   S L    + N++  L +  ++   +    +  I NL
Sbjct: 122 ISDISPLANLTKMYSLNLGANHNLSDLS--PLSNMT-GLNYLTVTESKVKD--VTPIANL 176

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS--- 117
           T L ++ L  N++     +   ++L SL   +   N++T I     N+  +  L      
Sbjct: 177 TDLYSLSLNYNQIEDISPL---ASLTSLHYFTAYVNQITDIT-PVANMTRLNSLKIGNNK 232

Query: 118 -VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
                 +  L  L +L +G N++     ++  DL  LK LN+  N +S    + L  L  
Sbjct: 233 ITDLSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQ 288

Query: 177 LKDLNLSFNKLEGEIPR 193
           L  L L+ N+L  E   
Sbjct: 289 LNSLFLNNNQLGNEDME 305

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 98.0 bits (245), Expect = 5e-23
 Identities = 46/196 (23%), Positives = 81/196 (41%), Gaps = 16/196 (8%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           LS LS LSN   L ++ ++ + +  V P   + N++  L    ++Y  I    +  + +L
Sbjct: 145 LSDLSPLSNMTGLNYLTVTESKVKDVTP---IANLT-DLYSLSLNYNQIED--ISPLASL 198

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS--- 117
           T L       N++     +   +N+  L  L + +N++T +     NL  + +L      
Sbjct: 199 TSLHYFTAYVNQITDITPV---ANMTRLNSLKIGNNKITDLS-PLANLSQLTWLEIGTNQ 254

Query: 118 -VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
                 +  L  L+ L +G N++  S      +L  L SL L+ N L       +  L  
Sbjct: 255 ISDINAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312

Query: 177 LKDLNLSFNKLEGEIP 192
           L  L LS N +    P
Sbjct: 313 LTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 37/193 (19%), Positives = 78/193 (40%), Gaps = 17/193 (8%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           +   ++        L    +  V+ +  + +    +   V++   ++   ++ I  LT L
Sbjct: 15  IFPDADLAEGIRAVLQKASVTDVVTQEELES----ITKLVVAGEKVAS--IQGIEYLTNL 68

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS----VI 119
             + L GN++     +   SNL  L  L + +N++T I     NL ++  L  +      
Sbjct: 69  EYLNLNGNQITDISPL---SNLVKLTNLYIGTNKITDIS-ALQNLTNLRELYLNEDNISD 124

Query: 120 PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKD 179
              +  L  +  L LG N    S      ++  L  L ++++ +    P  +  L  L  
Sbjct: 125 ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYS 181

Query: 180 LNLSFNKLEGEIP 192
           L+L++N++E   P
Sbjct: 182 LSLNYNQIEDISP 194

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  100 bits (252), Expect = 3e-24
 Identities = 27/108 (25%), Positives = 49/108 (45%), Gaps = 1/108 (0%)

Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCS 356
           + KG FG   K      G  + +K          ++F  E ++M+ + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 357 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            ++    + EY+  G+L   + S +      QR++   D+AS + YLH
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  100 bits (251), Expect = 3e-24
 Identities = 28/109 (25%), Positives = 57/109 (52%), Gaps = 5/109 (4%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           I  G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +  +  A+V ++    SL  +L++S    ++ + ++I    A  ++YLH
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  100 bits (251), Expect = 4e-24
 Identities = 32/113 (28%), Positives = 54/113 (47%), Gaps = 8/113 (7%)

Query: 296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
             + KG +G V++     G  VAVK+F+ +  +++   + E      +RH+N++  I+S 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWF-RETELYNTVMLRHENILGFIASD 71

Query: 356 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
                 +    L+  Y   GSL  YL      LD    L I++ +AS L +LH
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLH 122

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  100 bits (250), Expect = 5e-24
 Identities = 28/109 (25%), Positives = 50/109 (45%), Gaps = 7/109 (6%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           + +G FG V KA+     +VA+K    +     K+F +E   +  + H N++K+  +C N
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN 72

Query: 358 EEFKALVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLH 404
                LV+EY   GSL   L+ +           ++  +  +  + YLH
Sbjct: 73  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  101 bits (254), Expect = 1e-23
 Identities = 40/195 (20%), Positives = 72/195 (36%), Gaps = 9/195 (4%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
                S  +   L F+DLS N L      +     + SL++  +S+  +   +      L
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGL 395

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLNFS-- 117
            +L  +    + L      ++  +L +L  L +            F  L  +  L  +  
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455

Query: 118 -----VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLE 172
                 +P     L NL +L L   +L+   P +F  L SL+ LN++ N L        +
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515

Query: 173 KLLYLKDLNLSFNKL 187
           +L  L+ + L  N  
Sbjct: 516 RLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 94.0 bits (234), Expect = 5e-21
 Identities = 52/194 (26%), Positives = 82/194 (42%), Gaps = 16/194 (8%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
              +DLS NPL  +   +F       L+   +S C I         +L+ L+T+IL GN 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFS--FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLNFS-------VIPIEIG 124
           +  S+++   S L+SL+KL      L S+      +LK +  LN +        +P    
Sbjct: 88  IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 125 GLPNLEYLFLGYNRLQGSIPDSFGDLISLK----SLNLSKNNLSGAIPASLEKLLYLKDL 180
            L NLE+L L  N++Q         L  +     SL+LS N ++  I     K + L  L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKL 205

Query: 181 NLSFNKLEGEIPRG 194
            L  N     + + 
Sbjct: 206 TLRNNFDSLNVMKT 219

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 90.2 bits (224), Expect = 1e-19
 Identities = 38/210 (18%), Positives = 69/210 (32%), Gaps = 20/210 (9%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
              +   +    ++   L +  ++ V   ++       LE     +       L+ +  L
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG-WQHLELVNCKFGQFPTLKLKSLKRL 330

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLT---FWNLKDILYLNFS 117
           T         NK   + S     +L SL  L L  N L+         +    + YL+ S
Sbjct: 331 T------FTSNKGGNAFS---EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381

Query: 118 -----VIPIEIGGLPNLEYLFLGYNRLQGSIPDS-FGDLISLKSLNLSKNNLSGAIPASL 171
                 +     GL  LE+L   ++ L+     S F  L +L  L++S  +   A     
Sbjct: 382 FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 441

Query: 172 EKLLYLKDLNLSFNKLEGEIPRGGSFGNFS 201
             L  L+ L ++ N  +        F    
Sbjct: 442 NGLSSLEVLKMAGNSFQENFLP-DIFTELR 470

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 29/123 (23%), Positives = 50/123 (40%), Gaps = 8/123 (6%)

Query: 86  ASLRKLSLDSNELTSIP-LTFWNLKDILYLN-----FSVIPIE-IGGLPNLEYLFLGYNR 138
            S + L L  N L  +   +F++  ++  L+        I       L +L  L L  N 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 139 LQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFG 198
           +Q     +F  L SL+ L   + NL+      +  L  LK+LN++ N ++        F 
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFS 146

Query: 199 NFS 201
           N +
Sbjct: 147 NLT 149

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 28/160 (17%), Positives = 59/160 (36%), Gaps = 18/160 (11%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
           S+    + L  +D  ++ L  +   +   ++  +L +  +S+ +           L+ L 
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR-NLIYLDISHTHTRVAFNGIFNGLSSLE 448

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIG 124
            + + GN    +    + + L +L  L L   +L  +  T +N                 
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN----------------- 491

Query: 125 GLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLS 164
            L +L+ L +  N+L+      F  L SL+ + L  N   
Sbjct: 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 38/234 (16%), Positives = 66/234 (28%), Gaps = 36/234 (15%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVG--NVSHSLEFFVMSYCNISGGILEEIT 58
                  SN   L  +DLS+N + S+          +        +S   ++  I     
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAF 197

Query: 59  NLTKLTTIILGGNKLNGSISITLGSNLASLRKLSL------DSNELTSIPL-TFWNLKDI 111
              +L  + L  N  + ++  T    LA L    L      +   L          L ++
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257

Query: 112 ---------LYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGD-LISLKSLNLSKN 161
                    L      I      L N+    L    ++     S+      L+ +N    
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317

Query: 162 NLSGAIPASLEKLLY----------------LKDLNLSFNKLEGEIPRGGSFGN 199
                   SL++L +                L+ L+LS N L  +     S   
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 99.5 bits (248), Expect = 2e-23
 Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 8/113 (7%)

Query: 296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
             I KG FG V++ +   G EVAVK+F+ +  R++   + E      +RH+N++  I++ 
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 105

Query: 356 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           + +        LV +Y  HGSL  YL      + +   + + +  AS L +LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLH 156

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 17/192 (8%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           +  +  +     LT I+ SNN L  + P   + N++  L   +M+   I+   +  + NL
Sbjct: 58  IKSIDGVEYLNNLTQINFSNNQLTDITP---LKNLT-KLVDILMNNNQIAD--ITPLANL 111

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS--- 117
           T LT + L  N++     +    NL +L +L L SN ++ I      L  +  L+F    
Sbjct: 112 TNLTGLTLFNNQITDIDPL---KNLTNLNRLELSSNTISDIS-ALSGLTSLQQLSFGNQV 167

Query: 118 VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYL 177
                +  L  LE L +  N++  S       L +L+SL  + N +S   P  L  L  L
Sbjct: 168 TDLKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNL 223

Query: 178 KDLNLSFNKLEG 189
            +L+L+ N+L+ 
Sbjct: 224 DELSLNGNQLKD 235

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 49/196 (25%), Positives = 91/196 (46%), Gaps = 19/196 (9%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           ++ ++ L+N   LT + L NN +  + P   + N++ +L    +S   IS   +  ++ L
Sbjct: 102 IADITPLANLTNLTGLTLFNNQITDIDP---LKNLT-NLNRLELSSNTISD--ISALSGL 155

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS--- 117
           T L  +  G N++     +   +NL +L +L + SN+++ I      L ++  L  +   
Sbjct: 156 TSLQQLSFG-NQVTDLKPL---ANLTTLERLDISSNKVSDIS-VLAKLTNLESLIATNNQ 210

Query: 118 -VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
                 +G L NL+ L L  N+L+     +   L +L  L+L+ N +S   P  L  L  
Sbjct: 211 ISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTK 266

Query: 177 LKDLNLSFNKLEGEIP 192
           L +L L  N++    P
Sbjct: 267 LTELKLGANQISNISP 282

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 43/196 (21%), Positives = 85/196 (43%), Gaps = 19/196 (9%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           ++   S ++   +T +      + S+     V  +++ L     S   ++   +  + NL
Sbjct: 36  VTDTVSQTDLDQVTTLQADRLGIKSI---DGVEYLNN-LTQINFSNNQLTD--ITPLKNL 89

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS--- 117
           TKL  I++  N++     +   +NL +L  L+L +N++T I     NL ++  L  S   
Sbjct: 90  TKLVDILMNNNQIADITPL---ANLTNLTGLTLFNNQITDID-PLKNLTNLNRLELSSNT 145

Query: 118 -VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
                 + GL +L+ L  G             +L +L+ L++S N +S    + L KL  
Sbjct: 146 ISDISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTN 200

Query: 177 LKDLNLSFNKLEGEIP 192
           L+ L  + N++    P
Sbjct: 201 LESLIATNNQISDITP 216

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 86.9 bits (216), Expect = 9e-19
 Identities = 34/192 (17%), Positives = 80/192 (41%), Gaps = 16/192 (8%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           +S L+ LS    LT + L  N + ++ P   +  ++ +L    ++   +    +  I+NL
Sbjct: 255 ISNLAPLSGLTKLTELKLGANQISNISP---LAGLT-ALTNLELNENQLED--ISPISNL 308

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP 120
             LT + L  N ++    +   S+L  L++L   +N+++ +  +  NL +I +L+     
Sbjct: 309 KNLTYLTLYFNNISDISPV---SSLTKLQRLFFYNNKVSDVS-SLANLTNINWLSAGHNQ 364

Query: 121 I----EIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
           I     +  L  +  L L       +  +   ++    ++      L    PA++     
Sbjct: 365 ISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGS 422

Query: 177 LKDLNLSFNKLE 188
             + ++++N   
Sbjct: 423 YTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 37/190 (19%), Positives = 69/190 (36%), Gaps = 19/190 (10%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           + + +         L    +   + +T +      +         I    ++ +  L  L
Sbjct: 17  IFTDTALAEKMKTVLGKTNVTDTVSQTDLDQ----VTTLQADRLGIK--SIDGVEYLNNL 70

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS----VI 119
           T I    N+L     +    NL  L  + +++N++  I     NL ++  L         
Sbjct: 71  TQINFSNNQLTDITPL---KNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQITD 126

Query: 120 PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKD 179
              +  L NL  L L  N +  S   +   L SL+ L+   N ++   P  L  L  L+ 
Sbjct: 127 IDPLKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLER 181

Query: 180 LNLSFNKLEG 189
           L++S NK+  
Sbjct: 182 LDISSNKVSD 191

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 24/129 (18%), Positives = 40/129 (31%), Gaps = 26/129 (20%)

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEI 123
           +  I     +N    I   + LA   K  L    +T                     +  
Sbjct: 5   SATITQDTPIN---QIFTDTALAEKMKTVLGKTNVTDT-------------------VSQ 42

Query: 124 GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLS 183
             L  +  L      +     D    L +L  +N S N L+   P  L+ L  L D+ ++
Sbjct: 43  TDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN 98

Query: 184 FNKLEGEIP 192
            N++    P
Sbjct: 99  NNQIADITP 107

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 42/241 (17%), Positives = 80/241 (33%), Gaps = 39/241 (16%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVG-------------------NVSHSLEFFVMS 45
               N K L  + L NN +  + P  F                      +  +L+   + 
Sbjct: 70  GDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVH 129

Query: 46  YCNISGGILEEI-TNLTKLTTIILGGNKL-NGSISITLGSNLASLRKLSLDSNELTSIPL 103
              I+  + + +   L ++  + LG N L +  I       +  L  + +    +T+IP 
Sbjct: 130 ENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ 188

Query: 104 -TFWNLKDILYL---NFSVIPIEI-GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNL 158
               +L + L+L     + +      GL NL  L L +N +      S  +   L+ L+L
Sbjct: 189 GLPPSLTE-LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247

Query: 159 SKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQ 218
           + N L   +P  L    Y++ + L  N +              +  F          +  
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS----------AIGSNDFCPPGYNTKKASYS 296

Query: 219 V 219
            
Sbjct: 297 G 297

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 41/198 (20%), Positives = 73/198 (36%), Gaps = 23/198 (11%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEIT--NLTKLTTIILGG 70
           L  + +  N +  V    F G   + +    +    +    +E      + KL+ I +  
Sbjct: 123 LQELRVHENEITKVRKSVFNGL--NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 180

Query: 71  NKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKD--ILYLNF---SVIPIEI- 123
             +    +I  G    SL +L LD N++T +   +   L +   L L+F   S +     
Sbjct: 181 TNIT---TIPQGL-PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 236

Query: 124 GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG------AIPASLEKLLYL 177
              P+L  L L  N+L   +P    D   ++ + L  NN+S         P    K    
Sbjct: 237 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 295

Query: 178 KDLNLSFNKLE-GEIPRG 194
             ++L  N ++  EI   
Sbjct: 296 SGVSLFSNPVQYWEIQPS 313

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 36/201 (17%), Positives = 72/201 (35%), Gaps = 28/201 (13%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVL--PKTFVGNVSHSLEFFVMSYCNISGGILEEITN--L 60
           S  +    +  ++L  NPL S       F G     L +  ++  NI+      I     
Sbjct: 139 SVFNGLNQMIVVELGTNPLKSSGIENGAFQG--MKKLSYIRIADTNIT-----TIPQGLP 191

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLNFS-- 117
             LT + L GNK+   +       L +L KL L  N ++++   +  N   +  L+ +  
Sbjct: 192 PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 250

Query: 118 ---VIPIEIGGLPNLEYLFLGYNRLQGSIPDS-------FGDLISLKSLNLSKNNLSGAI 167
               +P  +     ++ ++L  N +  +I  +            S   ++L  N +    
Sbjct: 251 KLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309

Query: 168 --PASLEKLLYLKDLNLSFNK 186
             P++   +     + L   K
Sbjct: 310 IQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 31/140 (22%), Positives = 55/140 (39%), Gaps = 12/140 (8%)

Query: 63  LTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSI-PLTFWNLKDILYLNFS---- 117
              + L  NK+   I      NL +L  L L +N+++ I P  F  L  +  L  S    
Sbjct: 54  TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112

Query: 118 -VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNL-SGAIPA-SLEKL 174
             +P ++     L+ L +  N +       F  L  +  + L  N L S  I   + + +
Sbjct: 113 KELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170

Query: 175 LYLKDLNLSFNKLEGEIPRG 194
             L  + ++   +   IP+G
Sbjct: 171 KKLSYIRIADTNIT-TIPQG 189

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 26/108 (24%), Positives = 42/108 (38%), Gaps = 21/108 (19%)

Query: 87  SLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDS 146
            LR +      L  +P                +P      P+   L L  N++       
Sbjct: 32  HLRVVQCSDLGLEKVPKD--------------LP------PDTALLDLQNNKITEIKDGD 71

Query: 147 FGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG 194
           F +L +L +L L  N +S   P +   L+ L+ L LS N+L+ E+P  
Sbjct: 72  FKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEK 118

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 44/197 (22%), Positives = 75/197 (38%), Gaps = 16/197 (8%)

Query: 8   SNCKC-LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTI 66
           S C C  T I  ++  L SV P      +  S     +    +          LT+LT +
Sbjct: 3   SRCSCSGTEIRCNSKGLTSV-PT----GIPSSATRLELESNKLQSLPHGVFDKLTQLTKL 57

Query: 67  ILGGNKLN-GSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEI-- 123
            L  N L+             SL+ L L  N + ++   F  L+ + +L+F    ++   
Sbjct: 58  SLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMS 117

Query: 124 -----GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPA-SLEKLLYL 177
                  L NL YL + +   + +    F  L SL+ L ++ N+           +L  L
Sbjct: 118 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 177

Query: 178 KDLNLSFNKLEGEIPRG 194
             L+LS  +LE ++   
Sbjct: 178 TFLDLSQCQLE-QLSPT 193

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 40/198 (20%), Positives = 72/198 (36%), Gaps = 10/198 (5%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
                   LT + LS+N L      +     + SL++  +S+  +   +      L +L 
Sbjct: 46  GVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLE 104

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFS------ 117
            +    + L      ++  +L +L  L +            F  L  +  L  +      
Sbjct: 105 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164

Query: 118 -VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
             +P     L NL +L L   +L+   P +F  L SL+ LN+S NN         + L  
Sbjct: 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 224

Query: 177 LKDLNLSFNKLEGEIPRG 194
           L+ L+ S N +     + 
Sbjct: 225 LQVLDYSLNHIM-TSKKQ 241

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 83.5 bits (207), Expect = 4e-18
 Identities = 35/189 (18%), Positives = 68/189 (35%), Gaps = 29/189 (15%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPK-TFVGNVSHSLEFFVMSYCNIS---GGILEEITNL 60
           S+    + L  +D  ++ L  +     F+     +L +  +S+ +      GI      L
Sbjct: 95  SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL--RNLIYLDISHTHTRVAFNGIFN---GL 149

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLNFSVI 119
           + L  + + GN    +    + + L +L  L L   +L  +    F              
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN------------- 196

Query: 120 PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY-LK 178
                 L +L+ L + +N         +  L SL+ L+ S N++  +    L+     L 
Sbjct: 197 -----SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 251

Query: 179 DLNLSFNKL 187
            LNL+ N  
Sbjct: 252 FLNLTQNDF 260

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 25/188 (13%), Positives = 63/188 (33%), Gaps = 11/188 (5%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           +  L     +  +  +NN +  V             +   ++   I+     +    +++
Sbjct: 92  VQELLVGPSIETLHAANNNISRVSCSRGQ-----GKKNIYLANNKITMLRDLDEGCRSRV 146

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYL---NFSVI 119
             + L  N+++      L ++  +L  L+L  N +  +     +     L L     + +
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFM 206

Query: 120 PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLS-GAIPASLEKLLYLK 178
             E      + ++ L  N+L   I  +     +L+  +L  N    G +     K   ++
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265

Query: 179 DLNLSFNK 186
            +     K
Sbjct: 266 TVAKQTVK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 30/180 (16%), Positives = 70/180 (38%), Gaps = 13/180 (7%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
                ++++ L   L        + +++   +S   +S     ++   TKL  + L  N 
Sbjct: 12  YKIEKVTDSSLKQALASLRQS--AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYL---NFSVIPIEIGGLPNL 129
           L  ++ +    +L++LR L L++N +  +     +++  L+    N S +          
Sbjct: 70  LYETLDL---ESLSTLRTLDLNNNYVQELL-VGPSIET-LHAANNNISRVSCSR--GQGK 122

Query: 130 EYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG-AIPASLEKLLYLKDLNLSFNKLE 188
           + ++L  N++        G    ++ L+L  N +              L+ LNL +N + 
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 25/164 (15%), Positives = 61/164 (37%), Gaps = 7/164 (4%)

Query: 37  HSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSN 96
           +  +   ++  ++   +     +   +  + L GN L+  IS    +    L  L+L SN
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSN 68

Query: 97  ELTSIPLTFWNLKDILYLNFSVIPI-EIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKS 155
            L        +L  +  L+ +   + E+   P++E L    N +   +          K+
Sbjct: 69  VLYETL-DLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVS--CSRGQGKKN 124

Query: 156 LNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGN 199
           + L+ N ++            ++ L+L  N+++  +       +
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS 167

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 31/155 (20%), Positives = 58/155 (37%), Gaps = 16/155 (10%)

Query: 52  GILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKD 110
            I E   N  +     +  + L      +L  +  ++++L L  N L+ I          
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59

Query: 111 ILYLNFS----VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGA 166
           +  LN S       +++  L  L  L L  N +Q           S+++L+ + NN+S  
Sbjct: 60  LELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113

Query: 167 IPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFS 201
           +  S       K++ L+ NK+   +      G  S
Sbjct: 114 VSCSR--GQGKKNIYLANNKIT-MLRD-LDEGCRS 144

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 39/194 (20%), Positives = 67/194 (34%), Gaps = 31/194 (15%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L     L +   L  +DL+NN +  +L          S+E    +  NIS          
Sbjct: 70  LYETLDLESLSTLRTLDLNNNYVQELLV-------GPSIETLHAANNNISRVSCSRGQGK 122

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP 120
             +    L  NK+     +  G   + ++ L L  NE+ ++                   
Sbjct: 123 KNI---YLANNKITMLRDLDEG-CRSRVQYLDLKLNEIDTVN----------------FA 162

Query: 121 IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDL 180
                   LE+L L YN +   +         LK+L+LS N L+  +    +    +  +
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219

Query: 181 NLSFNKLEGEIPRG 194
           +L  NKL   I + 
Sbjct: 220 SLRNNKLV-LIEKA 232

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 27/176 (15%), Positives = 56/176 (31%), Gaps = 12/176 (6%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISG-GILEEITNLTKLTTIILGGN 71
              I L+NN +  +            +++  +    I      E   +   L  + L  N
Sbjct: 122 KKNIYLANNKITMLRDLDEGCR--SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 72  KLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLN-----FSVIPIEIGGL 126
            +     +      A L+ L L SN+L  +   F +   + +++       +I   +   
Sbjct: 180 FI---YDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFS 236

Query: 127 PNLEYLFLGYNRLQ-GSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLN 181
            NLE+  L  N    G++ D F     ++++                 +  L    
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 96.7 bits (241), Expect = 4e-22
 Identities = 53/192 (27%), Positives = 85/192 (44%), Gaps = 18/192 (9%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEIT--NLTKLTTIILGG 70
              ++L  N +  +   +F       LE   +S  +I    +E      L  L T+ L  
Sbjct: 66  TRLLNLHENQIQIIKVNSFKH--LRHLEILQLSRNHIR--TIEIGAFNGLANLNTLELFD 121

Query: 71  NKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLN------FSVIPIEI 123
           N+L  +I       L+ L++L L +N + SIP   F  +  +  L+       S I    
Sbjct: 122 NRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180

Query: 124 -GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNL 182
             GL NL YL L    L+  IP+    LI L  L+LS N+LS   P S + L++L+ L +
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238

Query: 183 SFNKLEGEIPRG 194
             ++++  I R 
Sbjct: 239 IQSQIQ-VIERN 249

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 96.4 bits (240), Expect = 5e-22
 Identities = 51/218 (23%), Positives = 87/218 (39%), Gaps = 16/218 (7%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEI-TNLTKL 63
           +S  + + L  + LS N + ++    F G    +L    +    ++  I       L+KL
Sbjct: 82  NSFKHLRHLEILQLSRNHIRTIEIGAFNG--LANLNTLELFDNRLT-TIPNGAFVYLSKL 138

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSL-DSNELTSIPL-TFWNLKDILYL-----NF 116
             + L  N +  SI     + + SLR+L L +   L+ I    F  L ++ YL     N 
Sbjct: 139 KELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197

Query: 117 SVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
             IP  +  L  L+ L L  N L    P SF  L+ L+ L + ++ +      + + L  
Sbjct: 198 REIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQS 256

Query: 177 LKDLNLSFNKLEGEIPRG--GSFGNFSAESFEGNELLC 212
           L ++NL+ N L   +P        +        N   C
Sbjct: 257 LVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 34/135 (25%), Positives = 56/135 (41%), Gaps = 9/135 (6%)

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLK--DILYL--- 114
           T    + L  N++   I +    +L  L  L L  N + +I +  F  L   + L L   
Sbjct: 64  TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122

Query: 115 NFSVIPIEI-GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPA-SLE 172
             + IP      L  L+ L+L  N ++     +F  + SL+ L+L +      I   + E
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182

Query: 173 KLLYLKDLNLSFNKL 187
            L  L+ LNL+   L
Sbjct: 183 GLSNLRYLNLAMCNL 197

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 27/112 (24%), Positives = 42/112 (37%), Gaps = 5/112 (4%)

Query: 87  SLRKLSLDSNELTSIPLTFWNLKDILYLNF----SVIPIEIGGLPNLEYLFLGYNRLQGS 142
              K+      L  +P        +L L+      +       L +LE L L  N ++  
Sbjct: 44  QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTI 103

Query: 143 IPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG 194
              +F  L +L +L L  N L+     +   L  LK+L L  N +E  IP  
Sbjct: 104 EIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSY 154

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 24/118 (20%), Positives = 43/118 (36%), Gaps = 28/118 (23%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L  + +L+    L  +DLS N L ++ P +F                            L
Sbjct: 197 LREIPNLTPLIKLDELDLSGNHLSAIRPGSF--------------------------QGL 230

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFS 117
             L  + +  +++   I      NL SL +++L  N LT +P   F  L  +  ++  
Sbjct: 231 MHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLH 287

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 93.9 bits (234), Expect = 6e-22
 Identities = 46/192 (23%), Positives = 66/192 (34%), Gaps = 16/192 (8%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNIS---GGILEEITNLTKLTTIILG 69
              I L  N +  V   +F      +L    +    ++          T L  L  + L 
Sbjct: 34  SQRIFLHGNRISHVPAASFRA--CRNLTILWLHSNVLARIDAAAF---TGLALLEQLDLS 88

Query: 70  GNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLN-----FSVIPIEI 123
            N    S+       L  L  L LD   L  +    F  L  + YL         +P + 
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148

Query: 124 -GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNL 182
              L NL +LFL  NR+      +F  L SL  L L +N ++   P +   L  L  L L
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208

Query: 183 SFNKLEGEIPRG 194
             N L   +P  
Sbjct: 209 FANNLS-ALPTE 219

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 57/189 (30%), Positives = 83/189 (43%), Gaps = 11/189 (5%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEI-TNLTKL 63
           +S   C+ LT + L +N L  +    F G     LE   +S       +       L +L
Sbjct: 50  ASFRACRNLTILWLHSNVLARIDAAAFTG--LALLEQLDLSDNAQLRSVDPATFHGLGRL 107

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLK--DILYLN---FS 117
            T+ L    L   +   L   LA+L+ L L  N L ++P  TF +L     L+L+    S
Sbjct: 108 HTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166

Query: 118 VIPIEI-GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
            +P     GL +L+ L L  NR+    P +F DL  L +L L  NNLS     +L  L  
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226

Query: 177 LKDLNLSFN 185
           L+ L L+ N
Sbjct: 227 LQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 73.5 bits (181), Expect = 7e-15
 Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 19/163 (11%)

Query: 13  LTFIDLSNNP-LDSVLPKTFVGNVSHSLEFFVMSYCNIS---GGILEEITNLTKLTTIIL 68
           L  +DLS+N  L SV P TF G     L    +  C +     G+      L  L  + L
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHG--LGRLHTLHLDRCGLQELGPGLFR---GLAALQYLYL 136

Query: 69  GGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLK--DILYLN---FSVIPIE 122
             N L  ++      +L +L  L L  N ++S+P   F  L   D L L+    + +   
Sbjct: 137 QDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195

Query: 123 I-GGLPNLEYLFLGYNRLQGSIP-DSFGDLISLKSLNLSKNNL 163
               L  L  L+L  N L  ++P ++   L +L+ L L+ N  
Sbjct: 196 AFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 28/118 (23%), Positives = 49/118 (41%), Gaps = 11/118 (9%)

Query: 86  ASLRKLSLDSNELTSIPL-TFWNLKDILYL-----NFSVIPIEI-GGLPNLEYLFLGYNR 138
           A+ +++ L  N ++ +P  +F   +++  L       + I      GL  LE L L  N 
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 139 LQGSIP-DSFGDLISLKSLNLSKNNLSGAIPA-SLEKLLYLKDLNLSFNKLEGEIPRG 194
              S+   +F  L  L +L+L +  L   +       L  L+ L L  N L+  +P  
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDD 147

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 20/82 (24%), Positives = 31/82 (37%), Gaps = 2/82 (2%)

Query: 113 YLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLE 172
                 +P+ I      + +FL  NR+      SF    +L  L L  N L+    A+  
Sbjct: 20  QQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77

Query: 173 KLLYLKDLNLSFNKLEGEIPRG 194
            L  L+ L+LS N     +   
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPA 99

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 50/219 (22%), Positives = 81/219 (36%), Gaps = 18/219 (8%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEE--ITNLTK 62
            +  +   L  + L  N +  +    F G    SL    +    ++  ++       L+K
Sbjct: 93  DTFRHLHHLEVLQLGRNSIRQIEVGAFNGL--ASLNTLELFDNWLT--VIPSGAFEYLSK 148

Query: 63  LTTIILGGNKLNGSISITLGSNLASLRKLSL-DSNELTSIPL-TFWNLKDILYL-----N 115
           L  + L  N +  SI     + + SL +L L +  +L  I    F  L ++ YL     N
Sbjct: 149 LRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN 207

Query: 116 FSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLL 175
              +P  +  L  LE L +  N      P SF  L SLK L +  + +S     + + L 
Sbjct: 208 IKDMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLA 266

Query: 176 YLKDLNLSFNKLEGEIPRG--GSFGNFSAESFEGNELLC 212
            L +LNL+ N L   +P                 N   C
Sbjct: 267 SLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 51/190 (26%), Positives = 74/190 (38%), Gaps = 38/190 (20%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
             +++L  N +  +   TF                           +L  L  + LG N 
Sbjct: 77  TRYLNLMENNIQMIQADTF--------------------------RHLHHLEVLQLGRNS 110

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLK--DILYL---NFSVIPIEI-GG 125
           +   I +   + LASL  L L  N LT IP   F  L     L+L       IP      
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169

Query: 126 LPNLEYLFLG-YNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSF 184
           +P+L  L LG   +L+     +F  L +LK LNL   N+   +P  L  L+ L++L +S 
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSG 227

Query: 185 NKLEGEIPRG 194
           N    EI  G
Sbjct: 228 NHFP-EIRPG 236

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 34/135 (25%), Positives = 51/135 (37%), Gaps = 9/135 (6%)

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLK--DILYLNF- 116
           +    + L  N +   I      +L  L  L L  N +  I +  F  L   + L L   
Sbjct: 75  SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133

Query: 117 --SVIPIEI-GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPA-SLE 172
             +VIP      L  L  L+L  N ++     +F  + SL  L+L +      I   + E
Sbjct: 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193

Query: 173 KLLYLKDLNLSFNKL 187
            L  LK LNL    +
Sbjct: 194 GLFNLKYLNLGMCNI 208

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 30/113 (26%), Positives = 45/113 (39%), Gaps = 7/113 (6%)

Query: 87  SLRKLSLDSNELTSIPLT-FWNLKDILYLNF----SVIPIEIGGLPNLEYLFLGYNRLQG 141
              K+      L+ +P     N +  L L       +       L +LE L LG N ++ 
Sbjct: 55  QFSKVVCTRRGLSEVPQGIPSNTR-YLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ 113

Query: 142 SIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG 194
               +F  L SL +L L  N L+     + E L  L++L L  N +E  IP  
Sbjct: 114 IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 22/118 (18%), Positives = 46/118 (38%), Gaps = 28/118 (23%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           +  + +L+    L  +++S N    + P +F                            L
Sbjct: 208 IKDMPNLTPLVGLEELEMSGNHFPEIRPGSF--------------------------HGL 241

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFS 117
           + L  + +  ++++  I       LASL +L+L  N L+S+P   F  L+ ++ L+  
Sbjct: 242 SSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLH 298

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 91.3 bits (227), Expect = 5e-21
 Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 21/203 (10%)

Query: 8   SNCKC-LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTI 66
            +       ++     L ++ P     ++        +S   +    L  +   T+LT +
Sbjct: 6   VSKVASHLEVNCDKRNLTALPP-----DLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 67  ILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKD--ILYLNF---SVIPI 121
            L   +L     + +   L  L  L L  N+L S+PL    L    +L ++F   + +P+
Sbjct: 61  NLDRAELT---KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117

Query: 122 EI-GGLPNLEYLFLGYNRLQGSIPDS-FGDLISLKSLNLSKNNLSGAIPASL-EKLLYLK 178
               GL  L+ L+L  N L+ ++P         L+ L+L+ NNL+  +PA L   L  L 
Sbjct: 118 GALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLD 175

Query: 179 DLNLSFNKLEGEIPRGGSFGNFS 201
            L L  N L   IP+ G FG+  
Sbjct: 176 TLLLQENSLYT-IPK-GFFGSHL 196

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 41/167 (24%), Positives = 65/167 (38%), Gaps = 20/167 (11%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
           ++L     LT ++L    L + L    V      L    +S+  +   +      L  LT
Sbjct: 49  ATLMPYTRLTQLNLDRAEL-TKLQ---VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALT 103

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP------LTFWNLKDILYLN--- 115
            + +  N+L  S+ +     L  L++L L  NEL ++P           L+  L L    
Sbjct: 104 VLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP--KLE-KLSLANNN 159

Query: 116 FSVIPIEI-GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKN 161
            + +P  +  GL NL+ L L  N L  +IP  F     L    L  N
Sbjct: 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 34/154 (22%), Positives = 49/154 (31%), Gaps = 44/154 (28%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNI---SGGILEEI 57
           L+ L        L  +DLS+N L S LP       +  L    +S+  +     G L  +
Sbjct: 67  LTKLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPA--LTVLDVSFNRLTSLPLGALRGL 123

Query: 58  TNL---------------------TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSN 96
             L                      KL  + L  N L   +   L + L +L  L L  N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182

Query: 97  ELTSIPLTFWNLK----------------DILYL 114
            L +IP  F+                   +ILY 
Sbjct: 183 SLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYF 216

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 92.6 bits (230), Expect = 1e-20
 Identities = 25/188 (13%), Positives = 63/188 (33%), Gaps = 11/188 (5%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           +  L     +  +  +NN +  V             +   ++   I+     +    +++
Sbjct: 92  VQELLVGPSIETLHAANNNISRVSCSRGQ-----GKKNIYLANNKITMLRDLDEGCRSRV 146

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYL---NFSVI 119
             + L  N+++      L ++  +L  L+L  N +  +     +     L L     + +
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFM 206

Query: 120 PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLS-GAIPASLEKLLYLK 178
             E      + ++ L  N+L   I  +     +L+  +L  N    G +     K   ++
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265

Query: 179 DLNLSFNK 186
            +     K
Sbjct: 266 TVAKQTVK 273

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 91.1 bits (226), Expect = 4e-20
 Identities = 29/178 (16%), Positives = 69/178 (38%), Gaps = 9/178 (5%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
                ++++ L   L          +++   +S   +S     ++   TKL  + L  N 
Sbjct: 12  YKIEKVTDSSLKQALASLRQSA--WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP-IEIGGLPNLEY 131
           L  ++ +    +L++LR L L++N +  +     +++  L+   + I  +        + 
Sbjct: 70  LYETLDL---ESLSTLRTLDLNNNYVQELL-VGPSIET-LHAANNNISRVSCSRGQGKKN 124

Query: 132 LFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG-AIPASLEKLLYLKDLNLSFNKLE 188
           ++L  N++        G    ++ L+L  N +              L+ LNL +N + 
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 87.6 bits (217), Expect = 5e-19
 Identities = 38/200 (19%), Positives = 69/200 (34%), Gaps = 21/200 (10%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L     L +   L  +DL+NN +  +L          S+E    +  NIS          
Sbjct: 70  LYETLDLESLSTLRTLDLNNNYVQELLV-------GPSIETLHAANNNISRVSCSRGQGK 122

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL--TFWNLKDILYLNFS- 117
             +    L  NK+     +  G   + ++ L L  NE+ ++       +   + +LN   
Sbjct: 123 KNI---YLANNKITMLRDLDEG-CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178

Query: 118 ----VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEK 173
                +  ++     L+ L L  N+L   +   F     +  ++L  N L   I  +L  
Sbjct: 179 NFIYDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235

Query: 174 LLYLKDLNLSFNKLEGEIPR 193
              L+  +L  N       R
Sbjct: 236 SQNLEHFDLRGNGFHCGTLR 255

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 25/163 (15%), Positives = 60/163 (36%), Gaps = 7/163 (4%)

Query: 38  SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNE 97
             +   ++  ++   +     +   +  + L GN L+   +  L      L  L+L SN 
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLA-PFTKLELLNLSSNV 69

Query: 98  LTSIPLTFWNLKDILYLNFSVIPI-EIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSL 156
           L        +L  +  L+ +   + E+   P++E L    N +   +  S       K++
Sbjct: 70  LYETL-DLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNI 125

Query: 157 NLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGN 199
            L+ N ++            ++ L+L  N+++  +       +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS 167

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 78.0 bits (192), Expect = 7e-16
 Identities = 31/155 (20%), Positives = 58/155 (37%), Gaps = 16/155 (10%)

Query: 52  GILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSI-PLTFWNLKD 110
            I E   N  +     +  + L      +L  +  ++++L L  N L+ I          
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59

Query: 111 ILYLNFS----VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGA 166
           +  LN S       +++  L  L  L L  N +Q           S+++L+ + NN+S  
Sbjct: 60  LELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113

Query: 167 IPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFS 201
           +  S       K++ L+ NK+   +      G  S
Sbjct: 114 VSCSR--GQGKKNIYLANNKIT-MLRD-LDEGCRS 144

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 31/190 (16%), Positives = 63/190 (33%), Gaps = 14/190 (7%)

Query: 6   SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISG-GILEEITNLTKLT 64
           S S  +    I L+NN +  +            +++  +    I      E   +   L 
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCR--SRVQYLDLKLNEIDTVNFAELAASSDTLE 172

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLN-----FSVI 119
            + L  N +     +      A L+ L L SN+L  +   F +   + +++       +I
Sbjct: 173 HLNLQYNFIY---DVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLI 229

Query: 120 PIEIGGLPNLEYLFLGYNRLQ-GSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLK 178
              +    NLE+  L  N    G++ D F     +    ++K  +      + E+     
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV--QTVAKQTVKKLTGQNEEECTVPT 287

Query: 179 DLNLSFNKLE 188
             +      E
Sbjct: 288 LGHYGAYCCE 297

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 22/201 (10%), Positives = 55/201 (27%), Gaps = 13/201 (6%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           +  +        L  +DLS+N L + +   F       + +  +    +   I + +   
Sbjct: 181 IYDVKGQVVFAKLKTLDLSSNKL-AFMGPEFQSA--AGVTWISLRNNKLVL-IEKALRFS 236

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSN-ELTSIPLTFWNLKDILYLNFSVI 119
             L    L GN  +        S    ++ ++  +  +LT        +  + +      
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCC 296

Query: 120 -PIEIGGLPNLEYLFLGYNRLQ-------GSIPDSFGDLISLKSLNLSKNNLSGAIPASL 171
             +       L  L    + L          +     +    + ++  K      I    
Sbjct: 297 EDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVT 356

Query: 172 EKLLYLKDLNLSFNKLEGEIP 192
            +      L      L+ ++ 
Sbjct: 357 LRKQAKITLEQKKKALDEQVS 377

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 27/204 (13%), Positives = 60/204 (29%), Gaps = 18/204 (8%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           ++F    ++   L  ++L  N +  V  +         L+   +S   ++  +  E  + 
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIYDVKGQVVF----AKLKTLDLSSNKLA-FMGPEFQSA 213

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFW-----NLKDILYLN 115
             +T I L  NKL   I   L     +L    L  N      L  +      ++ +    
Sbjct: 214 AGVTWISLRNNKLV-LIEKALR-FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271

Query: 116 FSVIPIEIG-GLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG----AIPAS 170
              +  +             G    +         LI+LK    +  +  G     +   
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECE 331

Query: 171 LEKLLYLKDLNLSFNKLEGEIPRG 194
            E     ++++    +    +   
Sbjct: 332 RENQARQREIDALKEQYR-TVIDQ 354

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 41/212 (19%), Positives = 77/212 (36%), Gaps = 31/212 (14%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           LS+L+    +  +D S+N ++ V     V      L    + + N++      + N   L
Sbjct: 198 LSTLAIPIAVEELDASHNSINVVRGPVNV-----ELTILKLQHNNLTD--TAWLLNYPGL 250

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEI 123
             + L  N+L   I       +  L +L + +N L ++ L                    
Sbjct: 251 VEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYG------------------ 291

Query: 124 GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLS 183
             +P L+ L L +N L   +  +      L++L L  N++   +  S      LK+L LS
Sbjct: 292 QPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLS 347

Query: 184 FNKLEGEIPRGGSFGNFSAESFEGNELLCGSP 215
            N  +        F N +  + +  +  C   
Sbjct: 348 HNDWD-CNSLRALFRNVARPAVDDADQHCKID 378

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 89.7 bits (223), Expect = 6e-20
 Identities = 38/187 (20%), Positives = 81/187 (43%), Gaps = 15/187 (8%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
           + L + + +  ++L++  ++ +    F     H+++   M +  I         N+  LT
Sbjct: 63  ALLDSFRQVELLNLNDLQIEEIDTYAFAYA--HTIQKLYMGFNAIRYLPPHVFQNVPLLT 120

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLNFS---VIP 120
            ++L  N L+ S+   +  N   L  LS+ +N L  I   TF     +  L  S   +  
Sbjct: 121 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179

Query: 121 IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDL 180
           +++  +P+L +  + YN L      +    I+++ L+ S N+++  +   +   + L  L
Sbjct: 180 VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTIL 231

Query: 181 NLSFNKL 187
            L  N L
Sbjct: 232 KLQHNNL 238

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 89.3 bits (222), Expect = 8e-20
 Identities = 42/194 (21%), Positives = 76/194 (39%), Gaps = 19/194 (9%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
               N   LT + +SNN L+ +   TF      SL+   +S   ++     +++ +  L 
Sbjct: 135 GIFHNTPKLTTLSMSNNNLERIEDDTFQAT--TSLQNLQLSSNRLTHV---DLSLIPSLF 189

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYL---NFSVIP 120
              +  N       ++  +   ++ +L    N +  +       L  IL L   N +   
Sbjct: 190 HANVSYNL------LSTLAIPIAVEELDASHNSINVVRGPVNVELT-ILKLQHNNLTDTA 242

Query: 121 IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDL 180
             +   P L  + L YN L+  +   F  +  L+ L +S N L  A+    + +  LK L
Sbjct: 243 -WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300

Query: 181 NLSFNKLEGEIPRG 194
           +LS N L   + R 
Sbjct: 301 DLSHNHLL-HVERN 313

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 33/169 (19%), Positives = 61/169 (36%), Gaps = 12/169 (7%)

Query: 59  NLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDI--LYLN 115
            L     +    + +   +   L  +   +  L+L+  ++  I    F     I  LY+ 
Sbjct: 43  TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 101

Query: 116 F---SVIPIEI-GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASL 171
           F     +P  +   +P L  L L  N L       F +   L +L++S NNL      + 
Sbjct: 102 FNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 161

Query: 172 EKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL--LCGSPNLQ 218
           +    L++L LS N+L   +       +    +   N L  L     ++
Sbjct: 162 QATTSLQNLQLSSNRLT-HVDLSL-IPSLFHANVSYNLLSTLAIPIAVE 208

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 50/241 (20%), Positives = 78/241 (32%), Gaps = 42/241 (17%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNIS---GGI---LEEI- 57
                 + L  + L NN +  +  K F       L+   +S  ++      +   L E+ 
Sbjct: 72  DDFKGLQHLYALVLVNNKISKIHEKAFSPL--RKLQKLYISKNHLVEIPPNLPSSLVELR 129

Query: 58  --------------TNLTKLTTIILGGNKL-NGSISITLGSNLASLRKLSLDSNELTSIP 102
                         + L  +  I +GGN L N          L  L  L +   +LT IP
Sbjct: 130 IHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIP 188

Query: 103 L-TFWNLKDILYL---NFSVIPIEI-GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLN 157
                 L   L+L       I +E       L  L LG+N+++     S   L +L+ L+
Sbjct: 189 KDLPETLN-ELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELH 247

Query: 158 LSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNL 217
           L  N LS  +PA L  L  L+ + L  N +                 F            
Sbjct: 248 LDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT----------KVGVNDFCPVGFGVKRAYY 296

Query: 218 Q 218
            
Sbjct: 297 N 297

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 41/198 (20%), Positives = 69/198 (34%), Gaps = 24/198 (12%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEIT-NLTKLTTIILGGN 71
           L  + + +N +  V    F G    ++    M    +     E    +  KL  + +   
Sbjct: 125 LVELRIHDNRIRKVPKGVFSGL--RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA 182

Query: 72  KLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKD--ILYLNF---SVIPIEI-G 124
           KL   I   L     +L +L LD N++ +I             L L      +I      
Sbjct: 183 KLT-GIPKDL---PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238

Query: 125 GLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPAS-------LEKLLYL 177
            LP L  L L  N+L   +P    DL  L+ + L  NN++  +  +         K  Y 
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296

Query: 178 KDLNLSFNKLE-GEIPRG 194
             ++L  N +   E+   
Sbjct: 297 NGISLFNNPVPYWEVQPA 314

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 77.4 bits (191), Expect = 5e-16
 Identities = 47/189 (24%), Positives = 73/189 (38%), Gaps = 40/189 (21%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
            T +DL NN +  +    F                            L  L  ++L  NK
Sbjct: 56  TTLLDLQNNDISELRKDDF--------------------------KGLQHLYALVLVNNK 89

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYL---NFSVIPIEI-GGLP 127
           ++  I     S L  L+KL +  N L  IP     +L + L +       +P  +  GL 
Sbjct: 90  IS-KIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVE-LRIHDNRIRKVPKGVFSGLR 147

Query: 128 NLEYLFLGYNRLQGSI--PDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFN 185
           N+  + +G N L+ S   P +F  L  L  L +S+  L+  IP  L     L +L+L  N
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDL--PETLNELHLDHN 203

Query: 186 KLEGEIPRG 194
           K++  I   
Sbjct: 204 KIQ-AIELE 211

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 30/163 (18%), Positives = 58/163 (35%), Gaps = 20/163 (12%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
           L ++ +S   L  +           +L    + +  I    LE++   +KL  + LG N+
Sbjct: 174 LNYLRISEAKLTGIPKDLP-----ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQ 228

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIE---------- 122
           +   I     S L +LR+L LD+N+L+ +P    +LK +  +      I           
Sbjct: 229 IR-MIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPV 287

Query: 123 --IGGLPNLEYLFLGYNRLQGSI--PDSFGDLISLKSLNLSKN 161
                      + L  N +      P +F  +    ++     
Sbjct: 288 GFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 29/113 (25%), Positives = 52/113 (46%), Gaps = 10/113 (8%)

Query: 87  SLRKLSLDSNELTSIPLT-FWNLKDILYL---NFSVIPIE-IGGLPNLEYLFLGYNRLQG 141
            LR +      L ++P     +   +L L   + S +  +   GL +L  L L  N++  
Sbjct: 34  HLRVVQCSDLGLKAVPKEISPDTT-LLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92

Query: 142 SIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG 194
               +F  L  L+ L +SKN+L   IP +L     L +L +  N++  ++P+G
Sbjct: 93  IHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKG 141

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 20/143 (13%), Positives = 49/143 (34%), Gaps = 23/143 (16%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEE--ITNLTKLTTIILGG 70
           L  + L +N + ++  +  +      L    + +  I   ++E   ++ L  L  + L  
Sbjct: 195 LNELHLDHNKIQAIELEDLLRY--SKLYRLGLGHNQIR--MIENGSLSFLPTLRELHLDN 250

Query: 71  NKLNGSISITLGSNLASLRKLSLDSNELTSIP-------LTFWNLKDILYLNFSVIPIEI 123
           NKL+  +   L  +L  L+ + L +N +T +                   ++    P+  
Sbjct: 251 NKLS-RVPAGL-PDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPY 308

Query: 124 G--------GLPNLEYLFLGYNR 138
                     + +   +  G  +
Sbjct: 309 WEVQPATFRCVTDRLAIQFGNYK 331

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 32/114 (28%), Positives = 48/114 (42%), Gaps = 6/114 (5%)

Query: 296 NLISKGGFGSVYKARL----GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIK 350
            +I +G FG VY   L    G  +  AVK  N          F  E  +MK   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 351 VISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++  C   E   L VL YM HG L  ++ +      +   +   + VA  ++YL
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 91.3 bits (226), Expect = 4e-20
 Identities = 45/189 (23%), Positives = 82/189 (43%), Gaps = 18/189 (9%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           +            +L    +   + +  +    +S++  + +  +I    ++ I  L  +
Sbjct: 14  IFPDDAFAETIKDNLKKKSVTDAVTQNEL----NSIDQIIANNSDIK--SVQGIQYLPNV 67

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIE- 122
           T + L GNKL     I   +NL +L  L LD N++  +  +  +LK +  L+     I  
Sbjct: 68  TKLFLNGNKLT---DIKPLTNLKNLGWLFLDENKIKDLS-SLKDLKKLKSLSLEHNGISD 123

Query: 123 ---IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKD 179
              +  LP LE L+LG N++  +       L  L +L+L  N +S  +P  L  L  L++
Sbjct: 124 INGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 179

Query: 180 LNLSFNKLE 188
           L LS N + 
Sbjct: 180 LYLSKNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 84.0 bits (207), Expect = 1e-17
 Identities = 40/193 (20%), Positives = 80/193 (41%), Gaps = 22/193 (11%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSH--SLEFFVMSYCNISGGILEEIT 58
           ++   + +    +  I  +N+ + S      V  + +  ++    ++   ++   ++ +T
Sbjct: 33  VTDAVTQNELNSIDQIIANNSDIKS------VQGIQYLPNVTKLFLNGNKLTD--IKPLT 84

Query: 59  NLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV 118
           NL  L  + L  NK+     ++   +L  L+ LSL+ N ++ I     +L  +  L    
Sbjct: 85  NLKNLGWLFLDENKIK---DLSSLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGN 140

Query: 119 IPIE----IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKL 174
             I     +  L  L+ L L  N++   I      L  L++L LSKN++S     +L  L
Sbjct: 141 NKITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS--DLRALAGL 196

Query: 175 LYLKDLNLSFNKL 187
             L  L L   + 
Sbjct: 197 KNLDVLELFSQEC 209

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 79.4 bits (195), Expect = 4e-16
 Identities = 39/191 (20%), Positives = 70/191 (36%), Gaps = 16/191 (8%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           +  +  +     +T + L+ N L  + P T + N    L +  +    I    L  + +L
Sbjct: 55  IKSVQGIQYLPNVTKLFLNGNKLTDIKPLTNLKN----LGWLFLDENKIK--DLSSLKDL 108

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP 120
            KL ++ L  N ++    I    +L  L  L L +N++T I      L  +  L+     
Sbjct: 109 KKLKSLSLEHNGIS---DINGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQ 164

Query: 121 IE----IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
           I     + GL  L+ L+L  N +  S   +   L +L  L L               L+ 
Sbjct: 165 ISDIVPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVV 222

Query: 177 LKDLNLSFNKL 187
              +  +   L
Sbjct: 223 PNTVKNTDGSL 233

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 90.9 bits (226), Expect = 5e-20
 Identities = 39/189 (20%), Positives = 73/189 (38%), Gaps = 15/189 (7%)

Query: 9   NCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIIL 68
           +C      D  +    S+        ++ +++   +S+  I+     ++     L  +IL
Sbjct: 3   SCDASGVCDGRSRSFTSIPS-----GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57

Query: 69  GGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLN-----FSVIPI- 121
             +++N +I      +L SL  L L  N L+S+    F  L  + YLN     +  + + 
Sbjct: 58  KSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116

Query: 122 -EIGGLPNLEYLFLGYNRLQGSIP-DSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKD 179
                L NL+ L +G       I    F  L SL  L +   +L      SL+ +  +  
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176

Query: 180 LNLSFNKLE 188
           L L  ++  
Sbjct: 177 LTLHLSESA 185

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 36/209 (17%), Positives = 73/209 (34%), Gaps = 24/209 (11%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L  + +++    +  + +    L   L   +       ++   +    +         +L
Sbjct: 280 LGKVETVT----IRRLHIPQFYLFYDLSTVYSLL--EKVKRITVENSKVFLVPCSFSQHL 333

Query: 61  TKLTTIILGGNKLNGSISITLG--SNLASLRKLSLDSNELTSIPL---TFWNLKDILYLN 115
             L  + L  N +               SL+ L L  N L S+         LK++  L+
Sbjct: 334 KSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLD 393

Query: 116 FS-----VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPAS 170
            S      +P        + +L L    ++  +        +L+ L++S NNL  +    
Sbjct: 394 ISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSLF 449

Query: 171 LEKLLYLKDLNLSFNKLEGEIPRGGSFGN 199
           L +L   ++L +S NKL+  +P    F  
Sbjct: 450 LPRL---QELYISRNKLK-TLPDASLFPV 474

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 42/211 (19%), Positives = 77/211 (36%), Gaps = 33/211 (15%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEE---ITNLT 61
           +  S  + +  I + N+ +  V           SLEF  +S   +    L+         
Sbjct: 304 TVYSLLEKVKRITVENSKVFLVPCSFSQHL--KSLEFLDLSENLMVEEYLKNSACKGAWP 361

Query: 62  KLTTIILGGNKLNGSISITLG--SNLASLRKLSLDSNELTSIPLTFWNLKDILYLN---- 115
            L T++L  N L  S+  T      L +L  L +  N    +P +    + + +LN    
Sbjct: 362 SLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSST 420

Query: 116 -FSVIPIEI------------------GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSL 156
              V+   I                    LP L+ L++  N+L+ ++PD+      L  +
Sbjct: 421 GIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDASL-FPVLLVM 478

Query: 157 NLSKNNLSGAIPASLEKLLYLKDLNLSFNKL 187
            +S+N L        ++L  L+ + L  N  
Sbjct: 479 KISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 32/184 (17%), Positives = 62/184 (33%), Gaps = 20/184 (10%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISG-GILEEITNLTKL 63
            +  +   L  +DLS+N L S+    F      SL++  +        G+     NLT L
Sbjct: 68  DAFYSLGSLEHLDLSDNHLSSLSSSWFGPL--SSLKYLNLMGNPYQTLGVTSLFPNLTNL 125

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEI 123
            T+ +G  +    I     + L SL +L + +  L +                      +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ-----------------SQSL 168

Query: 124 GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLS 183
             + ++ +L L  +     +      L S++ L L   NL+    + L        +   
Sbjct: 169 KSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228

Query: 184 FNKL 187
             + 
Sbjct: 229 AFRG 232

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 69.0 bits (169), Expect = 8e-13
 Identities = 24/219 (10%), Positives = 64/219 (29%), Gaps = 28/219 (12%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L   S   N   L  + + N    S + +     ++  L    +   ++     + + ++
Sbjct: 113 LGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS-LNELEIKALSLRNYQSQSLKSI 171

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP------------------ 102
             +  + L  ++    +       L+S+R L L    L                      
Sbjct: 172 RDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230

Query: 103 -------LTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKS 155
                   +F  L  +L     +  +E              +           + ++++ 
Sbjct: 231 RGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRR 290

Query: 156 LNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG 194
           L++ +  L   +      L  +K + +  +K+   +P  
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCS 328

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 25/194 (12%), Positives = 68/194 (35%), Gaps = 4/194 (2%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
            SL + + +  + L  +    +L      ++  S+ +  +   N++      +      +
Sbjct: 166 QSLKSIRDIHHLTLHLSESAFLLEIFA--DILSSVRYLELRDTNLARFQFSPLPVDEVSS 223

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP-IEI 123
            +     + +  ++    + L  L +  L+ +E+     T   L D       V+  +  
Sbjct: 224 PMKKLAFRGS-VLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK 282

Query: 124 GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLS 183
                +  L +    L   +   +  L  +K + +  + +     +  + L  L+ L+LS
Sbjct: 283 VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLS 342

Query: 184 FNKLEGEIPRGGSF 197
            N +  E  +  + 
Sbjct: 343 ENLMVEEYLKNSAC 356

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 34/114 (29%), Positives = 49/114 (42%), Gaps = 7/114 (6%)

Query: 91  LSLDSNELTSIPLT-FWNLKDILYLNF----SVIPIEIGGLPNLEYLFLGYNRLQGSIPD 145
               S   TSIP      +K  L L+F     +   ++    NL+ L L  +R+     D
Sbjct: 10  CDGRSRSFTSIPSGLTAAMK-SLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68

Query: 146 SFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGN 199
           +F  L SL+ L+LS N+LS    +    L  LK LNL  N  +  +     F N
Sbjct: 69  AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPN 121

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 24/139 (17%), Positives = 46/139 (33%), Gaps = 29/139 (20%)

Query: 2   SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT 61
               S    + + F++LS+  +  V           +LE   +S  N+          L 
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIRVVKTCIP-----QTLEVLDVSNNNLD----SFSLFLP 451

Query: 62  KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPI 121
           +L  + +  NKL    ++   S    L  + +  N+L S+P                   
Sbjct: 452 RLQELYISRNKLK---TLPDASLFPVLLVMKISRNQLKSVPDGI---------------- 492

Query: 122 EIGGLPNLEYLFLGYNRLQ 140
               L +L+ ++L  N   
Sbjct: 493 -FDRLTSLQKIWLHTNPWD 510

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 88.1 bits (219), Expect = 5e-20
 Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 23/197 (11%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEIT--NLTKLTTIILGG 70
              +DLS NPL  +   +F       L+   +S C I    +E+    +L+ L+T+IL G
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPE--LQVLDLSRCEIQ--TIEDGAYQSLSHLSTLILTG 85

Query: 71  NKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKD--ILYLN---FSVIPIE-- 122
           N +  S+++   S L+SL+KL      L S+      +LK    L +         +   
Sbjct: 86  NPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 123 IGGLPNLEYLFLGYNRLQGSIP-DSFGDLISLK----SLNLSKNNLSGAIPASLEKLLYL 177
              L NLE+L L  N++Q SI       L  +     SL+LS N ++  I     K + L
Sbjct: 145 FSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRL 202

Query: 178 KDLNLSFNKLEGEIPRG 194
           K+L L  N+L+  +P G
Sbjct: 203 KELALDTNQLK-SVPDG 218

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 74.2 bits (183), Expect = 4e-15
 Identities = 39/196 (19%), Positives = 72/196 (36%), Gaps = 25/196 (12%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSY---CNISGGILEEITNLT 61
            S      L  +DLS   + ++    +       L   +++     +++ G     + L+
Sbjct: 49  FSFPE---LQVLDLSRCEIQTIEDGAYQSLSH--LSTLILTGNPIQSLALGAF---SGLS 100

Query: 62  KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL--TFWNLKDILYLNFS-- 117
            L  ++     L  S+      +L +L++L++  N + S  L   F NL ++ +L+ S  
Sbjct: 101 SLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 118 ---VIPIEI-GGLPNLEY----LFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPA 169
               I       L  +      L L  N +   I       I LK L L  N L      
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDG 218

Query: 170 SLEKLLYLKDLNLSFN 185
             ++L  L+ + L  N
Sbjct: 219 IFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 30/142 (21%), Positives = 51/142 (35%), Gaps = 25/142 (17%)

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSVI 119
                + L  N L   +      +   L+ L L   E+ +I    +              
Sbjct: 28  FSTKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ------------- 73

Query: 120 PIEIGGLPNLEYLFLGYNRLQGSIP-DSFGDLISLKSLNLSKNNLSGAIPASL-EKLLYL 177
                 L +L  L L  N +Q S+   +F  L SL+ L   + NL+ ++       L  L
Sbjct: 74  -----SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTL 126

Query: 178 KDLNLSFNKLEGEIPRGGSFGN 199
           K+LN++ N ++        F N
Sbjct: 127 KELNVAHNLIQ-SFKLPEYFSN 147

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 89.6 bits (222), Expect = 1e-19
 Identities = 38/187 (20%), Positives = 81/187 (43%), Gaps = 15/187 (8%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
           + L + + +  ++L++  ++ +    F     H+++   M +  I         N+  LT
Sbjct: 69  ALLDSFRQVELLNLNDLQIEEIDTYAFAYA--HTIQKLYMGFNAIRYLPPHVFQNVPLLT 126

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLNFS---VIP 120
            ++L  N L+ S+   +  N   L  LS+ +N L  I   TF     +  L  S   +  
Sbjct: 127 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185

Query: 121 IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDL 180
           +++  +P+L +  + YN L      +    I+++ L+ S N+++  +   +   + L  L
Sbjct: 186 VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTIL 237

Query: 181 NLSFNKL 187
            L  N L
Sbjct: 238 KLQHNNL 244

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 87.7 bits (217), Expect = 7e-19
 Identities = 43/194 (22%), Positives = 76/194 (39%), Gaps = 19/194 (9%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
               N   LT + +SNN L+ +   TF      SL+   +S   ++     +++ +  L 
Sbjct: 141 GIFHNTPKLTTLSMSNNNLERIEDDTFQAT--TSLQNLQLSSNRLTHV---DLSLIPSLF 195

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYL---NFSVIP 120
              +  N L      +  +   ++ +L    N +  +       L  IL L   N +   
Sbjct: 196 HANVSYNLL------STLAIPIAVEELDASHNSINVVRGPVNVELT-ILKLQHNNLTDTA 248

Query: 121 IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDL 180
             +   P L  + L YN L+  +   F  +  L+ L +S N L  A+    + +  LK L
Sbjct: 249 -WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 306

Query: 181 NLSFNKLEGEIPRG 194
           +LS N L   + R 
Sbjct: 307 DLSHNHLL-HVERN 319

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 87.3 bits (216), Expect = 8e-19
 Identities = 41/212 (19%), Positives = 77/212 (36%), Gaps = 31/212 (14%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           LS+L+    +  +D S+N ++ V     V      L    + + N++      + N   L
Sbjct: 204 LSTLAIPIAVEELDASHNSINVVRGPVNV-----ELTILKLQHNNLTD--TAWLLNYPGL 256

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEI 123
             + L  N+L   I       +  L +L + +N L ++ L                    
Sbjct: 257 VEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYG------------------ 297

Query: 124 GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLS 183
             +P L+ L L +N L   +  +      L++L L  N++   +  S      LK+L LS
Sbjct: 298 QPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLS 353

Query: 184 FNKLEGEIPRGGSFGNFSAESFEGNELLCGSP 215
            N  +        F N +  + +  +  C   
Sbjct: 354 HNDWD-CNSLRALFRNVARPAVDDADQHCKID 384

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 82.7 bits (204), Expect = 3e-17
 Identities = 34/187 (18%), Positives = 68/187 (36%), Gaps = 14/187 (7%)

Query: 12  CLTFIDLSNNPLDSVLPKTFVGNVS---HSLEFFVMSYCNISGGILEEITNLTKLTTIIL 68
                   +  +D      + G      ++ +        +       + +  ++  + L
Sbjct: 23  LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 82

Query: 69  GGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLNFS-----VIPIE 122
              ++   I     +   +++KL +  N +  +P   F N+  +  L         +P  
Sbjct: 83  NDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRG 141

Query: 123 I-GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLN 181
           I    P L  L +  N L+    D+F    SL++L LS N L+  +  SL  +  L   N
Sbjct: 142 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHAN 198

Query: 182 LSFNKLE 188
           +S+N L 
Sbjct: 199 VSYNLLS 205

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 17/111 (15%), Positives = 39/111 (35%), Gaps = 18/111 (16%)

Query: 84  NLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSI 143
            L + + ++  ++ +  +P                    +     +E L L   +++   
Sbjct: 49  TLNNQKIVTFKNSTMRKLP-----------------AALLDSFRQVELLNLNDLQIEEID 91

Query: 144 PDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG 194
             +F    +++ L +  N +    P   + +  L  L L  N L   +PRG
Sbjct: 92  TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRG 141

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 31/114 (27%), Positives = 48/114 (42%), Gaps = 6/114 (5%)

Query: 296 NLISKGGFGSVYKARL----GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIK 350
            +I +G FG VY   L    G  +  AVK  N          F  E  +MK   H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 351 VISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++  C   E   L VL YM HG L  ++ +      +   +   + VA  +++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 35/153 (22%), Positives = 62/153 (40%), Gaps = 5/153 (3%)

Query: 254 LILRYRQRGKRLSNDANMPIVATWRMFSYLELCRATYKFSENNLISKGGFGSVYKARL-G 312
           LI       + L+  + + +        +  L        E   I +G FG V+  RL  
Sbjct: 81  LIDHLLSTQQPLTKKSGVVLHRAVPKDKW-VLNHEDLVLGE--QIGRGNFGEVFSGRLRA 137

Query: 313 DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHG 371
           D   VAVK             F  E  ++K   H N++++I  C+ ++   +V+E +  G
Sbjct: 138 DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197

Query: 372 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
               +L +    L +   L ++ D A+ +EYL 
Sbjct: 198 DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 86.6 bits (215), Expect = 2e-19
 Identities = 28/111 (25%), Positives = 50/111 (45%), Gaps = 8/111 (7%)

Query: 301 GGFGSVYKARL--------GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVI 352
           G F  ++K               EV +KV +   R   +SF     MM  + H++L+   
Sbjct: 19  GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNY 78

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
             C   +   LV E++  GSL+ YL  +   ++I  +L +   +A+A+ +L
Sbjct: 79  GVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 85.7 bits (213), Expect = 3e-19
 Identities = 29/108 (26%), Positives = 45/108 (41%), Gaps = 5/108 (4%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVF--NLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           I  G FG V+     +  +VA+K           F     E E+M  + H  L+++   C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVC 72

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
             +    LV E+M HG L  YL +   +      L + +DV   + YL
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 29/116 (25%), Positives = 54/116 (46%), Gaps = 6/116 (5%)

Query: 294 ENNLISKGGFGSVYKARLGDG----MEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNL 348
            + +I KG FG VY     D     ++ A+K  +     +  ++F  E  +M+ + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 349 IKVISSCSNEE-FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           + +I      E    ++L YM HG L +++ S      +   ++  + VA  +EYL
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 85.7 bits (213), Expect = 3e-19
 Identities = 31/108 (28%), Positives = 45/108 (41%), Gaps = 5/108 (4%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVF--NLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           +  G FG V   +     +VAVK+          F     E + M  + H  L+K    C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ---EAQTMMKLSHPKLVKFYGVC 72

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           S E    +V EY+ +G L  YL S    L+  Q L +  DV   + +L
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 86.3 bits (214), Expect = 5e-19
 Identities = 35/112 (31%), Positives = 53/112 (47%), Gaps = 7/112 (6%)

Query: 300 KGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISS 354
           KG FGSV   R        G  VAVK          + F+ E E++KS++H N++K    
Sbjct: 51  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 110

Query: 355 CSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           C +   +   L++EY+P+GSL  YL      +D  + L     +   +EYL 
Sbjct: 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 85.8 bits (213), Expect = 5e-19
 Identities = 35/112 (31%), Positives = 53/112 (47%), Gaps = 7/112 (6%)

Query: 300 KGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISS 354
           KG FGSV   R        G  VAVK          + F+ E E++KS++H N++K    
Sbjct: 20  KGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 79

Query: 355 CSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           C +   +   L++EY+P+GSL  YL      +D  + L     +   +EYL 
Sbjct: 80  CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 85.4 bits (212), Expect = 6e-19
 Identities = 28/108 (25%), Positives = 48/108 (44%), Gaps = 5/108 (4%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVF--NLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           +  G FG V   +     +VA+K+          F     E ++M ++ H+ L+++   C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE---EAKVMMNLSHEKLVQLYGVC 88

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           + +    ++ EYM +G L  YL          Q L +  DV  A+EYL
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 85.4 bits (212), Expect = 7e-19
 Identities = 29/118 (24%), Positives = 57/118 (48%), Gaps = 14/118 (11%)

Query: 298 ISKGGFGSVYKARL-----GDGMEVAVKV----FNLQCRRAFKSFDIECEMMKSIRHQNL 348
           + +G FG V   R        G +VAVK              K    E E+++++ H+N+
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENI 85

Query: 349 IKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +K    C+ +      L++E++P GSL++YL  +   +++ Q+L   + +   ++YL 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 31/138 (22%), Positives = 54/138 (39%), Gaps = 14/138 (10%)

Query: 272 PIVATWRMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGME-----VAVKVFNLQC 326
           P  A  R+    E  +         ++  G FG+VYK       E     VA+K      
Sbjct: 4   PNQALLRILKETEFKKI-------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56

Query: 327 -RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD 385
             +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 57  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 115

Query: 386 IFQRLNIMIDVASALEYL 403
               LN  + +A  + YL
Sbjct: 116 SQYLLNWCVQIAKGMNYL 133

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 86.8 bits (215), Expect = 1e-18
 Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 17/221 (7%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
           S+      + +IDL  N +  +  +TF       L+   +    ++      I  +  + 
Sbjct: 332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKF--LEKLQTLDLRDNALT-----TIHFIPSIP 384

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLK--DILYLNFSVIPIE 122
            I L GNKL     I L +NL  L +  L++ ++    L   +L+   +    FS    +
Sbjct: 385 DIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGD 444

Query: 123 --IGGLPNLEYLFLGYNRLQGSI-----PDSFGDLISLKSLNLSKNNLSGAIPASLEKLL 175
                 P+LE LFLG N LQ +       D F  L  L+ L L+ N L+   P     L 
Sbjct: 445 QTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLT 504

Query: 176 YLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN 216
            L+ L+L+ N+L   +       N        N+LL  +P+
Sbjct: 505 ALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQLLAPNPD 544

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 45/198 (22%), Positives = 71/198 (35%), Gaps = 19/198 (9%)

Query: 10  CKCLTFI-DLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIIL 68
           C     I       L  V P+       ++ E  ++S+  I          L +L  + L
Sbjct: 2   CSFDGRIAFYRFCNLTQV-PQVL-----NTTERLLLSFNYIRTVTASSFPFLEQLQLLEL 55

Query: 69  GGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLNFS--------VI 119
           G      +I      NL +LR L L S+++  +    F  L  +  L           + 
Sbjct: 56  GSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK 115

Query: 120 PIEIGGLPNLEYLFLGYNRLQG-SIPDSFGDLISLKSLNLSKNNLSGAIPASLEKL--LY 176
                 L  L  L L  N+++   +  SFG L SLKS++ S N +       LE L    
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175

Query: 177 LKDLNLSFNKLEGEIPRG 194
           L   +L+ N L   +   
Sbjct: 176 LSFFSLAANSLYSRVSVD 193

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 81.0 bits (200), Expect = 1e-16
 Identities = 40/184 (21%), Positives = 67/184 (36%), Gaps = 22/184 (11%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
           L  +D+S N     +   F                 IS      +     +     G + 
Sbjct: 206 LEILDVSGNGWTVDITGNFSNA--------------ISKSQAFSLILAHHIMGAGFGFHN 251

Query: 73  LNG-SISITLGSNLASLRKLSLDSNELTSI-PLTFWNLKDILYLNFS------VIPIEIG 124
           +     +   G   +S+R L L    + S+    F  LKD+  LN +      +      
Sbjct: 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311

Query: 125 GLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSF 184
           GL NL+ L L YN L      +F  L  +  ++L KN+++     + + L  L+ L+L  
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371

Query: 185 NKLE 188
           N L 
Sbjct: 372 NALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 36/205 (17%), Positives = 70/205 (34%), Gaps = 39/205 (19%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEE--ITNLTK 62
            +  N   L  +DL ++ +  + P  F G     L    + +C +S  +L++    NL  
Sbjct: 67  EAFRNLPNLRILDLGSSKIYFLHPDAFQGL--FHLFELRLYFCGLSDAVLKDGYFRNLKA 124

Query: 63  LTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLNFSVIPI 121
           LT + L  N++           L SL+ +   SN++  +       L+            
Sbjct: 125 LTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ------------ 172

Query: 122 EIGGLPNLEYLFLGYNRLQGSIPDSFGDL------ISLKSLNLSKNNLSGAIPA------ 169
                  L +  L  N L   +   +G        + L+ L++S N  +  I        
Sbjct: 173 ----GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAI 228

Query: 170 ------SLEKLLYLKDLNLSFNKLE 188
                 SL    ++      F+ ++
Sbjct: 229 SKSQAFSLILAHHIMGAGFGFHNIK 253

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 79.5 bits (196), Expect = 4e-16
 Identities = 42/209 (20%), Positives = 77/209 (36%), Gaps = 14/209 (6%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L    S      L  ID S+N +  V           +L FF ++  ++   +  +    
Sbjct: 138 LYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197

Query: 61  TK------LTTIILGGNKLNGSISITLGSNLASLRKLSLD-SNELTSIPLTFWNLKDILY 113
                   L  + + GN     I+    + ++  +  SL  ++ +      F N+KD   
Sbjct: 198 MNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQ 257

Query: 114 LNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEK 173
             F+ +        ++ +L L +  +       F  L  LK LNL+ N ++     +   
Sbjct: 258 NTFAGLA-----RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYG 312

Query: 174 LLYLKDLNLSFNKLEGEIPRGGSFGNFSA 202
           L  L+ LNLS+N L  E+    +F     
Sbjct: 313 LDNLQVLNLSYNLLG-ELY-SSNFYGLPK 339

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 78.7 bits (194), Expect = 7e-16
 Identities = 41/188 (21%), Positives = 74/188 (39%), Gaps = 5/188 (2%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT--K 62
               N K LT +DLS N + S+      G ++ SL+    S   I      E+  L    
Sbjct: 117 GYFRNLKALTRLDLSKNQIRSLYLHPSFGKLN-SLKSIDFSSNQIFLVCEHELEPLQGKT 175

Query: 63  LTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIE 122
           L+   L  N L   +S+  G  +   R + L+  +++    T     +            
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235

Query: 123 IGGLPNLEYLFLGYNRLQGSIPDSFGDL--ISLKSLNLSKNNLSGAIPASLEKLLYLKDL 180
           +    ++     G++ ++    ++F  L   S++ L+LS   +        E L  LK L
Sbjct: 236 LILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVL 295

Query: 181 NLSFNKLE 188
           NL++NK+ 
Sbjct: 296 NLAYNKIN 303

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 35/197 (17%), Positives = 67/197 (34%), Gaps = 26/197 (13%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
           SS    + L  ++L +      + K    N+ + L    +    I     +    L  L 
Sbjct: 42  SSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN-LRILDLGSSKIYFLHPDAFQGLFHLF 100

Query: 65  TIILGGNKL-NGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEI 123
            + L    L +  +      NL +L +L L  N++ S+ L                    
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL----------------HPSF 144

Query: 124 GGLPNLEYLFLGYNRLQGSIPDSFGDL--ISLKSLNLSKNNLSGAIPASLEKL------L 175
           G L +L+ +    N++          L   +L   +L+ N+L   +     K       +
Sbjct: 145 GKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNM 204

Query: 176 YLKDLNLSFNKLEGEIP 192
            L+ L++S N    +I 
Sbjct: 205 VLEILDVSGNGWTVDIT 221

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 56/265 (21%), Positives = 91/265 (34%), Gaps = 42/265 (15%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEI--- 57
           L  L  L     L  + L+ N   S          + SLE   +    +      E+   
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSE-NPSLEQLFLGENMLQLAWETELCWD 474

Query: 58  --TNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLN 115
               L+ L  + L  N LN S+   + S+L +LR LSL+SN LT +              
Sbjct: 475 VFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--------- 524

Query: 116 FSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIP-ASLEKL 174
                       NLE L +  N+L    PD F   +SL  L+++ N        ++    
Sbjct: 525 ----------PANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELSTFINW 571

Query: 175 LYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNS 234
           L   ++ ++                   +SF G  L     +L  + C       S K S
Sbjct: 572 LNHTNVTIAGPP--------ADIYCVYPDSFSGVSLF----SLSTEGCDEEEVLKSLKFS 619

Query: 235 LLLGIVLPLSTTFMIVVILLILRYR 259
           L +   + L+   M ++ +   R  
Sbjct: 620 LFIVCTVTLTLFLMTILTVTKFRGF 644

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 25/118 (21%), Positives = 46/118 (38%), Gaps = 18/118 (15%)

Query: 83  SNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGS 142
             L +  +L L  N + ++                        L  L+ L LG      +
Sbjct: 21  QVLNTTERLLLSFNYIRTVT-----------------ASSFPFLEQLQLLELGSQYTPLT 63

Query: 143 I-PDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGN 199
           I  ++F +L +L+ L+L  + +    P + + L +L +L L F  L   + + G F N
Sbjct: 64  IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 83.8 bits (208), Expect = 2e-18
 Identities = 31/110 (28%), Positives = 53/110 (48%), Gaps = 7/110 (6%)

Query: 298 ISKGGFGSVYKARL-GDGMEVAVKVF--NLQCRRAFKSFDIECEMMKSIRHQNLIKVISS 354
           +  G +G VY+       + VAVK    +      F     E  +MK I+H NL++++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGV 77

Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYL 403
           C+ E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 30/112 (26%), Positives = 46/112 (41%), Gaps = 7/112 (6%)

Query: 300 KGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISS 354
           KG FGSV   R        G  VAVK          + F  E +++K++    ++K    
Sbjct: 33  KGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGV 92

Query: 355 CSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
                 ++  LV+EY+P G L  +L      LD  + L     +   +EYL 
Sbjct: 93  SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 144

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 34/120 (28%), Positives = 55/120 (45%), Gaps = 16/120 (13%)

Query: 300 KGGFGSVYKARL----GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVIS 353
           +G FGSV +  L    G  ++VAVK   L    +R  + F  E   MK   H N+I+++ 
Sbjct: 44  EGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103

Query: 354 SCSNEEFKA-----LVLEYMPHGSLEKYL-----YSSNCILDIFQRLNIMIDVASALEYL 403
            C     +      ++L +M +G L  YL      +    + +   L  M+D+A  +EYL
Sbjct: 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL 163

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 84.8 bits (210), Expect = 5e-18
 Identities = 33/125 (26%), Positives = 56/125 (44%), Gaps = 9/125 (7%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVF--NLQCRRAFKSFDIECEMM 340
           E+ R          +  G +G VY+       + VAVK    +      F     E  +M
Sbjct: 216 EMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVM 270

Query: 341 KSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASA 399
           K I+H NL++++  C+ E    ++ E+M +G+L  YL   N   +     L +   ++SA
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330

Query: 400 LEYLH 404
           +EYL 
Sbjct: 331 MEYLE 335

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 51/192 (26%), Positives = 71/192 (36%), Gaps = 37/192 (19%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L  L  L N   L  ID+ NN L   LP         SLEF       +    L E+ NL
Sbjct: 143 LEKLPELQNSSFLKIIDVDNNSLKK-LPDLP-----PSLEFIAAGNNQLE--ELPELQNL 194

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP 120
             LT I    N L       L     SL  +   +N L  +P                  
Sbjct: 195 PFLTAIYADNNSLK-----KLPDLPLSLESIVAGNNILEELP------------------ 231

Query: 121 IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDL 180
            E+  LP L  ++   N L+ ++PD      SL++LN+  N L+  +P   + L +L   
Sbjct: 232 -ELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPELPQSLTFLDVS 285

Query: 181 NLSFNKLEGEIP 192
              F+ L    P
Sbjct: 286 ENIFSGLSELPP 297

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 74.6 bits (184), Expect = 9e-15
 Identities = 45/202 (22%), Positives = 74/202 (36%), Gaps = 33/202 (16%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L  L  L N   LT I   NN L   LP         SLE   +    ++  + E   +L
Sbjct: 227 LEELPELQNLPFLTTIYADNNLL-KTLPDLP-----PSLEALNVRDNYLTD-LPELPQSL 279

Query: 61  TKLTTIILGGNKLNGSIS------------ITLGSNLASLRKLSLDSNELTSIPLTFWNL 108
           T L       + L+                 +L     SL +L++ +N+L  +P     L
Sbjct: 280 TFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRL 339

Query: 109 K--DILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGA 166
           +     + + + +P       NL+ L + YN L+   PD    +  L+      N+    
Sbjct: 340 ERLIASFNHLAEVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRM-----NSHLAE 390

Query: 167 IPASLEKLLYLKDLNLSFNKLE 188
           +P   + L   K L++  N L 
Sbjct: 391 VPELPQNL---KQLHVETNPLR 409

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 35/184 (19%), Positives = 66/184 (35%), Gaps = 18/184 (9%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
           L      ++ L   +P     NV  S   +  ++               ++    L    
Sbjct: 13  LQEPLRHSSNLTE-MPVEA-ENVK-SKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69

Query: 73  LNGSISITLGSN--------LASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIG 124
              +  + L +            L  L    N LT +P    +LK +L  N ++  +   
Sbjct: 70  DRQAHELELNNLGLSSLPELPPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKALS-D 128

Query: 125 GLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSF 184
             P LEYL +  N+L+  +P+   +   LK +++  N+L   +P        L+ +    
Sbjct: 129 LPPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGN 182

Query: 185 NKLE 188
           N+LE
Sbjct: 183 NQLE 186

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 33/176 (18%), Positives = 66/176 (37%), Gaps = 23/176 (13%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
           L +++ S+N + S L          SLE   +S   +   +      L +L   I   N 
Sbjct: 299 LYYLNASSNEIRS-LCDLP-----PSLEELNVSNNKLIE-LPALPPRLERL---IASFNH 348

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLN-FSVIPIEIGGLPNLEY 131
           L       +     +L++L ++ N L   P    +++D+   +  + +P       NL+ 
Sbjct: 349 LA-----EVPELPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQ---NLKQ 400

Query: 132 LFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKL 187
           L +  N L+   PD      S++ L ++   +      + E    L+D     +  
Sbjct: 401 LHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 46.9 bits (112), Expect = 7e-06
 Identities = 20/122 (16%), Positives = 39/122 (31%), Gaps = 36/122 (29%)

Query: 84  NLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSI 143
           +   L++    S+ LT +P+                  E   + +    +  ++  + + 
Sbjct: 9   SNTFLQEPLRHSSNLTEMPV------------------EAENVKSKTEYYNAWSEWERNA 50

Query: 144 PDSFGDLI-------------SLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGE 190
           P   G+                   L L+   LS ++P        L+ L  S N L  E
Sbjct: 51  PPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-E 105

Query: 191 IP 192
           +P
Sbjct: 106 LP 107

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 81.9 bits (203), Expect = 7e-18
 Identities = 51/146 (34%), Positives = 70/146 (47%), Gaps = 13/146 (8%)

Query: 58  TNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLK--DILYL 114
             LTKL  + L  NKL  ++   +   L +L  L +  N+L ++P+  F  L     L L
Sbjct: 58  HRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116

Query: 115 N---FSVIPIEI-GGLPNLEYLFLGYNRLQGSIPD-SFGDLISLKSLNLSKNNLSGAIPA 169
           +      +P  +   L  L YL LGYN LQ S+P   F  L SLK L L  N L   +P 
Sbjct: 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPE 174

Query: 170 SL-EKLLYLKDLNLSFNKLEGEIPRG 194
              +KL  LK L L  N+L+  +P G
Sbjct: 175 GAFDKLTELKTLKLDNNQLK-RVPEG 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 16/146 (10%)

Query: 58  TNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLN- 115
            +  KL    L  NKL+ S+       L  LR L L+ N+L ++P   F  LK++  L  
Sbjct: 37  ADTKKLD---LQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92

Query: 116 ----FSVIPIEI-GGLPNLEYLFLGYNRLQGSIPDS-FGDLISLKSLNLSKNNLSGAIPA 169
                  +PI +   L NL  L L  N+L+ S+P   F  L  L  L+L  N L  ++P 
Sbjct: 93  TDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPK 150

Query: 170 SL-EKLLYLKDLNLSFNKLEGEIPRG 194
            + +KL  LK+L L  N+L+  +P G
Sbjct: 151 GVFDKLTSLKELRLYNNQLK-RVPEG 175

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 84.3 bits (208), Expect = 8e-18
 Identities = 42/208 (20%), Positives = 72/208 (34%), Gaps = 38/208 (18%)

Query: 10  CKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL------ 63
              +T ++++ N L S LP+        SLE+       +S  + E   +L  L      
Sbjct: 79  PPQITVLEITQNALIS-LPELP-----ASLEYLDACDNRLST-LPELPASLKHLDVDNNQ 131

Query: 64  -----------TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDIL 112
                        I    N+L       L     SL  LS+ +N+LT +P    +L+  L
Sbjct: 132 LTMLPELPALLEYINADNNQLT-----MLPELPTSLEVLSVRNNQLTFLPELPESLEA-L 185

Query: 113 YLNF---SVIPIEIGGLPNLE----YLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG 165
            ++      +P       + E    +     NR+   IP++   L    ++ L  N LS 
Sbjct: 186 DVSTNLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244

Query: 166 AIPASLEKLLYLKDLNLSFNKLEGEIPR 193
            I  SL +     D +           +
Sbjct: 245 RIRESLSQQTAQPDYHGPRIYFSMSDGQ 272

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 46/248 (18%), Positives = 95/248 (38%), Gaps = 39/248 (15%)

Query: 4   LSSLSNC--KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT 61
           +S L  C     + + L+   L S LP          +    ++   +   + E   +L 
Sbjct: 50  VSLLKECLINQFSELQLNRLNLSS-LPDNL----PPQITVLEITQNALI-SLPELPASLE 103

Query: 62  KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNF---SV 118
            L       N+L+     TL    ASL+ L +D+N+LT +P     L+  +  +    ++
Sbjct: 104 YL---DACDNRLS-----TLPELPASLKHLDVDNNQLTMLPELPALLE-YINADNNQLTM 154

Query: 119 IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLK 178
           +P       +LE L +  N+L   +P+      SL++L++S N L  ++PA   +  + +
Sbjct: 155 LPELPT---SLEVLSVRNNQLT-FLPEL---PESLEALDVSTNLLE-SLPAVPVRNHHSE 206

Query: 179 D----LNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNS 234
           +         N++   IP   +  +          ++     L  +  ++    T+  + 
Sbjct: 207 ETEIFFRCRENRIT-HIPE--NILSLDPTC----TIILEDNPLSSRIRESLSQQTAQPDY 259

Query: 235 LLLGIVLP 242
               I   
Sbjct: 260 HGPRIYFS 267

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 35/147 (23%), Positives = 59/147 (40%), Gaps = 14/147 (9%)

Query: 45  SYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLT 104
            Y  ISG   +  +   K     L G   N ++S+     +    +L L+   L+S+P  
Sbjct: 18  FYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSSLPDN 77

Query: 105 FWNLKDILYL---NFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKN 161
                 +L +       +P       +LEYL    NRL  ++P+      SLK L++  N
Sbjct: 78  LPPQITVLEITQNALISLPELPA---SLEYLDACDNRLS-TLPELPA---SLKHLDVDNN 130

Query: 162 NLSGAIPASLEKLLYLKDLNLSFNKLE 188
            L+  +P        L+ +N   N+L 
Sbjct: 131 QLT-MLPELPAL---LEYINADNNQLT 153

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 30/125 (24%), Positives = 53/125 (42%), Gaps = 7/125 (5%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARL----GDGMEVAVKVFNLQC-RRAFKSFDIECE 338
           E+  +     +  +I  G  G V   RL       + VA+K        R  + F  E  
Sbjct: 45  EIEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102

Query: 339 MMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 398
           +M    H N+I++    +      +V EYM +GSL+ +L + +    I Q + ++  V +
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162

Query: 399 ALEYL 403
            + YL
Sbjct: 163 GMRYL 167

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 82.8 bits (205), Expect = 8e-18
 Identities = 34/121 (28%), Positives = 54/121 (44%), Gaps = 17/121 (14%)

Query: 300 KGGFGSVYKARL----GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVIS 353
           KG FGSV +A+L    G  ++VAVK+           + F  E   MK   H ++ K++ 
Sbjct: 33  KGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVG 92

Query: 354 SCSNEEFKA------LVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEY 402
                  K       ++L +M HG L  +L +S        L +   +  M+D+A  +EY
Sbjct: 93  VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEY 152

Query: 403 L 403
           L
Sbjct: 153 L 153

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 26/109 (23%), Positives = 51/109 (46%), Gaps = 7/109 (6%)

Query: 301 GGFGSVYKARL-----GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISS 354
           G FG+V+K           + V +KV   +  R++F++       + S+ H ++++++  
Sbjct: 24  GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL 83

Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           C     + LV +Y+P GSL  ++      L     LN  + +A  + YL
Sbjct: 84  CPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 27/112 (24%), Positives = 47/112 (41%), Gaps = 7/112 (6%)

Query: 298 ISKGGFGSVYKARLGDGME-----VAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKV 351
           +  G FG+VYK       E     VA+K        +A K    E  +M S+ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           +  C     + L+ + MP G L  Y+      +     LN  + +A  + YL
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 30/125 (24%), Positives = 56/125 (44%), Gaps = 7/125 (5%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARL----GDGMEVAVKVFNLQC-RRAFKSFDIECE 338
           EL        +  ++  G FG V   RL       + VA+K   +    +  + F  E  
Sbjct: 41  ELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98

Query: 339 MMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 398
           +M    H N+I++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158

Query: 399 ALEYL 403
            ++YL
Sbjct: 159 GMKYL 163

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 30/126 (23%), Positives = 57/126 (45%), Gaps = 8/126 (6%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARL-----GDGMEVAVKVFNLQC-RRAFKSFDIEC 337
           E+  +     +  +I  G FG VYK  L        + VA+K        +    F  E 
Sbjct: 40  EIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 97

Query: 338 EMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 397
            +M    H N+I++    S  +   ++ EYM +G+L+K+L   +    + Q + ++  +A
Sbjct: 98  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157

Query: 398 SALEYL 403
           + ++YL
Sbjct: 158 AGMKYL 163

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 32/116 (27%), Positives = 52/116 (44%), Gaps = 16/116 (13%)

Query: 300 KGGFGSVYKARL-----GDGMEVAVKVFNLQC----RRAFKSFDIECEMMKSIRHQNLIK 350
           +G FG V          G G  VAVK          R  +K    E ++++++ H+++IK
Sbjct: 41  EGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ---EIDILRTLYHEHIIK 97

Query: 351 VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
               C +    +  LV+EY+P GSL  YL   +  + + Q L     +   + YLH
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH 151

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 39/122 (31%), Positives = 56/122 (45%), Gaps = 7/122 (5%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
            L     K  +   I KG FG V       G +VAVK   ++     ++F  E  +M  +
Sbjct: 189 ALNMKELKLLQ--TIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQL 243

Query: 344 RHQNLIKVISSCSNEEFKA-LVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALE 401
           RH NL++++     E+    +V EYM  GSL  YL S    +L     L   +DV  A+E
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 303

Query: 402 YL 403
           YL
Sbjct: 304 YL 305

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 27/117 (23%), Positives = 51/117 (43%), Gaps = 13/117 (11%)

Query: 300 KGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVI 352
            G FG VY+ ++         ++VAVK     C  +    F +E  ++    HQN+++ I
Sbjct: 40  HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCI 99

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYL 403
                   + +++E M  G L+ +L  +         L +   L++  D+A   +YL
Sbjct: 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 28/121 (23%), Positives = 57/121 (47%), Gaps = 5/121 (4%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R + K  +   +  G FG V+ A      +VAVK        + ++F  E  +MK++
Sbjct: 184 EIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTL 240

Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEY 402
           +H  L+K+ +  + E    ++ E+M  GSL  +L S       + + ++    +A  + +
Sbjct: 241 QHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299

Query: 403 L 403
           +
Sbjct: 300 I 300

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 35/191 (18%), Positives = 77/191 (40%), Gaps = 18/191 (9%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           ++ +  +     L  ++L +N +  + P   + N++  +    +S   +    +  I  L
Sbjct: 53  VTTIEGVQYLNNLIGLELKDNQITDLAP---LKNLTK-ITELELSGNPLK--NVSAIAGL 106

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP 120
             + T+ L   ++     +   + L++L+ L LD N++T+I      L ++ YL+     
Sbjct: 107 QSIKTLDLTSTQITDVTPL---AGLSNLQVLYLDLNQITNIS-PLAGLTNLQYLSIGNAQ 162

Query: 121 IE----IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
           +     +  L  L  L    N++   I      L +L  ++L  N +S   P  L     
Sbjct: 163 VSDLTPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSN 218

Query: 177 LKDLNLSFNKL 187
           L  + L+   +
Sbjct: 219 LFIVTLTNQTI 229

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 41/189 (21%), Positives = 83/189 (43%), Gaps = 18/189 (9%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
             + ++   +T +      + ++     V  +++ L    +    I+   L  + NLTK+
Sbjct: 34  TVTQADLDGITTLSAFGTGVTTI---EGVQYLNN-LIGLELKDNQITD--LAPLKNLTKI 87

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIE- 122
           T + L GN L    +++  + L S++ L L S ++T +      L ++  L   +  I  
Sbjct: 88  TELELSGNPLK---NVSAIAGLQSIKTLDLTSTQITDVT-PLAGLSNLQVLYLDLNQITN 143

Query: 123 ---IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKD 179
              + GL NL+YL +G  ++   +     +L  L +L    N +S   P  L  L  L +
Sbjct: 144 ISPLAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKISDISP--LASLPNLIE 199

Query: 180 LNLSFNKLE 188
           ++L  N++ 
Sbjct: 200 VHLKNNQIS 208

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 35/189 (18%), Positives = 69/189 (36%), Gaps = 18/189 (9%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           +           I    + +   + +  +      +         ++   +E +  L  L
Sbjct: 12  IFPDPALANAIKIAAGKSNVTDTVTQADLDG----ITTLSAFGTGVTT--IEGVQYLNNL 65

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPI-- 121
             + L  N++     +    NL  + +L L  N L ++      L+ I  L+ +   I  
Sbjct: 66  IGLELKDNQIT---DLAPLKNLTKITELELSGNPLKNVS-AIAGLQSIKTLDLTSTQITD 121

Query: 122 --EIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKD 179
              + GL NL+ L+L  N++  +I      L +L+ L++    +S   P  L  L  L  
Sbjct: 122 VTPLAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTT 177

Query: 180 LNLSFNKLE 188
           L    NK+ 
Sbjct: 178 LKADDNKIS 186

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 28/140 (20%), Positives = 55/140 (39%), Gaps = 12/140 (8%)

Query: 53  ILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDIL 112
           ++     L     I  G + +  +++    ++L  +  LS     +T+I      L +++
Sbjct: 11  VIFPDPALANAIKIAAGKSNVTDTVTQ---ADLDGITTLSAFGTGVTTIE-GVQYLNNLI 66

Query: 113 YLNFSVIPIE----IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIP 168
            L      I     +  L  +  L L  N L      +   L S+K+L+L+   ++   P
Sbjct: 67  GLELKDNQITDLAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP 124

Query: 169 ASLEKLLYLKDLNLSFNKLE 188
             L  L  L+ L L  N++ 
Sbjct: 125 --LAGLSNLQVLYLDLNQIT 142

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 32/192 (16%), Positives = 77/192 (40%), Gaps = 16/192 (8%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L  +S+++  + +  +DL++  +  V P   +  +S +L+   +    I+   +  +  L
Sbjct: 97  LKNVSAIAGLQSIKTLDLTSTQITDVTP---LAGLS-NLQVLYLDLNQITN--ISPLAGL 150

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP 120
           T L  + +G  +++    +T  +NL+ L  L  D N+++ I     +L +++ ++     
Sbjct: 151 TNLQYLSIGNAQVS---DLTPLANLSKLTTLKADDNKISDIS-PLASLPNLIEVHLKNNQ 206

Query: 121 I----EIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
           I     +    NL  + L    +         +L+    +           PA++     
Sbjct: 207 ISDVSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APATISDNGT 264

Query: 177 LKDLNLSFNKLE 188
               NL++N   
Sbjct: 265 YASPNLTWNLTS 276

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 31/111 (27%), Positives = 41/111 (36%), Gaps = 8/111 (7%)

Query: 300 KGGFGSVYKARL----GDGMEVAVKVFN---LQCRRAFKSFDIECEMMKSIRHQNLIKVI 352
            G FG V +       G  + VAVK      L    A   F  E   M S+ H+NLI++ 
Sbjct: 28  DGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLY 87

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
                   K +V E  P GSL   L        +       + VA  + YL
Sbjct: 88  GVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 28/109 (25%), Positives = 53/109 (48%), Gaps = 7/109 (6%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVF--NLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           +  G FG V+        +VAVK          AF +   E  +MK ++HQ L+++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAVV 77

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYL 403
           + E    ++ EYM +GSL  +L + +   L I + L++   +A  + ++
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 24/123 (19%), Positives = 49/123 (39%), Gaps = 8/123 (6%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNL 348
             +     + +GGF  V     L DG   A+K      ++  +    E +M +   H N+
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 349 IKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALE 401
           +++++ C  E        L+L +   G+L   +       +     Q L +++ +   LE
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 402 YLH 404
            +H
Sbjct: 149 AIH 151

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 48/198 (24%), Positives = 79/198 (39%), Gaps = 23/198 (11%)

Query: 9   NCKCLTFIDLSNNPLDSVLPKTFVGNVSHS------LEFFVMSYCNISGGILEEITNLT- 61
               +T +DLS N     + K F   ++ +      L        +      ++  N T 
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269

Query: 62  ------KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYL 114
                  + T  L  +K+  ++  ++ S+   L +L+L  NE+  I    FW L  +L L
Sbjct: 270 KGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKL 328

Query: 115 NFS-----VIPIEI-GGLPNLEYLFLGYNRLQGSIP-DSFGDLISLKSLNLSKNNLSGAI 167
           N S      I   +   L  LE L L YN ++ ++   SF  L +LK L L  N L    
Sbjct: 329 NLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVP 387

Query: 168 PASLEKLLYLKDLNLSFN 185
               ++L  L+ + L  N
Sbjct: 388 DGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 46/204 (22%), Positives = 69/204 (33%), Gaps = 50/204 (24%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
           + ++DLS N +  +   +F                          + L  L  + +    
Sbjct: 32  VNYVDLSLNSIAELNETSF--------------------------SRLQDLQFLKVEQQT 65

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSVIPIEIGGLPNLEY 131
               I       L+SL  L LD N+   +    F                   GL NLE 
Sbjct: 66  PGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFN------------------GLANLEV 107

Query: 132 LFLGYNRLQGSI--PDSFGDLISLKSLNLSKNNLSGAIPASL-EKLLYLKDLNLSFNKLE 188
           L L    L G++   + F  L SL+ L L  NN+    PAS    +     L+L+FNK++
Sbjct: 108 LTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167

Query: 189 GEIPRGGSFGNFSAESFEGNELLC 212
             I       NF  + F    L  
Sbjct: 168 -SICE-EDLLNFQGKHFTLLRLSS 189

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 41/222 (18%), Positives = 72/222 (32%), Gaps = 33/222 (14%)

Query: 2   SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFF--------VMSYCNISGGI 53
           SF  ++        +DL+ N + S+  +  +                   M+   +    
Sbjct: 148 SFFLNMRR---FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEK 204

Query: 54  LEEITNLTKLTTIILGGNKLNGSIS------------ITLGSNLASLRKLSLDSNELTSI 101
                  T +TT+ L GN    S++             +L  + +     S         
Sbjct: 205 CGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDP 264

Query: 102 P-LTFWNLKD----ILYLN---FSVIPIEI-GGLPNLEYLFLGYNRLQGSIPDSFGDLIS 152
              TF  L+        L+      +   +     +LE L L  N +     ++F  L  
Sbjct: 265 DNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324

Query: 153 LKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG 194
           L  LNLS+N L        E L  L+ L+LS+N +   +   
Sbjct: 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQ 365

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 39/200 (19%), Positives = 72/200 (36%), Gaps = 14/200 (7%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEIT--NLTKLTTIILGG 70
           L  + L  N    +    F G  +  LE   ++ CN+ G +L       LT L  ++L  
Sbjct: 81  LIILKLDYNQFLQLETGAFNGLAN--LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRD 138

Query: 71  NKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLE 130
           N +      +   N+     L L  N++ SI       ++ L  NF      +  L ++ 
Sbjct: 139 NNIKKIQPASFFLNMRRFHVLDLTFNKVKSIC------EEDLL-NFQGKHFTLLRLSSIT 191

Query: 131 YLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPA---SLEKLLYLKDLNLSFNKL 187
              +    L      +     S+ +L+LS N    ++            ++ L LS +  
Sbjct: 192 LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYN 251

Query: 188 EGEIPRGGSFGNFSAESFEG 207
            G      +F +    +F+G
Sbjct: 252 MGSSFGHTNFKDPDNFTFKG 271

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 31/124 (25%), Positives = 51/124 (41%), Gaps = 11/124 (8%)

Query: 86  ASLRKLSLDSNELTSIPLT-FWNLKD--ILYLNFSVIPIEIG-----GLPNLEYLFLGYN 137
           A +  + L  N +  +  T F  L+D   L +      + I      GL +L  L L YN
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 138 RLQGSIPDSFGDLISLKSLNLSKNNL-SGAIPA-SLEKLLYLKDLNLSFNKLEGEIPRGG 195
           +       +F  L +L+ L L++ NL    +     + L  L+ L L  N ++ +I    
Sbjct: 90  QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPAS 148

Query: 196 SFGN 199
            F N
Sbjct: 149 FFLN 152

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 39/235 (16%), Positives = 70/235 (29%), Gaps = 41/235 (17%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPK-TFVGNVSHSLEFFVMSY---CNISGGILEEITNL 60
           +S S  + L F+ +       V+   TF G    SL    + Y     +  G       L
Sbjct: 48  TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS--SLIILKLDYNQFLQLETGAFN---GL 102

Query: 61  TKLTTIILGGNKLNGSISITLGS--NLASLRKLSLDSNELTSI-PLTFWNLKDILYLNFS 117
             L  + L    L+    ++      L SL  L L  N +  I P +F+           
Sbjct: 103 ANLEVLTLTQCNLD-GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL---------- 151

Query: 118 VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFG----------DLISLKSLNLSKNNLSGAI 167
                   +     L L +N+++    +              L S+   ++++  L    
Sbjct: 152 -------NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEK 204

Query: 168 PASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPC 222
             +  K   +  L+LS N  + E      F   +    +   L            
Sbjct: 205 CGNPFKNTSITTLDLSGNGFK-ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGH 258

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 33/153 (21%), Positives = 57/153 (37%), Gaps = 21/153 (13%)

Query: 4   LSSLSNCKC-------LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEE 56
                N          +   DLS + + ++L   F       LE   ++   I+   +++
Sbjct: 261 FKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTD--LEQLTLAQNEIN--KIDD 316

Query: 57  --ITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILY 113
                LT L  + L  N L GSI   +  NL  L  L L  N + ++   +F  L ++  
Sbjct: 317 NAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKE 375

Query: 114 LNFS-----VIPIEI-GGLPNLEYLFLGYNRLQ 140
           L         +P  I   L +L+ ++L  N   
Sbjct: 376 LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 28/128 (21%), Positives = 51/128 (39%), Gaps = 12/128 (9%)

Query: 283 LELCRATYKFSENNLISKGGFGSVYKARL---GDGMEVAVKV----FNLQCRRAFKSFDI 335
           L L R     ++  L   G FGSV +         ++VA+KV                  
Sbjct: 4   LFLKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR--- 59

Query: 336 ECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 395
           E ++M  + +  ++++I  C  E    LV+E    G L K+L      + +     ++  
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 396 VASALEYL 403
           V+  ++YL
Sbjct: 119 VSMGMKYL 126

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 80.1 bits (198), Expect = 5e-17
 Identities = 46/189 (24%), Positives = 83/189 (43%), Gaps = 18/189 (9%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           + S          +L    +   + +  +    +S++  + +  +I    ++ I  L  +
Sbjct: 17  IFSDDAFAETIKDNLKKKSVTDAVTQNEL----NSIDQIIANNSDIK--SVQGIQYLPNV 70

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIE- 122
           T + L GNKL     I   +NL +L  L LD N++  +  +  +LK +  L+     I  
Sbjct: 71  TKLFLNGNKLT---DIKPLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSLEHNGISD 126

Query: 123 ---IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKD 179
              +  LP LE L+LG N++  +       L  L +L+L  N +S  +P  L  L  L++
Sbjct: 127 INGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 182

Query: 180 LNLSFNKLE 188
           L LS N + 
Sbjct: 183 LYLSKNHIS 191

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 70.5 bits (173), Expect = 8e-14
 Identities = 37/191 (19%), Positives = 71/191 (37%), Gaps = 16/191 (8%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           +  +  +     +T + L+ N L  + P   + N+ + L +  +    +    L  + +L
Sbjct: 58  IKSVQGIQYLPNVTKLFLNGNKLTDIKP---LANLKN-LGWLFLDENKVK--DLSSLKDL 111

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP 120
            KL ++ L  N ++    I    +L  L  L L +N++T I      L  +  L+     
Sbjct: 112 KKLKSLSLEHNGIS---DINGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQ 167

Query: 121 IE----IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
           I     + GL  L+ L+L  N +  S   +   L +L  L L               L+ 
Sbjct: 168 ISDIVPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVV 225

Query: 177 LKDLNLSFNKL 187
              +  +   L
Sbjct: 226 PNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 41/192 (21%), Positives = 82/192 (42%), Gaps = 16/192 (8%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L+ +  L+N K L ++ L  N +  +   + + ++   L+   + +  IS   +  + +L
Sbjct: 80  LTDIKPLANLKNLGWLFLDENKVKDL---SSLKDLKK-LKSLSLEHNGIS--DINGLVHL 133

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP 120
            +L ++ LG NK+     IT+ S L  L  LSL+ N+++ I      L  +  L  S   
Sbjct: 134 PQLESLYLGNNKIT---DITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNH 189

Query: 121 IE----IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
           I     + GL NL+ L L          +   +L+   ++  +  +L    P  +     
Sbjct: 190 ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGD 247

Query: 177 LKDLNLSFNKLE 188
            +  N+ ++  E
Sbjct: 248 YEKPNVKWHLPE 259

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 80.9 bits (200), Expect = 5e-17
 Identities = 41/188 (21%), Positives = 76/188 (40%), Gaps = 16/188 (8%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEE--ITNLTKLTTIILGG 70
           +  +DLSNN +  +           +L+  V++   I+   +EE   ++L  L  + L  
Sbjct: 54  VKSLDLSNNRITYISNSDLQR--CVNLQALVLTSNGIN--TIEEDSFSSLGSLEHLDLSY 109

Query: 71  NKLNGSISITLGSNLASLRKLSLDSNELTSIP--LTFWNLKDILYLN------FSVIPIE 122
           N L  ++S +    L+SL  L+L  N   ++     F +L  +  L       F+ I  +
Sbjct: 110 NYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168

Query: 123 I-GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLN 181
              GL  LE L +  + LQ   P S   + ++  L L        +   ++    ++ L 
Sbjct: 169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLE 228

Query: 182 LSFNKLEG 189
           L    L+ 
Sbjct: 229 LRDTDLDT 236

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 38/199 (19%), Positives = 79/199 (39%), Gaps = 22/199 (11%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEIT--NLTKLTTIILGG 70
           L  +DLS N L ++    F    S  L F  +        + E     +LTKL  + +G 
Sbjct: 102 LEHLDLSYNYLSNLSSSWFKPLSS--LTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGN 158

Query: 71  NKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLNFSVIPIEI------ 123
                 I     + L  L +L +D+++L S    +  +++++ +L   +    +      
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFV 218

Query: 124 GGLPNLEYLFLGYNRLQG----SIP----DSFGDLISLKSLNLSKNNLSGAIPASLEKLL 175
               ++E L L    L       +     +S     + +++ ++  +L   +   L ++ 
Sbjct: 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQIS 277

Query: 176 YLKDLNLSFNKLEGEIPRG 194
            L +L  S N+L+  +P G
Sbjct: 278 GLLELEFSRNQLKS-VPDG 295

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 27/195 (13%), Positives = 61/195 (31%), Gaps = 27/195 (13%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCN----ISGGILEEITNLTKLTTIIL 68
           LTF++L  NP  ++   +   +++  L+   +   +    I          LT L  + +
Sbjct: 126 LTFLNLLGNPYKTLGETSLFSHLT-KLQILRVGNMDTFTKIQRKDFA---GLTFLEELEI 181

Query: 69  GGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLNFSVIPIEI---- 123
             + L  S       ++ ++  L L   +   +  +       +  L      ++     
Sbjct: 182 DASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFS 240

Query: 124 ----------GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPAS-LE 172
                             + +    L   +      +  L  L  S+N L   +P    +
Sbjct: 241 ELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFD 298

Query: 173 KLLYLKDLNLSFNKL 187
           +L  L+ + L  N  
Sbjct: 299 RLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 33/118 (27%), Positives = 46/118 (38%), Gaps = 10/118 (8%)

Query: 86  ASLRKLSLDSNELTSIPL-TFWNLK--DILYLNFSVIP-IEIG---GLPNLEYLFLGYNR 138
            +++ L L +N +T I             L L  + I  IE      L +LE+L L YN 
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111

Query: 139 LQGSIP-DSFGDLISLKSLNLSKNNLSGAIPASL-EKLLYLKDLNLSFNKLEGEIPRG 194
           L  ++    F  L SL  LNL  N        SL   L  L+ L +       +I R 
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 22/149 (14%), Positives = 49/149 (32%), Gaps = 19/149 (12%)

Query: 7   LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEIT--NLTKLT 64
            +    L  +++  + L S  PK+       ++   ++        +L EI     + + 
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKS--IQNVSHLILHMKQHI--LLLEIFVDVTSSVE 225

Query: 65  TIILGGNKLNG-------SISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS 117
            + L    L+        +          + R + +    L  +      +  +L L FS
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFS 285

Query: 118 -----VIPIEI-GGLPNLEYLFLGYNRLQ 140
                 +P  I   L +L+ ++L  N   
Sbjct: 286 RNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 19/81 (23%), Positives = 36/81 (44%), Gaps = 5/81 (6%)

Query: 115 NFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPA-SLEK 173
           + + IP  +     ++ L L  NR+           ++L++L L+ N ++  I   S   
Sbjct: 42  SLNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSS 98

Query: 174 LLYLKDLNLSFNKLEGEIPRG 194
           L  L+ L+LS+N L   +   
Sbjct: 99  LGSLEHLDLSYNYLS-NLSSS 118

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 81.5 bits (201), Expect = 6e-17
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 5/121 (4%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R + +      + +G FG V+         VA+K        + ++F  E ++MK +
Sbjct: 263 EIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKL 319

Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEY 402
           RH+ L+++ +  S E    +V EYM  GSL  +L       L + Q +++   +AS + Y
Sbjct: 320 RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378

Query: 403 L 403
           +
Sbjct: 379 V 379

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 79.5 bits (197), Expect = 6e-17
 Identities = 31/128 (24%), Positives = 57/128 (44%), Gaps = 14/128 (10%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARL----GDGMEVAVKVFN----LQCRRAFKSFDI 335
            + R     +   ++ +G FG VY+       G+ + VAVK       L  +  F S   
Sbjct: 8   GIAREDVVLNR--ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS--- 62

Query: 336 ECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 395
           E  +MK++ H +++K+I     E    +++E  P+G L  YL  +   L +   +   + 
Sbjct: 63  EAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121

Query: 396 VASALEYL 403
           +  A+ YL
Sbjct: 122 ICKAMAYL 129

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 80.1 bits (198), Expect = 8e-17
 Identities = 28/117 (23%), Positives = 51/117 (43%), Gaps = 13/117 (11%)

Query: 300 KGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVI 352
            G FG VY+ ++         ++VAVK     C  +    F +E  ++    HQN+++ I
Sbjct: 81  HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCI 140

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYL 403
                   + ++LE M  G L+ +L  +         L +   L++  D+A   +YL
Sbjct: 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 81.0 bits (200), Expect = 9e-17
 Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 5/121 (4%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R + +      + +G FG V+         VA+K        + ++F  E ++MK +
Sbjct: 180 EIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKL 236

Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEY 402
           RH+ L+++ +  S E    +V EYM  GSL  +L       L + Q +++   +AS + Y
Sbjct: 237 RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295

Query: 403 L 403
           +
Sbjct: 296 V 296

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 37/110 (33%), Positives = 53/110 (48%), Gaps = 5/110 (4%)

Query: 296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
             I KG FG V       G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 356 SNEEFKA-LVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYL 403
             E+    +V EYM  GSL  YL S    +L     L   +DV  A+EYL
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 81.1 bits (200), Expect = 1e-16
 Identities = 28/125 (22%), Positives = 53/125 (42%), Gaps = 6/125 (4%)

Query: 283 LELCRATYKFSENNLISKGGFGSVYKARL---GDGMEVAVKVFNLQC-RRAFKSFDIECE 338
           L L R     ++  L   G FGSV +         ++VA+KV      +   +    E +
Sbjct: 330 LFLKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388

Query: 339 MMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 398
           +M  + +  ++++I  C  E    LV+E    G L K+L      + +     ++  V+ 
Sbjct: 389 IMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 447

Query: 399 ALEYL 403
            ++YL
Sbjct: 448 GMKYL 452

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 81.1 bits (200), Expect = 1e-16
 Identities = 39/199 (19%), Positives = 71/199 (35%), Gaps = 35/199 (17%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
           L  + +S+N L S LP          L         ++  +    + L +L+   +  N+
Sbjct: 143 LQELSVSDNQLAS-LPALP-----SELCKLWAYNNQLTS-LPMLPSGLQELS---VSDNQ 192

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLK--DILYLNFSVIPIEIGGL---- 126
           L      +L +  + L KL   +N LTS+P     LK   +     + +P+    L    
Sbjct: 193 LA-----SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLPSELKELM 247

Query: 127 -------------PNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEK 173
                          L  L +  N+L   +P+S   L S  ++NL  N LS     +L +
Sbjct: 248 VSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 306

Query: 174 LLYLKDLNLSFNKLEGEIP 192
           +      +    + +    
Sbjct: 307 ITSAPGYSGPIIRFDMAGA 325

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 40/210 (19%), Positives = 72/210 (34%), Gaps = 64/210 (30%)

Query: 4   LSSLSNCKC--LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT 61
           +  +  C       +++  + L + LP                                 
Sbjct: 31  VQKMRACLNNGNAVLNVGESGLTT-LPDCL----------------------------PA 61

Query: 62  KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLK--DILYLNFSVI 119
            +TT+++  N L      +L +    LR L +  N+LTS+P+    L    I     + +
Sbjct: 62  HITTLVIPDNNLT-----SLPALPPELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTHL 116

Query: 120 PIEIGGL-----------------PNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN 162
           P    GL                 P L+ L +  N+L  S+P        L  L    N 
Sbjct: 117 PALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA-SLPALPS---ELCKLWAYNNQ 172

Query: 163 LSGAIPASLEKLLYLKDLNLSFNKLEGEIP 192
           L+ ++P        L++L++S N+L   +P
Sbjct: 173 LT-SLPMLPSG---LQELSVSDNQLA-SLP 197

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 40/196 (20%), Positives = 75/196 (38%), Gaps = 21/196 (10%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
           L  + +S+N L S LP          L         ++  +    + L +L   I+ GN+
Sbjct: 183 LQELSVSDNQLAS-LPTLP-----SELYKLWAYNNRLTS-LPALPSGLKEL---IVSGNR 232

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYL---NFSVIPIEIGGLPNL 129
           L      +L    + L++L +  N LTS+P+    L   L +     + +P  +  L + 
Sbjct: 233 LT-----SLPVLPSELKELMVSGNRLTSLPMLPSGLL-SLSVYRNQLTRLPESLIHLSSE 286

Query: 130 EYLFLGYNRLQGSIPDSFGDLISLK--SLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKL 187
             + L  N L      +  ++ S    S  + + +++GA      + L+L   +      
Sbjct: 287 TTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAR 346

Query: 188 EGEIPRGGSFGNFSAE 203
           EGE      +  F  E
Sbjct: 347 EGEPAPADRWHMFGQE 362

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 24/120 (20%), Positives = 46/120 (38%), Gaps = 16/120 (13%)

Query: 300 KGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVI 352
           +G FG VY+              VA+K  N     R    F  E  +MK     ++++++
Sbjct: 35  QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQRLNIMIDVASALEYL 403
              S  +   +++E M  G L+ YL                 + + + +  ++A  + YL
Sbjct: 95  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 154

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 76.5 bits (189), Expect = 1e-16
 Identities = 30/150 (20%), Positives = 58/150 (38%), Gaps = 23/150 (15%)

Query: 38  SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNE 97
           SL +  ++  N++   L  I     +  + +         +    S L++L +L +   +
Sbjct: 45  SLTYITLANINVTD--LTGIEYAHNIKDLTINNIHAT---NYNPISGLSNLERLRIMGKD 99

Query: 98  LTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLN 157
           +TS  +                   + GL +L  L + ++    SI      L  + S++
Sbjct: 100 VTSDKIP-----------------NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142

Query: 158 LSKNNLSGAIPASLEKLLYLKDLNLSFNKL 187
           LS N     I   L+ L  LK LN+ F+ +
Sbjct: 143 LSYNGAITDIMP-LKTLPELKSLNIQFDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 76.5 bits (189), Expect = 2e-16
 Identities = 37/185 (20%), Positives = 67/185 (36%), Gaps = 27/185 (14%)

Query: 6   SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTT 65
           + +    LT+I L+N  +  +   T +    H+++   ++  + +      I+ L+ L  
Sbjct: 39  TEAQMNSLTYITLANINVTDL---TGIEYA-HNIKDLTINNIHATN--YNPISGLSNLER 92

Query: 66  IILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGG 125
           + + G  +  S  I   S L SL  L +  +      LT                 +I  
Sbjct: 93  LRIMGKDV-TSDKIPNLSGLTSLTLLDISHSAHDDSILT-----------------KINT 134

Query: 126 LPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFN 185
           LP +  + L YN     I      L  LKSLN+  + +       +E    L  L     
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191

Query: 186 KLEGE 190
            + G+
Sbjct: 192 TIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 72.3 bits (178), Expect = 4e-15
 Identities = 27/134 (20%), Positives = 53/134 (39%), Gaps = 9/134 (6%)

Query: 58  TNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS 117
           +        +LG +    +I+    + + SL  ++L +  +T +        +I  L  +
Sbjct: 20  STFKAYLNGLLGQSS-TANITE---AQMNSLTYITLANINVTDLT-GIEYAHNIKDLTIN 74

Query: 118 VIPIE----IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEK 173
            I       I GL NLE L +    +      +   L SL  L++S +    +I   +  
Sbjct: 75  NIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134

Query: 174 LLYLKDLNLSFNKL 187
           L  +  ++LS+N  
Sbjct: 135 LPKVNSIDLSYNGA 148

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.0 bits (159), Expect = 2e-12
 Identities = 24/163 (14%), Positives = 57/163 (34%), Gaps = 27/163 (16%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           L+ +     +  + ++N    +      +  +S +LE   +   +++   +  ++ LT L
Sbjct: 59  LTGIEYAHNIKDLTINNIHATNY---NPISGLS-NLERLRIMGKDVTSDKIPNLSGLTSL 114

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSN-ELTSIPLTFWNLKDILYLNFSVIPIE 122
           T + +  +  + SI   + + L  +  + L  N  +T I                     
Sbjct: 115 TLLDISHSAHDDSILTKI-NTLPKVNSIDLSYNGAITDIM-------------------P 154

Query: 123 IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG 165
           +  LP L+ L + ++ +         D   L  L      + G
Sbjct: 155 LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.4 bits (147), Expect = 5e-11
 Identities = 24/141 (17%), Positives = 42/141 (29%), Gaps = 23/141 (16%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
            +  + +S    L  + +    + S       G    SL    +S+      IL +I  L
Sbjct: 78  ATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLT--SLTLLDISHSAHDDSILTKINTL 135

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP 120
            K+ +I L  N     I       L  L+ L++  + +                      
Sbjct: 136 PKVNSIDLSYNGAITDIMPL--KTLPELKSLNIQFDGVHDYR------------------ 175

Query: 121 IEIGGLPNLEYLFLGYNRLQG 141
             I   P L  L+     + G
Sbjct: 176 -GIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 40.3 bits (95), Expect = 4e-04
 Identities = 16/101 (15%), Positives = 35/101 (34%), Gaps = 9/101 (8%)

Query: 95  SNELTSIPLTFWNLKDILYLNF---SVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLI 151
           S +  +IP +    K  L       S   I    + +L Y+ L    +   +        
Sbjct: 11  SQDNVNIPDS--TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAH 66

Query: 152 SLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIP 192
           ++K L ++  + +   P  +  L  L+ L +    +  +  
Sbjct: 67  NIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKI 105

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 36/125 (28%), Positives = 56/125 (44%), Gaps = 21/125 (16%)

Query: 300 KGGFGSVYKARL------GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVIS 353
           +G FG V+ A         D M VAVK        A K F  E E++ +++H++++K   
Sbjct: 25  EGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYG 84

Query: 354 SCSNEEFKALVLEYMPHGSLEKYL---------------YSSNCILDIFQRLNIMIDVAS 398
            C + +   +V EYM HG L K+L                 +   L + Q L+I   +AS
Sbjct: 85  VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIAS 144

Query: 399 ALEYL 403
            + YL
Sbjct: 145 GMVYL 149

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 37/210 (17%), Positives = 79/210 (37%), Gaps = 18/210 (8%)

Query: 2   SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT 61
            F  S ++ K L+   + ++      P++++  +  ++     +        +   + ++
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFGF--PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324

Query: 62  KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLT---FWNLKDILYLNFS- 117
               +    N L          +L  L  L L  N+L  +         +K +  L+ S 
Sbjct: 325 PFLHLDFSNNLL-TDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQ 383

Query: 118 ------VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASL 171
                     +     +L  L +  N L  +I         +K L+L  N +  +IP  +
Sbjct: 384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQV 440

Query: 172 EKLLYLKDLNLSFNKLEGEIPRGGSFGNFS 201
            KL  L++LN++ N+L+  +P  G F   +
Sbjct: 441 VKLEALQELNVASNQLK-SVPD-GIFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 72.2 bits (177), Expect = 6e-14
 Identities = 40/164 (24%), Positives = 64/164 (39%), Gaps = 12/164 (7%)

Query: 8   SNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNIS--GGILEEITNLTKLTT 65
           S       +D SNN L   + +         LE  ++    +     I E  T +  L  
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTE--LETLILQMNQLKELSKIAEMTTQMKSLQQ 378

Query: 66  IILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLT--FWNLKDILYL---NFSVIP 120
           + +  N ++        S   SL  L++ SN LT          +K +L L       IP
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIK-VLDLHSNKIKSIP 437

Query: 121 IEIGGLPNLEYLFLGYNRLQGSIPD-SFGDLISLKSLNLSKNNL 163
            ++  L  L+ L +  N+L+ S+PD  F  L SL+ + L  N  
Sbjct: 438 KQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 37/210 (17%), Positives = 68/210 (32%), Gaps = 23/210 (10%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNI------SGGIL 54
              +  L     + +  +SN  L   L          SL+   +              I 
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296

Query: 55  EEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLT-FWNLKDILY 113
           E  +N+          +     + +   S ++    L   +N LT        +L ++  
Sbjct: 297 EIFSNMNIKN---FTVSGTR-MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET 352

Query: 114 LNFSV-----IPIEIG---GLPNLEYLFLGYNRLQGSIPD-SFGDLISLKSLNLSKNNLS 164
           L   +     +         + +L+ L +  N +             SL SLN+S N L+
Sbjct: 353 LILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412

Query: 165 GAIPASLEKLLYLKDLNLSFNKLEGEIPRG 194
             I   L     +K L+L  NK++  IP+ 
Sbjct: 413 DTIFRCLPPR--IKVLDLHSNKIK-SIPKQ 439

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 40/179 (22%), Positives = 69/179 (38%), Gaps = 15/179 (8%)

Query: 14  TFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKL 73
             +D S N L  V PK    ++S       +S   IS     +I +L+KL  +I+  N++
Sbjct: 3   FLVDRSKNGLIHV-PK----DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRI 57

Query: 74  NGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLN-----FSVIPI--EIGGL 126
              + I++      L  L L  N+L  I        ++ +L+     F  +PI  E G +
Sbjct: 58  Q-YLDISVFKFNQELEYLDLSHNKLVKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNM 114

Query: 127 PNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFN 185
             L++L L    L+ S       L   K L +              +    + L++ F 
Sbjct: 115 SQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 36/227 (15%), Positives = 70/227 (30%), Gaps = 51/227 (22%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
            T +++S N +  +                                +L+KL  +I+  N+
Sbjct: 23  TTILNISQNYISELWTSDI--------------------------LSLSKLRILIISHNR 56

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYL 132
           +   + I++      L  L L  N+L  I                          NL++L
Sbjct: 57  IQ-YLDISVFKFNQELEYLDLSHNKLVKIS--------------------CHPTVNLKHL 95

Query: 133 FLGYNRLQGSIPDS--FGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGE 190
            L +N    ++P    FG++  LK L LS  +L  +    +  L   K L +       +
Sbjct: 96  DLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEK 154

Query: 191 IPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNSLLL 237
                   +F+ ES           +  +      + +    N   +
Sbjct: 155 ED-PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 15/75 (20%), Positives = 27/75 (36%), Gaps = 2/75 (2%)

Query: 113 YLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLE 172
                 +P ++        L +  N +          L  L+ L +S N +     +  +
Sbjct: 9   KNGLIHVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK 66

Query: 173 KLLYLKDLNLSFNKL 187
               L+ L+LS NKL
Sbjct: 67  FNQELEYLDLSHNKL 81

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 29/202 (14%), Positives = 61/202 (30%), Gaps = 14/202 (6%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L   ++ S           +  LD  +       +S+       + C+    IL ++   
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219

Query: 61  TKLTTIILGGNKL--NGSISITLGSNLASLRKLSLDSNELTSIP------LTFWNLKDIL 112
            KL+ + L   +   N  I I       ++   S+ + +L           +  +LK + 
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279

Query: 113 YLNFSVIPIEIG------GLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGA 166
                                N+       +  +         +     L+ S N L+  
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDT 339

Query: 167 IPASLEKLLYLKDLNLSFNKLE 188
           +  +   L  L+ L L  N+L+
Sbjct: 340 VFENCGHLTELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 26/187 (13%), Positives = 59/187 (31%), Gaps = 8/187 (4%)

Query: 4   LSSLS--NCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT 61
           L  +S      L  +DLS N  D++      GN+S  L+F  +S  ++    +  I +L 
Sbjct: 81  LVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMS-QLKFLGLSTTHLEKSSVLPIAHLN 139

Query: 62  KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPI 121
               +++ G             +  +     +         +   ++K +  L  S    
Sbjct: 140 ISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS---- 195

Query: 122 EIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIP-ASLEKLLYLKDL 180
            I  +          + L     +     ++L ++  + N+    +       + Y    
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255

Query: 181 NLSFNKL 187
           N+     
Sbjct: 256 NVKLQGQ 262

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 23/108 (21%), Positives = 43/108 (39%), Gaps = 6/108 (5%)

Query: 301 GGFGSVYKARL----GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           G FG V++          + VA+K           + F  E   M+   H +++K+I   
Sbjct: 26  GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           +      +++E    G L  +L      LD+   +     +++AL YL
Sbjct: 86  TENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 26/114 (22%), Positives = 49/114 (42%), Gaps = 13/114 (11%)

Query: 298 ISKGGFGSVYKARL---GDGMEVAVKV-----FNLQCRRAFKSFDIECEMMKSIRHQNLI 349
           +  G FG+V K           VAVK+      +   +    +   E  +M+ + +  ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPYIV 81

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           ++I  C  E +  LV+E    G L KYL   N  +     + ++  V+  ++YL
Sbjct: 82  RMIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYL 133

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 34/124 (27%), Positives = 53/124 (42%), Gaps = 20/124 (16%)

Query: 300 KGGFGSVYKARL------GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVIS 353
           +G FG V+ A         D M VAVK        A + F  E E++  ++HQ++++   
Sbjct: 51  EGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFG 110

Query: 354 SCSNEEFKALVLEYMPHGSLEKYLYSS--------------NCILDIFQRLNIMIDVASA 399
            C+      +V EYM HG L ++L S                  L + Q L +   VA+ 
Sbjct: 111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAG 170

Query: 400 LEYL 403
           + YL
Sbjct: 171 MVYL 174

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.0 bits (192), Expect = 5e-16
 Identities = 54/196 (27%), Positives = 83/196 (42%), Gaps = 37/196 (18%)

Query: 8   SNCKC-LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEIT--NLTKLT 64
           +NC C    +  S   L +V P+    ++        +S+ N+S  +  E T   LT L 
Sbjct: 14  ANCLCASNILSCSKQQLPNV-PQ----SLPSYTALLDLSHNNLSR-LRAEWTPTRLTNLH 67

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYLNFSVIPIEI 123
           +++L  N LN  IS      + +LR L L SN L ++    F                  
Sbjct: 68  SLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFS----------------- 109

Query: 124 GGLPNLEYLFLGYNRLQGSIP-DSFGDLISLKSLNLSKNNLSGAIPA----SLEKLLYLK 178
             L  LE L L  N +   +  ++F D+  L+ L LS+N +S   P        KL  L 
Sbjct: 110 -DLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLM 166

Query: 179 DLNLSFNKLEGEIPRG 194
            L+LS NKL+ ++P  
Sbjct: 167 LLDLSSNKLK-KLPLT 181

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.0 bits (174), Expect = 8e-14
 Identities = 32/142 (22%), Positives = 53/142 (37%), Gaps = 23/142 (16%)

Query: 63  LTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIE 122
              + L  N L+   +    + L +L  L L  N L  I    +                
Sbjct: 41  TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFV--------------- 85

Query: 123 IGGLPNLEYLFLGYNRLQGSIP-DSFGDLISLKSLNLSKNNLSGAIPA-SLEKLLYLKDL 180
              +PNL YL L  N L  ++    F DL +L+ L L  N++   +   + E +  L+ L
Sbjct: 86  --PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKL 141

Query: 181 NLSFNKLEGEIPRGGSFGNFSA 202
            LS N++    P      + + 
Sbjct: 142 YLSQNQIS-RFPV-ELIKDGNK 161

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 68.3 bits (167), Expect = 7e-13
 Identities = 32/164 (19%), Positives = 63/164 (38%), Gaps = 28/164 (17%)

Query: 3   FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNIS---GGILEEITN 59
             + L+N   L  + LS+N L+ +  + FV   +  L +  +S  ++      +    ++
Sbjct: 59  TPTRLTN---LHSLLLSHNHLNFISSEAFVPVPN--LRYLDLSSNHLHTLDEFLF---SD 110

Query: 60  LTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSV 118
           L  L  ++L  N +   +      ++A L+KL L  N+++  P+    +           
Sbjct: 111 LQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGN--------- 160

Query: 119 IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN 162
                  LP L  L L  N+L+         L +     L  +N
Sbjct: 161 ------KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 77.3 bits (191), Expect = 6e-16
 Identities = 37/131 (28%), Positives = 60/131 (45%), Gaps = 26/131 (19%)

Query: 296 NLISKGGFGSVYKARL---GDGMEVAVKV----FNLQCRRAFKSFDIECEMMKSI-RHQN 347
           ++I +G FG V KAR+   G  M+ A+K      +    R F     E E++  +  H N
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG---ELEVLCKLGHHPN 87

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------YSSNCILDIFQRLNI 392
           +I ++ +C +  +  L +EY PHG+L  +L                S+   L   Q L+ 
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 393 MIDVASALEYL 403
             DVA  ++YL
Sbjct: 148 AADVARGMDYL 158

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 77.6 bits (191), Expect = 6e-16
 Identities = 45/195 (23%), Positives = 75/195 (38%), Gaps = 17/195 (8%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEI-TNLTKLTTI-ILGG 70
              +      L  +    F G     LE   +S  ++   I  ++ +NL KL  I I   
Sbjct: 32  AIELRFVLTKLRVIQKGAFSGF--GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89

Query: 71  NKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYL----NFSVIPIEIG- 124
           N L   I+     NL +L+ L + +  +  +P +   +    + L    N ++  IE   
Sbjct: 90  NNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148

Query: 125 --GLP-NLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPA-SLEKLLYLKDL 180
             GL      L+L  N +Q  I +S  +   L  LNLS NN    +P            L
Sbjct: 149 FVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 207

Query: 181 NLSFNKLEGEIPRGG 195
           ++S  ++   +P  G
Sbjct: 208 DISRTRIH-SLPSYG 221

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 36/196 (18%), Positives = 61/196 (31%), Gaps = 20/196 (10%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPK-TFVGNVSHSLEFFVMSYCN----ISGGILEEITN 59
            + S    L  I++S N +  V+    F       L    +   N    I+        N
Sbjct: 48  GAFSGFGDLEKIEISQNDVLEVIEADVFSNL--PKLHEIRIEKANNLLYINPEAF---QN 102

Query: 60  LTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSN-ELTSIP-LTFWNLKD---ILYL 114
           L  L  +++    +   +      +      L +  N  + +I   +F  L     IL+L
Sbjct: 103 LPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161

Query: 115 N---FSVIPIEI-GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPAS 170
           N      I      G    E      N L+    D F        L++S+  +       
Sbjct: 162 NKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 221

Query: 171 LEKLLYLKDLNLSFNK 186
           LE L  L+  +    K
Sbjct: 222 LENLKKLRARSTYNLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 55.6 bits (134), Expect = 9e-09
 Identities = 27/128 (21%), Positives = 47/128 (36%), Gaps = 10/128 (7%)

Query: 86  ASLRKLSLDSNELTSIP-LTFWNLKDI--LYLNFSVIPIEIG-----GLPNLEYLFL-GY 136
            +  +L     +L  I    F    D+  + ++ + +   I       LP L  + +   
Sbjct: 30  RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89

Query: 137 NRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGS 196
           N L    P++F +L +L+ L +S   +           L    L++  N     I R  S
Sbjct: 90  NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER-NS 148

Query: 197 FGNFSAES 204
           F   S ES
Sbjct: 149 FVGLSFES 156

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 50.2 bits (120), Expect = 5e-07
 Identities = 27/143 (18%), Positives = 49/143 (34%), Gaps = 12/143 (8%)

Query: 1   LSFLSSLSNCKCLTFIDLS-NNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITN 59
           +  + SL        +D+  N  + ++   +FVG +S       ++   I   I     N
Sbjct: 122 VHKIHSLQ----KVLLDIQDNINIHTIERNSFVG-LSFESVILWLNKNGIQE-IHNSAFN 175

Query: 60  LTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYL---N 115
            T+L  + L  N     +   +    +    L +    + S+P     NLK +      N
Sbjct: 176 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 235

Query: 116 FSVIPIEIGGLPNLEYLFLGYNR 138
              +P  +  L  L    L Y  
Sbjct: 236 LKKLPT-LEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 21/110 (19%), Positives = 37/110 (33%), Gaps = 23/110 (20%)

Query: 87  SLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDS 146
           S R      +++T IP              S +P       N   L     +L+     +
Sbjct: 10  SNRVFLCQESKVTEIP--------------SDLP------RNAIELRFVLTKLRVIQKGA 49

Query: 147 FGDLISLKSLNLSKNNLSGAIPAS-LEKLLYLKDLNLS-FNKLEGEIPRG 194
           F     L+ + +S+N++   I A     L  L ++ +   N L   I   
Sbjct: 50  FSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPE 98

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 78.4 bits (193), Expect = 8e-16
 Identities = 24/108 (22%), Positives = 43/108 (39%), Gaps = 6/108 (5%)

Query: 301 GGFGSVYKARL----GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           G FG V++          M VA+K           + F  E   M+   H +++K+I   
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 403
           +      +++E    G L  +L      LD+   +     +++AL YL
Sbjct: 461 TENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 28/122 (22%), Positives = 57/122 (46%), Gaps = 8/122 (6%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN-LQCRRAFKSFDIECEMMKSIRHQN 347
           + +  ++++ +G   +V++ R    G   A+KVFN +   R       E E++K + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 348 LIK---VISSCSNEEFKALVLEYMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEY 402
           ++K   +    +      L++E+ P GSL   L    +   L   + L ++ DV   + +
Sbjct: 69  IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 403 LH 404
           L 
Sbjct: 128 LR 129

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 31/122 (25%), Positives = 51/122 (41%), Gaps = 10/122 (8%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNL--QCRRAFKSFDIECEMMKSIRHQ 346
            KF     I +G F +VYK       +EVA          +   + F  E EM+K ++H 
Sbjct: 28  LKFDI--EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 85

Query: 347 NLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 402
           N+++   S  +         LV E M  G+L+ YL     ++ I    +    +   L++
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQF 144

Query: 403 LH 404
           LH
Sbjct: 145 LH 146

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 75.3 bits (185), Expect = 5e-15
 Identities = 28/122 (22%), Positives = 57/122 (46%), Gaps = 8/122 (6%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN-LQCRRAFKSFDIECEMMKSIRHQN 347
           + +  ++++ +G   +V++ R    G   A+KVFN +   R       E E++K + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 348 LIK---VISSCSNEEFKALVLEYMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEY 402
           ++K   +    +      L++E+ P GSL   L    +   L   + L ++ DV   + +
Sbjct: 69  IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 403 LH 404
           L 
Sbjct: 128 LR 129

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 75.1 bits (185), Expect = 5e-15
 Identities = 37/192 (19%), Positives = 76/192 (39%), Gaps = 24/192 (12%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSH--SLEFFVMSYCNISGGILEEIT 58
           ++ ++ +     LT +  ++N + ++       ++S   +L +       ++     ++T
Sbjct: 54  ITDMTGIEKLTGLTKLICTSNNITTL-------DLSQNTNLTYLACDSNKLTN---LDVT 103

Query: 59  NLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV 118
            LTKLT +    NKL   + +   S    L  L+   N LT I ++       L  + + 
Sbjct: 104 PLTKLTYLNCDTNKLT-KLDV---SQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNK 159

Query: 119 I--PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY 176
               +++     L  L   +N++             L  LN   NN++  +   L + + 
Sbjct: 160 KITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQ 213

Query: 177 LKDLNLSFNKLE 188
           L  L+ S NKL 
Sbjct: 214 LTFLDCSSNKLT 225

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 41/186 (22%), Positives = 66/186 (35%), Gaps = 42/186 (22%)

Query: 6   SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTT 65
           S      LT +D  N+ +                              +  I  LT LT 
Sbjct: 37  SEEQLATLTSLDCHNSSITD----------------------------MTGIEKLTGLTK 68

Query: 66  IILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS---VIPIE 122
           +I   N +  ++ +   S   +L  L+ DSN+LT++ +T   L  + YLN     +  ++
Sbjct: 69  LICTSNNIT-TLDL---SQNTNLTYLACDSNKLTNLDVT--PLTKLTYLNCDTNKLTKLD 122

Query: 123 IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNL 182
           +   P L YL    N L   I         L  L+   N     +   +     L  L+ 
Sbjct: 123 VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDC 177

Query: 183 SFNKLE 188
           SFNK+ 
Sbjct: 178 SFNKIT 183

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 36/184 (19%), Positives = 68/184 (36%), Gaps = 19/184 (10%)

Query: 6   SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTT 65
            +S    LT+++ + N L  +            L                ++T  T+LTT
Sbjct: 122 DVSQNPLLTYLNCARNTLTEIDVSHN-----TQLTELDCHLNKKIT--KLDVTPQTQLTT 174

Query: 66  IILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS---VIPIE 122
           +    NK+   + +   S    L +L+ D+N +T + L       + +L+ S   +  I+
Sbjct: 175 LDCSFNKIT-ELDV---SQNKLLNRLNCDTNNITKLDLN--QNIQLTFLDCSSNKLTEID 228

Query: 123 IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNL 182
           +  L  L Y     N L   +  S   L  L +L+  + +L         +L+Y +    
Sbjct: 229 VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGC 285

Query: 183 SFNK 186
              K
Sbjct: 286 RKIK 289

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 23/184 (12%), Positives = 53/184 (28%), Gaps = 33/184 (17%)

Query: 6   SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTT 65
            +S    LT +      L  +       +++H+ +               ++T+ T+L  
Sbjct: 249 DVSTLSKLTTLHCIQTDLLEI-------DLTHNTQLIYFQAEGCRKIKELDVTHNTQLYL 301

Query: 66  IILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGG 125
           +      +   + +   S    L  L L++ ELT +                     +  
Sbjct: 302 LDCQAAGIT-ELDL---SQNPKLVYLYLNNTELTELD--------------------VSH 337

Query: 126 LPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFN 185
              L+ L      +Q     S G + +L +   ++         +L        ++    
Sbjct: 338 NTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLL 395

Query: 186 KLEG 189
              G
Sbjct: 396 DQFG 399

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 73.1 bits (180), Expect = 6e-15
 Identities = 37/187 (19%), Positives = 77/187 (41%), Gaps = 17/187 (9%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           +            +L    +  ++ +  +      ++ F     NI    L  +   T L
Sbjct: 12  VFPDPGLANAVKQNLGKQSVTDLVSQKEL----SGVQNFNGDNSNIQ--SLAGMQFFTNL 65

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSI-PLTFWNLKDILYLNFSVIP-- 120
             + L  N+++    ++   +L  L +LS++ N L ++  +    L   L+L+ + +   
Sbjct: 66  KELHLSHNQIS---DLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSR-LFLDNNELRDT 121

Query: 121 IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDL 180
             +  L NLE L +  N+L+ SI    G L  L+ L+L  N ++      L +L  +  +
Sbjct: 122 DSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWI 177

Query: 181 NLSFNKL 187
           +L+  K 
Sbjct: 178 DLTGQKC 184

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 29/139 (20%), Positives = 53/139 (38%), Gaps = 13/139 (9%)

Query: 54  LEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILY 113
           +     L       LG   +     +     L+ ++  + D++ + S+        ++  
Sbjct: 12  VFPDPGLANAVKQNLGKQSVT---DLVSQKELSGVQNFNGDNSNIQSLA-GMQFFTNLKE 67

Query: 114 LNFSVIPIE----IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPA 169
           L+ S   I     +  L  LE L +  NRL+ ++  +      L  L L  N L      
Sbjct: 68  LHLSHNQISDLSPLKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNELRD--TD 122

Query: 170 SLEKLLYLKDLNLSFNKLE 188
           SL  L  L+ L++  NKL+
Sbjct: 123 SLIHLKNLEILSIRNNKLK 141

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 56.6 bits (137), Expect = 3e-09
 Identities = 27/185 (14%), Positives = 55/185 (29%), Gaps = 31/185 (16%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           LS L +   L  + ++ N L ++         S  L    +    +     + + +L  L
Sbjct: 78  LSPLKDLTKLEELSVNRNRLKNLNGIP-----SACLSRLFLDNNELRD--TDSLIHLKNL 130

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEI 123
             + +  NKL    SI +   L+ L  L L  NE+T+                      +
Sbjct: 131 EILSIRNNKLK---SIVMLGFLSKLEVLDLHGNEITNTG-------------------GL 168

Query: 124 GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLS 183
             L  + ++ L   +          +L    ++           P  +       D  + 
Sbjct: 169 TRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVL 226

Query: 184 FNKLE 188
           +    
Sbjct: 227 WELPV 231

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 73.4 bits (181), Expect = 8e-15
 Identities = 24/128 (18%), Positives = 50/128 (39%), Gaps = 28/128 (21%)

Query: 301 GGFGSVYKARL------GDGMEVAVKVFN----LQCRRAFKSFDIECEMMKSIRHQNLIK 350
             FG VYK  L           VA+K          R  F+    E  +   ++H N++ 
Sbjct: 20  DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH---EAMLRARLQHPNVVC 76

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYL---------------YSSNCILDIFQRLNIMID 395
           ++   + ++  +++  Y  HG L ++L                +    L+    ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 396 VASALEYL 403
           +A+ +EYL
Sbjct: 137 IAAGMEYL 144

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 73.4 bits (181), Expect = 8e-15
 Identities = 28/134 (20%), Positives = 50/134 (37%), Gaps = 30/134 (22%)

Query: 300 KGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVI 352
           +G FG V KA             VAVK+          +    E  ++K + H ++IK+ 
Sbjct: 33  EGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLY 92

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYLYSS-----------------------NCILDIFQR 389
            +CS +    L++EY  +GSL  +L  S                          L +   
Sbjct: 93  GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDL 152

Query: 390 LNIMIDVASALEYL 403
           ++    ++  ++YL
Sbjct: 153 ISFAWQISQGMQYL 166

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 31/134 (23%), Positives = 52/134 (38%), Gaps = 30/134 (22%)

Query: 300 KGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVI 352
           +G FG V++AR            VAVK+   +        F  E  +M    + N++K++
Sbjct: 57  EGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLL 116

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYLYSS-----------------------NCILDIFQR 389
             C+  +   L+ EYM +G L ++L S                           L   ++
Sbjct: 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQ 176

Query: 390 LNIMIDVASALEYL 403
           L I   VA+ + YL
Sbjct: 177 LCIARQVAAGMAYL 190

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 26/199 (13%)

Query: 8   SNCKC-LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTI 66
            +        +L    +   +      N  +S++  + +  +I    ++ I  L  +  +
Sbjct: 15  DDAFAETIKANLKKKSVTDAVT----QNELNSIDQIIANNSDIKS--VQGIQYLPNVRYL 68

Query: 67  ILGGNKLNGSISITLGS--NLASLRKLSLDSNELTSIPLT-FWNLKDILYLNFSV----- 118
            LGGNKL+      + +   L +L  L L  N+L S+P   F  L ++  L         
Sbjct: 69  ALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS 123

Query: 119 IPIEI-GGLPNLEYLFLGYNRLQGSIPDS-FGDLISLKSLNLSKNNLSGAIPASL-EKLL 175
           +P  +   L NL YL L +N+LQ S+P   F  L +L  L+LS N L  ++P  + +KL 
Sbjct: 124 LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLT 181

Query: 176 YLKDLNLSFNKLEGEIPRG 194
            LKDL L  N+L+  +P G
Sbjct: 182 QLKDLRLYQNQLKS-VPDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 46.2 bits (110), Expect = 9e-06
 Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 46/162 (28%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCN------ISGGILEEITNLTKLTTI 66
           LT++ L+ N L S+    F       L               +  G+ +++TNLT L   
Sbjct: 87  LTYLILTGNQLQSLPNGVF-----DKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN-- 139

Query: 67  ILGGNKLNGSISITLG--SNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIG 124
            L  N+L    S+  G    L +L +L L  N+L S+P                      
Sbjct: 140 -LAHNQLQ---SLPKGVFDKLTNLTELDLSYNQLQSLP---------------------E 174

Query: 125 G----LPNLEYLFLGYNRLQGSIPD-SFGDLISLKSLNLSKN 161
           G    L  L+ L L  N+L+ S+PD  F  L SL+ + L  N
Sbjct: 175 GVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 24/116 (20%), Positives = 54/116 (46%), Gaps = 5/116 (4%)

Query: 290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMK-SIRHQNL 348
             F   +++  G  G++    + D  +VAVK    +C   F   D E ++++ S  H N+
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNV 80

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           I+   +  + +F+ + +E     +L++Y+   +      + + ++    S L +LH
Sbjct: 81  IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH 135

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 73.6 bits (180), Expect = 3e-14
 Identities = 32/125 (25%), Positives = 57/125 (45%), Gaps = 12/125 (9%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQ-CRRAFKSFDIECEMMKSIRHQN 347
           ++  E   +  GGFG V +      G +VA+K    +   +  + + +E ++MK + H N
Sbjct: 16  WEMKE--RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73

Query: 348 LIKVI------SSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASA 399
           ++            +  +   L +EY   G L KYL  + + C L       ++ D++SA
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 400 LEYLH 404
           L YLH
Sbjct: 134 LRYLH 138

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 29/129 (22%), Positives = 53/129 (41%), Gaps = 25/129 (19%)

Query: 300 KGGFGSVYKARL--------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLI 349
           +G FG V  A           + + VAVK+       +       E EMMK I +H+N+I
Sbjct: 91  EGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 150

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMI 394
            ++ +C+ +    +++EY   G+L +YL +                   +     ++   
Sbjct: 151 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 210

Query: 395 DVASALEYL 403
            +A  +EYL
Sbjct: 211 QLARGMEYL 219

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 29/129 (22%), Positives = 53/129 (41%), Gaps = 25/129 (19%)

Query: 300 KGGFGSVYKARL--------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLI 349
           +G FG V  A           + + VAVK+       +       E EMMK I +H+N+I
Sbjct: 45  EGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 104

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMI 394
            ++ +C+ +    +++EY   G+L +YL +                   +     ++   
Sbjct: 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164

Query: 395 DVASALEYL 403
            +A  +EYL
Sbjct: 165 QLARGMEYL 173

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 32/121 (26%), Positives = 58/121 (47%), Gaps = 6/121 (4%)

Query: 290 YKFSENN---LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH 345
           Y++ EN    ++ KG +G VY  R L + + +A+K    +  R  +    E  + K ++H
Sbjct: 19  YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH 78

Query: 346 QNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYL 403
           +N+++ + S S   F  + +E +P GSL   L S    L   ++        +   L+YL
Sbjct: 79  KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138

Query: 404 H 404
           H
Sbjct: 139 H 139

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 69.6 bits (171), Expect = 8e-14
 Identities = 38/200 (19%), Positives = 69/200 (34%), Gaps = 25/200 (12%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEI-----TNLTKLTTII 67
              + L    L ++    F      ++    +S        L+++      NL+K+T I 
Sbjct: 33  TQTLKLIETHLRTIPSHAFSN--LPNISRIYVSIDVT----LQQLESHSFYNLSKVTHIE 86

Query: 68  LGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP-LTFWNLKDILYL-------NFSVI 119
           +   +    I       L  L+ L + +  L   P LT     DI ++         + I
Sbjct: 87  IRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSI 146

Query: 120 PIEI-GGLPN-LEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPA-SLEKLL- 175
           P+    GL N    L L  N    S+     +   L ++ L+KN     I   +   +  
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205

Query: 176 YLKDLNLSFNKLEGEIPRGG 195
               L++S   +   +P  G
Sbjct: 206 GPSLLDVSQTSVT-ALPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 60.8 bits (148), Expect = 8e-11
 Identities = 40/194 (20%), Positives = 73/194 (37%), Gaps = 22/194 (11%)

Query: 5   SSLSNCKCLTFIDLS-NNPLDSVLPKTFVGNVSHSLEFFVMSYCN----ISGGILEEITN 59
            + SN   ++ I +S +  L  +   +F       +    +        I    L     
Sbjct: 49  HAFSNLPNISRIYVSIDVTLQQLESHSFYNL--SKVTHIEIRNTRNLTYIDPDAL---KE 103

Query: 60  LTKLTTIILGGNKLNGSISITLGSNLASLRKLSL-DSNELTSIPL-TFW---NLKDILYL 114
           L  L  + +    L     +T   +      L + D+  +TSIP+  F    N    L L
Sbjct: 104 LPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163

Query: 115 N---FSVIPIEIGGLPNLEYLFLGYNRLQGSIP-DSFGDLIS-LKSLNLSKNNLSGAIPA 169
               F+ +         L+ ++L  N+    I  D+FG + S    L++S+ +++ A+P+
Sbjct: 164 YNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPS 222

Query: 170 -SLEKLLYLKDLNL 182
             LE L  L   N 
Sbjct: 223 KGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 28/135 (20%), Positives = 48/135 (35%), Gaps = 13/135 (9%)

Query: 83  SNLASLRKLSLDSNELTSIP-LTFWNLKDILYL----NFSVIPIEIG---GLPNLEYLFL 134
           S   S + L L    L +IP   F NL +I  +    + ++  +E      L  + ++ +
Sbjct: 28  SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87

Query: 135 GYNRLQGSIP-DSFGDLISLKSLNLSKNNLSGAIPA--SLEKLLYLKDLNLSFNKLEGEI 191
              R    I  D+  +L  LK L +    L    P    +        L ++ N     I
Sbjct: 88  RNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSI 146

Query: 192 PRGGSFGNFSAESFE 206
           P   +F     E+  
Sbjct: 147 PV-NAFQGLCNETLT 160

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 69.3 bits (170), Expect = 9e-14
 Identities = 33/130 (25%), Positives = 60/130 (46%), Gaps = 10/130 (7%)

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLK--DILYLN---FS 117
           T I L  N +   I     S    LR++ L +N+++ +    F  L+  + L L     +
Sbjct: 35  TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93

Query: 118 VIPIEI-GGLPNLEYLFLGYNRLQGSIP-DSFGDLISLKSLNLSKNNLSGAIPASLEKLL 175
            +P  +  GL +L+ L L  N++   +  D+F DL +L  L+L  N L      +   L 
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152

Query: 176 YLKDLNLSFN 185
            ++ ++L+ N
Sbjct: 153 AIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 63.5 bits (155), Expect = 8e-12
 Identities = 31/117 (26%), Positives = 55/117 (47%), Gaps = 10/117 (8%)

Query: 86  ASLRKLSLDSNELTSIPLT-FWNLKDILYLNFS---VIPIEIG---GLPNLEYLFLGYNR 138
            ++ ++ L+ N +  IP   F   K +  ++ S   +  +      GL +L  L L  N+
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91

Query: 139 LQGSIPDS-FGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG 194
           +   +P S F  L SL+ L L+ N ++     + + L  L  L+L  NKL+  I +G
Sbjct: 92  IT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKG 146

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.1 bits (141), Expect = 5e-10
 Identities = 36/150 (24%), Positives = 62/150 (41%), Gaps = 46/150 (30%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
           L  IDLSNN +  + P  F G                          L  L +++L GNK
Sbjct: 58  LRRIDLSNNQISELAPDAFQG--------------------------LRSLNSLVLYGNK 91

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSVIPIEIGGLPNLEY 131
           +   +  +L   L SL+ L L++N++  + +  F +                  L NL  
Sbjct: 92  IT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQD------------------LHNLNL 132

Query: 132 LFLGYNRLQGSIPDSFGDLISLKSLNLSKN 161
           L L  N+LQ     +F  L ++++++L++N
Sbjct: 133 LSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 26/128 (20%), Positives = 48/128 (37%), Gaps = 24/128 (18%)

Query: 300 KGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKV 351
           +G FG V +A             VAVK+          ++   E +++  I  H N++ +
Sbjct: 37  RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96

Query: 352 ISSCSNEEFKALV-LEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMID 395
           + +C+      +V +E+   G+L  YL S                   L +   +     
Sbjct: 97  LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 156

Query: 396 VASALEYL 403
           VA  +E+L
Sbjct: 157 VAKGMEFL 164

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 31/129 (24%), Positives = 52/129 (40%), Gaps = 25/129 (19%)

Query: 300 KGGFGSVYKARL--------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLI 349
           +G FG V  A              +VAVK+       +       E EMMK I +H+N+I
Sbjct: 79  EGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNII 138

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMI 394
            ++ +C+ +    +++EY   G+L +YL +                   L     ++   
Sbjct: 139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 198

Query: 395 DVASALEYL 403
            VA  +EYL
Sbjct: 199 QVARGMEYL 207

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 27/132 (20%), Positives = 50/132 (37%), Gaps = 15/132 (11%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH 345
           R    F E  ++ +G FG V KAR   D    A+K           +   E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNH 61

Query: 346 QNLIKVISSCSNEEFKA-------------LVLEYMPHGSLEKYLYSSNCILDIFQRLNI 392
           Q +++  ++                     + +EY  +G+L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 393 MIDVASALEYLH 404
              +  AL Y+H
Sbjct: 122 FRQILEALSYIH 133

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 69.9 bits (171), Expect = 4e-13
 Identities = 33/152 (21%), Positives = 55/152 (36%), Gaps = 16/152 (10%)

Query: 60  LTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYL----- 114
            +  T +    N           S L  L+ L L  N L +        K++  L     
Sbjct: 352 PSSFTFLNFTQNVF-TDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDV 410

Query: 115 -----NFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPA 169
                N            ++  L L  N L GS+         +K L+L  N +  +IP 
Sbjct: 411 SLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPK 467

Query: 170 SLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFS 201
            +  L  L++LN++ N+L+  +P  G F   +
Sbjct: 468 DVTHLQALQELNVASNQLK-SVPD-GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 66.4 bits (162), Expect = 5e-12
 Identities = 37/159 (23%), Positives = 66/159 (41%), Gaps = 14/159 (8%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNIS--GGILEEITNLTKLTTIILGG 70
            TF++ + N     + +         L+  ++    +     +     N++ L T+ +  
Sbjct: 355 FTFLNFTQNVFTDSVFQGCSTLKR--LQTLILQRNGLKNFFKVALMTKNMSSLETLDVSL 412

Query: 71  NKLNGSISITLGSNLASLRKLSLDSNELTSIP---LTFWNLKDILYLN---FSVIPIEIG 124
           N LN        +   S+  L+L SN LT      L    +K +L L+      IP ++ 
Sbjct: 413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP-PKVK-VLDLHNNRIMSIPKDVT 470

Query: 125 GLPNLEYLFLGYNRLQGSIPD-SFGDLISLKSLNLSKNN 162
            L  L+ L +  N+L+ S+PD  F  L SL+ + L  N 
Sbjct: 471 HLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 46/251 (18%), Positives = 89/251 (35%), Gaps = 14/251 (5%)

Query: 10  CKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILG 69
            +  + +D SN  L  V       ++    +   +S  +IS   + +I+ L++L  + L 
Sbjct: 30  NELESMVDYSNRNLTHVPK-----DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLS 84

Query: 70  GNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDI-LYLN-FSVIPI--EIG 124
            N++  S+   +      L  L +  N L +I      +L+ + L  N F V+P+  E G
Sbjct: 85  HNRIR-SLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASLRHLDLSFNDFDVLPVCKEFG 143

Query: 125 GLPNLEYLFLGYNRLQGSIPDSFGDL-ISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLS 183
            L  L +L L   + +         L +S   L+L   ++ G    SL ++     L+L 
Sbjct: 144 NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESL-QIPNTTVLHLV 202

Query: 184 FNKL-EGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGIHHTSSKNSLLLGIVLP 242
           F+      +    S            +L   +    +          +  N  L  I   
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262

Query: 243 LSTTFMIVVIL 253
              +  +    
Sbjct: 263 WKCSVKLFQFF 273

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 20/189 (10%), Positives = 49/189 (25%), Gaps = 15/189 (7%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL---TKLTTIILG 69
           L+ I L++     ++          +L    + +   +     ++        +  + + 
Sbjct: 225 LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIY 284

Query: 70  GNKLNGSISITLGSN----LASLRKLSLDSNELTSIP-LTFWNLKDILYLNFSVIPIEI- 123
              +   I     +     L SL    + +          +    ++     S+      
Sbjct: 285 NLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFI 344

Query: 124 -----GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLK 178
                    +  +L    N    S+      L  L++L L +N L             + 
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMS 403

Query: 179 DLNLSFNKL 187
            L      L
Sbjct: 404 SLETLDVSL 412

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 25/190 (13%), Positives = 54/190 (28%), Gaps = 17/190 (8%)

Query: 16  IDLSNNPLDSVLPKTFVGNVSH----SLEFFVMSYCNISGGILEEITNLTKLTTIILGGN 71
           +    N L SV     V  + H    +++    +   +   + E     T L   +    
Sbjct: 201 LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE 260

Query: 72  KL-NGSISITLGSNLASLRKLSLDSNELTSIP-----------LTFWNLKDILYLNFSVI 119
                S+ +        +  L++ +  +T              L    ++ +    F   
Sbjct: 261 TTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFS 320

Query: 120 PIEIG-GLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLK 178
              +      +    L  +              S   LN ++N  + ++      L  L+
Sbjct: 321 KEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQ 380

Query: 179 DLNLSFNKLE 188
            L L  N L+
Sbjct: 381 TLILQRNGLK 390

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 26/127 (20%), Positives = 51/127 (40%), Gaps = 27/127 (21%)

Query: 301 GGFGSVYKARL------GDGMEVAVK----VFNLQCRRAFKSFDIECEMMKSI-RHQNLI 349
           G FG V +A           ++VAVK      +   + A  S   E ++M  + +H+N++
Sbjct: 57  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQHENIV 113

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYL-------------YSSNCILDIFQRLNIMIDV 396
            ++ +C++     ++ EY  +G L  +L               +N        L+    V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173

Query: 397 ASALEYL 403
           A  + +L
Sbjct: 174 AQGMAFL 180

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 68.0 bits (166), Expect = 6e-13
 Identities = 36/194 (18%), Positives = 68/194 (35%), Gaps = 28/194 (14%)

Query: 3   FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTK 62
             ++  +   L   ++S    D+ L +     +   L+   ++  +      E++     
Sbjct: 116 LEATGPDLNILNLRNVSWATRDAWLAELQ-QWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174

Query: 63  LTTIILGGNKLNGSISIT---LGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVI 119
           L+T+ L  N   G   +          +L+ L+L +  + +       L           
Sbjct: 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL----------- 223

Query: 120 PIEIGGLPNLEYLFLGYNRLQGSIPD-SFGDLISLKSLNLSKNNLS---GAIPASLEKLL 175
                    L+ L L +N L+ +    S      L SLNLS   L      +PA L    
Sbjct: 224 ---AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSV-- 278

Query: 176 YLKDLNLSFNKLEG 189
               L+LS+N+L+ 
Sbjct: 279 ----LDLSYNRLDR 288

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 35/203 (17%), Positives = 67/203 (33%), Gaps = 22/203 (10%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHS-LEFFVMSYCNISGGILEEITNLT--KLTTIILG 69
           L  + +    + S +    +  +  S L+   +    ++G     +   T   L  + L 
Sbjct: 70  LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129

Query: 70  GNKLNG---SISITLGSNLASLRKLSLDSNELTSIPLTFW-NLKDILYLNFS-------- 117
                     ++         L+ LS+      +           +  L+ S        
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189

Query: 118 --VIPIEIGGLPNLEYLFLGYNRLQ---GSIPDSFGDLISLKSLNLSKNNLSGAIPASLE 172
             +  +     P L+ L L    ++   G         + L+ L+LS N+L  A  A   
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249

Query: 173 KLLY-LKDLNLSFNKLEGEIPRG 194
                L  LNLSF  L+ ++P+G
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKG 271

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 64.9 bits (158), Expect = 7e-12
 Identities = 35/168 (20%), Positives = 54/168 (32%), Gaps = 29/168 (17%)

Query: 5   SSLSNCKCLTFIDLSNNPL--DSVLPKTFVGNVSHSLEFFVMSYCN---ISGGILEEITN 59
             +     L+ +DLS+NP   +  L          +L+   +        SG        
Sbjct: 167 EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226

Query: 60  LTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVI 119
             +L  + L  N L  +         + L  L+L    L  +P                 
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP----------------- 269

Query: 120 PIEIGGLP-NLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGA 166
                GLP  L  L L YNRL    P S  +L  + +L+L  N    +
Sbjct: 270 ----KGLPAKLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 58.8 bits (142), Expect = 7e-10
 Identities = 34/182 (18%), Positives = 54/182 (29%), Gaps = 22/182 (12%)

Query: 36  SHSLEFFVMSYCNISGGILE---EITNLTKLTTIILGGNKLNGSISITLGSN-LASLRKL 91
           S SL+   +    I   IL     +  ++ L  + L   ++ G+    L       L  L
Sbjct: 67  SLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126

Query: 92  SLDSNELTSIPLTFWNLK----------DILYLNFSVIPIE-IGGLPNLEYLFLGYNRLQ 140
           +L +    +       L+           I   +      E +   P L  L L  N   
Sbjct: 127 NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL 186

Query: 141 GSIP----DSFGDLISLKSLNLSKNN---LSGAIPASLEKLLYLKDLNLSFNKLEGEIPR 193
           G              +L+ L L        SG   A     + L+ L+LS N L      
Sbjct: 187 GERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246

Query: 194 GG 195
             
Sbjct: 247 PS 248

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 68.3 bits (167), Expect = 9e-13
 Identities = 24/121 (19%), Positives = 48/121 (39%), Gaps = 11/121 (9%)

Query: 291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECE-MMKSIRHQNLI 349
                 ++  G  G+V       G  VAVK   +          +E + + +S  H N+I
Sbjct: 16  LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVI 72

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------NIMIDVASALEYL 403
           +   S + + F  + LE     +L+  + S N   +  +        +++  +AS + +L
Sbjct: 73  RYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 404 H 404
           H
Sbjct: 132 H 132

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 68.3 bits (167), Expect = 9e-13
 Identities = 19/113 (16%), Positives = 46/113 (40%), Gaps = 6/113 (5%)

Query: 296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNL--IKV 351
             I  GG   V++         A+K  NL+    +   S+  E   +  ++  +   I++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
                 +++  +V+E   +  L  +L      +D ++R +   ++  A+  +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH 172

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 19/113 (16%), Positives = 46/113 (40%), Gaps = 6/113 (5%)

Query: 296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNL--IKV 351
             I  GG   V++         A+K  NL+    +   S+  E   +  ++  +   I++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
                 +++  +V+E   +  L  +L      +D ++R +   ++  A+  +H
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH 144

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 29/132 (21%), Positives = 50/132 (37%), Gaps = 31/132 (23%)

Query: 300 KGGFGSVYKARL------GDGMEVAVKV----FNLQCRRAFKSFDIECEMMKSI-RHQNL 348
            G FG V +A           M VAVK+     +L  R A  S   E +++  +  H N+
Sbjct: 33  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKVLSYLGNHMNI 89

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYL-----------------YSSNCILDIFQRLN 391
           + ++ +C+      ++ EY  +G L  +L                       LD+   L+
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 392 IMIDVASALEYL 403
               VA  + +L
Sbjct: 150 FSYQVAKGMAFL 161

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 32/137 (23%), Positives = 49/137 (35%), Gaps = 36/137 (26%)

Query: 300 KGGFGSVYKARL------GDGMEVAVK----VFNLQCRRAFKSFDIECEMMKSI-RHQNL 348
            G FG V  A        G  ++VAVK      +   R A  S   E +MM  +  H+N+
Sbjct: 55  SGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS---ELKMMTQLGSHENI 111

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYL----------------------YSSNCILDI 386
           + ++ +C+      L+ EY  +G L  YL                           +L  
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 387 FQRLNIMIDVASALEYL 403
              L     VA  +E+L
Sbjct: 172 EDLLCFAYQVAKGMEFL 188

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 23/124 (18%), Positives = 45/124 (36%), Gaps = 10/124 (8%)

Query: 291 KFSENNLISKGGFGSVYKARLGD------GMEVAVKVFNLQCRRAFKSFDIECEMMKSIR 344
               ++L+ +G F  VY+A  GD        +  +KV        F       E +K   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 345 HQNLIKVISSCSNEEFKALVLEYMPHGSL----EKYLYSSNCILDIFQRLNIMIDVASAL 400
               +K  S+   +    LV E   +G+L      Y  +   ++     ++  + +   +
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185

Query: 401 EYLH 404
           E +H
Sbjct: 186 EQVH 189

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 20/119 (16%), Positives = 48/119 (40%), Gaps = 6/119 (5%)

Query: 290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQN 347
             +S    I  GG   V++         A+K  NL+    +   S+  E   +  ++  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 348 L--IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
              I++      +++  +V+E   +  L  +L      +D ++R +   ++  A+  +H
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH 125

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 23/110 (20%), Positives = 43/110 (39%), Gaps = 7/110 (6%)

Query: 296 NLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISS 354
             + +G FG V++ +    G + AVK   L+  R       E      +    ++ +  +
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118

Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
                +  + +E +  GSL + +    C L   + L  +      LEYLH
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLH 167

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 27/131 (20%), Positives = 51/131 (38%), Gaps = 22/131 (16%)

Query: 292 FSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIK 350
           F E  LI  GGFG V+KA+   DG    +K       +A +    E + +  + H N++ 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68

Query: 351 VISSCSNEEFKA----------------LVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIM 393
                   ++                  + +E+   G+LE+++       LD    L + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128

Query: 394 IDVASALEYLH 404
             +   ++Y+H
Sbjct: 129 EQITKGVDYIH 139

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 64.3 bits (157), Expect = 4e-12
 Identities = 29/134 (21%), Positives = 53/134 (39%), Gaps = 24/134 (17%)

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSVIPIE 122
             + L  N+     +  +   L  LRK++  +N++T I    F                 
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAF----------------- 77

Query: 123 IGGLPNLEYLFLGYNRLQGSIPDS-FGDLISLKSLNLSKNNLSGAIPA-SLEKLLYLKDL 180
             G   +  + L  NRL+ ++    F  L SLK+L L  N ++  +   S   L  ++ L
Sbjct: 78  -EGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLL 134

Query: 181 NLSFNKLEGEIPRG 194
           +L  N++   +  G
Sbjct: 135 SLYDNQIT-TVAPG 147

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.9 bits (156), Expect = 6e-12
 Identities = 32/128 (25%), Positives = 52/128 (40%), Gaps = 20/128 (15%)

Query: 59  NLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV 118
            L +L  I    NK+   I        + + ++ L SN L ++      +          
Sbjct: 55  KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQ---HKMFK-------- 102

Query: 119 IPIEIGGLPNLEYLFLGYNRLQGSIP-DSFGDLISLKSLNLSKNNLSGAIPASLEKLLYL 177
                 GL +L+ L L  NR+   +  DSF  L S++ L+L  N ++   P + + L  L
Sbjct: 103 ------GLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSL 155

Query: 178 KDLNLSFN 185
             LNL  N
Sbjct: 156 STLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 62.0 bits (151), Expect = 2e-11
 Identities = 34/165 (20%), Positives = 55/165 (33%), Gaps = 52/165 (31%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L           L  I+ SNN +  +    F G                           
Sbjct: 47  LEATGIFKKLPQLRKINFSNNKITDIEEGAFEG--------------------------A 80

Query: 61  TKLTTIILGGNKLNGSISITLG--SNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFS 117
           + +  I+L  N+L    ++       L SL+ L L SN +T +   +F            
Sbjct: 81  SGVNEILLTSNRLE---NVQHKMFKGLESLKTLMLRSNRITCVGNDSF------------ 125

Query: 118 VIPIEIGGLPNLEYLFLGYNRLQGSIPD-SFGDLISLKSLNLSKN 161
                  GL ++  L L  N++  ++   +F  L SL +LNL  N
Sbjct: 126 ------IGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 57.0 bits (138), Expect = 1e-09
 Identities = 21/110 (19%), Positives = 38/110 (34%), Gaps = 19/110 (17%)

Query: 86  ASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPD 145
               +L L++NE T +  T           F         LP L  +    N++      
Sbjct: 32  QYTAELRLNNNEFTVLEAT---------GIFK-------KLPQLRKINFSNNKITDIEEG 75

Query: 146 SFGDLISLKSLNLSKNNLSGAIPASL-EKLLYLKDLNLSFNKLEGEIPRG 194
           +F     +  + L+ N L   +   + + L  LK L L  N++   +   
Sbjct: 76  AFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGND 123

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 29/126 (23%), Positives = 55/126 (43%), Gaps = 11/126 (8%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-HQN 347
            +     ++++GGF  VY+A+ +G G E A+K          ++   E   MK +  H N
Sbjct: 28  LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87

Query: 348 LIKVISSCS-------NEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVAS 398
           +++  S+ S         + + L+L  +  G L ++L    S   L     L I      
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147

Query: 399 ALEYLH 404
           A++++H
Sbjct: 148 AVQHMH 153

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 65.0 bits (159), Expect = 6e-12
 Identities = 24/115 (20%), Positives = 53/115 (46%), Gaps = 1/115 (0%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLI 349
            +     +  G FG VYKA+    G   A KV   +     + + +E E++ +  H  ++
Sbjct: 20  VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIV 79

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           K++ +  ++    +++E+ P G+++  +   +  L   Q   +   +  AL +LH
Sbjct: 80  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 134

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 27/121 (22%), Positives = 52/121 (42%), Gaps = 7/121 (5%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI--ECEMMKSI-RHQ 346
           +F E   I  G FGSV+K     DG   A+K        +    +   E      + +H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 347 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYL 403
           ++++  S+ + ++   +  EY   GSL   +  +  I+  F   +  ++++ V   L Y+
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 404 H 404
           H
Sbjct: 132 H 132

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 65.9 bits (160), Expect = 8e-12
 Identities = 34/178 (19%), Positives = 64/178 (35%), Gaps = 25/178 (14%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L + S+L     +    L +     +L  + +      +    +++ +++  +L  +  L
Sbjct: 405 LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQL 462

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP 120
             +T + L  N+L  ++   L + L  L  L    N L ++                   
Sbjct: 463 LLVTHLDLSHNRLR-ALPPAL-AALRCLEVLQASDNALENVD------------------ 502

Query: 121 IEIGGLPNLEYLFLGYNRLQG-SIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYL 177
             +  LP L+ L L  NRLQ  +          L  LNL  N+L        E+L  +
Sbjct: 503 -GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 64.4 bits (156), Expect = 2e-11
 Identities = 32/189 (16%), Positives = 64/189 (33%), Gaps = 9/189 (4%)

Query: 2   SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT 61
            +    +  + L   +LS      +  +         LE            ++  +  L 
Sbjct: 340 CWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLL 399

Query: 62  KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVI-- 119
                +   + L     +      A L  L        S+    +    +L+L    +  
Sbjct: 400 YEKETLQYFSTLKAVDPM----RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV 455

Query: 120 PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKD 179
              +  L  + +L L +NRL+ ++P +   L  L+ L  S N L   +   +  L  L++
Sbjct: 456 LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQE 512

Query: 180 LNLSFNKLE 188
           L L  N+L+
Sbjct: 513 LLLCNNRLQ 521

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 63.6 bits (155), Expect = 9e-12
 Identities = 45/136 (33%), Positives = 69/136 (50%), Gaps = 13/136 (9%)

Query: 68  LGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLK--DILYLN---FSVIPI 121
           L    L  ++S      L  L  L+LD N+L ++    F +L     L L     + +P+
Sbjct: 42  LQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPL 100

Query: 122 EI-GGLPNLEYLFLGYNRLQGSIPDS-FGDLISLKSLNLSKNNLSGAIPASL-EKLLYLK 178
            +   L  L+ L+LG N+L+ S+P   F  L  LK L L+ N L  +IPA   +KL  L+
Sbjct: 101 GVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQ 158

Query: 179 DLNLSFNKLEGEIPRG 194
            L+LS N+L+  +P G
Sbjct: 159 TLSLSTNQLQS-VPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 30/162 (18%)

Query: 17  DLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCN------ISGGILEEITNLTKLTTIILGG 70
           DL +  L ++   TF       L        +      +S G+ +++T L  L    L  
Sbjct: 41  DLQSTGLATLSDATF-----RGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLG---LAN 92

Query: 71  NKLNGSISITLGSNLASLRKLSLDSNELTSIP------LTFWNLKDILYLN---FSVIPI 121
           N+L  S+ + +  +L  L KL L  N+L S+P      LT   LK  L LN      IP 
Sbjct: 93  NQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLT--KLK-ELRLNTNQLQSIPA 148

Query: 122 EI-GGLPNLEYLFLGYNRLQGSIPD-SFGDLISLKSLNLSKN 161
                L NL+ L L  N+LQ S+P  +F  L  L+++ L  N
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 50.1 bits (120), Expect = 4e-07
 Identities = 32/110 (29%), Positives = 46/110 (41%), Gaps = 20/110 (18%)

Query: 86  ASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPD 145
           A   KL L S  L ++                       GL  L +L L YN+LQ     
Sbjct: 35  ADTEKLDLQSTGLATLS-----------------DATFRGLTKLTWLNLDYNQLQTLSAG 77

Query: 146 SFGDLISLKSLNLSKNNLSGAIPASL-EKLLYLKDLNLSFNKLEGEIPRG 194
            F DL  L +L L+ N L+ ++P  + + L  L  L L  N+L+  +P G
Sbjct: 78  VFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSG 125

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 23/115 (20%), Positives = 49/115 (42%), Gaps = 10/115 (8%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNL-----QCRRAFKSFDIECEMMKSIRHQNLIK 350
            I +G FG     +   DG +  +K  N+     + R   +    E  ++ +++H N+++
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR---EVAVLANMKHPNIVQ 87

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLH 404
              S        +V++Y   G L K +      +    Q L+  + +  AL+++H
Sbjct: 88  YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 22/133 (16%), Positives = 51/133 (38%), Gaps = 22/133 (16%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNL----QCRRAFKSFDIECEMMKSIRH 345
            F     + +GGFG V++A+   D    A+K   L      R        E + +  + H
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALAKLEH 62

Query: 346 QNLIKVISSCSNEEFKA------------LVLEYMPHGSLEKYL--YSSNCILDIFQRLN 391
             +++  ++   +                + ++     +L+ ++    +    +    L+
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 392 IMIDVASALEYLH 404
           I + +A A+E+LH
Sbjct: 123 IFLQIAEAVEFLH 135

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 29/115 (25%), Positives = 47/115 (40%), Gaps = 3/115 (2%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLI 349
            F     + +G +GSVYKA     G  VA+K   ++     +    E  +M+     +++
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVV 87

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           K   S        +V+EY   GS+   +   N  L   +   I+      LEYLH
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 62.7 bits (153), Expect = 3e-11
 Identities = 31/124 (25%), Positives = 52/124 (41%), Gaps = 13/124 (10%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNL------QCRRAFKSFDIECEMMKSI 343
            F     I +G F  VY+A  L DG+ VA+K   +      + R        E +++K +
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQL 89

Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASAL 400
            H N+IK  +S   +    +VLE    G L + +        +          + + SAL
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149

Query: 401 EYLH 404
           E++H
Sbjct: 150 EHMH 153

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 62.3 bits (152), Expect = 4e-11
 Identities = 22/116 (18%), Positives = 40/116 (34%), Gaps = 8/116 (6%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVIS 353
            I  G +G   K R   DG  +  K  +         +    E  +++ ++H N+++   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 354 SCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLH 404
              +     L  V+EY   G L   +               L +M  +  AL+  H
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 62.2 bits (152), Expect = 4e-11
 Identities = 21/112 (18%), Positives = 42/112 (37%), Gaps = 5/112 (4%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECEMMKSIRHQNLIKVI 352
            + KGGF   ++          A K+     L      +   +E  + +S+ HQ+++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
               + +F  +VLE     SL +       + +   R   +  +    +YLH
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH 132

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 21/112 (18%), Positives = 42/112 (37%), Gaps = 5/112 (4%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECEMMKSIRHQNLIKVI 352
            + KGGF   ++          A K+     L      +   +E  + +S+ HQ+++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
               + +F  +VLE     SL +       + +   R   +  +    +YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH 158

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 61.9 bits (151), Expect = 5e-11
 Identities = 31/115 (26%), Positives = 57/115 (49%), Gaps = 3/115 (2%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLI 349
           K++    I +G  G+VY A  +  G EVA++  NLQ +   +    E  +M+  ++ N++
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             + S    +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH 133

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 61.8 bits (151), Expect = 6e-11
 Identities = 25/112 (22%), Positives = 55/112 (49%), Gaps = 4/112 (3%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECEMMKSIRHQNLIKVI 352
           L+ KG F  VY+A  +  G+EVA+K+ +   +      +    E ++   ++H +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +   +  +  LVLE   +G + +YL +        +  + M  + + + YLH
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 30/115 (26%), Positives = 54/115 (46%), Gaps = 3/115 (2%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLI 349
                  I +G  G V  AR    G +VAVK+ +L+ ++  +    E  +M+  +H N++
Sbjct: 46  LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVV 105

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           ++  S    E   +++E++  G+L   +  S   L+  Q   +   V  AL YLH
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH 158

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 61.2 bits (149), Expect = 9e-11
 Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 9/116 (7%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           I  G    V  A       +VA+K  NL +C+ +      E + M    H N++   +S 
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 356 SNEEFKALVLEYMPHGSL-------EKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             ++   LV++ +  GS+              + +LD      I+ +V   LEYLH
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 26/118 (22%), Positives = 41/118 (34%), Gaps = 5/118 (4%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECE---MMKSIRHQ 346
            F   + +  G +G V+K R   DG   AVK      R          E     K  +H 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 347 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             +++  +        L  E     SL+++  +    L   Q    + D   AL +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 31/118 (26%), Positives = 49/118 (41%), Gaps = 5/118 (4%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI---ECEMMKSIRHQ 346
            FS+   I  G FG+VY AR + +   VA+K  +   +++ + +     E   ++ +RH 
Sbjct: 55  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114

Query: 347 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           N I+       E    LV+EY   GS    L      L   +   +       L YLH
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 22/117 (18%), Positives = 51/117 (43%), Gaps = 13/117 (11%)

Query: 297 LISKGGFGSVYKA---RLGDGMEVAVKVFNLQCRRAFKS-FDIECEMMKSIRHQNLIKVI 352
            I+ GG G +Y A    + +G  V +K          ++    E + +  + H +++++ 
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 353 -----SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
                +    +    +V+EY+   SL++        L + + +  ++++  AL YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH 199

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.4 bits (143), Expect = 6e-10
 Identities = 25/114 (21%), Positives = 37/114 (32%), Gaps = 24/114 (21%)

Query: 53  ILEEITNLTKLTTIILGGNKLNGSISITLGS--NLASLRKLSLDSNELTSI-PLTFWNLK 109
            L  +     LT + +          + L     L  LR L++  + L  + P  F    
Sbjct: 23  SLHHLPGAENLTELYIENQ--QHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFH--- 77

Query: 110 DILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNL 163
                            P L  L L +N L+     +   L SL+ L LS N L
Sbjct: 78  ---------------FTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 24/106 (22%), Positives = 37/106 (34%), Gaps = 5/106 (4%)

Query: 110 DILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPD-SFGDLISLKSLNLSKNNLSGAIP 168
                        + G  NL  L++   +    +       L  L++L + K+ L    P
Sbjct: 14  RCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73

Query: 169 ASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAES--FEGNELLC 212
            +      L  LNLSFN LE  +    +    S +     GN L C
Sbjct: 74  DAFHFTPRLSRLNLSFNALE-SLSW-KTVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.8 bits (126), Expect = 8e-08
 Identities = 23/97 (23%), Positives = 38/97 (39%), Gaps = 8/97 (8%)

Query: 98  LTSIPLTFWNLKDILYLNFS------VIPIE-IGGLPNLEYLFLGYNRLQGSIPDSFGDL 150
                      +++  L          + +  + GL  L  L +  + L+   PD+F   
Sbjct: 20  ALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFT 79

Query: 151 ISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKL 187
             L  LNLS N L  ++     + L L++L LS N L
Sbjct: 80  PRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.0 bits (98), Expect = 2e-04
 Identities = 16/103 (15%), Positives = 30/103 (29%), Gaps = 28/103 (27%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNP-LDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITN 59
           L  L  L   + LT + + N   L  +  +                              
Sbjct: 21  LDSLHHLPGAENLTELYIENQQHLQHLELRDL--------------------------RG 54

Query: 60  LTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP 102
           L +L  + +  + L   ++         L +L+L  N L S+ 
Sbjct: 55  LGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALESLS 96

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 28/115 (24%), Positives = 48/115 (41%), Gaps = 4/115 (3%)

Query: 292 FSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDIECEMMKSIRHQNLI 349
           F++   I KG FG V+K         VA+K+ +L +     +    E  ++       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH 136

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 26/121 (21%), Positives = 48/121 (39%), Gaps = 8/121 (6%)

Query: 290 YKFSENNLISKG--GFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI--ECEMMKSIR 344
           Y+     +I KG     +V  AR    G  V V+  NL+         +  E  + K   
Sbjct: 27  YELLT--VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84

Query: 345 HQNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYL 403
           H N++   ++   +    +V  +M +GS +  +       ++      I+  V  AL+Y+
Sbjct: 85  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144

Query: 404 H 404
           H
Sbjct: 145 H 145

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 55.8 bits (135), Expect = 1e-09
 Identities = 31/128 (24%), Positives = 46/128 (35%), Gaps = 20/128 (15%)

Query: 59  NLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV 118
             + +  ++L  ++ N      L      L  LS  +  LTSI             N   
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIA------------NLP- 61

Query: 119 IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG-AIPASLEKLLYL 177
                  L  L+ L L  NR+ G +        +L  LNLS N +   +    L+KL  L
Sbjct: 62  ------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENL 115

Query: 178 KDLNLSFN 185
           K L+L   
Sbjct: 116 KSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.5 bits (103), Expect = 2e-05
 Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 8/98 (8%)

Query: 7   LSNCKCLTFIDLSNNPLDSV--LPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
               + L F+   N  L S+  LPK       + L+   +S   +SGG+         LT
Sbjct: 38  TDEFEELEFLSTINVGLTSIANLPKL------NKLKKLELSDNRVSGGLEVLAEKCPNLT 91

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP 102
            + L GNK+    +I     L +L+ L L + E+T++ 
Sbjct: 92  HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN 129

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.0 bits (99), Expect = 6e-05
 Identities = 27/105 (25%), Positives = 40/105 (38%), Gaps = 18/105 (17%)

Query: 84  NLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSI 143
             + +++L LD++                      +         LE+L      L  SI
Sbjct: 15  TPSDVKELVLDNSRSNEGK----------------LEGLTDEFEELEFLSTINVGLT-SI 57

Query: 144 PDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLE 188
            +    L  LK L LS N +SG +    EK   L  LNLS NK++
Sbjct: 58  AN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 29/109 (26%), Positives = 50/109 (45%), Gaps = 5/109 (4%)

Query: 300 KGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           KG FG+VY AR       +A+KV     L+          E E+   +RH N++++    
Sbjct: 19  KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            +     L+LEY P G++ + L   +   +       + ++A+AL Y H
Sbjct: 79  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH 126

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 34/117 (29%), Positives = 57/117 (48%), Gaps = 11/117 (9%)

Query: 86  ASLRKLSLDSNELTSIPLT-FWNLKDILYLNFS-----VIPIEI-GGLPNLEYLFLGYNR 138
            + + L L  N++T +    F +L ++  L         +P+ +   L  L  L LG N+
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99

Query: 139 LQGSIPDS-FGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG 194
           L   +P + F  L+ LK L +  N L+  +P  +E+L +L  L L  N+L+  IP G
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHG 153

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 51.6 bits (124), Expect = 8e-08
 Identities = 31/133 (23%), Positives = 51/133 (38%), Gaps = 31/133 (23%)

Query: 59  NLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP------LTFWNLKDIL 112
           +L  L  + LG N+L  ++ + +  +L  L  L L +N+LT +P      L         
Sbjct: 62  SLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLV-------- 112

Query: 113 YLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLE 172
                          +L+ LF+  N+L   +P     L  L  L L +N L      + +
Sbjct: 113 ---------------HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFD 156

Query: 173 KLLYLKDLNLSFN 185
           +L  L    L  N
Sbjct: 157 RLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 36/151 (23%), Positives = 59/151 (39%), Gaps = 33/151 (21%)

Query: 17  DLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNIS---GGILEEITNLTKLTTIILGGNKL 73
            L +N +  + P  F   ++  L+   +    +     G+ + +T LT L    LG N+L
Sbjct: 46  YLHDNQITKLEPGVFDSLIN--LKELYLGSNQLGALPVGVFDSLTQLTVLD---LGTNQL 100

Query: 74  NGSISITLG--SNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEY 131
                +       L  L++L +  N+LT +P     L                   +L +
Sbjct: 101 T---VLPSAVFDRLVHLKELFMCCNKLTELPRGIERLT------------------HLTH 139

Query: 132 LFLGYNRLQGSIPD-SFGDLISLKSLNLSKN 161
           L L  N+L+ SIP  +F  L SL    L  N
Sbjct: 140 LALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 55.9 bits (135), Expect = 1e-09
 Identities = 34/128 (26%), Positives = 48/128 (37%), Gaps = 20/128 (15%)

Query: 59  NLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV 118
               +  ++L   K N      L +   +L  LSL +  L S+             N   
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVS------------NLP- 68

Query: 119 IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG-AIPASLEKLLYL 177
                  LP L+ L L  NR+ G +      L +L  LNLS N L   +    L+KL  L
Sbjct: 69  ------KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECL 122

Query: 178 KDLNLSFN 185
           K L+L   
Sbjct: 123 KSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.9 bits (109), Expect = 4e-06
 Identities = 33/119 (27%), Positives = 48/119 (40%), Gaps = 12/119 (10%)

Query: 7   LSNCKCLTFIDLSNNPLDSV--LPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
            +    L F+ L N  L SV  LPK         L+   +S   I GG+      L  LT
Sbjct: 45  TAEFVNLEFLSLINVGLISVSNLPK------LPKLKKLELSENRIFGGLDMLAEKLPNLT 98

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP----LTFWNLKDILYLNFSVI 119
            + L GNKL    ++     L  L+ L L + E+T++       F  L  + YL+    
Sbjct: 99  HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDR 157

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.4 bits (100), Expect = 6e-05
 Identities = 32/105 (30%), Positives = 44/105 (41%), Gaps = 18/105 (17%)

Query: 84  NLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSI 143
             A++R+L LD+ +                     I        NLE+L L    L  S+
Sbjct: 22  TPAAVRELVLDNCKSNDG----------------KIEGLTAEFVNLEFLSLINVGLI-SV 64

Query: 144 PDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLE 188
             +   L  LK L LS+N + G +    EKL  L  LNLS NKL+
Sbjct: 65  -SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 29/104 (27%), Positives = 47/104 (45%), Gaps = 6/104 (5%)

Query: 95  SNELTSIPLTFWNLKDILYLN---FSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLI 151
           +  L  +P         LYL+   F+++P E+    +L  + L  NR+      SF ++ 
Sbjct: 19  NKGLKVLPKGIPRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMT 78

Query: 152 SLKSLNLSKNNLSGAIPASL-EKLLYLKDLNLSFNKLEGEIPRG 194
            L +L LS N L   IP    + L  L+ L+L  N +   +P G
Sbjct: 79  QLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEG 120

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 31/105 (29%), Positives = 44/105 (41%), Gaps = 22/105 (20%)

Query: 59  NLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFS 117
           N   LT I L  N+++ ++S    SN+  L  L L  N L  IP  TF            
Sbjct: 52  NYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPPRTF------------ 98

Query: 118 VIPIEIGGLPNLEYLFLGYNRLQGSIPD-SFGDLISLKSLNLSKN 161
                  GL +L  L L  N +   +P+ +F DL +L  L +  N
Sbjct: 99  ------DGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.9 bits (112), Expect = 2e-06
 Identities = 34/127 (26%), Positives = 52/127 (40%), Gaps = 48/127 (37%)

Query: 7   LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTI 66
           LSN K LT IDLSNN + ++  ++F                          +N+T+L T+
Sbjct: 50  LSNYKHLTLIDLSNNRISTLSNQSF--------------------------SNMTQLLTL 83

Query: 67  ILGGNKLNGSISITLG--SNLASLRKLSLDSNELTSIPL-TFWNLK-------------- 109
           IL  N+L     I       L SLR LSL  N+++ +P   F +L               
Sbjct: 84  ILSYNRLR---CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140

Query: 110 --DILYL 114
             ++ +L
Sbjct: 141 DCNMQWL 147

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 28/129 (21%), Positives = 56/129 (43%), Gaps = 21/129 (16%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECEMMKS 342
            + Y  S+  ++  G FG V+K      G+++A K+     ++ +   K+   E  +M  
Sbjct: 86  NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKN---EISVMNQ 142

Query: 343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYS-SNCILDIFQRLNIMID 395
           + H NLI++  +  ++    LV+EY+  G L      E Y  +  + I         M  
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI-------LFMKQ 195

Query: 396 VASALEYLH 404
           +   + ++H
Sbjct: 196 ICEGIRHMH 204

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 22/129 (17%), Positives = 49/129 (37%), Gaps = 25/129 (19%)

Query: 300 KGGFGSVYKARLGDGMEVAVKVFN---LQCRRAFKSFDI--------------ECEMMKS 342
           +G F  +      D    A+K +    L+ +R F   +               E +++  
Sbjct: 41  QGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99

Query: 343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-------YSSNCILDIFQRLNIMID 395
           I+++  +      +N +   ++ EYM + S+ K+         +  C + I     I+  
Sbjct: 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKS 159

Query: 396 VASALEYLH 404
           V ++  Y+H
Sbjct: 160 VLNSFSYIH 168

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 28/133 (21%), Positives = 50/133 (37%), Gaps = 30/133 (22%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI-----ECEMM 340
              Y+  E   + KG F  V +   +  G E A  + N    +   + D      E  + 
Sbjct: 10  TEEYQLFE--ELGKGAFSVVRRCVKVLAGQEYAAMIIN---TKKLSARDHQKLEREARIC 64

Query: 341 KSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLN 391
           + ++H N++++  S S E    L+ + +  G L      +  YS    S+CI  I     
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL---- 120

Query: 392 IMIDVASALEYLH 404
                  A+ + H
Sbjct: 121 ------EAVLHCH 127

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 56.8 bits (138), Expect = 3e-09
 Identities = 29/128 (22%), Positives = 53/128 (41%), Gaps = 22/128 (17%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH 345
           R T+ F E  ++  G F  V+  +    G   A+K           S + E  ++K I+H
Sbjct: 8   RKTFIFME--VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65

Query: 346 QNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDV 396
           +N++ +     +     LV++ +  G L     E+ +Y+    S  I  +          
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL--------- 116

Query: 397 ASALEYLH 404
            SA++YLH
Sbjct: 117 -SAVKYLH 123

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 56.0 bits (136), Expect = 5e-09
 Identities = 30/133 (22%), Positives = 50/133 (37%), Gaps = 30/133 (22%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI-----ECEMM 340
              Y   E   + KG F  V +      G+E A K+ N    +   + D      E  + 
Sbjct: 5   SDNYDVKE--ELGKGAFSVVRRCVHKTTGLEFAAKIIN---TKKLSARDFQKLEREARIC 59

Query: 341 KSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLN 391
           + ++H N++++  S   E F  LV + +  G L      +  YS    S+CI  I     
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---- 115

Query: 392 IMIDVASALEYLH 404
                  ++ Y H
Sbjct: 116 ------ESIAYCH 122

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 30/127 (23%), Positives = 54/127 (42%), Gaps = 17/127 (13%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECEMMKS 342
              YK     ++ KG FG V   +    G E AVKV +   ++ +   +S   E +++K 
Sbjct: 25  SDRYKGQR--VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82

Query: 343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVA 397
           + H N++K+     ++ +  LV E    G L      +  +S      I ++      V 
Sbjct: 83  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VL 136

Query: 398 SALEYLH 404
           S + Y+H
Sbjct: 137 SGITYMH 143

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 30/133 (22%), Positives = 50/133 (37%), Gaps = 30/133 (22%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI-----ECEMM 340
              Y   E   + KG F  V +      G+E A K+ N    +   + D      E  + 
Sbjct: 28  SDNYDVKE--ELGKGAFSVVRRCVHKTTGLEFAAKIIN---TKKLSARDFQKLEREARIC 82

Query: 341 KSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLN 391
           + ++H N++++  S   E F  LV + +  G L      +  YS    S+CI  I     
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---- 138

Query: 392 IMIDVASALEYLH 404
                  ++ Y H
Sbjct: 139 ------ESIAYCH 145

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 55.7 bits (135), Expect = 7e-09
 Identities = 32/115 (27%), Positives = 51/115 (44%), Gaps = 17/115 (14%)

Query: 300 KGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           KG FG+VY AR   +   +A+KV     L+          E E+   +RH N++++ +  
Sbjct: 24  KGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALEYLH 404
            + +   L+LE+ P G L K L           R +       M ++A AL Y H
Sbjct: 84  HDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCH 131

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 56.1 bits (136), Expect = 7e-09
 Identities = 40/206 (19%), Positives = 73/206 (35%), Gaps = 33/206 (16%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSH---SLEFFVMSYCNIS----GGILEEI 57
           S+L     L  + LS+N L     +     +      LE   + YC++S      +   +
Sbjct: 107 STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVL 166

Query: 58  TNLTKLTTIILGGNKLNGS----ISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILY 113
                   + +  N +N +    +   L  +   L  L L+S  +TS       L  I+ 
Sbjct: 167 RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRD--LCGIVA 224

Query: 114 LNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLI-----SLKSLNLSKNNLS---- 164
                         +L  L LG N+L           +      L++L + +  ++    
Sbjct: 225 SK-----------ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGC 273

Query: 165 GAIPASLEKLLYLKDLNLSFNKLEGE 190
           G +   L     LK+L+L+ N+L  E
Sbjct: 274 GDLCRVLRAKESLKELSLAGNELGDE 299

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 56.1 bits (136), Expect = 7e-09
 Identities = 35/209 (16%), Positives = 68/209 (32%), Gaps = 33/209 (15%)

Query: 2   SFLSSLSNCKCLTFIDLSNNPLDSVLPKTF---VGNVSHSLEFFVMSYCNIS----GGIL 54
              S+L     L  ++L +N L  V        +   S  ++   +  C ++    G + 
Sbjct: 47  DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 106

Query: 55  EEITNLTKLTTIILGGNKLNGS----ISITLGSNLASLRKLSLDSNELTSIPLTFWNLKD 110
             +  L  L  + L  N L  +    +   L      L KL L+   L++          
Sbjct: 107 STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSA--------AS 158

Query: 111 ILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGS----IPDSFGD-LISLKSLNLSKNNLS- 164
              L        +   P+ + L +  N +  +    +     D    L++L L    ++ 
Sbjct: 159 CEPLASV-----LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTS 213

Query: 165 ---GAIPASLEKLLYLKDLNLSFNKLEGE 190
                +   +     L++L L  NKL   
Sbjct: 214 DNCRDLCGIVASKASLRELALGSNKLGDV 242

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 38/207 (18%), Positives = 71/207 (34%), Gaps = 35/207 (16%)

Query: 5   SSLSNCKCLTFIDLSNNPLD----SVLPKTFVGNVSHSLEFFVMSYCNIS----GGILEE 56
           S L        + +SNN ++     VL +    +    LE   +  C ++      +   
Sbjct: 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPC-QLEALKLESCGVTSDNCRDLCGI 222

Query: 57  ITNLTKLTTIILGGNKLNGS----ISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDIL 112
           + +   L  + LG NKL       +   L    + LR L +    +T+       L  +L
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGD--LCRVL 280

Query: 113 YLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLI-----SLKSLNLSKNNLSG-- 165
                          +L+ L L  N L         + +      L+SL +   + +   
Sbjct: 281 RAK-----------ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC 329

Query: 166 --AIPASLEKLLYLKDLNLSFNKLEGE 190
                + L +  +L +L +S N+LE  
Sbjct: 330 CSHFSSVLAQNRFLLELQISNNRLEDA 356

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 40/204 (19%), Positives = 71/204 (34%), Gaps = 33/204 (16%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSH---SLEFFVMSYCNIS----GGILEEI 57
             +++   L  + L +N L  V        + H    L    +  C I+    G +   +
Sbjct: 221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVL 280

Query: 58  TNLTKLTTIILGGNKLNGS----ISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILY 113
                L  + L GN+L       +  TL      L  L + S   T+      +   +L 
Sbjct: 281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAA--CCSHFSSVLA 338

Query: 114 LNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLI-----SLKSLNLSKNNLS---- 164
            N             L  L +  NRL+ +        +      L+ L L+  ++S    
Sbjct: 339 QN-----------RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSC 387

Query: 165 GAIPASLEKLLYLKDLNLSFNKLE 188
            ++ A+L     L++L+LS N L 
Sbjct: 388 SSLAATLLANHSLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 32/197 (16%), Positives = 62/197 (31%), Gaps = 33/197 (16%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTF---VGNVSHSLEFFVMSYCNISG----GILEEI 57
             L   + L  + L+ N L     +     +      LE   +  C+ +          +
Sbjct: 278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVL 337

Query: 58  TNLTKLTTIILGGNKLNGS----ISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILY 113
                L  + +  N+L  +    +   LG   + LR L L   +++    +  +L   L 
Sbjct: 338 AQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS--SCSSLAATLL 395

Query: 114 LNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLI-----SLKSLNLSKNNLSGAIP 168
            N            +L  L L  N L  +      + +      L+ L L     S  + 
Sbjct: 396 AN-----------HSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 444

Query: 169 ASLEKLL----YLKDLN 181
             L+ L      L+ ++
Sbjct: 445 DRLQALEKDKPSLRVIS 461

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 45.3 bits (108), Expect = 3e-05
 Identities = 33/195 (16%), Positives = 61/195 (31%), Gaps = 31/195 (15%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNIS----GGILEEITNLTKLTTIIL 68
           +  +D+    L        +  +    +   +  C ++      I   +     L  + L
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQ-CQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 69  GGNKLNGS----ISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIG 124
             N+L       +   L +    ++KLSL +  LT        L   L            
Sbjct: 64  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV--LSSTLRTL--------- 112

Query: 125 GLPNLEYLFLGYNRLQGSIPDSFGDLI-----SLKSLNLSKNNLS----GAIPASLEKLL 175
             P L+ L L  N L  +      + +      L+ L L   +LS      + + L    
Sbjct: 113 --PTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKP 170

Query: 176 YLKDLNLSFNKLEGE 190
             K+L +S N +   
Sbjct: 171 DFKELTVSNNDINEA 185

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 55.3 bits (134), Expect = 9e-09
 Identities = 31/143 (21%), Positives = 50/143 (34%), Gaps = 36/143 (25%)

Query: 280 FSYLELCRATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI--- 335
             +       Y      ++ KG FG V K +      E AVKV N   + + K+ D    
Sbjct: 14  LYFQGTFAERYNIVC--MLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTI 68

Query: 336 --ECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--- 390
             E E++K + H N++K+     +     +V E    G L             F  +   
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL-------------FDEIIKR 115

Query: 391 ---------NIMIDVASALEYLH 404
                     I+  V S + Y+H
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMH 138

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 55.3 bits (134), Expect = 1e-08
 Identities = 30/128 (23%), Positives = 60/128 (46%), Gaps = 7/128 (5%)

Query: 283 LELCRATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFK-SFDI----E 336
           L++     ++ + + + +G F +VYKAR       VA+K   L  R   K   +     E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62

Query: 337 CEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 396
            ++++ + H N+I ++ +  ++   +LV ++M    LE  +  ++ +L        M+  
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121

Query: 397 ASALEYLH 404
              LEYLH
Sbjct: 122 LQGLEYLH 129

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 26/150 (17%), Positives = 53/150 (35%), Gaps = 16/150 (10%)

Query: 263 KRLSNDANMPIVATWRMFSYLELCRATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKV 321
           + L    ++       + S        Y+  +   +  G +G V   R     +E A+K+
Sbjct: 12  ENLYFQGDLQATPGMFITSKKGHLSEMYQRVK--KLGSGAYGEVLLCRDKVTHVERAIKI 69

Query: 322 FNLQCRRAFKSFDI--ECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL-----E 374
                     +  +  E  ++K + H N++K+     ++    LV+E    G L      
Sbjct: 70  IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129

Query: 375 KYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +  ++            I+  V S + YLH
Sbjct: 130 RMKFNEV------DAAVIIKQVLSGVTYLH 153

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 27/123 (21%), Positives = 44/123 (35%), Gaps = 17/123 (13%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNL 348
           Y   E   +  G FG V++      G     K  N        +   E  +M  + H  L
Sbjct: 53  YDILE--ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110

Query: 349 IKVISSCSNEEFKALVLEYMPHGSL------EKYLYS-SNCILDIFQRLNIMIDVASALE 401
           I +  +  ++    L+LE++  G L      E Y  S +  I       N M      L+
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI-------NYMRQACEGLK 163

Query: 402 YLH 404
           ++H
Sbjct: 164 HMH 166

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 53.1 bits (128), Expect = 1e-08
 Identities = 24/109 (22%), Positives = 39/109 (35%), Gaps = 7/109 (6%)

Query: 83  SNLASLRKLSLDSNELTSI---PLTFWNLKDILYLNFSVIP-IE-IGGLPNLEYLFLGYN 137
           +N    R+L L   ++  I     T     D +  + + I  ++    L  L+ L +  N
Sbjct: 16  TNAVRDRELDLRGYKIPVIENLGATLDQF-DAIDFSDNEIRKLDGFPLLRRLKTLLVNNN 74

Query: 138 RLQGSIPDSFGDLISLKSLNLSKNNLSG-AIPASLEKLLYLKDLNLSFN 185
           R+          L  L  L L+ N+L        L  L  L  L +  N
Sbjct: 75  RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 49.3 bits (118), Expect = 3e-07
 Identities = 28/135 (20%), Positives = 46/135 (34%), Gaps = 26/135 (19%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSV--LPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTK 62
           +  +N      +DL    +  +  L  T         +    S   I    L+    L +
Sbjct: 13  AQYTNAVRDRELDLRGYKIPVIENLGATLD-----QFDAIDFSDNEIR--KLDGFPLLRR 65

Query: 63  LTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIE 122
           L T+++  N++   I   L   L  L +L L +N L         L D+  L        
Sbjct: 66  LKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLV-------ELGDLDPL-------- 109

Query: 123 IGGLPNLEYLFLGYN 137
              L +L YL +  N
Sbjct: 110 -ASLKSLTYLCILRN 123

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 28/122 (22%), Positives = 56/122 (45%), Gaps = 4/122 (3%)

Query: 286 CRATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDI-ECEMMKS 342
            ++  K+    L+ +G +G V K R    G  VA+K F      +  K   + E +++K 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80

Query: 343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 402
           +RH+NL+ ++  C  ++   LV E++ H ++   L      LD       +  + + + +
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 403 LH 404
            H
Sbjct: 140 CH 141

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 32/129 (24%), Positives = 50/129 (38%), Gaps = 28/129 (21%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-HQN 347
           Y+  E+ L  +G    V     L    E AVK+   Q          E EM+   + H+N
Sbjct: 14  YQLQEDVL-GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRN 72

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------------NIMID 395
           ++++I     E+   LV E M  GS+                +             ++ D
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQD 119

Query: 396 VASALEYLH 404
           VASAL++LH
Sbjct: 120 VASALDFLH 128

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 23/135 (17%), Positives = 44/135 (32%), Gaps = 39/135 (28%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECE-MMK 341
              Y+  E   I  G +    +       ME AVK+ +               E E +++
Sbjct: 21  TDGYEVKE--DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-------EIEILLR 71

Query: 342 SIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL----------- 390
             +H N+I +     + ++  +V E M  G L               ++           
Sbjct: 72  YGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREA 118

Query: 391 -NIMIDVASALEYLH 404
             ++  +   +EYLH
Sbjct: 119 SAVLFTITKTVEYLH 133

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 52.7 bits (127), Expect = 3e-08
 Identities = 28/111 (25%), Positives = 41/111 (36%), Gaps = 21/111 (18%)

Query: 86  ASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPD 145
               +L L+ NEL  I                      G LP+L  L L  N+L   I  
Sbjct: 29  LHTTELLLNDNELGRISSDG----------------LFGRLPHLVKLELKRNQLT-GIEP 71

Query: 146 S-FGDLISLKSLNLSKNNLSGAIPASL-EKLLYLKDLNLSFNKLEGEIPRG 194
           + F     ++ L L +N +   I   +   L  LK LNL  N++   +  G
Sbjct: 72  NAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPG 120

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.4 bits (121), Expect = 1e-07
 Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 15/109 (13%)

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP------LTFWNLKDILYLN-- 115
           T ++L  N+L    S  L   L  L KL L  N+LT I        +  ++++ L L   
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS--HIQE-LQLGEN 88

Query: 116 -FSVIPIEI-GGLPNLEYLFLGYNRLQGSIPD-SFGDLISLKSLNLSKN 161
               I  ++  GL  L+ L L  N++   +   SF  L SL SLNL+ N
Sbjct: 89  KIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 41.9 bits (99), Expect = 1e-04
 Identities = 20/106 (18%), Positives = 37/106 (34%), Gaps = 32/106 (30%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
           L  ++L  N L  + P  F                             + +  + LG NK
Sbjct: 56  LVKLELKRNQLTGIEPNAF--------------------------EGASHIQELQLGENK 89

Query: 73  LNGSISITLGS--NLASLRKLSLDSNELTSIPL-TFWNLKDILYLN 115
           +     I+      L  L+ L+L  N+++ +   +F +L  +  LN
Sbjct: 90  IK---EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 28/132 (21%), Positives = 49/132 (37%), Gaps = 23/132 (17%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDI-----EC 337
           R  Y  S+   +  G  G V  A       +VA+++ +        A ++        E 
Sbjct: 134 RDEYIMSK--TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 191

Query: 338 EMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNI 392
           E++K + H  +IK+ +    E++  +VLE M  G L                  F     
Sbjct: 192 EILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY---- 246

Query: 393 MIDVASALEYLH 404
              +  A++YLH
Sbjct: 247 --QMLLAVQYLH 256

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.8 bits (127), Expect = 3e-08
 Identities = 41/118 (34%), Positives = 59/118 (50%), Gaps = 12/118 (10%)

Query: 86  ASLRKLSLDSNELTSIPLT-FWNLKDILYLNFS-----VIPIEI-GGLPNLEYLFLGYNR 138
           A    L L++N L S+P   F  L  +  L         +P  +   L +L YL L  N+
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87

Query: 139 LQGSIPDS-FGDLISLKSLNLSKNNLSGAIPASL-EKLLYLKDLNLSFNKLEGEIPRG 194
           LQ S+P+  F  L  LK L L+ N L  ++P  + +KL  LKDL L  N+L+  +P G
Sbjct: 88  LQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDG 142

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.9 bits (117), Expect = 6e-07
 Identities = 35/105 (33%), Positives = 46/105 (43%), Gaps = 5/105 (4%)

Query: 94  DSNELTSIPLTFWNLKDILYLNF----SVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGD 149
            S   TS+P         L L      S+       L +L  L+LG N+LQ      F  
Sbjct: 15  YSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNK 74

Query: 150 LISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG 194
           L SL  LNLS N L        +KL  LK+L L+ N+L+  +P G
Sbjct: 75  LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDG 118

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 43/161 (26%), Positives = 66/161 (40%), Gaps = 46/161 (28%)

Query: 14  TFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCN------ISGGILEEITNLTKLTTII 67
           T++DL  N L S+    F       L      Y        +  G+  ++T+LT L    
Sbjct: 31  TYLDLETNSLKSLPNGVF-----DELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN--- 82

Query: 68  LGGNKLNGSISITLG--SNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGG 125
           L  N+L    S+  G    L  L++L+L++N+L S+P                      G
Sbjct: 83  LSTNQLQ---SLPNGVFDKLTQLKELALNTNQLQSLP---------------------DG 118

Query: 126 ----LPNLEYLFLGYNRLQGSIPD-SFGDLISLKSLNLSKN 161
               L  L+ L L  N+L+ S+PD  F  L SL+ + L  N
Sbjct: 119 VFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 31/140 (22%), Positives = 52/140 (37%), Gaps = 23/140 (16%)

Query: 279 MFSYLELCRATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFD 334
           M  Y +  R  Y  S+   +  G  G V  A       +VA+K+ +        A ++  
Sbjct: 1   MSVYPKALRDEYIMSK--TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADP 58

Query: 335 I-----ECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCIL 384
                 E E++K + H  +IK+ +    E++  +VLE M  G L                
Sbjct: 59  ALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK 117

Query: 385 DIFQRLNIMIDVASALEYLH 404
             F        +  A++YLH
Sbjct: 118 LYFY------QMLLAVQYLH 131

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 22/93 (23%), Positives = 37/93 (39%), Gaps = 8/93 (8%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI-----ECEMM 340
           +  Y       I +G +G V  A         A+K+ N    R     D+     E  +M
Sbjct: 25  QKKYHLKG--AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82

Query: 341 KSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL 373
           K + H N+ ++     +E++  LV+E    G L
Sbjct: 83  KKLHHPNIARLYEVYEDEQYICLVMELCHGGHL 115

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 30/147 (20%), Positives = 54/147 (36%), Gaps = 13/147 (8%)

Query: 270 NMPIVATWRMFSYLELCRA---TYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQ 325
           +M   +  R    ++L         F    L+  G +G VYK R +  G   A+KV ++ 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 326 CRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKA------LVLEYMPHGSL-EKYL 377
                +    E  M+K    H+N+     +   +          LV+E+   GS+ +   
Sbjct: 61  -GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119

Query: 378 YSSNCILDIFQRLNIMIDVASALEYLH 404
            +    L       I  ++   L +LH
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLH 146

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 53.0 bits (128), Expect = 5e-08
 Identities = 26/114 (22%), Positives = 51/114 (44%), Gaps = 9/114 (7%)

Query: 297 LISKGGFGSVYKA---RLGDGMEVAVKVFNLQCRR--AFKS-FDIECEMMKSIRHQNLIK 350
            +  GG  +VY A    L   ++VA+K   +  R        F+ E      + HQN++ 
Sbjct: 18  KLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +I     ++   LV+EY+   +L +Y+  S+  L +   +N    +   +++ H
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH 128

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 21/93 (22%), Positives = 40/93 (43%), Gaps = 9/93 (9%)

Query: 298 ISKGGFGSVYKARL------GDGMEVAVKVFNLQ-CRRAFKSFDIECEMMKSI-RHQNLI 349
           + +G FG V +A             VAVK+          ++   E +++  I  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 350 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSN 381
            ++ +C+      +V +E+   G+L  YL S  
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 38/210 (18%), Positives = 62/210 (29%), Gaps = 32/210 (15%)

Query: 4   LSSLSNCKCLTFIDLSNNPLD----SVLPKTFVGNVSHSLEFFVMSYCNIS--------- 50
            + L     +  I LS N +       L +         LE    S              
Sbjct: 25  FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK--KDLEIAEFSDIFTGRVKDEIPEA 82

Query: 51  -GGILEEITNLTKLTTIILGGNKLNGSISITLGSNLA---SLRKLSLDSNELTSIPLTFW 106
              +L+ +    KL T+ L  N    +    L   L+    L  L L +N L        
Sbjct: 83  LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAK- 141

Query: 107 NLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQG----SIPDSFGDLISLKSLNLSKNN 162
            +   L      +  +    P L  +  G NRL+         +F     L ++ + +N 
Sbjct: 142 -IARALQEL--AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNG 198

Query: 163 L-----SGAIPASLEKLLYLKDLNLSFNKL 187
           +        +   L     LK L+L  N  
Sbjct: 199 IRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 38/217 (17%), Positives = 71/217 (32%), Gaps = 40/217 (18%)

Query: 2   SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVG--NVSHSLEFFVMSYCNIS--------- 50
             L +L  C  L  + LS+N       +  +   +    LE   +    +          
Sbjct: 85  LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR 144

Query: 51  ----GGILEEITNLTKLTTIILGGNKLNGSISITLGSNLA---SLRKLSLDSNELTSIPL 103
                 + ++  N   L +II G N+L                 L  + +  N +    +
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204

Query: 104 TFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRL--QG--SIPDSFGDLISLKSLNLS 159
               L + L                L+ L L  N     G  ++  +     +L+ L L+
Sbjct: 205 EHL-LLEGLAYC-----------QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 252

Query: 160 KNNLSG----AIPASLEKL--LYLKDLNLSFNKLEGE 190
              LS     A+  +  KL  + L+ L L +N++E +
Sbjct: 253 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELD 289

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 28/177 (15%), Positives = 53/177 (29%), Gaps = 31/177 (17%)

Query: 38  SLEFFVMSYCNISG----GILEEITNLTKLTTIILGGNKLNGSISITLGSNLA---SLRK 90
           S+E   +    I+      +   +     +  I+L GN +    +  L  N+A    L  
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 91  LSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDL 150
                            +KD +     ++   +   P L  + L  N    +  +   D 
Sbjct: 65  AEFSDIFTG-------RVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF 117

Query: 151 I----SLKSLNLSKNNLS-------------GAIPASLEKLLYLKDLNLSFNKLEGE 190
           +     L+ L L  N L               A+    +    L+ +    N+LE  
Sbjct: 118 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG 174

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 53.0 bits (128), Expect = 5e-08
 Identities = 31/124 (25%), Positives = 47/124 (37%), Gaps = 14/124 (11%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH 345
              Y       I +G +G V  A   G  +  A K            F  E E+MKS+ H
Sbjct: 8   NQYYTLEN--TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH 65

Query: 346 QNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASAL 400
            N+I++  +  +     LV+E    G L      K ++  +    I +      DV SA+
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAV 119

Query: 401 EYLH 404
            Y H
Sbjct: 120 AYCH 123

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 27/137 (19%), Positives = 53/137 (38%), Gaps = 31/137 (22%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECEM--M 340
              Y+  E  +I KG F  V +      G + AVK+ +           + D++ E    
Sbjct: 23  EDVYELCE--VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80

Query: 341 KSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL---------EKYLYS----SNCILDIF 387
             ++H ++++++ + S++    +V E+M    L           ++YS    S+ +  I 
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140

Query: 388 QRLNIMIDVASALEYLH 404
                      AL Y H
Sbjct: 141 ----------EALRYCH 147

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 31/136 (22%), Positives = 53/136 (38%), Gaps = 22/136 (16%)

Query: 280 FSYLELCRATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI--- 335
             +       Y      ++ KG FG V K +      E AVKV N   + + K+ D    
Sbjct: 14  LYFQGTFAERYNIVC--MLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTI 68

Query: 336 --ECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQ 388
             E E++K + H N++K+     +     +V E    G L     ++  +S +       
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH------D 122

Query: 389 RLNIMIDVASALEYLH 404
              I+  V S + Y+H
Sbjct: 123 AARIIKQVFSGITYMH 138

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 52.7 bits (127), Expect = 9e-08
 Identities = 27/125 (21%), Positives = 55/125 (44%), Gaps = 14/125 (11%)

Query: 289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNL 348
              ++   +I  G FG V++A+L +  EVA+K      R   +    E ++M+ ++H N+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94

Query: 349 IK----VISSCSNEEFKA--LVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASA 399
           +       S+   ++     LVLEY+P  ++ +           + +      M  +  +
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153

Query: 400 LEYLH 404
           L Y+H
Sbjct: 154 LAYIH 158

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 24/126 (19%), Positives = 42/126 (33%), Gaps = 17/126 (13%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH 345
              Y   E   +  G FG V++      G   A K          ++   E + M  +RH
Sbjct: 156 LDHYDIHE--ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213

Query: 346 QNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYS-SNCILDIFQRLNIMIDVAS 398
             L+ +  +  ++    ++ E+M  G L      E    S    +         M  V  
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV-------EYMRQVCK 266

Query: 399 ALEYLH 404
            L ++H
Sbjct: 267 GLCHMH 272

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 27/145 (18%), Positives = 55/145 (37%), Gaps = 27/145 (18%)

Query: 278 RMFSYLELCRATYKFSENNLISKGGFGSVYKAR---LGDGMEVAVKVFNLQCRRAFKSFD 334
           ++ S  E     +++ E   + +G +G VYKA+     D  + A+K              
Sbjct: 10  KLSSERERVEDLFEY-EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE------GTGIS 62

Query: 335 IE--CEM--MKSIRHQN---LIKVISSCSNEEFKALVLEYMPHGSLEKYL--------YS 379
           +    E+  ++ ++H N   L KV  S ++ +   L+ +Y  H  L   +          
Sbjct: 63  MSACREIALLRELKHPNVISLQKVFLSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANK 120

Query: 380 SNCILDIFQRLNIMIDVASALEYLH 404
               L      +++  +   + YLH
Sbjct: 121 KPVQLPRGMVKSLLYQILDGIHYLH 145

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.3 bits (121), Expect = 1e-07
 Identities = 35/111 (31%), Positives = 54/111 (48%), Gaps = 22/111 (19%)

Query: 86  ASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPD 145
           +S  +L L+SN+L S+P   ++                  L  L  L L  N++Q S+PD
Sbjct: 28  SSATRLELESNKLQSLPHGVFD-----------------KLTQLTKLSLSQNQIQ-SLPD 69

Query: 146 S-FGDLISLKSLNLSKNNLSGAIPASL-EKLLYLKDLNLSFNKLEGEIPRG 194
             F  L  L  L L +N L  ++P  + +KL  LK+L L  N+L+  +P G
Sbjct: 70  GVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKS-VPDG 118

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.8 bits (104), Expect = 2e-05
 Identities = 25/72 (34%), Positives = 37/72 (51%), Gaps = 4/72 (5%)

Query: 125 GLP-NLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASL-EKLLYLKDLNL 182
           G+P +   L L  N+LQ      F  L  L  L+LS+N +  ++P  + +KL  L  L L
Sbjct: 25  GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYL 83

Query: 183 SFNKLEGEIPRG 194
             NKL+  +P G
Sbjct: 84  HENKLQ-SLPNG 94

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.0 bits (102), Expect = 4e-05
 Identities = 31/104 (29%), Positives = 45/104 (43%), Gaps = 22/104 (21%)

Query: 60  LTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSV 118
           LT+LT + L  N++  S+   +   L  L  L L  N+L S+P   F  L          
Sbjct: 51  LTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLT--------- 100

Query: 119 IPIEIGGLPNLEYLFLGYNRLQGSIPD-SFGDLISLKSLNLSKN 161
                     L+ L L  N+L+ S+PD  F  L SL+ + L  N
Sbjct: 101 ---------QLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 27/130 (20%), Positives = 51/130 (39%), Gaps = 7/130 (5%)

Query: 280 FSYLELCRATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN-LQCRRAFKSFDIEC 337
             +       + F     +  G FG V+       G+E  +K  N  + +   +  + E 
Sbjct: 14  LYFQGTIDDLFIFKR--KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEI 71

Query: 338 EMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNIMI 394
           E++KS+ H N+IK+     +     +V+E    G L + + S+              +M 
Sbjct: 72  EVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131

Query: 395 DVASALEYLH 404
            + +AL Y H
Sbjct: 132 QMMNALAYFH 141

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 51.8 bits (125), Expect = 1e-07
 Identities = 28/118 (23%), Positives = 50/118 (42%), Gaps = 7/118 (5%)

Query: 291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDI----ECEMMKSIRHQ 346
           K+ +   + +G +G VYKA+   G  VA+K   L      +        E  ++K + H 
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED--EGIPSTAIREISLLKELHHP 79

Query: 347 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           N++ +I    +E    LV E+M    L+K L  +   L   Q    +  +   + + H
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 25/116 (21%), Positives = 49/116 (42%), Gaps = 9/116 (7%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI----ECEMMKSIRHQNLIK- 350
           L+ +G +G V +          AVK+   +  R   + +     E ++++ +RH+N+I+ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 351 --VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             V+ +   ++   +V+EY   G  E           + Q       +   LEYLH
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH 126

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 51.8 bits (125), Expect = 1e-07
 Identities = 27/110 (24%), Positives = 46/110 (41%), Gaps = 4/110 (3%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDI-ECEMMKSIRHQNLIKVISS 354
           I +G +G V+K R    G  VA+K F   +     K   + E  M+K ++H NL+ ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
              +    LV EY  H ++   L      +      +I      A+ + H
Sbjct: 71  FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 18/117 (15%), Positives = 38/117 (32%), Gaps = 17/117 (14%)

Query: 297 LISKGGFGSVYKA---RLGDGMEVAVKVFNLQC------RRAFKSFDIECEMMKSIRHQN 347
                     ++A    L    +VA+   + Q        +   S       +  I    
Sbjct: 38  FHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLS---RTLRLSRIDKPG 92

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           + +V+          +V E++  GSL++   +S         +  M  +A+A +  H
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH 146

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 24/139 (17%), Positives = 49/139 (35%), Gaps = 32/139 (23%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI---------E 336
              Y+  E  ++ +G    V +        E AVK+ ++    +F + ++         E
Sbjct: 16  YENYEPKE--ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73

Query: 337 CEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDI 386
            ++++ +  H N+I++  +     F  LV + M  G L     EK   S       +  +
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133

Query: 387 FQRLNIMIDVASALEYLHF 405
                        +  LH 
Sbjct: 134 L----------EVICALHK 142

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 35/123 (28%), Positives = 57/123 (46%), Gaps = 27/123 (21%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI------ECEMMKSIRHQNLI 349
            +  G FG V        G +VAVK+ N   R+  +S D+      E + +K  RH ++I
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQNLKLFRHPHII 74

Query: 350 K---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALE 401
           K   VIS+   + F  +V+EY+  G L  Y+     +       +FQ++       SA++
Sbjct: 75  KLYQVIST-PTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------LSAVD 125

Query: 402 YLH 404
           Y H
Sbjct: 126 YCH 128

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 50.1 bits (120), Expect = 2e-07
 Identities = 30/141 (21%), Positives = 50/141 (35%), Gaps = 8/141 (5%)

Query: 53  ILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDIL 112
           +   ++ L     + L  N +     I+  S + +LR LSL  N +  I         + 
Sbjct: 40  MDATLSTLKACKHLALSTNNIE---KISSLSGMENLRILSLGRNLIKKIENLDAVADTLE 96

Query: 113 YLNFSVIPIE----IGGLPNLEYLFLGYNRLQG-SIPDSFGDLISLKSLNLSKNNLSGAI 167
            L  S   I     I  L NL  L++  N++      D    L  L+ L L+ N L    
Sbjct: 97  ELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156

Query: 168 PASLEKLLYLKDLNLSFNKLE 188
             +     Y  ++      L+
Sbjct: 157 KENNATSEYRIEVVKRLPNLK 177

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 33/126 (26%), Positives = 58/126 (46%), Gaps = 15/126 (11%)

Query: 83  SNLASLRKLSLDSNELTSI----PLTFWNLKDILYLNFSVIPIEIGGL----PNLEYLFL 134
           S L + + L+L +N +  I     +   NL+ IL L  ++I  +I  L      LE L++
Sbjct: 45  STLKACKHLALSTNNIEKISSLSGME--NLR-ILSLGRNLIK-KIENLDAVADTLEELWI 100

Query: 135 GYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIP-ASLEKLLYLKDLNLSFNKLEGEIPR 193
            YN++  S+      L++L+ L +S N ++       L  L  L+DL L+ N L  +   
Sbjct: 101 SYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158

Query: 194 GGSFGN 199
             +   
Sbjct: 159 NNATSE 164

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 32/129 (24%), Positives = 50/129 (38%), Gaps = 12/129 (9%)

Query: 4   LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKL 63
           +SSLS  + L  + L  N +  +     +  V+ +LE   +SY  I+   L  I  L  L
Sbjct: 63  ISSLSGMENLRILSLGRNLIKKI---ENLDAVADTLEELWISYNQIA--SLSGIEKLVNL 117

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEI 123
             + +  NK+     I   + L  L  L L  N L +         +  Y         +
Sbjct: 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE--YRIEV-----V 170

Query: 124 GGLPNLEYL 132
             LPNL+ L
Sbjct: 171 KRLPNLKKL 179

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 30/118 (25%), Positives = 53/118 (44%), Gaps = 20/118 (16%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI-----ECEMMKSIRHQNLIKV 351
           I KG F  V  AR +  G EVA+K+ +   +       +     E  +MK + H N++K+
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIID---KTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-----IFQRLNIMIDVASALEYLH 404
                 E+   L++EY   G +  YL +   + +      F+++       SA++Y H
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYCH 131

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 25/116 (21%), Positives = 51/116 (43%), Gaps = 3/116 (2%)

Query: 291 KFSENNLISKGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDI-ECEMMKSIRHQNL 348
            + + + + +G + +VYK +       VA+K   L+         I E  ++K ++H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           + +      E+   LV EY+    L++YL     I+++      +  +   L Y H
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 20/176 (11%), Positives = 38/176 (21%), Gaps = 37/176 (21%)

Query: 264 RLSNDANMPIVATWRMFSYLELCRATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVF 322
                   P  A   + S L       K  E   +  G    V+  R +    + A+KVF
Sbjct: 38  EAVTATVWPQNAETTVDSLLSQGERKLKLVE--PLRVGDRSVVFLVRDVERLEDFALKVF 95

Query: 323 N---LQCRRAFKSFDIECEMMKSIRHQNLI---------------------KVISSCSNE 358
                  R   +           +  ++                               +
Sbjct: 96  TMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQ 155

Query: 359 EFKA-----LVLEYM-----PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +  A     L++           S   ++Y       I     +   +      L 
Sbjct: 156 DDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 24/119 (20%), Positives = 43/119 (36%), Gaps = 30/119 (25%)

Query: 300 KGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-HQNLIKVISSCSN 357
           +G F    K          AVK+ +   +R   +   E   +K    H N++K+     +
Sbjct: 21  EGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVFHD 77

Query: 358 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------------NIMIDVASALEYLH 404
           +    LV+E +  G L             F+R+             IM  + SA+ ++H
Sbjct: 78  QLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHMH 123

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 50.7 bits (122), Expect = 4e-07
 Identities = 30/132 (22%), Positives = 62/132 (46%), Gaps = 16/132 (12%)

Query: 286 CRATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI----ECEMM 340
           C    K+ +   I +G FG V+KAR    G +VA+K   ++  +  + F I    E +++
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 70

Query: 341 KSIRHQN---LIKVISSCSNEEFKA-----LVLEYMPHGSLEKYLYSSNCILDIFQRLNI 392
           + ++H+N   LI++  + ++   +      LV ++  H  L   L +      + +   +
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129

Query: 393 MIDVASALEYLH 404
           M  + + L Y+H
Sbjct: 130 MQMLLNGLYYIH 141

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 31/126 (24%), Positives = 59/126 (46%), Gaps = 15/126 (11%)

Query: 289 TYKFSENNLISKGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQN 347
              +++  +I  G FG VY+A+L D G  VA+K      R   +    E ++M+ + H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108

Query: 348 LIKVI------SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVAS 398
           ++++           +E +  LVL+Y+P   +     Y  +   +  I+ +L  M  +  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFR 167

Query: 399 ALEYLH 404
           +L Y+H
Sbjct: 168 SLAYIH 173

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 50.2 bits (121), Expect = 4e-07
 Identities = 27/109 (24%), Positives = 51/109 (46%), Gaps = 3/109 (2%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRR-AFKSFDI-ECEMMKSIRHQNLIKVISSC 355
           I +G +G VYKA+   G   A+K   L+       S  I E  ++K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             ++   LV E++    L+K L      L+     + ++ + + + Y H
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 34/123 (27%), Positives = 59/123 (47%), Gaps = 27/123 (21%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI------ECEMMKSIRHQNLI 349
            +  G FG V   +    G +VAVK+ N   R+  +S D+      E + +K  RH ++I
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILN---RQKIRSLDVVGKIRREIQNLKLFRHPHII 79

Query: 350 K---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALE 401
           K   VIS+  ++ F  +V+EY+  G L  Y+  +  +       +FQ++       S ++
Sbjct: 80  KLYQVIST-PSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRLFQQI------LSGVD 130

Query: 402 YLH 404
           Y H
Sbjct: 131 YCH 133

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 49.9 bits (120), Expect = 6e-07
 Identities = 19/128 (14%), Positives = 45/128 (35%), Gaps = 22/128 (17%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI--ECEMMKSI 343
              Y  +E   + +G FG V++            K       +      +  E  ++   
Sbjct: 4   YEKYMIAE--DLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIA 58

Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYS-SNCILDIFQRLNIMIDV 396
           RH+N++ +  S  + E   ++ E++    +        +  +    +       + +  V
Sbjct: 59  RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV-------SYVHQV 111

Query: 397 ASALEYLH 404
             AL++LH
Sbjct: 112 CEALQFLH 119

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 49.6 bits (117), Expect = 8e-07
 Identities = 33/160 (20%), Positives = 62/160 (38%), Gaps = 17/160 (10%)

Query: 38  SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNE 97
            L    +   N      +   NL  L   I+ G   +  +   LGS+L +L KL L    
Sbjct: 173 LLNNLKIKGTNNLSIGKKPRPNLKSLE--IISGGLPDSVVEDILGSDLPNLEKLVLYVGV 230

Query: 98  LTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGD---LISLK 154
                    ++     L            PNL++L +     Q  + + F +   L  L+
Sbjct: 231 EDYGFDG--DMNVFRPL------FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLE 282

Query: 155 SLNLSKNNLSG----AIPASLEKLLYLKDLNLSFNKLEGE 190
           ++++S   L+      +   ++K+ +LK +N+ +N L  E
Sbjct: 283 TMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.9 bits (105), Expect = 3e-05
 Identities = 30/176 (17%), Positives = 56/176 (31%), Gaps = 28/176 (15%)

Query: 14  TFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEI-----TNLTKL----- 63
               L+N  +      +       +L+   +    +   ++E+I      NL KL     
Sbjct: 170 AMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVG 229

Query: 64  TTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEI 123
                    +N    +       +L+ L +   E            +++   F    I  
Sbjct: 230 VEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQ----------NVVVEMFLESDI-- 277

Query: 124 GGLPNLEYLFLGYNRLQGS----IPDSFGDLISLKSLNLSKNNLSGAIPASLEKLL 175
             LP LE + +    L       + D    +  LK +N+  N LS  +   L+K L
Sbjct: 278 --LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL 331

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 26/137 (18%), Positives = 51/137 (37%), Gaps = 27/137 (19%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKV-------------FNLQCRRAFKS 332
             +Y       +  G +G V   +      E A+KV              N    +  + 
Sbjct: 35  GESYFKVR--KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92

Query: 333 FDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIF 387
              E  ++KS+ H N+IK+     ++++  LV E+   G L      ++ +      +I 
Sbjct: 93  IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM 152

Query: 388 QRLNIMIDVASALEYLH 404
           ++      + S + YLH
Sbjct: 153 KQ------ILSGICYLH 163

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 49.1 bits (118), Expect = 9e-07
 Identities = 26/112 (23%), Positives = 51/112 (45%), Gaps = 8/112 (7%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI----ECEMMKSIRHQNLIKVI 352
           I +G +G+V+KA+       VA+K   L      +        E  ++K ++H+N++++ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLH 67

Query: 353 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
               +++   LV E+     L+KY  S N  LD     + +  +   L + H
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 27/131 (20%), Positives = 44/131 (33%), Gaps = 22/131 (16%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDI---ECEM 339
              Y   E   +  G F  V K R    G+E A K       +  R     +    E  +
Sbjct: 11  EDFYDIGE--ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68

Query: 340 MKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQRLNIM 393
           ++ + H N+I +     N     L+LE +  G L     +K   S            + +
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFI 121

Query: 394 IDVASALEYLH 404
             +   + YLH
Sbjct: 122 KQILDGVNYLH 132

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 48.7 bits (117), Expect = 1e-06
 Identities = 25/125 (20%), Positives = 45/125 (36%), Gaps = 33/125 (26%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNL--------QCRRAFKSFDIECEMMKSIRHQN 347
            + +G +G V  A        VAVK+ ++          ++       E  + K + H+N
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-------EICINKMLNHEN 66

Query: 348 LIK---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASA 399
           ++K         N ++  L LEY   G L   +     +        F +L       + 
Sbjct: 67  VVKFYGHRRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAG 117

Query: 400 LEYLH 404
           + YLH
Sbjct: 118 VVYLH 122

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 48.7 bits (117), Expect = 1e-06
 Identities = 33/131 (25%), Positives = 48/131 (36%), Gaps = 22/131 (16%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN----LQCRRAFKSFDIECEM-- 339
              Y+  E   +  G F  V K R  G G E A K          RR     +IE E+  
Sbjct: 4   EDHYEMGE--ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 340 MKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQRLNIM 393
           ++ IRH N+I +     N+    L+LE +  G L     EK   +              +
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFL 114

Query: 394 IDVASALEYLH 404
             +   + YLH
Sbjct: 115 KQILDGVHYLH 125

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 21/157 (13%), Positives = 43/157 (27%), Gaps = 36/157 (22%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKS---------- 332
           EL           ++ +    +  +A     G    V V     R    +          
Sbjct: 67  ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126

Query: 333 ------------------FDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM-PHGSL 373
                             F    +++K  + + +I+V     +    +    Y     +L
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186

Query: 374 EKYL------YSSNCILDIFQRLNIMIDVASALEYLH 404
           + +        S++  L    RL + + V   L  LH
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 223

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 27/125 (21%), Positives = 51/125 (40%), Gaps = 15/125 (12%)

Query: 290 YKFSENNLISKGGFGSVYKA---RLGDGMEVAVKVFNLQCRR--AFKS-FDIECEMMKSI 343
           Y+  E  ++  GG   V+ A   R     +VAVKV      R  +F   F  E +   ++
Sbjct: 14  YELGE--ILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAAL 69

Query: 344 RHQNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 399
            H  ++ V  +   E        +V+EY+   +L   +  +   +   + + ++ D   A
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQA 128

Query: 400 LEYLH 404
           L + H
Sbjct: 129 LNFSH 133

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 28/131 (21%), Positives = 45/131 (34%), Gaps = 22/131 (16%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDI-----ECEM 339
              Y   E   +  G F  V K R    G+E A K     Q R + +         E  +
Sbjct: 11  EDFYDIGE--ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68

Query: 340 MKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQRLNIM 393
           ++ + H N+I +     N     L+LE +  G L     +K   S            + +
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFI 121

Query: 394 IDVASALEYLH 404
             +   + YLH
Sbjct: 122 KQILDGVNYLH 132

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 27/116 (23%), Positives = 43/116 (37%), Gaps = 17/116 (14%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI--ECEMMKSIRHQNLIKVIS 353
            I  G FG     R       VAVK      R A    ++  E    +S+RH N+++   
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHPNIVRFKE 83

Query: 354 SCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLH 404
                   A+++EY   G L + + ++           FQ+L       S + Y H
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------LSGVSYCH 133

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 24/118 (20%), Positives = 45/118 (38%), Gaps = 11/118 (9%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI------ECEMMKSIRHQ--N 347
           L+  GGFGSVY    + D + VA+K         +           E  ++K +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 348 LIKVISSCSNEEFKALVLEY-MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +I+++      +   L+LE   P   L  ++     + +   R +    V  A+ + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH 166

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 25/125 (20%), Positives = 45/125 (36%), Gaps = 33/125 (26%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNL--------QCRRAFKSFDIECEMMKSIRHQN 347
            + +G +G V  A        VAVK+ ++          ++       E  + K + H+N
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-------EICINKMLNHEN 66

Query: 348 LIK---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASA 399
           ++K         N ++  L LEY   G L   +     +        F +L       + 
Sbjct: 67  VVKFYGHRRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAG 117

Query: 400 LEYLH 404
           + YLH
Sbjct: 118 VVYLH 122

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 29/142 (20%), Positives = 48/142 (33%), Gaps = 41/142 (28%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDI----------------- 335
            I KG +G V  A    D    A+KV +   L  +  F                      
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 336 ------ECEMMKSIRHQNLIK---VISSCSNEEFKALVLEYMPHGSLEKYL----YSSNC 382
                 E  ++K + H N++K   V+   + +    +V E +  G + +       S + 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSEDQ 138

Query: 383 ILDIFQRLNIMIDVASALEYLH 404
               FQ      D+   +EYLH
Sbjct: 139 ARFYFQ------DLIKGIEYLH 154

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 21/124 (16%), Positives = 52/124 (41%), Gaps = 10/124 (8%)

Query: 289 TYKFSENNL-----ISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDI--ECEMM 340
             +  +++      +  G  G V+K      G+ +A K+ +L+ + A ++  I  E +++
Sbjct: 27  VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN-QIIRELQVL 85

Query: 341 KSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 400
                  ++    +  ++   ++ +E+M  GSL++ +      +       + I V   L
Sbjct: 86  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGL 144

Query: 401 EYLH 404
            YL 
Sbjct: 145 TYLR 148

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 29/131 (22%), Positives = 47/131 (35%), Gaps = 22/131 (16%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDI---ECEM 339
              Y   E   +  G F  V K R    G++ A K       +  R   S +    E  +
Sbjct: 10  DDYYDTGE--ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 340 MKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQRLNIM 393
           +K I+H N+I +     N+    L+LE +  G L     EK   +              +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFL 120

Query: 394 IDVASALEYLH 404
             + + + YLH
Sbjct: 121 KQILNGVYYLH 131

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 25/122 (20%), Positives = 54/122 (44%), Gaps = 5/122 (4%)

Query: 286 CRATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRR-AFKSFDI-ECEMMKS 342
             +  ++     + +G +G VYKA        VA+K   L+          I E  ++K 
Sbjct: 30  ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89

Query: 343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 402
           ++H+N+I++ S   +     L+ EY  +  L+KY+   N  + +    + +  + + + +
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNF 147

Query: 403 LH 404
            H
Sbjct: 148 CH 149

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 28/128 (21%), Positives = 46/128 (35%), Gaps = 24/128 (18%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH 345
              ++      + +G    VY+ +  G     A+KV         K    E  ++  + H
Sbjct: 52  SDFFEVES--ELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSH 107

Query: 346 QNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDV 396
            N+IK+          +LVLE +  G L     EK  YS    ++ +  I          
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL--------- 158

Query: 397 ASALEYLH 404
             A+ YLH
Sbjct: 159 -EAVAYLH 165

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 20/114 (17%), Positives = 43/114 (37%), Gaps = 9/114 (7%)

Query: 297 LISKGGFGSVYKA---RLGDGMEVAVKVFNLQCRR--AFKS-FDIECEMMKSIRHQNLIK 350
           L+ +GG G VY+A          VA+K+ +        F++    E      ++  +++ 
Sbjct: 41  LVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +      +    + +  +    L   L      L   + + I+  + SAL+  H
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH 151

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 31/123 (25%), Positives = 48/123 (39%), Gaps = 23/123 (18%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFN--------LQCRRAFKSFDIECEMMKSIRHQNL 348
           +  G FG V+ A       EV VK                      +E  ++  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILD------IFQRLNIMIDVASALE 401
           IKV+    N+ F  LV+E    G L+ + +   +  LD      IF++L       SA+ 
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQL------VSAVG 144

Query: 402 YLH 404
           YL 
Sbjct: 145 YLR 147

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 28/141 (19%), Positives = 49/141 (34%), Gaps = 37/141 (26%)

Query: 287 RATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNL--------QCRRAFKSFDIEC 337
              Y   +  +I +G    V +      G E AVK+  +        Q     ++   E 
Sbjct: 93  YQKYDPKD--VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET 150

Query: 338 EMMKSIR-HQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------ 390
            +++ +  H ++I +I S  +  F  LV + M  G L             F  L      
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-------------FDYLTEKVAL 197

Query: 391 ------NIMIDVASALEYLHF 405
                 +IM  +  A+ +LH 
Sbjct: 198 SEKETRSIMRSLLEAVSFLHA 218

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 23/134 (17%), Positives = 48/134 (35%), Gaps = 37/134 (27%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECE---MMKSIRH 345
           Y+ S+  L   G  G V +      G + A+K+          S     E     ++   
Sbjct: 30  YQLSKQVL-GLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGG 81

Query: 346 QNLIKVI----SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLN--------- 391
            +++ ++    +    +    +++E M  G L             I +R +         
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAA 131

Query: 392 -IMIDVASALEYLH 404
            IM D+ +A+++LH
Sbjct: 132 EIMRDIGTAIQFLH 145

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 16/92 (17%), Positives = 34/92 (36%), Gaps = 2/92 (2%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNL 348
            F     + +GGFG V++A+   D    A+K   L  R  A +    E + +  + H  +
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSS 380
           ++  ++      +    E       ++     
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 23/134 (17%), Positives = 45/134 (33%), Gaps = 25/134 (18%)

Query: 291 KFSENNLISKGGFGSVYKARLGDGMEVAVK-------------VFN--LQCRRAFKSFDI 335
            ++    IS G +G+V      +G+ VA+K             + +    C+R  +    
Sbjct: 23  PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR---- 78

Query: 336 ECEMMKSIRHQNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRL 390
           E  ++    H N++    +             LV E M    L + ++    ++      
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQ 137

Query: 391 NIMIDVASALEYLH 404
             M  +   L  LH
Sbjct: 138 YFMYHILLGLHVLH 151

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 45.3 bits (108), Expect = 5e-06
 Identities = 29/102 (28%), Positives = 47/102 (46%), Gaps = 23/102 (22%)

Query: 94  DSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISL 153
            +  L S+P              + IP       + + L+L  N++    P  F  L++L
Sbjct: 20  QNIRLASVP--------------AGIPT------DKQRLWLNNNQITKLEPGVFDHLVNL 59

Query: 154 KSLNLSKNNLSGAIPASL-EKLLYLKDLNLSFNKLEGEIPRG 194
           + L  + N L+ AIP  + +KL  L  L+L+ N L+  IPRG
Sbjct: 60  QQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLKS-IPRG 99

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 45.3 bits (108), Expect = 6e-06
 Identities = 29/102 (28%), Positives = 44/102 (43%), Gaps = 23/102 (22%)

Query: 94  DSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISL 153
               L S+P              + IP         + L+L  N++    P  F  L  L
Sbjct: 17  SGKSLASVP--------------TGIPT------TTQVLYLYDNQITKLEPGVFDRLTQL 56

Query: 154 KSLNLSKNNLSGAIPASL-EKLLYLKDLNLSFNKLEGEIPRG 194
             L+L  N L+  +PA + +KL  L  L+L+ N+L+  IPRG
Sbjct: 57  TRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLKS-IPRG 96

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 46.8 bits (112), Expect = 6e-06
 Identities = 31/134 (23%), Positives = 52/134 (38%), Gaps = 16/134 (11%)

Query: 286 CRATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRR-AFKSFDI----ECEM 339
             AT ++     I  G +G+VYKAR    G  VA+K   +           I    E  +
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 340 MKSIR---HQN---LIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCI-LDIFQRL 390
           ++ +    H N   L+ V ++   +      LV E++    L  YL  +    L      
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 391 NIMIDVASALEYLH 404
           ++M      L++LH
Sbjct: 124 DLMRQFLRGLDFLH 137

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 20/120 (16%), Positives = 40/120 (33%), Gaps = 23/120 (19%)

Query: 300 KGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI-----ECEMMKSIRHQ-NLIKVI 352
           +G F  V +      G E A K      +R            E  +++  +    +I + 
Sbjct: 39  RGKFAVVRQCISKSTGQEYAAKFLK---KRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 353 SSCSNEEFKALVLEYMPHGSL-EKYLYSSNCILDIFQRL------NIMIDVASALEYLHF 405
               N     L+LEY   G +         C+ ++ + +       ++  +   + YLH 
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSL------CLPELAEMVSENDVIRLIKQILEGVYYLHQ 149

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 46.5 bits (111), Expect = 8e-06
 Identities = 30/120 (25%), Positives = 52/120 (43%), Gaps = 13/120 (10%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFN----LQCRRAFKSFDI--ECEMMKSIR----H 345
           L+ KGGFG+V+    L D ++VA+KV      L       S     E  ++  +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 346 QNLIKVISSCSNEEFKALVLEY-MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             +I+++     +E   LVLE  +P   L  Y+     + +   R      V +A+++ H
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 46.6 bits (111), Expect = 8e-06
 Identities = 33/194 (17%), Positives = 68/194 (35%), Gaps = 31/194 (15%)

Query: 11  KCLTFIDLSNNPLD----SVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITN-LTKLTT 65
             L  ++L+   +     +V+         H+L+   ++ C +    L  +     +   
Sbjct: 72  SSLRQLNLAGVRMTPVKCTVVAAVLGSG-RHALDEVNLASCQLDPAGLRTLLPVFLRARK 130

Query: 66  IILGGNKLN----GSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPI 121
           + L  N L       +   L  +   +  L L +N LT+  +    L + L  N      
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAV--LMEGLAGN------ 182

Query: 122 EIGGLPNLEYLFLGYNRLQ----GSIPDSFGDLISLKSLNLSKNNLSG----AIPASLEK 173
                 ++ +L L +  L       +         L+ LN++ N        A+  +  +
Sbjct: 183 -----TSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAARE 237

Query: 174 LLYLKDLNLSFNKL 187
              L+ L+L FN+L
Sbjct: 238 HPSLELLHLYFNEL 251

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 46.6 bits (110), Expect = 9e-06
 Identities = 19/144 (13%), Positives = 41/144 (28%), Gaps = 36/144 (25%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCR---------------------------- 327
           ++ +    +  +A     G    V V     R                            
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 328 RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM-PHGSLEKYL------YSS 380
           +    F    +++K  + + +I+V     +    +    Y     +L+ +        S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 381 NCILDIFQRLNIMIDVASALEYLH 404
           +  L    RL + + V   L  LH
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH 228

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 24/126 (19%), Positives = 57/126 (45%), Gaps = 18/126 (14%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVK----VFN--LQCRRAFKSFDIECEMMKSI 343
           ++   +LI  G +G V +A    +   VA+K    VF   + C+R  +    E  ++  +
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRL 109

Query: 344 RHQNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 398
            H +++K   ++     E+F    +VLE       +K   +   + ++  +  ++ ++  
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLV 167

Query: 399 ALEYLH 404
            ++Y+H
Sbjct: 168 GVKYVH 173

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 28/114 (24%), Positives = 49/114 (42%), Gaps = 8/114 (7%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI-ECEMMKSIRHQNLIKVISSC 355
           +  G + +VYK      G+ VA+K   L       S  I E  +MK ++H+N++++    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLH 404
             E    LV E+M +  L+KY+ S         L++         +   L + H
Sbjct: 73  HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 45.6 bits (109), Expect = 1e-05
 Identities = 27/115 (23%), Positives = 50/115 (43%), Gaps = 9/115 (7%)

Query: 296 NLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI----ECEMMKSIRHQNLIK 350
             I +G +G VYKAR    G  VA+K   L      +        E  ++K + H N++K
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVK 66

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLH 404
           ++     E    LV E++    L+K++ +S    + +    + +  +   L + H
Sbjct: 67  LLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 23/131 (17%), Positives = 46/131 (35%), Gaps = 19/131 (14%)

Query: 289 TYKFSENNL-----ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECE---M 339
            + F+  +L     I +G +GSV K      G  +AVK          +   +  +   +
Sbjct: 16  HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK-QLLMDLDVV 74

Query: 340 MKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IM 393
           M+S     +++   +   E    + +E M   S +K+         +   +       I 
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKIT 131

Query: 394 IDVASALEYLH 404
           +    AL +L 
Sbjct: 132 LATVKALNHLK 142

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 44.1 bits (105), Expect = 4e-05
 Identities = 29/141 (20%), Positives = 49/141 (34%), Gaps = 32/141 (22%)

Query: 286 CRATYKFSENNLISKGGFGSVYKAR--LGDGMEVAVKVFNLQCRRAFKSFDIECE----- 338
           CRA  ++     I +G +G V+KAR     G  VA+K   +             E     
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---------QTGEEGMPLS 57

Query: 339 ---------MMKSIRHQN---LIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYS-SNCI 383
                     +++  H N   L  V +    +      LV E++    L  YL       
Sbjct: 58  TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG 116

Query: 384 LDIFQRLNIMIDVASALEYLH 404
           +      ++M  +   L++LH
Sbjct: 117 VPTETIKDMMFQLLRGLDFLH 137

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 45/207 (21%), Positives = 77/207 (37%), Gaps = 36/207 (17%)

Query: 7   LSNCKCLTFIDLSNNPLD----SVLPKTFVGNVSHSLEFFVMSYCNISGGILEEI----- 57
            S    +T +DLS N L       L + F    + S+    +S  ++     +E+     
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPA-SVTSLNLSGNSLGFKNSDELVQILA 76

Query: 58  TNLTKLTTIILGGNKLNG----SISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILY 113
                +T++ L GN L+      +  TL +   ++  L L  N+ +S   +    K    
Sbjct: 77  AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSE--FKQAFS 134

Query: 114 LNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLI-----SLKSLNLSKNNLSGAIP 168
              +          ++  L L  N L     D    ++     ++ SLNL  NNL+    
Sbjct: 135 NLPA----------SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNC 184

Query: 169 ASLEKLLY-----LKDLNLSFNKLEGE 190
           A L K L      +  L+LS N L  +
Sbjct: 185 AELAKFLASIPASVTSLDLSANLLGLK 211

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 39/209 (18%), Positives = 69/209 (33%), Gaps = 36/209 (17%)

Query: 2   SFLSSLSNCKC-LTFIDLSNNPLD----SVLPKTFVGNVSHSLEFFVMSYCNISGGILEE 56
             +  L+     +T ++LS N L       L KT        +    + + + S     E
Sbjct: 70  ELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFT-ITVLDLGWNDFSSKSSSE 128

Query: 57  I-----TNLTKLTTIILGGNKLNG----SISITLGSNLASLRKLSLDSNELTSIPLTFWN 107
                      +T++ L GN L       +   L +  A++  L+L  N L S       
Sbjct: 129 FKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAE-- 186

Query: 108 LKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLI-----SLKSLNLSKNN 162
           L   L    +          ++  L L  N L          +       + SLNL  N 
Sbjct: 187 LAKFLASIPA----------SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC 236

Query: 163 LSG----AIPASLEKLLYLKDLNLSFNKL 187
           L G     +    + L +L+ + L ++ +
Sbjct: 237 LHGPSLENLKLLKDSLKHLQTVYLDYDIV 265

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 22/81 (27%), Positives = 38/81 (46%), Gaps = 16/81 (19%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI------ECEMMKSIRHQNLI 349
            + +G FG V  A       +VA+K  +   R+  K  D+      E   +K +RH ++I
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFIS---RQLLKKSDMHMRVEREISYLKLLRHPHII 72

Query: 350 K---VISSCSNEEFKALVLEY 367
           K   VI++   +    +V+EY
Sbjct: 73  KLYDVITT-PTDIV--MVIEY 90

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 25/131 (19%), Positives = 53/131 (40%), Gaps = 20/131 (15%)

Query: 289 TYKFSENNL-----ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEM--- 339
           + +   ++L     + +G +G V K R +  G  +AVK          +   +  ++   
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK-RLLMDLDIS 59

Query: 340 MKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IM 393
           M+++     +    +   E    + +E M   SL+K+      ++D  Q +       I 
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQ---VIDKGQTIPEDILGKIA 115

Query: 394 IDVASALEYLH 404
           + +  ALE+LH
Sbjct: 116 VSIVKALEHLH 126

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 25/134 (18%), Positives = 47/134 (35%), Gaps = 13/134 (9%)

Query: 281 SYLELCRATYKFSENNL-----ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFD 334
            YL +    Y+   N+L     +  G  G V+K R    G  +AVK       +      
Sbjct: 11  GYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK-R 69

Query: 335 IECE---MMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL-DIFQRL 390
           I  +   ++KS     +++   +        + +E M   + +        I   I  + 
Sbjct: 70  ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK- 128

Query: 391 NIMIDVASALEYLH 404
            + + +  AL YL 
Sbjct: 129 -MTVAIVKALYYLK 141

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 35/192 (18%), Positives = 63/192 (32%), Gaps = 26/192 (13%)

Query: 2   SFLSSLSNCKCLTFIDLSNNPLDSVLPKTF--VGNVSHSLEFFVMSYC--NISGGILEEI 57
              +  + C+ L  +DL  + +D V         +   SL    +S     +S   LE +
Sbjct: 147 GLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERL 206

Query: 58  -TNLTKLTTIILGGNKLNGSISIT----LGSNLASLRKLSLDSNELTSIPLTFWNLKDIL 112
            T    L ++     KLN ++ +     L      L +L          P  +  L   L
Sbjct: 207 VTRCPNLKSL-----KLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVAL 261

Query: 113 YLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG-AIPASL 171
                       G   L  L   ++ +   +P  +     L +LNLS   +    +   L
Sbjct: 262 -----------SGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLL 310

Query: 172 EKLLYLKDLNLS 183
            +   L+ L + 
Sbjct: 311 CQCPKLQRLWVL 322

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 44.0 bits (104), Expect = 6e-05
 Identities = 24/126 (19%), Positives = 52/126 (41%), Gaps = 18/126 (14%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVK----VFN--LQCRRAFKSFDIECEMMKSI 343
            +   +LI +G +G VY A        VA+K    +F   + C+R  +    E  ++  +
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRL 82

Query: 344 RHQNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 398
           +   +I+   +I      +F    +VLE      L+K   +   + +   +  I+ ++  
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLL 140

Query: 399 ALEYLH 404
              ++H
Sbjct: 141 GENFIH 146

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 43.4 bits (103), Expect = 7e-05
 Identities = 23/128 (17%), Positives = 48/128 (37%), Gaps = 15/128 (11%)

Query: 289 TYKFSENNLISKGGFGSVYKARLGD-GMEVAVK-VFNLQCRRAFKSFDIECEMMKSIRHQ 346
             +F    +  +G FG+V   +    GM VA+K V     R   +      + +  + H 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNRELQ-IMQDLAVLHHP 79

Query: 347 NLIK---VISSCSNEEFK----ALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDV 396
           N+++      +    + +     +V+EY+P   H     Y         I  ++  +  +
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-FLFQL 138

Query: 397 ASALEYLH 404
             ++  LH
Sbjct: 139 IRSIGCLH 146

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 43.6 bits (103), Expect = 8e-05
 Identities = 18/124 (14%), Positives = 41/124 (33%), Gaps = 36/124 (29%)

Query: 300 KGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECE---MMKSIRHQNLIKVI--- 352
            G  G V +        + A+K+                E     ++ +  ++++++   
Sbjct: 72  LGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVY 124

Query: 353 -SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLN----------IMIDVASAL 400
            +  +  +   +V+E +  G L             I  R +          IM  +  A+
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 401 EYLH 404
           +YLH
Sbjct: 175 QYLH 178

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 43.0 bits (102), Expect = 9e-05
 Identities = 18/127 (14%), Positives = 41/127 (32%), Gaps = 42/127 (33%)

Query: 300 KGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECE---MMKSIRHQNLIKVI--- 352
            G  G V +        + A+K+                E     ++ +  ++++++   
Sbjct: 28  LGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVY 80

Query: 353 -SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--------------NIMIDVA 397
            +  +  +   +V+E +  G L             F R+               IM  + 
Sbjct: 81  ENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKSIG 127

Query: 398 SALEYLH 404
            A++YLH
Sbjct: 128 EAIQYLH 134

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 28/110 (25%), Positives = 47/110 (42%), Gaps = 7/110 (6%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLI-KVISSC 355
           I  G FG +   + L     VA+K+  ++ R       +E    K +   + I +V    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 356 SNEEFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
              ++ A+VLE +  G SLE      +    +   L I I + S +EY+H
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 19/109 (17%), Positives = 37/109 (33%), Gaps = 5/109 (4%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLI-KVISSC 355
           I +G FG +++   L +  +VA+K    +          E    K +     I  V    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
                  LV++ +   SLE  L        +         + + ++ +H
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 27/130 (20%), Positives = 50/130 (38%), Gaps = 27/130 (20%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVK----VFN--LQCRRAFKSFDIECEMMKSI 343
            +     +  G +GSV  A     G +VA+K     F   +  +RA++    E  ++K +
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHM 80

Query: 344 RHQNLIK----VISSCSNEEFKA--LVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMI 394
           +H+N+I        + S   F    LV+ +M       +            ++Q L    
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK--- 137

Query: 395 DVASALEYLH 404
                L+Y+H
Sbjct: 138 ----GLKYIH 143

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 29/114 (25%), Positives = 50/114 (43%), Gaps = 9/114 (7%)

Query: 297 LISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIEC-----EMMKSIRHQNLIK 350
           ++ +G F +V  AR      E A+K+  L+ R   K   +       ++M  + H   +K
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +  +  ++E     L Y  +G L KY+       +   R     ++ SALEYLH
Sbjct: 95  LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH 147

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 22/110 (20%), Positives = 47/110 (42%), Gaps = 5/110 (4%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLI-KVISSC 355
           I  G FG +Y    +    EVA+K+ N++ +        E ++ + ++    I  V    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 405
              ++  LV++ +   SLE      +  L +   L +   + + +E++H 
Sbjct: 73  VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 40/197 (20%), Positives = 75/197 (38%), Gaps = 19/197 (9%)

Query: 4   LSSLSNCKCLTFIDLSNNPL-DSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTK 62
           L+   +   +  +DLSN+ +  S L    + +    L+   +    +S  I+  +   + 
Sbjct: 86  LAEHFSPFRVQHMDLSNSVIEVSTLHG--ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSN 143

Query: 63  LTTIILGG-NKLNGSISITLGSNLASLRKLSLDS-NELTSIPLTFW---NLKDILYLNFS 117
           L  + L G +  +     TL S+ + L +L+L    + T   +        + I  LN S
Sbjct: 144 LVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203

Query: 118 VIPIEIG---------GLPNLEYLFLGY-NRLQGSIPDSFGDLISLKSLNLSK-NNLSGA 166
                +            PNL +L L     L+      F  L  L+ L+LS+  ++   
Sbjct: 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPE 263

Query: 167 IPASLEKLLYLKDLNLS 183
               L ++  LK L + 
Sbjct: 264 TLLELGEIPTLKTLQVF 280

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 21/89 (23%), Positives = 43/89 (48%), Gaps = 15/89 (16%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVK---VFN--LQCRRAFKSFDIECEMMKSIR 344
           +++  + I +G +G V  A    + + VA+K    F     C+R  +    E +++   R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 83

Query: 345 HQNLIK---VISSCSNEEFKA--LVLEYM 368
           H+N+I    +I + + E+ K   +V + M
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLM 112

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 24/109 (22%), Positives = 48/109 (44%), Gaps = 5/109 (4%)

Query: 298 ISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLI-KVISSC 355
           I  G FG +Y    +  G EVA+K+  ++ +       IE ++ K ++    I  +    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +  ++  +V+E +   SLE      +    +   L +   + S +EY+H
Sbjct: 75  AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 23/89 (25%), Positives = 39/89 (43%), Gaps = 15/89 (16%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVK---VFN--LQCRRAFKSFDIECEMMKSIR 344
            F   +L+ +G +G V  A     G  VA+K    F+  L   R  +    E +++K  +
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFK 67

Query: 345 HQNLIK---VISSCSNEEFKA--LVLEYM 368
           H+N+I    +    S E F    ++ E M
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELM 96

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 40.6 bits (94), Expect = 6e-04
 Identities = 27/167 (16%), Positives = 51/167 (30%), Gaps = 52/167 (31%)

Query: 286 CRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKV--------FNLQCRRAFKSFDIEC 337
           C  T K      I +G FG V++    D   VA+K+         N   ++ F+    E 
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 338 EMMKSI---------RHQNLIKVISSC------------------------------SNE 358
            + K +         R +  I + S                                  +
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 359 EFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +   +VLE+   G  LE+       +  +    +I+  + ++L    
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAE 178

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 23/114 (20%), Positives = 45/114 (39%), Gaps = 9/114 (7%)

Query: 297 LISKGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDIEC-----EMMKSIRHQNLIK 350
            +  G FG V   +  +     A+K+  L  ++  K   IE       +++++    L+K
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 351 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +  S  +     +V+EY+  G +  +L       +   R      +    EYLH
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLH 158

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	405
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.97
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.94
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.94
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.94
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.94
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.94
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.94
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.93
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.93
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.93
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.92
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.92
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.92
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.92
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.92
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.91
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.91
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.91
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.91
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.91
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.91
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.91
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.91
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.91
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.9
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.9
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.9
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.9
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.9
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.9
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.9
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.89
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.89
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.89
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.89
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.89
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.89
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.88
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.88
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.88
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.88
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.88
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.87
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.87
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.87
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.87
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.87
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.86
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.86
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.86
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.86
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.86
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.86
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.86
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.86
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.86
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.86
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.85
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.85
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.85
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.85
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.85
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.85
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.85
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.85
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.85
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.85
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.85
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.85
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.84
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.84
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.84
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.84
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.84
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.84
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.83
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.83
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.83
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.83
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.83
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.83
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.83
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.82
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.82
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.82
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.82
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.81
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.8
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.79
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.79
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.79
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.79
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.79
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.79
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.78
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.78
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.78
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.78
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.78
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.77
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.77
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.77
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.77
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.77
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.77
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.77
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.77
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.76
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.75
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.75
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.75
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.75
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.75
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.75
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.74
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.74
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.74
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.74
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.73
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.73
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.73
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.73
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.73
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.73
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.72
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.72
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.72
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.72
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.72
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.71
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.71
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.71
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.71
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.71
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.71
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.71
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.71
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.71
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.71
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.7
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.7
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.7
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.7
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.7
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.7
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.7
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.7
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.7
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.7
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.69
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.69
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.69
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.69
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.69
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.69
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.69
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.69
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.68
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.68
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.68
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.68
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.68
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.68
3niz_A	311	Rhodanese family protein; structural genomics, str	99.68
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.68
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.67
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.67
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.67
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.67
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.67
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.67
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.67
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.67
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.67
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.67
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.67
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.67
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.67
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.67
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.66
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.66
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.66
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.66
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.66
3uqc_A	286	Probable conserved transmembrane protein; structur	99.66
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.66
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.66
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.66
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.66
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.66
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.66
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.66
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.66
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.66
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.66
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.66
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.66
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.65
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.65
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.65
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.65
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.65
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.65
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.65
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.65
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.65
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.65
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.65
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.65
3bhy_A	283	Death-associated protein kinase 3; death associate	99.65
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.65
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.65
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.64
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.64
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.64
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.64
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.64
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.64
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.64
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.64
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.64
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.64
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.64
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.64
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.64
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.64
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.64
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.64
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.64
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.64
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.64
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.64
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.64
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.63
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.63
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.63
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.63
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.63
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.63
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.63
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.63
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.63
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.63
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.63
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.63
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.63
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.63
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.63
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.63
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.63
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.63
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.62
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.62
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.62
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.62
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.62
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.62
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.62
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.62
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.62
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.62
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.62
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.62
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.62
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.62
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.62
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.62
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.62
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.62
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.61
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.61
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.61
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.61
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.61
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.61
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.61
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.61
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.61
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.6
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.6
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.6
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.6
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.6
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.6
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.6
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.6
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.6
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.6
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.6
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.59
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.59
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.59
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.59
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.59
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.59
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.59
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.59
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.58
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.58
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.58
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.58
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.58
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.58
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.58
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.57
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.57
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.57
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.57
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.57
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.57
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.57
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.57
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.57
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.57
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.57
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.57
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.57
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.57
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.56
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.56
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.56
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.56
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.56
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.55
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.55
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.55
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.55
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.55
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.54
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.54
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.54
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.53
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.53
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.53
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.53
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.53
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.53
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.53
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.52
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.52
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.52
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.52
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.52
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.5
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.5
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.5
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.49
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.49
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.49
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.49
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.49
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.49
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.49
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.48
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.48
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.48
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.48
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.48
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.48
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.48
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.47
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.47
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.45
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.45
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.43
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.42
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.41
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.41
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.4
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.4
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.38
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.37
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.33
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.33
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.31
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.29
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.29
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.28
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.05
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.0
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.9
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.82
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.76
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.66
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.62
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.54
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	98.49
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.45
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	98.35
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.29
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.28
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	98.25
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	98.17
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.06
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.91
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.9
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.88
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.77
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.55
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.47
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.43
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.04
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	96.81
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.69
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	96.51
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	96.34
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	96.29
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.14
3ats_A	357	Putative uncharacterized protein; hypothetical pro	95.81
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	94.99
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	94.89
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	94.56
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	86.41
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.38
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	83.43
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	82.61
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	80.89
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	80.53

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.97  E-value=2.6e-30  Score=239.39  Aligned_cols=210  Identities=29%  Similarity=0.523  Sum_probs=151.9

Q ss_pred             ccccCCCCCcCCeeeCcC-CcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcch
Q 036754            3 FLSSLSNCKCLTFIDLSN-NPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITL   81 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~   81 (405)
                      +|+.|.++++|++|+|++ |.+.+..|.. +++++ +|++|+|++|++++..|..|..+++|++|+|++|.+++.+|..+
T Consensus        68 ~~~~l~~l~~L~~L~L~~~n~l~~~~p~~-l~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  145 (313)
T 1ogq_A           68 IPSSLANLPYLNFLYIGGINNLVGPIPPA-IAKLT-QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI  145 (313)
T ss_dssp             CCGGGGGCTTCSEEEEEEETTEESCCCGG-GGGCT-TCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGG
T ss_pred             cChhHhCCCCCCeeeCCCCCcccccCChh-HhcCC-CCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHH
Confidence            455666666666666663 6666666665 44554 66666666666666666666666666666666666665555554


Q ss_pred             hcCCCCCCeeeCCCCCCC-CCchhhhccc-cCccccCC-----------------------C------CChhccCCCCCC
Q 036754           82 GSNLASLRKLSLDSNELT-SIPLTFWNLK-DILYLNFS-----------------------V------IPIEIGGLPNLE  130 (405)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~-~L~~l~l~-----------------------~------~p~~~~~l~~L~  130 (405)
                       ..+++|++|+|++|+++ .+|..+.++. .|+.|+++                       .      .|..+..+++|+
T Consensus       146 -~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~  224 (313)
T 1ogq_A          146 -SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQ  224 (313)
T ss_dssp             -GGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCS
T ss_pred             -hcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCC
Confidence             35666666666666665 5565555554 55555443                       2      345567778888


Q ss_pred             EEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCC
Q 036754          131 YLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL  210 (405)
Q Consensus       131 ~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~  210 (405)
                      +|++++|.+.+.+|. +..+++|++|++++|.+++.+|..+..+++|+.|++++|.+++.+|....++++..+++.+|++
T Consensus       225 ~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~  303 (313)
T 1ogq_A          225 KIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC  303 (313)
T ss_dssp             EEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSE
T ss_pred             EEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCC
Confidence            888888888765554 7788899999999999998899999999999999999999999999988899999999999999


Q ss_pred             ccCCCC
Q 036754          211 LCGSPN  216 (405)
Q Consensus       211 ~c~~~~  216 (405)
                      .|+.|.
T Consensus       304 lc~~p~  309 (313)
T 1ogq_A          304 LCGSPL  309 (313)
T ss_dssp             EESTTS
T ss_pred             ccCCCC
Confidence            998754

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.96  E-value=1.4e-29  Score=262.16  Aligned_cols=216  Identities=36%  Similarity=0.584  Sum_probs=174.9

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchh
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG   82 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   82 (405)
                      +|+.|..+++|+.|+|++|++++..|.. ++.++ +|+.|+|++|++++.+|..++.+++|++|+|++|+++|.+|..+.
T Consensus       458 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~  535 (768)
T 3rgz_A          458 IPQELMYVKTLETLILDFNDLTGEIPSG-LSNCT-NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG  535 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSCCCSCCCGG-GGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGG
T ss_pred             CCHHHcCCCCceEEEecCCcccCcCCHH-HhcCC-CCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHc
Confidence            4556667777777777777777777766 55555 777777777777777777777777888888888887777777664


Q ss_pred             cCCCCCCeeeCCCCCCC-CCchhhhc------------------------------------------------------
Q 036754           83 SNLASLRKLSLDSNELT-SIPLTFWN------------------------------------------------------  107 (405)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~-~lp~~~~~------------------------------------------------------  107 (405)
                       ++++|++|+|++|+++ .+|..++.                                                      
T Consensus       536 -~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  614 (768)
T 3rgz_A          536 -DCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCN  614 (768)
T ss_dssp             -GCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSC
T ss_pred             -CCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccc
Confidence             7788888888888776 66654432                                                      


Q ss_pred             ----------------cccCccccCCC------CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccC
Q 036754          108 ----------------LKDILYLNFSV------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG  165 (405)
Q Consensus       108 ----------------l~~L~~l~l~~------~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~  165 (405)
                                      ++.|+.|+++.      +|..++++++|+.|++++|.++|.+|..|+++++|++|++++|+++|
T Consensus       615 l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g  694 (768)
T 3rgz_A          615 ITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDG  694 (768)
T ss_dssp             TTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEE
T ss_pred             cccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccC
Confidence                            34456666654      78889999999999999999999999999999999999999999999


Q ss_pred             ccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCccCCCCCCCCCCCC
Q 036754          166 AIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKT  224 (405)
Q Consensus       166 ~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~~~c~~  224 (405)
                      .+|..+..+++|+.|++++|+++|.+|..+.+.++....+.||+.+||.|-   .+|..
T Consensus       695 ~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~  750 (768)
T 3rgz_A          695 RIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDP  750 (768)
T ss_dssp             CCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCS
T ss_pred             cCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCC
Confidence            999999999999999999999999999999999999999999999999763   25653

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.94  E-value=2.1e-27  Score=221.27  Aligned_cols=200  Identities=21%  Similarity=0.234  Sum_probs=133.6

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchh
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG   82 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   82 (405)
                      +|+.+.++++|++|+|++|.+. .+|.. ++.++ +|++|+|++|.++ .+|..+..+++|++|+|++|++.+.+|..+.
T Consensus        96 lp~~l~~l~~L~~L~L~~n~l~-~lp~~-~~~l~-~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~  171 (328)
T 4fcg_A           96 FPDQAFRLSHLQHMTIDAAGLM-ELPDT-MQQFA-GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA  171 (328)
T ss_dssp             CCSCGGGGTTCSEEEEESSCCC-CCCSC-GGGGT-TCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSE
T ss_pred             cChhhhhCCCCCEEECCCCCcc-chhHH-HhccC-CCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHh
Confidence            4555666777777777777776 45555 45555 6777777777776 4566677777777777777666666666552


Q ss_pred             --------cCCCCCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCccccc
Q 036754           83 --------SNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGD  149 (405)
Q Consensus        83 --------~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~  149 (405)
                              .++++|++|+|++|+++.+|..+.++++|+.|+++.     +|..++.+++|++|++++|.+.+.+|..|+.
T Consensus       172 ~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~  251 (328)
T 4fcg_A          172 STDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGG  251 (328)
T ss_dssp             EEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTC
T ss_pred             hccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcC
Confidence                    236777777777777777777777777777766543     5666667777777777777777677777777


Q ss_pred             CCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCC-CccCCCCccccc
Q 036754          150 LISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFE  206 (405)
Q Consensus       150 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~-~~~~~~~~~~~~  206 (405)
                      +++|+.|++++|.+.+.+|..+..+++|+.|++++|.+.+.+|.. ..++++..+.+.
T Consensus       252 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~  309 (328)
T 4fcg_A          252 RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP  309 (328)
T ss_dssp             CCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECC
T ss_pred             CCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCC
Confidence            777777777777776677777777777777777777666666642 334444444443

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.94  E-value=7.3e-27  Score=226.56  Aligned_cols=207  Identities=23%  Similarity=0.298  Sum_probs=159.7

Q ss_pred             ccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcC
Q 036754            5 SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSN   84 (405)
Q Consensus         5 ~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~   84 (405)
                      +.|.++++|+.|+|++|.|.++.+.. +.+++ +|+.|+|++|+++...++.|..+++|++|+|++|.++ .+|...+.+
T Consensus        82 ~~~~~l~~L~~L~Ls~n~i~~i~~~~-~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~  158 (440)
T 3zyj_A           82 NSFKHLRHLEILQLSRNHIRTIEIGA-FNGLA-NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNR  158 (440)
T ss_dssp             TTTSSCSSCCEEECCSSCCCEECGGG-GTTCS-SCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCC-EECTTTTTT
T ss_pred             HHhhCCCCCCEEECCCCcCCccChhh-ccCCc-cCCEEECCCCcCCeeCHhHhhccccCceeeCCCCccc-ccCHHHhhh
Confidence            45667777777777777777766666 44554 6777777777777666666777777777777777776 556555567


Q ss_pred             CCCCCeeeCCC-CCCCCCch-hhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeee
Q 036754           85 LASLRKLSLDS-NELTSIPL-TFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLN  157 (405)
Q Consensus        85 l~~L~~L~Ls~-N~l~~lp~-~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  157 (405)
                      +++|++|+|++ |.++.+|. .+.++++|++|+++.     +| .+..+++|++|++++|.+++..|..|.++++|+.|+
T Consensus       159 l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  237 (440)
T 3zyj_A          159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW  237 (440)
T ss_dssp             CTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEE
Confidence            77777777777 34555554 466777777777664     44 467788899999999999988889999999999999


Q ss_pred             cccccccCccchhHHhcccCCccccccCcccCcCCCC-CccCCCCcccccCCCCccCCC
Q 036754          158 LSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSP  215 (405)
Q Consensus       158 l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~  215 (405)
                      +++|.+++..+..|..+++|+.|++++|.+++.++.. ..+.+++.+++.+|||.|.|.
T Consensus       238 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             CTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred             CCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence            9999999888889999999999999999999776653 567888999999999999764

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.94  E-value=2.6e-27  Score=219.17  Aligned_cols=197  Identities=25%  Similarity=0.388  Sum_probs=180.3

Q ss_pred             CcCCeeeCcCCcCcc--cCCchhhhcccccccEEEccc-CcccccCCccccCccCCCeeecCCcccccccCcchhcCCCC
Q 036754           11 KCLTFIDLSNNPLDS--VLPKTFVGNVSHSLEFFVMSY-CNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLAS   87 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~--~~~~~f~~~~~~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~   87 (405)
                      .+++.|+|++|.+.+  .+|.. +++++ +|++|+|++ |.+.+.+|..|+.+++|++|+|++|.+++.+|..+ .++++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~-l~~l~-~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~  126 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSS-LANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL-SQIKT  126 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGG-GGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGG-GGCTT
T ss_pred             ceEEEEECCCCCccCCcccChh-HhCCC-CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHH-hCCCC
Confidence            679999999999998  88887 67776 999999995 99999999999999999999999999998888876 58999


Q ss_pred             CCeeeCCCCCCC-CCchhhhccccCccccCCC------CChhccCCC-CCCEEeccCCcccccCCcccccCCCCCeeecc
Q 036754           88 LRKLSLDSNELT-SIPLTFWNLKDILYLNFSV------IPIEIGGLP-NLEYLFLGYNRLQGSIPDSFGDLISLKSLNLS  159 (405)
Q Consensus        88 L~~L~Ls~N~l~-~lp~~~~~l~~L~~l~l~~------~p~~~~~l~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~  159 (405)
                      |++|+|++|+++ .+|..+.++++|++|+++.      +|..+..++ +|++|++++|.+.+.+|..+..++ |+.|+++
T Consensus       127 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls  205 (313)
T 1ogq_A          127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLS  205 (313)
T ss_dssp             CCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECC
T ss_pred             CCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECc
Confidence            999999999999 7899999999999999875      788899998 999999999999999999999987 9999999


Q ss_pred             cccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCc
Q 036754          160 KNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL  211 (405)
Q Consensus       160 ~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~  211 (405)
                      +|.+++..|..+..+++|+.|++++|.+++.+|....+++++.+++.+|...
T Consensus       206 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~  257 (313)
T 1ogq_A          206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY  257 (313)
T ss_dssp             SSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCE
T ss_pred             CCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCccc
Confidence            9999988999999999999999999999988887777788888899888765

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.94  E-value=1.3e-26  Score=212.09  Aligned_cols=201  Identities=24%  Similarity=0.257  Sum_probs=179.6

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      .++++++++.+++++|.++.+.+..     +++++.|+|++|.+++..+..|..+++|++|+|++|.++ .++..  ..+
T Consensus         5 ~~~~l~~l~~l~~~~~~l~~ip~~~-----~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~--~~l   76 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLTALPPDL-----PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD--GTL   76 (290)
T ss_dssp             EEECSTTCCEEECTTSCCSSCCSCC-----CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECC--SCC
T ss_pred             cccccCCccEEECCCCCCCcCCCCC-----CCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccC-cccCC--CCC
Confidence            5778999999999999998765543     248999999999999998999999999999999999998 55554  589


Q ss_pred             CCCCeeeCCCCCCCCCchhhhccccCccccCCC-----CC-hhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecc
Q 036754           86 ASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IP-IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLS  159 (405)
Q Consensus        86 ~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~  159 (405)
                      ++|++|+|++|+++.+|..+..+++|++|+++.     +| ..|.++++|++|++++|++++..+..|..+++|+.|+++
T Consensus        77 ~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  156 (290)
T 1p9a_G           77 PVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA  156 (290)
T ss_dssp             TTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CcCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECC
Confidence            999999999999999999999999999999875     44 568999999999999999998888889999999999999


Q ss_pred             cccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCccCC
Q 036754          160 KNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS  214 (405)
Q Consensus       160 ~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~~  214 (405)
                      +|++++..+..|..+++|+.|++++|.++..++......+++.+.+.+|||.|.|
T Consensus       157 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c  211 (290)
T 1p9a_G          157 NNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC  211 (290)
T ss_dssp             TSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             CCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence            9999988888889999999999999999976666667778999999999999964

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.94  E-value=1e-26  Score=226.28  Aligned_cols=206  Identities=23%  Similarity=0.256  Sum_probs=136.7

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      .|.++++|+.|+|++|.|.++.|.. +..++ +|+.|+|++|+++...+..|..+++|++|+|++|+++ .+|...+.++
T Consensus        94 ~~~~l~~L~~L~Ls~n~i~~~~~~~-~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l  170 (452)
T 3zyi_A           94 TFRHLHHLEVLQLGRNSIRQIEVGA-FNGLA-SLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRV  170 (452)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTT-TTTCT-TCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTC
T ss_pred             HcCCCCCCCEEECCCCccCCcChhh-ccCcc-cCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcC
Confidence            4455555555555555555554444 33333 5555555555555544444555555555555555554 4444444455


Q ss_pred             CCCCeeeCCC-CCCCCCch-hhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeec
Q 036754           86 ASLRKLSLDS-NELTSIPL-TFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNL  158 (405)
Q Consensus        86 ~~L~~L~Ls~-N~l~~lp~-~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l  158 (405)
                      ++|++|+|++ |.++.+|. .+.++++|++|+++.     +| .+..+++|++|++++|.+.+..|..|..+++|+.|++
T Consensus       171 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  249 (452)
T 3zyi_A          171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWV  249 (452)
T ss_dssp             TTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEEC
T ss_pred             CcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEe
Confidence            5555555555 33444443 345566666666553     33 4667788888888888888888888888999999999


Q ss_pred             ccccccCccchhHHhcccCCccccccCcccCcCCCC-CccCCCCcccccCCCCccCCC
Q 036754          159 SKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSP  215 (405)
Q Consensus       159 ~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~  215 (405)
                      ++|.+++..+..|..+++|+.|++++|.+++.++.. ..+.+++.+++.+||+.|.|.
T Consensus       250 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          250 MNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD  307 (452)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred             CCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence            999998888888888999999999999998766653 457788889999999998764

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.94  E-value=1.9e-26  Score=238.61  Aligned_cols=206  Identities=31%  Similarity=0.491  Sum_probs=125.0

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhc
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGS   83 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   83 (405)
                      |+.|+++++|+.|+|++|.+.+..|.. ++.++ +|+.|+|++|++++.+|..+..+++|++|+|++|++++.+|..+. 
T Consensus       435 p~~l~~l~~L~~L~L~~n~l~~~~p~~-~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-  511 (768)
T 3rgz_A          435 PSSLGSLSKLRDLKLWLNMLEGEIPQE-LMYVK-TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG-  511 (768)
T ss_dssp             CGGGGGCTTCCEEECCSSCCCSCCCGG-GGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGG-
T ss_pred             cHHHhcCCCCCEEECCCCcccCcCCHH-HcCCC-CceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHh-
Confidence            334445555555555555555555544 33333 555555555555555555555566666666666666555555543 


Q ss_pred             CCCCCCeeeCCCCCCC-CCchhhhccccCccccCCC------CChh----------------------------------
Q 036754           84 NLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFSV------IPIE----------------------------------  122 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~l~l~~------~p~~----------------------------------  122 (405)
                      .+++|++|+|++|+++ .+|..+.++++|+.|+++.      +|..                                  
T Consensus       512 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (768)
T 3rgz_A          512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAG  591 (768)
T ss_dssp             GCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSE
T ss_pred             cCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccc
Confidence            5666666666666665 5566666666666655542      2221                                  


Q ss_pred             ------------------------------------ccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCc
Q 036754          123 ------------------------------------IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGA  166 (405)
Q Consensus       123 ------------------------------------~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~  166 (405)
                                                          ++.+++|++|++++|+++|.+|..++.+++|+.|++++|.++|.
T Consensus       592 ~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~  671 (768)
T 3rgz_A          592 NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS  671 (768)
T ss_dssp             EEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSC
T ss_pred             cccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCC
Confidence                                                22345666777777777777777777777777777777777777


Q ss_pred             cchhHHhcccCCccccccCcccCcCCCC-CccCCCCcccccCCCCcc
Q 036754          167 IPASLEKLLYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLC  212 (405)
Q Consensus       167 ~~~~~~~l~~L~~l~l~~n~l~~~~p~~-~~~~~~~~~~~~~n~~~c  212 (405)
                      +|..+.++++|+.|++++|+++|.+|.. ..+.+++.+++++|++..
T Consensus       672 ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g  718 (768)
T 3rgz_A          672 IPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG  718 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEE
T ss_pred             CChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccc
Confidence            7777777777777777777777766653 455666777777776543

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.94  E-value=1.6e-26  Score=211.13  Aligned_cols=203  Identities=24%  Similarity=0.249  Sum_probs=179.1

Q ss_pred             CCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcc-cccccCcchhcCCCCC
Q 036754           10 CKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK-LNGSISITLGSNLASL   88 (405)
Q Consensus        10 l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~l~~L   88 (405)
                      .++|+.|+|++|.+.+..+.. ++.++ +|+.|+|++|.+++..|..|..+++|++|+|++|. +. .++...+..+++|
T Consensus        31 ~~~l~~L~l~~n~i~~~~~~~-~~~~~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~-~~~~~~~~~l~~L  107 (285)
T 1ozn_A           31 PAASQRIFLHGNRISHVPAAS-FRACR-NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR-SVDPATFHGLGRL  107 (285)
T ss_dssp             CTTCSEEECTTSCCCEECTTT-TTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCC-CCCTTTTTTCTTC
T ss_pred             CCCceEEEeeCCcCCccCHHH-cccCC-CCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCcc-ccCHHHhcCCcCC
Confidence            468999999999999988777 56776 99999999999999889999999999999999998 66 6655556799999


Q ss_pred             CeeeCCCCCCCCC-chhhhccccCccccCCC-----CC-hhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccc
Q 036754           89 RKLSLDSNELTSI-PLTFWNLKDILYLNFSV-----IP-IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKN  161 (405)
Q Consensus        89 ~~L~Ls~N~l~~l-p~~~~~l~~L~~l~l~~-----~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n  161 (405)
                      ++|+|++|+++.+ |..+.++++|++|+++.     +| ..+.++++|++|++++|.+.+..+..|..+++|+.|++++|
T Consensus       108 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  187 (285)
T 1ozn_A          108 HTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN  187 (285)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCC
Confidence            9999999999977 56678899999999875     44 34788999999999999999877778999999999999999


Q ss_pred             cccCccchhHHhcccCCccccccCcccCcCCC-CCccCCCCcccccCCCCccCCC
Q 036754          162 NLSGAIPASLEKLLYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLCGSP  215 (405)
Q Consensus       162 ~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~~c~~~  215 (405)
                      .+++..|..+..+++|+.|++++|.+++.++. ...+++++.+++.+|++.|.++
T Consensus       188 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~  242 (285)
T 1ozn_A          188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR  242 (285)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred             cccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence            99988899999999999999999999986654 4667889999999999998653

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=4.7e-26  Score=207.00  Aligned_cols=207  Identities=27%  Similarity=0.305  Sum_probs=177.6

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchh
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG   82 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   82 (405)
                      +|+.+.  ++|+.|+|++|.+++..+.. ++.++ +|+.|+|++|++++..+..|..+++|++|+|++|.++ .++...+
T Consensus        22 ip~~l~--~~l~~L~ls~n~l~~~~~~~-~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~   96 (276)
T 2z62_A           22 IPDNLP--FSTKNLDLSFNPLRHLGSYS-FFSFP-ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAF   96 (276)
T ss_dssp             CCSSSC--TTCCEEECTTCCCCEECTTT-TTTCT-TCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTT
T ss_pred             cCCCCC--CCccEEECCCCcccccCHhH-hcccc-CCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccC-ccChhhh
Confidence            344443  47999999999999988876 56676 9999999999999988889999999999999999998 5555555


Q ss_pred             cCCCCCCeeeCCCCCCCCCch-hhhccccCccccCCC-------CChhccCCCCCCEEeccCCcccccCCcccccCCCCC
Q 036754           83 SNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSV-------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLK  154 (405)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~lp~-~~~~l~~L~~l~l~~-------~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  154 (405)
                      .++++|++|++++|+++.++. .+.++++|+.|+++.       +|..+.++++|++|++++|.+.+..+..+..+++|+
T Consensus        97 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  176 (276)
T 2z62_A           97 SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP  176 (276)
T ss_dssp             TTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCT
T ss_pred             cCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcc
Confidence            799999999999999998766 688899999998864       577899999999999999999988888888888887


Q ss_pred             ----eeecccccccCccchhHHhcccCCccccccCcccCcCCCC-CccCCCCcccccCCCCccCCC
Q 036754          155 ----SLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSP  215 (405)
Q Consensus       155 ----~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~  215 (405)
                          .|++++|.+++..+..+. ..+|+.|++++|.+++.++.. ..+.+++.+++.+|++.|.++
T Consensus       177 ~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          177 LLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             TCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             ccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence                899999999976665554 458999999999999777654 568899999999999999775

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.93  E-value=7.2e-26  Score=220.48  Aligned_cols=204  Identities=24%  Similarity=0.316  Sum_probs=125.0

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCcc--ccCccCCCeeecCCcccccccCcchhc
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEE--ITNLTKLTTIILGGNKLNGSISITLGS   83 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~~~~   83 (405)
                      .|.++++|++|+|++|.+++..|.. ++.++ +|++|+|++|++++..+..  |..+++|++|+|++|++++..|..++.
T Consensus        74 ~~~~l~~L~~L~Ls~n~l~~~~~~~-~~~l~-~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  151 (455)
T 3v47_A           74 TFRGLSSLIILKLDYNQFLQLETGA-FNGLA-NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL  151 (455)
T ss_dssp             TTTTCTTCCEEECTTCTTCEECTTT-TTTCT-TCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGG
T ss_pred             cccccccCCEEeCCCCccCccChhh-ccCcc-cCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccC
Confidence            4666666666666666666666655 44554 6666666666666543333  666666666666666666444555445


Q ss_pred             CCCCCCeeeCCCCCCCCC-chhhhcc----------------------------------ccCcccc-------------
Q 036754           84 NLASLRKLSLDSNELTSI-PLTFWNL----------------------------------KDILYLN-------------  115 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~l-p~~~~~l----------------------------------~~L~~l~-------------  115 (405)
                      ++++|++|+|++|+++.+ |..+..+                                  ++|+.|+             
T Consensus       152 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~  231 (455)
T 3v47_A          152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKR  231 (455)
T ss_dssp             GCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHH
T ss_pred             CCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhh
Confidence            666677777766666533 2222111                                  1222222             


Q ss_pred             --------------------------------------------------CCC------CChhccCCCCCCEEeccCCcc
Q 036754          116 --------------------------------------------------FSV------IPIEIGGLPNLEYLFLGYNRL  139 (405)
Q Consensus       116 --------------------------------------------------l~~------~p~~~~~l~~L~~L~l~~n~l  139 (405)
                                                                        ++.      .|..+.++++|++|++++|.+
T Consensus       232 ~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l  311 (455)
T 3v47_A          232 FFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEI  311 (455)
T ss_dssp             HHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             hhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcc
Confidence                                                              221      233456667777777777777


Q ss_pred             cccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCC-CCccCCCCcccccCCCCc
Q 036754          140 QGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELL  211 (405)
Q Consensus       140 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~~  211 (405)
                      .+..|..|..+++|++|++++|.+++..|..+..+++|+.|++++|.+++.+|. ...+++++.+++.+|...
T Consensus       312 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  384 (455)
T 3v47_A          312 NKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK  384 (455)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             cccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccc
Confidence            766677777777777777777777766666777777777777777777665553 345566666666666543

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=3.7e-28  Score=238.22  Aligned_cols=197  Identities=23%  Similarity=0.228  Sum_probs=119.3

Q ss_pred             CCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcc--------
Q 036754            9 NCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISIT--------   80 (405)
Q Consensus         9 ~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--------   80 (405)
                      .+++|+.|+|++|.+++..|.. ++.++ +|+.|+|++|.+++..|  +..+++|++|+|++|.++ .+|..        
T Consensus        32 ~~~~L~~L~Ls~n~l~~~~~~~-~~~l~-~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~-~l~~~~~L~~L~L  106 (487)
T 3oja_A           32 SAWNVKELDLSGNPLSQISAAD-LAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVGPSIETLHA  106 (487)
T ss_dssp             TGGGCCEEECCSSCCCCCCGGG-GTTCT-TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEE-EEEECTTCCEEEC
T ss_pred             cCCCccEEEeeCCcCCCCCHHH-HhCCC-CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCC-CCCCCCCcCEEEC
Confidence            3448999999999999887777 66776 89999999999988665  888899999999999887 33321        


Q ss_pred             --------hhcCCCCCCeeeCCCCCCCCC-chhhhccccCccccCCC------CChhcc-CCCCCCEEeccCCcccccCC
Q 036754           81 --------LGSNLASLRKLSLDSNELTSI-PLTFWNLKDILYLNFSV------IPIEIG-GLPNLEYLFLGYNRLQGSIP  144 (405)
Q Consensus        81 --------~~~~l~~L~~L~Ls~N~l~~l-p~~~~~l~~L~~l~l~~------~p~~~~-~l~~L~~L~l~~n~l~~~~p  144 (405)
                              ....+++|++|+|++|.++.+ |..+.++++|+.|+++.      .|..+. .+++|++|++++|.+++..+
T Consensus       107 ~~N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~  186 (487)
T 3oja_A          107 ANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG  186 (487)
T ss_dssp             CSSCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC
T ss_pred             cCCcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc
Confidence                    001234455555555555543 33445555555555543      233333 45555555555555554322


Q ss_pred             cccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCccC
Q 036754          145 DSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCG  213 (405)
Q Consensus       145 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~  213 (405)
                        +..+++|+.|++++|.+++.+| .+..+++|+.|++++|.+++.++....++++..+++.+|++.|+
T Consensus       187 --~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~  252 (487)
T 3oja_A          187 --QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG  252 (487)
T ss_dssp             --CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred             --cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence              2235556666666666654333 35555566666666666655444444455555555666655543

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=2.5e-25  Score=201.56  Aligned_cols=198  Identities=27%  Similarity=0.356  Sum_probs=172.9

Q ss_pred             cCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCee
Q 036754           12 CLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKL   91 (405)
Q Consensus        12 ~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L   91 (405)
                      .++.+++++|.++.+ |.. +   +.+|+.|+|++|+++...+..|..+++|++|+|++|.++ .+|..++.++++|++|
T Consensus        17 ~~~~l~~~~~~l~~i-p~~-~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L   90 (270)
T 2o6q_A           17 NKNSVDCSSKKLTAI-PSN-I---PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETL   90 (270)
T ss_dssp             TTTEEECTTSCCSSC-CSC-C---CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCCTTTTSSCTTCCEE
T ss_pred             CCCEEEccCCCCCcc-CCC-C---CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeChhhhcCCCCCCEE
Confidence            578999999999874 443 2   348999999999999988888999999999999999998 7888887889999999


Q ss_pred             eCCCCCCCCCchh-hhccccCccccCCC-----C-ChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccccccc
Q 036754           92 SLDSNELTSIPLT-FWNLKDILYLNFSV-----I-PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLS  164 (405)
Q Consensus        92 ~Ls~N~l~~lp~~-~~~l~~L~~l~l~~-----~-p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~  164 (405)
                      +|++|+++.+|.. +.++++|++|+++.     + +..+.++++|++|++++|.+.+..+..|..+++|+.|++++|.++
T Consensus        91 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  170 (270)
T 2o6q_A           91 WVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK  170 (270)
T ss_dssp             ECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             ECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCc
Confidence            9999999988764 57889999998875     3 345789999999999999999877777999999999999999999


Q ss_pred             CccchhHHhcccCCccccccCcccCcCCC-CCccCCCCcccccCCCCccCCC
Q 036754          165 GAIPASLEKLLYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLCGSP  215 (405)
Q Consensus       165 ~~~~~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~~c~~~  215 (405)
                      +..+..|..+++|+.|++++|.+++.++. ...+.+++.+++.+||+.|.+.
T Consensus       171 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          171 RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             EeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence            88888899999999999999999976665 4567889999999999999764

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.93  E-value=8e-26  Score=206.44  Aligned_cols=208  Identities=26%  Similarity=0.299  Sum_probs=176.1

Q ss_pred             ccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCc-ccccCCccccCccCCCeeecCCcccccccCcchhc
Q 036754            5 SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCN-ISGGILEEITNLTKLTTIILGGNKLNGSISITLGS   83 (405)
Q Consensus         5 ~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   83 (405)
                      ..|.++++|++|+|++|.+.+..|.. ++.++ +|+.|+|++|. +....|..|..+++|++|+|++|.++ .++...+.
T Consensus        50 ~~~~~~~~L~~L~l~~n~l~~~~~~~-~~~l~-~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~  126 (285)
T 1ozn_A           50 ASFRACRNLTILWLHSNVLARIDAAA-FTGLA-LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR  126 (285)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTT-TTTCT-TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTT
T ss_pred             HHcccCCCCCEEECCCCccceeCHhh-cCCcc-CCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCC-EECHhHhh
Confidence            46889999999999999999988887 66676 99999999998 88877899999999999999999998 45555557


Q ss_pred             CCCCCCeeeCCCCCCCCCchh-hhccccCccccCCC-----CCh-hccCCCCCCEEeccCCcccccCCcccccCCCCCee
Q 036754           84 NLASLRKLSLDSNELTSIPLT-FWNLKDILYLNFSV-----IPI-EIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSL  156 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~lp~~-~~~l~~L~~l~l~~-----~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L  156 (405)
                      ++++|++|+|++|+++.+|.. +..+++|+.|+++.     +|. .+.++++|++|++++|.+.+..|..|..+++|+.|
T Consensus       127 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  206 (285)
T 1ozn_A          127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL  206 (285)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred             CCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEe
Confidence            899999999999999988765 77899999999876     343 58889999999999999999889999999999999


Q ss_pred             ecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCccCCC
Q 036754          157 NLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP  215 (405)
Q Consensus       157 ~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  215 (405)
                      ++++|.+++..+..+..+++|+.|++++|++.+..+....+..+.......+...|..|
T Consensus       207 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p  265 (285)
T 1ozn_A          207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP  265 (285)
T ss_dssp             ECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred             eCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCc
Confidence            99999999888888999999999999999998755432222233344455666666544

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.93  E-value=2.8e-25  Score=204.96  Aligned_cols=204  Identities=21%  Similarity=0.251  Sum_probs=112.4

Q ss_pred             CCCCCcCCeeeCcCCcCcccC--CchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcC
Q 036754            7 LSNCKCLTFIDLSNNPLDSVL--PKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSN   84 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~--~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~   84 (405)
                      |.++++|+.|+|++|.+....  +.. +..++ +|+.|+|++|.++. +|..+..+++|++|++++|++++..+...+..
T Consensus        48 ~~~l~~L~~L~L~~n~l~~~~~~~~~-~~~~~-~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~  124 (306)
T 2z66_A           48 FDKLTQLTKLSLSSNGLSFKGCCSQS-DFGTT-SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS  124 (306)
T ss_dssp             TTTCTTCSEEECCSSCCCEEEEEEHH-HHSCS-CCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTT
T ss_pred             hhccccCCEEECCCCccCcccCcccc-ccccc-ccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhh
Confidence            445555555555555554321  223 22232 55555555555543 34445556666666666666552222133345


Q ss_pred             CCCCCeeeCCCCCCCC-CchhhhccccCccccCCC-------CChhccCCCCCCEEeccCCcccccCCcccccCCCCCee
Q 036754           85 LASLRKLSLDSNELTS-IPLTFWNLKDILYLNFSV-------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSL  156 (405)
Q Consensus        85 l~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~l~l~~-------~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L  156 (405)
                      +++|++|++++|.++. .|..+.++++|+.|+++.       .|..+..+++|++|++++|.+.+..|..|..+++|+.|
T Consensus       125 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  204 (306)
T 2z66_A          125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL  204 (306)
T ss_dssp             CTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             ccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEE
Confidence            6666666666666653 334455556666665543       34455566666666666666665556666666666666


Q ss_pred             ecccccccCccchhHHhcccCCccccccCcccCcCCCC-Ccc-CCCCcccccCCCCccC
Q 036754          157 NLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG-GSF-GNFSAESFEGNELLCG  213 (405)
Q Consensus       157 ~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~-~~~-~~~~~~~~~~n~~~c~  213 (405)
                      ++++|.+++..+..+..+++|+.|++++|.+++.+|.. ..+ .++..+++.+|++.|.
T Consensus       205 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~  263 (306)
T 2z66_A          205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  263 (306)
T ss_dssp             ECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred             ECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence            66666666555555666666666666666666555432 233 3556666666666554

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.92  E-value=3.6e-25  Score=208.44  Aligned_cols=176  Identities=21%  Similarity=0.202  Sum_probs=134.0

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCe
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~   90 (405)
                      ++|++|+|++|.++++.+.. ++.++ +|+.|+|++|++++..|..|..+++|++|+|++|+++ .+|...+.++++|++
T Consensus        52 ~~L~~L~l~~n~i~~~~~~~-~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~  128 (353)
T 2z80_A           52 EAVKSLDLSNNRITYISNSD-LQRCV-NLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTF  128 (353)
T ss_dssp             TTCCEEECTTSCCCEECTTT-TTTCT-TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSE
T ss_pred             ccCcEEECCCCcCcccCHHH-hccCC-CCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCE
Confidence            47889999999988877666 56666 8999999999988888888888899999999999887 677776678889999


Q ss_pred             eeCCCCCCCCCch--hhhccccCccccCCC-------CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccc
Q 036754           91 LSLDSNELTSIPL--TFWNLKDILYLNFSV-------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKN  161 (405)
Q Consensus        91 L~Ls~N~l~~lp~--~~~~l~~L~~l~l~~-------~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n  161 (405)
                      |+|++|+++.+|.  .+.++++|+.|+++.       .|..+.++++|++|++++|.+.+..|..+..+++|++|++++|
T Consensus       129 L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n  208 (353)
T 2z80_A          129 LNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK  208 (353)
T ss_dssp             EECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECS
T ss_pred             EECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCC
Confidence            9999998888876  677888888887754       2456777888888888888888777877877777777777777


Q ss_pred             cccCccchhHHhcccCCccccccCcccC
Q 036754          162 NLSGAIPASLEKLLYLKDLNLSFNKLEG  189 (405)
Q Consensus       162 ~l~~~~~~~~~~l~~L~~l~l~~n~l~~  189 (405)
                      .+....+..+..+++|+.|++++|.+++
T Consensus       209 ~l~~~~~~~~~~~~~L~~L~L~~n~l~~  236 (353)
T 2z80_A          209 QHILLLEIFVDVTSSVECLELRDTDLDT  236 (353)
T ss_dssp             CSTTHHHHHHHHTTTEEEEEEESCBCTT
T ss_pred             ccccchhhhhhhcccccEEECCCCcccc
Confidence            6654433333445555555555555554

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.92  E-value=9.3e-25  Score=203.31  Aligned_cols=182  Identities=19%  Similarity=0.268  Sum_probs=167.2

Q ss_pred             cccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccC---------ccCCCeeecCCcc
Q 036754            2 SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITN---------LTKLTTIILGGNK   72 (405)
Q Consensus         2 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~---------l~~L~~L~L~~N~   72 (405)
                      ++|+.|+++++|++|+|++|.+. .+|.. ++.++ +|+.|+|++|++.+.+|..+..         +++|++|+|++|.
T Consensus       118 ~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~-l~~l~-~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~  194 (328)
T 4fcg_A          118 ELPDTMQQFAGLETLTLARNPLR-ALPAS-IASLN-RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTG  194 (328)
T ss_dssp             CCCSCGGGGTTCSEEEEESCCCC-CCCGG-GGGCT-TCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEEC
T ss_pred             chhHHHhccCCCCEEECCCCccc-cCcHH-HhcCc-CCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCC
Confidence            36778999999999999999999 56776 67776 9999999999998888887764         9999999999999


Q ss_pred             cccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCC------CChhccCCCCCCEEeccCCcccccCCcc
Q 036754           73 LNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV------IPIEIGGLPNLEYLFLGYNRLQGSIPDS  146 (405)
Q Consensus        73 l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~------~p~~~~~l~~L~~L~l~~n~l~~~~p~~  146 (405)
                      ++ .+|..+ .++++|++|+|++|+++.+|..+..+++|+.|+++.      +|..++++++|++|++++|.+.+.+|..
T Consensus       195 l~-~lp~~l-~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~  272 (328)
T 4fcg_A          195 IR-SLPASI-ANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD  272 (328)
T ss_dssp             CC-CCCGGG-GGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTT
T ss_pred             cC-cchHhh-cCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchh
Confidence            98 899886 589999999999999999999999999999999875      6788999999999999999999999999


Q ss_pred             cccCCCCCeeecccccccCccchhHHhcccCCccccccCccc
Q 036754          147 FGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       147 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~  188 (405)
                      +..+++|+.|++++|++.+.+|..+.++++|+.+++..+.+.
T Consensus       273 ~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          273 IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             GGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             hhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            999999999999999999999999999999999999988765

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.92  E-value=9e-25  Score=220.41  Aligned_cols=207  Identities=20%  Similarity=0.200  Sum_probs=181.1

Q ss_pred             cCCCCCcCCeeeCcCCcCcccC--CchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhc
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVL--PKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGS   83 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~--~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   83 (405)
                      .+..+++|+.|+|++|.+++..  |.. ++.++ +|+.|++++|.+++ +|..+..+++|+.|++++|++.+..|...+.
T Consensus       345 ~~~~l~~L~~L~ls~n~l~~~~~~~~~-~~~~~-~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  421 (606)
T 3vq2_A          345 KKVALPSLSYLDLSRNALSFSGCCSYS-DLGTN-SLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFL  421 (606)
T ss_dssp             CCCCCTTCCEEECCSSCEEEEEECCHH-HHCCS-CCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTT
T ss_pred             hhccCCCCCEEECcCCccCCCcchhhh-hccCC-cccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhh
Confidence            4668899999999999998773  666 56666 89999999999987 5688999999999999999998666645567


Q ss_pred             CCCCCCeeeCCCCCCC-CCchhhhccccCccccCCC-------CChhccCCCCCCEEeccCCcccccCCcccccCCCCCe
Q 036754           84 NLASLRKLSLDSNELT-SIPLTFWNLKDILYLNFSV-------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKS  155 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~l~l~~-------~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  155 (405)
                      ++++|++|++++|.++ ..|..+.++++|+.|+++.       +|..+.++++|++|++++|.+.+..|..|..+++|++
T Consensus       422 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  501 (606)
T 3vq2_A          422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL  501 (606)
T ss_dssp             TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             ccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCE
Confidence            9999999999999998 4677889999999999875       4667899999999999999999999999999999999


Q ss_pred             eecccccccCccchhHHhcccCCccccccCcccCcCCCCCccC-CCCcccccCCCCccCCC
Q 036754          156 LNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFG-NFSAESFEGNELLCGSP  215 (405)
Q Consensus       156 L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~-~~~~~~~~~n~~~c~~~  215 (405)
                      |++++|++++..|..+..+++|+.|++++|.++..++....+. +++.+++.+||+.|.++
T Consensus       502 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~  562 (606)
T 3vq2_A          502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE  562 (606)
T ss_dssp             EECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred             EECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence            9999999999999999999999999999999996655555554 58999999999999765

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.92  E-value=5.9e-25  Score=215.40  Aligned_cols=208  Identities=27%  Similarity=0.320  Sum_probs=146.4

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhc
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGS   83 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   83 (405)
                      +.+|.++++|++|+|++|++..+.+.. ++.++ +|+.|+|++|++++..+..|..+++|+.|+|++|.+++ ++...+.
T Consensus        73 ~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~  149 (477)
T 2id5_A           73 PGAFNNLFNLRTLGLRSNRLKLIPLGV-FTGLS-NLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFS  149 (477)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCSCCTTS-STTCT-TCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCE-ECTTSST
T ss_pred             hhhhhCCccCCEEECCCCcCCccCccc-ccCCC-CCCEEECCCCccccCChhHccccccCCEEECCCCccce-eChhhcc
Confidence            456778888888888888887766655 45555 78888888888877777777777777777777777763 3333345


Q ss_pred             CCCCCCeeeCCCCCCCCCchh-hhccccCcc------------------------ccCCC--------------------
Q 036754           84 NLASLRKLSLDSNELTSIPLT-FWNLKDILY------------------------LNFSV--------------------  118 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~lp~~-~~~l~~L~~------------------------l~l~~--------------------  118 (405)
                      ++++|++|+|++|+++.+|.. +.++++|+.                        |+++.                    
T Consensus       150 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L  229 (477)
T 2id5_A          150 GLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL  229 (477)
T ss_dssp             TCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEE
T ss_pred             CCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEE
Confidence            677777777777777665532 333333333                        33221                    


Q ss_pred             ---------CC-hhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCccc
Q 036754          119 ---------IP-IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       119 ---------~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~  188 (405)
                               +| ..+.++++|++|++++|.+.+..+..|..+++|+.|++++|.+++..|..|..+++|+.|++++|.++
T Consensus       230 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  309 (477)
T 2id5_A          230 SITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT  309 (477)
T ss_dssp             EEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCS
T ss_pred             ECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCc
Confidence                     22 24566777888888888877777777778888888888888888777778888888888888888887


Q ss_pred             CcCCCC-CccCCCCcccccCCCCccCC
Q 036754          189 GEIPRG-GSFGNFSAESFEGNELLCGS  214 (405)
Q Consensus       189 ~~~p~~-~~~~~~~~~~~~~n~~~c~~  214 (405)
                      +.++.. ..+++++.+++.+|++.|.+
T Consensus       310 ~~~~~~~~~l~~L~~L~l~~N~l~c~c  336 (477)
T 2id5_A          310 TLEESVFHSVGNLETLILDSNPLACDC  336 (477)
T ss_dssp             CCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred             eeCHhHcCCCcccCEEEccCCCccCcc
Confidence            665543 45677888888888888765

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.92  E-value=8.3e-25  Score=220.68  Aligned_cols=206  Identities=23%  Similarity=0.219  Sum_probs=163.2

Q ss_pred             CCCCCcCCeeeCcCCcCcccC--CchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcC
Q 036754            7 LSNCKCLTFIDLSNNPLDSVL--PKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSN   84 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~--~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~   84 (405)
                      +.++++|+.|++++|.+.+..  +.. ++.++ +|+.|++++|++.+..|..|..+++|+.|++++|.+++..+...+.+
T Consensus       346 ~~~l~~L~~L~l~~n~l~~~~~~~~~-~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~  423 (606)
T 3t6q_A          346 LENLENLRELDLSHDDIETSDCCNLQ-LRNLS-HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN  423 (606)
T ss_dssp             TTTCTTCCEEECCSSCCCEEEESTTT-TTTCT-TCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTT
T ss_pred             hhccCcCCEEECCCCccccccCcchh-cccCC-CCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhC
Confidence            667777777777777777665  444 45555 78888888888877777788888888888888888876666665567


Q ss_pred             CCCCCeeeCCCCCCCCC-chhhhccccCccccCCCC---------ChhccCCCCCCEEeccCCcccccCCcccccCCCCC
Q 036754           85 LASLRKLSLDSNELTSI-PLTFWNLKDILYLNFSVI---------PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLK  154 (405)
Q Consensus        85 l~~L~~L~Ls~N~l~~l-p~~~~~l~~L~~l~l~~~---------p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  154 (405)
                      +++|++|++++|.++.. |..+..+++|+.|+++..         +..+..+++|++|++++|.+.+..|..|..+++|+
T Consensus       424 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  503 (606)
T 3t6q_A          424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN  503 (606)
T ss_dssp             CTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             cccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCC
Confidence            88888888888888744 566778888888887752         13577888999999999999888888889999999


Q ss_pred             eeecccccccCccchhHHhcccCCccccccCcccCcCCCC-CccCCCCcccccCCCCccCCC
Q 036754          155 SLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSP  215 (405)
Q Consensus       155 ~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~  215 (405)
                      .|++++|++++..|..+..++.| .|++++|.+++.+|.. ..+++++.+++.+||+.|.++
T Consensus       504 ~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          504 HVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS  564 (606)
T ss_dssp             EEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred             EEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence            99999999988888888889999 8999999998777753 556788899999999988654

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.91  E-value=4e-24  Score=208.04  Aligned_cols=197  Identities=24%  Similarity=0.310  Sum_probs=176.3

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCe
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~   90 (405)
                      ++|+.|+|++|+|.++.|.. +++++ +|+.|+|++|++++..+..|.++++|++|+|++|+++ .+|...+.++++|++
T Consensus        75 ~~l~~L~L~~n~i~~~~~~~-~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~  151 (452)
T 3zyi_A           75 SNTRYLNLMENNIQMIQADT-FRHLH-HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRE  151 (452)
T ss_dssp             TTCSEEECCSSCCCEECTTT-TTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS-BCCTTTSSSCTTCCE
T ss_pred             CCccEEECcCCcCceECHHH-cCCCC-CCCEEECCCCccCCcChhhccCcccCCEEECCCCcCC-ccChhhhcccCCCCE
Confidence            58999999999999998888 66776 9999999999999999999999999999999999998 778777789999999


Q ss_pred             eeCCCCCCCCCch-hhhccccCccccCCC------CC-hhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccccc
Q 036754           91 LSLDSNELTSIPL-TFWNLKDILYLNFSV------IP-IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN  162 (405)
Q Consensus        91 L~Ls~N~l~~lp~-~~~~l~~L~~l~l~~------~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~  162 (405)
                      |+|++|+++.+|. .+.++++|+.|+++.      ++ ..+.++++|++|++++|.+++ +| .+..+++|+.|++++|.
T Consensus       152 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~  229 (452)
T 3zyi_A          152 LWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNH  229 (452)
T ss_dssp             EECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSC
T ss_pred             EECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCc
Confidence            9999999998876 678899999999875      33 358899999999999999985 44 58899999999999999


Q ss_pred             ccCccchhHHhcccCCccccccCcccCcCCC-CCccCCCCcccccCCCCcc
Q 036754          163 LSGAIPASLEKLLYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLC  212 (405)
Q Consensus       163 l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~~c  212 (405)
                      +++..|..|..+++|+.|++++|.+++..|. ...+++++.+++.+|.+..
T Consensus       230 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  280 (452)
T 3zyi_A          230 FPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS  280 (452)
T ss_dssp             CSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCc
Confidence            9999999999999999999999999987665 4567889999999997653

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.91  E-value=3e-24  Score=219.48  Aligned_cols=211  Identities=22%  Similarity=0.233  Sum_probs=169.8

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccc--cccCcch
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLN--GSISITL   81 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~   81 (405)
                      +.+|.++++|+.|+|++|.+.+.+|...++.++ +|+.|++++|++.+..+..|..+++|+.|++++|.+.  +.+|..+
T Consensus       398 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~  476 (680)
T 1ziw_A          398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE-NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF  476 (680)
T ss_dssp             TTTTTTCTTCCEEECCSSCCEEECCSGGGTTCT-TCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTT
T ss_pred             hhhhhCCCCCCEEeCCCCcCccccCcccccCcc-cccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCccc
Confidence            345677777777777777777655543355555 7788888888777777777777888888888888775  3456555


Q ss_pred             hcCCCCCCeeeCCCCCCCCCch-hhhccccCccccCCCC----------C----hhccCCCCCCEEeccCCcccccCCcc
Q 036754           82 GSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSVI----------P----IEIGGLPNLEYLFLGYNRLQGSIPDS  146 (405)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~~lp~-~~~~l~~L~~l~l~~~----------p----~~~~~l~~L~~L~l~~n~l~~~~p~~  146 (405)
                       .++++|++|+|++|+++.+|. .+.++++|++|+++..          |    ..+.++++|++|++++|.+....+..
T Consensus       477 -~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~  555 (680)
T 1ziw_A          477 -QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV  555 (680)
T ss_dssp             -TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred             -ccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHH
Confidence             589999999999999998865 4778999999998752          1    12788999999999999999666667


Q ss_pred             cccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCC--ccCCCCcccccCCCCccCCCC
Q 036754          147 FGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGG--SFGNFSAESFEGNELLCGSPN  216 (405)
Q Consensus       147 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~--~~~~~~~~~~~~n~~~c~~~~  216 (405)
                      |.++++|+.|++++|.+++.++..|..+++|+.|++++|.+++.+|...  .+.+++.+++.+|||.|.|+.
T Consensus       556 ~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             cccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            9999999999999999998888888999999999999999998776532  578899999999999998763

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.91  E-value=6e-24  Score=206.03  Aligned_cols=197  Identities=25%  Similarity=0.336  Sum_probs=176.0

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCe
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~   90 (405)
                      ++++.|+|++|++.++.+.. +++++ +|+.|+|++|.++...+..|.++++|++|+|++|+++ .+|...+.++++|++
T Consensus        64 ~~l~~L~L~~n~i~~~~~~~-~~~l~-~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~  140 (440)
T 3zyj_A           64 TNTRLLNLHENQIQIIKVNS-FKHLR-HLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKE  140 (440)
T ss_dssp             TTCSEEECCSCCCCEECTTT-TSSCS-SCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCS-SCCTTTSCSCSSCCE
T ss_pred             CCCcEEEccCCcCCeeCHHH-hhCCC-CCCEEECCCCcCCccChhhccCCccCCEEECCCCcCC-eeCHhHhhccccCce
Confidence            57999999999999988888 66776 9999999999999998899999999999999999998 778777789999999


Q ss_pred             eeCCCCCCCCCch-hhhccccCccccCCC------CC-hhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccccc
Q 036754           91 LSLDSNELTSIPL-TFWNLKDILYLNFSV------IP-IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN  162 (405)
Q Consensus        91 L~Ls~N~l~~lp~-~~~~l~~L~~l~l~~------~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~  162 (405)
                      |+|++|+++.+|. .+.++++|+.|+++.      ++ ..+.++++|++|++++|.++ .+| .+..+++|+.|++++|.
T Consensus       141 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~  218 (440)
T 3zyj_A          141 LWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNH  218 (440)
T ss_dssp             EECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSC
T ss_pred             eeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCc
Confidence            9999999998876 678899999999875      33 36889999999999999998 455 48899999999999999


Q ss_pred             ccCccchhHHhcccCCccccccCcccCcCCC-CCccCCCCcccccCCCCcc
Q 036754          163 LSGAIPASLEKLLYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLC  212 (405)
Q Consensus       163 l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~~c  212 (405)
                      +++..|..|..+++|+.|++++|.+++..+. ...+.+++.+++.+|.+..
T Consensus       219 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  269 (440)
T 3zyj_A          219 LSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL  269 (440)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC
T ss_pred             cCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc
Confidence            9999999999999999999999999987765 4567889999999997654

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.91  E-value=1.1e-23  Score=201.11  Aligned_cols=199  Identities=21%  Similarity=0.244  Sum_probs=117.6

Q ss_pred             CCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCC
Q 036754            8 SNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLAS   87 (405)
Q Consensus         8 ~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~   87 (405)
                      .++++|++|+|++|.+.+..+.. ++.++ +|+.|+|++|.+++..|..|+.+++|++|+|++|.++ .+|..++.++++
T Consensus        66 ~~l~~L~~L~L~~n~i~~~~~~~-~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~  142 (390)
T 3o6n_A           66 DSFRQVELLNLNDLQIEEIDTYA-FAYAH-TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPK  142 (390)
T ss_dssp             HHCCCCSEEECTTSCCCEECTTT-TTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTT
T ss_pred             cccccCcEEECCCCcccccChhh-ccCCC-CcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCC
Confidence            44555555555555555544444 33333 4555555555555544444555555555555555554 444444444555


Q ss_pred             CCeeeCCCCCCCCCch-hhhccccCccccCCC------------------------------------------------
Q 036754           88 LRKLSLDSNELTSIPL-TFWNLKDILYLNFSV------------------------------------------------  118 (405)
Q Consensus        88 L~~L~Ls~N~l~~lp~-~~~~l~~L~~l~l~~------------------------------------------------  118 (405)
                      |++|++++|+++.++. .+.++++|+.|+++.                                                
T Consensus       143 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~  222 (390)
T 3o6n_A          143 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRG  222 (390)
T ss_dssp             CCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEEC
T ss_pred             CcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeeccc
Confidence            5555555555544322 233444444443322                                                


Q ss_pred             -----------------CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccc
Q 036754          119 -----------------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLN  181 (405)
Q Consensus       119 -----------------~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~  181 (405)
                                       -+..+..+++|++|++++|.+.+..|..|..+++|+.|++++|.+++ +|..+..+++|+.|+
T Consensus       223 ~~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~  301 (390)
T 3o6n_A          223 PVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD  301 (390)
T ss_dssp             CCCSSCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEE
T ss_pred             cccccccEEECCCCCCcccHHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEE
Confidence                             01234566788888888888887778888888888888888888875 455556677888888


Q ss_pred             cccCcccCcCCCCCccCCCCcccccCCCC
Q 036754          182 LSFNKLEGEIPRGGSFGNFSAESFEGNEL  210 (405)
Q Consensus       182 l~~n~l~~~~p~~~~~~~~~~~~~~~n~~  210 (405)
                      +++|.+++.++....+++++.+++.+|+.
T Consensus       302 L~~n~l~~~~~~~~~l~~L~~L~L~~N~i  330 (390)
T 3o6n_A          302 LSHNHLLHVERNQPQFDRLENLYLDHNSI  330 (390)
T ss_dssp             CCSSCCCCCGGGHHHHTTCSEEECCSSCC
T ss_pred             CCCCcceecCccccccCcCCEEECCCCcc
Confidence            88888776555555567777777777765

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.91  E-value=1.1e-23  Score=212.08  Aligned_cols=201  Identities=22%  Similarity=0.268  Sum_probs=101.6

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      .|+++++|++|+|++|.+++..|.. ++.++ +|+.|+|++|.+++..+..|..+++|++|+|++|.+++ ++...+.++
T Consensus        94 ~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~-~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l  170 (597)
T 3oja_B           94 AFAYAHTIQKLYMGFNAIRYLPPHV-FQNVP-LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQAT  170 (597)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTT-TTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB-CCTTTTTTC
T ss_pred             HhcCCCCCCEEECCCCcCCCCCHHH-HcCCC-CCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCC-CChhhhhcC
Confidence            4455555555555555555544444 34443 55555555555554444444555555555555555552 222222355


Q ss_pred             CCCCeeeCCCCCCCCCchh------------------------------------------------------------h
Q 036754           86 ASLRKLSLDSNELTSIPLT------------------------------------------------------------F  105 (405)
Q Consensus        86 ~~L~~L~Ls~N~l~~lp~~------------------------------------------------------------~  105 (405)
                      ++|++|+|++|.++.+|..                                                            +
T Consensus       171 ~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~~~~l  250 (597)
T 3oja_B          171 TSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWL  250 (597)
T ss_dssp             TTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCCCGGG
T ss_pred             CcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCCChhh
Confidence            5555555555555433211                                                            1


Q ss_pred             hccccCccccCCC------CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCc
Q 036754          106 WNLKDILYLNFSV------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKD  179 (405)
Q Consensus       106 ~~l~~L~~l~l~~------~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  179 (405)
                      ..+++|+.|+++.      .|..++++++|++|++++|.+.+ +|..+..+++|+.|++++|.++ .+|..+..+++|+.
T Consensus       251 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~  328 (597)
T 3oja_B          251 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN  328 (597)
T ss_dssp             GGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSE
T ss_pred             ccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCE
Confidence            1222223333222      13334444444444444444443 2333344555555555555555 34555566666666


Q ss_pred             cccccCcccCcCCCCCccCCCCcccccCCCCccC
Q 036754          180 LNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCG  213 (405)
Q Consensus       180 l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~  213 (405)
                      |++++|.+++..  ...++++..+++.+|++.|.
T Consensus       329 L~L~~N~l~~~~--~~~~~~L~~L~l~~N~~~~~  360 (597)
T 3oja_B          329 LYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCN  360 (597)
T ss_dssp             EECCSSCCCCCC--CCTTCCCSEEECCSSCEEHH
T ss_pred             EECCCCCCCCcC--hhhcCCCCEEEeeCCCCCCh
Confidence            666666665442  34466777788888888774

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.91  E-value=7.7e-24  Score=214.43  Aligned_cols=205  Identities=17%  Similarity=0.193  Sum_probs=173.2

Q ss_pred             ccccCCCCCc-CCeeeCcCCcCcccCCchhhhcc-cccccEEEcccCcccccCCcccc-------CccCCCeeecCCccc
Q 036754            3 FLSSLSNCKC-LTFIDLSNNPLDSVLPKTFVGNV-SHSLEFFVMSYCNISGGILEEIT-------NLTKLTTIILGGNKL   73 (405)
Q Consensus         3 ~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~f~~~~-~~~L~~L~L~~n~l~~~~~~~~~-------~l~~L~~L~L~~N~l   73 (405)
                      +|+.|.++++ |+.|+|++|.++ .+|.. ++.. ..+|+.|++++|.+++..|..+.       .+++|++|+|++|++
T Consensus       368 lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l  445 (636)
T 4eco_A          368 IPANFCGFTEQVENLSFAHNKLK-YIPNI-FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQI  445 (636)
T ss_dssp             CCTTSEEECTTCCEEECCSSCCS-SCCSC-CCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCC
T ss_pred             ccHhhhhhcccCcEEEccCCcCc-ccchh-hhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCcc
Confidence            5677888888 999999999998 45655 3322 12799999999999998888888       788999999999999


Q ss_pred             ccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccc--------cCccccCCC-----CChhcc--CCCCCCEEeccCCc
Q 036754           74 NGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLK--------DILYLNFSV-----IPIEIG--GLPNLEYLFLGYNR  138 (405)
Q Consensus        74 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~--------~L~~l~l~~-----~p~~~~--~l~~L~~L~l~~n~  138 (405)
                      + .+|..++..+++|++|+|++|+++.+|.......        +|+.|+++.     +|..+.  .+++|++|++++|+
T Consensus       446 ~-~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~  524 (636)
T 4eco_A          446 S-KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNS  524 (636)
T ss_dssp             C-SCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCCBCCGGGSTTTCTTCCEEECCSSC
T ss_pred             C-cCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCCccChhhhhccCCCcCEEECCCCC
Confidence            8 8898888889999999999999999987655432        888888765     788887  89999999999999


Q ss_pred             ccccCCcccccCCCCCeeec------ccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCcc
Q 036754          139 LQGSIPDSFGDLISLKSLNL------SKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC  212 (405)
Q Consensus       139 l~~~~p~~~~~l~~L~~L~l------~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c  212 (405)
                      +++ +|..+..+++|+.|++      ++|.+.+.+|..+..+++|+.|++++|.+ +.+|... .++++.+++++|++.|
T Consensus       525 l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~-~~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          525 FSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI-TPNISVLDIKDNPNIS  601 (636)
T ss_dssp             CSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC-CTTCCEEECCSCTTCE
T ss_pred             CCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhH-hCcCCEEECcCCCCcc
Confidence            997 8889999999999999      56788889999999999999999999999 4566542 3789999999999887


Q ss_pred             C
Q 036754          213 G  213 (405)
Q Consensus       213 ~  213 (405)
                      .
T Consensus       602 ~  602 (636)
T 4eco_A          602 I  602 (636)
T ss_dssp             E
T ss_pred             c
Confidence            4

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=1.7e-23  Score=187.36  Aligned_cols=180  Identities=28%  Similarity=0.357  Sum_probs=148.1

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCe
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~   90 (405)
                      ...+.++++++.++.+.+..     +.+|+.|+|++|++++..+..|..+++|++|+|++|.++ .++...+.++++|++
T Consensus        14 ~~~~~l~~~~~~l~~~p~~~-----~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~   87 (251)
T 3m19_A           14 EGKKEVDCQGKSLDSVPSGI-----PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGT   87 (251)
T ss_dssp             GGGTEEECTTCCCSSCCSCC-----CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCE
T ss_pred             CCCeEEecCCCCccccCCCC-----CCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCC-ccCHhHhccCCcCCE
Confidence            46789999999998755432     248999999999999988889999999999999999998 455565678999999


Q ss_pred             eeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchh
Q 036754           91 LSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPAS  170 (405)
Q Consensus        91 L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~  170 (405)
                      |+|++|+++.+|..                 .+.++++|++|++++|.+++..+..|..+++|+.|++++|.+++..+..
T Consensus        88 L~L~~n~l~~~~~~-----------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  150 (251)
T 3m19_A           88 LGLANNQLASLPLG-----------------VFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGA  150 (251)
T ss_dssp             EECTTSCCCCCCTT-----------------TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred             EECCCCcccccChh-----------------HhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHH
Confidence            99999999987754                 3456778888888888888777777788888888888888888777777


Q ss_pred             HHhcccCCccccccCcccCcCCC-CCccCCCCcccccCCCCccC
Q 036754          171 LEKLLYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLCG  213 (405)
Q Consensus       171 ~~~l~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~~c~  213 (405)
                      +..+++|+.|++++|.+++.++. ...+++++.+++.+|++.|.
T Consensus       151 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          151 FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             cCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            88888888888888888876663 45667888888888888775

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.91  E-value=3.5e-23  Score=192.94  Aligned_cols=197  Identities=23%  Similarity=0.257  Sum_probs=122.4

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcch---------
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITL---------   81 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---------   81 (405)
                      ++|+.|+|++|+++++.+.. +++++ +|++|+|++|++++..|..|+.+++|++|+|++|.++ .+|..+         
T Consensus        52 ~~l~~L~L~~n~i~~~~~~~-~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~~L~~L~l  128 (330)
T 1xku_A           52 PDTALLDLQNNKITEIKDGD-FKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRV  128 (330)
T ss_dssp             TTCCEEECCSSCCCCBCTTT-TTTCT-TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCCTTCCEEEC
T ss_pred             CCCeEEECCCCcCCEeChhh-hccCC-CCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhcccccEEEC
Confidence            35566666666665555544 44444 5666666666666555556666666666666666554 444433         


Q ss_pred             ------------hcCCCCCCeeeCCCCCCC---CCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccc
Q 036754           82 ------------GSNLASLRKLSLDSNELT---SIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQG  141 (405)
Q Consensus        82 ------------~~~l~~L~~L~Ls~N~l~---~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~  141 (405)
                                  +.++++|++|++++|.++   ..+..+.++++|++|+++.     +|..+.  ++|++|++++|.+.+
T Consensus       129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~l~~  206 (330)
T 1xku_A          129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKITK  206 (330)
T ss_dssp             CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCC--TTCSEEECTTSCCCE
T ss_pred             CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCcccc--ccCCEEECCCCcCCc
Confidence                        344555555555555554   2233445555555555443     333222  567777777777776


Q ss_pred             cCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCcc
Q 036754          142 SIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC  212 (405)
Q Consensus       142 ~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c  212 (405)
                      ..|..|..+++|+.|++++|.+++..+..+..+++|+.|++++|.++..+.....+++++.+++.+|++..
T Consensus       207 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~  277 (330)
T 1xku_A          207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA  277 (330)
T ss_dssp             ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCC
T ss_pred             cCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCCc
Confidence            66777778888888888888887776777777888888888888877544445666777777787777644

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=1.5e-23  Score=190.08  Aligned_cols=185  Identities=28%  Similarity=0.351  Sum_probs=139.2

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCC
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLA   86 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~   86 (405)
                      +..+++|+.|++++|.+.....   ++.++ +|+.|+|++|.+++.  ..+..+++|++|+|++|.++ .++...+.+++
T Consensus        37 ~~~l~~L~~L~l~~~~i~~~~~---l~~l~-~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~-~~~~~~~~~l~  109 (272)
T 3rfs_A           37 QNELNSIDQIIANNSDIKSVQG---IQYLP-NVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQ-SLPNGVFDKLT  109 (272)
T ss_dssp             HHHHTTCCEEECTTSCCCCCTT---GGGCT-TCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCC-CCCTTTTTTCT
T ss_pred             cccccceeeeeeCCCCcccccc---cccCC-CCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccC-ccChhHhcCCc
Confidence            4567788888888888875432   45565 888888888888763  46788888888888888887 56666556888


Q ss_pred             CCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCc
Q 036754           87 SLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGA  166 (405)
Q Consensus        87 ~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~  166 (405)
                      +|++|+|++|+++.+|..                 .+.++++|++|++++|.+.+..+..|..+++|+.|++++|.+++.
T Consensus       110 ~L~~L~L~~n~l~~~~~~-----------------~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  172 (272)
T 3rfs_A          110 NLKELVLVENQLQSLPDG-----------------VFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL  172 (272)
T ss_dssp             TCCEEECTTSCCCCCCTT-----------------TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCCEEECCCCcCCccCHH-----------------HhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCcc
Confidence            888888888888876644                 245567778888888888776666677788888888888888777


Q ss_pred             cchhHHhcccCCccccccCcccCcCCCC-CccCCCCcccccCCCCccCCC
Q 036754          167 IPASLEKLLYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSP  215 (405)
Q Consensus       167 ~~~~~~~l~~L~~l~l~~n~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~  215 (405)
                      .+..+..+++|+.|++++|.+++.+|.. ..+++++.+++.+|++.|.++
T Consensus       173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  222 (272)
T 3rfs_A          173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP  222 (272)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence            7767777788888888888887766653 556777777888887777654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.91  E-value=5.9e-24  Score=196.02  Aligned_cols=199  Identities=23%  Similarity=0.287  Sum_probs=173.3

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCccccc--CCccccCccCCCeeecCCcccccccCcchhcCCCCC
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGG--ILEEITNLTKLTTIILGGNKLNGSISITLGSNLASL   88 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L   88 (405)
                      ++|++|+|++|.+..+.+.. ++.++ +|+.|+|++|+++..  .+..+..+++|++|+|++|.++ .+|..+ ..+++|
T Consensus        28 ~~l~~L~L~~n~l~~i~~~~-~~~l~-~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~-~~l~~L  103 (306)
T 2z66_A           28 SSATRLELESNKLQSLPHGV-FDKLT-QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF-LGLEQL  103 (306)
T ss_dssp             TTCCEEECCSSCCCCCCTTT-TTTCT-TCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEE-ETCTTC
T ss_pred             CCCCEEECCCCccCccCHhH-hhccc-cCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhc-CCCCCC
Confidence            68999999999999766655 66776 999999999999843  3677788999999999999998 678775 589999


Q ss_pred             CeeeCCCCCCCCCch--hhhccccCccccCCC------CChhccCCCCCCEEeccCCcccc-cCCcccccCCCCCeeecc
Q 036754           89 RKLSLDSNELTSIPL--TFWNLKDILYLNFSV------IPIEIGGLPNLEYLFLGYNRLQG-SIPDSFGDLISLKSLNLS  159 (405)
Q Consensus        89 ~~L~Ls~N~l~~lp~--~~~~l~~L~~l~l~~------~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~l~  159 (405)
                      ++|++++|+++.++.  .+.++++|++|+++.      .|..+.++++|++|++++|.+.+ ..|..+..+++|+.|+++
T Consensus       104 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls  183 (306)
T 2z66_A          104 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS  183 (306)
T ss_dssp             CEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECT
T ss_pred             CEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECC
Confidence            999999999998875  788999999999876      45668899999999999999986 678899999999999999


Q ss_pred             cccccCccchhHHhcccCCccccccCcccCcCCC-CCccCCCCcccccCCCCccC
Q 036754          160 KNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLCG  213 (405)
Q Consensus       160 ~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~~c~  213 (405)
                      +|.+++..|..+..+++|+.|++++|.+++..+. ...+.+++.+++.+|.....
T Consensus       184 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  238 (306)
T 2z66_A          184 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS  238 (306)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBC
T ss_pred             CCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCccc
Confidence            9999988899999999999999999999876653 45678899999999987553

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.91  E-value=1.1e-23  Score=204.97  Aligned_cols=208  Identities=20%  Similarity=0.244  Sum_probs=170.1

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCc-chh
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISI-TLG   82 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~   82 (405)
                      ++.|+++++|++|+|++|.+.+.++...++.++ +|++|+|++|++++..|..|+.+++|++|+|++|++++.++. ..+
T Consensus        47 ~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  125 (455)
T 3v47_A           47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS-SLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFF  125 (455)
T ss_dssp             TTTTSSCTTCCEEECCCCSTTCEECTTTTTTCT-TCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTT
T ss_pred             hhHhccCccccEEECcCCcccceECcccccccc-cCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccc
Confidence            567899999999999999998555444367776 999999999999998899999999999999999999865544 345


Q ss_pred             cCCCCCCeeeCCCCCCCCC-chh-hhccccCccccCCC------CChhccC-----------------------------
Q 036754           83 SNLASLRKLSLDSNELTSI-PLT-FWNLKDILYLNFSV------IPIEIGG-----------------------------  125 (405)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~l-p~~-~~~l~~L~~l~l~~------~p~~~~~-----------------------------  125 (405)
                      ..+++|++|+|++|+++.+ |.. +.++++|++|+++.      .|..+..                             
T Consensus       126 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~  205 (455)
T 3v47_A          126 KPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC  205 (455)
T ss_dssp             TTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHH
T ss_pred             cCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhcccccc
Confidence            6899999999999999976 555 78899999998764      1221111                             


Q ss_pred             -----C---------------------------------------------------------------CCCCEEeccCC
Q 036754          126 -----L---------------------------------------------------------------PNLEYLFLGYN  137 (405)
Q Consensus       126 -----l---------------------------------------------------------------~~L~~L~l~~n  137 (405)
                           +                                                               ++|++|++++|
T Consensus       206 ~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n  285 (455)
T 3v47_A          206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKS  285 (455)
T ss_dssp             CCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSS
T ss_pred             ccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCc
Confidence                 1                                                               35666666666


Q ss_pred             cccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCC-CCccCCCCcccccCCCCcc
Q 036754          138 RLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLC  212 (405)
Q Consensus       138 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~~c  212 (405)
                      .+.+..|..|+.+++|+.|++++|.+++..|..+..+++|+.|++++|.+++.+|. ...+.+++.+++.+|....
T Consensus       286 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  361 (455)
T 3v47_A          286 KIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA  361 (455)
T ss_dssp             CCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCE
T ss_pred             cccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccc
Confidence            66666788899999999999999999998899999999999999999999887665 3668899999999997643

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.91  E-value=2.3e-24  Score=225.27  Aligned_cols=205  Identities=23%  Similarity=0.291  Sum_probs=137.4

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhc
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGS   83 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   83 (405)
                      +..|..+++|+.|+|++|++.+..|.. ++.++ +|+.|+|++|++++..|..|..+++|++|+|++|++. .++...+.
T Consensus       283 ~~~~~~l~~L~~L~L~~n~i~~~~~~~-~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~  359 (844)
T 3j0a_A          283 SRVFETLKDLKVLNLAYNKINKIADEA-FYGLD-NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFK  359 (844)
T ss_dssp             SCCSSSCCCCCEEEEESCCCCEECTTT-TTTCS-SCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCC-CCCSSCSC
T ss_pred             hhhhhcCCCCCEEECCCCcCCCCChHH-hcCCC-CCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCC-ccChhhhc
Confidence            345677888888888888888777776 45555 7888888888887777778888888888888888876 55555556


Q ss_pred             CCCCCCeeeCCCCCCCCCch-----------------------------------------hhhccccCccccCCC----
Q 036754           84 NLASLRKLSLDSNELTSIPL-----------------------------------------TFWNLKDILYLNFSV----  118 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~lp~-----------------------------------------~~~~l~~L~~l~l~~----  118 (405)
                      ++++|++|+|++|.++.++.                                         .+.++++|+.|+++.    
T Consensus       360 ~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~  439 (844)
T 3j0a_A          360 FLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS  439 (844)
T ss_dssp             SCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCC
T ss_pred             CCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCccc
Confidence            77777777777777664431                                         011333444443322    


Q ss_pred             --------------------------------CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCc
Q 036754          119 --------------------------------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGA  166 (405)
Q Consensus       119 --------------------------------~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~  166 (405)
                                                      .|..+.++++|++|+|++|.+++.+|..|..+++|+.|++++|++++.
T Consensus       440 ~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l  519 (844)
T 3j0a_A          440 SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVL  519 (844)
T ss_dssp             CCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSC
T ss_pred             ccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCcc
Confidence                                            012244556666666666666666666666666677777777766665


Q ss_pred             cchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCccCCC
Q 036754          167 IPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP  215 (405)
Q Consensus       167 ~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  215 (405)
                      ++..+.  ++|+.|++++|.+++.+|..  +.++..+++.+||+.|.|+
T Consensus       520 ~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          520 SHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECE  564 (844)
T ss_dssp             CCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSS
T ss_pred             Chhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccc
Confidence            555543  56667777777776666643  5678889999999999765

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.91  E-value=3.3e-24  Score=204.56  Aligned_cols=199  Identities=19%  Similarity=0.186  Sum_probs=130.0

Q ss_pred             CCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCC
Q 036754           10 CKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLR   89 (405)
Q Consensus        10 l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~   89 (405)
                      +++++.|++++|.+..+.+.. +..++ +|+.|+|++|.+++..+..|..+++|++|+|++|.++ .++...+.++++|+
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~-~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~  120 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAAL-LDSFR-QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLT  120 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHH-HHHCC-CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCC
T ss_pred             cCCceEEEecCCchhhCChhH-hcccc-cCcEEECCCCcccccChhhccCCCCcCEEECCCCCCC-cCCHHHhcCCCCCC
Confidence            466777777777776654443 45555 6777777777777766667777777777777777776 44444445677777


Q ss_pred             eeeCCCCCCCCCchhh-hccccCccccCCC------CChhccCCCCCCEEeccCCcccccCC------------------
Q 036754           90 KLSLDSNELTSIPLTF-WNLKDILYLNFSV------IPIEIGGLPNLEYLFLGYNRLQGSIP------------------  144 (405)
Q Consensus        90 ~L~Ls~N~l~~lp~~~-~~l~~L~~l~l~~------~p~~~~~l~~L~~L~l~~n~l~~~~p------------------  144 (405)
                      +|+|++|+++.+|... .++++|++|+++.      .|..+.++++|++|++++|.+.+...                  
T Consensus       121 ~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~  200 (390)
T 3o6n_A          121 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLST  200 (390)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSE
T ss_pred             EEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccc
Confidence            7777777777776653 5677777776654      23346666666666666666553211                  


Q ss_pred             -----------------------------------------cccccCCCCCeeecccccccCccchhHHhcccCCccccc
Q 036754          145 -----------------------------------------DSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLS  183 (405)
Q Consensus       145 -----------------------------------------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~  183 (405)
                                                               ..+..+++|+.|++++|.+++..|..+..+++|+.|+++
T Consensus       201 ~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  280 (390)
T 3o6n_A          201 LAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS  280 (390)
T ss_dssp             EECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECC
T ss_pred             cCCCCcceEEECCCCeeeeccccccccccEEECCCCCCcccHHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECC
Confidence                                                     123445667777777777776667777777777777777


Q ss_pred             cCcccCcCCCCCccCCCCcccccCCCCc
Q 036754          184 FNKLEGEIPRGGSFGNFSAESFEGNELL  211 (405)
Q Consensus       184 ~n~l~~~~p~~~~~~~~~~~~~~~n~~~  211 (405)
                      +|.+++.++....+++++.+++.+|...
T Consensus       281 ~n~l~~~~~~~~~l~~L~~L~L~~n~l~  308 (390)
T 3o6n_A          281 NNRLVALNLYGQPIPTLKVLDLSHNHLL  308 (390)
T ss_dssp             SSCCCEEECSSSCCTTCCEEECCSSCCC
T ss_pred             CCcCcccCcccCCCCCCCEEECCCCcce
Confidence            7777665544555667777777777553

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.90  E-value=2.2e-24  Score=218.44  Aligned_cols=180  Identities=26%  Similarity=0.381  Sum_probs=148.0

Q ss_pred             CCchhhhcccccccEEEcccCccccc-----------------CCcccc--CccCCCeeecCCcccccccCcchhcCCCC
Q 036754           27 LPKTFVGNVSHSLEFFVMSYCNISGG-----------------ILEEIT--NLTKLTTIILGGNKLNGSISITLGSNLAS   87 (405)
Q Consensus        27 ~~~~f~~~~~~~L~~L~L~~n~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~~l~~   87 (405)
                      +|.. +++++ +|++|+|++|.+++.                 +|..++  ++++|++|+|++|++.+.+|..+. ++++
T Consensus       198 ip~~-l~~l~-~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~  274 (636)
T 4eco_A          198 VSKA-VMRLT-KLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPE  274 (636)
T ss_dssp             ECGG-GGGCT-TCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT-TCSS
T ss_pred             CCHH-Hhccc-CCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh-cCCC
Confidence            5666 66776 899999999999886                 888888  899999999999998888887764 8999


Q ss_pred             CCeeeCCCCC-CC--CCchhhhcc------ccCccccCCC-----CCh--hccCCCCCCEEeccCCcccccCCcccccCC
Q 036754           88 LRKLSLDSNE-LT--SIPLTFWNL------KDILYLNFSV-----IPI--EIGGLPNLEYLFLGYNRLQGSIPDSFGDLI  151 (405)
Q Consensus        88 L~~L~Ls~N~-l~--~lp~~~~~l------~~L~~l~l~~-----~p~--~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~  151 (405)
                      |++|+|++|+ ++  .+|..++++      ++|+.|+++.     +|.  .++++++|++|++++|.+.|.+| .|+.++
T Consensus       275 L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~  353 (636)
T 4eco_A          275 MQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEI  353 (636)
T ss_dssp             CCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEE
T ss_pred             CCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCC
Confidence            9999999998 87  488888776      8888888764     777  78889999999999999988888 888899


Q ss_pred             CCCeeecccccccCccchhHHhccc-CCccccccCcccCcCCCC-Cc--cCCCCcccccCCCCcc
Q 036754          152 SLKSLNLSKNNLSGAIPASLEKLLY-LKDLNLSFNKLEGEIPRG-GS--FGNFSAESFEGNELLC  212 (405)
Q Consensus       152 ~L~~L~l~~n~l~~~~~~~~~~l~~-L~~l~l~~n~l~~~~p~~-~~--~~~~~~~~~~~n~~~c  212 (405)
                      +|+.|++++|.++ .+|..+..+++ |+.|++++|.++ .+|.. ..  +.+++.+++.+|....
T Consensus       354 ~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~  416 (636)
T 4eco_A          354 KLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGS  416 (636)
T ss_dssp             EESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTT
T ss_pred             CCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCC
Confidence            9999999999988 67778888888 999999999988 44543 22  2367788888887643

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=2e-23  Score=186.82  Aligned_cols=162  Identities=26%  Similarity=0.332  Sum_probs=144.9

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCe
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~   90 (405)
                      ++|+.|+|++|.+.+..+.. ++.++ +|+.|+|++|.+++..+..|..+++|++|+|++|+++ .+|...+..+++|++
T Consensus        35 ~~l~~L~L~~n~l~~~~~~~-~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~  111 (251)
T 3m19_A           35 ADTEKLDLQSTGLATLSDAT-FRGLT-KLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDK  111 (251)
T ss_dssp             TTCCEEECTTSCCCCCCTTT-TTTCT-TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCE
T ss_pred             CCCCEEEccCCCcCccCHhH-hcCcc-cCCEEECCCCcCCccCHhHhccCCcCCEEECCCCccc-ccChhHhcccCCCCE
Confidence            58999999999999988877 66776 9999999999999988889999999999999999998 677777789999999


Q ss_pred             eeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchh
Q 036754           91 LSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPAS  170 (405)
Q Consensus        91 L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~  170 (405)
                      |+|++|+|+.+|..                 .+.++++|++|++++|.+.+..+..|+.+++|+.|++++|.+++..+..
T Consensus       112 L~L~~N~l~~~~~~-----------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  174 (251)
T 3m19_A          112 LYLGGNQLKSLPSG-----------------VFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGA  174 (251)
T ss_dssp             EECCSSCCCCCCTT-----------------TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred             EEcCCCcCCCcChh-----------------HhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHH
Confidence            99999999988754                 3456788999999999999877778999999999999999999888888


Q ss_pred             HHhcccCCccccccCcccCcCC
Q 036754          171 LEKLLYLKDLNLSFNKLEGEIP  192 (405)
Q Consensus       171 ~~~l~~L~~l~l~~n~l~~~~p  192 (405)
                      +..+++|+.|++++|.+.+...
T Consensus       175 ~~~l~~L~~L~l~~N~~~c~~~  196 (251)
T 3m19_A          175 FDRLGKLQTITLFGNQFDCSRC  196 (251)
T ss_dssp             TTTCTTCCEEECCSCCBCTTST
T ss_pred             HhCCCCCCEEEeeCCceeCCcc
Confidence            9999999999999999987643

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.90  E-value=2.6e-23  Score=194.03  Aligned_cols=196  Identities=23%  Similarity=0.254  Sum_probs=126.0

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCe
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~   90 (405)
                      ++|+.|+|++|.+.+..|.. +++++ +|+.|+|++|++++..|..|+.+++|++|+|++|.++ .+|..++   ++|++
T Consensus        54 ~~l~~L~l~~n~i~~~~~~~-~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~---~~L~~  127 (332)
T 2ft3_A           54 PDTTLLDLQNNDISELRKDD-FKGLQ-HLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP---SSLVE  127 (332)
T ss_dssp             TTCCEEECCSSCCCEECTTT-TTTCT-TCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC---TTCCE
T ss_pred             CCCeEEECCCCcCCccCHhH-hhCCC-CCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc---ccCCE
Confidence            45666777777666665555 44554 6677777777666666666666666666666666665 5555443   45666


Q ss_pred             eeCCCCCCCCCchh-hhccccCccccCCCC--------ChhccCC--------------------CCCCEEeccCCcccc
Q 036754           91 LSLDSNELTSIPLT-FWNLKDILYLNFSVI--------PIEIGGL--------------------PNLEYLFLGYNRLQG  141 (405)
Q Consensus        91 L~Ls~N~l~~lp~~-~~~l~~L~~l~l~~~--------p~~~~~l--------------------~~L~~L~l~~n~l~~  141 (405)
                      |++++|+++.+|.. +.++++|+.|+++..        |..+..+                    ++|++|++++|.+.+
T Consensus       128 L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~  207 (332)
T 2ft3_A          128 LRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQA  207 (332)
T ss_dssp             EECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCC
T ss_pred             EECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCc
Confidence            66666666555432 445555555544321        1112111                    467777777777776


Q ss_pred             cCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCcc
Q 036754          142 SIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC  212 (405)
Q Consensus       142 ~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c  212 (405)
                      ..+..|..+++|+.|++++|.+++..+..+..+++|+.|++++|.++..++....+++++.+++.+|++..
T Consensus       208 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~l~~  278 (332)
T 2ft3_A          208 IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITK  278 (332)
T ss_dssp             CCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSCCCB
T ss_pred             cCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCCCCc
Confidence            66677777788888888888887777777777788888888888777444445566777777777777654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.90  E-value=7.4e-24  Score=193.53  Aligned_cols=116  Identities=29%  Similarity=0.464  Sum_probs=101.0

Q ss_pred             ccCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      ++|...+.||+|+||+||+|++.      ++..||||+++.......++|.+|++++++++|||||+++|+|.+.+..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            45666788999999999999863      467899999987666667889999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSN------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||||++|||.++|+..+            ..++|.++++|+.|||+||+|||+
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~  146 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS  146 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999997532            469999999999999999999994

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.90  E-value=2.4e-24  Score=222.74  Aligned_cols=204  Identities=18%  Similarity=0.278  Sum_probs=174.4

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcc-----------------cCCchhhh--cccccccEEEcccCcccccCCccccCccCC
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDS-----------------VLPKTFVG--NVSHSLEFFVMSYCNISGGILEEITNLTKL   63 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~-----------------~~~~~f~~--~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L   63 (405)
                      +|+.|+++++|+.|+|++|.+++                 .+|.. ++  +++ +|+.|+|++|++.+.+|..|+++++|
T Consensus       440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~-l~f~~L~-~L~~L~Ls~N~l~~~iP~~l~~L~~L  517 (876)
T 4ecn_A          440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE-LSWSNLK-DLTDVELYNCPNMTQLPDFLYDLPEL  517 (876)
T ss_dssp             ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCT-TCCEEEEESCTTCCSCCGGGGGCSSC
T ss_pred             hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChh-hhhccCC-CCCEEECcCCCCCccChHHHhCCCCC
Confidence            67889999999999999999999                 36766 44  776 99999999999999999999999999


Q ss_pred             CeeecCCcc-ccc-ccCcchh------cCCCCCCeeeCCCCCCCCCch--hhhccccCccccCCC-----CChhccCCCC
Q 036754           64 TTIILGGNK-LNG-SISITLG------SNLASLRKLSLDSNELTSIPL--TFWNLKDILYLNFSV-----IPIEIGGLPN  128 (405)
Q Consensus        64 ~~L~L~~N~-l~~-~~~~~~~------~~l~~L~~L~Ls~N~l~~lp~--~~~~l~~L~~l~l~~-----~p~~~~~l~~  128 (405)
                      +.|+|++|+ ++| .+|..+.      ..+++|++|+|++|+++.+|.  .+.++++|+.|+++.     +| .++++++
T Consensus       518 ~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~Ls~N~l~~lp-~~~~L~~  596 (876)
T 4ecn_A          518 QSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLE-AFGTNVK  596 (876)
T ss_dssp             CEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEEECTTSCCCBCC-CCCTTSE
T ss_pred             CEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEEECCCCCcccch-hhcCCCc
Confidence            999999998 988 7887764      234499999999999999999  899999999998875     67 8899999


Q ss_pred             CCEEeccCCcccccCCcccccCCC-CCeeecccccccCccchhHHhccc--CCccccccCcccCcCCCCC------ccCC
Q 036754          129 LEYLFLGYNRLQGSIPDSFGDLIS-LKSLNLSKNNLSGAIPASLEKLLY--LKDLNLSFNKLEGEIPRGG------SFGN  199 (405)
Q Consensus       129 L~~L~l~~n~l~~~~p~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~--L~~l~l~~n~l~~~~p~~~------~~~~  199 (405)
                      |++|++++|.+. .+|..+..+++ |+.|++++|.++ .+|..+..+..  |+.|++++|.+.+.+|...      ...+
T Consensus       597 L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~  674 (876)
T 4ecn_A          597 LTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN  674 (876)
T ss_dssp             ESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCC
T ss_pred             ceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCC
Confidence            999999999999 78888999999 999999999998 67777766654  9999999999988776432      2235


Q ss_pred             CCcccccCCCCc
Q 036754          200 FSAESFEGNELL  211 (405)
Q Consensus       200 ~~~~~~~~n~~~  211 (405)
                      ++.+++.+|...
T Consensus       675 L~~L~Ls~N~L~  686 (876)
T 4ecn_A          675 ASTVTLSYNEIQ  686 (876)
T ss_dssp             EEEEECCSSCCC
T ss_pred             cCEEEccCCcCC
Confidence            666777777654

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.90  E-value=1.6e-24  Score=200.34  Aligned_cols=196  Identities=20%  Similarity=0.217  Sum_probs=161.5

Q ss_pred             CCCcCCeeeCcCCcCcccCCchhh-hcccccccEEEcccCcccccCCccccCc-----cCCCeeecCCcccccccCcchh
Q 036754            9 NCKCLTFIDLSNNPLDSVLPKTFV-GNVSHSLEFFVMSYCNISGGILEEITNL-----TKLTTIILGGNKLNGSISITLG   82 (405)
Q Consensus         9 ~l~~L~~L~Ls~N~l~~~~~~~f~-~~~~~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~   82 (405)
                      ++++|++|+|++|++++..|..++ +.++ +|+.|+|++|++++. |..+..+     ++|++|+|++|+++ .++...+
T Consensus        93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~-~~~~~~~  169 (312)
T 1wwl_A           93 GISGLQELTLENLEVTGTAPPPLLEATGP-DLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSL-NFSCEQV  169 (312)
T ss_dssp             TTSCCCEEEEEEEBCBSCCCCCSSSCCSC-CCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCC-CCCTTTC
T ss_pred             CcCCccEEEccCCcccchhHHHHHHhcCC-CccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCc-cchHHHh
Confidence            689999999999999988887743 6666 899999999999987 8888877     89999999999998 4554444


Q ss_pred             cCCCCCCeeeCCCCCCCC---Cchhh--hccccCccccCCCC-----C----hhccCCCCCCEEeccCCcccccCC-ccc
Q 036754           83 SNLASLRKLSLDSNELTS---IPLTF--WNLKDILYLNFSVI-----P----IEIGGLPNLEYLFLGYNRLQGSIP-DSF  147 (405)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~---lp~~~--~~l~~L~~l~l~~~-----p----~~~~~l~~L~~L~l~~n~l~~~~p-~~~  147 (405)
                      .++++|++|+|++|+++.   +|..+  .++++|++|+++..     +    ..+.++++|++|++++|.+.+..| ..+
T Consensus       170 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  249 (312)
T 1wwl_A          170 RVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC  249 (312)
T ss_dssp             CCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCC
T ss_pred             ccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhh
Confidence            689999999999999873   35555  78899999988762     1    223577999999999999998775 456


Q ss_pred             ccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCc
Q 036754          148 GDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL  211 (405)
Q Consensus       148 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~  211 (405)
                      ..+++|+.|++++|.++ .+|..+.  ++|+.|++++|++++. |....+++++.+++.+|++.
T Consensus       250 ~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~  309 (312)
T 1wwl_A          250 DWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFL  309 (312)
T ss_dssp             CCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTT
T ss_pred             hhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCC
Confidence            77899999999999998 5666554  7899999999999977 55777888999999999864

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.90  E-value=3.5e-23  Score=192.93  Aligned_cols=203  Identities=21%  Similarity=0.254  Sum_probs=156.6

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccC---------------------cccccCCccccCccCCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYC---------------------NISGGILEEITNLTKLT   64 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n---------------------~l~~~~~~~~~~l~~L~   64 (405)
                      .|+++++|++|+|++|.+++..|.. ++.++ +|++|+|++|                     ++++..+..|..+++|+
T Consensus        71 ~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~-~L~~L~Ls~n~l~~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  148 (330)
T 1xku_A           71 DFKNLKNLHTLILINNKISKISPGA-FAPLV-KLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI  148 (330)
T ss_dssp             TTTTCTTCCEEECCSSCCCCBCTTT-TTTCT-TCCEEECCSSCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCC
T ss_pred             hhccCCCCCEEECCCCcCCeeCHHH-hcCCC-CCCEEECCCCcCCccChhhcccccEEECCCCcccccCHhHhcCCcccc
Confidence            4556666666666666666655555 33443 4555555555                     45554555678888999


Q ss_pred             eeecCCccccc-ccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCC------CChhccCCCCCCEEeccCC
Q 036754           65 TIILGGNKLNG-SISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV------IPIEIGGLPNLEYLFLGYN  137 (405)
Q Consensus        65 ~L~L~~N~l~~-~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~------~p~~~~~l~~L~~L~l~~n  137 (405)
                      +|++++|.+.. .+....+.++++|++|++++|+++.+|..+.  ++|+.|+++.      .|..+.++++|++|++++|
T Consensus       149 ~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n  226 (330)
T 1xku_A          149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN  226 (330)
T ss_dssp             EEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSS
T ss_pred             EEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCC
Confidence            99999998862 1333445689999999999999999988765  7888888875      3678899999999999999


Q ss_pred             cccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCC-------ccCCCCcccccCCCC
Q 036754          138 RLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGG-------SFGNFSAESFEGNEL  210 (405)
Q Consensus       138 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~-------~~~~~~~~~~~~n~~  210 (405)
                      .+.+..+..+..+++|+.|++++|.++ .+|..+..+++|+.|++++|.+++..+...       ....+..+++.+||+
T Consensus       227 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~  305 (330)
T 1xku_A          227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV  305 (330)
T ss_dssp             CCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred             cCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcc
Confidence            999888889999999999999999999 678889999999999999999997665432       235667788999998


Q ss_pred             ccC
Q 036754          211 LCG  213 (405)
Q Consensus       211 ~c~  213 (405)
                      .+.
T Consensus       306 ~~~  308 (330)
T 1xku_A          306 QYW  308 (330)
T ss_dssp             CGG
T ss_pred             ccc
Confidence            663

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=6.5e-24  Score=188.61  Aligned_cols=191  Identities=17%  Similarity=0.136  Sum_probs=156.4

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCc-ccccCCccccCccCCCeeecCC-cccccccCcchhcCCCCC
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCN-ISGGILEEITNLTKLTTIILGG-NKLNGSISITLGSNLASL   88 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~l~~L   88 (405)
                      ++|+.|+|++|+++++.+.. ++.++ +|+.|++++|+ ++...+..|..+++|++|+|++ |+++ .+|...+.++++|
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~-~~~l~-~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~-~i~~~~f~~l~~L  107 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHA-FSNLP-NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT-YIDPDALKELPLL  107 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTT-TTTCT-TCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCC-EECTTSEECCTTC
T ss_pred             CcccEEEEeCCcceEECHHH-ccCCC-CCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCee-EcCHHHhCCCCCC
Confidence            38999999999999988877 56666 99999999997 8888888999999999999998 9998 7777777899999


Q ss_pred             CeeeCCCCCCCCCchhhhccccCc---cccCCC------CC-hhccCCCCCC-EEeccCCcccccCCcccccCCCCCeee
Q 036754           89 RKLSLDSNELTSIPLTFWNLKDIL---YLNFSV------IP-IEIGGLPNLE-YLFLGYNRLQGSIPDSFGDLISLKSLN  157 (405)
Q Consensus        89 ~~L~Ls~N~l~~lp~~~~~l~~L~---~l~l~~------~p-~~~~~l~~L~-~L~l~~n~l~~~~p~~~~~l~~L~~L~  157 (405)
                      ++|++++|+++.+|. +..+.+|+   .|+++.      +| ..+.++++|+ +|++++|.++...+..|.. ++|+.|+
T Consensus       108 ~~L~l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~  185 (239)
T 2xwt_C          108 KFLGIFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVY  185 (239)
T ss_dssp             CEEEEEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEE
T ss_pred             CEEeCCCCCCccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEE
Confidence            999999999999987 77777776   776654      33 3477888899 9999999988544445555 7899999


Q ss_pred             ccccc-ccCccchhHHhc-ccCCccccccCcccCcCCCCCccCCCCcccccCC
Q 036754          158 LSKNN-LSGAIPASLEKL-LYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGN  208 (405)
Q Consensus       158 l~~n~-l~~~~~~~~~~l-~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n  208 (405)
                      +++|+ +++..+..|..+ ++|+.|++++|.+++.++.  .+.+++.+.+.++
T Consensus       186 L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             CTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred             cCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence            99995 887777888888 8999999999998865443  5667777776654

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.90  E-value=7.4e-24  Score=213.19  Aligned_cols=200  Identities=21%  Similarity=0.241  Sum_probs=148.5

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCC
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLA   86 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~   86 (405)
                      |.++++|++|+|++|.+.++.|.. ++.++ +|+.|+|++|.+++..|..|+.+++|++|+|++|.++ .+|..++.+++
T Consensus        71 ~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~  147 (597)
T 3oja_B           71 LDSFRQVELLNLNDLQIEEIDTYA-FAYAH-TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP  147 (597)
T ss_dssp             HHHCCCCSEEECTTSCCCEECTTT-TTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCT
T ss_pred             HccCCCCcEEECCCCCCCCCChHH-hcCCC-CCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCC
Confidence            577899999999999999888877 66666 8999999999999988888999999999999999998 78888777899


Q ss_pred             CCCeeeCCCCCCCCCch-hhhccccCccccCCCCC---hhccCC------------------------------------
Q 036754           87 SLRKLSLDSNELTSIPL-TFWNLKDILYLNFSVIP---IEIGGL------------------------------------  126 (405)
Q Consensus        87 ~L~~L~Ls~N~l~~lp~-~~~~l~~L~~l~l~~~p---~~~~~l------------------------------------  126 (405)
                      +|++|+|++|.++.+++ .+.++++|+.|+++...   ..+..+                                    
T Consensus       148 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~  227 (597)
T 3oja_B          148 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVR  227 (597)
T ss_dssp             TCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEE
T ss_pred             CCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccc
Confidence            99999999999997654 67888888888876410   001111                                    


Q ss_pred             ----CCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCc
Q 036754          127 ----PNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSA  202 (405)
Q Consensus       127 ----~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~  202 (405)
                          ++|+.|++++|.+.+  +..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++.++....++++..
T Consensus       228 ~~~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~  305 (597)
T 3oja_B          228 GPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKV  305 (597)
T ss_dssp             CSCCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCE
T ss_pred             cccCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcE
Confidence                234444444444443  24566677777777777777777777777777777777777777765554555666677


Q ss_pred             ccccCCCCc
Q 036754          203 ESFEGNELL  211 (405)
Q Consensus       203 ~~~~~n~~~  211 (405)
                      +++.+|.+.
T Consensus       306 L~Ls~N~l~  314 (597)
T 3oja_B          306 LDLSHNHLL  314 (597)
T ss_dssp             EECCSSCCC
T ss_pred             EECCCCCCC
Confidence            777666553

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.90  E-value=6.6e-23  Score=191.27  Aligned_cols=199  Identities=20%  Similarity=0.230  Sum_probs=140.8

Q ss_pred             ccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcC
Q 036754            5 SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSN   84 (405)
Q Consensus         5 ~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~   84 (405)
                      ++|.++++|++|+|++|++++..|.. ++.++ +|++|+|++|+++. +|..+.  ++|++|++++|.++ .+|...+.+
T Consensus        72 ~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~-~L~~L~L~~n~l~~-l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~  145 (332)
T 2ft3_A           72 DDFKGLQHLYALVLVNNKISKIHEKA-FSPLR-KLQKLYISKNHLVE-IPPNLP--SSLVELRIHDNRIR-KVPKGVFSG  145 (332)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECGGG-STTCT-TCCEEECCSSCCCS-CCSSCC--TTCCEEECCSSCCC-CCCSGGGSS
T ss_pred             hHhhCCCCCcEEECCCCccCccCHhH-hhCcC-CCCEEECCCCcCCc-cCcccc--ccCCEEECCCCccC-ccCHhHhCC
Confidence            35677777777777777777766665 45554 67777777776664 333322  45666666666655 444444445


Q ss_pred             CCCCCeeeCCCCCCC-------------------------CCchhhhccccCccccCCC-----C-ChhccCCCCCCEEe
Q 036754           85 LASLRKLSLDSNELT-------------------------SIPLTFWNLKDILYLNFSV-----I-PIEIGGLPNLEYLF  133 (405)
Q Consensus        85 l~~L~~L~Ls~N~l~-------------------------~lp~~~~~l~~L~~l~l~~-----~-p~~~~~l~~L~~L~  133 (405)
                      +++|++|++++|.++                         .+|..+.  ++|+.|+++.     + |..+.++++|++|+
T Consensus       146 l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~  223 (332)
T 2ft3_A          146 LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLG  223 (332)
T ss_dssp             CSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCB
T ss_pred             CccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence            555555555555554                         4443322  4566666554     2 35788999999999


Q ss_pred             ccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCC-------ccCCCCccccc
Q 036754          134 LGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGG-------SFGNFSAESFE  206 (405)
Q Consensus       134 l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~-------~~~~~~~~~~~  206 (405)
                      +++|.+.+..+..|..+++|+.|++++|.++ .+|..+..+++|+.|++++|.+++..+...       ...++..+++.
T Consensus       224 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~  302 (332)
T 2ft3_A          224 LGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLF  302 (332)
T ss_dssp             CCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECC
T ss_pred             CCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEee
Confidence            9999999888889999999999999999999 678889999999999999999997665431       13557788899


Q ss_pred             CCCCcc
Q 036754          207 GNELLC  212 (405)
Q Consensus       207 ~n~~~c  212 (405)
                      +|++.+
T Consensus       303 ~N~~~~  308 (332)
T 2ft3_A          303 NNPVPY  308 (332)
T ss_dssp             SSSSCG
T ss_pred             cCcccc
Confidence            999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.90  E-value=1.4e-23  Score=194.29  Aligned_cols=116  Identities=29%  Similarity=0.456  Sum_probs=102.6

Q ss_pred             ccCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      ++|...+.||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            35556678999999999999864      478899999987666667889999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSN--------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||||++|+|.++++..+              ..++|.++++|+.|||+||+|||+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~  176 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG  176 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            999999999999997542              358999999999999999999994

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.89  E-value=3.4e-23  Score=188.02  Aligned_cols=185  Identities=24%  Similarity=0.301  Sum_probs=160.0

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      .|.++++|++|+|++|.+.+..+.. ++.++ +|+.|+|++|++++..+..|..+++|++|++++|+++ .++...+.++
T Consensus        47 ~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l  123 (276)
T 2z62_A           47 SFFSFPELQVLDLSRCEIQTIEDGA-YQSLS-HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHL  123 (276)
T ss_dssp             TTTTCTTCSEEECTTCCCCEECTTT-TTTCT-TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCC-CSTTCCCTTC
T ss_pred             HhccccCCcEEECCCCcCCccCHHH-ccCCc-CCCEEECCCCccCccChhhhcCCccccEEECCCCCcc-ccCchhcccC
Confidence            7889999999999999999988877 56666 9999999999999988899999999999999999998 4555445689


Q ss_pred             CCCCeeeCCCCCCCC--CchhhhccccCccccCCC-----C-ChhccCCCCCC----EEeccCCcccccCCcccccCCCC
Q 036754           86 ASLRKLSLDSNELTS--IPLTFWNLKDILYLNFSV-----I-PIEIGGLPNLE----YLFLGYNRLQGSIPDSFGDLISL  153 (405)
Q Consensus        86 ~~L~~L~Ls~N~l~~--lp~~~~~l~~L~~l~l~~-----~-p~~~~~l~~L~----~L~l~~n~l~~~~p~~~~~l~~L  153 (405)
                      ++|++|++++|+++.  +|..+.++++|+.|+++.     + +..+..+++|+    +|++++|.+.+..+..+.. .+|
T Consensus       124 ~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L  202 (276)
T 2z62_A          124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRL  202 (276)
T ss_dssp             TTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCE
T ss_pred             CCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-Ccc
Confidence            999999999999986  788999999999999886     2 34555555665    8999999999766665544 589


Q ss_pred             CeeecccccccCccchhHHhcccCCccccccCcccCcCCCC
Q 036754          154 KSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG  194 (405)
Q Consensus       154 ~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~  194 (405)
                      +.|++++|.+++..+..+..+++|+.|++++|++++..|..
T Consensus       203 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             EEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred             cEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence            99999999999888888899999999999999999876643

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.89  E-value=1.3e-23  Score=217.22  Aligned_cols=179  Identities=21%  Similarity=0.289  Sum_probs=152.8

Q ss_pred             CCchhhhcccccccEEEcccCcccc-----------------cCCcccc--CccCCCeeecCCcccccccCcchhcCCCC
Q 036754           27 LPKTFVGNVSHSLEFFVMSYCNISG-----------------GILEEIT--NLTKLTTIILGGNKLNGSISITLGSNLAS   87 (405)
Q Consensus        27 ~~~~f~~~~~~~L~~L~L~~n~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~~l~~   87 (405)
                      +|.. +++++ +|+.|+|++|++++                 .+|..++  ++++|++|+|++|++.+.+|..+ .++++
T Consensus       440 IP~~-l~~L~-~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l-~~L~~  516 (876)
T 4ecn_A          440 ISKA-IQRLT-KLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL-YDLPE  516 (876)
T ss_dssp             ECGG-GGGCT-TCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGG-GGCSS
T ss_pred             hhHH-HhcCC-CCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHH-hCCCC
Confidence            5666 67776 89999999999998                 3888877  99999999999999998999776 48999


Q ss_pred             CCeeeCCCCC-CCC--Cchhhhccc-------cCccccCCC-----CCh--hccCCCCCCEEeccCCcccccCCcccccC
Q 036754           88 LRKLSLDSNE-LTS--IPLTFWNLK-------DILYLNFSV-----IPI--EIGGLPNLEYLFLGYNRLQGSIPDSFGDL  150 (405)
Q Consensus        88 L~~L~Ls~N~-l~~--lp~~~~~l~-------~L~~l~l~~-----~p~--~~~~l~~L~~L~l~~n~l~~~~p~~~~~l  150 (405)
                      |++|+|++|+ ++.  +|..+.++.       +|+.|+++.     +|.  .++++++|++|++++|.+. .+| .|+.+
T Consensus       517 L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L  594 (876)
T 4ecn_A          517 LQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTN  594 (876)
T ss_dssp             CCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTT
T ss_pred             CCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCC
Confidence            9999999998 884  898888776       899988765     787  8999999999999999998 778 89999


Q ss_pred             CCCCeeecccccccCccchhHHhccc-CCccccccCcccCcCCCC-Ccc--CCCCcccccCCCCcc
Q 036754          151 ISLKSLNLSKNNLSGAIPASLEKLLY-LKDLNLSFNKLEGEIPRG-GSF--GNFSAESFEGNELLC  212 (405)
Q Consensus       151 ~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~l~l~~n~l~~~~p~~-~~~--~~~~~~~~~~n~~~c  212 (405)
                      ++|+.|++++|.++ .+|..+..+++ |+.|++++|.++ .+|.. ...  .+++.+++.+|.+..
T Consensus       595 ~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g  658 (876)
T 4ecn_A          595 VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS  658 (876)
T ss_dssp             SEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTT
T ss_pred             CcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCC
Confidence            99999999999999 78888999999 999999999998 45543 323  237888888887643

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.89  E-value=8.2e-23  Score=185.12  Aligned_cols=164  Identities=24%  Similarity=0.348  Sum_probs=117.4

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhc
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGS   83 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   83 (405)
                      ++.+..+++|++|+|++|.+.+. + . ++.++ +|++|+|++|.+++..+..|..+++|++|+|++|+++ .++...+.
T Consensus        56 ~~~l~~l~~L~~L~l~~n~l~~~-~-~-l~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~  130 (272)
T 3rfs_A           56 VQGIQYLPNVRYLALGGNKLHDI-S-A-LKELT-NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFD  130 (272)
T ss_dssp             CTTGGGCTTCCEEECTTSCCCCC-G-G-GTTCT-TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTT
T ss_pred             ccccccCCCCcEEECCCCCCCCc-h-h-hcCCC-CCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCC-ccCHHHhc
Confidence            45688999999999999999874 3 3 66776 9999999999999988888999999999999999998 66666667


Q ss_pred             CCCCCCeeeCCCCCCCCCchh-hhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccccc
Q 036754           84 NLASLRKLSLDSNELTSIPLT-FWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN  162 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~lp~~-~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~  162 (405)
                      ++++|++|+|++|+++.+|.. +.++++                  |++|++++|.+++..+..|+.+++|+.|++++|.
T Consensus       131 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~------------------L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~  192 (272)
T 3rfs_A          131 KLTNLTYLNLAHNQLQSLPKGVFDKLTN------------------LTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ  192 (272)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTT------------------CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cCCCCCEEECCCCccCccCHHHhccCcc------------------CCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence            999999999999999988764 344444                  4555555555544444444445555555555555


Q ss_pred             ccCccchhHHhcccCCccccccCcccCc
Q 036754          163 LSGAIPASLEKLLYLKDLNLSFNKLEGE  190 (405)
Q Consensus       163 l~~~~~~~~~~l~~L~~l~l~~n~l~~~  190 (405)
                      +++..+..+..+++|+.|++++|.+.+.
T Consensus       193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~  220 (272)
T 3rfs_A          193 LKSVPDGVFDRLTSLQYIWLHDNPWDCT  220 (272)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCccCHHHHhCCcCCCEEEccCCCcccc
Confidence            5444444444445555555555544443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.89  E-value=1.4e-22  Score=183.34  Aligned_cols=179  Identities=27%  Similarity=0.346  Sum_probs=159.4

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCe
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~   90 (405)
                      ++|+.|+|++|++.++.+.. ++.++ +|++|+|++|+++...+..|..+++|++|+|++|.++ .+|...+.++++|++
T Consensus        37 ~~l~~L~l~~n~l~~~~~~~-~~~l~-~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~  113 (270)
T 2o6q_A           37 ADTKKLDLQSNKLSSLPSKA-FHRLT-KLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAE  113 (270)
T ss_dssp             TTCSEEECCSSCCSCCCTTS-SSSCT-TCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCC-CCCTTTTTTCSSCCE
T ss_pred             CCCCEEECcCCCCCeeCHHH-hcCCC-CCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCC-cCCHhHcccccCCCE
Confidence            57999999999999888777 66776 9999999999999877778899999999999999998 677777789999999


Q ss_pred             eeCCCCCCCCCch-hhhccccCccccCCC-----CCh-hccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccc
Q 036754           91 LSLDSNELTSIPL-TFWNLKDILYLNFSV-----IPI-EIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNL  163 (405)
Q Consensus        91 L~Ls~N~l~~lp~-~~~~l~~L~~l~l~~-----~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l  163 (405)
                      |+|++|+++.+|. .+.++++|++|+++.     +|. .+..+++|++|++++|.+.+..+..|..+++|+.|++++|.+
T Consensus       114 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  193 (270)
T 2o6q_A          114 LRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQL  193 (270)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcC
Confidence            9999999998865 467899999999875     444 478899999999999999988888899999999999999999


Q ss_pred             cCccchhHHhcccCCccccccCcccCcCC
Q 036754          164 SGAIPASLEKLLYLKDLNLSFNKLEGEIP  192 (405)
Q Consensus       164 ~~~~~~~~~~l~~L~~l~l~~n~l~~~~p  192 (405)
                      ++..+..+..+++|+.|++++|++.+..+
T Consensus       194 ~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          194 KRVPEGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             SCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             CcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence            98888889999999999999999986554

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.89  E-value=4.9e-23  Score=188.91  Aligned_cols=114  Identities=20%  Similarity=0.375  Sum_probs=97.8

Q ss_pred             CCccCcccccCCCceEEEeeC------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          292 FSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      +...+.||+|+||+||+|++.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+||
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            344567999999999999863      46789999997543 33457899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||++|||.++|+.+.               ..++|.++++|+.|||+||+|||+
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~  163 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS  163 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999996431               358999999999999999999994

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.89  E-value=5.3e-23  Score=190.65  Aligned_cols=199  Identities=22%  Similarity=0.207  Sum_probs=132.5

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcc------
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISIT------   80 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~------   80 (405)
                      +..+++|+.|+|++|++.+..|.. ++.++ +|+.|+|++|.+++..+  +..+++|++|+|++|.++ .++..      
T Consensus        30 ~~~~~~L~~L~L~~n~l~~~~~~~-~~~l~-~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~-~l~~~~~L~~L  104 (317)
T 3o53_A           30 RQSAWNVKELDLSGNPLSQISAAD-LAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVGPSIETL  104 (317)
T ss_dssp             HTTGGGCSEEECTTSCCCCCCHHH-HTTCT-TCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEE-EEEECTTCCEE
T ss_pred             hccCCCCCEEECcCCccCcCCHHH-hhCCC-cCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccc-cccCCCCcCEE
Confidence            355678999999999998877766 56666 89999999999887554  888888888888888876 33211      


Q ss_pred             ----------hhcCCCCCCeeeCCCCCCCCCch-hhhccccCccccCCC------CChhc-cCCCCCCEEeccCCccccc
Q 036754           81 ----------LGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSV------IPIEI-GGLPNLEYLFLGYNRLQGS  142 (405)
Q Consensus        81 ----------~~~~l~~L~~L~Ls~N~l~~lp~-~~~~l~~L~~l~l~~------~p~~~-~~l~~L~~L~l~~n~l~~~  142 (405)
                                ....+++|++|++++|+++.++. .+..+++|++|+++.      .|..+ ..+++|++|++++|.+++.
T Consensus       105 ~l~~n~l~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~  184 (317)
T 3o53_A          105 HAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV  184 (317)
T ss_dssp             ECCSSCCSEEEECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred             ECCCCccCCcCccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc
Confidence                      01234556666666666665533 555666677766654      12333 3567777777777777644


Q ss_pred             CCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCccC
Q 036754          143 IPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCG  213 (405)
Q Consensus       143 ~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~  213 (405)
                       |. ...+++|+.|++++|.+++. |..+..+++|+.|++++|.+++.++....+++++.+++.+|++.|+
T Consensus       185 -~~-~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~  252 (317)
T 3o53_A          185 -KG-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG  252 (317)
T ss_dssp             -EC-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHH
T ss_pred             -cc-ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCc
Confidence             22 23467777777777777744 3346677777777777777775544455566777777777776653

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.89  E-value=4e-23  Score=202.38  Aligned_cols=207  Identities=20%  Similarity=0.212  Sum_probs=146.3

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCC------------------------ccccCcc
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGIL------------------------EEITNLT   61 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~------------------------~~~~~l~   61 (405)
                      .|.++++|+.|+|++|.+.+..+.. ++.++ +|+.|+|++|++++..+                        ..|..++
T Consensus       123 ~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~-~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~  200 (477)
T 2id5_A          123 MFQDLYNLKSLEVGDNDLVYISHRA-FSGLN-SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLY  200 (477)
T ss_dssp             TTTTCTTCCEEEECCTTCCEECTTS-STTCT-TCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCT
T ss_pred             HccccccCCEEECCCCccceeChhh-ccCCC-CCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCc
Confidence            4555666666666666665555544 33443 55555555555554444                        4444455


Q ss_pred             CCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCch-hhhccccCccccCCC------CChhccCCCCCCEEec
Q 036754           62 KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSV------IPIEIGGLPNLEYLFL  134 (405)
Q Consensus        62 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~-~~~~l~~L~~l~l~~------~p~~~~~l~~L~~L~l  134 (405)
                      +|+.|++++|.+.+.+|...+ ...+|++|+|++|+++.+|. .+.++++|+.|+++.      .+..+.++++|++|++
T Consensus       201 ~L~~L~l~~~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  279 (477)
T 2id5_A          201 RLKVLEISHWPYLDTMTPNCL-YGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQL  279 (477)
T ss_dssp             TCCEEEEECCTTCCEECTTTT-TTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEEC
T ss_pred             ccceeeCCCCccccccCcccc-cCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEEC
Confidence            555555555544444555444 34477888888888888884 577899999999886      2446889999999999


Q ss_pred             cCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCccCC
Q 036754          135 GYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS  214 (405)
Q Consensus       135 ~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~~  214 (405)
                      ++|.+.+..|..|..+++|+.|++++|.+++..+..|..+++|+.|++++|++.+..+....+.......+.++...|..
T Consensus       280 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~  359 (477)
T 2id5_A          280 VGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCAT  359 (477)
T ss_dssp             CSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEE
T ss_pred             CCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCC
Confidence            99999999999999999999999999999988888889999999999999999865443222223334556677777765


Q ss_pred             C
Q 036754          215 P  215 (405)
Q Consensus       215 ~  215 (405)
                      |
T Consensus       360 p  360 (477)
T 2id5_A          360 P  360 (477)
T ss_dssp             S
T ss_pred             c
Confidence            4

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.88  E-value=6e-23  Score=189.67  Aligned_cols=196  Identities=19%  Similarity=0.165  Sum_probs=158.7

Q ss_pred             CCcCCeeeCcCCcCcccCCchhh-hcccccccEEEcccCcccccCC----ccccCccCCCeeecCCcccccccCcchhcC
Q 036754           10 CKCLTFIDLSNNPLDSVLPKTFV-GNVSHSLEFFVMSYCNISGGIL----EEITNLTKLTTIILGGNKLNGSISITLGSN   84 (405)
Q Consensus        10 l~~L~~L~Ls~N~l~~~~~~~f~-~~~~~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~   84 (405)
                      +++|++|+|++|.+.+..|..++ +.++ +|+.|+|++|.+++..+    ..+..+++|++|+|++|.++ .++...+.+
T Consensus        90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~-~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~-~~~~~~~~~  167 (310)
T 4glp_A           90 YSRLKELTLEDLKITGTMPPLPLEATGL-ALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSP-AFSCEQVRA  167 (310)
T ss_dssp             HSCCCEEEEESCCCBSCCCCCSSSCCCB-CCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSC-CCCTTSCCC
T ss_pred             cCceeEEEeeCCEeccchhhhhhhccCC-CCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcc-hhhHHHhcc
Confidence            45699999999999999888754 6666 89999999999987555    34567899999999999997 455555568


Q ss_pred             CCCCCeeeCCCCCCCC---Cchh--hhccccCccccCCC-----CCh----hccCCCCCCEEeccCCcccccCCcccccC
Q 036754           85 LASLRKLSLDSNELTS---IPLT--FWNLKDILYLNFSV-----IPI----EIGGLPNLEYLFLGYNRLQGSIPDSFGDL  150 (405)
Q Consensus        85 l~~L~~L~Ls~N~l~~---lp~~--~~~l~~L~~l~l~~-----~p~----~~~~l~~L~~L~l~~n~l~~~~p~~~~~l  150 (405)
                      +++|++|+|++|++..   ++..  +..+++|++|+++.     +|.    .+.++++|++|++++|.+.+..|..+..+
T Consensus       168 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~  247 (310)
T 4glp_A          168 FPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC  247 (310)
T ss_dssp             CTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred             CCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence            9999999999999863   4333  36788999998876     233    24678999999999999998878888777


Q ss_pred             ---CCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCc
Q 036754          151 ---ISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL  211 (405)
Q Consensus       151 ---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~  211 (405)
                         ++|++|++++|.++ .+|..+.  ++|+.|++++|.+++. |....+++++.+++++|++.
T Consensus       248 ~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          248 MWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             CCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSCEECSSTTTS
T ss_pred             cCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccEEECcCCCCC
Confidence               69999999999999 4566553  7999999999999975 44567789999999999874

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.88  E-value=4e-22  Score=182.15  Aligned_cols=173  Identities=25%  Similarity=0.231  Sum_probs=151.8

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCe
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~   90 (405)
                      ++++.|+|++|.+++..+.. +..++ +|+.|+|++|.+++..+.  +.+++|++|+|++|+++ .+|..+ ..+++|++
T Consensus        31 ~~l~~L~L~~N~l~~~~~~~-~~~l~-~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~-~~l~~L~~  104 (290)
T 1p9a_G           31 KDTTILHLSENLLYTFSLAT-LMPYT-RLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLG-QTLPALTV  104 (290)
T ss_dssp             TTCCEEECTTSCCSEEEGGG-GTTCT-TCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCT-TTCTTCCE
T ss_pred             CCCCEEEcCCCcCCccCHHH-hhcCC-CCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhh-ccCCCCCE
Confidence            68999999999999988887 56666 999999999999885443  78999999999999998 888766 58999999


Q ss_pred             eeCCCCCCCCCc-hhhhccccCccccCCC-----CC-hhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccc
Q 036754           91 LSLDSNELTSIP-LTFWNLKDILYLNFSV-----IP-IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNL  163 (405)
Q Consensus        91 L~Ls~N~l~~lp-~~~~~l~~L~~l~l~~-----~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l  163 (405)
                      |+|++|+|+.+| ..+.++++|++|+++.     +| ..+..+++|++|++++|++++..+..|..+++|+.|++++|++
T Consensus       105 L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l  184 (290)
T 1p9a_G          105 LDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL  184 (290)
T ss_dssp             EECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcC
Confidence            999999999887 4688999999999875     44 4567899999999999999977777789999999999999999


Q ss_pred             cCccchhHHhcccCCccccccCcccCc
Q 036754          164 SGAIPASLEKLLYLKDLNLSFNKLEGE  190 (405)
Q Consensus       164 ~~~~~~~~~~l~~L~~l~l~~n~l~~~  190 (405)
                      + .+|..+....+|+.+++++|++.+.
T Consensus       185 ~-~ip~~~~~~~~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          185 Y-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (290)
T ss_dssp             C-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             C-ccChhhcccccCCeEEeCCCCccCc
Confidence            9 5677777888999999999998754

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.88  E-value=1.6e-22  Score=202.35  Aligned_cols=201  Identities=24%  Similarity=0.299  Sum_probs=160.0

Q ss_pred             CCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccC--CccccCccCCCeeecCCcccccccCcchhcCCCC
Q 036754           10 CKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGI--LEEITNLTKLTTIILGGNKLNGSISITLGSNLAS   87 (405)
Q Consensus        10 l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~   87 (405)
                      +++|+.|++++|.+.+..+.   ..++ +|+.|++++|++++..  |..+..+++|++|++++|.++ .++.. +.++++
T Consensus       324 l~~L~~L~l~~n~~~~~~~~---~~~~-~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~-~~~l~~  397 (570)
T 2z63_A          324 LKSLKRLTFTSNKGGNAFSE---VDLP-SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSN-FLGLEQ  397 (570)
T ss_dssp             CSSCCEEEEESCBSCCBCCC---CBCT-TCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEE-EEEEE-EETCTT
T ss_pred             ccccCEEeCcCCcccccccc---ccCC-CCCEEeCcCCccCccccccccccccCccCEEECCCCccc-ccccc-ccccCC
Confidence            34444444444444443332   3444 7888888888887654  677888899999999999887 55555 468999


Q ss_pred             CCeeeCCCCCCCCCch--hhhccccCccccCCC------CChhccCCCCCCEEeccCCccc-ccCCcccccCCCCCeeec
Q 036754           88 LRKLSLDSNELTSIPL--TFWNLKDILYLNFSV------IPIEIGGLPNLEYLFLGYNRLQ-GSIPDSFGDLISLKSLNL  158 (405)
Q Consensus        88 L~~L~Ls~N~l~~lp~--~~~~l~~L~~l~l~~------~p~~~~~l~~L~~L~l~~n~l~-~~~p~~~~~l~~L~~L~l  158 (405)
                      |++|++++|.++.++.  .+.++++|++|+++.      .|..+.++++|++|++++|.+. +.+|..+..+++|+.|++
T Consensus       398 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l  477 (570)
T 2z63_A          398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL  477 (570)
T ss_dssp             CCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred             CCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEEC
Confidence            9999999999886543  677888999998875      5667888999999999999987 578889999999999999


Q ss_pred             ccccccCccchhHHhcccCCccccccCcccCcCCC-CCccCCCCcccccCCCCccCCCC
Q 036754          159 SKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLCGSPN  216 (405)
Q Consensus       159 ~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~~c~~~~  216 (405)
                      ++|.+++..|..+..+++|+.|++++|.+++.+|. ...+++++.+++.+|++.|.++.
T Consensus       478 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             CCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence            99999988899999999999999999999987775 45678899999999999987653

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.88  E-value=4.8e-22  Score=200.48  Aligned_cols=203  Identities=26%  Similarity=0.299  Sum_probs=144.0

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      .|+++++|++|+|++|.++. +|.. ++.++ +|+.|++++|++++..|..+..+++|++|++++|.+.+.+|...+..+
T Consensus       273 ~~~~l~~L~~L~l~~n~l~~-lp~~-l~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l  349 (606)
T 3t6q_A          273 TFHCFSGLQELDLTATHLSE-LPSG-LVGLS-TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENL  349 (606)
T ss_dssp             TTTTCTTCSEEECTTSCCSC-CCSS-CCSCT-TCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTC
T ss_pred             HhccccCCCEEeccCCccCC-CChh-hcccc-cCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhcc
Confidence            36777888888888888874 4444 45555 788888888888877777788888888888888887777777666678


Q ss_pred             CCCCeeeCCCCCCCCC---chhhhccccCccccCCC------CChhccCCCCCCEEeccCCcccccCCcc-cccCCCCCe
Q 036754           86 ASLRKLSLDSNELTSI---PLTFWNLKDILYLNFSV------IPIEIGGLPNLEYLFLGYNRLQGSIPDS-FGDLISLKS  155 (405)
Q Consensus        86 ~~L~~L~Ls~N~l~~l---p~~~~~l~~L~~l~l~~------~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~  155 (405)
                      ++|++|++++|.++.+   |..+.++++|+.|+++.      .|..+.++++|++|++++|.+.+..|.. +..+++|+.
T Consensus       350 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~  429 (606)
T 3t6q_A          350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV  429 (606)
T ss_dssp             TTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCE
T ss_pred             CcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCE
Confidence            8888888888887754   55677777777777764      3556667777777777777777655443 677777777


Q ss_pred             eecccccccCccchhHHhcccCCccccccCcccCc-CCC---CCccCCCCcccccCCCCc
Q 036754          156 LNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGE-IPR---GGSFGNFSAESFEGNELL  211 (405)
Q Consensus       156 L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~-~p~---~~~~~~~~~~~~~~n~~~  211 (405)
                      |++++|.+++..|..+..+++|+.|++++|.+.+. ++.   ...+++++.+++.+|...
T Consensus       430 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~  489 (606)
T 3t6q_A          430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS  489 (606)
T ss_dssp             EECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCC
T ss_pred             EECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccC
Confidence            77777777777777777777777777777777652 221   234566666667666543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.88  E-value=1.5e-22  Score=187.16  Aligned_cols=180  Identities=18%  Similarity=0.196  Sum_probs=150.8

Q ss_pred             ccccC--CCCCcCCeeeCcCCcCcccCCchhhhccc----ccccEEEcccCcccccCCccccCccCCCeeecCCcccccc
Q 036754            3 FLSSL--SNCKCLTFIDLSNNPLDSVLPKTFVGNVS----HSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGS   76 (405)
Q Consensus         3 ~~~~~--~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~   76 (405)
                      +|..+  ..+++|++|+|++|++++. |.. ++.+.    ++|++|+|++|++++..|+.|+.+++|++|+|++|++.+.
T Consensus       111 ~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~-~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  188 (312)
T 1wwl_A          111 APPPLLEATGPDLNILNLRNVSWATR-DAW-LAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE  188 (312)
T ss_dssp             CCCCSSSCCSCCCSEEEEESCBCSSS-SSH-HHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHH
T ss_pred             hHHHHHHhcCCCccEEEccCCCCcch-hHH-HHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcc
Confidence            35555  8899999999999999998 766 55551    3899999999999998889999999999999999998765


Q ss_pred             --cCcch-hcCCCCCCeeeCCCCCCCCCch---h-hhccccCccccCCC-----CC--hhccCCCCCCEEeccCCccccc
Q 036754           77 --ISITL-GSNLASLRKLSLDSNELTSIPL---T-FWNLKDILYLNFSV-----IP--IEIGGLPNLEYLFLGYNRLQGS  142 (405)
Q Consensus        77 --~~~~~-~~~l~~L~~L~Ls~N~l~~lp~---~-~~~l~~L~~l~l~~-----~p--~~~~~l~~L~~L~l~~n~l~~~  142 (405)
                        ++..+ +..+++|++|+|++|+++.+|.   . +.++++|+.|+++.     .+  ..+..+++|++|++++|.++ .
T Consensus       189 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~  267 (312)
T 1wwl_A          189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-Q  267 (312)
T ss_dssp             HHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-S
T ss_pred             hHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-h
Confidence              23333 3689999999999999996543   2 34678999999875     22  34566899999999999999 6


Q ss_pred             CCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccC
Q 036754          143 IPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEG  189 (405)
Q Consensus       143 ~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~  189 (405)
                      +|..+.  ++|+.|++++|++++. |. +..+++|+.|++++|++++
T Consensus       268 ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          268 VPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             hhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            777766  8999999999999976 55 8899999999999999975

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=3.1e-22  Score=184.65  Aligned_cols=190  Identities=23%  Similarity=0.349  Sum_probs=161.5

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCC
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLA   86 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~   86 (405)
                      +..+++|+.|++++|.+... | . +..++ +|+.|+|++|.+++..+  +..+++|++|+|++|+++ .++ . +..++
T Consensus        37 ~~~l~~L~~L~l~~~~i~~l-~-~-~~~l~-~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~-~~~-~-~~~l~  107 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVTTI-E-G-VQYLN-NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-A-IAGLQ  107 (308)
T ss_dssp             HHHHHTCCEEECTTSCCCCC-T-T-GGGCT-TCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-G-GTTCT
T ss_pred             HHHcCCcCEEEeeCCCccCc-h-h-hhccC-CCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCC-Cch-h-hcCCC
Confidence            45688999999999999875 4 3 55666 99999999999988554  999999999999999998 455 3 45899


Q ss_pred             CCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccc
Q 036754           87 SLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKN  161 (405)
Q Consensus        87 ~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n  161 (405)
                      +|++|+|++|+++.+|. +..+++|+.|+++.     ++. +..+++|++|++++|.+.+..+  +..+++|+.|++++|
T Consensus       108 ~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n  183 (308)
T 1h6u_A          108 SIKTLDLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDN  183 (308)
T ss_dssp             TCCEEECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred             CCCEEECCCCCCCCchh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCC
Confidence            99999999999998875 88899999999875     343 8889999999999999986444  899999999999999


Q ss_pred             cccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCcc
Q 036754          162 NLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC  212 (405)
Q Consensus       162 ~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c  212 (405)
                      .+++..+  +..+++|+.|++++|.+++..+ ...+++++.+++.+|++.+
T Consensus       184 ~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          184 KISDISP--LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CCCCCGG--GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEEEC
T ss_pred             ccCcChh--hcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCeeec
Confidence            9987654  7899999999999999997664 6677889999999998755

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.88  E-value=2.3e-22  Score=183.73  Aligned_cols=113  Identities=27%  Similarity=0.451  Sum_probs=98.6

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +++...+.||+|+||+||+|++.+  .||||+++...  ....+.|.+|+.++++++|||||+++|+|.+ +..+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            456667889999999999998743  59999987543  3446789999999999999999999998864 568999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |++|+|.++|+..+..++|.++++|+.|||+||+|||+
T Consensus       113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~  150 (307)
T 3omv_A          113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA  150 (307)
T ss_dssp             CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999998766689999999999999999999994

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.87  E-value=1.7e-21  Score=182.75  Aligned_cols=191  Identities=23%  Similarity=0.337  Sum_probs=118.4

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCC
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLA   86 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~   86 (405)
                      +..+++|+.|++++|.+.+..+   ++.++ +|+.|++++|.+.+..+  +..+++|+.|++++|.+++ ++.  +..++
T Consensus       151 ~~~l~~L~~L~l~~~~~~~~~~---~~~l~-~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~--~~~~~  221 (347)
T 4fmz_A          151 LSNMTGLNYLTVTESKVKDVTP---IANLT-DLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD-ITP--VANMT  221 (347)
T ss_dssp             GTTCTTCCEEECCSSCCCCCGG---GGGCT-TCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG--GGGCT
T ss_pred             hhhCCCCcEEEecCCCcCCchh---hccCC-CCCEEEccCCccccccc--ccCCCccceeecccCCCCC-Cch--hhcCC
Confidence            4445555555555555544333   23333 55566666555554322  5555666666666666552 222  34667


Q ss_pred             CCCeeeCCCCCCCCCchhhhccccCccccCCCC----ChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccccc
Q 036754           87 SLRKLSLDSNELTSIPLTFWNLKDILYLNFSVI----PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN  162 (405)
Q Consensus        87 ~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~----p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~  162 (405)
                      +|++|++++|+++.+|. +..+++|+.|+++..    ...+..+++|++|++++|.+.+.  ..+..+++|+.|++++|.
T Consensus       222 ~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~  298 (347)
T 4fmz_A          222 RLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQ  298 (347)
T ss_dssp             TCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSC
T ss_pred             cCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCChhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCc
Confidence            77777777777776665 666677777766541    13466677777777777777643  346777777777777777


Q ss_pred             ccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCC
Q 036754          163 LSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL  210 (405)
Q Consensus       163 l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~  210 (405)
                      +++..|..+..+++|+.|++++|.+++.+| ...+++++.+++.+|+.
T Consensus       299 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~i  345 (347)
T 4fmz_A          299 LGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQVI  345 (347)
T ss_dssp             CCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC--
T ss_pred             CCCcChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhhcc
Confidence            777777777777777777777777776655 55566777777777754

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.87  E-value=5.7e-22  Score=207.13  Aligned_cols=205  Identities=21%  Similarity=0.256  Sum_probs=127.4

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCcc--ccCccCCCeeecCCcccccccCcch
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEE--ITNLTKLTTIILGGNKLNGSISITL   81 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~~   81 (405)
                      +.+|.++++|++|+|++|.+.+..|.. +++++ +|+.|+|++|.+++..|..  |+.+++|++|+|++|.+++..+...
T Consensus        66 ~~~f~~L~~L~~L~Ls~N~l~~~~p~~-~~~l~-~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~  143 (844)
T 3j0a_A           66 KEAFRNLPNLRILDLGSSKIYFLHPDA-FQGLF-HLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPS  143 (844)
T ss_dssp             TTTTSSCTTCCEEECTTCCCCEECTTS-SCSCS-SCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGG
T ss_pred             HHHhcCCCCCCEEECCCCcCcccCHhH-ccCCc-ccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchh
Confidence            445777777777777777777777766 55555 7777777777777655544  7777777777777777764444344


Q ss_pred             hcCCCCCCeeeCCCCCCCCC-chhhhcc--cc------------------------------CccccCC-----------
Q 036754           82 GSNLASLRKLSLDSNELTSI-PLTFWNL--KD------------------------------ILYLNFS-----------  117 (405)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~~l-p~~~~~l--~~------------------------------L~~l~l~-----------  117 (405)
                      +.++++|++|+|++|.++.+ |..+..+  ++                              |+.|+++           
T Consensus       144 ~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~  223 (844)
T 3j0a_A          144 FGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGN  223 (844)
T ss_dssp             GGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSG
T ss_pred             HhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHH
Confidence            45777777777777777632 3333222  11                              2222221           


Q ss_pred             ---------------------------------------------------C------CChhccCCCCCCEEeccCCccc
Q 036754          118 ---------------------------------------------------V------IPIEIGGLPNLEYLFLGYNRLQ  140 (405)
Q Consensus       118 ---------------------------------------------------~------~p~~~~~l~~L~~L~l~~n~l~  140 (405)
                                                                         .      .|..+..+++|++|++++|.+.
T Consensus       224 ~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~  303 (844)
T 3j0a_A          224 FSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN  303 (844)
T ss_dssp             GGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCC
T ss_pred             HHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCC
Confidence                                                               1      1223445666666666666666


Q ss_pred             ccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCC-CCccCCCCcccccCCCC
Q 036754          141 GSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNEL  210 (405)
Q Consensus       141 ~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~  210 (405)
                      +..|..|..+++|+.|++++|.+++..|..+..+++|+.|++++|.+.+..+. ...+++++.+++.+|..
T Consensus       304 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l  374 (844)
T 3j0a_A          304 KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL  374 (844)
T ss_dssp             EECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCS
T ss_pred             CCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCC
Confidence            66666666677777777777777666666666777777777777776655443 23355556666655543

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.87  E-value=4.2e-22  Score=198.52  Aligned_cols=195  Identities=23%  Similarity=0.259  Sum_probs=161.4

Q ss_pred             CCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCc---cccCccCCCeeecCCcccccccCc--chhcC
Q 036754           10 CKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILE---EITNLTKLTTIILGGNKLNGSISI--TLGSN   84 (405)
Q Consensus        10 l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~~~--~~~~~   84 (405)
                      +++|+.|++++|.+. .+|..+++.++ +|+.|+|++|++++..|.   .++.+++|++|+|++|+++ .++.  ..+..
T Consensus       309 ~~~L~~L~l~~n~l~-~ip~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~~~  385 (549)
T 2z81_A          309 LEKVKRITVENSKVF-LVPCSFSQHLK-SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLT  385 (549)
T ss_dssp             STTCCEEEEESSCCC-CCCHHHHHHCT-TCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCC-CHHHHHHHGGG
T ss_pred             cccceEEEeccCccc-cCCHHHHhcCc-cccEEEccCCccccccccchhhhhccccCcEEEccCCccc-ccccchhhhhc
Confidence            357888999999986 46666455666 899999999999986643   4788999999999999998 4443  34568


Q ss_pred             CCCCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecc
Q 036754           85 LASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLS  159 (405)
Q Consensus        85 l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~  159 (405)
                      +++|++|+|++|+++.+|..+..+++|++|+++.     +|..+  .++|++|++++|++++.+    ..+++|++|+++
T Consensus       386 l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls  459 (549)
T 2z81_A          386 LKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYIS  459 (549)
T ss_dssp             CTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSCCCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECC
T ss_pred             CCCCCEEECCCCCCccCChhhcccccccEEECCCCCcccccchh--cCCceEEECCCCChhhhc----ccCChhcEEECC
Confidence            9999999999999999999999999999999876     33333  268999999999998643    578999999999


Q ss_pred             cccccCccchhHHhcccCCccccccCcccCcCCC-CCccCCCCcccccCCCCccCCC
Q 036754          160 KNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLCGSP  215 (405)
Q Consensus       160 ~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~~c~~~  215 (405)
                      +|+++ .+|. ...+++|+.|++++|.+++.+|. ...+.+++.+++++|++.|.++
T Consensus       460 ~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          460 RNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             SSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             CCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            99999 4555 46799999999999999988876 4678899999999999988654

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.87  E-value=8.3e-22  Score=196.96  Aligned_cols=150  Identities=23%  Similarity=0.226  Sum_probs=69.3

Q ss_pred             ccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCc---hhhhccccCccccCCC------CCh-hccCCCCC
Q 036754           60 LTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIP---LTFWNLKDILYLNFSV------IPI-EIGGLPNL  129 (405)
Q Consensus        60 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp---~~~~~l~~L~~l~l~~------~p~-~~~~l~~L  129 (405)
                      +++|++|++++|++++.+|..+ .++++|++|+|++|+++.+|   ..+.++++|+.|+++.      +|. .+..+++|
T Consensus       352 l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L  430 (562)
T 3a79_B          352 PSSFTFLNFTQNVFTDSVFQGC-STLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI  430 (562)
T ss_dssp             CCCCCEEECCSSCCCTTTTTTC-CSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred             CCCceEEECCCCccccchhhhh-cccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence            3444444444444443333332 24444444444444444332   2334444444444432      222 13344444


Q ss_pred             CEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCC-CCccCCCCcccccCC
Q 036754          130 EYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGN  208 (405)
Q Consensus       130 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n  208 (405)
                      ++|++++|.+++..|..+.  ++|+.|++++|.++ .+|..+..+++|+.|++++|.++..++. ...+++++.+++.+|
T Consensus       431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N  507 (562)
T 3a79_B          431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN  507 (562)
T ss_dssp             CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSC
T ss_pred             CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCC
Confidence            4444444444433333222  45555555555555 2333333555666666666666543333 344555555666666


Q ss_pred             CCccC
Q 036754          209 ELLCG  213 (405)
Q Consensus       209 ~~~c~  213 (405)
                      ++.|.
T Consensus       508 ~~~c~  512 (562)
T 3a79_B          508 PWDCT  512 (562)
T ss_dssp             CBCCC
T ss_pred             CcCCC
Confidence            65554

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.87  E-value=3e-22  Score=199.54  Aligned_cols=202  Identities=21%  Similarity=0.224  Sum_probs=168.1

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchh
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG   82 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   82 (405)
                      +|+.+.  ++|++|+|++|.+++..|.. ++.++ +|++|+|++|++++..|+.|..+++|++|+|++|+++ .++...+
T Consensus        20 ip~~~~--~~L~~L~Ls~n~l~~~~~~~-~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~   94 (549)
T 2z81_A           20 IPSGLT--AAMKSLDLSFNKITYIGHGD-LRACA-NLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWF   94 (549)
T ss_dssp             CCSCCC--TTCCEEECCSSCCCEECSST-TSSCT-TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC-SCCHHHH
T ss_pred             ccccCC--CCccEEECcCCccCccChhh-hhcCC-cccEEECCCCCcCccChhhccccccCCEEECCCCccC-ccCHHHh
Confidence            444443  68999999999999988887 66776 9999999999999999999999999999999999998 5565555


Q ss_pred             cCCCCCCeeeCCCCCCCC--CchhhhccccCccccCCC------CC-hhccCCCCCCEEeccCCcccccCCcccccCCCC
Q 036754           83 SNLASLRKLSLDSNELTS--IPLTFWNLKDILYLNFSV------IP-IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISL  153 (405)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~--lp~~~~~l~~L~~l~l~~------~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L  153 (405)
                      .++++|++|+|++|+++.  +|..+.++++|+.|+++.      +| ..+.++++|++|++++|.+.+..|..++.+++|
T Consensus        95 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L  174 (549)
T 2z81_A           95 GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI  174 (549)
T ss_dssp             TTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEE
T ss_pred             ccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccC
Confidence            799999999999999994  467889999999998764      33 478899999999999999999999999999999


Q ss_pred             CeeecccccccCccchhHHhcccCCccccccCcccCcC----CCCCccCCCCcccccCCC
Q 036754          154 KSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEI----PRGGSFGNFSAESFEGNE  209 (405)
Q Consensus       154 ~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~----p~~~~~~~~~~~~~~~n~  209 (405)
                      +.|+++.|.+....+..+..+++|+.|++++|.+++..    +......++..+.+.+|.
T Consensus       175 ~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~  234 (549)
T 2z81_A          175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV  234 (549)
T ss_dssp             EEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCE
T ss_pred             ceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccc
Confidence            99999999987544444567899999999999998742    222234555666665554

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.86  E-value=7.8e-22  Score=182.68  Aligned_cols=114  Identities=23%  Similarity=0.270  Sum_probs=103.1

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ..|...+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.++++++|||||++++++.+.+..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            3466778899999999999995 579999999998766566677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++...  .+++.++..|+.||++||+|||+
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~  188 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHA  188 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999764  59999999999999999999994

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.86  E-value=2.4e-21  Score=178.62  Aligned_cols=173  Identities=20%  Similarity=0.312  Sum_probs=150.7

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhc
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGS   83 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   83 (405)
                      ++.+..+++|+.|+|++|.+.+..+   ++.++ +|+.|+|++|++++.  ..+..+++|++|+|++|+++ .++.  +.
T Consensus        56 l~~~~~l~~L~~L~L~~n~i~~~~~---~~~l~-~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~-~~~~--l~  126 (308)
T 1h6u_A           56 IEGVQYLNNLIGLELKDNQITDLAP---LKNLT-KITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQIT-DVTP--LA  126 (308)
T ss_dssp             CTTGGGCTTCCEEECCSSCCCCCGG---GTTCC-SCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCC-CCGG--GT
T ss_pred             chhhhccCCCCEEEccCCcCCCChh---HccCC-CCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCC-Cchh--hc
Confidence            3468889999999999999988665   55666 999999999999874  36899999999999999998 4554  46


Q ss_pred             CCCCCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeec
Q 036754           84 NLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNL  158 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l  158 (405)
                      .+++|++|++++|+++.+|. +..+++|+.|+++.     ++. +..+++|++|++++|.+++..+  +..+++|+.|++
T Consensus       127 ~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L  202 (308)
T 1h6u_A          127 GLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHL  202 (308)
T ss_dssp             TCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEEC
T ss_pred             CCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEc
Confidence            89999999999999998876 88999999999875     444 8899999999999999986544  899999999999


Q ss_pred             ccccccCccchhHHhcccCCccccccCcccCcC
Q 036754          159 SKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEI  191 (405)
Q Consensus       159 ~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~  191 (405)
                      ++|.+++..+  +..+++|+.|++++|.+++.+
T Consensus       203 ~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~  233 (308)
T 1h6u_A          203 KNNQISDVSP--LANTSNLFIVTLTNQTITNQP  233 (308)
T ss_dssp             TTSCCCBCGG--GTTCTTCCEEEEEEEEEECCC
T ss_pred             cCCccCcccc--ccCCCCCCEEEccCCeeecCC
Confidence            9999997653  789999999999999998643

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.86  E-value=1.7e-21  Score=197.04  Aligned_cols=163  Identities=29%  Similarity=0.376  Sum_probs=109.0

Q ss_pred             cCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCee
Q 036754           12 CLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKL   91 (405)
Q Consensus        12 ~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L   91 (405)
                      ++++|||++|+|+++.|.+ +.+++ +|++|+|++|+|+++.|+.|.++++|++|+|++|+|+ .+|...|.++++|++|
T Consensus        53 ~~~~LdLs~N~i~~l~~~~-f~~l~-~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~f~~L~~L~~L  129 (635)
T 4g8a_A           53 STKNLDLSFNPLRHLGSYS-FFSFP-ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKL  129 (635)
T ss_dssp             TCCEEECTTSCCCEECTTT-TTTCT-TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECGGGGTTCTTCCEE
T ss_pred             CCCEEEeeCCCCCCCCHHH-HhCCC-CCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC-CCCHHHhcCCCCCCEE
Confidence            5666666666666666655 44554 6666666666666666666666666666666666666 5565555666666666


Q ss_pred             eCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccc-cCCcccccCCCCCeeecccccccCccchh
Q 036754           92 SLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQG-SIPDSFGDLISLKSLNLSKNNLSGAIPAS  170 (405)
Q Consensus        92 ~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~~~~  170 (405)
                      +|++|+++.+|..                 .|+++++|++|++++|.+.+ ..|..++.+++|++|++++|++++..+..
T Consensus       130 ~Ls~N~l~~l~~~-----------------~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  192 (635)
T 4g8a_A          130 VAVETNLASLENF-----------------PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD  192 (635)
T ss_dssp             ECTTSCCCCSTTC-----------------CCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred             ECCCCcCCCCChh-----------------hhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccc
Confidence            6666666665532                 35667778888888887764 34667777888888888888887777777


Q ss_pred             HHhcccCC----ccccccCcccCcCCCC
Q 036754          171 LEKLLYLK----DLNLSFNKLEGEIPRG  194 (405)
Q Consensus       171 ~~~l~~L~----~l~l~~n~l~~~~p~~  194 (405)
                      +..+.+++    .++++.|.+....+..
T Consensus       193 l~~L~~l~~~~~~~~ls~n~l~~i~~~~  220 (635)
T 4g8a_A          193 LRVLHQMPLLNLSLDLSLNPMNFIQPGA  220 (635)
T ss_dssp             GHHHHTCTTCCCEEECTTCCCCEECTTT
T ss_pred             ccchhhhhhhhhhhhcccCcccccCccc
Confidence            77666554    3556677776555443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.86  E-value=2.7e-21  Score=169.38  Aligned_cols=157  Identities=24%  Similarity=0.284  Sum_probs=133.8

Q ss_pred             CCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCC-ccccCccCCCeeecCCcccccccCcchhcCCCCCCee
Q 036754           13 LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGIL-EEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKL   91 (405)
Q Consensus        13 L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L   91 (405)
                      -+.+++++|.++.+ |.. +   +..++.|+|++|++++..+ +.|..+++|++|+|++|+|+ .++...+.++++|++|
T Consensus        13 ~~~l~~s~n~l~~i-P~~-~---~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L   86 (220)
T 2v70_A           13 GTTVDCSNQKLNKI-PEH-I---PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEI   86 (220)
T ss_dssp             TTEEECCSSCCSSC-CSC-C---CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCC-EECTTTTTTCTTCCEE
T ss_pred             CCEeEeCCCCcccC-ccC-C---CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCC-EECHHHhCCCCCCCEE
Confidence            46899999999875 443 2   3378999999999998755 55899999999999999998 5666556799999999


Q ss_pred             eCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhH
Q 036754           92 SLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASL  171 (405)
Q Consensus        92 ~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~  171 (405)
                      +|++|+++.+|..                 .+.++++|++|++++|.+.+..|..|..+++|+.|++++|.+++..|..|
T Consensus        87 ~Ls~N~l~~~~~~-----------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  149 (220)
T 2v70_A           87 LLTSNRLENVQHK-----------------MFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAF  149 (220)
T ss_dssp             ECCSSCCCCCCGG-----------------GGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTT
T ss_pred             ECCCCccCccCHh-----------------HhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHh
Confidence            9999999987654                 35667889999999999998889999999999999999999998889999


Q ss_pred             HhcccCCccccccCcccCcCC
Q 036754          172 EKLLYLKDLNLSFNKLEGEIP  192 (405)
Q Consensus       172 ~~l~~L~~l~l~~n~l~~~~p  192 (405)
                      ..+++|+.|++++|.+.+..+
T Consensus       150 ~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          150 DTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             TTCTTCCEEECCSCCEECSGG
T ss_pred             cCCCCCCEEEecCcCCcCCCc
Confidence            999999999999998876543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.86  E-value=1.2e-21  Score=181.61  Aligned_cols=116  Identities=20%  Similarity=0.318  Sum_probs=96.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ++|...+.||+|+||+||+|+. .+|+.||||++....  ....+.+.+|+.++++++|||||++++++.+.+..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4567778999999999999984 578999999997543  3345678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||++|||.+++...+ ..+++.++..|+.||+.||+|||+
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~  143 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD  143 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999997654 457899999999999999999994

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.86  E-value=8.1e-22  Score=197.24  Aligned_cols=184  Identities=22%  Similarity=0.266  Sum_probs=164.6

Q ss_pred             CCCCcCCeeeCcCCcCcccC--CchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            8 SNCKCLTFIDLSNNPLDSVL--PKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         8 ~~l~~L~~L~Ls~N~l~~~~--~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      ..+++|+.|+|++|.+++..  |.. +..++ +|+.|++++|.+.+..+. +..+++|+.|++++|.+.+..|...+.++
T Consensus       344 ~~~~~L~~L~l~~n~l~~~~~~~~~-~~~~~-~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l  420 (570)
T 2z63_A          344 VDLPSLEFLDLSRNGLSFKGCCSQS-DFGTT-SLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSL  420 (570)
T ss_dssp             CBCTTCCEEECCSSCCBEEEEEEHH-HHTCS-CCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTC
T ss_pred             ccCCCCCEEeCcCCccCcccccccc-ccccC-ccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcC
Confidence            67899999999999998765  555 55666 999999999999886555 99999999999999999866665666799


Q ss_pred             CCCCeeeCCCCCCCC-CchhhhccccCccccCCC-------CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeee
Q 036754           86 ASLRKLSLDSNELTS-IPLTFWNLKDILYLNFSV-------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLN  157 (405)
Q Consensus        86 ~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~l~l~~-------~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  157 (405)
                      ++|++|++++|.++. .|..+.++++|+.|+++.       +|..+..+++|++|++++|.+++..|..|..+++|+.|+
T Consensus       421 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  500 (570)
T 2z63_A          421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN  500 (570)
T ss_dssp             TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEe
Confidence            999999999999984 577788999999999875       577889999999999999999998899999999999999


Q ss_pred             cccccccCccchhHHhcccCCccccccCcccCcCCCC
Q 036754          158 LSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG  194 (405)
Q Consensus       158 l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~  194 (405)
                      +++|.+++.+|..+..+++|+.+++++|++++..|..
T Consensus       501 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  537 (570)
T 2z63_A          501 MASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  537 (570)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             CCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence            9999999988888999999999999999999988764

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.86  E-value=2.7e-21  Score=167.92  Aligned_cols=149  Identities=27%  Similarity=0.301  Sum_probs=85.3

Q ss_pred             cccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchh-hhccccCccccC
Q 036754           38 SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLT-FWNLKDILYLNF  116 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~-~~~l~~L~~l~l  116 (405)
                      +|++|++++|++++..+..|..+++|++|+|++|+++ .+|...+.++++|++|+|++|+++.+|.. +.++++|++|++
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  107 (208)
T 2o6s_A           29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL  107 (208)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-ccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence            4445555555544444444444455555555555444 33433334444555555555544444332 233333333333


Q ss_pred             CC-----CC-hhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCc
Q 036754          117 SV-----IP-IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGE  190 (405)
Q Consensus       117 ~~-----~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~  190 (405)
                      +.     +| ..+.++++|++|++++|.+++..+..|..+++|+.|++++|++.+.       ++.|+.|+++.|.++|.
T Consensus       108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g~  180 (208)
T 2o6s_A          108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGV  180 (208)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC-------TTTTHHHHHHHHHCTTT
T ss_pred             CCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC-------CCCHHHHHHHHHhCCce
Confidence            22     11 1355677888888888888876666678888888888888877653       34677788888888887


Q ss_pred             CCCC
Q 036754          191 IPRG  194 (405)
Q Consensus       191 ~p~~  194 (405)
                      +|..
T Consensus       181 ip~~  184 (208)
T 2o6s_A          181 VRNS  184 (208)
T ss_dssp             BBCT
T ss_pred             eecc
Confidence            7753

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.86  E-value=9.1e-22  Score=185.65  Aligned_cols=179  Identities=28%  Similarity=0.277  Sum_probs=132.6

Q ss_pred             CCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCcccc-CccCCCeeecCCcccccccCcchhcCCCCCCee
Q 036754           13 LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEIT-NLTKLTTIILGGNKLNGSISITLGSNLASLRKL   91 (405)
Q Consensus        13 L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L   91 (405)
                      -+.+++++|.+..+ |.. +   +..++.|+|++|++++..+..|. .+++|++|+|++|+|+ .++...+.++++|++|
T Consensus        20 ~~~l~c~~~~l~~i-P~~-~---~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L   93 (361)
T 2xot_A           20 SNILSCSKQQLPNV-PQS-L---PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYL   93 (361)
T ss_dssp             TTEEECCSSCCSSC-CSS-C---CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCC-EECTTTTTTCTTCCEE
T ss_pred             CCEEEeCCCCcCcc-Ccc-C---CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCC-ccChhhccCCCCCCEE
Confidence            36899999999874 433 2   34789999999999998888887 8999999999999998 6666656789999999


Q ss_pred             eCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhH
Q 036754           92 SLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASL  171 (405)
Q Consensus        92 ~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~  171 (405)
                      +|++|+|+.+|..                 .|.++++|++|+|++|.+.+..|..|..+++|+.|+|++|.+++..+..|
T Consensus        94 ~Ls~N~l~~~~~~-----------------~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~  156 (361)
T 2xot_A           94 DLSSNHLHTLDEF-----------------LFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELI  156 (361)
T ss_dssp             ECCSSCCCEECTT-----------------TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGT
T ss_pred             ECCCCcCCcCCHH-----------------HhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHh
Confidence            9999999877653                 34556777888888888877777777888888888888888876555554


Q ss_pred             ---HhcccCCccccccCcccCcCCCC-CccCC--CCcccccCCCCccCC
Q 036754          172 ---EKLLYLKDLNLSFNKLEGEIPRG-GSFGN--FSAESFEGNELLCGS  214 (405)
Q Consensus       172 ---~~l~~L~~l~l~~n~l~~~~p~~-~~~~~--~~~~~~~~n~~~c~~  214 (405)
                         ..+++|+.|++++|.|++.++.. ..+..  +..+++.+||+.|.|
T Consensus       157 ~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C  205 (361)
T 2xot_A          157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDC  205 (361)
T ss_dssp             C----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred             cCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCc
Confidence               56777888888888777544321 12222  255677888887764

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.86  E-value=1.6e-21  Score=180.12  Aligned_cols=180  Identities=17%  Similarity=0.144  Sum_probs=148.8

Q ss_pred             cccC--CCCCcCCeeeCcCCcCcccCCc---hhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccc--
Q 036754            4 LSSL--SNCKCLTFIDLSNNPLDSVLPK---TFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGS--   76 (405)
Q Consensus         4 ~~~~--~~l~~L~~L~Ls~N~l~~~~~~---~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--   76 (405)
                      +..+  .++++|++|+|++|.+.+..+.   ..+..++ +|+.|+|++|++++..+..|+.+++|++|+|++|++.+.  
T Consensus       108 ~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  186 (310)
T 4glp_A          108 PPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKP-GLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERG  186 (310)
T ss_dssp             CCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCS-CCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHH
T ss_pred             hhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhcc-CCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchh
Confidence            4455  8899999999999999986662   1133455 999999999999998999999999999999999998753  


Q ss_pred             cC-cchhcCCCCCCeeeCCCCCCCCCchh----hhccccCccccCCC------CChhccCC---CCCCEEeccCCccccc
Q 036754           77 IS-ITLGSNLASLRKLSLDSNELTSIPLT----FWNLKDILYLNFSV------IPIEIGGL---PNLEYLFLGYNRLQGS  142 (405)
Q Consensus        77 ~~-~~~~~~l~~L~~L~Ls~N~l~~lp~~----~~~l~~L~~l~l~~------~p~~~~~l---~~L~~L~l~~n~l~~~  142 (405)
                      ++ ...+..+++|++|+|++|+++.+|..    +.++++|++|+++.      .|..+..+   ++|++|++++|+++ .
T Consensus       187 ~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~  265 (310)
T 4glp_A          187 LMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-Q  265 (310)
T ss_dssp             HHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-S
T ss_pred             hhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-c
Confidence            32 23335899999999999999987763    46789999999876      36666666   79999999999999 5


Q ss_pred             CCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccC
Q 036754          143 IPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEG  189 (405)
Q Consensus       143 ~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~  189 (405)
                      +|..+.  ++|+.|++++|++++. |. +..+++|+.|++++|+++.
T Consensus       266 lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          266 VPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             hhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence            677664  7999999999999975 33 5788999999999999874

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.86  E-value=1.4e-21  Score=193.47  Aligned_cols=138  Identities=20%  Similarity=0.244  Sum_probs=107.7

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchh
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG   82 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   82 (405)
                      +|+.+.  ++|+.|+|++|.+.+..|.. +..++ +|++|+|++|++++..|+.|+.+++|++|+|++|+++ .+|..  
T Consensus        15 ip~~~~--~~L~~L~Ls~n~i~~~~~~~-~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--   87 (520)
T 2z7x_B           15 VPKDLS--QKTTILNISQNYISELWTSD-ILSLS-KLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--   87 (520)
T ss_dssp             CCCSCC--TTCSEEECCSSCCCCCCHHH-HTTCT-TCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--
T ss_pred             cccccc--ccccEEECCCCcccccChhh-ccccc-cccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--
Confidence            454454  78999999999999887777 56666 8999999999999988999999999999999999998 78776  


Q ss_pred             cCCCCCCeeeCCCCCCCC--CchhhhccccCccccCCCC---ChhccCCCCC--CEEeccCCcc--cccCCcccc
Q 036754           83 SNLASLRKLSLDSNELTS--IPLTFWNLKDILYLNFSVI---PIEIGGLPNL--EYLFLGYNRL--QGSIPDSFG  148 (405)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~--lp~~~~~l~~L~~l~l~~~---p~~~~~l~~L--~~L~l~~n~l--~~~~p~~~~  148 (405)
                       .+++|++|+|++|+++.  +|..+.++++|++|+++..   ...+..+++|  ++|++++|.+  .+..|..+.
T Consensus        88 -~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~  161 (520)
T 2z7x_B           88 -PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQ  161 (520)
T ss_dssp             -CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCCTTTTT
T ss_pred             -ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeeccccccccccccccc
Confidence             68999999999999985  5788899999988887641   1234555555  6666666666  444444433

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.86  E-value=3.9e-21  Score=168.36  Aligned_cols=154  Identities=22%  Similarity=0.267  Sum_probs=128.6

Q ss_pred             CCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeee
Q 036754           13 LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLS   92 (405)
Q Consensus        13 L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~   92 (405)
                      -+.+++++|.++.+.+..     +.+|+.|+|++|++++..+..|..+++|++|+|++|+++ .++...+.++++|++|+
T Consensus        13 ~~~v~c~~~~l~~iP~~l-----~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~   86 (220)
T 2v9t_B           13 NNIVDCRGKGLTEIPTNL-----PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLV   86 (220)
T ss_dssp             TTEEECTTSCCSSCCSSC-----CTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCC-EECTTTTTTCSSCCEEE
T ss_pred             CCEEEcCCCCcCcCCCcc-----CcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCC-CcCHHHhhCCcCCCEEE
Confidence            368999999998754432     248999999999999988889999999999999999998 44444456899999999


Q ss_pred             CCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHH
Q 036754           93 LDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLE  172 (405)
Q Consensus        93 Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~  172 (405)
                      |++|+|+.+|..                 .|.++++|++|++++|.+.+..|..|..+++|+.|++++|.+++..+..|.
T Consensus        87 Ls~N~l~~l~~~-----------------~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  149 (220)
T 2v9t_B           87 LYGNKITELPKS-----------------LFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS  149 (220)
T ss_dssp             CCSSCCCCCCTT-----------------TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred             CCCCcCCccCHh-----------------HccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHh
Confidence            999999988765                 345678889999999999988888899999999999999999888777788


Q ss_pred             hcccCCccccccCcccC
Q 036754          173 KLLYLKDLNLSFNKLEG  189 (405)
Q Consensus       173 ~l~~L~~l~l~~n~l~~  189 (405)
                      .+++|+.|++++|++.+
T Consensus       150 ~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B          150 PLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             TCTTCCEEECCSSCEEC
T ss_pred             CCCCCCEEEeCCCCcCC
Confidence            88888888888887764

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.85  E-value=7e-21  Score=194.55  Aligned_cols=205  Identities=20%  Similarity=0.190  Sum_probs=144.9

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhccc---------------------------ccccEEEcccCcccccCCcccc
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVS---------------------------HSLEFFVMSYCNISGGILEEIT   58 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~---------------------------~~L~~L~L~~n~l~~~~~~~~~   58 (405)
                      .|..+++|+.|+|++|.+.+..+.. +..++                           .+|+.|++++|++++..|..|.
T Consensus       324 ~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~  402 (680)
T 1ziw_A          324 SFQWLKCLEHLNMEDNDIPGIKSNM-FTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS  402 (680)
T ss_dssp             TTTTCTTCCEEECCSCCBCCCCTTT-TTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTT
T ss_pred             hcccCCCCCEEECCCCccCCCChhH-hccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhh
Confidence            5777888888888888888877665 33433                           1345555555666666677777


Q ss_pred             CccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCC-chhhhccccCccccCCC--------CChhccCCCCC
Q 036754           59 NLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSI-PLTFWNLKDILYLNFSV--------IPIEIGGLPNL  129 (405)
Q Consensus        59 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~l-p~~~~~l~~L~~l~l~~--------~p~~~~~l~~L  129 (405)
                      .+++|+.|+|++|.+++.+|...+.++++|++|++++|+++.+ +..+..++.|+.|+++.        +|..+.++++|
T Consensus       403 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L  482 (680)
T 1ziw_A          403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL  482 (680)
T ss_dssp             TCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC
T ss_pred             CCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC
Confidence            7778888888888877667765566778888888888877754 44566677777776643        46667778888


Q ss_pred             CEEeccCCcccccCCcccccCCCCCeeecccccccCccc--------hhHHhcccCCccccccCcccCcCCC-CCccCCC
Q 036754          130 EYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIP--------ASLEKLLYLKDLNLSFNKLEGEIPR-GGSFGNF  200 (405)
Q Consensus       130 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~--------~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~~~~  200 (405)
                      ++|++++|.+++..|..|..+++|+.|++++|.+++..+        ..+..+++|+.|++++|.++..++. ...+.++
T Consensus       483 ~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L  562 (680)
T 1ziw_A          483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL  562 (680)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCc
Confidence            888888888887777777888888888888888775422        2366777888888888888754443 3556777


Q ss_pred             CcccccCCCCc
Q 036754          201 SAESFEGNELL  211 (405)
Q Consensus       201 ~~~~~~~n~~~  211 (405)
                      +.+++.+|...
T Consensus       563 ~~L~Ls~N~l~  573 (680)
T 1ziw_A          563 KIIDLGLNNLN  573 (680)
T ss_dssp             CEEECCSSCCC
T ss_pred             ceeECCCCCCC
Confidence            77777777654

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.85  E-value=2.1e-21  Score=194.03  Aligned_cols=123  Identities=22%  Similarity=0.291  Sum_probs=90.6

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCe
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~   90 (405)
                      ++|+.|+|++|.+.++.|.. ++.++ +|+.|+|++|++++..|+.|..+++|++|+|++|+++ .+|..   .+++|++
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~-~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~---~l~~L~~  125 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPD-ISFLS-ELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC---PMASLRH  125 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGG-TTTCT-TCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC---CCTTCSE
T ss_pred             CCcCEEECCCCCccccChhh-hccCC-CccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc---ccccCCE
Confidence            67888888888888877766 56665 8888888888888888888888888888888888887 77765   6888888


Q ss_pred             eeCCCCCCCCCc--hhhhccccCccccCCCC---ChhccCCCCC--CEEeccCCcc
Q 036754           91 LSLDSNELTSIP--LTFWNLKDILYLNFSVI---PIEIGGLPNL--EYLFLGYNRL  139 (405)
Q Consensus        91 L~Ls~N~l~~lp--~~~~~l~~L~~l~l~~~---p~~~~~l~~L--~~L~l~~n~l  139 (405)
                      |+|++|+++.+|  ..+.++++|++|+++..   ...+.++++|  ++|++++|.+
T Consensus       126 L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l  181 (562)
T 3a79_B          126 LDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSY  181 (562)
T ss_dssp             EECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSC
T ss_pred             EECCCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccc
Confidence            888888888654  67888888888776541   1223333333  5555555544

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.85  E-value=5e-21  Score=193.69  Aligned_cols=207  Identities=22%  Similarity=0.260  Sum_probs=175.9

Q ss_pred             cCCCCCcCCeeeCcCCcCccc--CCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhc
Q 036754            6 SLSNCKCLTFIDLSNNPLDSV--LPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGS   83 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~--~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   83 (405)
                      ....+++|+.|++++|.+...  .+.. ..... +|+.|+++.|.+.. .+..+..+++|+.+++++|+.....+...+.
T Consensus       366 ~~~~l~~L~~L~ls~n~l~~~~~~~~~-~~~~~-~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~  442 (635)
T 4g8a_A          366 SEVDLPSLEFLDLSRNGLSFKGCCSQS-DFGTI-SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL  442 (635)
T ss_dssp             CCCBCTTCCEEECCSSCCBEEEECCHH-HHSCS-CCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTT
T ss_pred             ccccccccccchhhccccccccccccc-hhhhh-hhhhhhcccccccc-ccccccccccccchhhhhccccccccccccc
Confidence            345678899999999988643  3444 33344 78999999988766 4556888999999999999988777777778


Q ss_pred             CCCCCCeeeCCCCCCCCC-chhhhccccCccccCCC-------CChhccCCCCCCEEeccCCcccccCCcccccCCCCCe
Q 036754           84 NLASLRKLSLDSNELTSI-PLTFWNLKDILYLNFSV-------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKS  155 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~l-p~~~~~l~~L~~l~l~~-------~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  155 (405)
                      .+++|+.++++.|.++.+ |..+..++.|+.|+++.       .|..+..+++|++|++++|++++..|..|.++++|++
T Consensus       443 ~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~  522 (635)
T 4g8a_A          443 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV  522 (635)
T ss_dssp             TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             cccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCE
Confidence            999999999999999954 56677889999998875       5667899999999999999999999999999999999


Q ss_pred             eecccccccCccchhHHhcccCCccccccCcccCcCCCC-Ccc-CCCCcccccCCCCccCCC
Q 036754          156 LNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG-GSF-GNFSAESFEGNELLCGSP  215 (405)
Q Consensus       156 L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~-~~~-~~~~~~~~~~n~~~c~~~  215 (405)
                      |+|++|++++..|..|..+++|+.|++++|++++.+|.. ..+ .+++.+++.+|||.|.|.
T Consensus       523 L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          523 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             EECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             EECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            999999999999999999999999999999999988864 334 678999999999999763

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.85  E-value=1.3e-21  Score=178.45  Aligned_cols=115  Identities=24%  Similarity=0.330  Sum_probs=103.4

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.||+|+||+||+|+. .+|+.||||++.+..   ....+.+.+|++++++++|||||++++++.+.+..||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5678889999999999999984 678999999997542   334567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||++|||.+++...+ .+++.++..++.||+.||+|||+
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~  150 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG  150 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997654 79999999999999999999994

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.85  E-value=3.3e-21  Score=190.81  Aligned_cols=171  Identities=20%  Similarity=0.211  Sum_probs=139.9

Q ss_pred             cccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCC---CchhhhccccCccc
Q 036754           38 SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTS---IPLTFWNLKDILYL  114 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~---lp~~~~~l~~L~~l  114 (405)
                      +|+.|++++|.+....  .+..+++|++|++++|++++.+|..+ .++++|++|+|++|+++.   +|..+.++++|+.|
T Consensus       303 ~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L  379 (520)
T 2z7x_B          303 NIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENC-GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQL  379 (520)
T ss_dssp             CCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTC-CCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEE
T ss_pred             ceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhh-ccCCCCCEEEccCCccCccccchHHHhhCCCCCEE
Confidence            4666666666654421  12678999999999999997777766 589999999999999995   45678899999999


Q ss_pred             cCCC------CChh-ccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcc
Q 036754          115 NFSV------IPIE-IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKL  187 (405)
Q Consensus       115 ~l~~------~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l  187 (405)
                      +++.      +|.. +..+++|++|++++|.+.+..|..+.  ++|+.|++++|+++ .+|..+..+++|+.|++++|.+
T Consensus       380 ~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l  456 (520)
T 2z7x_B          380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL  456 (520)
T ss_dssp             ECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCC
T ss_pred             ECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcC
Confidence            9875      4543 77889999999999999887777664  79999999999999 6677777999999999999999


Q ss_pred             cCcCCC-CCccCCCCcccccCCCCccCC
Q 036754          188 EGEIPR-GGSFGNFSAESFEGNELLCGS  214 (405)
Q Consensus       188 ~~~~p~-~~~~~~~~~~~~~~n~~~c~~  214 (405)
                      +..++. ...+++++.+++.+|++.|.|
T Consensus       457 ~~l~~~~~~~l~~L~~L~l~~N~~~c~c  484 (520)
T 2z7x_B          457 KSVPDGIFDRLTSLQKIWLHTNPWDCSC  484 (520)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             CccCHHHhccCCcccEEECcCCCCcccC
Confidence            965554 566788999999999998864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.85  E-value=2.3e-21  Score=184.00  Aligned_cols=114  Identities=23%  Similarity=0.270  Sum_probs=103.6

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ..|...+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            4577778999999999999995 578999999998766566677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++...  .+++.++..|+.||++||+|||+
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~  265 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHA  265 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999764  59999999999999999999994

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.85  E-value=8.3e-21  Score=185.29  Aligned_cols=189  Identities=27%  Similarity=0.356  Sum_probs=105.9

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      .+.++++|+.|++++|.+.+..  . +..++ +|+.|++++|.+++..|  ++.+++|+.|++++|.++ .++ . +..+
T Consensus       172 ~~~~l~~L~~L~l~~n~l~~~~--~-l~~l~-~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~-~~~-~-l~~l  242 (466)
T 1o6v_A          172 PLANLTTLERLDISSNKVSDIS--V-LAKLT-NLESLIATNNQISDITP--LGILTNLDELSLNGNQLK-DIG-T-LASL  242 (466)
T ss_dssp             GGTTCTTCCEEECCSSCCCCCG--G-GGGCT-TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC-CCG-G-GGGC
T ss_pred             hhccCCCCCEEECcCCcCCCCh--h-hccCC-CCCEEEecCCccccccc--ccccCCCCEEECCCCCcc-cch-h-hhcC
Confidence            4667777777777777776542  2 44444 67777777777766444  555666666666666665 332 2 2356


Q ss_pred             CCCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccc
Q 036754           86 ASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSK  160 (405)
Q Consensus        86 ~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~  160 (405)
                      ++|++|++++|.++.++. +..+++|+.|+++.     +|. +..+++|++|++++|.+.+..+  +..+++|+.|++++
T Consensus       243 ~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~  318 (466)
T 1o6v_A          243 TNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYF  318 (466)
T ss_dssp             TTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCS
T ss_pred             CCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcC
Confidence            666666666666665544 55555566555543     222 4555556666666665554332  45555555555555


Q ss_pred             ccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCC
Q 036754          161 NNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL  210 (405)
Q Consensus       161 n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~  210 (405)
                      |.+++..|  +..+++|+.|++++|.+++. +....+++++.+++.+|+.
T Consensus       319 n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l  365 (466)
T 1o6v_A          319 NNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQI  365 (466)
T ss_dssp             SCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCC
T ss_pred             CcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCcc
Confidence            55554433  44555555555555555543 3333444455555555543

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.85  E-value=9.7e-21  Score=166.89  Aligned_cols=156  Identities=24%  Similarity=0.302  Sum_probs=132.8

Q ss_pred             CCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeee
Q 036754           13 LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLS   92 (405)
Q Consensus        13 L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~   92 (405)
                      .+.++.+++.+..+.+..     +.+|+.|+|++|++++..|..|..+++|++|+|++|+|+ .+|...+.++++|++|+
T Consensus        21 ~~~v~c~~~~l~~ip~~~-----~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~   94 (229)
T 3e6j_A           21 GTTVDCRSKRHASVPAGI-----PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLD   94 (229)
T ss_dssp             TTEEECTTSCCSSCCSCC-----CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred             CCEeEccCCCcCccCCCC-----CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcccCCCcCEEE
Confidence            577999999997755432     248999999999999988999999999999999999997 78877778999999999


Q ss_pred             CCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHH
Q 036754           93 LDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLE  172 (405)
Q Consensus        93 Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~  172 (405)
                      |++|+|+.+|..                 .+..+++|++|++++|.+. .+|..+..+++|+.|++++|.+++..+..+.
T Consensus        95 Ls~N~l~~l~~~-----------------~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~  156 (229)
T 3e6j_A           95 LGTNQLTVLPSA-----------------VFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFD  156 (229)
T ss_dssp             CCSSCCCCCCTT-----------------TTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTT
T ss_pred             CCCCcCCccChh-----------------HhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHh
Confidence            999999987754                 3456788899999999998 6788888999999999999999877777888


Q ss_pred             hcccCCccccccCcccCcCC
Q 036754          173 KLLYLKDLNLSFNKLEGEIP  192 (405)
Q Consensus       173 ~l~~L~~l~l~~n~l~~~~p  192 (405)
                      .+++|+.|++++|.+.+..+
T Consensus       157 ~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          157 RLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             TCTTCCEEECTTSCBCTTBG
T ss_pred             CCCCCCEEEeeCCCccCCcc
Confidence            88999999999998876554

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.85  E-value=4.3e-21  Score=193.48  Aligned_cols=191  Identities=20%  Similarity=0.179  Sum_probs=107.9

Q ss_pred             CeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeC
Q 036754           14 TFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSL   93 (405)
Q Consensus        14 ~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L   93 (405)
                      +.++.+++.++.+++..     +.+|+.|+|++|++++..+..|.++++|++|+|++|.++ .+++..+.++++|++|+|
T Consensus        14 ~~~~c~~~~l~~ip~~~-----~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~i~~~~~~~l~~L~~L~L   87 (606)
T 3vq2_A           14 ITYQCMDQKLSKVPDDI-----PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE-TIEDKAWHGLHHLSNLIL   87 (606)
T ss_dssp             TEEECTTSCCSSCCTTS-----CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEEC
T ss_pred             CceEccCCCcccCCCCC-----CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCccc-ccCHHHhhchhhcCEeEC
Confidence            34555555555433221     125555555555555555555555555555555555555 232222345555555555


Q ss_pred             CCCCCCCC-chhhhccccCccccCCC-----CC-hhccCCCCCCEEeccCCcccc-cCCcccccCCCCCeeecccccccC
Q 036754           94 DSNELTSI-PLTFWNLKDILYLNFSV-----IP-IEIGGLPNLEYLFLGYNRLQG-SIPDSFGDLISLKSLNLSKNNLSG  165 (405)
Q Consensus        94 s~N~l~~l-p~~~~~l~~L~~l~l~~-----~p-~~~~~l~~L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~  165 (405)
                      ++|+++.+ |..+.++++|++|+++.     +| ..++++++|++|++++|.+.+ .+|..|+++++|++|++++|.+++
T Consensus        88 s~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~  167 (606)
T 3vq2_A           88 TGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT  167 (606)
T ss_dssp             TTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCE
T ss_pred             CCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCccee
Confidence            55555544 44555555555555543     22 346666677777777777664 346667777777777777777766


Q ss_pred             ccchhHHhcccCC----ccccccCcccCcCCCCCccCCCCcccccCCCC
Q 036754          166 AIPASLEKLLYLK----DLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL  210 (405)
Q Consensus       166 ~~~~~~~~l~~L~----~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~  210 (405)
                      ..|..+..+.+|+    .+++++|.+++.++......+++.+++.+|..
T Consensus       168 ~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~  216 (606)
T 3vq2_A          168 ITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFN  216 (606)
T ss_dssp             ECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCS
T ss_pred             cChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCcc
Confidence            6666666666554    56777777665555544444556666666643

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.85  E-value=2.3e-21  Score=172.13  Aligned_cols=173  Identities=20%  Similarity=0.160  Sum_probs=148.7

Q ss_pred             cCCCCCcCCeeeCcCCc-CcccCCchhhhcccccccEEEccc-CcccccCCccccCccCCCeeecCCcccccccCcchhc
Q 036754            6 SLSNCKCLTFIDLSNNP-LDSVLPKTFVGNVSHSLEFFVMSY-CNISGGILEEITNLTKLTTIILGGNKLNGSISITLGS   83 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~-l~~~~~~~f~~~~~~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   83 (405)
                      .|.++++|++|+|++|+ ++++.+.. ++.++ +|++|++++ |+++...+..|..+++|++|++++|.++ .+|.  +.
T Consensus        50 ~~~~l~~L~~L~l~~n~~l~~i~~~~-f~~l~-~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~-~lp~--~~  124 (239)
T 2xwt_C           50 AFSNLPNISRIYVSIDVTLQQLESHS-FYNLS-KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD--LT  124 (239)
T ss_dssp             TTTTCTTCCEEEEECCSSCCEECTTT-EESCT-TCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCC-SCCC--CT
T ss_pred             HccCCCCCcEEeCCCCCCcceeCHhH-cCCCc-CCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCc-cccc--cc
Confidence            68899999999999997 88888777 56676 999999999 9999988889999999999999999998 5786  46


Q ss_pred             CCCCCC---eeeCCCC-CCCCCchh-hhccccCc-cccCCC-----CChhccCCCCCCEEeccCCc-ccccCCcccccC-
Q 036754           84 NLASLR---KLSLDSN-ELTSIPLT-FWNLKDIL-YLNFSV-----IPIEIGGLPNLEYLFLGYNR-LQGSIPDSFGDL-  150 (405)
Q Consensus        84 ~l~~L~---~L~Ls~N-~l~~lp~~-~~~l~~L~-~l~l~~-----~p~~~~~l~~L~~L~l~~n~-l~~~~p~~~~~l-  150 (405)
                      .+++|+   +|++++| +++.+|.. +.++++|+ .|+++.     +|......++|++|++++|+ +++..+..|..+ 
T Consensus       125 ~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~  204 (239)
T 2xwt_C          125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY  204 (239)
T ss_dssp             TCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCS
T ss_pred             cccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccc
Confidence            888998   9999999 99988764 78899999 998865     55544444899999999995 998778889999 


Q ss_pred             CCCCeeecccccccCccchhHHhcccCCccccccCc
Q 036754          151 ISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNK  186 (405)
Q Consensus       151 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~  186 (405)
                      ++|+.|++++|++++.++.   .+++|+.|+++++.
T Consensus       205 ~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~~  237 (239)
T 2xwt_C          205 SGPSLLDVSQTSVTALPSK---GLEHLKELIARNTW  237 (239)
T ss_dssp             BCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC-
T ss_pred             cCCcEEECCCCccccCChh---HhccCceeeccCcc
Confidence            9999999999999965544   57788888887763

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.85  E-value=2.7e-21  Score=175.43  Aligned_cols=111  Identities=26%  Similarity=0.374  Sum_probs=96.1

Q ss_pred             ccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeec----CCeeEEEEe
Q 036754          294 ENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSN----EEFKALVLE  366 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e  366 (405)
                      ..+.||+|+||+||+|.. .++..||+|++....  ....+.|.+|+.++++++|||||++++++.+    .+..|||||
T Consensus        30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE  109 (290)
T 3fpq_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence            345799999999999985 568899999997543  3345679999999999999999999999864    356899999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||++|+|.+++...+ .+++..+..|+.||++||+|||+
T Consensus       110 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~  147 (290)
T 3fpq_A          110 LMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT  147 (290)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999997654 79999999999999999999995

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.85  E-value=4.2e-21  Score=176.21  Aligned_cols=110  Identities=30%  Similarity=0.427  Sum_probs=92.7

Q ss_pred             CCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCC----eeEEEEec
Q 036754          292 FSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE----FKALVLEY  367 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~  367 (405)
                      +...+.||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||+++|+|...+    ..||||||
T Consensus         5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey   82 (303)
T 3hmm_A            5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence            45567899999999999998 6899999999654321 223446777788999999999999997653    57999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |++|+|.++++..  .++|.++.+++.|+|+||+|||+
T Consensus        83 ~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~  118 (303)
T 3hmm_A           83 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHM  118 (303)
T ss_dssp             CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999864  58999999999999999999994

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.84  E-value=5.8e-22  Score=194.20  Aligned_cols=205  Identities=19%  Similarity=0.158  Sum_probs=154.0

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCc----------------cccCccCCCeee
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILE----------------EITNLTKLTTII   67 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~----------------~~~~l~~L~~L~   67 (405)
                      +++|+++++|++|+|++|.+++..|   ++.++ +|+.|+|++|.+++..+.                ....+++|+.|+
T Consensus        51 ~~~~~~l~~L~~L~Ls~N~l~~~~~---l~~l~-~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~  126 (487)
T 3oja_A           51 AADLAPFTKLELLNLSSNVLYETLD---LESLS-TLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIY  126 (487)
T ss_dssp             GGGGTTCTTCCEEECTTSCCEEEEE---CTTCT-TCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEE
T ss_pred             HHHHhCCCCCCEEEeeCCCCCCCcc---cccCC-CCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEE
Confidence            4578888999999999999887665   44555 777777777776653221                112357889999


Q ss_pred             cCCcccccccCcchhcCCCCCCeeeCCCCCCCC-Cchhhh-ccccCccccCCCCC----hhccCCCCCCEEeccCCcccc
Q 036754           68 LGGNKLNGSISITLGSNLASLRKLSLDSNELTS-IPLTFW-NLKDILYLNFSVIP----IEIGGLPNLEYLFLGYNRLQG  141 (405)
Q Consensus        68 L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~-~l~~L~~l~l~~~p----~~~~~l~~L~~L~l~~n~l~~  141 (405)
                      |++|.+++..|..+ .++++|++|+|++|.++. .|..+. ++++|+.|+++...    .....+++|++|++++|.+++
T Consensus       127 L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~  205 (487)
T 3oja_A          127 LANNKITMLRDLDE-GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAF  205 (487)
T ss_dssp             CCSSCCCSGGGBCG-GGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCE
T ss_pred             CCCCCCCCCCchhh-cCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCCCCC
Confidence            99999986555555 589999999999999995 466665 78999999988621    234468999999999999997


Q ss_pred             cCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCccc-CcCCC-CCccCCCCccccc-------CCCCcc
Q 036754          142 SIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLE-GEIPR-GGSFGNFSAESFE-------GNELLC  212 (405)
Q Consensus       142 ~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~-~~~p~-~~~~~~~~~~~~~-------~n~~~c  212 (405)
                      .+| .|..+++|+.|++++|.+++ +|..+..+++|+.|++++|.+. +.+|. ...++.+..+.+.       .++..|
T Consensus       206 ~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~~~~~~~~~~~~c  283 (487)
T 3oja_A          206 MGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC  283 (487)
T ss_dssp             ECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHHHHHHTSSSSCCC
T ss_pred             CCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEeccccccccCCCcccc
Confidence            555 59999999999999999995 6777888999999999999998 33332 2334444444443       666666


Q ss_pred             CCC
Q 036754          213 GSP  215 (405)
Q Consensus       213 ~~~  215 (405)
                      .++
T Consensus       284 ~~~  286 (487)
T 3oja_A          284 TVP  286 (487)
T ss_dssp             SST
T ss_pred             cCC
Confidence            543

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.84  E-value=9.5e-21  Score=178.64  Aligned_cols=160  Identities=24%  Similarity=0.250  Sum_probs=135.4

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCe
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~   90 (405)
                      +.++.|+|++|+|+++.+..|...++ +|+.|+|++|++++..++.|..+++|++|+|++|+|+ .++...+.++++|++
T Consensus        39 ~~l~~L~Ls~N~l~~l~~~~~~~~l~-~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~  116 (361)
T 2xot_A           39 SYTALLDLSHNNLSRLRAEWTPTRLT-NLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEV  116 (361)
T ss_dssp             TTCSEEECCSSCCCEECTTSSSSCCT-TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCE
T ss_pred             CCCCEEECCCCCCCccChhhhhhccc-ccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCC-cCCHHHhCCCcCCCE
Confidence            35899999999999988887432666 9999999999999988899999999999999999998 677777789999999


Q ss_pred             eeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCccc---ccCCCCCeeecccccccCcc
Q 036754           91 LSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSF---GDLISLKSLNLSKNNLSGAI  167 (405)
Q Consensus        91 L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~---~~l~~L~~L~l~~n~l~~~~  167 (405)
                      |+|++|+|+.++..                 .|.++++|++|+|++|.+.+..+..|   ..+++|+.|+|++|.+++..
T Consensus       117 L~L~~N~i~~~~~~-----------------~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~  179 (361)
T 2xot_A          117 LLLYNNHIVVVDRN-----------------AFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLP  179 (361)
T ss_dssp             EECCSSCCCEECTT-----------------TTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCC
T ss_pred             EECCCCcccEECHH-----------------HhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccC
Confidence            99999999977432                 45667889999999999986555555   56899999999999999877


Q ss_pred             chhHHhccc--CCccccccCcccC
Q 036754          168 PASLEKLLY--LKDLNLSFNKLEG  189 (405)
Q Consensus       168 ~~~~~~l~~--L~~l~l~~n~l~~  189 (405)
                      +..+..++.  ++.|++++|++.+
T Consensus       180 ~~~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          180 LTDLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             HHHHHHSCHHHHTTEECCSSCEEC
T ss_pred             HHHhhhccHhhcceEEecCCCccC
Confidence            788888877  4889999998875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.84  E-value=4.3e-21  Score=177.17  Aligned_cols=110  Identities=19%  Similarity=0.268  Sum_probs=97.6

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +.|...++||+|+||.||+|+. .+|+.||||+++....     ..+|+.++++++|||||++++++.+.+..|||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            4456667899999999999995 5789999999975432     246999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.++++..+ .+++.++..|+.||++||+|||+
T Consensus       133 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~  168 (336)
T 4g3f_A          133 EGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHT  168 (336)
T ss_dssp             TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999997654 79999999999999999999995

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.84  E-value=3.5e-20  Score=160.85  Aligned_cols=156  Identities=28%  Similarity=0.265  Sum_probs=101.8

Q ss_pred             ccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCC
Q 036754           39 LEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV  118 (405)
Q Consensus        39 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~  118 (405)
                      -+.++.+++.++.. |..+  .++|++|++++|+++ .++...+.++++|++|+|++|+++.+|...             
T Consensus         9 ~~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-------------   71 (208)
T 2o6s_A            9 GTTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGV-------------   71 (208)
T ss_dssp             TTEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTT-------------
T ss_pred             CCEEEecCCCccCC-CCCC--CCCCcEEEcCCCccC-cCChhhhcccccCcEEECCCCccCccChhh-------------
Confidence            35677777777653 4333  458999999999998 677777779999999999999999887642             


Q ss_pred             CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCC-CCcc
Q 036754          119 IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPR-GGSF  197 (405)
Q Consensus       119 ~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~  197 (405)
                          +.++++|++|++++|.+++..+..|..+++|++|++++|.+++..+..+..+++|+.|++++|.+++.++. ...+
T Consensus        72 ----~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  147 (208)
T 2o6s_A           72 ----FNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL  147 (208)
T ss_dssp             ----TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred             ----cCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccC
Confidence                33445566666666666554444455666666666666666655555555566666666666666554443 2345


Q ss_pred             CCCCcccccCCCCccCCC
Q 036754          198 GNFSAESFEGNELLCGSP  215 (405)
Q Consensus       198 ~~~~~~~~~~n~~~c~~~  215 (405)
                      .+++.+++.+|++.|.++
T Consensus       148 ~~L~~L~l~~N~~~~~~~  165 (208)
T 2o6s_A          148 TSLQYIWLHDNPWDCTCP  165 (208)
T ss_dssp             TTCCEEECCSCCBCCCTT
T ss_pred             CCccEEEecCCCeecCCC
Confidence            555556666666555443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.84  E-value=1.9e-21  Score=182.86  Aligned_cols=199  Identities=19%  Similarity=0.212  Sum_probs=167.9

Q ss_pred             CCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCC
Q 036754            8 SNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLAS   87 (405)
Q Consensus         8 ~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~   87 (405)
                      ..|+.....|+++|.++.++...     +++|+.|++++|++++..+..|..+++|++|+|++|.++ .++...+.++++
T Consensus        28 ~~C~~~~~c~~~~~~l~~iP~~~-----~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~  101 (353)
T 2z80_A           28 LSCDRNGICKGSSGSLNSIPSGL-----TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS  101 (353)
T ss_dssp             CEECTTSEEECCSTTCSSCCTTC-----CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC-EECTTTTTTCTT
T ss_pred             CCCCCCeEeeCCCCCcccccccc-----cccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccC-ccCHhhcCCCCC
Confidence            34677778999999998754432     238999999999999988889999999999999999998 455454569999


Q ss_pred             CCeeeCCCCCCCCCchh-hhccccCccccCCC-----CCh--hccCCCCCCEEeccCC-cccccCCcccccCCCCCeeec
Q 036754           88 LRKLSLDSNELTSIPLT-FWNLKDILYLNFSV-----IPI--EIGGLPNLEYLFLGYN-RLQGSIPDSFGDLISLKSLNL  158 (405)
Q Consensus        88 L~~L~Ls~N~l~~lp~~-~~~l~~L~~l~l~~-----~p~--~~~~l~~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L~l  158 (405)
                      |++|+|++|+++.+|.. +.++++|++|+++.     +|.  .+.++++|++|++++| .+.+..+..|..+++|+.|++
T Consensus       102 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l  181 (353)
T 2z80_A          102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEI  181 (353)
T ss_dssp             CCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEE
T ss_pred             CCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEEC
Confidence            99999999999999876 78899999999875     555  6889999999999999 577777888999999999999


Q ss_pred             ccccccCccchhHHhcccCCccccccCcccCcCCCC-CccCCCCcccccCCCCcc
Q 036754          159 SKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLC  212 (405)
Q Consensus       159 ~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~-~~~~~~~~~~~~~n~~~c  212 (405)
                      ++|.+++..|..+..+++|+.|++++|.+...++.. ..+++++.+++.+|....
T Consensus       182 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~  236 (353)
T 2z80_A          182 DASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT  236 (353)
T ss_dssp             EETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTT
T ss_pred             CCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccc
Confidence            999999988999999999999999999986543322 235788888998887643

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.84  E-value=5.5e-20  Score=172.40  Aligned_cols=189  Identities=23%  Similarity=0.368  Sum_probs=109.1

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCC
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLA   86 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~   86 (405)
                      +..+++|+.|++++|.+... |.  ++.++ +|++|++++|+++...+  +..+++|++|++++|.++ .+| . +.+++
T Consensus        40 ~~~l~~L~~L~l~~~~i~~~-~~--~~~~~-~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~-~~~-~-~~~l~  110 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVASI-QG--IEYLT-NLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DIS-A-LQNLT  110 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCCC-TT--GGGCT-TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-G-GTTCT
T ss_pred             chhcccccEEEEeCCccccc-hh--hhhcC-CccEEEccCCccccchh--hhcCCcCCEEEccCCccc-Cch-H-HcCCC
Confidence            34556667777777666553 22  34444 66777777776665333  666667777777777665 343 2 34666


Q ss_pred             CCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccc
Q 036754           87 SLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKN  161 (405)
Q Consensus        87 ~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n  161 (405)
                      +|++|++++|+++.+|. +..+++|+.|+++.     .+..+..+++|++|++++|.+.+..+  +..+++|+.|++++|
T Consensus       111 ~L~~L~l~~n~i~~~~~-~~~l~~L~~L~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n  187 (347)
T 4fmz_A          111 NLRELYLNEDNISDISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN  187 (347)
T ss_dssp             TCSEEECTTSCCCCCGG-GTTCTTCCEEECTTCTTCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred             cCCEEECcCCcccCchh-hccCCceeEEECCCCCCcccccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence            67777777776666655 55666666666554     22335566666666666666653322  556666666666666


Q ss_pred             cccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCC
Q 036754          162 NLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL  210 (405)
Q Consensus       162 ~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~  210 (405)
                      .+.+..+  +..+++|+.+++++|.+.+..+ ...+++++.+++.+|..
T Consensus       188 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l  233 (347)
T 4fmz_A          188 QIEDISP--LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKI  233 (347)
T ss_dssp             CCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCC
T ss_pred             ccccccc--ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCcc
Confidence            6654332  5555556666666665554333 33445555555555543

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.83  E-value=2.3e-20  Score=163.47  Aligned_cols=136  Identities=25%  Similarity=0.340  Sum_probs=123.5

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCe
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~   90 (405)
                      ++|+.|+|++|.|.++.+.. +..++ +|+.|+|++|++++..|+.|..+++|++|+|++|+|+ .+|..++.++++|++
T Consensus        32 ~~l~~L~l~~n~i~~i~~~~-~~~l~-~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~  108 (220)
T 2v9t_B           32 ETITEIRLEQNTIKVIPPGA-FSPYK-KLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQL  108 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTS-STTCT-TCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCE
T ss_pred             cCCCEEECCCCcCCCcCHhH-hhCCC-CCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCE
Confidence            68999999999999988877 56666 9999999999999999999999999999999999998 888888889999999


Q ss_pred             eeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCc
Q 036754           91 LSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGA  166 (405)
Q Consensus        91 L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~  166 (405)
                      |+|++|+|+.++..                 .+.++++|++|++++|.+++..+..|..+++|+.|++++|++...
T Consensus       109 L~L~~N~l~~~~~~-----------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  167 (220)
T 2v9t_B          109 LLLNANKINCLRVD-----------------AFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD  167 (220)
T ss_dssp             EECCSSCCCCCCTT-----------------TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             EECCCCCCCEeCHH-----------------HcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence            99999999977543                 456788999999999999988888899999999999999999753

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.83  E-value=8.6e-20  Score=178.11  Aligned_cols=186  Identities=27%  Similarity=0.407  Sum_probs=82.4

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCC
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLA   86 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~   86 (405)
                      ++++++|+.|+++ |.+.+..+   +++++ +|+.|++++|.+++.  ..+..+++|++|++++|.+++..|   +..++
T Consensus       152 ~~~l~~L~~L~l~-~~~~~~~~---~~~l~-~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~---~~~l~  221 (466)
T 1o6v_A          152 LSGLTSLQQLSFG-NQVTDLKP---LANLT-TLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP---LGILT  221 (466)
T ss_dssp             GTTCTTCSEEEEE-ESCCCCGG---GTTCT-TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG---GGGCT
T ss_pred             hccCCcccEeecC-CcccCchh---hccCC-CCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc---ccccC
Confidence            4444555555543 23332221   23333 455555555554432  124444555555555555442222   12344


Q ss_pred             CCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccc
Q 036754           87 SLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKN  161 (405)
Q Consensus        87 ~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n  161 (405)
                      +|++|++++|+++.++ .+..+++|+.|+++.     .+ .+..+++|++|++++|.+.+..+  +..+++|+.|++++|
T Consensus       222 ~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~-~~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n  297 (466)
T 1o6v_A          222 NLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN  297 (466)
T ss_dssp             TCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSS
T ss_pred             CCCEEECCCCCcccch-hhhcCCCCCEEECCCCccccch-hhhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCC
Confidence            5555555555544443 234444444444433     11 14444555555555555443222  444455555555555


Q ss_pred             cccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCC
Q 036754          162 NLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNE  209 (405)
Q Consensus       162 ~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~  209 (405)
                      .+++..+  +..+++|+.|++++|.+++..| ...+++++.+++.+|.
T Consensus       298 ~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~  342 (466)
T 1o6v_A          298 QLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNK  342 (466)
T ss_dssp             CCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSC
T ss_pred             cccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCc
Confidence            5543322  3444455555555555544333 3334444444444443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.83  E-value=2.1e-20  Score=168.09  Aligned_cols=114  Identities=22%  Similarity=0.343  Sum_probs=96.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.||+|+||+||+|.. .+|+.||+|++.+..   ......+.+|+.++++++|||||++++++.+.+..||||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5678888999999999999984 578999999997542   233567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+ +|+|.+++...+ .+++.++..++.||+.||+|||+
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~  130 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHR  130 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999 679999998654 79999999999999999999994

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.83  E-value=7.4e-20  Score=177.74  Aligned_cols=184  Identities=21%  Similarity=0.214  Sum_probs=103.1

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      .|+.+++|++|+|++|.++++ |   ++.++ +|+.|++++|++++. +  ++.+++|++|++++|++++ +|   +..+
T Consensus        59 ~l~~l~~L~~L~Ls~n~l~~~-~---~~~l~-~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~---~~~l  126 (457)
T 3bz5_A           59 GIEKLTGLTKLICTSNNITTL-D---LSQNT-NLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD---VSQN  126 (457)
T ss_dssp             TGGGCTTCSEEECCSSCCSCC-C---CTTCT-TCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC---CTTC
T ss_pred             hhcccCCCCEEEccCCcCCeE-c---cccCC-CCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec---CCCC
Confidence            344455555555555555443 2   23333 555555555555542 1  4555555555555555552 33   2355


Q ss_pred             CCCCeeeCCCCCCCCCchhhhccccCccccCCCCC----hhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccc
Q 036754           86 ASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP----IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKN  161 (405)
Q Consensus        86 ~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p----~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n  161 (405)
                      ++|++|++++|+++.+|  +.++++|++|+++...    ..+..+++|++|++++|.+++ +|  ++.+++|+.|++++|
T Consensus       127 ~~L~~L~l~~N~l~~l~--l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N  201 (457)
T 3bz5_A          127 PLLTYLNCARNTLTEID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTN  201 (457)
T ss_dssp             TTCCEEECTTSCCSCCC--CTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSS
T ss_pred             CcCCEEECCCCccceec--cccCCcCCEEECCCCCcccccccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCC
Confidence            55555555555555543  4455555555544310    135566777777777777765 33  666677777777777


Q ss_pred             cccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCc
Q 036754          162 NLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL  211 (405)
Q Consensus       162 ~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~  211 (405)
                      .+++.   .+..+++|+.|++++|.+++ +| ...+++++.+++.+|.+.
T Consensus       202 ~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip-~~~l~~L~~L~l~~N~l~  246 (457)
T 3bz5_A          202 NITKL---DLNQNIQLTFLDCSSNKLTE-ID-VTPLTQLTYFDCSVNPLT  246 (457)
T ss_dssp             CCSCC---CCTTCTTCSEEECCSSCCSC-CC-CTTCTTCSEEECCSSCCS
T ss_pred             cCCee---ccccCCCCCEEECcCCcccc-cC-ccccCCCCEEEeeCCcCC
Confidence            77654   25566777777777777766 33 445566666666666543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.83  E-value=2.3e-20  Score=170.65  Aligned_cols=171  Identities=25%  Similarity=0.351  Sum_probs=112.4

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCC
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLA   86 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~   86 (405)
                      +..+++|+.|++++|.+... +.  ++.++ +|+.|+|++|++++..+  +..+++|++|+|++|.++ .+|.  +..++
T Consensus        42 ~~~l~~L~~L~l~~~~i~~~-~~--~~~l~-~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~-~~~~--l~~l~  112 (291)
T 1h6t_A           42 QNELNSIDQIIANNSDIKSV-QG--IQYLP-NVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLSS--LKDLK  112 (291)
T ss_dssp             HHHHHTCCEEECTTSCCCCC-TT--GGGCT-TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CGGG--GTTCT
T ss_pred             hhhcCcccEEEccCCCcccC-hh--HhcCC-CCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCC-CChh--hccCC
Confidence            45677888888888888765 32  45555 88888888888887544  888888888888888887 4543  35788


Q ss_pred             CCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCc
Q 036754           87 SLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGA  166 (405)
Q Consensus        87 ~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~  166 (405)
                      +|++|+|++|+++.++ .+..                  +++|++|++++|.+.+.  ..+..+++|+.|++++|.+++.
T Consensus       113 ~L~~L~L~~n~i~~~~-~l~~------------------l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~  171 (291)
T 1h6t_A          113 KLKSLSLEHNGISDIN-GLVH------------------LPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI  171 (291)
T ss_dssp             TCCEEECTTSCCCCCG-GGGG------------------CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred             CCCEEECCCCcCCCCh-hhcC------------------CCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccc
Confidence            8888888888888764 3333                  45556666666665543  3455566666666666666544


Q ss_pred             cchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCC
Q 036754          167 IPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL  210 (405)
Q Consensus       167 ~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~  210 (405)
                      .+  +..+++|+.|++++|.+++. +....++++..+++.+|+.
T Consensus       172 ~~--l~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i  212 (291)
T 1h6t_A          172 VP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQEC  212 (291)
T ss_dssp             GG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEE
T ss_pred             hh--hcCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcc
Confidence            33  55556666666666665542 3344455555555555554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.83  E-value=5.6e-20  Score=160.94  Aligned_cols=139  Identities=23%  Similarity=0.270  Sum_probs=123.1

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCe
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~   90 (405)
                      +.++.|+|++|.|++..|..+++.++ +|+.|+|++|++++..+..|..+++|++|+|++|+++ .++...+.++++|++
T Consensus        32 ~~~~~L~L~~N~l~~~~~~~~~~~l~-~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~  109 (220)
T 2v70_A           32 QYTAELRLNNNEFTVLEATGIFKKLP-QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKT  109 (220)
T ss_dssp             TTCSEEECCSSCCCEECCCCCGGGCT-TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCGGGGTTCSSCCE
T ss_pred             CCCCEEEcCCCcCCccCchhhhccCC-CCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccC-ccCHhHhcCCcCCCE
Confidence            35799999999999987755467776 9999999999999988889999999999999999998 667666679999999


Q ss_pred             eeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccc
Q 036754           91 LSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIP  168 (405)
Q Consensus        91 L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~  168 (405)
                      |+|++|+|+.+++.                 .+.++++|++|++++|.+++..|..|..+++|+.|++++|++.+..+
T Consensus       110 L~Ls~N~l~~~~~~-----------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          110 LMLRSNRITCVGND-----------------SFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             EECTTSCCCCBCTT-----------------SSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             EECCCCcCCeECHh-----------------HcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            99999999977432                 45678899999999999999889999999999999999999986544

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.83  E-value=8.3e-20  Score=160.91  Aligned_cols=137  Identities=23%  Similarity=0.268  Sum_probs=122.7

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCe
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~   90 (405)
                      ++|+.|+|++|.|+++.|.. ++.++ +|+.|+|++|+++...+..|..+++|++|+|++|+|+ .+|...+..+++|++
T Consensus        40 ~~L~~L~Ls~n~i~~~~~~~-~~~l~-~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~  116 (229)
T 3e6j_A           40 TNAQILYLHDNQITKLEPGV-FDSLI-NLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKE  116 (229)
T ss_dssp             TTCSEEECCSSCCCCCCTTT-TTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCE
T ss_pred             CCCCEEEcCCCccCccCHHH-hhCcc-CCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCC-ccChhHhCcchhhCe
Confidence            78999999999999988887 66676 9999999999998877788999999999999999998 777777779999999


Q ss_pred             eeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccc
Q 036754           91 LSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIP  168 (405)
Q Consensus        91 L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~  168 (405)
                      |+|++|+|+.+|..+                  .++++|++|++++|.+.+..+..|..+++|+.|++++|++....+
T Consensus       117 L~Ls~N~l~~lp~~~------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          117 LFMCCNKLTELPRGI------------------ERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             EECCSSCCCSCCTTG------------------GGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             EeccCCcccccCccc------------------ccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            999999999888664                  446789999999999998777889999999999999999986543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.82  E-value=2.5e-20  Score=170.31  Aligned_cols=115  Identities=20%  Similarity=0.358  Sum_probs=95.4

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeeeecCC---------
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSCSNEE---------  359 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---------  359 (405)
                      +|...+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+.++++++|||||++++++...+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            567778999999999999985 5789999999975443 34567899999999999999999999886543         


Q ss_pred             ---eeEEEEecCCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 ---FKALVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ---~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                         ..|||||||++|+|.+++....  ...++..+..|+.||++||+|||+
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~  136 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS  136 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH
Confidence               3789999999999999998654  235677788999999999999994

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.82  E-value=6.6e-21  Score=173.75  Aligned_cols=115  Identities=20%  Similarity=0.270  Sum_probs=95.8

Q ss_pred             ccCCccCcccccCCCceEEEee----CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL----GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      ++|...+.||+|+||+||+|+.    ..++.||||++++..  ......+.+|++++++++|||||++++++.+.+..||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4677888999999999999974    246789999997543  2334568889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||||++|||.+++...+ .+++.++..++.||+.||+|||+
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~  144 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHS  144 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999997654 79999999999999999999994

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.82  E-value=5.7e-21  Score=176.93  Aligned_cols=188  Identities=20%  Similarity=0.162  Sum_probs=144.9

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      .|..+++|++|+|++|.+++..+.      + +|+.|++++|++++..+..   +++|++|++++|++++ ++...+..+
T Consensus        75 ~~~~l~~L~~L~Ls~n~l~~l~~~------~-~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~-~~~~~~~~l  143 (317)
T 3o53_A           75 DLESLSTLRTLDLNNNYVQELLVG------P-SIETLHAANNNISRVSCSR---GQGKKNIYLANNKITM-LRDLDEGCR  143 (317)
T ss_dssp             EETTCTTCCEEECCSSEEEEEEEC------T-TCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCS-GGGBCTGGG
T ss_pred             hhhhcCCCCEEECcCCccccccCC------C-CcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCC-ccchhhhcc
Confidence            388999999999999999875432      3 8999999999998865543   5789999999999984 544444688


Q ss_pred             CCCCeeeCCCCCCCCCc-hhh-hccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeec
Q 036754           86 ASLRKLSLDSNELTSIP-LTF-WNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNL  158 (405)
Q Consensus        86 ~~L~~L~Ls~N~l~~lp-~~~-~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l  158 (405)
                      ++|++|+|++|.++.++ ..+ ..+++|++|+++.     +| ....+++|++|++++|.+.+. |..+..+++|+.|++
T Consensus       144 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L  221 (317)
T 3o53_A          144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISL  221 (317)
T ss_dssp             SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEEC
T ss_pred             CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccc-cccccccCCEEECCCCcCCcc-hhhhcccCcccEEEC
Confidence            99999999999999654 444 3688899988876     22 233588999999999999864 455889999999999


Q ss_pred             ccccccCccchhHHhcccCCccccccCccc-CcCCC-CCccCCCCcccccC
Q 036754          159 SKNNLSGAIPASLEKLLYLKDLNLSFNKLE-GEIPR-GGSFGNFSAESFEG  207 (405)
Q Consensus       159 ~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~-~~~p~-~~~~~~~~~~~~~~  207 (405)
                      ++|.++ .+|..+..+++|+.|++++|.+. +.+|. ...+++++.+.+.+
T Consensus       222 ~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~  271 (317)
T 3o53_A          222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT  271 (317)
T ss_dssp             TTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHH
T ss_pred             cCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCC
Confidence            999998 46777888999999999999998 33332 23344455555553

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.82  E-value=1.1e-19  Score=176.53  Aligned_cols=189  Identities=20%  Similarity=0.182  Sum_probs=160.8

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhc
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGS   83 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   83 (405)
                      +.+++++++|++|+|++|.+++. | . ++.++ +|+.|+|++|++++. |  ++.+++|++|+|++|.+++ +|   +.
T Consensus        35 ~~~~~~l~~L~~L~Ls~n~l~~~-~-~-l~~l~-~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~---~~  103 (457)
T 3bz5_A           35 TISEEQLATLTSLDCHNSSITDM-T-G-IEKLT-GLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD---VT  103 (457)
T ss_dssp             EEEHHHHTTCCEEECCSSCCCCC-T-T-GGGCT-TCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC---CT
T ss_pred             ccChhHcCCCCEEEccCCCcccC-h-h-hcccC-CCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee---cC
Confidence            34677899999999999999986 5 3 66776 999999999999985 3  8899999999999999984 55   35


Q ss_pred             CCCCCCeeeCCCCCCCCCchhhhccccCccccCCCCC---hhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccc
Q 036754           84 NLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP---IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSK  160 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p---~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~  160 (405)
                      ++++|++|++++|+++.+|  +..+++|++|+++...   ..++++++|++|++++|...+.+  .+..+++|+.|++++
T Consensus       104 ~l~~L~~L~L~~N~l~~l~--~~~l~~L~~L~l~~N~l~~l~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~  179 (457)
T 3bz5_A          104 PLTKLTYLNCDTNKLTKLD--VSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSF  179 (457)
T ss_dssp             TCTTCCEEECCSSCCSCCC--CTTCTTCCEEECTTSCCSCCCCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCS
T ss_pred             CCCcCCEEECCCCcCCeec--CCCCCcCCEEECCCCccceeccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCC
Confidence            8999999999999999987  7899999999887511   13788999999999999766555  488999999999999


Q ss_pred             ccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCcc
Q 036754          161 NNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC  212 (405)
Q Consensus       161 n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c  212 (405)
                      |.+++. |  +..+++|+.|++++|.+++.  ....+++++.+++.+|....
T Consensus       180 n~l~~l-~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~  226 (457)
T 3bz5_A          180 NKITEL-D--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE  226 (457)
T ss_dssp             SCCCCC-C--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC
T ss_pred             Ccccee-c--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc
Confidence            999974 4  77899999999999999976  35667888999999987643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.81  E-value=2.8e-20  Score=173.57  Aligned_cols=118  Identities=21%  Similarity=0.361  Sum_probs=99.3

Q ss_pred             hhccCCccCcccccCCCceEEEeeC------CCcEEEEEEeecccc-chhHHHHHHHHHhhcCCC-CCcceEEeeeecC-
Q 036754          288 ATYKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRH-QNLIKVISSCSNE-  358 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~-  358 (405)
                      ..++|...+.||+|+||+||+|...      .++.||||++..... ...+.|.+|+.++.+++| ||||+++|+|... 
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            4466777889999999999999853      246899999976543 345679999999999965 8999999998764 


Q ss_pred             CeeEEEEecCCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 EFKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +..+||||||++|+|.++|+..               +..++|.+++.|+.|||+||+|||+
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~  203 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS  203 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh
Confidence            5689999999999999999753               2358999999999999999999994

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.81  E-value=1e-19  Score=181.92  Aligned_cols=173  Identities=24%  Similarity=0.295  Sum_probs=147.7

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      .+..+++|+.|+|++|.+..+.  . ++.++ +|+.|+|++|++++..|  +..+++|+.|+|++|.++ .+| .+ ..+
T Consensus        38 ~~~~L~~L~~L~l~~n~i~~l~--~-l~~l~-~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~-~l~-~l-~~l  108 (605)
T 1m9s_A           38 TQNELNSIDQIIANNSDIKSVQ--G-IQYLP-NVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLS-SL-KDL  108 (605)
T ss_dssp             CHHHHTTCCCCBCTTCCCCCCT--T-GGGCT-TCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCC-CCT-TS-TTC
T ss_pred             chhcCCCCCEEECcCCCCCCCh--H-HccCC-CCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCC-CCh-hh-ccC
Confidence            3557889999999999998754  2 56666 99999999999998655  899999999999999998 455 34 589


Q ss_pred             CCCCeeeCCCCCCCCCchhhhccccCccccCCCC----ChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccc
Q 036754           86 ASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVI----PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKN  161 (405)
Q Consensus        86 ~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~----p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n  161 (405)
                      ++|++|+|++|+++.+| .+..+++|+.|+++..    ...+..+++|+.|+|++|.+.+..|  +..+++|+.|+|++|
T Consensus       109 ~~L~~L~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N  185 (605)
T 1m9s_A          109 KKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN  185 (605)
T ss_dssp             TTCCEEECTTSCCCCCG-GGGGCTTCSEEECCSSCCCCCGGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred             CCCCEEEecCCCCCCCc-cccCCCccCEEECCCCccCCchhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCC
Confidence            99999999999999875 5888999999998751    2568899999999999999997666  899999999999999


Q ss_pred             cccCccchhHHhcccCCccccccCcccCcCC
Q 036754          162 NLSGAIPASLEKLLYLKDLNLSFNKLEGEIP  192 (405)
Q Consensus       162 ~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p  192 (405)
                      .+++.  ..+..+++|+.|++++|.+.+.+.
T Consensus       186 ~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~  214 (605)
T 1m9s_A          186 HISDL--RALAGLKNLDVLELFSQECLNKPI  214 (605)
T ss_dssp             CCCBC--GGGTTCTTCSEEECCSEEEECCCC
T ss_pred             CCCCC--hHHccCCCCCEEEccCCcCcCCcc
Confidence            99865  368899999999999999986543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.80  E-value=5.6e-21  Score=181.96  Aligned_cols=205  Identities=20%  Similarity=0.195  Sum_probs=100.4

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchh---hhcccccccEEEcccC---cccccCCccc-------cCccCCCeeecCC
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTF---VGNVSHSLEFFVMSYC---NISGGILEEI-------TNLTKLTTIILGG   70 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f---~~~~~~~L~~L~L~~n---~l~~~~~~~~-------~~l~~L~~L~L~~   70 (405)
                      +..+..+++|+.|+|++|.+....+..+   +..++ +|+.|+|++|   ++++.+|..+       ..+++|++|+|++
T Consensus        25 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~-~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~  103 (386)
T 2ca6_A           25 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK-DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  103 (386)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCT-TCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCC-CccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence            3445555666666666666655433221   22333 5666666654   2333334333       4555666666666


Q ss_pred             ccccc----ccCcchhcCCCCCCeeeCCCCCCCC-----Cchhhhcc---------ccCccccCCCC-------C---hh
Q 036754           71 NKLNG----SISITLGSNLASLRKLSLDSNELTS-----IPLTFWNL---------KDILYLNFSVI-------P---IE  122 (405)
Q Consensus        71 N~l~~----~~~~~~~~~l~~L~~L~Ls~N~l~~-----lp~~~~~l---------~~L~~l~l~~~-------p---~~  122 (405)
                      |.+++    .+|..+ ..+++|++|+|++|.++.     ++..+..+         ++|++|+++..       |   ..
T Consensus       104 n~l~~~~~~~l~~~l-~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~  182 (386)
T 2ca6_A          104 NAFGPTAQEPLIDFL-SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT  182 (386)
T ss_dssp             CCCCTTTHHHHHHHH-HHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred             CcCCHHHHHHHHHHH-HhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence            66553    234333 345566666666665542     12222222         55555555431       1   23


Q ss_pred             ccCCCCCCEEeccCCccc--c---cCCcccccCCCCCeeeccccccc----CccchhHHhcccCCccccccCcccCc---
Q 036754          123 IGGLPNLEYLFLGYNRLQ--G---SIPDSFGDLISLKSLNLSKNNLS----GAIPASLEKLLYLKDLNLSFNKLEGE---  190 (405)
Q Consensus       123 ~~~l~~L~~L~l~~n~l~--~---~~p~~~~~l~~L~~L~l~~n~l~----~~~~~~~~~l~~L~~l~l~~n~l~~~---  190 (405)
                      +..+++|++|++++|.+.  +   ..|..+..+++|+.|+|++|.++    ..+|..+..+++|+.|++++|.+++.   
T Consensus       183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~  262 (386)
T 2ca6_A          183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA  262 (386)
T ss_dssp             HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred             HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence            344555666666666554  1   22334555555666666666553    34445555555566666665555433   


Q ss_pred             -CCCC---CccCCCCcccccCCCC
Q 036754          191 -IPRG---GSFGNFSAESFEGNEL  210 (405)
Q Consensus       191 -~p~~---~~~~~~~~~~~~~n~~  210 (405)
                       ++..   +..++++.+++.+|..
T Consensus       263 ~l~~~l~~~~~~~L~~L~L~~n~i  286 (386)
T 2ca6_A          263 AVVDAFSKLENIGLQTLRLQYNEI  286 (386)
T ss_dssp             HHHHHHHTCSSCCCCEEECCSSCC
T ss_pred             HHHHHHhhccCCCeEEEECcCCcC
Confidence             1111   2244555555555543

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.79  E-value=1.3e-18  Score=148.80  Aligned_cols=175  Identities=21%  Similarity=0.269  Sum_probs=131.3

Q ss_pred             CCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCc-cccCccCCCeeecCCcccccccCcchhcCCCCCCee
Q 036754           13 LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILE-EITNLTKLTTIILGGNKLNGSISITLGSNLASLRKL   91 (405)
Q Consensus        13 L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L   91 (405)
                      -+.+++++|.+..+ |.. +   +.+|+.|+|++|++++..+. .|..+++|++|+|++|+|++..|.. +.++++|++|
T Consensus        10 ~~~l~~s~~~l~~i-p~~-~---~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L   83 (192)
T 1w8a_A           10 GTTVDCTGRGLKEI-PRD-I---PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA-FEGASHIQEL   83 (192)
T ss_dssp             TTEEECTTSCCSSC-CSC-C---CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTT-TTTCTTCCEE
T ss_pred             CCEEEcCCCCcCcC-ccC-C---CCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhH-cCCcccCCEE
Confidence            37899999999764 443 2   23899999999999987765 4899999999999999999554555 4689999999


Q ss_pred             eCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccch-h
Q 036754           92 SLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPA-S  170 (405)
Q Consensus        92 ~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~-~  170 (405)
                      +|++|+|+.++..                 .+.++++|++|++++|++++..|..|..+++|+.|++++|++++..+. +
T Consensus        84 ~Ls~N~l~~~~~~-----------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~  146 (192)
T 1w8a_A           84 QLGENKIKEISNK-----------------MFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW  146 (192)
T ss_dssp             ECCSCCCCEECSS-----------------SSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH
T ss_pred             ECCCCcCCccCHH-----------------HhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchH
Confidence            9999999977643                 356788999999999999999999999999999999999999876552 2


Q ss_pred             HHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCccCC
Q 036754          171 LEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS  214 (405)
Q Consensus       171 ~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~~  214 (405)
                      +..  .++...+..+...+..|..  +......++..+.+.|..
T Consensus       147 ~~~--~l~~~~~~~~~~~C~~P~~--l~~~~l~~l~~~~~~C~~  186 (192)
T 1w8a_A          147 FAE--WLRKKSLNGGAARCGAPSK--VRDVQIKDLPHSEFKCSS  186 (192)
T ss_dssp             HHH--HHHHHCCSGGGCBBCSSTT--TTTSBGGGSCTTTCCCCC
T ss_pred             HHH--HHHHcCCCCCCCCCCCChH--HcCCChhhCcHhhcCcCC
Confidence            221  2333334444444333332  333444556666666754

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.79  E-value=5.7e-19  Score=174.84  Aligned_cols=172  Identities=23%  Similarity=0.235  Sum_probs=106.2

Q ss_pred             cCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCee
Q 036754           12 CLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKL   91 (405)
Q Consensus        12 ~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L   91 (405)
                      +|+.|+|++|.|++ +|..+.    ++|+.|+|++|+++. +|   ..+++|++|+|++|+|++ +|. +. +  +|++|
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~----~~L~~L~Ls~N~l~~-ip---~~l~~L~~L~Ls~N~l~~-ip~-l~-~--~L~~L  125 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP----PQITVLEITQNALIS-LP---ELPASLEYLDACDNRLST-LPE-LP-A--SLKHL  125 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC----TTCSEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-CC-T--TCCEE
T ss_pred             CccEEEeCCCCCCc-cCHhHc----CCCCEEECcCCCCcc-cc---cccCCCCEEEccCCCCCC-cch-hh-c--CCCEE
Confidence            67777777777776 443311    267777777777764 44   345677777777777763 665 32 2  67777


Q ss_pred             eCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCc
Q 036754           92 SLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGA  166 (405)
Q Consensus        92 ~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~  166 (405)
                      +|++|+|+.+|.   .+++|+.|+++.     +|.   .+++|++|++++|.+++ +|. |.  ++|+.|++++|.++ .
T Consensus       126 ~Ls~N~l~~lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~  194 (571)
T 3cvr_A          126 DVDNNQLTMLPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-S  194 (571)
T ss_dssp             ECCSSCCSCCCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-S
T ss_pred             ECCCCcCCCCCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-c
Confidence            777777777766   456666666554     343   35667777777777764 444 44  66777777777766 3


Q ss_pred             cchhHHhcccC-------CccccccCcccCcCCCCCccCCCCcccccCCCCc
Q 036754          167 IPASLEKLLYL-------KDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL  211 (405)
Q Consensus       167 ~~~~~~~l~~L-------~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~  211 (405)
                      +|. +..  +|       +.|++++|.|+..++....++++..+++.+|++.
T Consensus       195 lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~L~~N~l~  243 (571)
T 3cvr_A          195 LPA-VPV--RNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLS  243 (571)
T ss_dssp             CCC-CC----------CCEEEECCSSCCCCCCGGGGGSCTTEEEECCSSSCC
T ss_pred             hhh-HHH--hhhcccccceEEecCCCcceecCHHHhcCCCCCEEEeeCCcCC
Confidence            333 332  45       6677777776654443445666666666666653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.79  E-value=3e-19  Score=177.62  Aligned_cols=116  Identities=17%  Similarity=0.259  Sum_probs=104.6

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ++|...+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.+|+.++|||||++++++.+.+..|||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            4567778999999999999985 578999999997655555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++......+++.++..++.||++||+|||+
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~  273 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE  273 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999997665679999999999999999999994

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.79  E-value=5.3e-21  Score=190.16  Aligned_cols=181  Identities=21%  Similarity=0.132  Sum_probs=149.1

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCc-------------ccccCCccccCccCCCeee-cCCcc
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCN-------------ISGGILEEITNLTKLTTII-LGGNK   72 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~-------------l~~~~~~~~~~l~~L~~L~-L~~N~   72 (405)
                      +..+++|+.|+|++|++.. +|.. ++++. +|+.|++++|.             +.+..|..++.+++|+.|+ ++.|.
T Consensus       345 ~~~~~~L~~L~Ls~n~L~~-Lp~~-i~~l~-~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~  421 (567)
T 1dce_A          345 SATDEQLFRCELSVEKSTV-LQSE-LESCK-ELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAY  421 (567)
T ss_dssp             CSTTTTSSSCCCCHHHHHH-HHHH-HHHHH-HHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHH
T ss_pred             cccCccceeccCChhhHHh-hHHH-HHHHH-HHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcc
Confidence            4678999999999999975 5766 78887 89999998775             5677788888999999998 67665


Q ss_pred             cccccCcchh-----c--CCCCCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCccc
Q 036754           73 LNGSISITLG-----S--NLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQ  140 (405)
Q Consensus        73 l~~~~~~~~~-----~--~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~  140 (405)
                      +. .++...+     .  ....|+.|+|++|+|+.+|. +.++++|+.|+++.     +|..++++++|++|+|++|.++
T Consensus       422 ~~-~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~  499 (567)
T 1dce_A          422 LD-DLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE  499 (567)
T ss_dssp             HH-HHHHHHHHHHHHHHHHHTTCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred             cc-hhhhhhhhcccccccCccCceEEEecCCCCCCCcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCC
Confidence            53 2322110     0  12358999999999999987 88999999988765     7888999999999999999999


Q ss_pred             ccCCcccccCCCCCeeecccccccCcc-chhHHhcccCCccccccCcccCcCCCC
Q 036754          141 GSIPDSFGDLISLKSLNLSKNNLSGAI-PASLEKLLYLKDLNLSFNKLEGEIPRG  194 (405)
Q Consensus       141 ~~~p~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~l~l~~n~l~~~~p~~  194 (405)
                      + +| .++.+++|+.|++++|.+++.. |..+..+++|+.|++++|.+++.+|..
T Consensus       500 ~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  552 (567)
T 1dce_A          500 N-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ  552 (567)
T ss_dssp             C-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred             C-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence            6 66 7999999999999999999877 899999999999999999999887754

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.79  E-value=4.8e-19  Score=159.37  Aligned_cols=170  Identities=21%  Similarity=0.230  Sum_probs=103.2

Q ss_pred             CCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCC
Q 036754            9 NCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASL   88 (405)
Q Consensus         9 ~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L   88 (405)
                      ++.++..+++++|.+.+..+   +..++ +|+.|++++|+++. ++ .+..+++|++|+|++|+++ .++.  +.++++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~~~---~~~l~-~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~-~~~~--l~~l~~L   87 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLVS---QKELS-GVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQIS-DLSP--LKDLTKL   87 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEEC---HHHHT-TCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG--GTTCSSC
T ss_pred             HHHHHHHHHhcCCCcccccc---hhhcC-cCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccC-CChh--hccCCCC
Confidence            45567777788888776552   44555 78888888888775 33 5777888888888888887 4444  3578888


Q ss_pred             CeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccc
Q 036754           89 RKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIP  168 (405)
Q Consensus        89 ~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~  168 (405)
                      ++|+|++|+++.+|....                    ++|++|++++|.+++. + .+..+++|+.|++++|.+++. +
T Consensus        88 ~~L~L~~N~l~~l~~~~~--------------------~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~  144 (263)
T 1xeu_A           88 EELSVNRNRLKNLNGIPS--------------------ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V  144 (263)
T ss_dssp             CEEECCSSCCSCCTTCCC--------------------SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G
T ss_pred             CEEECCCCccCCcCcccc--------------------CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h
Confidence            888888888877654211                    4455555555555532 2 355555555555555555543 2


Q ss_pred             hhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCcc
Q 036754          169 ASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC  212 (405)
Q Consensus       169 ~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c  212 (405)
                       .+..+++|+.|++++|.+++. +....+++++.+++.+|++.+
T Consensus       145 -~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~  186 (263)
T 1xeu_A          145 -MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVN  186 (263)
T ss_dssp             -GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEEC
T ss_pred             -HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccC
Confidence             345555555555555555544 333444555555555555433

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.79  E-value=9.4e-20  Score=170.00  Aligned_cols=174  Identities=22%  Similarity=0.221  Sum_probs=74.8

Q ss_pred             CCCcCCeeeCcCCcCccc-CCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCc-ccccc-cCcchhcCC
Q 036754            9 NCKCLTFIDLSNNPLDSV-LPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGN-KLNGS-ISITLGSNL   85 (405)
Q Consensus         9 ~l~~L~~L~Ls~N~l~~~-~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~~l   85 (405)
                      ++++|+.|+|++|.+.+. .|.. +..++ +|+.|+|++|.+++..+..++.+++|++|+|++| .+++. ++..+ .++
T Consensus        91 ~~~~L~~L~L~~~~l~~~~~~~~-~~~~~-~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~-~~~  167 (336)
T 2ast_B           91 SPFRVQHMDLSNSVIEVSTLHGI-LSQCS-KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL-SSC  167 (336)
T ss_dssp             CCBCCCEEECTTCEECHHHHHHH-HTTBC-CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHH-HHC
T ss_pred             cCCCCCEEEccCCCcCHHHHHHH-HhhCC-CCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHH-hcC
Confidence            344444555554444433 2322 33333 4555555555444444444444445555555544 33321 22222 244


Q ss_pred             CCCCeeeCCCC-CCCC--Cchhhhccc-cCccccCCCC---------ChhccCCCCCCEEeccCCc-ccccCCcccccCC
Q 036754           86 ASLRKLSLDSN-ELTS--IPLTFWNLK-DILYLNFSVI---------PIEIGGLPNLEYLFLGYNR-LQGSIPDSFGDLI  151 (405)
Q Consensus        86 ~~L~~L~Ls~N-~l~~--lp~~~~~l~-~L~~l~l~~~---------p~~~~~l~~L~~L~l~~n~-l~~~~p~~~~~l~  151 (405)
                      ++|++|++++| .++.  ++..+..++ +|+.|+++..         |..+.++++|++|++++|. +++..+..+..++
T Consensus       168 ~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~  247 (336)
T 2ast_B          168 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN  247 (336)
T ss_dssp             TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred             CCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCC
Confidence            44555555554 4442  344444444 4444444332         2223344445555555554 3333344444445


Q ss_pred             CCCeeeccccc-ccCccchhHHhcccCCccccccC
Q 036754          152 SLKSLNLSKNN-LSGAIPASLEKLLYLKDLNLSFN  185 (405)
Q Consensus       152 ~L~~L~l~~n~-l~~~~~~~~~~l~~L~~l~l~~n  185 (405)
                      +|+.|++++|. +.......+.++++|+.|++++|
T Consensus       248 ~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~  282 (336)
T 2ast_B          248 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  282 (336)
T ss_dssp             TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             CCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence            55555555443 11111113444444555555444

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.78  E-value=5e-19  Score=166.14  Aligned_cols=199  Identities=20%  Similarity=0.151  Sum_probs=151.2

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccC-CccccCccCCCe-eecCCcccccccCcc
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGI-LEEITNLTKLTT-IILGGNKLNGSISIT   80 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~-L~L~~N~l~~~~~~~   80 (405)
                      +|+.+  .+++++|+|++|+|+.+.+++ +++++ +|+.|+|++|++.+.+ ++.|.++++|+. +++++|+++ .++.+
T Consensus        24 iP~~l--~~~l~~L~Ls~N~i~~i~~~~-f~~l~-~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~-~l~~~   98 (350)
T 4ay9_X           24 IPSDL--PRNAIELRFVLTKLRVIQKGA-FSGFG-DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPE   98 (350)
T ss_dssp             CCTTC--CTTCSEEEEESCCCSEECTTS-STTCT-TCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCC-EECTT
T ss_pred             cCcCc--CCCCCEEEccCCcCCCcCHHH-HcCCC-CCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCccc-ccCch
Confidence            44444  357999999999999888877 56676 9999999999986644 457899998775 677789998 77777


Q ss_pred             hhcCCCCCCeeeCCCCCCCCCchh-hhccccCccccCCC------CCh-hccCC-CCCCEEeccCCcccccCCcccccCC
Q 036754           81 LGSNLASLRKLSLDSNELTSIPLT-FWNLKDILYLNFSV------IPI-EIGGL-PNLEYLFLGYNRLQGSIPDSFGDLI  151 (405)
Q Consensus        81 ~~~~l~~L~~L~Ls~N~l~~lp~~-~~~l~~L~~l~l~~------~p~-~~~~l-~~L~~L~l~~n~l~~~~p~~~~~l~  151 (405)
                      .+.++++|++|++++|+++.+|.. +....++..+++..      +|. .+..+ ..++.|++++|.++...+..| ...
T Consensus        99 ~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~  177 (350)
T 4ay9_X           99 AFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAF-NGT  177 (350)
T ss_dssp             SBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSS-TTE
T ss_pred             hhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhc-ccc
Confidence            778999999999999999988753 44555666665432      332 45555 468899999999996555444 567


Q ss_pred             CCCeeeccc-ccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCC
Q 036754          152 SLKSLNLSK-NNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNE  209 (405)
Q Consensus       152 ~L~~L~l~~-n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~  209 (405)
                      +|+.|++++ |.++...++.|..+++|+.|++++|.|+..++.  .+.++..+...++.
T Consensus       178 ~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~--~~~~L~~L~~l~~~  234 (350)
T 4ay9_X          178 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY--GLENLKKLRARSTY  234 (350)
T ss_dssp             EEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSS--SCTTCCEEECTTCT
T ss_pred             chhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChh--hhccchHhhhccCC
Confidence            899999975 677766667889999999999999999865543  35566666655443

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.78  E-value=4.7e-20  Score=172.07  Aligned_cols=172  Identities=20%  Similarity=0.203  Sum_probs=95.8

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCccccc-CCccccCccCCCeeecCCcccccccCcchhcCCCCCC
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGG-ILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLR   89 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~   89 (405)
                      ++++.|++++|.+.+..+..  ..++ +|+.|+|++|.+++. ++..+..+++|++|+|++|.+++..+..+ ..+++|+
T Consensus        70 ~~l~~L~l~~n~l~~~~~~~--~~~~-~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l-~~~~~L~  145 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAEH--FSPF-RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTL-AKNSNLV  145 (336)
T ss_dssp             TTCSEEECTTCEECSCCCSC--CCCB-CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHH-TTCTTCS
T ss_pred             ccceEEEcCCccccccchhh--ccCC-CCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHH-hcCCCCC
Confidence            45666666666666555543  1333 566666666665543 55555666666666666666654444444 3466666


Q ss_pred             eeeCCCC-CCC--CCchhhhccccCccccCCCC--------ChhccCCC-CCCEEeccCCc--cc-ccCCcccccCCCCC
Q 036754           90 KLSLDSN-ELT--SIPLTFWNLKDILYLNFSVI--------PIEIGGLP-NLEYLFLGYNR--LQ-GSIPDSFGDLISLK  154 (405)
Q Consensus        90 ~L~Ls~N-~l~--~lp~~~~~l~~L~~l~l~~~--------p~~~~~l~-~L~~L~l~~n~--l~-~~~p~~~~~l~~L~  154 (405)
                      +|+|++| .++  .+|..+.++++|+.|+++..        +..+..++ +|++|++++|.  +. +.+|..+..+++|+
T Consensus       146 ~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~  225 (336)
T 2ast_B          146 RLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV  225 (336)
T ss_dssp             EEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCS
T ss_pred             EEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCC
Confidence            6666666 455  24555555566666655432        22344555 66666666662  32 23444455566666


Q ss_pred             eeeccccc-ccCccchhHHhcccCCccccccCc
Q 036754          155 SLNLSKNN-LSGAIPASLEKLLYLKDLNLSFNK  186 (405)
Q Consensus       155 ~L~l~~n~-l~~~~~~~~~~l~~L~~l~l~~n~  186 (405)
                      .|++++|. +++..+..+..+++|+.|++++|.
T Consensus       226 ~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~  258 (336)
T 2ast_B          226 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY  258 (336)
T ss_dssp             EEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred             EEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence            66666665 444445555566666666666553

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.78  E-value=3.1e-20  Score=176.79  Aligned_cols=209  Identities=17%  Similarity=0.210  Sum_probs=165.9

Q ss_pred             ccccCCCCCcCCeeeCcCCc---CcccCCchh------hhcccccccEEEcccCcccc----cCCccccCccCCCeeecC
Q 036754            3 FLSSLSNCKCLTFIDLSNNP---LDSVLPKTF------VGNVSHSLEFFVMSYCNISG----GILEEITNLTKLTTIILG   69 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~---l~~~~~~~f------~~~~~~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~   69 (405)
                      +.+.|.++++|+.|+|++|.   +.+..|..+      +..++ +|+.|+|++|.++.    .+|..+..+++|++|+|+
T Consensus        52 l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~-~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~  130 (386)
T 2ca6_A           52 LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCP-KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLH  130 (386)
T ss_dssp             HHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCT-TCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECC
T ss_pred             HHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCC-cccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECc
Confidence            34568899999999999964   445556552      24555 99999999999987    577788999999999999


Q ss_pred             CcccccccCcchh---cCC---------CCCCeeeCCCCCCC--CCc---hhhhccccCccccCCCC-----------Ch
Q 036754           70 GNKLNGSISITLG---SNL---------ASLRKLSLDSNELT--SIP---LTFWNLKDILYLNFSVI-----------PI  121 (405)
Q Consensus        70 ~N~l~~~~~~~~~---~~l---------~~L~~L~Ls~N~l~--~lp---~~~~~l~~L~~l~l~~~-----------p~  121 (405)
                      +|.+++..+..+.   ..+         ++|++|+|++|+++  .+|   ..+..+++|+.|+++..           |.
T Consensus       131 ~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~  210 (386)
T 2ca6_A          131 NNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLE  210 (386)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHT
T ss_pred             CCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHH
Confidence            9999743333332   233         89999999999997  455   46678889999998762           22


Q ss_pred             hccCCCCCCEEeccCCccc----ccCCcccccCCCCCeeecccccccCc----cchhHHh--cccCCccccccCcccC--
Q 036754          122 EIGGLPNLEYLFLGYNRLQ----GSIPDSFGDLISLKSLNLSKNNLSGA----IPASLEK--LLYLKDLNLSFNKLEG--  189 (405)
Q Consensus       122 ~~~~l~~L~~L~l~~n~l~----~~~p~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~--l~~L~~l~l~~n~l~~--  189 (405)
                      .+..+++|++|+|++|.+.    +.+|..+..+++|+.|++++|.+++.    ++..+..  +++|+.|++++|.+++  
T Consensus       211 ~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g  290 (386)
T 2ca6_A          211 GLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA  290 (386)
T ss_dssp             TGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHH
T ss_pred             HhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHH
Confidence            6778999999999999995    57788899999999999999999865    4566644  8999999999999987  


Q ss_pred             --cCCCC--CccCCCCcccccCCCCcc
Q 036754          190 --EIPRG--GSFGNFSAESFEGNELLC  212 (405)
Q Consensus       190 --~~p~~--~~~~~~~~~~~~~n~~~c  212 (405)
                        .+|..  ..++++..+++.+|++..
T Consensus       291 ~~~l~~~l~~~l~~L~~L~l~~N~l~~  317 (386)
T 2ca6_A          291 VRTLKTVIDEKMPDLLFLELNGNRFSE  317 (386)
T ss_dssp             HHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             HHHHHHHHHhcCCCceEEEccCCcCCc
Confidence              35543  346889999999998643

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.78  E-value=1e-18  Score=159.65  Aligned_cols=154  Identities=26%  Similarity=0.375  Sum_probs=130.7

Q ss_pred             ccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcC
Q 036754            5 SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSN   84 (405)
Q Consensus         5 ~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~   84 (405)
                      +.+..+++|+.|+|++|++++..+   ++.++ +|+.|+|++|++++.  ..+..+++|++|+|++|+++ .++ .+ ..
T Consensus        62 ~~~~~l~~L~~L~L~~n~l~~~~~---l~~l~-~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~-~~~-~l-~~  132 (291)
T 1h6t_A           62 QGIQYLPNVTKLFLNGNKLTDIKP---LANLK-NLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGIS-DIN-GL-VH  132 (291)
T ss_dssp             TTGGGCTTCCEEECCSSCCCCCGG---GTTCT-TCCEEECCSSCCCCG--GGGTTCTTCCEEECTTSCCC-CCG-GG-GG
T ss_pred             hhHhcCCCCCEEEccCCccCCCcc---cccCC-CCCEEECCCCcCCCC--hhhccCCCCCEEECCCCcCC-CCh-hh-cC
Confidence            467889999999999999998765   55666 999999999999873  34899999999999999998 454 33 58


Q ss_pred             CCCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccccccc
Q 036754           85 LASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLS  164 (405)
Q Consensus        85 l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~  164 (405)
                      +++|++|++++|+++.++                   .+..+++|++|++++|.+.+..|  +..+++|+.|++++|.++
T Consensus       133 l~~L~~L~l~~n~l~~~~-------------------~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~  191 (291)
T 1h6t_A          133 LPQLESLYLGNNKITDIT-------------------VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS  191 (291)
T ss_dssp             CTTCCEEECCSSCCCCCG-------------------GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             CCCCCEEEccCCcCCcch-------------------hhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence            999999999999999763                   24557889999999999986555  889999999999999998


Q ss_pred             CccchhHHhcccCCccccccCcccCc
Q 036754          165 GAIPASLEKLLYLKDLNLSFNKLEGE  190 (405)
Q Consensus       165 ~~~~~~~~~l~~L~~l~l~~n~l~~~  190 (405)
                      +. + .+..+++|+.|++++|.+...
T Consensus       192 ~l-~-~l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          192 DL-R-ALAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             BC-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred             CC-h-hhccCCCCCEEECcCCcccCC
Confidence            64 4 488899999999999998753

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.78  E-value=7.5e-19  Score=151.07  Aligned_cols=153  Identities=22%  Similarity=0.325  Sum_probs=108.2

Q ss_pred             CCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCC
Q 036754            8 SNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLAS   87 (405)
Q Consensus         8 ~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~   87 (405)
                      +.+++|+.|++++|.+..+ | . +..++ +|+.|++++|.++.  +..+..+++|++|++++|.+++..+..+ ..+++
T Consensus        41 ~~l~~L~~L~l~~n~i~~l-~-~-l~~l~-~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l-~~l~~  113 (197)
T 4ezg_A           41 AQMNSLTYITLANINVTDL-T-G-IEYAH-NIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNL-SGLTS  113 (197)
T ss_dssp             HHHHTCCEEEEESSCCSCC-T-T-GGGCT-TCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCC-TTCTT
T ss_pred             hhcCCccEEeccCCCccCh-H-H-HhcCC-CCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhh-cCCCC
Confidence            4567788888888888743 3 2 45555 78888888886543  3467778888888888888875556555 47888


Q ss_pred             CCeeeCCCCCCCC-CchhhhccccCccccCCCCChhccCCCCCCEEeccCCc-ccccCCcccccCCCCCeeecccccccC
Q 036754           88 LRKLSLDSNELTS-IPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNR-LQGSIPDSFGDLISLKSLNLSKNNLSG  165 (405)
Q Consensus        88 L~~L~Ls~N~l~~-lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~-l~~~~p~~~~~l~~L~~L~l~~n~l~~  165 (405)
                      |++|+|++|+++. .|.                  .+..+++|++|++++|. +. .+| .+..+++|+.|++++|.+++
T Consensus       114 L~~L~Ls~n~i~~~~~~------------------~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~  173 (197)
T 4ezg_A          114 LTLLDISHSAHDDSILT------------------KINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD  173 (197)
T ss_dssp             CCEEECCSSBCBGGGHH------------------HHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC
T ss_pred             CCEEEecCCccCcHhHH------------------HHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC
Confidence            8888888888774 333                  34556778888888887 54 455 57888888888888888875


Q ss_pred             ccchhHHhcccCCccccccCcccC
Q 036754          166 AIPASLEKLLYLKDLNLSFNKLEG  189 (405)
Q Consensus       166 ~~~~~~~~l~~L~~l~l~~n~l~~  189 (405)
                      . + .+..+++|+.|++++|++.+
T Consensus       174 ~-~-~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          174 Y-R-GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             C-T-TGGGCSSCCEEEECBC----
T ss_pred             h-H-HhccCCCCCEEEeeCcccCC
Confidence            3 3 67788888888888887753

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.77  E-value=1.3e-18  Score=172.38  Aligned_cols=158  Identities=24%  Similarity=0.259  Sum_probs=131.8

Q ss_pred             CCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCC
Q 036754           10 CKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLR   89 (405)
Q Consensus        10 l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~   89 (405)
                      +++|+.|+|++|+|+. +| .   .+ ++|+.|+|++|++++ +|. +..  +|++|+|++|+|++ +|.    .+++|+
T Consensus        79 ~~~L~~L~Ls~N~l~~-ip-~---~l-~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~----~l~~L~  143 (571)
T 3cvr_A           79 PPQITVLEITQNALIS-LP-E---LP-ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE----LPALLE  143 (571)
T ss_dssp             CTTCSEEECCSSCCSC-CC-C---CC-TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC----CCTTCC
T ss_pred             cCCCCEEECcCCCCcc-cc-c---cc-CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC----cCcccc
Confidence            3789999999999985 55 3   22 389999999999998 666 665  99999999999984 776    589999


Q ss_pred             eeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCC-------Ceee
Q 036754           90 KLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISL-------KSLN  157 (405)
Q Consensus        90 ~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L-------~~L~  157 (405)
                      +|+|++|+|+.+|.   .+++|+.|+++.     +|. +.  ++|++|++++|.++ .+|. |..  +|       +.|+
T Consensus       144 ~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~  213 (571)
T 3cvr_A          144 YINADNNQLTMLPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFR  213 (571)
T ss_dssp             EEECCSSCCSCCCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEE
T ss_pred             EEeCCCCccCcCCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEe
Confidence            99999999999987   567888887765     666 55  89999999999999 5666 654  77       9999


Q ss_pred             cccccccCccchhHHhcccCCccccccCcccCcCCC
Q 036754          158 LSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPR  193 (405)
Q Consensus       158 l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~  193 (405)
                      +++|.++ .+|..+..+++|+.|++++|.+++.+|.
T Consensus       214 Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~  248 (571)
T 3cvr_A          214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE  248 (571)
T ss_dssp             CCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred             cCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence            9999999 4677778899999999999999987664

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.77  E-value=1.8e-18  Score=172.93  Aligned_cols=159  Identities=23%  Similarity=0.327  Sum_probs=134.5

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhc
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGS   83 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   83 (405)
                      ++.|..+++|+.|+|++|.|.+..|   +..++ +|+.|+|++|.+++.  ..+..+++|+.|+|++|.++ .++ .+ .
T Consensus        58 l~~l~~l~~L~~L~Ls~N~l~~~~~---l~~l~-~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~-~l~-~l-~  128 (605)
T 1m9s_A           58 VQGIQYLPNVTKLFLNGNKLTDIKP---LTNLK-NLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGIS-DIN-GL-V  128 (605)
T ss_dssp             CTTGGGCTTCCEEECTTSCCCCCGG---GGGCT-TCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCC-CCG-GG-G
T ss_pred             ChHHccCCCCCEEEeeCCCCCCChh---hccCC-CCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCC-CCc-cc-c
Confidence            4578899999999999999998766   55666 999999999999873  37899999999999999998 454 33 5


Q ss_pred             CCCCCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeec
Q 036754           84 NLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNL  158 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l  158 (405)
                      .+++|+.|+|++|+++.+ ..+..+++|+.|+++.     +++ +..+++|+.|+|++|.+.+. | .+..+++|+.|+|
T Consensus       129 ~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L  204 (605)
T 1m9s_A          129 HLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLEL  204 (605)
T ss_dssp             GCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEC
T ss_pred             CCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEc
Confidence            899999999999999988 5788999999999875     444 88999999999999999964 3 6899999999999


Q ss_pred             ccccccCccchhHHhcc
Q 036754          159 SKNNLSGAIPASLEKLL  175 (405)
Q Consensus       159 ~~n~l~~~~~~~~~~l~  175 (405)
                      ++|++.+.+...+..+.
T Consensus       205 ~~N~l~~~p~~~~~~l~  221 (605)
T 1m9s_A          205 FSQECLNKPINHQSNLV  221 (605)
T ss_dssp             CSEEEECCCCCCCSSCE
T ss_pred             cCCcCcCCcccccccEE
Confidence            99999865444433333

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.77  E-value=4.2e-19  Score=159.76  Aligned_cols=153  Identities=25%  Similarity=0.281  Sum_probs=132.0

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      .+..+++|+.|++++|.+..+.  . ++.++ +|+.|+|++|++++..+  +..+++|++|+|++|+++ .+|...  . 
T Consensus        36 ~~~~l~~L~~L~l~~n~i~~l~--~-l~~l~-~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~-~l~~~~--~-  105 (263)
T 1xeu_A           36 SQKELSGVQNFNGDNSNIQSLA--G-MQFFT-NLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK-NLNGIP--S-  105 (263)
T ss_dssp             CHHHHTTCSEEECTTSCCCCCT--T-GGGCT-TCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCS-CCTTCC--C-
T ss_pred             chhhcCcCcEEECcCCCcccch--H-HhhCC-CCCEEECCCCccCCChh--hccCCCCCEEECCCCccC-CcCccc--c-
Confidence            5678899999999999998754  3 56666 99999999999998655  999999999999999998 566533  3 


Q ss_pred             CCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccC
Q 036754           86 ASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG  165 (405)
Q Consensus        86 ~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~  165 (405)
                      ++|++|+|++|+++.+|                   .+.++++|++|++++|++++. + .+..+++|+.|++++|.+++
T Consensus       106 ~~L~~L~L~~N~l~~~~-------------------~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~  164 (263)
T 1xeu_A          106 ACLSRLFLDNNELRDTD-------------------SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN  164 (263)
T ss_dssp             SSCCEEECCSSCCSBSG-------------------GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred             CcccEEEccCCccCCCh-------------------hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence            99999999999999764                   245678999999999999964 4 68999999999999999997


Q ss_pred             ccchhHHhcccCCccccccCcccCcC
Q 036754          166 AIPASLEKLLYLKDLNLSFNKLEGEI  191 (405)
Q Consensus       166 ~~~~~~~~l~~L~~l~l~~n~l~~~~  191 (405)
                      .  ..+..+++|+.|++++|.+.+.+
T Consensus       165 ~--~~l~~l~~L~~L~l~~N~~~~~~  188 (263)
T 1xeu_A          165 T--GGLTRLKKVNWIDLTGQKCVNEP  188 (263)
T ss_dssp             C--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred             h--HHhccCCCCCEEeCCCCcccCCc
Confidence            6  67889999999999999998654

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.77  E-value=4.6e-19  Score=151.74  Aligned_cols=157  Identities=29%  Similarity=0.323  Sum_probs=124.1

Q ss_pred             ccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCC
Q 036754           39 LEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV  118 (405)
Q Consensus        39 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~  118 (405)
                      -+.+++++|+++. +|..+..  +|++|+|++|++++..+...+..+++|++|+|++|+|+.+++.              
T Consensus        10 ~~~l~~s~~~l~~-ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--------------   72 (192)
T 1w8a_A           10 GTTVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN--------------   72 (192)
T ss_dssp             TTEEECTTSCCSS-CCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTT--------------
T ss_pred             CCEEEcCCCCcCc-CccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHh--------------
Confidence            4789999999965 5665543  8999999999998444444567899999999999999976422              


Q ss_pred             CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccC
Q 036754          119 IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFG  198 (405)
Q Consensus       119 ~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~  198 (405)
                         .+.++++|++|++++|++++..|..|..+++|++|++++|++++..|..+..+++|+.|++++|.+.+..+-.....
T Consensus        73 ---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~  149 (192)
T 1w8a_A           73 ---AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAE  149 (192)
T ss_dssp             ---TTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHH
T ss_pred             ---HcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHH
Confidence               45678899999999999999989889999999999999999999999999999999999999999987655321111


Q ss_pred             CCCcccccCCCCccCCC
Q 036754          199 NFSAESFEGNELLCGSP  215 (405)
Q Consensus       199 ~~~~~~~~~n~~~c~~~  215 (405)
                      .+....+.++...|..|
T Consensus       150 ~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A          150 WLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             HHHHHCCSGGGCBBCSS
T ss_pred             HHHHcCCCCCCCCCCCC
Confidence            12222344556667655

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.77  E-value=5.2e-19  Score=171.60  Aligned_cols=152  Identities=24%  Similarity=0.327  Sum_probs=69.9

Q ss_pred             cccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCC
Q 036754           38 SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS  117 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~  117 (405)
                      +|+.|++++|.+++ +|+.   +++|++|++++|+++ .+|.    ..++|++|++++|+++.+| .+.++++|++|+++
T Consensus        92 ~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~----~~~~L~~L~L~~n~l~~lp-~~~~l~~L~~L~l~  161 (454)
T 1jl5_A           92 HLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSD----LPPLLEYLGVSNNQLEKLP-ELQNSSFLKIIDVD  161 (454)
T ss_dssp             TCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCS----CCTTCCEEECCSSCCSSCC-CCTTCTTCCEEECC
T ss_pred             CCCEEEccCCcCCc-cccc---cCCCcEEECCCCccC-cccC----CCCCCCEEECcCCCCCCCc-ccCCCCCCCEEECC
Confidence            55666666666555 3332   234444444444444 2221    1145555555555555555 35555555555544


Q ss_pred             C-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCC
Q 036754          118 V-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIP  192 (405)
Q Consensus       118 ~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p  192 (405)
                      .     +|..   .++|++|++++|.+.+ +| .++.+++|+.|++++|.+++. |..   .++|+.|++++|.++ .+|
T Consensus       162 ~N~l~~lp~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~n~l~-~lp  231 (454)
T 1jl5_A          162 NNSLKKLPDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL-PDL---PLSLESIVAGNNILE-ELP  231 (454)
T ss_dssp             SSCCSCCCCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-CCC---CTTCCEEECCSSCCS-SCC
T ss_pred             CCcCcccCCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC-CCC---cCcccEEECcCCcCC-ccc
Confidence            3     2211   2345555555555553 33 355555555555555555431 211   124444444444444 233


Q ss_pred             CCCccCCCCcccccCCC
Q 036754          193 RGGSFGNFSAESFEGNE  209 (405)
Q Consensus       193 ~~~~~~~~~~~~~~~n~  209 (405)
                      ....+++++.+++.+|.
T Consensus       232 ~~~~l~~L~~L~l~~N~  248 (454)
T 1jl5_A          232 ELQNLPFLTTIYADNNL  248 (454)
T ss_dssp             CCTTCTTCCEEECCSSC
T ss_pred             ccCCCCCCCEEECCCCc
Confidence            33334444444444443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.77  E-value=1e-18  Score=165.78  Aligned_cols=114  Identities=23%  Similarity=0.276  Sum_probs=97.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeec------CCe
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSN------EEF  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  360 (405)
                      ++|...+.||+|+||+||+|.. .+|+.||||+++...  ....+.+.+|+.+|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            3577778999999999999985 579999999996543  2345678899999999999999999998754      367


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|||||||+ |+|.+++...+ .+++.++..|+.||+.||+|||+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~  176 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHS  176 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            899999996 68999997654 79999999999999999999994

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.77  E-value=1.6e-19  Score=170.26  Aligned_cols=202  Identities=24%  Similarity=0.225  Sum_probs=145.0

Q ss_pred             CCCCCcCCeeeCcCCcCcccCC----chhhhcccccccEEEcccCcccccCCccccCc-----cCCCeeecCCccccccc
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLP----KTFVGNVSHSLEFFVMSYCNISGGILEEITNL-----TKLTTIILGGNKLNGSI   77 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~----~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~   77 (405)
                      +...++|++|||++|.+++..+    .. +..++.+|+.|+|++|++++..+..+..+     ++|++|+|++|.+++..
T Consensus        18 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~-l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~   96 (362)
T 3goz_A           18 TSIPHGVTSLDLSLNNLYSISTVELIQA-FANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKS   96 (362)
T ss_dssp             HTSCTTCCEEECTTSCGGGSCHHHHHHH-HHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSC
T ss_pred             HhCCCCceEEEccCCCCChHHHHHHHHH-HHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHH
Confidence            3455669999999999988776    44 44444379999999999998878777775     89999999999998554


Q ss_pred             Ccchh---cCC-CCCCeeeCCCCCCCCCch-hhh----c-cccCccccCCC----------CChhccCCC-CCCEEeccC
Q 036754           78 SITLG---SNL-ASLRKLSLDSNELTSIPL-TFW----N-LKDILYLNFSV----------IPIEIGGLP-NLEYLFLGY  136 (405)
Q Consensus        78 ~~~~~---~~l-~~L~~L~Ls~N~l~~lp~-~~~----~-l~~L~~l~l~~----------~p~~~~~l~-~L~~L~l~~  136 (405)
                      +..+.   ..+ ++|++|+|++|+++..+. .+.    . ..+|++|+++.          ++..+..++ +|++|++++
T Consensus        97 ~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~  176 (362)
T 3goz_A           97 SDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRG  176 (362)
T ss_dssp             HHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTT
T ss_pred             HHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecC
Confidence            44332   234 899999999999986654 332    2 25788888775          223344555 889999999


Q ss_pred             CcccccCCcccc----cC-CCCCeeecccccccCc----cchhHHhc-ccCCccccccCcccCcCCC-----CCccCCCC
Q 036754          137 NRLQGSIPDSFG----DL-ISLKSLNLSKNNLSGA----IPASLEKL-LYLKDLNLSFNKLEGEIPR-----GGSFGNFS  201 (405)
Q Consensus       137 n~l~~~~p~~~~----~l-~~L~~L~l~~n~l~~~----~~~~~~~l-~~L~~l~l~~n~l~~~~p~-----~~~~~~~~  201 (405)
                      |.+.+..+..+.    .+ ++|++|++++|.+++.    ++..+... ++|+.|++++|.+++..+.     .....+++
T Consensus       177 n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~  256 (362)
T 3goz_A          177 NNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ  256 (362)
T ss_dssp             SCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCS
T ss_pred             CCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCcc
Confidence            988876665444    34 5899999999988753    44555553 4888999999888765431     23456677


Q ss_pred             cccccCCC
Q 036754          202 AESFEGNE  209 (405)
Q Consensus       202 ~~~~~~n~  209 (405)
                      .+++++|.
T Consensus       257 ~L~L~~n~  264 (362)
T 3goz_A          257 TVYLDYDI  264 (362)
T ss_dssp             EEEEEHHH
T ss_pred             EEEeccCC
Confidence            77777665

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.77  E-value=5.1e-18  Score=170.02  Aligned_cols=77  Identities=27%  Similarity=0.239  Sum_probs=52.1

Q ss_pred             CCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCccccc
Q 036754          127 PNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFE  206 (405)
Q Consensus       127 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~  206 (405)
                      ++|++|++++|.+++ +|   ..+++|+.|++++|.++. +|.   .+++|+.|++++|.++..++....++++..+++.
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~  292 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLE  292 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEec
Confidence            556677777776664 44   345677777777777774 343   4667788888888887544445566777888888


Q ss_pred             CCCCc
Q 036754          207 GNELL  211 (405)
Q Consensus       207 ~n~~~  211 (405)
                      +|++.
T Consensus       293 ~N~l~  297 (622)
T 3g06_A          293 GNPLS  297 (622)
T ss_dssp             SCCCC
T ss_pred             CCCCC
Confidence            88764

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.76  E-value=6.6e-19  Score=165.30  Aligned_cols=202  Identities=18%  Similarity=0.163  Sum_probs=153.8

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      +|.++++|++|+|++|++.+.+|...+.+++.-++.+.++.|+++...|+.|..+++|++|++++|+++ .+|...+...
T Consensus        49 ~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~~~~~~~  127 (350)
T 4ay9_X           49 AFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS  127 (350)
T ss_dssp             SSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCS-SCCCCTTCCB
T ss_pred             HHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccc-cCCchhhccc
Confidence            689999999999999999776665436666633446778889999999999999999999999999998 6666555577


Q ss_pred             CCCCeeeCCC-CCCCCCchh-hhccc-cCccccCCC-----CChhccCCCCCCEEeccC-CcccccCCcccccCCCCCee
Q 036754           86 ASLRKLSLDS-NELTSIPLT-FWNLK-DILYLNFSV-----IPIEIGGLPNLEYLFLGY-NRLQGSIPDSFGDLISLKSL  156 (405)
Q Consensus        86 ~~L~~L~Ls~-N~l~~lp~~-~~~l~-~L~~l~l~~-----~p~~~~~l~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~L  156 (405)
                      .++..|++.+ |+++.+|.. +..+. .++.|+++.     +|.......+|++|++++ |.+....++.|..+++|+.|
T Consensus       128 ~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~L  207 (350)
T 4ay9_X          128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL  207 (350)
T ss_dssp             SSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEE
T ss_pred             chhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchh
Confidence            8888999966 678888754 44443 567777654     676666778899999985 67776556779999999999


Q ss_pred             ecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCcc
Q 036754          157 NLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC  212 (405)
Q Consensus       157 ~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c  212 (405)
                      ++++|+++..++..+.++++|+.++.  +.++ .+|....+.++..+.+. +++.|
T Consensus       208 dLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP~l~~l~~L~~l~l~-~~~~c  259 (350)
T 4ay9_X          208 DISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPTLEKLVALMEASLT-YPSHC  259 (350)
T ss_dssp             ECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCCCTTTCCSCCEEECS-CHHHH
T ss_pred             hcCCCCcCccChhhhccchHhhhccC--CCcC-cCCCchhCcChhhCcCC-CCccc
Confidence            99999999776666665555554443  3343 56666777788777764 55555

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.75  E-value=2.1e-18  Score=159.85  Aligned_cols=126  Identities=35%  Similarity=0.561  Sum_probs=111.2

Q ss_pred             hHHHHHHhhhccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCC
Q 036754          280 FSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE  359 (405)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  359 (405)
                      +++.++...+++|...+.||+|+||.||+|...+|+.||||++........+.+.+|+.++.+++||||+++++++...+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            33445566778899999999999999999998889999999987766666778999999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++||||+++|+|.+++....   ..++|.++..++.|+++||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~  157 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT  157 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC
Confidence            9999999999999999997543   358999999999999999999994

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.75  E-value=7.9e-19  Score=179.73  Aligned_cols=173  Identities=23%  Similarity=0.252  Sum_probs=114.9

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccc---------cCCccccCccCCCeeecCCcccccccCcch
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISG---------GILEEITNLTKLTTIILGGNKLNGSISITL   81 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~---------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~   81 (405)
                      +.++.|+|++|.+... +..       .|+.++|++|.+.+         ..++.|..+++|+.|+|++|.+. .+|..+
T Consensus       173 ~~~~~l~L~~n~~~~~-~~~-------~l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~  243 (727)
T 4b8c_D          173 PLTPKIELFANGKDEA-NQA-------LLQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANI  243 (727)
T ss_dssp             ---------------------------------------------------------CCCCCCEEECTTSCCS-CCCGGG
T ss_pred             CccceEEeeCCCCCcc-hhh-------HhhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhh
Confidence            5578888888888764 322       23444444444333         34677888899999999999987 888888


Q ss_pred             hcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCee
Q 036754           82 GSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSL  156 (405)
Q Consensus        82 ~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L  156 (405)
                      + ++++|++|+|++|.|+.+|..+.++++|++|+++.     +|..++++++|++|+|++|.+. .+|..|+.+++|+.|
T Consensus       244 ~-~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L  321 (727)
T 4b8c_D          244 F-KYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFL  321 (727)
T ss_dssp             G-GCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCE
T ss_pred             c-CCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEE
Confidence            7 78999999999999999998888999999888765     7888899999999999999998 678889999999999


Q ss_pred             ecccccccCccchhHHhccc-CCccccccCcccCcCCCC
Q 036754          157 NLSKNNLSGAIPASLEKLLY-LKDLNLSFNKLEGEIPRG  194 (405)
Q Consensus       157 ~l~~n~l~~~~~~~~~~l~~-L~~l~l~~n~l~~~~p~~  194 (405)
                      +|++|.+++.+|..+..+.. +..+++++|.+++.+|..
T Consensus       322 ~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~  360 (727)
T 4b8c_D          322 GVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE  360 (727)
T ss_dssp             ECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred             eCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence            99999999999988876533 234788999999888763

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.75  E-value=6.7e-18  Score=141.19  Aligned_cols=86  Identities=21%  Similarity=0.349  Sum_probs=38.5

Q ss_pred             CcCCeeeCcCCcCc-ccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCC
Q 036754           11 KCLTFIDLSNNPLD-SVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLR   89 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~-~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~   89 (405)
                      ++|+.|+|++|.+. +.+|.. +..++ +|+.|+|++|.+++.  ..+..+++|++|+|++|++++.+|.. +.++++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~-~~~l~-~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~   98 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGL-TAEFV-NLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDML-AEKLPNLT   98 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSC-CGGGG-GCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHH-HHHCTTCC
T ss_pred             ccCCEEECCCCCCChhhHHHH-HHhCC-CCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHH-HhhCCCCC
Confidence            44555555555544 233333 23333 455555555554443  34444445555555555544323322 22344455


Q ss_pred             eeeCCCCCCCCC
Q 036754           90 KLSLDSNELTSI  101 (405)
Q Consensus        90 ~L~Ls~N~l~~l  101 (405)
                      +|+|++|+++.+
T Consensus        99 ~L~Ls~N~l~~~  110 (168)
T 2ell_A           99 HLNLSGNKLKDI  110 (168)
T ss_dssp             EEECBSSSCCSS
T ss_pred             EEeccCCccCcc
Confidence            555555444443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.75  E-value=1.1e-18  Score=169.29  Aligned_cols=186  Identities=21%  Similarity=0.205  Sum_probs=92.5

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhccc------------ccccEEEcccCcccccCCccccCccCCCeeecCC
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVS------------HSLEFFVMSYCNISGGILEEITNLTKLTTIILGG   70 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~------------~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~   70 (405)
                      +|++|+++++|++|++++|.+.+..|.. ++++.            .+++.|++++|.+++ +|..   .++|++|++++
T Consensus        26 iP~~i~~L~~L~~L~l~~n~~~~~~p~~-~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~  100 (454)
T 1jl5_A           26 MPVEAENVKSKTEYYNAWSEWERNAPPG-NGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLESLVASC  100 (454)
T ss_dssp             --------CCHHHHHHHHHHHHHTSCTT-SCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCSEEECCS
T ss_pred             CChhHhcccchhhhhccCCcccccCCcc-cccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCCEEEccC
Confidence            3444444455555555555444444444 23222            012445555554444 1221   23455555555


Q ss_pred             cccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCc
Q 036754           71 NKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPD  145 (405)
Q Consensus        71 N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~  145 (405)
                      |.+++ +|.    .+++|++|++++|+++.+|...   ++|++|+++.     +| .++++++|++|++++|.+++ +|.
T Consensus       101 n~l~~-lp~----~~~~L~~L~l~~n~l~~l~~~~---~~L~~L~L~~n~l~~lp-~~~~l~~L~~L~l~~N~l~~-lp~  170 (454)
T 1jl5_A          101 NSLTE-LPE----LPQSLKSLLVDNNNLKALSDLP---PLLEYLGVSNNQLEKLP-ELQNSSFLKIIDVDNNSLKK-LPD  170 (454)
T ss_dssp             SCCSS-CCC----CCTTCCEEECCSSCCSCCCSCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSC-CCC
T ss_pred             CcCCc-ccc----ccCCCcEEECCCCccCcccCCC---CCCCEEECcCCCCCCCc-ccCCCCCCCEEECCCCcCcc-cCC
Confidence            55552 442    1245555566555555544321   3455555432     45 46666667777777766664 443


Q ss_pred             ccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCc
Q 036754          146 SFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL  211 (405)
Q Consensus       146 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~  211 (405)
                      .+   ++|++|++++|.+++ +| .+..+++|+.|++++|.+++. |..  ..+++.+++.+|...
T Consensus       171 ~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l-~~~--~~~L~~L~l~~n~l~  228 (454)
T 1jl5_A          171 LP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL-PDL--PLSLESIVAGNNILE  228 (454)
T ss_dssp             CC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-CCC--CTTCCEEECCSSCCS
T ss_pred             Cc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC-CCC--cCcccEEECcCCcCC
Confidence            32   466667777776665 34 466677777777777776652 222  235666666666543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.75  E-value=2.5e-19  Score=168.97  Aligned_cols=205  Identities=20%  Similarity=0.205  Sum_probs=152.9

Q ss_pred             ccCCCCC-cCCeeeCcCCcCcccCCchhhhcc----cccccEEEcccCcccccCCccccC----c-cCCCeeecCCcccc
Q 036754            5 SSLSNCK-CLTFIDLSNNPLDSVLPKTFVGNV----SHSLEFFVMSYCNISGGILEEITN----L-TKLTTIILGGNKLN   74 (405)
Q Consensus         5 ~~~~~l~-~L~~L~Ls~N~l~~~~~~~f~~~~----~~~L~~L~L~~n~l~~~~~~~~~~----l-~~L~~L~L~~N~l~   74 (405)
                      +.|.+++ +|++|+|++|.+.+..+..+ ..+    ..+|+.|+|++|++++..+..+..    + ++|++|+|++|.++
T Consensus        44 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l-~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~  122 (362)
T 3goz_A           44 QAFANTPASVTSLNLSGNSLGFKNSDEL-VQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS  122 (362)
T ss_dssp             HHHHTCCTTCCEEECCSSCGGGSCHHHH-HHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGG
T ss_pred             HHHHhCCCceeEEECcCCCCCHHHHHHH-HHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCC
Confidence            5677888 89999999999998877763 332    138999999999999877775544    3 89999999999998


Q ss_pred             cccCcchh---cC-CCCCCeeeCCCCCCC-----CCchhhhccc-cCccccCCCCC----------hhccCC-CCCCEEe
Q 036754           75 GSISITLG---SN-LASLRKLSLDSNELT-----SIPLTFWNLK-DILYLNFSVIP----------IEIGGL-PNLEYLF  133 (405)
Q Consensus        75 ~~~~~~~~---~~-l~~L~~L~Ls~N~l~-----~lp~~~~~l~-~L~~l~l~~~p----------~~~~~l-~~L~~L~  133 (405)
                      +..+..+.   .. .++|++|+|++|+++     .++..+..+. +|+.|+++...          ..+..+ ++|++|+
T Consensus       123 ~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~  202 (362)
T 3goz_A          123 SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLD  202 (362)
T ss_dssp             GSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEE
T ss_pred             cHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEE
Confidence            44333332   23 369999999999998     3444555565 89999987621          134455 5999999


Q ss_pred             ccCCccccc----CCccccc-CCCCCeeecccccccCccchhH----HhcccCCccccccCcccCcCC--------CCCc
Q 036754          134 LGYNRLQGS----IPDSFGD-LISLKSLNLSKNNLSGAIPASL----EKLLYLKDLNLSFNKLEGEIP--------RGGS  196 (405)
Q Consensus       134 l~~n~l~~~----~p~~~~~-l~~L~~L~l~~n~l~~~~~~~~----~~l~~L~~l~l~~n~l~~~~p--------~~~~  196 (405)
                      +++|.+.+.    ++..+.. .++|++|++++|.+++..+..+    ..+++|+.|++++|.+.+..+        ....
T Consensus       203 Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~  282 (362)
T 3goz_A          203 LSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPN  282 (362)
T ss_dssp             CTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTT
T ss_pred             CCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhcc
Confidence            999999863    4455555 4599999999999987655443    456889999999999654332        2344


Q ss_pred             cCCCCcccccCCCC
Q 036754          197 FGNFSAESFEGNEL  210 (405)
Q Consensus       197 ~~~~~~~~~~~n~~  210 (405)
                      ..++..+++++|+.
T Consensus       283 l~~L~~LdL~~N~l  296 (362)
T 3goz_A          283 IQKIILVDKNGKEI  296 (362)
T ss_dssp             CCEEEEECTTSCBC
T ss_pred             CCceEEEecCCCcC
Confidence            56677788888864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.75  E-value=6.9e-18  Score=155.57  Aligned_cols=116  Identities=23%  Similarity=0.359  Sum_probs=105.2

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ++|...+.||+|+||+||+|.. .+++.||+|.+........+.+.+|+.++.+++||||+++++++...+..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            4566778999999999999996 468999999987665666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++......+++.++..++.|+++||+|||+
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~  126 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS  126 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999998766679999999999999999999994

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.74  E-value=4.6e-18  Score=168.96  Aligned_cols=116  Identities=19%  Similarity=0.265  Sum_probs=98.4

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHH---HHHHHHhhcCCCCCcceEEeeeecCCee
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSF---DIECEMMKSIRHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~  361 (405)
                      .++|...++||+|+||+||+|+. .+|+.||+|++.+..   .......   ..++.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            35788889999999999999985 578999999997542   1222222   3346677888999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||||||+||||.++|...+ .+++..+..|+.||+.||+|||.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~  310 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHN  310 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999997654 79999999999999999999995

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.74  E-value=6e-18  Score=162.95  Aligned_cols=126  Identities=17%  Similarity=0.170  Sum_probs=109.3

Q ss_pred             hHHHHHHhhhccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeee
Q 036754          280 FSYLELCRATYKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSC  355 (405)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~  355 (405)
                      ..+.++....++|...++||+|+||+||+|+.. +++.||+|++.+..   ......+.+|+.++..++||||+++++++
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345566667788999999999999999999964 57899999997532   22334588899999999999999999999


Q ss_pred             ecCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       356 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+.+..|+||||+++|+|.+++......+++..+..++.||+.||+|||.
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~  193 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ  193 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999999999999998755679999999999999999999994

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.74  E-value=2.5e-17  Score=165.00  Aligned_cols=175  Identities=24%  Similarity=0.184  Sum_probs=86.8

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCe
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~   90 (405)
                      ++|+.|+|++|.|+.+.+ .    + ++|+.|+|++|+++. +|.   .+++|++|+|++|+++ .+|.    .+++|+.
T Consensus        61 ~~L~~L~L~~N~l~~lp~-~----l-~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~l~~----~l~~L~~  125 (622)
T 3g06_A           61 AHITTLVIPDNNLTSLPA-L----P-PELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLT-HLPA----LPSGLCK  125 (622)
T ss_dssp             TTCSEEEECSCCCSCCCC-C----C-TTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCC-CCCC----CCTTCCE
T ss_pred             CCCcEEEecCCCCCCCCC-c----C-CCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCC-CCCC----CCCCcCE
Confidence            456666666666654332 1    1 256666666666654 232   4455555555555554 3333    2334444


Q ss_pred             eeCCCCCCCCCchhhhccccCccccCCC-----CChhc-----------------cCCCCCCEEeccCCcccccCCcccc
Q 036754           91 LSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEI-----------------GGLPNLEYLFLGYNRLQGSIPDSFG  148 (405)
Q Consensus        91 L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~-----------------~~l~~L~~L~l~~n~l~~~~p~~~~  148 (405)
                      |++++|+++.+|..+   ++|++|+++.     +|..+                 ..+++|++|++++|.+++ +|..+.
T Consensus       126 L~L~~N~l~~lp~~l---~~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l~~~~~  201 (622)
T 3g06_A          126 LWIFGNQLTSLPVLP---PGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTLPS  201 (622)
T ss_dssp             EECCSSCCSCCCCCC---TTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCCCCT
T ss_pred             EECCCCCCCcCCCCC---CCCCEEECcCCcCCCcCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-CCCccc
Confidence            444444444443321   2233333221     11100                 122556666666666553 222111


Q ss_pred             -----------------cCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCc
Q 036754          149 -----------------DLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL  211 (405)
Q Consensus       149 -----------------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~  211 (405)
                                       .+++|+.|++++|.+++ +|   ..+++|+.|++++|.++.. |.  .+.++..+++.+|.+.
T Consensus       202 ~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~l-p~--~~~~L~~L~Ls~N~L~  274 (622)
T 3g06_A          202 ELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSL-PM--LPSGLLSLSVYRNQLT  274 (622)
T ss_dssp             TCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCC-CC--CCTTCCEEECCSSCCC
T ss_pred             hhhEEECcCCcccccCCCCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcC-Cc--ccccCcEEeCCCCCCC
Confidence                             12556666666666664 33   2346677777777777643 33  4556677777777654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.74  E-value=9.9e-18  Score=158.62  Aligned_cols=116  Identities=25%  Similarity=0.458  Sum_probs=102.4

Q ss_pred             ccCCccCcccccCCCceEEEeeC----CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG----DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      .+|...+.||+|+||.||+|+..    .+..||||.++... ....+.|.+|+.++.+++||||+++++++...+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            46777889999999999999853    56789999997653 33456799999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.++++..+..+++.++..++.||++||+|||+
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  165 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD  165 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999998766679999999999999999999994

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.73  E-value=1.5e-17  Score=154.05  Aligned_cols=125  Identities=24%  Similarity=0.262  Sum_probs=107.3

Q ss_pred             hhHHHHHHhhhcc----------CCccCcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCC
Q 036754          279 MFSYLELCRATYK----------FSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQN  347 (405)
Q Consensus       279 ~~~~~~~~~~~~~----------~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n  347 (405)
                      .++++++..++..          |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++.+++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4555566555543          445568999999999999965 78999999998766666778899999999999999


Q ss_pred             cceEEeeeecCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       348 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++++++...+..++||||+++|+|.+++...  .+++.++..++.|+++||+|||+
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~  159 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHA  159 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999998653  59999999999999999999994

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.73  E-value=1e-17  Score=155.59  Aligned_cols=129  Identities=36%  Similarity=0.518  Sum_probs=112.6

Q ss_pred             hhhhHHHHHHhhhccCCccCcccccCCCceEEEeeCCCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeee
Q 036754          277 WRMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSC  355 (405)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~  355 (405)
                      ...+++.++....++|...+.||+|+||.||+|...+|+.||||++..... .....+.+|+.++.+++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            345677888889999999999999999999999988899999999975432 2334688999999999999999999999


Q ss_pred             ecCCeeEEEEecCCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          356 SNEEFKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       356 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ...+..++||||+++|+|.+++....   ..++|..+..++.|+++||+|||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~  149 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD  149 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999999999999998643   349999999999999999999994

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.73  E-value=1.7e-17  Score=142.48  Aligned_cols=134  Identities=17%  Similarity=0.283  Sum_probs=112.7

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      .+..+++|++|++++|.+....  . +..++ +|+.|++++|++++..+..++.+++|++|+|++|.+++..+..+ ..+
T Consensus        61 ~l~~l~~L~~L~l~~n~~~~~~--~-l~~l~-~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l-~~l  135 (197)
T 4ezg_A           61 GIEYAHNIKDLTINNIHATNYN--P-ISGLS-NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI-NTL  135 (197)
T ss_dssp             TGGGCTTCSEEEEESCCCSCCG--G-GTTCT-TCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHH-TTC
T ss_pred             HHhcCCCCCEEEccCCCCCcch--h-hhcCC-CCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHH-hhC
Confidence            6888999999999999876542  3 66666 99999999999999889999999999999999999996666665 589


Q ss_pred             CCCCeeeCCCCC-CCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccccccc
Q 036754           86 ASLRKLSLDSNE-LTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLS  164 (405)
Q Consensus        86 ~~L~~L~Ls~N~-l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~  164 (405)
                      ++|++|+|++|. ++.+| .                  +.++++|++|++++|.+.+ ++ .+..+++|+.|++++|++.
T Consensus       136 ~~L~~L~L~~n~~i~~~~-~------------------l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          136 PKVNSIDLSYNGAITDIM-P------------------LKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             SSCCEEECCSCTBCCCCG-G------------------GGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred             CCCCEEEccCCCCccccH-h------------------hcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence            999999999998 88775 2                  3457889999999999985 44 7899999999999999986


Q ss_pred             C
Q 036754          165 G  165 (405)
Q Consensus       165 ~  165 (405)
                      +
T Consensus       195 ~  195 (197)
T 4ezg_A          195 G  195 (197)
T ss_dssp             -
T ss_pred             C
Confidence            3

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.73  E-value=2.8e-17  Score=138.60  Aligned_cols=134  Identities=25%  Similarity=0.240  Sum_probs=110.9

Q ss_pred             cCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCee
Q 036754           12 CLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKL   91 (405)
Q Consensus        12 ~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L   91 (405)
                      ..+.+++++|++..+....     +++|+.|++++|++++..+..|..+++|++|+|++|+++ .+|...+.++++|++|
T Consensus         8 ~~~~l~~~~~~l~~~p~~~-----~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L   81 (177)
T 2o6r_A            8 SGTEIRCNSKGLTSVPTGI-----PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTIL   81 (177)
T ss_dssp             ETTEEECCSSCCSSCCTTC-----CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred             CCCEEEecCCCCccCCCCC-----CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcce-EeChhHccCCCccCEE
Confidence            3578999999998754332     248999999999999877778899999999999999998 6777766789999999


Q ss_pred             eCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccc
Q 036754           92 SLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIP  168 (405)
Q Consensus        92 ~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~  168 (405)
                      +|++|+++.+|..                 .+.++++|++|++++|.+++..+..|..+++|+.|++++|++.+..|
T Consensus        82 ~l~~N~l~~~~~~-----------------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           82 YLHENKLQSLPNG-----------------VFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             ECCSSCCCCCCTT-----------------TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ECCCCCccccCHH-----------------HhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            9999999877654                 34567889999999999997777677889999999999999987654

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.73  E-value=3.7e-19  Score=176.87  Aligned_cols=174  Identities=23%  Similarity=0.221  Sum_probs=132.3

Q ss_pred             ccccCCCCCcCCeeeCcCCc-------------CcccCCchhhhcccccccEEE-cccCcccccCCc-----cccC--cc
Q 036754            3 FLSSLSNCKCLTFIDLSNNP-------------LDSVLPKTFVGNVSHSLEFFV-MSYCNISGGILE-----EITN--LT   61 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~-------------l~~~~~~~f~~~~~~~L~~L~-L~~n~l~~~~~~-----~~~~--l~   61 (405)
                      +|+.+++|++|+.|++++|.             +.+..|.. ++.++ +|+.|+ ++.|.+.....-     .+..  ..
T Consensus       364 Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~-l~~l~-~L~~L~~l~~n~~~~L~~l~l~~n~i~~l~~~  441 (567)
T 1dce_A          364 LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKET-LQYFS-TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYA  441 (567)
T ss_dssp             HHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHH-HHHHH-HHHHHCGGGHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHH-HHHHH-hcccCcchhhcccchhhhhhhhcccccccCcc
Confidence            57788899999999998775             55555655 56665 777777 555543221100     1111  12


Q ss_pred             CCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccC
Q 036754           62 KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGY  136 (405)
Q Consensus        62 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~  136 (405)
                      .|+.|+|++|.|+ .+|. + .++++|+.|+|++|+|+.+|..+.++++|+.|+++.     +| .++++++|++|++++
T Consensus       442 ~L~~L~Ls~n~l~-~lp~-~-~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~  517 (567)
T 1dce_A          442 DVRVLHLAHKDLT-VLCH-L-EQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCN  517 (567)
T ss_dssp             TCSEEECTTSCCS-SCCC-G-GGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCS
T ss_pred             CceEEEecCCCCC-CCcC-c-cccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCC
Confidence            5888888888887 5775 4 578888888888888888888888888888888764     66 788999999999999


Q ss_pred             CcccccC-CcccccCCCCCeeecccccccCccch---hHHhcccCCcccc
Q 036754          137 NRLQGSI-PDSFGDLISLKSLNLSKNNLSGAIPA---SLEKLLYLKDLNL  182 (405)
Q Consensus       137 n~l~~~~-p~~~~~l~~L~~L~l~~n~l~~~~~~---~~~~l~~L~~l~l  182 (405)
                      |.+++.. |..++.+++|+.|++++|++++.+|.   .+..+++|+.|++
T Consensus       518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            9999876 99999999999999999999977653   3445788887753

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.73  E-value=3.6e-17  Score=139.92  Aligned_cols=130  Identities=26%  Similarity=0.288  Sum_probs=104.7

Q ss_pred             CCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeee
Q 036754           13 LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLS   92 (405)
Q Consensus        13 L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~   92 (405)
                      -+.+++++|.+..+.+..     +.+|+.|+|++|+++. +|..|..+++|++|+|++|.|+ .++...+.++++|++|+
T Consensus        12 ~~~l~~~~~~l~~ip~~~-----~~~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~   84 (193)
T 2wfh_A           12 DTVVRCSNKGLKVLPKGI-----PRDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLI   84 (193)
T ss_dssp             TTEEECTTSCCSSCCSCC-----CTTCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred             CCEEEcCCCCCCcCCCCC-----CCCCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCC-EeCHhHccCCCCCCEEE
Confidence            367899999988654332     2489999999999974 6688899999999999999998 56666667899999999


Q ss_pred             CCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCc
Q 036754           93 LDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGA  166 (405)
Q Consensus        93 Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~  166 (405)
                      |++|+|+.+|..                 .|.++++|++|++++|.++...+..|..+++|+.|++++|++...
T Consensus        85 Ls~N~l~~i~~~-----------------~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           85 LSYNRLRCIPPR-----------------TFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             CCSSCCCBCCTT-----------------TTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             CCCCccCEeCHH-----------------HhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            999999877643                 456678889999999999877777788889999999999988643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.72  E-value=1.9e-17  Score=155.28  Aligned_cols=116  Identities=20%  Similarity=0.271  Sum_probs=99.6

Q ss_pred             HHHhhhccCCccCcccccCCCceEEEee----CCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeecC
Q 036754          284 ELCRATYKFSENNLISKGGFGSVYKARL----GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNE  358 (405)
Q Consensus       284 ~~~~~~~~~~~~~~lg~G~fg~v~~~~~----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  358 (405)
                      .+....+.|...+.||+|+||+||+|+.    .+++.||+|.+....  ....+.+|++++..+ +|||||++++++.+.
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            3344456788889999999999999974    346889999986542  335678899999988 699999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +..||||||+++|+|.+++.    .+++.++..++.|+++||+|||+
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~  135 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQ  135 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999983    48999999999999999999994

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.72  E-value=3.8e-17  Score=149.73  Aligned_cols=115  Identities=27%  Similarity=0.343  Sum_probs=103.7

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ...|...+.||+|+||+||+|.. .+|+.||+|++........+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            34677888999999999999984 67899999999876656667789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++...  .+++.++..++.|+++||+|||+
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~  134 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS  134 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999764  58999999999999999999994

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.72  E-value=4e-17  Score=147.21  Aligned_cols=115  Identities=25%  Similarity=0.376  Sum_probs=103.2

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      ++|...+.||+|+||.||+|...++..||+|++.... ...+.+.+|+.++.+++||||+++++++...+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            4566778999999999999998888899999997543 234578899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++......+++..+..++.|+++||+|||+
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~  124 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE  124 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh
Confidence            999999998766679999999999999999999994

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.72  E-value=1.6e-17  Score=135.97  Aligned_cols=125  Identities=21%  Similarity=0.216  Sum_probs=75.0

Q ss_pred             cccEEEcccCccc-ccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCC-CchhhhccccCcccc
Q 036754           38 SLEFFVMSYCNIS-GGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTS-IPLTFWNLKDILYLN  115 (405)
Q Consensus        38 ~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~l~  115 (405)
                      +|+.|++++|.++ +.+|..+..+++|++|++++|.+++ +  ..+..+++|++|+|++|.++. +|..+          
T Consensus        18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~-~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~----------   84 (149)
T 2je0_A           18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-I--ANLPKLNKLKKLELSDNRVSGGLEVLA----------   84 (149)
T ss_dssp             GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCC-C--TTCCCCTTCCEEECCSSCCCSCTHHHH----------
T ss_pred             cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCC-c--hhhhcCCCCCEEECCCCcccchHHHHh----------
Confidence            5666666666665 4555566666666666666666653 3  223466666666666666664 44332          


Q ss_pred             CCCCChhccCCCCCCEEeccCCccccc-CCcccccCCCCCeeecccccccCccc---hhHHhcccCCccccc
Q 036754          116 FSVIPIEIGGLPNLEYLFLGYNRLQGS-IPDSFGDLISLKSLNLSKNNLSGAIP---ASLEKLLYLKDLNLS  183 (405)
Q Consensus       116 l~~~p~~~~~l~~L~~L~l~~n~l~~~-~p~~~~~l~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~l~l~  183 (405)
                              .++++|++|++++|.+.+. .+..+..+++|++|++++|.+++..+   ..+..+++|+.|+++
T Consensus        85 --------~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           85 --------EKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             --------HHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             --------hhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence                    2345566666666666642 23556666667777777776665544   456666677666654

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.72  E-value=3.4e-17  Score=136.88  Aligned_cols=133  Identities=23%  Similarity=0.243  Sum_probs=113.4

Q ss_pred             ccccEEEcccCccc-ccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCC-CchhhhccccCccc
Q 036754           37 HSLEFFVMSYCNIS-GGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTS-IPLTFWNLKDILYL  114 (405)
Q Consensus        37 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~l  114 (405)
                      ++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++ + .. +..+++|++|+|++|+++. +|..+         
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~-~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~---------   91 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-V-SN-LPKLPKLKKLELSENRIFGGLDMLA---------   91 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCC-C-SS-CCCCSSCCEEEEESCCCCSCCCHHH---------
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCC-h-hh-hccCCCCCEEECcCCcCchHHHHHH---------
Confidence            48999999999998 6788889999999999999999984 4 33 4689999999999999996 55443         


Q ss_pred             cCCCCChhccCCCCCCEEeccCCcccccCC-cccccCCCCCeeecccccccCccc---hhHHhcccCCccccccCcccCc
Q 036754          115 NFSVIPIEIGGLPNLEYLFLGYNRLQGSIP-DSFGDLISLKSLNLSKNNLSGAIP---ASLEKLLYLKDLNLSFNKLEGE  190 (405)
Q Consensus       115 ~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~l~l~~n~l~~~  190 (405)
                               .++++|++|++++|.+++..+ ..+..+++|+.|++++|.+++..+   ..+..+++|+.|+++.|.+...
T Consensus        92 ---------~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~  162 (168)
T 2ell_A           92 ---------EKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA  162 (168)
T ss_dssp             ---------HHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred             ---------hhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence                     346889999999999986432 788999999999999999997766   5888999999999999988743

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.71  E-value=2.5e-17  Score=138.88  Aligned_cols=137  Identities=19%  Similarity=0.246  Sum_probs=101.3

Q ss_pred             ccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcC
Q 036754            5 SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSN   84 (405)
Q Consensus         5 ~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~   84 (405)
                      +.+.++++|+.|+|++|++..+ |.  +..+.++|+.|+|++|.+++.  ..|..+++|++|+|++|.++ .+|..++..
T Consensus        13 ~~~~~~~~L~~L~l~~n~l~~i-~~--~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~   86 (176)
T 1a9n_A           13 AQYTNAVRDRELDLRGYKIPVI-EN--LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQA   86 (176)
T ss_dssp             CEEECTTSCEEEECTTSCCCSC-CC--GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHH
T ss_pred             HhcCCcCCceEEEeeCCCCchh-HH--hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhc
Confidence            3466788888899998888865 44  223333788888888888875  57888888888888888887 667666667


Q ss_pred             CCCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcc----cccCCCCCeeeccc
Q 036754           85 LASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDS----FGDLISLKSLNLSK  160 (405)
Q Consensus        85 l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~----~~~l~~L~~L~l~~  160 (405)
                      +++|++|+|++|+++.+|..                ..+..+++|++|++++|++. ..|..    +..+++|+.|++++
T Consensus        87 l~~L~~L~L~~N~i~~~~~~----------------~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~  149 (176)
T 1a9n_A           87 LPDLTELILTNNSLVELGDL----------------DPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQK  149 (176)
T ss_dssp             CTTCCEEECCSCCCCCGGGG----------------GGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEE
T ss_pred             CCCCCEEECCCCcCCcchhh----------------HhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCc
Confidence            88888888888888877651                02345677888888888887 34543    77778888888887


Q ss_pred             cccc
Q 036754          161 NNLS  164 (405)
Q Consensus       161 n~l~  164 (405)
                      |...
T Consensus       150 n~~~  153 (176)
T 1a9n_A          150 VKLK  153 (176)
T ss_dssp             CCHH
T ss_pred             CCHH
Confidence            7765

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.71  E-value=2.9e-17  Score=152.48  Aligned_cols=115  Identities=25%  Similarity=0.443  Sum_probs=101.1

Q ss_pred             cCCccCcccccCCCceEEEeeC----CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          291 KFSENNLISKGGFGSVYKARLG----DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      .|...+.||+|+||.||+|...    .+..||||.++... ....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus        50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  129 (325)
T 3kul_A           50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT  129 (325)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEE
T ss_pred             HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEe
Confidence            4566688999999999999863    34569999997653 344567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.++++.....+++.++..++.|+++||+|||+
T Consensus       130 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~  169 (325)
T 3kul_A          130 EYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD  169 (325)
T ss_dssp             ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999998766679999999999999999999994

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.71  E-value=3.8e-19  Score=173.16  Aligned_cols=151  Identities=19%  Similarity=0.171  Sum_probs=64.7

Q ss_pred             cccEEEcccCccccc----CCccccCccCCCeeecCCcccccc----cCcchhcCCCCCCeeeCCCCCCCC-----Cchh
Q 036754           38 SLEFFVMSYCNISGG----ILEEITNLTKLTTIILGGNKLNGS----ISITLGSNLASLRKLSLDSNELTS-----IPLT  104 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~~l~~L~~L~Ls~N~l~~-----lp~~  104 (405)
                      +|+.|+|++|.++..    ++..+..+++|+.|+|++|.+++.    +...++..+++|++|+|++|+++.     ++..
T Consensus       200 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~  279 (461)
T 1z7x_W          200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV  279 (461)
T ss_dssp             CCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred             CceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHH
Confidence            444444444444431    233344444555555555544321    112222234455555555555543     3444


Q ss_pred             hhccccCccccCCCCCh------hc-----cCCCCCCEEeccCCccccc----CCcccccCCCCCeeecccccccCccch
Q 036754          105 FWNLKDILYLNFSVIPI------EI-----GGLPNLEYLFLGYNRLQGS----IPDSFGDLISLKSLNLSKNNLSGAIPA  169 (405)
Q Consensus       105 ~~~l~~L~~l~l~~~p~------~~-----~~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~n~l~~~~~~  169 (405)
                      +.++++|+.|+++...-      .+     ...++|++|++++|.+.+.    ++..+..+++|++|++++|.+++..+.
T Consensus       280 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~  359 (461)
T 1z7x_W          280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR  359 (461)
T ss_dssp             HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred             HhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHH
Confidence            44444555555443110      01     1123455555555554432    233334445555555555555433333


Q ss_pred             hHHh-----cccCCccccccCccc
Q 036754          170 SLEK-----LLYLKDLNLSFNKLE  188 (405)
Q Consensus       170 ~~~~-----l~~L~~l~l~~n~l~  188 (405)
                      .+..     .++|+.|++++|.++
T Consensus       360 ~l~~~l~~~~~~L~~L~L~~n~i~  383 (461)
T 1z7x_W          360 ELCQGLGQPGSVLRVLWLADCDVS  383 (461)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCC
T ss_pred             HHHHHHcCCCCceEEEECCCCCCC
Confidence            3322     334555555555544

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.71  E-value=2.9e-17  Score=157.06  Aligned_cols=126  Identities=18%  Similarity=0.219  Sum_probs=109.4

Q ss_pred             hHHHHHHhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeee
Q 036754          280 FSYLELCRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSC  355 (405)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~  355 (405)
                      ..+.+.....++|...+.||+|+||.||+++. .+|+.||+|++++..   ......+.+|..++.+++|+||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            44556666678899999999999999999996 578999999997532   23345678899999999999999999999


Q ss_pred             ecCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       356 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+.+..|+||||+++|+|.+++...+..+++..+..++.||+.||+|||+
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~  180 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR  180 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999998655579999999999999999999994

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.71  E-value=6.7e-17  Score=148.64  Aligned_cols=127  Identities=33%  Similarity=0.490  Sum_probs=110.8

Q ss_pred             hhhHHHHHHhhhccCCcc------CcccccCCCceEEEeeCCCcEEEEEEeeccc----cchhHHHHHHHHHhhcCCCCC
Q 036754          278 RMFSYLELCRATYKFSEN------NLISKGGFGSVYKARLGDGMEVAVKVFNLQC----RRAFKSFDIECEMMKSIRHQN  347 (405)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~------~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~n  347 (405)
                      ..+++.++..++.+|...      +.||+|+||.||+|.. +++.||||.+....    ....+.+.+|+.++.+++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            457778888899888877      8899999999999987 68899999986432    234567889999999999999


Q ss_pred             cceEEeeeecCCeeEEEEecCCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       348 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++++++...+..++||||+++|+|.+++...  ...++|..+..++.|+++||+|||.
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~  151 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE  151 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            999999999999999999999999999998643  2469999999999999999999994

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.71  E-value=2.7e-17  Score=152.77  Aligned_cols=117  Identities=25%  Similarity=0.348  Sum_probs=103.5

Q ss_pred             hhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      ...+|...+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            345677888999999999999995 688999999997543  23456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++...+ .+++.++..++.|+++||+|||+
T Consensus        93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~  132 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQ  132 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999997654 69999999999999999999994

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.71  E-value=2.4e-17  Score=155.88  Aligned_cols=114  Identities=21%  Similarity=0.371  Sum_probs=96.7

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +...+.||+|+||.||+|.. .+|+.||+|+++.......+.+.+|+.++.+++||||+++++++...+..++||||+++
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            33456799999999999985 57899999999876555667889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++......+++.++..++.||++||+|||+
T Consensus       171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~  205 (373)
T 2x4f_A          171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ  205 (373)
T ss_dssp             CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999997665579999999999999999999994

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.71  E-value=1.3e-17  Score=158.10  Aligned_cols=117  Identities=26%  Similarity=0.412  Sum_probs=102.8

Q ss_pred             hccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          289 TYKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      .++|...+.||+|+||.||+|... +++.||||.++... ......|.+|++++.+++|||||++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            346667789999999999999975 78999999987543 2334578899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.++++..+..+++.++..++.|||+||+|||+
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~  231 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES  231 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999998655568999999999999999999994

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.71  E-value=8.8e-19  Score=170.57  Aligned_cols=174  Identities=18%  Similarity=0.193  Sum_probs=73.3

Q ss_pred             cCCeeeCcCCcCcc----cCCchhhhcccccccEEEcccCcccccCCcccc-----CccCCCeeecCCccccccc----C
Q 036754           12 CLTFIDLSNNPLDS----VLPKTFVGNVSHSLEFFVMSYCNISGGILEEIT-----NLTKLTTIILGGNKLNGSI----S   78 (405)
Q Consensus        12 ~L~~L~Ls~N~l~~----~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~----~   78 (405)
                      +|++|+|++|.++.    .++.. +..++ +|+.|+|++|.++...+..+.     ..++|++|+|++|.+++..    +
T Consensus        86 ~L~~L~L~~n~i~~~~~~~l~~~-l~~~~-~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~  163 (461)
T 1z7x_W           86 KIQKLSLQNCCLTGAGCGVLSST-LRTLP-TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA  163 (461)
T ss_dssp             CCCEEECTTSCCBGGGHHHHHHH-TTSCT-TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             ceeEEEccCCCCCHHHHHHHHHH-HccCC-ceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence            45555555555543    22333 33333 555555555555432222221     1234555555555554211    1


Q ss_pred             cchhcCCCCCCeeeCCCCCCCCC-chhhh-----ccccCccccCCC----------CChhccCCCCCCEEeccCCccccc
Q 036754           79 ITLGSNLASLRKLSLDSNELTSI-PLTFW-----NLKDILYLNFSV----------IPIEIGGLPNLEYLFLGYNRLQGS  142 (405)
Q Consensus        79 ~~~~~~l~~L~~L~Ls~N~l~~l-p~~~~-----~l~~L~~l~l~~----------~p~~~~~l~~L~~L~l~~n~l~~~  142 (405)
                      ..+ ..+++|++|+|++|.++.. +..+.     ..++|+.|+++.          ++..+..+++|++|++++|.+.+.
T Consensus       164 ~~l-~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~  242 (461)
T 1z7x_W          164 SVL-RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV  242 (461)
T ss_dssp             HHH-HHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             HHH-hhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence            111 2344555555555554421 11111     122444444433          122333445555555555544322


Q ss_pred             C-----CcccccCCCCCeeecccccccCc----cchhHHhcccCCccccccCccc
Q 036754          143 I-----PDSFGDLISLKSLNLSKNNLSGA----IPASLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       143 ~-----p~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~l~l~~n~l~  188 (405)
                      .     +..+..+++|++|++++|.+++.    ++..+..+++|+.|++++|.++
T Consensus       243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~  297 (461)
T 1z7x_W          243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG  297 (461)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred             HHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCc
Confidence            1     11112344555555555554432    3344444455555555555443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.71  E-value=3.7e-17  Score=147.39  Aligned_cols=115  Identities=24%  Similarity=0.490  Sum_probs=100.8

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecC--CeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE--EFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  365 (405)
                      .+|...+.||+|+||.||+|+. +++.||||++....  ....+.+.+|+.++.+++||||+++++++...  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            4566778999999999999998 48899999997543  33456789999999999999999999999876  7789999


Q ss_pred             ecCCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++..... .+++.++..++.|+++||+|||+
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  129 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT  129 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            99999999999987543 58999999999999999999995

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.70  E-value=4.8e-18  Score=173.94  Aligned_cols=163  Identities=24%  Similarity=0.273  Sum_probs=109.7

Q ss_pred             cCCeeeCcCCcCcccC---------CchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchh
Q 036754           12 CLTFIDLSNNPLDSVL---------PKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG   82 (405)
Q Consensus        12 ~L~~L~Ls~N~l~~~~---------~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   82 (405)
                      .|+.++|+.|.|.+..         |.. +..+. +|+.|+|++|.+.. +|..+..+++|++|+|++|.|+ .+|..+ 
T Consensus       192 ~l~~l~Ls~~~i~~~~~~~n~~~~~~~~-~~~l~-~L~~L~Ls~n~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~-  266 (727)
T 4b8c_D          192 LLQHKKLSQYSIDEDDDIENRMVMPKDS-KYDDQ-LWHALDLSNLQIFN-ISANIFKYDFLTRLYLNGNSLT-ELPAEI-  266 (727)
T ss_dssp             -------------------------------CCC-CCCEEECTTSCCSC-CCGGGGGCCSCSCCBCTTSCCS-CCCGGG-
T ss_pred             HhhcCccCcccccCccccccceecChhh-hccCC-CCcEEECCCCCCCC-CChhhcCCCCCCEEEeeCCcCc-ccChhh-
Confidence            3455556665554432         444 45555 78888888888874 6666668888888888888888 788776 


Q ss_pred             cCCCCCCeeeCCCCCCCCCchhhhccccCccccCCC-----CChhccCCCCCCEEeccCCcccccCCcccccCCC-CCee
Q 036754           83 SNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV-----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLIS-LKSL  156 (405)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~-----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~-L~~L  156 (405)
                      .+|++|++|+|++|+|+.+|..+.++++|++|+++.     +|..|+++++|++|+|++|.+++.+|..+..+.. +..+
T Consensus       267 ~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l  346 (727)
T 4b8c_D          267 KNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIF  346 (727)
T ss_dssp             GGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHH
T ss_pred             hCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHH
Confidence            478888888888888888888888888888888764     7878899999999999999999999988866532 3357


Q ss_pred             ecccccccCccchhHHhcccCCccccccC
Q 036754          157 NLSKNNLSGAIPASLEKLLYLKDLNLSFN  185 (405)
Q Consensus       157 ~l~~n~l~~~~~~~~~~l~~L~~l~l~~n  185 (405)
                      ++++|.+++.+|..+      +.|+++.|
T Consensus       347 ~l~~N~l~~~~p~~l------~~l~l~~n  369 (727)
T 4b8c_D          347 YLRDNRPEIPLPHER------RFIEINTD  369 (727)
T ss_dssp             HHHHCCCCCCCCCC---------------
T ss_pred             hhccCcccCcCcccc------ceeEeecc
Confidence            899999998888654      44556555

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.70  E-value=5.8e-17  Score=132.62  Aligned_cols=131  Identities=19%  Similarity=0.224  Sum_probs=109.8

Q ss_pred             CCCcCCeeeCcCCcCc-ccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCC
Q 036754            9 NCKCLTFIDLSNNPLD-SVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLAS   87 (405)
Q Consensus         9 ~l~~L~~L~Ls~N~l~-~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~   87 (405)
                      ..++|+.|++++|.++ +.+|.. ++.++ +|+.|++++|.+++.  ..+..+++|++|+|++|.+++.+|..+ ..+++
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~~~-~~~l~-~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~-~~l~~   89 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLEGL-TDEFE-ELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLA-EKCPN   89 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCCSC-CTTCT-TCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHH-HHCTT
T ss_pred             CCccCeEEEccCCcCChhHHHHH-HhhcC-CCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHh-hhCCC
Confidence            4578999999999998 667766 56776 999999999999886  778999999999999999986566544 47999


Q ss_pred             CCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCC---cccccCCCCCeeeccc
Q 036754           88 LRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIP---DSFGDLISLKSLNLSK  160 (405)
Q Consensus        88 L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~l~~L~~L~l~~  160 (405)
                      |++|++++|+++.+|..                ..+..+++|++|++++|++.+..+   ..+..+++|+.|++++
T Consensus        90 L~~L~ls~N~i~~~~~~----------------~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           90 LTHLNLSGNKIKDLSTI----------------EPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CCEEECTTSCCCSHHHH----------------GGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CCEEECCCCcCCChHHH----------------HHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            99999999999976521                135567889999999999997666   5789999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.70  E-value=4.4e-17  Score=148.45  Aligned_cols=116  Identities=26%  Similarity=0.412  Sum_probs=102.7

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CC-------cEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCee
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DG-------MEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  361 (405)
                      ++|...+.||+|+||+||+|... ++       ..||+|.+........+.+.+|+.++.+++||||+++++++...+..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            45667788999999999999853 23       57999999776666677899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+++|+|.+++...+..+++..+..++.|+++||+|||+
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~  131 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE  131 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            99999999999999998766569999999999999999999994

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.70  E-value=8.1e-17  Score=137.75  Aligned_cols=128  Identities=26%  Similarity=0.359  Sum_probs=82.0

Q ss_pred             cEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCCC
Q 036754           40 EFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVI  119 (405)
Q Consensus        40 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~  119 (405)
                      +.+++++|+++. +|..+.  ++|+.|+|++|+++ .+|..+ .++++|++|+|++|+|+.++..               
T Consensus        13 ~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~-~ip~~~-~~l~~L~~L~Ls~N~i~~i~~~---------------   72 (193)
T 2wfh_A           13 TVVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFT-LVPKEL-SNYKHLTLIDLSNNRISTLSNQ---------------   72 (193)
T ss_dssp             TEEECTTSCCSS-CCSCCC--TTCCEEECCSSCCC-SCCGGG-GGCTTCCEEECCSSCCCCCCTT---------------
T ss_pred             CEEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCc-hhHHHh-hcccCCCEEECCCCcCCEeCHh---------------
Confidence            566677776664 343332  46777777777776 666433 4677777777777777665432               


Q ss_pred             ChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccC
Q 036754          120 PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEG  189 (405)
Q Consensus       120 p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~  189 (405)
                        .|.++++|++|++++|.+++..|..|..+++|+.|++++|.++...+..|..+++|+.|++++|.+.+
T Consensus        73 --~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           73 --SFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             --TTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             --HccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence              34456667777777777776666667777777777777777776555566666666666666665543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.70  E-value=6.2e-17  Score=153.66  Aligned_cols=116  Identities=18%  Similarity=0.249  Sum_probs=103.5

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +.|...+.||+|+||.||+|.. .+|+.||+|.+..........+.+|+.++.+++||||+++++++......++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            4567778899999999999985 468899999997655445567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++......+++.++..++.||++||+|||+
T Consensus       131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~  167 (387)
T 1kob_A          131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE  167 (387)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999997665579999999999999999999994

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.70  E-value=7.1e-17  Score=151.85  Aligned_cols=115  Identities=22%  Similarity=0.325  Sum_probs=101.3

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccc------hhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRR------AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  362 (405)
                      +.|...+.||+|+||.||+|.. .+|+.||+|.+......      ....+.+|+.++.+++||||+++++++.+.+..+
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            4566778999999999999985 46899999999754321      3467889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++... ..+++.++..++.||++||+|||+
T Consensus        92 lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~  133 (361)
T 2yab_A           92 LILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHT  133 (361)
T ss_dssp             EEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999764 379999999999999999999994

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.70  E-value=7.2e-17  Score=152.53  Aligned_cols=116  Identities=26%  Similarity=0.458  Sum_probs=100.2

Q ss_pred             ccCCccCcccccCCCceEEEee--------CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARL--------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEE  359 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  359 (405)
                      ++|...+.||+|+||.||+|+.        .++..||||+++... ......+.+|+.++.++ +||||+++++++...+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            4567778999999999999974        235679999997653 33456789999999999 8999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..|+||||+++|+|.+++...+               ..+++.++..++.||++||+|||+
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  221 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS  221 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999999997643               248999999999999999999994

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.70  E-value=8.6e-17  Score=149.00  Aligned_cols=115  Identities=17%  Similarity=0.241  Sum_probs=101.5

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ++|...+.||+|+||.||+|.. .+++.||+|.+... ......+.+|+.++..++||||+++++++.+.+..++||||+
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            4566778899999999999985 46889999998643 234456789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++......+++.++..++.|+++||+|||+
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~  120 (321)
T 1tki_A           84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS  120 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999997765579999999999999999999994

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.70  E-value=3.8e-17  Score=149.47  Aligned_cols=116  Identities=30%  Similarity=0.495  Sum_probs=101.7

Q ss_pred             ccCCccCcccccCCCceEEEee-----CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeec--CCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN--EEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  362 (405)
                      ++|...+.||+|+||+||+|.+     .+++.||||++........+.+.+|+.++.+++||||+++++++..  ....+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            4566778999999999999984     3678999999986666666789999999999999999999998855  35689


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++...+..+++.++..++.|+++||+|||+
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~  132 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT  132 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc
Confidence            9999999999999998766569999999999999999999994

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.69  E-value=1e-16  Score=135.16  Aligned_cols=134  Identities=28%  Similarity=0.309  Sum_probs=114.1

Q ss_pred             cccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCC
Q 036754           38 SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS  117 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~  117 (405)
                      +.+.+++++|+++.. |..+  .++|+.|++++|+++ .+|...+..+++|++|+|++|+++.+|..             
T Consensus         8 ~~~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-------------   70 (177)
T 2o6r_A            8 SGTEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDG-------------   70 (177)
T ss_dssp             ETTEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTT-------------
T ss_pred             CCCEEEecCCCCccC-CCCC--CCCCcEEEeCCCccc-EeCHHHhcCcccccEEECCCCcceEeChh-------------
Confidence            467899999998874 4433  368999999999998 67777667899999999999999987754             


Q ss_pred             CCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCC
Q 036754          118 VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIP  192 (405)
Q Consensus       118 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p  192 (405)
                          .+.++++|++|++++|.+++..+..|..+++|++|++++|.+++..+..+..+++|+.|++++|.+.+..|
T Consensus        71 ----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           71 ----VFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             ----TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ----HccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence                34567899999999999998877788999999999999999998777778889999999999999987665

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.69  E-value=7.5e-17  Score=146.52  Aligned_cols=116  Identities=24%  Similarity=0.379  Sum_probs=100.3

Q ss_pred             hccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      .++|...+.||+|+||.||+|...++..||+|++..... ....+.+|++++.+++|+||+++++++...+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            446677789999999999999988888999999975432 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++......+++.++..++.|+++||+|||+
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~  138 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES  138 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999998755579999999999999999999994

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.69  E-value=6.9e-17  Score=150.55  Aligned_cols=115  Identities=24%  Similarity=0.304  Sum_probs=101.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.||+|+||+||+|.. .+|+.||+|++++..   ......+.+|+.++.+++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            5677788999999999999985 468999999997642   334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+ .+++.++..++.||+.||+|||+
T Consensus        85 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~  123 (337)
T 1o6l_A           85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHS  123 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997643 68999999999999999999994

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.69  E-value=5.8e-17  Score=146.01  Aligned_cols=116  Identities=27%  Similarity=0.346  Sum_probs=103.2

Q ss_pred             hccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      .++|...+.||+|+||.||+|...++..||+|++.... .....+.+|+.++.+++||||+++++++......++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            35667778999999999999998888899999997543 23466889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++......+++.++..++.|+++||+|||+
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~  122 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES  122 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999998765569999999999999999999994

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.69  E-value=5e-17  Score=155.29  Aligned_cols=123  Identities=20%  Similarity=0.230  Sum_probs=106.4

Q ss_pred             HHHHHHhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeee
Q 036754          281 SYLELCRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCS  356 (405)
Q Consensus       281 ~~~~~~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  356 (405)
                      .+.++....++|...+.||+|+||+||+|+. .+++.||+|++.+..   ......+.+|+.++..++|||||++++++.
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3445566677899999999999999999995 468899999997532   233456788999999999999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          357 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       357 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +.+..|+||||+++|+|.+++...  .+++..+..++.||+.||+|||+
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~  186 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHS  186 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999764  48999999999999999999994

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.69  E-value=5.9e-17  Score=149.31  Aligned_cols=117  Identities=32%  Similarity=0.464  Sum_probs=102.2

Q ss_pred             hhccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          288 ATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ...+|...+.||+|+||+||+|+. .|+.||||++....  ......+.+|+.++.+++||||+++++++...+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            345677778999999999999987 68899999986543  234567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++....  ..+++..+..++.|+++||+|||+
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  155 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN  155 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc
Confidence            9999999999997654  238999999999999999999995

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.69  E-value=1e-16  Score=148.28  Aligned_cols=115  Identities=23%  Similarity=0.282  Sum_probs=101.8

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      .+|...+.||+|+||.||+++. .+|+.||+|+++...   ......+.+|+.++..++||||+++++++.+.+..|+||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            5677788999999999999985 478999999997643   234566788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||+
T Consensus        86 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~  124 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHS  124 (318)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999998654 68999999999999999999995

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.69  E-value=1e-16  Score=149.73  Aligned_cols=122  Identities=27%  Similarity=0.386  Sum_probs=104.9

Q ss_pred             HHHhhhccCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeee
Q 036754          284 ELCRATYKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCS  356 (405)
Q Consensus       284 ~~~~~~~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  356 (405)
                      .+....++|...+.||+|+||.||+|...      +++.||+|.++... ......+.+|+.++.+++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            33445567888899999999999999863      34789999997653 334567899999999999999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          357 NEEFKALVLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       357 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..+..++||||+++|+|.+++....                       ..+++.++..++.||++||+|||+
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~  192 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE  192 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999999999997632                       468999999999999999999994

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.68  E-value=1.4e-16  Score=143.39  Aligned_cols=115  Identities=25%  Similarity=0.366  Sum_probs=103.0

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      .+|...+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++.+++||||+++++++...+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            45667788999999999999988888999999976432 34678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++......+++..+..++.|+++||+|||+
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  122 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE  122 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999998766679999999999999999999994

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.68  E-value=1.1e-16  Score=157.05  Aligned_cols=116  Identities=27%  Similarity=0.435  Sum_probs=102.1

Q ss_pred             hccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          289 TYKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ..+|...+.||+|+||.||+|... .+..||||.++... ...+.|.+|+.++.+++|||||+++++|...+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            345667789999999999999965 47899999997543 3457799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.++++... ..+++..+..++.||++||+|||+
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~  336 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK  336 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999998643 468999999999999999999994

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.68  E-value=1.3e-16  Score=148.12  Aligned_cols=114  Identities=22%  Similarity=0.326  Sum_probs=100.4

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc------chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR------RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      .|...+.||+|+||.||+|.. .+|..||+|.+.....      .....+.+|+.++.+++||||+++++++......++
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   91 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   91 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            466678899999999999995 4689999999975432      135678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++... ..+++.++..++.||++||+|||+
T Consensus        92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~  132 (326)
T 2y0a_A           92 ILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHS  132 (326)
T ss_dssp             EEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999754 479999999999999999999994

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.68  E-value=1.7e-16  Score=147.42  Aligned_cols=116  Identities=20%  Similarity=0.327  Sum_probs=97.1

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC--------
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE--------  359 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------  359 (405)
                      .+|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.++.+++|||||++++++....        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            45667789999999999999964 78999999997543 334577899999999999999999999885543        


Q ss_pred             -------------------------------------------------eeEEEEecCCCCCHHHHHhcCC--CCCCHHH
Q 036754          360 -------------------------------------------------FKALVLEYMPHGSLEKYLYSSN--CILDIFQ  388 (405)
Q Consensus       360 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~  388 (405)
                                                                       ..++||||+++|+|.+++....  ...++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             3789999999999999998654  3467778


Q ss_pred             HHHHHHHHHHHHhhhcC
Q 036754          389 RLNIMIDVASALEYLHF  405 (405)
Q Consensus       389 ~~~i~~~ia~gl~yLH~  405 (405)
                      +..++.||++||+|||+
T Consensus       166 ~~~i~~qi~~aL~~LH~  182 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHS  182 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHh
Confidence            89999999999999994

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.68  E-value=1.2e-16  Score=148.10  Aligned_cols=113  Identities=25%  Similarity=0.362  Sum_probs=96.6

Q ss_pred             hccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCC----eeEEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE----FKALV  364 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv  364 (405)
                      ..+|...+.||+|+||+||+|+.. ++.||||++.... .....+.+|+..+.+++|||||++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            346777889999999999999874 7899999996543 23344567999999999999999999988744    36999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++...  .++|..+..++.|+++||+|||+
T Consensus       101 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~  139 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHE  139 (322)
T ss_dssp             EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTC
T ss_pred             EecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999764  49999999999999999999995

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.68  E-value=1.4e-16  Score=150.12  Aligned_cols=115  Identities=20%  Similarity=0.392  Sum_probs=101.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ++|...+.||+|+||.||+|.. .+|..||+|++....  ....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            4567778999999999999985 468999999997543  2345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++.... .+++.++..++.||++||+|||+
T Consensus       109 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~  146 (362)
T 2bdw_A          109 LVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHS  146 (362)
T ss_dssp             CCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999997654 68999999999999999999994

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.68  E-value=1.8e-16  Score=146.23  Aligned_cols=115  Identities=24%  Similarity=0.321  Sum_probs=100.2

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||+||+|...+|+.||+|++....  ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  100 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF  100 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence            4577778999999999999998889999999996543  23346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++ +|.+++......+++.++..++.|+++||+|||+
T Consensus       101 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~  137 (311)
T 3niz_A          101 MEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ  137 (311)
T ss_dssp             CSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            985 8999887766679999999999999999999994

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.68  E-value=1.7e-16  Score=143.72  Aligned_cols=115  Identities=27%  Similarity=0.344  Sum_probs=102.8

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +.|...+.||+|+||.||+|.. .++..||+|.+..........+.+|++++.+++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            4566778899999999999985 457789999998766666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++...+ .+++.++..++.|+++||+|||+
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~  124 (277)
T 3f3z_A           89 TGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHK  124 (277)
T ss_dssp             CSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999887644 68999999999999999999994

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.67  E-value=1.2e-16  Score=150.86  Aligned_cols=116  Identities=24%  Similarity=0.433  Sum_probs=100.1

Q ss_pred             ccCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  362 (405)
                      .+|...+.||+|+||.||+|+..      ++..||||+++... ......+.+|+.++.+++|||||++++++......+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            45667788999999999999843      46789999996543 344567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++...+      ..+++.++..++.||++||+|||+
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  199 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE  199 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999997532      358999999999999999999994

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.67  E-value=3.1e-16  Score=144.80  Aligned_cols=110  Identities=25%  Similarity=0.288  Sum_probs=98.4

Q ss_pred             cCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEecCCCCC
Q 036754          295 NNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPHGS  372 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~  372 (405)
                      .+.||+|+||.||+|.. .+++.||||++..........+.+|+.++.++ +||||+++++++...+..++||||+++|+
T Consensus        18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   97 (316)
T 2ac3_A           18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS   97 (316)
T ss_dssp             CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence            36799999999999984 57899999999766555667889999999885 79999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          373 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       373 L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |.+++...+ .+++.++..++.|+++||+|||+
T Consensus        98 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~  129 (316)
T 2ac3_A           98 ILSHIHKRR-HFNELEASVVVQDVASALDFLHN  129 (316)
T ss_dssp             HHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            999997644 68999999999999999999994

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.67  E-value=2e-16  Score=149.80  Aligned_cols=115  Identities=23%  Similarity=0.261  Sum_probs=101.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++.+++|||||++++++.+.+..|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            4577778999999999999985 468899999997543   334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus        95 e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~  133 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQN  133 (384)
T ss_dssp             CCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997643 69999999999999999999994

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.67  E-value=9.7e-17  Score=148.80  Aligned_cols=115  Identities=19%  Similarity=0.232  Sum_probs=98.6

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++..++||||+++++++...+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            45677789999999999999854 78999999986543 23346688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++.... .+++.++..++.|+++||+|||+
T Consensus        87 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~  123 (323)
T 3tki_A           87 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHG  123 (323)
T ss_dssp             CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999987543 69999999999999999999994

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.67  E-value=1.7e-16  Score=145.05  Aligned_cols=115  Identities=22%  Similarity=0.346  Sum_probs=100.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      +.|...+.||+|+||.||+|.. .++..||+|.+....   ....+.+.+|+..+.+++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            3466778899999999999984 568899999986432   233567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+ .+++.++..++.|+++||+|||+
T Consensus        91 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~  129 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHD  129 (294)
T ss_dssp             ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997654 68999999999999999999994

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.67  E-value=1.7e-16  Score=148.36  Aligned_cols=118  Identities=19%  Similarity=0.297  Sum_probs=101.4

Q ss_pred             hhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCee
Q 036754          287 RATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       287 ~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  361 (405)
                      ...++|...+.||+|+||.||+|+. .+|+.||+|+++...   ......+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            3456788889999999999999996 468999999997642   23455677888888876 999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+||||+++|+|.+++...+ .+++.++..++.||+.||+|||+
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~  136 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHS  136 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999997643 68999999999999999999994

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.67  E-value=2.3e-16  Score=148.54  Aligned_cols=114  Identities=19%  Similarity=0.201  Sum_probs=100.5

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +.|...+.||+|+||+||++.. .+++.||+|++.... .....+.+|+..+.+++||||+++++++.+.+..++||||+
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            4567778999999999999995 478999999997543 23356789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++...+ .+++..+..++.|+++||+|||+
T Consensus        99 ~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~  134 (361)
T 3uc3_A           99 SGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHS  134 (361)
T ss_dssp             CSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999997644 69999999999999999999994

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.67  E-value=2.4e-16  Score=147.71  Aligned_cols=115  Identities=19%  Similarity=0.251  Sum_probs=101.8

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.||+|+||.||+++. .+|+.||+|++....   ......+.+|+.++.+++||||+++++++.+.+..|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            4677788999999999999995 468999999997543   234567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||.
T Consensus       121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~  159 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS  159 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997644 68999999999999999999994

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.67  E-value=1.7e-16  Score=148.79  Aligned_cols=116  Identities=23%  Similarity=0.267  Sum_probs=101.1

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  363 (405)
                      .++|...+.||+|+||+||+|+. .+|+.||+|++++..   ......+.+|..++..+ +||||+++++++.+.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            35677889999999999999985 468999999997642   33455678899999988 79999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++...+ .+++.++..++.||+.||+|||+
T Consensus       102 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~  142 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHD  142 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999997654 69999999999999999999994

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.67  E-value=2.3e-16  Score=142.93  Aligned_cols=117  Identities=23%  Similarity=0.425  Sum_probs=103.5

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      .++|...+.||+|+||.||+|+. .+|+.||+|.+....   ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35677788999999999999985 578999999997543   22346788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++......+++.++..++.|+++||+|||.
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~  130 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS  130 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999998765679999999999999999999994

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.67  E-value=2.1e-16  Score=144.87  Aligned_cols=116  Identities=21%  Similarity=0.350  Sum_probs=100.3

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +.|...+.||+|+||.||+|... ++..||+|.+..........+.+|+.++.+++||||+++++++...+..++||||+
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            45666788999999999999964 58899999997666666778899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++......+++..+..++.|+++||+|||.
T Consensus        99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  135 (302)
T 2j7t_A           99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS  135 (302)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc
Confidence            9999999987655579999999999999999999994

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.67  E-value=1.3e-16  Score=154.91  Aligned_cols=116  Identities=22%  Similarity=0.379  Sum_probs=101.0

Q ss_pred             hhccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          288 ATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ..++|...+.||+|+||.||+|...++..||||+++... ...+.|.+|+.++.+++|||||++++++. .+..++||||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            345667778999999999999999888899999997543 34678999999999999999999999986 5678999999


Q ss_pred             CCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.++++... ..+++.++..++.|||+||+|||+
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~  302 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ  302 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999997532 358899999999999999999994

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.67  E-value=2.1e-16  Score=153.33  Aligned_cols=115  Identities=32%  Similarity=0.431  Sum_probs=100.0

Q ss_pred             hhccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCC-eeEEEEe
Q 036754          288 ATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE-FKALVLE  366 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  366 (405)
                      ...+|...+.||+|+||.||+|... |+.||||+++...  ..+.|.+|+.++.+++|||||++++++...+ ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3456777789999999999999874 7899999997543  4567899999999999999999999987655 7899999


Q ss_pred             cCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.++++..+ ..+++..+..++.|||+||+|||+
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~  307 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG  307 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999998654 347999999999999999999994

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.67  E-value=2.5e-16  Score=145.65  Aligned_cols=116  Identities=25%  Similarity=0.352  Sum_probs=99.5

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC--eeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE--FKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  365 (405)
                      +.|...+.||+|+||+||+|... +|+.||||++.... ......+.+|++++.+++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            35667789999999999999964 58999999997543 334567889999999999999999999987654  779999


Q ss_pred             ecCCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++....  ..+++.++..++.|+++||+|||+
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~  130 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE  130 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997643  248999999999999999999994

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.66  E-value=1.5e-16  Score=149.21  Aligned_cols=116  Identities=18%  Similarity=0.283  Sum_probs=99.8

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-----cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-----RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      +.|...+.||+|+||+||+|.. .+|+.||||++....     ......+.+|+.++..++||||+++++++...+..|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3466678899999999999985 568999999996432     1235678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++...   +..+++..+..++.||++||+|||+
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~  148 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD  148 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999887642   2358999999999999999999994

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.66  E-value=2.5e-16  Score=147.26  Aligned_cols=115  Identities=22%  Similarity=0.242  Sum_probs=100.5

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  364 (405)
                      .+|...+.||+|+||.||+|+. .+++.||+|++....   ......+.+|..++.++ +||||+++++++.+.+..|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            4577788999999999999996 468899999997653   23345678899999887 899999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++...+ .+++..+..++.||+.||+|||+
T Consensus        89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~  128 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHE  128 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999997643 68999999999999999999994

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.66  E-value=3.7e-16  Score=142.17  Aligned_cols=114  Identities=31%  Similarity=0.493  Sum_probs=98.3

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccc-------hhHHHHHHHHHhhcCCCCCcceEEeeeecCCee
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRR-------AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  361 (405)
                      ++|...+.||+|+||.||+|.. .+++.||+|++......       ..+.+.+|+.++.+++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            4566778899999999999996 57899999998653321       1267889999999999999999999986654  


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+++|+|.+++......+++..+..++.|+++||+|||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~  140 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN  140 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh
Confidence            69999999999999998776689999999999999999999995

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.66  E-value=2.9e-16  Score=143.04  Aligned_cols=114  Identities=23%  Similarity=0.336  Sum_probs=100.6

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +|...+.||+|+||.||+|...+|+.||+|++....  ......+.+|+.++.+++||||+++++++...+..++||||+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence            456678899999999999998789999999986543  233467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++ +|.+++......+++..+..++.|+++||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  118 (288)
T 1ob3_A           83 DQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD  118 (288)
T ss_dssp             SE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            86 9999998765679999999999999999999994

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.66  E-value=3.5e-16  Score=148.88  Aligned_cols=116  Identities=22%  Similarity=0.253  Sum_probs=102.3

Q ss_pred             ccCCccCccccc--CCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNLISKG--GFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G--~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      .+|...+.||+|  +||.||+|.. .+|+.||||++....  ......+.+|+.++.+++|||||++++++...+..++|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            456777899999  9999999996 478999999997653  33456788899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++.... ..+++..+..++.||++||+|||+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~  146 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH  146 (389)
T ss_dssp             EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999997652 469999999999999999999994

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.66  E-value=2.8e-16  Score=143.04  Aligned_cols=113  Identities=14%  Similarity=0.060  Sum_probs=97.6

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeecccc---chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCR---RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      +.|...+.||+|+||.||+|... +|+.||+|++.....   ...+.+.+|+..+.+++|+||+++++++...+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            34667789999999999999964 589999999976432   23467899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...   ....++.+++.|+++||+|||+
T Consensus       111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~  147 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHR  147 (286)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHH
Confidence            999999999999542   4666789999999999999994

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.66  E-value=1.9e-16  Score=153.75  Aligned_cols=115  Identities=25%  Similarity=0.389  Sum_probs=99.9

Q ss_pred             hccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      .++|...+.||+|+||.||+|....+..||||+++... ...+.|.+|+.++.+++||||+++++++.. +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            34566678899999999999998877889999997543 235678999999999999999999999876 7789999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++... +..+++.++..++.||++||+|||.
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  298 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER  298 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999753 2468999999999999999999994

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.66  E-value=3e-16  Score=152.66  Aligned_cols=115  Identities=25%  Similarity=0.346  Sum_probs=101.5

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.||+|+||.||+|.. .+|+.||||++....   ......+.+|+.++..++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4566678899999999999995 478999999997543   233567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+ .+++.++..++.||++||+|||+
T Consensus        96 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~  134 (476)
T 2y94_A           96 EYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHR  134 (476)
T ss_dssp             ECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997543 69999999999999999999995

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.66  E-value=1.8e-16  Score=147.21  Aligned_cols=116  Identities=22%  Similarity=0.316  Sum_probs=95.9

Q ss_pred             hccCCccCcccccCCCceEEEee----CCCcEEEEEEeeccc----cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCe
Q 036754          289 TYKFSENNLISKGGFGSVYKARL----GDGMEVAVKVFNLQC----RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF  360 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  360 (405)
                      .++|...+.||+|+||.||++..    .+|+.||+|+++...    ......+.+|+.++.+++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35677788999999999999986    478999999997542    2234567889999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++||||+++|+|.+++...+ .+++..+..++.||+.||+|||.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~  139 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQ  139 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999999997644 68999999999999999999994

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.66  E-value=1.4e-16  Score=149.75  Aligned_cols=122  Identities=20%  Similarity=0.356  Sum_probs=101.6

Q ss_pred             HHHhhhccCCccCcccccCCCceEEEee------CCCcEEEEEEeecccc-chhHHHHHHHHHhhcC-CCCCcceEEeee
Q 036754          284 ELCRATYKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSI-RHQNLIKVISSC  355 (405)
Q Consensus       284 ~~~~~~~~~~~~~~lg~G~fg~v~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~  355 (405)
                      +.....++|...+.||+|+||.||+|..      .+++.||||+++.... ...+.+.+|++++.++ +|||||++++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            3344566788889999999999999973      3468899999976433 3456789999999999 789999999998


Q ss_pred             ecCC-eeEEEEecCCCCCHHHHHhcCCC----------------------------------------------------
Q 036754          356 SNEE-FKALVLEYMPHGSLEKYLYSSNC----------------------------------------------------  382 (405)
Q Consensus       356 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------  382 (405)
                      ...+ ..++||||+++|+|.+++.....                                                    
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            8754 48999999999999999976431                                                    


Q ss_pred             -------------CCCHHHHHHHHHHHHHHHhhhcC
Q 036754          383 -------------ILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       383 -------------~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                                   .+++..+..++.|+++||+|||+
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~  211 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS  211 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH
Confidence                         18899999999999999999994

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.66  E-value=2.4e-16  Score=147.76  Aligned_cols=113  Identities=20%  Similarity=0.247  Sum_probs=93.8

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +.|...+.||+|+||.||+|... +++.||||+++...  ..+.+.+|+.++.+++||||+++++++...+..++||||+
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  130 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV  130 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence            45667788999999999999964 57899999997543  3356778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++...+ .+++.++..++.|+++||+|||+
T Consensus       131 ~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~  166 (349)
T 2w4o_A          131 TGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHE  166 (349)
T ss_dssp             CSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999997654 68999999999999999999994

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.66  E-value=3.4e-16  Score=142.39  Aligned_cols=116  Identities=24%  Similarity=0.326  Sum_probs=101.3

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +.|...+.||+|+||.||++.. .++..||+|.+.... ......+.+|++++.+++||||+++++++......++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            3466678999999999999985 568899999997654 33457789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++...   ...+++..+..++.|+++||+|||.
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~  142 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS  142 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999988642   2579999999999999999999994

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.66  E-value=3.7e-16  Score=145.00  Aligned_cols=116  Identities=30%  Similarity=0.490  Sum_probs=101.0

Q ss_pred             ccCCccCcccccCCCceEEEee-----CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCC--eeE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE--FKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~  362 (405)
                      .+|...+.||+|+||.||++..     .+|+.||+|++........+.+.+|+.++.+++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            4566678899999999999984     368899999998766666778999999999999999999999886643  689


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++...+..+++.++..++.|+++||+|||.
T Consensus       121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  163 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT  163 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999998766679999999999999999999994

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.66  E-value=6.5e-16  Score=141.08  Aligned_cols=114  Identities=24%  Similarity=0.332  Sum_probs=98.1

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +....+||+|+||.||+|.. .++..||+|.+........+.+.+|+.++.+++||||+++++++...+..++||||+++
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  103 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG  103 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence            34445899999999999995 56889999999776555667889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++....  ..+++..+..++.|+++||+|||.
T Consensus       104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  140 (295)
T 2clq_A          104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD  140 (295)
T ss_dssp             EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh
Confidence            99999998653  346788899999999999999994

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.66  E-value=2.7e-16  Score=145.98  Aligned_cols=116  Identities=26%  Similarity=0.375  Sum_probs=101.3

Q ss_pred             ccCCccCcccccCCCceEEEee-----CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeee--cCCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCS--NEEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~  362 (405)
                      ++|...+.||+|+||.||+|..     .++..||||++........+.+.+|++++.+++|+||+++++++.  .....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            4566778999999999999984     467899999998765566677899999999999999999999876  456789


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++...+..+++.++..++.|+++||+|||+
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~  145 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS  145 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999997655569999999999999999999994

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.66  E-value=3e-16  Score=151.51  Aligned_cols=115  Identities=17%  Similarity=0.258  Sum_probs=100.0

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ++|...+.||+|+||.||+|.. .+|+.||+|.+....  ....+.+.+|+.++.+++|||||++++++.+.+..++|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            4567778999999999999984 578999999997543  2345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+ .+++.++..++.||++||+|||+
T Consensus        91 ~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~  128 (444)
T 3soa_A           91 LVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQ  128 (444)
T ss_dssp             CCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999998754 69999999999999999999994

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.66  E-value=1e-18  Score=150.33  Aligned_cols=155  Identities=21%  Similarity=0.296  Sum_probs=117.3

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCc------hhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcc
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPK------TFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISIT   80 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~------~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~   80 (405)
                      +...+.++.++++.|.+.+..|.      . ++.++ +|+.|+|++|.+++ +| .+..+++|++|+|++|.++ .+|..
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~-~~~l~-~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~   88 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDAT-LSTLK-ACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENL   88 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHH-HHHTT-TCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHH-HhcCC-CCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccch
Confidence            45667888889999998888776      5 56665 89999999998887 55 8888889999999999887 77765


Q ss_pred             hhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCC-cccccCCCCCeeecc
Q 036754           81 LGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIP-DSFGDLISLKSLNLS  159 (405)
Q Consensus        81 ~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~  159 (405)
                      + ..+++|++|+|++|+++.+| .+.                  .+++|++|++++|.+.+..+ ..+..+++|+.|+++
T Consensus        89 ~-~~~~~L~~L~L~~N~l~~l~-~~~------------------~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~  148 (198)
T 1ds9_A           89 D-AVADTLEELWISYNQIASLS-GIE------------------KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLA  148 (198)
T ss_dssp             H-HHHHHCSEEEEEEEECCCHH-HHH------------------HHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEEC
T ss_pred             h-hcCCcCCEEECcCCcCCcCC-ccc------------------cCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEec
Confidence            4 46788999999999888776 333                  34567888888888874332 467788888888888


Q ss_pred             cccccCccch----------hHHhcccCCccccccCccc
Q 036754          160 KNNLSGAIPA----------SLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       160 ~n~l~~~~~~----------~~~~l~~L~~l~l~~n~l~  188 (405)
                      +|++.+..|.          .+..+++|+.|+  .|.++
T Consensus       149 ~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          149 GNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             SCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             CCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            8888766554          367778888776  45443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.66  E-value=4.1e-16  Score=142.97  Aligned_cols=115  Identities=24%  Similarity=0.482  Sum_probs=97.4

Q ss_pred             cCCccCcccccCCCceEEEee-----CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecC--CeeE
Q 036754          291 KFSENNLISKGGFGSVYKARL-----GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE--EFKA  362 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  362 (405)
                      .|...+.||+|+||.||+|.+     .+++.||+|++.... ......+.+|+.++.+++||||+++++++...  ...+
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  101 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK  101 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence            355668899999999999983     468899999997543 33457788999999999999999999999876  6689


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++......+++.++..++.|+++||+|||+
T Consensus       102 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~  144 (302)
T 4e5w_A          102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS  144 (302)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc
Confidence            9999999999999997655679999999999999999999994

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.65  E-value=2.6e-16  Score=149.50  Aligned_cols=116  Identities=21%  Similarity=0.235  Sum_probs=99.7

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  363 (405)
                      ..+|...++||+|+||+||+|+. .+++.||+|++++..   ......+.+|..++.++ +|||||++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            35677889999999999999995 467899999997643   23345677899998877 89999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|..++...+ .+++..+..++.||+.||+|||.
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~  171 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHE  171 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999997644 69999999999999999999994

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.65  E-value=3.8e-16  Score=141.92  Aligned_cols=116  Identities=22%  Similarity=0.299  Sum_probs=101.4

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc--cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      .+|...+.||+|+||.||+|... +++.||+|.+....  ......+.+|+..+.++ +||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            45677789999999999999964 78999999997542  33456788899999999 9999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++....   ..+++.++..++.||++||+|||.
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~  133 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS  133 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999997531   468999999999999999999994

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.65  E-value=7.8e-16  Score=142.82  Aligned_cols=107  Identities=20%  Similarity=0.229  Sum_probs=95.6

Q ss_pred             cCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCC-CCCcceEEeeeecCCeeEEEEecCCCCC
Q 036754          295 NNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEFKALVLEYMPHGS  372 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  372 (405)
                      .+.||+|+||.||+|.. .+|+.||||++...   ....+.+|+..+.++. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            47899999999999996 46899999998643   3456678999999997 9999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          373 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       373 L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |.+++...+ .+++.++..++.|+++||+|||+
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~  124 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMHD  124 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999998754 79999999999999999999994

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.65  E-value=3.6e-16  Score=143.58  Aligned_cols=115  Identities=20%  Similarity=0.271  Sum_probs=98.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ++|...+.||+|+||.||++.. .+|+.||+|.++.........+.+|+.++.+++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            4566778999999999999995 478999999998655445567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++...+ .+++.++..++.|+++||+|||.
T Consensus        89 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~  124 (304)
T 2jam_A           89 SGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHE  124 (304)
T ss_dssp             CSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999987544 68999999999999999999994

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.65  E-value=4.4e-16  Score=143.55  Aligned_cols=117  Identities=24%  Similarity=0.390  Sum_probs=100.7

Q ss_pred             hccCCccCcccccCCCceEEEee------CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCee
Q 036754          289 TYKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  361 (405)
                      ..+|...+.||+|+||.||+|..      .++..||+|.+.... ....+.+.+|+.++.+++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            35566778899999999999984      245789999997543 33456788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+++|+|.+++....                       ..+++.++..++.|+++||+|||+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  168 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE  168 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999997643                       238899999999999999999994

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.65  E-value=4e-16  Score=148.08  Aligned_cols=116  Identities=27%  Similarity=0.441  Sum_probs=100.0

Q ss_pred             ccCCccCcccccCCCceEEEee--------CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARL--------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEE  359 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  359 (405)
                      ++|...+.||+|+||.||+|+.        ..+..||||+++... ......+.+|++++.++ +|||||++++++...+
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            4566678899999999999984        223679999997653 33457789999999999 9999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++||||+++|+|.+++....               ..+++.++..++.|+++||+|||+
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  209 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS  209 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999999997643               358999999999999999999994

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.65  E-value=3.4e-16  Score=144.58  Aligned_cols=116  Identities=20%  Similarity=0.267  Sum_probs=99.4

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeec----CCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN----EEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv  364 (405)
                      ++|...+.||+|+||.||++.. .+|+.||+|++..........+.+|+.++.+++||||+++++++..    ....++|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            4577788999999999999995 6789999999876655566788999999999999999999999862    4578899


Q ss_pred             EecCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++..   ....+++.++..++.|+++||+|||+
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~  152 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA  152 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999875   34579999999999999999999994

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.65  E-value=4.4e-16  Score=144.21  Aligned_cols=115  Identities=22%  Similarity=0.339  Sum_probs=100.8

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccc------hhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRR------AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  362 (405)
                      +.|...+.||+|+||.||+|.. .+|+.||+|.+......      ....+.+|+.++.+++||||+++++++...+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            3466678899999999999995 46899999999754321      3567899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++.... .+++..+..++.|+++||+|||+
T Consensus        92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~  133 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHT  133 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999997643 68999999999999999999994

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.65  E-value=4.1e-16  Score=140.62  Aligned_cols=113  Identities=27%  Similarity=0.422  Sum_probs=94.9

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeecccc----chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCR----RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      .+|...+.||+|+||.||+|.. .|+.||||+++....    ...+.+.+|+.++..++||||+++++++...+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            4566778999999999999997 488999999865432    23467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++..  ..+++..+..++.|+++||+|||+
T Consensus        86 e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~  123 (271)
T 3dtc_A           86 EFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHD  123 (271)
T ss_dssp             ECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999864  368999999999999999999994

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.65  E-value=3.4e-16  Score=146.60  Aligned_cols=114  Identities=27%  Similarity=0.343  Sum_probs=99.4

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      .|...+.||+|+||.||+|.. .+|+.||||++....   ....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            466678899999999999985 678999999997543   2334678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |++ |++.+++...+..+++.++..++.|+++||+|||.
T Consensus       135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~  172 (348)
T 1u5q_A          135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS  172 (348)
T ss_dssp             CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            998 68988886555679999999999999999999994

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.65  E-value=7.5e-16  Score=140.59  Aligned_cols=114  Identities=25%  Similarity=0.341  Sum_probs=98.6

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +|...+.||+|+||+||+|.. .+|+.||+|++....  ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   82 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence            466678899999999999996 468899999997543  23346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++ ++.+++......+++..+..++.|+++||+|||+
T Consensus        83 ~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~  119 (292)
T 3o0g_A           83 CDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS  119 (292)
T ss_dssp             CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            986 6777666655679999999999999999999994

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.65  E-value=4.6e-16  Score=145.43  Aligned_cols=118  Identities=26%  Similarity=0.445  Sum_probs=99.1

Q ss_pred             hhccCCccCcccccCCCceEEEee------CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCC
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEE  359 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  359 (405)
                      ..++|...+.||+|+||.||+|..      ..+..||+|.+.... ......+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            345677788999999999999985      245689999997543 33456789999999999 9999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhcCCC----------------------CCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSNC----------------------ILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++||||+++|+|.+++.....                      .+++..+..++.|+++||+|||+
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  190 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF  190 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999999999976532                      37999999999999999999994

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.65  E-value=5.6e-16  Score=140.65  Aligned_cols=115  Identities=23%  Similarity=0.331  Sum_probs=100.6

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeecccc------chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCR------RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  362 (405)
                      ++|...+.||+|+||.||+|... +|+.||+|.+.....      .....+.+|+.++.+++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            34666788999999999999964 689999999875421      13567899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++.... .+++.++..++.|+++||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~  126 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHS  126 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999997543 68999999999999999999994

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.65  E-value=5.2e-16  Score=144.52  Aligned_cols=115  Identities=25%  Similarity=0.439  Sum_probs=99.5

Q ss_pred             cCCccCcccccCCCceEEEeeCC-----CcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          291 KFSENNLISKGGFGSVYKARLGD-----GMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      .|...+.||+|+||.||+|....     +..||+|.++... ......+.+|+.++.+++||||+++++++...+..++|
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  124 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII  124 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence            34556789999999999998532     2469999997543 33456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++......+++.++..++.|+++||+|||+
T Consensus       125 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  165 (333)
T 1mqb_A          125 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN  165 (333)
T ss_dssp             EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999998766679999999999999999999994

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.65  E-value=2e-16  Score=153.26  Aligned_cols=116  Identities=23%  Similarity=0.286  Sum_probs=93.5

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeecc---ccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ---CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      .++|...+.||+|+||.||+|.. .+|+.||||++...   .......+.+|+.++.+++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            35677788999999999999984 57899999999754   233445678899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++...+ .+++..+..++.||++||+|||.
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~  266 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHS  266 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhh
Confidence            99999999999997644 78999999999999999999993

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.64  E-value=4.1e-16  Score=143.67  Aligned_cols=116  Identities=22%  Similarity=0.367  Sum_probs=100.7

Q ss_pred             ccCCccCcccccCCCceEEEee------CCCcEEEEEEeecccc-chhHHHHHHHHHhhcC-CCCCcceEEeeeecCCee
Q 036754          290 YKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  361 (405)
                      ++|...+.||+|+||.||+|+.      .+++.||+|.++.... ...+.+.+|+.++.++ +||||+++++++...+..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            4566778999999999999974      3467899999975543 3456789999999999 999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCCC-----------------CCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNC-----------------ILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~-----------------~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+++|+|.+++.....                 .+++.++..++.|+++||+|||+
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  163 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS  163 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999976532                 48999999999999999999994

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.64  E-value=6.1e-16  Score=144.08  Aligned_cols=116  Identities=26%  Similarity=0.459  Sum_probs=99.1

Q ss_pred             ccCCccCcccccCCCceEEEeeC--------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLG--------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEE  359 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  359 (405)
                      ++|...+.||+|+||.||+|...        ++..||+|++.... ......+.+|+.++.++ +||||+++++++...+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            46677789999999999999852        46789999997543 33456788999999999 9999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++||||+++|+|.+++....               ..+++.++..++.|+++||+|||+
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  175 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS  175 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999999997643               248999999999999999999994

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.64  E-value=7.1e-16  Score=155.03  Aligned_cols=108  Identities=22%  Similarity=0.390  Sum_probs=95.6

Q ss_pred             cccccCCCceEEEeeC---CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCCC
Q 036754          297 LISKGGFGSVYKARLG---DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGS  372 (405)
Q Consensus       297 ~lg~G~fg~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  372 (405)
                      .||+|+||.||+|...   ++..||||+++... ....+.|.+|+.++.+++|||||+++++|.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6899999999999853   45679999997653 3456789999999999999999999999976 56899999999999


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          373 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       373 L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |.+++......+++.++..++.||++||+|||+
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~  454 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE  454 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999998766679999999999999999999994

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.64  E-value=2.6e-16  Score=155.89  Aligned_cols=115  Identities=25%  Similarity=0.389  Sum_probs=100.1

Q ss_pred             hccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      .++|...+.||+|+||.||+|....+..||||+++... ...+.|.+|+.++.+++|+|||++++++.. +..+|||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            34566778899999999999998877889999997643 235678999999999999999999999876 6789999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.++++.. ...+++.++..++.||++||+|||.
T Consensus       344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  381 (535)
T 2h8h_A          344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER  381 (535)
T ss_dssp             TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999753 2468999999999999999999994

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.64  E-value=3.4e-16  Score=142.52  Aligned_cols=117  Identities=26%  Similarity=0.432  Sum_probs=102.5

Q ss_pred             hhccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          288 ATYKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ...+|...+.||+|+||.||+|... .+..||+|.+... ....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4456777789999999999999964 4788999998653 3345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++.... ..+++..+..++.|+++||+|||+
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~  129 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK  129 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH
Confidence            999999999997643 468999999999999999999994

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.64  E-value=4.1e-16  Score=146.16  Aligned_cols=116  Identities=17%  Similarity=0.171  Sum_probs=101.2

Q ss_pred             hccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  363 (405)
                      ..+|...+.||+|+||.||+|+.. +|+.||+|+++...   ......+..|..++..+ +||+|+++++++.+.+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            356778889999999999999964 57899999997642   23456678899999887 89999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++...+ .+++.++..++.||+.||+|||.
T Consensus        99 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~  139 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQS  139 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999997644 69999999999999999999994

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.64  E-value=4.2e-16  Score=147.02  Aligned_cols=115  Identities=17%  Similarity=0.203  Sum_probs=96.5

Q ss_pred             hhccCCccCcccccCCCceEEEe------eCCCcEEEEEEeeccccchhHHHHHHHHHhhcCC---CCCcceEEeeeecC
Q 036754          288 ATYKFSENNLISKGGFGSVYKAR------LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR---HQNLIKVISSCSNE  358 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  358 (405)
                      ..+.|...+.||+|+||+||+|.      ...++.||+|++....   ..++.+|+..+.+++   |+|++++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            34567777899999999999994      4568899999987543   345667777777776   99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 EFKALVLEYMPHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 ~~~~lv~e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +..++||||+++|+|.+++..    ....++|..+..|+.||++||+|||+
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~  190 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD  190 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh
Confidence            999999999999999999974    23569999999999999999999995

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.64  E-value=6.8e-16  Score=142.67  Aligned_cols=115  Identities=23%  Similarity=0.353  Sum_probs=87.5

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      .+|...+.||+|+||.||+|.. .+|+.||+|+++... ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   84 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF   84 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence            4567778999999999999985 568999999997543 23446788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSN-----CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++ |+|.+++....     ..+++..+..++.||++||+|||+
T Consensus        85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~  126 (317)
T 2pmi_A           85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE  126 (317)
T ss_dssp             CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            98 59999886431     358999999999999999999994

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.64  E-value=6.7e-16  Score=152.62  Aligned_cols=117  Identities=20%  Similarity=0.290  Sum_probs=102.7

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      .++|...++||+|+||.||+|.. .+|+.||+|++....   ......+.+|+.++.+++|||||++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            45677889999999999999985 578999999997542   23445678999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++...+ ..+++..+..++.||+.||+|||+
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~  304 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR  304 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999997654 359999999999999999999994

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.64  E-value=6.8e-16  Score=145.27  Aligned_cols=115  Identities=18%  Similarity=0.220  Sum_probs=102.0

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            4677788999999999999996 468999999997653 33456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++...+ .+++..+..++.|+++||+|||+
T Consensus       113 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~  149 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE  149 (360)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999997654 68999999999999999999994

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.64  E-value=5.4e-16  Score=140.55  Aligned_cols=117  Identities=26%  Similarity=0.368  Sum_probs=101.7

Q ss_pred             hhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      +.++|...+.||+|+||.||+|.. .++..||+|++....   ......+.+|+.++.+++||||+++++++......++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            345677788999999999999985 457789999986542   2234678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++.... .+++..+..++.|+++||+|||.
T Consensus        87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~  127 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS  127 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999997643 68999999999999999999995

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.64  E-value=4.2e-16  Score=142.70  Aligned_cols=114  Identities=23%  Similarity=0.318  Sum_probs=93.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc--------------------------chhHHHHHHHHHhhc
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR--------------------------RAFKSFDIECEMMKS  342 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~  342 (405)
                      ++|...+.||+|+||.||+|.. .+++.||||++.....                          ...+.+.+|+.++.+
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            4677778999999999999985 5688999999865321                          123568899999999


Q ss_pred             CCCCCcceEEeeeec--CCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          343 IRHQNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       343 l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+++++++..  .+..++||||+++|+|.+++..  ..+++.++..++.|+++||+|||+
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~  155 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHY  155 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999876  5678999999999999887543  469999999999999999999994

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.64  E-value=1.8e-16  Score=146.07  Aligned_cols=115  Identities=21%  Similarity=0.341  Sum_probs=98.2

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC----ee
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE----FK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~  361 (405)
                      +.|...+.||+|+||.||+|.. .+++.||||+++...   ......+.+|+..+.+++||||+++++++....    ..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            4566778999999999999994 678999999997643   233457889999999999999999999887644    34


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+++|+|.+++...+ .+++.++..++.|+++||+|||+
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~  134 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ  134 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999997644 68999999999999999999994

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.64  E-value=8.1e-16  Score=139.56  Aligned_cols=115  Identities=22%  Similarity=0.306  Sum_probs=98.2

Q ss_pred             ccCCccCcccccCCCceEEEeeC----CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG----DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      ++|...+.||+|+||.||+|...    .+..||+|...... ....+.+.+|+..+.+++||||+++++++. .+..++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence            45667788999999999999853    24579999986543 334567889999999999999999999974 5678999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++...+..+++.++..++.|+++||+|||+
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~  134 (281)
T 1mp8_A           94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES  134 (281)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999998766679999999999999999999994

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.64  E-value=7.5e-16  Score=143.00  Aligned_cols=117  Identities=23%  Similarity=0.420  Sum_probs=98.3

Q ss_pred             hccCCccCcccccCCCceEEEee------CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCee
Q 036754          289 TYKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  361 (405)
                      ..+|...+.||+|+||.||+|+.      .++..||||.+.... ......+.+|+.++.+++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            35677788999999999999984      346789999996443 34456788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+++|+|.+++....      ..+++.++..++.|+++||+|||.
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~  158 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE  158 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence            99999999999999998653      358999999999999999999994

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.64  E-value=7.3e-16  Score=141.83  Aligned_cols=111  Identities=24%  Similarity=0.432  Sum_probs=95.7

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      .+|...+.||+|+||.||+|+. .++.||+|.+...  ...+.+.+|+..+.+++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            3566678899999999999987 4788999998643  34567899999999999999999999886  44789999999


Q ss_pred             CCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++....  ..+++..+..++.|+++||+|||+
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~  120 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS  120 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHh
Confidence            999999998654  247899999999999999999995

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.64  E-value=9.4e-16  Score=144.39  Aligned_cols=127  Identities=19%  Similarity=0.195  Sum_probs=107.4

Q ss_pred             hhhHHHHHHhhhccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccc-----------hhHHHHHHHHHhhcCCCC
Q 036754          278 RMFSYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRR-----------AFKSFDIECEMMKSIRHQ  346 (405)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~  346 (405)
                      ......++.....+|...+.||+|+||.||+|...+|..||||++......           ..+.+.+|+.++.+++||
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   89 (362)
T 3pg1_A           10 MRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP   89 (362)
T ss_dssp             HHHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred             HHHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCc
Confidence            344556777788899999999999999999999878999999998543211           136788999999999999


Q ss_pred             CcceEEeeeec-----CCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          347 NLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       347 niv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++++++..     ....++||||++ |+|.+++...+..+++..+..++.|+++||+|||+
T Consensus        90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  152 (362)
T 3pg1_A           90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE  152 (362)
T ss_dssp             TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999998843     346899999998 69999988766679999999999999999999994

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.64  E-value=4.6e-16  Score=144.83  Aligned_cols=114  Identities=22%  Similarity=0.304  Sum_probs=99.6

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      .+|...+.||+|+||.||+|.. .+|+.||+|++....   ......+.+|+.++..++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4566778999999999999995 678999999997542   223457889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+ +|+|.+++...+ .+++.++..++.|+++||+|||+
T Consensus        89 E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~  126 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHR  126 (336)
T ss_dssp             CCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999 689999987654 69999999999999999999994

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.64  E-value=7.3e-16  Score=143.29  Aligned_cols=113  Identities=22%  Similarity=0.289  Sum_probs=99.1

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      .+|...+.||+|+||.||+|+. .+|+.||||.+....  ....+.+|+.++.++ +|+||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            4577778999999999999994 678999999986542  234578899999999 999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      + +|+|.+++...+..+++..+..++.|+++||+|||+
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  123 (330)
T 2izr_A           87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS  123 (330)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9 899999998765679999999999999999999994

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.64  E-value=8.6e-16  Score=139.49  Aligned_cols=115  Identities=20%  Similarity=0.392  Sum_probs=101.1

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ++|...+.||+|+||.||+|.. .+|+.||+|++....  ......+.+|+.++.+++||||+++++++...+..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            4567778999999999999985 468899999997543  2345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++.... .+++..+..++.|+++||+|||+
T Consensus        86 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~  123 (284)
T 3kk8_A           86 LVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHS  123 (284)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999887654 68999999999999999999994

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.64  E-value=6.7e-16  Score=151.58  Aligned_cols=114  Identities=20%  Similarity=0.267  Sum_probs=96.5

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      .|...+.||+|+||+||+|.. .++..||+|++....  ......+.+|+.++..++|||||++++++......++||||
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  117 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC  117 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            466678899999999999995 478899999997543  33456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++.... .+++..+..++.||++||+|||+
T Consensus       118 ~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~  154 (494)
T 3lij_A          118 YKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHK  154 (494)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999887643 68999999999999999999994

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.63  E-value=8.2e-16  Score=151.34  Aligned_cols=116  Identities=23%  Similarity=0.340  Sum_probs=98.4

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc-------------chhHHHHHHHHHhhcCCCCCcceEEee
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR-------------RAFKSFDIECEMMKSIRHQNLIKVISS  354 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~~  354 (405)
                      .+.|...+.||+|+||+||+|.. .++..||+|++.....             .....+.+|+.++.+++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            34567778999999999999995 4678999999865321             234678899999999999999999999


Q ss_pred             eecCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       355 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +......++||||+++|+|.+++.... .+++..+..++.||+.||+|||+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~  164 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHK  164 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999987644 69999999999999999999994

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.63  E-value=8.8e-16  Score=140.24  Aligned_cols=115  Identities=17%  Similarity=0.253  Sum_probs=100.5

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      .+|...+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++.+++|+||+++++++...+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            45667789999999999999964 57899999987543   234567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+ .+++.++..++.|+++||+|||+
T Consensus        95 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~  133 (294)
T 2rku_A           95 ELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHR  133 (294)
T ss_dssp             ECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999887543 68999999999999999999994

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.63  E-value=5.5e-16  Score=147.88  Aligned_cols=116  Identities=25%  Similarity=0.352  Sum_probs=99.4

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC--eeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE--FKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  365 (405)
                      +.|...+.||+|+||+||+|... +|+.||||++.... ......+.+|++++.+++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            35667789999999999999964 58999999997543 334567789999999999999999999987654  679999


Q ss_pred             ecCCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++....  ..+++..+..++.|+++||+|||+
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  130 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE  130 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997543  239999999999999999999994

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.63  E-value=1e-15  Score=139.30  Aligned_cols=109  Identities=22%  Similarity=0.380  Sum_probs=95.5

Q ss_pred             CcccccCCCceEEEeeC---CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCCC
Q 036754          296 NLISKGGFGSVYKARLG---DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHG  371 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  371 (405)
                      +.||+|+||.||+|...   ++..||+|.++... ....+.+.+|++++.+++||||+++++++ ..+..++||||+++|
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~   94 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG   94 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence            37999999999999853   57789999997643 34466789999999999999999999999 456789999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          372 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       372 ~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|.+++......+++.++..++.|+++||+|||+
T Consensus        95 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~  128 (287)
T 1u59_A           95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE  128 (287)
T ss_dssp             EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999997666679999999999999999999994

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.63  E-value=1.1e-15  Score=138.17  Aligned_cols=115  Identities=24%  Similarity=0.351  Sum_probs=101.3

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.||+|+||.||+|... +|+.||+|.+....   ......+.+|+..+.+++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            45667789999999999999964 78999999997543   233567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+ .+++.++..++.|+++||+|||.
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~  129 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHR  129 (276)
T ss_dssp             ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997654 68999999999999999999994

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.63  E-value=8.7e-16  Score=138.82  Aligned_cols=115  Identities=19%  Similarity=0.237  Sum_probs=101.1

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            45667788999999999999964 78999999997543 33456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++... ..+++.++..++.|+++||+|||+
T Consensus        87 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~  123 (276)
T 2yex_A           87 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHG  123 (276)
T ss_dssp             CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999998654 368999999999999999999994

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.63  E-value=4.5e-16  Score=145.72  Aligned_cols=115  Identities=18%  Similarity=0.321  Sum_probs=100.7

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccch-----------------hHHHHHHHHHhhcCCCCCcceEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRA-----------------FKSFDIECEMMKSIRHQNLIKVI  352 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l~  352 (405)
                      ++|...+.||+|+||.||+|.. +|+.||+|.+.......                 ...+.+|+.++.+++||||++++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            4677778999999999999999 89999999997543211                 17889999999999999999999


Q ss_pred             eeeecCCeeEEEEecCCCCCHHHH------HhcC-CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          353 SSCSNEEFKALVLEYMPHGSLEKY------LYSS-NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       353 ~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++...+..++||||+++|+|.++      +... ...+++..+..++.|+++||+|||+
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  169 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN  169 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc
Confidence            999999999999999999999998      6542 3579999999999999999999993

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.63  E-value=8.3e-16  Score=139.70  Aligned_cols=115  Identities=28%  Similarity=0.384  Sum_probs=100.9

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.||+|+||.||+|... ++..||+|.+....   ......+.+|+.++.+++||||+++++++...+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46777789999999999999864 67889999996542   223467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+ .+++..+..++.|+++||+|||+
T Consensus        94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~  132 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHE  132 (284)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             EeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997654 68999999999999999999995

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.63  E-value=6.5e-16  Score=144.30  Aligned_cols=111  Identities=20%  Similarity=0.314  Sum_probs=96.4

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||.||+|.. .+|+.||+|++.....    ...+|++++.++ +||||+++++++.+.+..|+||||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            4567778999999999999985 4688999999975432    234678888887 799999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++...+ .+++.++..++.||++||+|||+
T Consensus        98 ~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~  134 (342)
T 2qr7_A           98 MKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHA  134 (342)
T ss_dssp             CCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999997654 69999999999999999999994

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.63  E-value=6.8e-16  Score=145.75  Aligned_cols=116  Identities=28%  Similarity=0.318  Sum_probs=92.2

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHH-hhcCCCCCcceEEeeeecCCeeEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEM-MKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      .++|...+.||+|+||.||+|+. .+++.||+|++++..   ......+.+|..+ +..++|||||++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            35677788999999999999995 467899999997653   2233456667776 577899999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++...+ .+++..+..++.||+.||+|||.
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~  157 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHS  157 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999997644 68999999999999999999994

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.63  E-value=1e-15  Score=142.58  Aligned_cols=115  Identities=17%  Similarity=0.253  Sum_probs=100.7

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      .+|...+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++.+++|+||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            45667789999999999999964 57899999987542   234567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++++|.+++...+ .+++.++..++.|+++||+|||+
T Consensus       121 e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~  159 (335)
T 2owb_A          121 ELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHR  159 (335)
T ss_dssp             CCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999887543 68999999999999999999994

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.63  E-value=6.7e-16  Score=148.34  Aligned_cols=115  Identities=21%  Similarity=0.229  Sum_probs=96.6

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--------cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--------RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE  359 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  359 (405)
                      .++|...+.||+|+||.||+|.. .+++.||||++....        ......+.+|+.++.+++||||+++++++.. +
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            35677788999999999999985 567899999997532        1122357899999999999999999999754 5


Q ss_pred             eeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++||||+++|+|.+++...+ .+++.++..++.|+++||+|||+
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~  257 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHE  257 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            6799999999999999987544 79999999999999999999994

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.63  E-value=6.3e-16  Score=141.64  Aligned_cols=117  Identities=23%  Similarity=0.284  Sum_probs=86.8

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      .++|...+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+..+.+++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            45677888999999999999984 578899999986543 3345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYS-------SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++..       ....+++..+..++.|+++||+|||.
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  139 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK  139 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999864       23468999999999999999999994

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.63  E-value=6.4e-16  Score=146.07  Aligned_cols=114  Identities=28%  Similarity=0.461  Sum_probs=96.8

Q ss_pred             CCccCcccccCCCceEEEeeC--CC--cEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeec-CCeeEEEE
Q 036754          292 FSENNLISKGGFGSVYKARLG--DG--MEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSN-EEFKALVL  365 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  365 (405)
                      |...+.||+|+||.||+|+..  ++  ..||+|.++... ....+.|.+|+.++.+++||||++++++|.. .+..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            445578999999999999853  22  468999986543 3456789999999999999999999998754 56789999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++......+++.++..++.||++||+|||+
T Consensus       171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  210 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS  210 (373)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred             ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999998766678999999999999999999994

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.63  E-value=9.5e-16  Score=141.31  Aligned_cols=115  Identities=21%  Similarity=0.158  Sum_probs=96.3

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc--cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.||+|+||+||+|... +|+.||||++....  ......+..|+..+.++ +|+||++++++|...+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            35677789999999999999964 78999999986532  22334556666666655 8999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+ +|+|.+++...+..++|..+..++.|+++||+|||+
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  175 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS  175 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999 669999987766679999999999999999999994

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.63  E-value=1.9e-15  Score=139.15  Aligned_cols=116  Identities=26%  Similarity=0.359  Sum_probs=99.4

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      .+|...+.||+|+||.||+|.. .+|+.||+|+++...   ......+.+|+.++.+++|+||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            4567778999999999999985 578999999997532   334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++..   ....+++..+..++.|+++||+|||.
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  154 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS  154 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh
Confidence            99999999999864   23568999999999999999999994

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.63  E-value=9.2e-16  Score=150.34  Aligned_cols=115  Identities=23%  Similarity=0.311  Sum_probs=101.2

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +.|...+.||+|+||+||+|.. .+++.||||++....  ......+.+|+.++.+++|||||++++++......++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            3456678999999999999995 478999999996542  3345678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+ .+++..+..++.|+++||+|||+
T Consensus       102 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~  139 (486)
T 3mwu_A          102 LYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHK  139 (486)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999887654 69999999999999999999994

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.63  E-value=1.1e-15  Score=149.75  Aligned_cols=114  Identities=25%  Similarity=0.359  Sum_probs=101.1

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      .|...+.||+|+||.||+|.. .+|+.||||++....   ......+.+|+.++.+++|||||++++++......++|||
T Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  106 (484)
T 3nyv_A           27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE  106 (484)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            456678899999999999995 478999999996542   3345678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+ .+++.++..++.||++||+|||.
T Consensus       107 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~  144 (484)
T 3nyv_A          107 VYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHK  144 (484)
T ss_dssp             CCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999997654 69999999999999999999994

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.62  E-value=1.9e-15  Score=138.64  Aligned_cols=114  Identities=25%  Similarity=0.327  Sum_probs=100.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +.|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++.+++||||+++++++......++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            3466778899999999999985 568899999997554 34467889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++..  ..+++..+..++.|+++||+|||.
T Consensus       102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~  137 (303)
T 3a7i_A          102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHS  137 (303)
T ss_dssp             CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999865  368999999999999999999994

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.62  E-value=7.9e-16  Score=140.88  Aligned_cols=115  Identities=23%  Similarity=0.318  Sum_probs=99.1

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeec-----------
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN-----------  357 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----------  357 (405)
                      .+|...+.||+|+||.||+|.. .+|+.||+|.+... ......+.+|+.++.+++||||+++++++..           
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            4567778999999999999995 57899999999643 3345678899999999999999999998754           


Q ss_pred             --CCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          358 --EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       358 --~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                        ....++||||+++|+|.+++......+++.++..++.|+++||+|||+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~  134 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS  134 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh
Confidence              356789999999999999998766568899999999999999999994

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.62  E-value=1.3e-15  Score=140.28  Aligned_cols=116  Identities=16%  Similarity=0.164  Sum_probs=101.6

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc---chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR---RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      .++|...+.||+|+||.||+|.. .+++.||+|++.....   .....+.+|+.++.+++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            35677788999999999999995 4788999999975432   2346788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++...+ .+++.++..++.|+++||+|||.
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~  152 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHA  152 (309)
T ss_dssp             EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999997643 68999999999999999999994

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.62  E-value=9.9e-16  Score=142.36  Aligned_cols=116  Identities=20%  Similarity=0.318  Sum_probs=98.4

Q ss_pred             hhccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      ..++|...+.||+|+||+||+|.. .+++.||||+++....  .....+.+|+.++.+++||||+++++++...+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            345678889999999999999984 5789999999965432  2345677899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++ +|.+++.... .+++..+..++.|+++||+|||+
T Consensus       112 ~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~  150 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHS  150 (329)
T ss_dssp             EECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            999985 9999997654 68999999999999999999994

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.62  E-value=1e-15  Score=128.86  Aligned_cols=130  Identities=20%  Similarity=0.194  Sum_probs=107.4

Q ss_pred             cccccccEEEcccCcccccCCccccCcc-CCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCc
Q 036754           34 NVSHSLEFFVMSYCNISGGILEEITNLT-KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDIL  112 (405)
Q Consensus        34 ~~~~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~  112 (405)
                      ++. +|+.|++++|+++.. |. +..+. +|++|+|++|.+++ + .. +..+++|++|+|++|+++.+|..+       
T Consensus        17 ~~~-~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~-~-~~-l~~l~~L~~L~Ls~N~l~~~~~~~-------   83 (176)
T 1a9n_A           17 NAV-RDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRK-L-DG-FPLLRRLKTLLVNNNRICRIGEGL-------   83 (176)
T ss_dssp             CTT-SCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCE-E-CC-CCCCSSCCEEECCSSCCCEECSCH-------
T ss_pred             CcC-CceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCc-c-cc-cccCCCCCEEECCCCcccccCcch-------
Confidence            444 899999999999864 54 55555 99999999999984 5 33 468999999999999999887543       


Q ss_pred             cccCCCCChhccCCCCCCEEeccCCcccccCCc--ccccCCCCCeeecccccccCccch----hHHhcccCCccccccCc
Q 036754          113 YLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPD--SFGDLISLKSLNLSKNNLSGAIPA----SLEKLLYLKDLNLSFNK  186 (405)
Q Consensus       113 ~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~--~~~~l~~L~~L~l~~n~l~~~~~~----~~~~l~~L~~l~l~~n~  186 (405)
                                +..+++|++|++++|.+. .+|.  .+..+++|+.|++++|+++. .|.    .+..+++|+.|+++.|.
T Consensus        84 ----------~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~  151 (176)
T 1a9n_A           84 ----------DQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVK  151 (176)
T ss_dssp             ----------HHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECC
T ss_pred             ----------hhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCC
Confidence                      345788999999999997 4565  78999999999999999985 455    48999999999999997


Q ss_pred             cc
Q 036754          187 LE  188 (405)
Q Consensus       187 l~  188 (405)
                      +.
T Consensus       152 ~~  153 (176)
T 1a9n_A          152 LK  153 (176)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.62  E-value=5.6e-16  Score=143.46  Aligned_cols=120  Identities=23%  Similarity=0.346  Sum_probs=101.8

Q ss_pred             HhhhccCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecC
Q 036754          286 CRATYKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE  358 (405)
Q Consensus       286 ~~~~~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  358 (405)
                      ....++|...+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.++.+++|+||+++++++...
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            334566777889999999999999753      36789999997543 23455788999999999999999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 EFKALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 ~~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +..++||||+++|+|.+++...+         ..+++.++..++.|+++||+|||.
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  156 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA  156 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999987521         357899999999999999999994

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.62  E-value=9.7e-16  Score=142.28  Aligned_cols=115  Identities=24%  Similarity=0.399  Sum_probs=93.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCc----EEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGM----EVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      .+|...+.||+|+||+||+|.. .+++    .||+|.++... ....+.+.+|+.++.+++||||++++++|.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            4567778999999999999985 3444    35888875433 345578999999999999999999999998754 789


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+||+++|+|.+++...+..+++..+..++.|+++||+|||+
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~  135 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED  135 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            999999999999998876789999999999999999999994

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.62  E-value=1.2e-15  Score=140.45  Aligned_cols=115  Identities=24%  Similarity=0.273  Sum_probs=99.8

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ++|...+.||+|+||+||+|.. .+|+.||+|++.....  ...+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            3466678899999999999996 4589999999865432  234668899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++++|.+++... ..+++..+..++.|+++||+|||+
T Consensus        83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~  120 (311)
T 4agu_A           83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHK  120 (311)
T ss_dssp             CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999988654 368999999999999999999994

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.62  E-value=1.4e-15  Score=138.54  Aligned_cols=113  Identities=26%  Similarity=0.373  Sum_probs=96.6

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeec----CCeeEEE
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSN----EEFKALV  364 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv  364 (405)
                      |...+.||+|+||.||+|.. .++..||+|.+....  ....+.+.+|+.++.+++||||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            44556799999999999985 567889999987543  3345678899999999999999999998765    4568999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++...+ .+++..+..++.|+++||+|||+
T Consensus       108 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~  147 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT  147 (290)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHc
Confidence            99999999999997643 68999999999999999999995

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.62  E-value=1.6e-15  Score=149.34  Aligned_cols=117  Identities=19%  Similarity=0.327  Sum_probs=102.4

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      .++|...++||+|+||.||+|+. .+|+.||+|++.+..   ......+.+|+.++.+++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            35677788999999999999996 468999999997543   23456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++....   ..+++..+..++.||+.||+|||+
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~  307 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ  307 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999997542   469999999999999999999994

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.62  E-value=1.3e-15  Score=139.41  Aligned_cols=115  Identities=20%  Similarity=0.285  Sum_probs=100.1

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---------cchhHHHHHHHHHhhcCC-CCCcceEEeeeecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---------RRAFKSFDIECEMMKSIR-HQNLIKVISSCSNE  358 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  358 (405)
                      ++|...+.||+|+||.||+|.. .+|+.||||.+....         ......+.+|+.++.++. ||||+++++++...
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (298)
T 1phk_A           17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   96 (298)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence            4677778999999999999996 468999999996542         122456788999999995 99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +..++||||+++|+|.+++.... .+++.++..++.|+++||+|||.
T Consensus        97 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~  142 (298)
T 1phk_A           97 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHK  142 (298)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999997643 68999999999999999999994

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.62  E-value=7.6e-16  Score=139.47  Aligned_cols=117  Identities=20%  Similarity=0.278  Sum_probs=99.8

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeee--cCCeeEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCS--NEEFKAL  363 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l  363 (405)
                      .++|...+.||+|+||.||++.. .+|+.||+|.+....  ....+.+.+|+.++.+++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            35677778999999999999985 478999999997543  334567889999999999999999999874  4678999


Q ss_pred             EEecCCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++...   +..+++..+..++.|+++||+|||.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~  129 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR  129 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            99999999999999753   2459999999999999999999994

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.62  E-value=7.8e-16  Score=143.89  Aligned_cols=118  Identities=25%  Similarity=0.328  Sum_probs=98.3

Q ss_pred             hhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-----cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCee
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-----RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  361 (405)
                      ...+|...+.||+|+||.||+|.. .++..||+|++....     ....+.+.+|+.++.+++||||+++++++.+.+..
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  103 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI  103 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence            345577788999999999999985 567899999986542     34457789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcC---------------------------------------CCCCCHHHHHHHHHHHHHHHhh
Q 036754          362 ALVLEYMPHGSLEKYLYSS---------------------------------------NCILDIFQRLNIMIDVASALEY  402 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~---------------------------------------~~~l~~~~~~~i~~~ia~gl~y  402 (405)
                      ++||||+++|+|.+++...                                       ...+++..+..++.|+++||+|
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  183 (345)
T 3hko_A          104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY  183 (345)
T ss_dssp             EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence            9999999999999998521                                       0123566788899999999999


Q ss_pred             hcC
Q 036754          403 LHF  405 (405)
Q Consensus       403 LH~  405 (405)
                      ||+
T Consensus       184 LH~  186 (345)
T 3hko_A          184 LHN  186 (345)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            994

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.62  E-value=9.6e-16  Score=142.79  Aligned_cols=115  Identities=27%  Similarity=0.362  Sum_probs=99.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc--------chhHHHHHHHHHhhcCCCCCcceEEeeeecCCe
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR--------RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  360 (405)
                      ++|...+.||+|+||.||+|.. .+++.||||++.....        .....+.+|+.++.+++||||+++++++...+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            4677788999999999999984 5789999999975421        133467789999999999999999999999999


Q ss_pred             eEEEEecCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++||||+.+| +|.+++.... .+++..+..++.|+++||+|||.
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~  148 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRL  148 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999877 9999997654 69999999999999999999994

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.62  E-value=2.2e-15  Score=139.88  Aligned_cols=116  Identities=31%  Similarity=0.569  Sum_probs=97.4

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcE--EEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGME--VAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  364 (405)
                      ++|...+.||+|+||.||+|.. .+|..  +|+|.+.... ....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            4566778899999999999985 45654  4999886532 34456788999999999 999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++...+               ..+++.++..++.|+++||+|||.
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  160 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ  160 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999997643               368999999999999999999994

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.62  E-value=2.4e-15  Score=139.07  Aligned_cols=112  Identities=27%  Similarity=0.464  Sum_probs=96.6

Q ss_pred             CCccCcccccCCCceEEEee-----CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeec--CCeeEE
Q 036754          292 FSENNLISKGGFGSVYKARL-----GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSN--EEFKAL  363 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  363 (405)
                      |...+.||+|+||+||++.+     .+++.||||++.... ......+.+|++++.+++||||+++++++..  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            36678899999999988864     267899999997653 2345678999999999999999999999987  467899


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++...  .+++.++..++.|+++||+|||+
T Consensus       113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~  152 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHA  152 (318)
T ss_dssp             EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999999764  48999999999999999999994

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.62  E-value=1.6e-15  Score=139.85  Aligned_cols=115  Identities=26%  Similarity=0.336  Sum_probs=96.8

Q ss_pred             hccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          289 TYKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      .+.|...+.||+|+||.||+|... +|+.||+|.+....  ....+.+|+.++.+++||||+++++++...+..++||||
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  105 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY  105 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence            346777889999999999999864 58999999987542  346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++......+++..+..++.|+++||+|||.
T Consensus       106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~  143 (314)
T 3com_A          106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF  143 (314)
T ss_dssp             CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999997545579999999999999999999994

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.61  E-value=1.1e-15  Score=138.42  Aligned_cols=114  Identities=24%  Similarity=0.394  Sum_probs=98.5

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      ++|...+.||+|+||.||+|...++..||+|.+.... .....+.+|+.++.+++||||+++++++. .+..++||||++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   90 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME   90 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence            4566778999999999999998888899999986543 33567889999999999999999999886 456899999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++.... ..+++.++..++.|+++||+|||+
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  127 (279)
T 1qpc_A           91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE  127 (279)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999996532 258999999999999999999994

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.61  E-value=1.5e-15  Score=138.90  Aligned_cols=116  Identities=28%  Similarity=0.434  Sum_probs=97.5

Q ss_pred             ccCCccCcccccCCCceEEEeeCC----CcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeee-cCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLGD----GMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCS-NEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~l  363 (405)
                      ..|...+.||+|+||.||+|....    +..||+|.+.... ....+.+.+|+.++.+++||||+++++++. ..+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            346667889999999999998532    2358999986543 344567899999999999999999999864 4567899


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++......+++.++..++.|+++||+|||+
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~  146 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS  146 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999998766678999999999999999999994

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.61  E-value=1.7e-15  Score=138.44  Aligned_cols=114  Identities=25%  Similarity=0.372  Sum_probs=96.8

Q ss_pred             CCccCcccccCCCceEEEeeC-C---CcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCee-EEEE
Q 036754          292 FSENNLISKGGFGSVYKARLG-D---GMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK-ALVL  365 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv~  365 (405)
                      |...+.||+|+||+||+|... +   +..||+|.+.... ....+.+.+|+.++.+++||||+++++++...+.. ++||
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            444578999999999999842 2   2379999986543 33457789999999999999999999999776554 8999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+.+|+|.+++......+++.++..++.|+++||+|||+
T Consensus       103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  142 (298)
T 3pls_A          103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE  142 (298)
T ss_dssp             CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999998766679999999999999999999994

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.61  E-value=2.3e-15  Score=137.82  Aligned_cols=109  Identities=32%  Similarity=0.463  Sum_probs=91.0

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhc--CCCCCcceEEeeeec----CCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKS--IRHQNLIKVISSCSN----EEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~~~~l  363 (405)
                      ++|...+.||+|+||+||+|+. +|+.||||++....   ...+.+|.+++..  ++||||+++++++..    ....++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            4677788999999999999988 68999999986532   3344556665555  899999999998654    345889


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhc
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      ||||+++|+|.++++.  ..+++..+..++.|+++||+|||
T Consensus        84 v~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH  122 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLH  122 (301)
T ss_dssp             EECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHH
T ss_pred             ehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999964  36999999999999999999999

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.61  E-value=2.3e-15  Score=136.94  Aligned_cols=115  Identities=23%  Similarity=0.321  Sum_probs=101.5

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ++|...+.||+|+||.||+|+.. +++.||+|++....  ......+.+|+.++.+++||||+++++++...+..++|||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            45677789999999999999964 78899999997543  2345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+ .+++.++..++.|+++||+|||.
T Consensus       102 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~  139 (287)
T 2wei_A          102 LYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHK  139 (287)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999887544 68999999999999999999994

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.61  E-value=1.2e-15  Score=141.22  Aligned_cols=118  Identities=29%  Similarity=0.502  Sum_probs=92.7

Q ss_pred             hhccCCccCcccccCCCceEEEeeCC-C---cEEEEEEeecc--ccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCee
Q 036754          288 ATYKFSENNLISKGGFGSVYKARLGD-G---MEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  361 (405)
                      ..++|...+.||+|+||.||+|.... +   ..||||.++..  .....+.+.+|+.++.+++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            44567788899999999999998543 3   27999999754  344567899999999999999999999999876554


Q ss_pred             ------EEEEecCCCCCHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ------ALVLEYMPHGSLEKYLYSSN-----CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ------~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                            ++||||+++|+|.+++....     ..+++.++..++.|+++||+|||+
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~  155 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS  155 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc
Confidence                  89999999999999986422     258999999999999999999994

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.61  E-value=1.9e-15  Score=137.06  Aligned_cols=112  Identities=23%  Similarity=0.447  Sum_probs=95.8

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeec-----------
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN-----------  357 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----------  357 (405)
                      .+|...+.||+|+||.||+|... +|+.||+|.+....    ..+.+|+.++.+++||||+++++++..           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            35667789999999999999964 78999999987543    356789999999999999999998754           


Q ss_pred             -----CCeeEEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          358 -----EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       358 -----~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                           ....++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  140 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS  140 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence                 345789999999999999997542 469999999999999999999994

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.61  E-value=3e-15  Score=141.11  Aligned_cols=116  Identities=24%  Similarity=0.380  Sum_probs=100.7

Q ss_pred             hccCCccCcccccCCCceEEEeeC-CCcEEEEEEeecccc--------chhHHHHHHHHHhhcC-CCCCcceEEeeeecC
Q 036754          289 TYKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCR--------RAFKSFDIECEMMKSI-RHQNLIKVISSCSNE  358 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  358 (405)
                      ..+|...+.||+|+||.||+|... +|+.||||+++....        ...+.+.+|+.++.++ +||||+++++++...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            345777789999999999999974 789999999875431        1245678899999999 899999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ...++||||+++|+|.+++.... .+++..+..++.||++||+|||.
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~  218 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHA  218 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999999999997643 68999999999999999999994

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.61  E-value=2.3e-15  Score=136.57  Aligned_cols=116  Identities=25%  Similarity=0.427  Sum_probs=98.4

Q ss_pred             hccCCccCcccccCCCceEEEeeCC----CcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGD----GMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      .++|...+.||+|+||.||+|....    +..||+|.+.... ....+.+.+|+.++.+++||||+++++++.. +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            3567777899999999999998532    3469999987653 3345678999999999999999999999864 45689


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++...+..+++..+..++.|+++||+|||.
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~  131 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES  131 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999998765679999999999999999999994

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.60  E-value=2.9e-15  Score=139.25  Aligned_cols=115  Identities=25%  Similarity=0.373  Sum_probs=99.5

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ++|...+.||+|+||.||+|.. .+|+.||+|++.....  .....+.+|+.++.+++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            4566778999999999999996 4589999999865432  234567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++++|.+++.... .+++..+..++.|+++||+|||+
T Consensus       105 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~  142 (331)
T 4aaa_A          105 FVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHS  142 (331)
T ss_dssp             CCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999988876543 69999999999999999999994

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.60  E-value=1.1e-15  Score=143.72  Aligned_cols=115  Identities=21%  Similarity=0.274  Sum_probs=99.7

Q ss_pred             ccCCccCcccccCCCceEEEee----CCCcEEEEEEeeccc----cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCe
Q 036754          290 YKFSENNLISKGGFGSVYKARL----GDGMEVAVKVFNLQC----RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEF  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  360 (405)
                      .+|...+.||+|+||.||++..    .+|+.||||+++...    ......+.+|+.++.++ +|+||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            4677788999999999999986    368999999986532    23345677899999999 69999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++||||+++|+|.+++...+ .+++.++..++.||++||+|||.
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~  177 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHK  177 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999997644 68999999999999999999994

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.60  E-value=2.7e-15  Score=151.25  Aligned_cols=108  Identities=23%  Similarity=0.356  Sum_probs=93.7

Q ss_pred             CcccccCCCceEEEee---CCCcEEEEEEeecccc--chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARL---GDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.||+|+||.||+|.+   ..++.||||+++....  ...+++.+|+.++.+++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4699999999999964   3467899999976432  345789999999999999999999999964 558899999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.+++...+ .+++.++..|+.||++||+|||+
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~  487 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEE  487 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999997654 79999999999999999999994

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.60  E-value=1.4e-15  Score=140.29  Aligned_cols=122  Identities=20%  Similarity=0.356  Sum_probs=101.2

Q ss_pred             HHHhhhccCCccCcccccCCCceEEEee------CCCcEEEEEEeecccc-chhHHHHHHHHHhhcC-CCCCcceEEeee
Q 036754          284 ELCRATYKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQCR-RAFKSFDIECEMMKSI-RHQNLIKVISSC  355 (405)
Q Consensus       284 ~~~~~~~~~~~~~~lg~G~fg~v~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~  355 (405)
                      +.....++|...+.||+|+||.||+|..      .+++.||||.+..... .....+.+|+.++.++ +||||+++++++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            3334456788889999999999999973      3568899999976533 3456788999999999 799999999998


Q ss_pred             ecCC-eeEEEEecCCCCCHHHHHhcCCC---------------CCCHHHHHHHHHHHHHHHhhhcC
Q 036754          356 SNEE-FKALVLEYMPHGSLEKYLYSSNC---------------ILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       356 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ...+ ..++||||+++|+|.+++.....               .+++..+..++.|+++||+|||+
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~  166 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS  166 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh
Confidence            7654 58999999999999999986542               28899999999999999999994

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.60  E-value=1.6e-15  Score=140.41  Aligned_cols=114  Identities=22%  Similarity=0.243  Sum_probs=94.8

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--------cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCe
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--------RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  360 (405)
                      ++|...+.||+|+||.||+|.. .+++.||||.+....        ......+.+|+.++.+++||||+++++++...+ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            4566778999999999999985 467899999986432        122345789999999999999999999987655 


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++||||+++|+|.+++... ..+++..+..++.||++||+|||.
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~  132 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHE  132 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            89999999999999998754 378999999999999999999994

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.60  E-value=7.7e-16  Score=142.79  Aligned_cols=114  Identities=22%  Similarity=0.371  Sum_probs=96.8

Q ss_pred             cCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccccc-hhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRR-AFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +|...+.||+|+||.||+|... +++.||+|++...... ....+.+|+.++.+++||||+++++++...+..++||||+
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   82 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence            4666788999999999999964 7899999998654322 2234567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      + |+|.+++...+..+++..+..++.|+++||+|||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~  118 (324)
T 3mtl_A           83 D-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR  118 (324)
T ss_dssp             S-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            8 59999998776679999999999999999999994

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.60  E-value=3.4e-15  Score=137.80  Aligned_cols=113  Identities=23%  Similarity=0.257  Sum_probs=92.6

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeee------------
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCS------------  356 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~------------  356 (405)
                      ..|...+.||+|+||.||+|... +|+.||+|++........+.+.+|+.++.+++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            35666788999999999999964 58999999997665556678899999999999999999998873            


Q ss_pred             --cCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          357 --NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       357 --~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                        .....++||||++ |+|.+++..  ..+++..+..++.|+++||+|||+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~  138 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHS  138 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHh
Confidence              3467899999998 699999864  358999999999999999999994

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.60  E-value=2.2e-15  Score=137.40  Aligned_cols=114  Identities=22%  Similarity=0.334  Sum_probs=95.5

Q ss_pred             ccCCccC-cccccCCCceEEEee---CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENN-LISKGGFGSVYKARL---GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~-~lg~G~fg~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      ..|...+ .||+|+||.||+|..   ..++.||||+++...  ....+.+.+|+.++.+++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4455555 899999999999964   346889999997543  23356789999999999999999999998 5677899


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++...+ .+++.++..++.|+++||+|||+
T Consensus        95 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~  135 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEE  135 (291)
T ss_dssp             EEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999998654 68999999999999999999994

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.60  E-value=1.9e-15  Score=139.27  Aligned_cols=118  Identities=29%  Similarity=0.485  Sum_probs=94.4

Q ss_pred             hhccCCccCcccccCCCceEEEeeC----CCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC--
Q 036754          288 ATYKFSENNLISKGGFGSVYKARLG----DGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE--  359 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--  359 (405)
                      ...+|...+.||+|+||.||+|...    .+..||+|.+....  ......+.+|+.++.+++||||+++++++...+  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3456677788999999999999853    34589999987543  334567899999999999999999999987654  


Q ss_pred             ---eeEEEEecCCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 ---FKALVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ---~~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                         ..++||||+++|+|.+++...     ...+++.++..++.|+++||+|||.
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  165 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN  165 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh
Confidence               359999999999999998532     2469999999999999999999995

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.60  E-value=2e-15  Score=140.45  Aligned_cols=118  Identities=21%  Similarity=0.350  Sum_probs=100.0

Q ss_pred             hhccCCccCcccccCCCceEEEeeC-CC-----cEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCC
Q 036754          288 ATYKFSENNLISKGGFGSVYKARLG-DG-----MEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEE  359 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  359 (405)
                      ..++|...+.||+|+||.||+|... .+     ..||+|.+.... ......+.+|+.++.++ +||||+++++++...+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            3456777889999999999999853 22     479999997553 23456788999999999 8999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSS-------------NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++||||+++|+|.+++...             ...+++..+..++.|+++||+|||+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  182 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS  182 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence            999999999999999998742             2357999999999999999999994

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.60  E-value=2.4e-16  Score=146.96  Aligned_cols=112  Identities=19%  Similarity=0.275  Sum_probs=90.1

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccc--------cchhHHHHHHHHHhhcCC---------CCCcceEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--------RRAFKSFDIECEMMKSIR---------HQNLIKVI  352 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l~  352 (405)
                      ++|...+.||+|+||.||+|+. +|+.||||++....        ....+.+.+|+.++.+++         |+|||++.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            3455678899999999999988 78999999997542        223467888999888875         77777766


Q ss_pred             eee-----------------ec-------------CCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhh
Q 036754          353 SSC-----------------SN-------------EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY  402 (405)
Q Consensus       353 ~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~y  402 (405)
                      +.+                 .+             .+..++||||+++|++.+.+.+  ..+++.++..++.||++||+|
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence            643                 22             6789999999999987776644  368999999999999999999


Q ss_pred             hc
Q 036754          403 LH  404 (405)
Q Consensus       403 LH  404 (405)
                      ||
T Consensus       177 lH  178 (336)
T 2vuw_A          177 AE  178 (336)
T ss_dssp             HH
T ss_pred             HH
Confidence            99

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.59  E-value=3.5e-15  Score=139.47  Aligned_cols=114  Identities=18%  Similarity=0.284  Sum_probs=99.9

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCC--CCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRH--QNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~  365 (405)
                      ..|...+.||+|+||.||++...+++.||||++....  ......+.+|+.++.+++|  +||+++++++...+..++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            3567778999999999999998889999999987543  3345678899999999987  99999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      | +.+|+|.+++...+ .+++.++..++.|+++||+|||+
T Consensus        89 e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~  126 (343)
T 3dbq_A           89 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ  126 (343)
T ss_dssp             C-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             e-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9 56789999998754 78999999999999999999994

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.59  E-value=3.6e-15  Score=141.89  Aligned_cols=113  Identities=18%  Similarity=0.288  Sum_probs=99.5

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCC--CCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIR--HQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      .|...+.||+|+||.||++....++.||||++....  ......+.+|+.++.+++  |+||+++++++...+..++|||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E  136 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  136 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence            477788999999999999998779999999997543  334567899999999996  5999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       +.+|+|.+++.... .+++.++..++.||++||+|||.
T Consensus       137 -~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~  173 (390)
T 2zmd_A          137 -CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ  173 (390)
T ss_dssp             -CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             -cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence             56789999998754 78999999999999999999995

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.59  E-value=2.7e-15  Score=136.69  Aligned_cols=114  Identities=25%  Similarity=0.417  Sum_probs=95.3

Q ss_pred             hccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ..+|...+.||+|+||.||+|+..  ..||+|+++...  ....+.+.+|+.++.+++|+||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            345777789999999999999864  359999986543  33456789999999999999999999965 4566899999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++......+++.++..++.|+++||+|||+
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~  138 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA  138 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999997666679999999999999999999994

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.59  E-value=2e-15  Score=141.32  Aligned_cols=117  Identities=24%  Similarity=0.389  Sum_probs=95.6

Q ss_pred             hhccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc-----chhHHHHHHHHHhhcCCCCCcceEEeeeecCCee
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR-----RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  361 (405)
                      ...+|...+.||+|+||.||+|.. .+|+.||||++.....     .....+.+|+.++.+++||||+++++++...+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            345677888999999999999995 4689999999865321     1235678999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+++ +|.+++......+++.++..++.|+++||+|||+
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  130 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ  130 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999986 8999987766678999999999999999999994

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.59  E-value=1e-15  Score=142.07  Aligned_cols=115  Identities=23%  Similarity=0.380  Sum_probs=95.5

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcE----EEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGME----VAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      .+|...+.||+|+||.||+|.. .++..    ||+|.+.... ......+.+|+..+.+++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            3566678899999999999985 44544    7777775432 333456778999999999999999999886 466889


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++...+..+++..+..++.|+++||+|||+
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~  133 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE  133 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999998765678999999999999999999994

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.59  E-value=6.3e-15  Score=123.24  Aligned_cols=84  Identities=29%  Similarity=0.308  Sum_probs=47.9

Q ss_pred             CCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeee
Q 036754           13 LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLS   92 (405)
Q Consensus        13 L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~   92 (405)
                      .+.|++++|.+..+....     +.+|+.|+|++|++++..|..|..+++|++|+|++|+|+ .+|...|.++++|++|+
T Consensus        11 ~~~l~~s~n~l~~ip~~~-----~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~   84 (170)
T 3g39_A           11 GTTVDCSGKSLASVPTGI-----PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLS   84 (170)
T ss_dssp             TTEEECTTSCCSSCCSCC-----CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred             CCEEEeCCCCcCccCccC-----CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcC-ccChhhccCCCCCCEEE
Confidence            456666666666533221     125666666666666655666666666666666666665 45555444555555555


Q ss_pred             CCCCCCCCCc
Q 036754           93 LDSNELTSIP  102 (405)
Q Consensus        93 Ls~N~l~~lp  102 (405)
                      |++|+|+.+|
T Consensus        85 L~~N~l~~~~   94 (170)
T 3g39_A           85 LNDNQLKSIP   94 (170)
T ss_dssp             CCSSCCCCCC
T ss_pred             CCCCccCEeC
Confidence            5555555444

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.59  E-value=3.8e-15  Score=144.86  Aligned_cols=114  Identities=18%  Similarity=0.249  Sum_probs=88.6

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeec-----CCee
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSN-----EEFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~  361 (405)
                      ++|...+.||+|+||+||+|.. .+|+.||||++....  ....+.+.+|+.++.+++|||||++++++..     ....
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            4677789999999999999984 478999999986532  3345678899999999999999999999843     3578


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+||||+. |+|.+++... ..+++..+..++.||++||+|||+
T Consensus       133 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~  174 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHS  174 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999985 6999999764 379999999999999999999994

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.58  E-value=5.5e-15  Score=135.17  Aligned_cols=115  Identities=24%  Similarity=0.364  Sum_probs=97.0

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ++|...+.||+|+||.||+|... +|+.||+|.+....  ......+.+|+.++.+++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            35667788999999999999964 78999999986543  2234678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |++ |+|.+++.... ..+++..+..++.|+++||+|||+
T Consensus        83 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  121 (299)
T 2r3i_A           83 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS  121 (299)
T ss_dssp             CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            998 59999987653 468999999999999999999994

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.58  E-value=6.6e-15  Score=134.54  Aligned_cols=113  Identities=15%  Similarity=0.160  Sum_probs=99.4

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      .+|...+.||+|+||.||+|.. .+|+.||+|++....  ....+.+|+..+.++ +|+|++++++++......++||||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   87 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   87 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence            4567778999999999999994 678999999986432  334577899999999 899999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      + +|+|.+++...+..+++.++..++.||++||+|||+
T Consensus        88 ~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~  124 (298)
T 1csn_A           88 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE  124 (298)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             c-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9 999999998766679999999999999999999995

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.58  E-value=4.4e-15  Score=143.22  Aligned_cols=114  Identities=19%  Similarity=0.246  Sum_probs=98.1

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecC-----Cee
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE-----EFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  361 (405)
                      ++|...+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|+.++.+++|+||+++++++...     ...
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            4677788999999999999985 568899999996532  33456789999999999999999999998765     578


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+||||++ |+|.+++... ..+++..+..++.||++||+|||+
T Consensus       106 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~  147 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHE  147 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999987 5999999764 369999999999999999999994

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.58  E-value=9.9e-15  Score=133.89  Aligned_cols=115  Identities=22%  Similarity=0.342  Sum_probs=95.4

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc----cchhHHHHHHHHHhhcCCCCCcceEEeeee--cCCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC----RRAFKSFDIECEMMKSIRHQNLIKVISSCS--NEEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~  362 (405)
                      ++|...+.||+|+||.||++.. .+++.||+|++....    ......+.+|+.++.+++|+||+++++++.  .....+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            4677889999999999999995 568899999997542    234567899999999999999999999884  456789


Q ss_pred             EEEecCCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++| +.+++... ...+++..+..++.|+++||+|||+
T Consensus        85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~  127 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS  127 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence            999999986 77776543 3569999999999999999999994

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.58  E-value=8.5e-15  Score=136.27  Aligned_cols=111  Identities=31%  Similarity=0.385  Sum_probs=92.2

Q ss_pred             hccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhh--cCCCCCcceEEeeeecC----CeeE
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMK--SIRHQNLIKVISSCSNE----EFKA  362 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~----~~~~  362 (405)
                      .++|...+.||+|+||.||+|+.. |+.||||++....   ...+..|.+++.  .++||||+++++++...    ...+
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            356778899999999999999874 8999999986432   223344444444  45999999999998876    7889


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++...  .+++..+..++.|+++||+|||+
T Consensus       112 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~  152 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHT  152 (337)
T ss_dssp             EEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHS
T ss_pred             EEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999764  58999999999999999999994

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.58  E-value=5.8e-15  Score=149.83  Aligned_cols=116  Identities=18%  Similarity=0.193  Sum_probs=101.2

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  363 (405)
                      ..+|...++||+|+||.||+|.. .+++.||||++++..   ......+..|..++..+ +|++|+++++++.+.+..|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            35677888999999999999995 467899999997542   33456678899999887 79999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++...+ .+++..+..|+.||+.||+|||+
T Consensus       420 V~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~  460 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQS  460 (674)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999998654 69999999999999999999994

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.58  E-value=2.6e-15  Score=135.96  Aligned_cols=114  Identities=32%  Similarity=0.429  Sum_probs=95.9

Q ss_pred             hccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecC-CeeEEEEec
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNE-EFKALVLEY  367 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  367 (405)
                      .++|...+.||+|+||.||+|.. .|+.||||.++..  ...+.+.+|+.++.+++||||+++++++... +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            34667778999999999999987 5889999998643  2456788999999999999999999987554 578999999


Q ss_pred             CCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++.... ..+++..+..++.|+++||+|||.
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  135 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG  135 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999997543 237899999999999999999994

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.57  E-value=8.5e-15  Score=136.61  Aligned_cols=109  Identities=31%  Similarity=0.493  Sum_probs=95.1

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhc--CCCCCcceEEeeeecCC----eeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKS--IRHQNLIKVISSCSNEE----FKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~l  363 (405)
                      ++|...+.||+|+||.||+|+. +|+.||||.+...   ....+.+|++++..  ++||||+++++++....    ..++
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l  117 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL  117 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence            4677788999999999999998 5899999998643   23556778888776  79999999999998765    7899


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhc
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      ||||+++|+|.+++...  .+++.++..++.|+++||+|||
T Consensus       118 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH  156 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH  156 (342)
T ss_dssp             EECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999764  5899999999999999999999

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.57  E-value=9.5e-15  Score=122.60  Aligned_cols=84  Identities=26%  Similarity=0.348  Sum_probs=50.0

Q ss_pred             CeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeC
Q 036754           14 TFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSL   93 (405)
Q Consensus        14 ~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L   93 (405)
                      +.+++++|.+..+ |.. +   +.+|+.|+|++|++++..|..|..+++|++|+|++|+|+ .+|...+.++++|++|+|
T Consensus        15 ~~l~~~~n~l~~i-P~~-~---~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L   88 (174)
T 2r9u_A           15 TLVNCQNIRLASV-PAG-I---PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDL   88 (174)
T ss_dssp             SEEECCSSCCSSC-CSC-C---CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred             cEEEeCCCCCCcc-CCC-c---CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCC-ccChhHhCCcchhhEEEC
Confidence            5667777766543 322 1   136666666666666666666666666666666666665 455555455666666666


Q ss_pred             CCCCCCCCch
Q 036754           94 DSNELTSIPL  103 (405)
Q Consensus        94 s~N~l~~lp~  103 (405)
                      ++|+|+.+|.
T Consensus        89 ~~N~l~~l~~   98 (174)
T 2r9u_A           89 NDNHLKSIPR   98 (174)
T ss_dssp             CSSCCCCCCT
T ss_pred             CCCccceeCH
Confidence            6666555543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.57  E-value=5.3e-15  Score=140.38  Aligned_cols=113  Identities=24%  Similarity=0.353  Sum_probs=91.5

Q ss_pred             hhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeec---------
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN---------  357 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------  357 (405)
                      ...+|...+.||+|+||+||+|.. .+|+.||+|++......    ..+|+.+++.++|||||++++++..         
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~   80 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP   80 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence            445677889999999999999985 67899999998654222    2369999999999999999998843         


Q ss_pred             -----------------------------CCeeEEEEecCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          358 -----------------------------EEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       358 -----------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                                                   ....++||||++ |+|.+.+..   .+..+++..+..++.|+++||+|||+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  159 (383)
T 3eb0_A           81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS  159 (383)
T ss_dssp             -----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                                         334889999998 588777753   33579999999999999999999995

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.57  E-value=2.4e-15  Score=139.43  Aligned_cols=123  Identities=23%  Similarity=0.301  Sum_probs=103.4

Q ss_pred             HHHHHhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeec--
Q 036754          282 YLELCRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSN--  357 (405)
Q Consensus       282 ~~~~~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--  357 (405)
                      +.++....+.|...+.||+|+||.||+|.. .+|+.||+|++.... .....+.+|+..+.++ +||||+++++++..  
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            334444556778889999999999999995 578999999986543 3346788999999998 89999999999876  


Q ss_pred             ----CCeeEEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          358 ----EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       358 ----~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                          .+..++||||+++|+|.+++.... ..+++..+..++.|+++||+|||.
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  147 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ  147 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                467899999999999999997643 468999999999999999999994

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.57  E-value=5.1e-15  Score=137.66  Aligned_cols=115  Identities=25%  Similarity=0.344  Sum_probs=97.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCC-CCCcceEEeeee--------cCC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-HQNLIKVISSCS--------NEE  359 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~~~  359 (405)
                      .+|...+.||+|+||.||+|.. .+|+.||+|++..........+.+|+..+.++. ||||+++++++.        ...
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            4567778999999999999995 578999999987665556677899999999996 999999999984        344


Q ss_pred             eeEEEEecCCCCCHHHHHhc--CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~--~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++||||++ |+|.+++..  ....+++.++..++.||++||+|||.
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  154 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR  154 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            5789999996 699998864  33469999999999999999999995

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.57  E-value=4.2e-15  Score=135.35  Aligned_cols=115  Identities=25%  Similarity=0.330  Sum_probs=90.7

Q ss_pred             ccCCccCcccccCCCceEEEeeC--CC--cEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG--DG--MEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  362 (405)
                      ++|...+.||+|+||.||+|+..  ++  ..||+|.++...   ....+.+.+|+.++.+++||||+++++++.... .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            45677789999999999999842  33  368999986542   334567899999999999999999999987654 88


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++......+++..+..++.|+++||+|||+
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~  139 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES  139 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999998655568999999999999999999994

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.57  E-value=8.8e-15  Score=148.06  Aligned_cols=114  Identities=23%  Similarity=0.320  Sum_probs=97.0

Q ss_pred             cCCccCcccccCCCceEEEeeC----CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          291 KFSENNLISKGGFGSVYKARLG----DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      +|...+.||+|+||.||+|...    .+..||+|.++... ....+.+.+|+.++.+++||||+++++++. .+..++||
T Consensus       391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~  469 (656)
T 2j0j_A          391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM  469 (656)
T ss_dssp             GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEE
Confidence            4555678999999999999863    24679999986543 334567899999999999999999999985 46689999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+..+++..+..++.|+++||+|||+
T Consensus       470 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~  509 (656)
T 2j0j_A          470 ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES  509 (656)
T ss_dssp             ECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999998766679999999999999999999994

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.57  E-value=8.7e-15  Score=137.65  Aligned_cols=120  Identities=23%  Similarity=0.239  Sum_probs=101.1

Q ss_pred             HHHhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCC-----CCCcceEEeeeec
Q 036754          284 ELCRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-----HQNLIKVISSCSN  357 (405)
Q Consensus       284 ~~~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~~~~~  357 (405)
                      +.....++|...+.||+|+||+||+|.. .+++.||||+++.. ......+..|+.++.+++     ||||+++++++..
T Consensus        29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~  107 (360)
T 3llt_A           29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY  107 (360)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred             cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence            3334456778889999999999999995 57889999998643 233455677888888886     9999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          358 EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       358 ~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+..++||||+ +|+|.+++.... ..+++.++..++.||++||+|||+
T Consensus       108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  155 (360)
T 3llt_A          108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK  155 (360)
T ss_dssp             TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999 889999997654 458999999999999999999994

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.57  E-value=6.6e-15  Score=136.67  Aligned_cols=115  Identities=24%  Similarity=0.403  Sum_probs=97.3

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcE----EEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGME----VAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      .+|...+.||+|+||.||+|.. .+++.    ||+|.+.... ......+.+|+.++.+++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            4577778999999999999985 44544    5777765432 345678899999999999999999999998654 789


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+||+++|+|.+++......+++..+..++.|+++||+|||+
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  135 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED  135 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            999999999999998776679999999999999999999994

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.57  E-value=5.1e-15  Score=139.53  Aligned_cols=116  Identities=16%  Similarity=0.215  Sum_probs=93.6

Q ss_pred             hccCCccCcccccCCCceEEEeeCC------CcEEEEEEeeccccch-----------hHHHHHHHHHhhcCCCCCcceE
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGD------GMEVAVKVFNLQCRRA-----------FKSFDIECEMMKSIRHQNLIKV  351 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l  351 (405)
                      ..+|...+.||+|+||.||+|....      ++.||||++.......           ...+..|+..+..++|+||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            3467778899999999999998643      4789999986543211           1223456667888999999999


Q ss_pred             EeeeecC----CeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          352 ISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       352 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++++...    ...++||||+ +|+|.+++......+++.++..++.||++||+|||+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~  170 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE  170 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9998764    4589999999 999999998765679999999999999999999994

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.57  E-value=6.9e-15  Score=136.89  Aligned_cols=113  Identities=32%  Similarity=0.441  Sum_probs=89.9

Q ss_pred             hccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeec-----CCeeEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN-----EEFKAL  363 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~~l  363 (405)
                      .++|...+.||+|+||.||+|+. +++.||||++....... .....|+..+..++|+||+++++++..     ....++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            35677788999999999999987 68999999997543221 112344555667899999999985532     335789


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++....  .++..+..++.||++||+|||+
T Consensus        90 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~  129 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHT  129 (336)
T ss_dssp             EECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHC
T ss_pred             EEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHh
Confidence            999999999999997654  5899999999999999999995

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.57  E-value=1.1e-14  Score=136.44  Aligned_cols=115  Identities=23%  Similarity=0.362  Sum_probs=97.8

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeec--------C
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSN--------E  358 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~  358 (405)
                      .+|...+.||+|+||.||+|.. .+|+.||+|++....  ......+.+|+.++.+++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            4677778999999999999996 578999999986543  2334577899999999999999999999876        3


Q ss_pred             CeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +..++||||+++ ++.+.+......+++.++..++.|+++||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~  142 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR  142 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            468999999985 8888887765679999999999999999999994

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.57  E-value=1e-14  Score=132.75  Aligned_cols=116  Identities=19%  Similarity=0.154  Sum_probs=93.6

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc-ch-hHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR-RA-FKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      .++|...+.||+|+||.||+|.. .+|+.||+|+++.... .. ...+..+...+..++||||+++++++...+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            35677788999999999999995 5789999999975432 22 233444555588889999999999999999999999


Q ss_pred             ecCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++ +|.+++..   ....+++..+..++.|+++||+|||+
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  127 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS  127 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            99984 88887753   34579999999999999999999994

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.56  E-value=1.9e-15  Score=139.55  Aligned_cols=115  Identities=23%  Similarity=0.449  Sum_probs=99.9

Q ss_pred             hccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      .++|...+.||+|+||.||+|....  .||+|++....  ....+.+.+|+.++.+++|+||+++++++...+..++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            4567778899999999999998743  59999986542  2334567789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++...+..+++.++..++.|+++||+|||+
T Consensus       110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~  148 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA  148 (319)
T ss_dssp             CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH
T ss_pred             cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999998766679999999999999999999994

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.56  E-value=6.1e-15  Score=137.02  Aligned_cols=191  Identities=15%  Similarity=0.124  Sum_probs=116.9

Q ss_pred             CCcCCeeeCcCCcCc--ccCCchhhhcccccccEEEcccCcccccCCccccC--------ccCCCeeecCCcccccccCc
Q 036754           10 CKCLTFIDLSNNPLD--SVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITN--------LTKLTTIILGGNKLNGSISI   79 (405)
Q Consensus        10 l~~L~~L~Ls~N~l~--~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~--------l~~L~~L~L~~N~l~~~~~~   79 (405)
                      +++|+.|||++|+|.  ...+..+    + .+..+.+..|.+   .+..|.+        +++|+.|+|++ .++ .++.
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~----~-~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~-~I~~  117 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTY----P-NGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIK-NIED  117 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSS----G-GGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCC-EECT
T ss_pred             hccCeEEecCcceeEEecCccccc----c-cccccccccccc---CHHHhcccccccccccCCCcEEECCc-ccc-chhH
Confidence            788999999999998  3332221    1 123333333322   2233444        66666666666 555 5666


Q ss_pred             chhcCCCCCCeeeCCCCCCCCCchh-hhccccCccccCCC--------------------------------CCh-----
Q 036754           80 TLGSNLASLRKLSLDSNELTSIPLT-FWNLKDILYLNFSV--------------------------------IPI-----  121 (405)
Q Consensus        80 ~~~~~l~~L~~L~Ls~N~l~~lp~~-~~~l~~L~~l~l~~--------------------------------~p~-----  121 (405)
                      ..|.++++|+.|++++|.++.++.. |.+..++..+....                                ++.     
T Consensus       118 ~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~  197 (329)
T 3sb4_A          118 AAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKA  197 (329)
T ss_dssp             TTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHT
T ss_pred             HHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhc
Confidence            6666666666666666665544332 22222222222111                                000     


Q ss_pred             ----------------------hc-cCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCC
Q 036754          122 ----------------------EI-GGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLK  178 (405)
Q Consensus       122 ----------------------~~-~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  178 (405)
                                            .+ ..+++|+.+++++|.+....+..|.++++|+.+++++| ++...+..|.++.+|+
T Consensus       198 ~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~  276 (329)
T 3sb4_A          198 GLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLA  276 (329)
T ss_dssp             TCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred             ccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhcc
Confidence                                  00 13788999999999888777788999999999999988 7767788899999998


Q ss_pred             -ccccccCcccCcCCC-CCccCCCCcccccCCCCcc
Q 036754          179 -DLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLC  212 (405)
Q Consensus       179 -~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~~c  212 (405)
                       .+++.+ .++...+. .....+++.+.+.+|....
T Consensus       277 ~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~  311 (329)
T 3sb4_A          277 GTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITT  311 (329)
T ss_dssp             EEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCE
T ss_pred             EEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCc
Confidence             999887 55533332 3345667777776665433

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.56  E-value=6.6e-15  Score=140.50  Aligned_cols=105  Identities=17%  Similarity=0.225  Sum_probs=88.4

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhh-cCCCCCcceEEeeeec----CCeeEEEEecCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMK-SIRHQNLIKVISSCSN----EEFKALVLEYMP  369 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~~lv~e~~~  369 (405)
                      ++||+|+||+||+|.. .+|+.||||+++..     ..+.+|+.++. ..+||||+++++++..    ....|+||||++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~  142 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD  142 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence            5799999999999985 46889999998632     34567888764 4589999999998865    567899999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++.... ..+++.++..++.||++||+|||+
T Consensus       143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  179 (400)
T 1nxk_A          143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS  179 (400)
T ss_dssp             SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999998653 469999999999999999999994

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.56  E-value=1.3e-14  Score=134.76  Aligned_cols=110  Identities=16%  Similarity=0.222  Sum_probs=96.0

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEecCCCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPHG  371 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  371 (405)
                      +.||+|+||.||+|.. .+|+.||+|++....  ......+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~  114 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG  114 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence            6799999999999985 468999999997543  23456788999999998 5699999999999999999999999999


Q ss_pred             CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          372 SLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       372 ~L~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|.+++... ...+++.++..++.|+++||+|||.
T Consensus       115 ~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~  149 (327)
T 3lm5_A          115 EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ  149 (327)
T ss_dssp             EGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999998653 2579999999999999999999994

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.56  E-value=1.1e-14  Score=121.74  Aligned_cols=109  Identities=26%  Similarity=0.265  Sum_probs=83.3

Q ss_pred             cccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCC
Q 036754           38 SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS  117 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~  117 (405)
                      +.+.+++++|+++. +|..+.  ++|++|+|++|+|+ .++...+.++++|++|+|++|+|+.+|..             
T Consensus        10 ~~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~-------------   72 (170)
T 3g39_A           10 SGTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLTVLPAG-------------   72 (170)
T ss_dssp             ETTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTT-------------
T ss_pred             CCCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCC-ccChhhhcCcccCCEEECCCCCcCccChh-------------
Confidence            46788888888876 455442  78888888888888 45444456888888888888888877654             


Q ss_pred             CCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCcc
Q 036754          118 VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAI  167 (405)
Q Consensus       118 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~  167 (405)
                          .|.++++|++|+|++|++++..+..|..+++|+.|++++|+++...
T Consensus        73 ----~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  118 (170)
T 3g39_A           73 ----VFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC  118 (170)
T ss_dssp             ----TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred             ----hccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence                3456778888888888888777777888888888888888887553

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.55  E-value=2e-14  Score=132.17  Aligned_cols=116  Identities=25%  Similarity=0.354  Sum_probs=93.6

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc-----chhHHHHHHHHHhhcC---CCCCcceEEeeeecCC
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR-----RAFKSFDIECEMMKSI---RHQNLIKVISSCSNEE  359 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~  359 (405)
                      ..+|...+.||+|+||+||+|.. .+|+.||+|++.....     .....+.+|+..+.++   +||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            45677888999999999999994 5789999999864321     1234566777777666   4999999999987654


Q ss_pred             -----eeEEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 -----FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 -----~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                           ..++||||++ |+|.+++.... ..+++.++..++.|+++||+|||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~  138 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA  138 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                 4789999997 59999997654 349999999999999999999994

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.55  E-value=1.2e-16  Score=137.42  Aligned_cols=136  Identities=22%  Similarity=0.274  Sum_probs=113.3

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhc
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGS   83 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   83 (405)
                      ++.|.++++|++|+|++|.+.+ +| . ++.++ +|+.|++++|.++. +|..+..+++|++|+|++|+++ .+| .+ .
T Consensus        41 ~~~~~~l~~L~~L~ls~n~l~~-l~-~-~~~l~-~L~~L~l~~n~l~~-l~~~~~~~~~L~~L~L~~N~l~-~l~-~~-~  112 (198)
T 1ds9_A           41 DATLSTLKACKHLALSTNNIEK-IS-S-LSGME-NLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SLS-GI-E  112 (198)
T ss_dssp             HHHHHHTTTCSEEECSEEEESC-CC-C-HHHHT-TCCEEEEEEEEECS-CSSHHHHHHHCSEEEEEEEECC-CHH-HH-H
T ss_pred             hHHHhcCCCCCEEECCCCCCcc-cc-c-cccCC-CCCEEECCCCCccc-ccchhhcCCcCCEEECcCCcCC-cCC-cc-c
Confidence            3478899999999999999998 55 4 66776 99999999999985 7778888999999999999998 466 44 5


Q ss_pred             CCCCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcc----------cccCCCC
Q 036754           84 NLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDS----------FGDLISL  153 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~----------~~~l~~L  153 (405)
                      .+++|++|+|++|+++.+|..                ..+..+++|++|++++|++.+.+|..          +..+++|
T Consensus       113 ~l~~L~~L~l~~N~i~~~~~~----------------~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L  176 (198)
T 1ds9_A          113 KLVNLRVLYMSNNKITNWGEI----------------DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL  176 (198)
T ss_dssp             HHHHSSEEEESEEECCCHHHH----------------HHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSC
T ss_pred             cCCCCCEEECCCCcCCchhHH----------------HHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCc
Confidence            899999999999999977641                13456789999999999998776653          7889999


Q ss_pred             CeeecccccccC
Q 036754          154 KSLNLSKNNLSG  165 (405)
Q Consensus       154 ~~L~l~~n~l~~  165 (405)
                      +.|+  +|.++.
T Consensus       177 ~~Ld--~~~i~~  186 (198)
T 1ds9_A          177 KKLD--GMPVDV  186 (198)
T ss_dssp             SEEC--CGGGTT
T ss_pred             EEEC--CcccCH
Confidence            9987  777763

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.55  E-value=1.4e-14  Score=132.60  Aligned_cols=105  Identities=17%  Similarity=0.245  Sum_probs=90.6

Q ss_pred             CcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHh-hcCCCCCcceEEeeeec----CCeeEEEEecCC
Q 036754          296 NLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMM-KSIRHQNLIKVISSCSN----EEFKALVLEYMP  369 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~e~~~  369 (405)
                      +.||+|+||.||++.. .+++.||+|+++..     ..+.+|+..+ ...+||||+++++++..    ....++||||++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~   98 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD   98 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence            6799999999999985 57899999998642     3456788877 55699999999999876    667899999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++.... ..+++.++..++.|+++||+|||.
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  135 (299)
T 3m2w_A           99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS  135 (299)
T ss_dssp             SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999998654 469999999999999999999994

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.55  E-value=7.3e-15  Score=138.59  Aligned_cols=113  Identities=22%  Similarity=0.289  Sum_probs=90.2

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC------e
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE------F  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~  360 (405)
                      ..|...+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|+.++.+++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4566778899999999999985 578999999985432  234567889999999999999999999987653      4


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .|+||||+ +++|.+++...  .+++..+..++.|+++||+|||+
T Consensus       105 ~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~  146 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHA  146 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            69999999 78999999763  58999999999999999999994

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.55  E-value=1.9e-14  Score=136.85  Aligned_cols=114  Identities=21%  Similarity=0.321  Sum_probs=89.5

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeecc--ccchhHHHHHHHHHhhcCC-CCCcceEEeeeecCC--eeE
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIR-HQNLIKVISSCSNEE--FKA  362 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~  362 (405)
                      ..+|...+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.++.++. ||||+++++++...+  ..|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            34677788999999999999984 57899999998643  2334567789999999997 999999999987544  689


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||++ |+|.++++..  .+++..+..++.|+++||+|||+
T Consensus        88 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~  127 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHS  127 (388)
T ss_dssp             EEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999998 5999999763  58999999999999999999994

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.54  E-value=2.5e-14  Score=132.75  Aligned_cols=109  Identities=19%  Similarity=0.309  Sum_probs=95.6

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCC-CCCcceEEeeeec--CCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-HQNLIKVISSCSN--EEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  365 (405)
                      ++|...+.||+|+||.||+|.. .+++.||+|++...   ..+.+.+|+.++.+++ |+||+++++++..  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            4577778999999999999984 67899999998643   3456889999999997 9999999999987  66789999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++.    .+++.++..++.|+++||+|||+
T Consensus       113 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~  148 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS  148 (330)
T ss_dssp             ECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999885    38899999999999999999994

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.54  E-value=7.2e-15  Score=149.84  Aligned_cols=113  Identities=20%  Similarity=0.320  Sum_probs=94.3

Q ss_pred             ccCCccCcccccCCCceEEEeeC--CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCe-----e
Q 036754          290 YKFSENNLISKGGFGSVYKARLG--DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF-----K  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~  361 (405)
                      ++|...+.||+|+||.||+|...  +|+.||||++.... ......+.+|+.++.+++|||||++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            45667788999999999999864  68999999986543 3345678899999999999999999999987554     6


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||||+++|+|.+++..   .++|.++..++.||++||+|||+
T Consensus       160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~  200 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS  200 (681)
T ss_dssp             EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999998754   68999999999999999999994

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.54  E-value=8.2e-15  Score=137.05  Aligned_cols=114  Identities=21%  Similarity=0.186  Sum_probs=90.0

Q ss_pred             ccCCccCcccccCCCceEEEeeC----CCcEEEEEEeeccccc-----------hhHHHHHHHHHhhcCCCCCcceEEee
Q 036754          290 YKFSENNLISKGGFGSVYKARLG----DGMEVAVKVFNLQCRR-----------AFKSFDIECEMMKSIRHQNLIKVISS  354 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~~  354 (405)
                      ++|...+.||+|+||.||+|...    .+..||+|........           ....+.+|+..+..++|+||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            35677789999999999999964    5688999998754321           12346678889999999999999999


Q ss_pred             eec----CCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          355 CSN----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       355 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +..    ....++||||+ +|+|.+++...+ .+++.++..++.||++||+|||+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~  169 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHE  169 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            887    67899999999 999999997654 79999999999999999999994

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.53  E-value=3.1e-15  Score=141.70  Aligned_cols=115  Identities=17%  Similarity=0.186  Sum_probs=90.4

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeecc---ccchhHHHHHHH---HHhhcCCCCCcceEE-------eee
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ---CRRAFKSFDIEC---EMMKSIRHQNLIKVI-------SSC  355 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~~  355 (405)
                      ++|...+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|+   +.+++++|||||+++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            4566678999999999999995 57899999999743   234457788999   566677899999998       444


Q ss_pred             ecCC-----------------eeEEEEecCCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          356 SNEE-----------------FKALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       356 ~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ...+                 ..++||||+ +|+|.+++...+      ..++|..+..|+.||++||+|||+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  224 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH  224 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence            4432                 278999999 689999997532      123368888999999999999994

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.53  E-value=2e-14  Score=134.76  Aligned_cols=113  Identities=19%  Similarity=0.225  Sum_probs=96.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecC-----CeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE-----EFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~  362 (405)
                      ++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++.+++||||+++++++...     ...+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            4567778999999999999995 468999999996543 23456788999999999999999999987653     6789


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||++ |+|.+++...  .+++..+..++.|+++||+|||+
T Consensus        91 lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~  130 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHG  130 (353)
T ss_dssp             EEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999998 5999998763  58999999999999999999994

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.53  E-value=5.1e-15  Score=136.34  Aligned_cols=116  Identities=23%  Similarity=0.326  Sum_probs=91.8

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc------chhHHHHHHHHHhhcC----CCCCcceEEeeeec
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR------RAFKSFDIECEMMKSI----RHQNLIKVISSCSN  357 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~l~~~~~~  357 (405)
                      ..+|...+.||+|+||.||+|.. .+++.||+|++.....      .....+.+|+..+.++    +|+||+++++++..
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            45677888999999999999985 5788999999965432      1233456788888888    89999999999999


Q ss_pred             CCeeEEEEec-CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          358 EEFKALVLEY-MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       358 ~~~~~lv~e~-~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+..++|+|| +++|+|.+++...+ .+++..+..++.|+++||+|||+
T Consensus       110 ~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~  157 (312)
T 2iwi_A          110 QEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHS  157 (312)
T ss_dssp             ---CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999 78999999997644 68999999999999999999994

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.53  E-value=2.3e-14  Score=132.10  Aligned_cols=119  Identities=17%  Similarity=0.267  Sum_probs=102.1

Q ss_pred             HHhhhccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCC--CCCcceEEeeeecCCe
Q 036754          285 LCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIR--HQNLIKVISSCSNEEF  360 (405)
Q Consensus       285 ~~~~~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~  360 (405)
                      +.....+|...+.||+|+||.||++...+++.||||.+....  ......+.+|+.++.+++  |+||+++++++...+.
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            333445677788999999999999998889999999996543  334567889999999997  5999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++||| +.+|+|.+++...+ .+++.++..++.|+++||+|||.
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~  145 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ  145 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999 66789999998654 78999999999999999999994

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.53  E-value=2.8e-14  Score=119.75  Aligned_cols=107  Identities=23%  Similarity=0.293  Sum_probs=81.3

Q ss_pred             ccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCC
Q 036754           39 LEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV  118 (405)
Q Consensus        39 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~  118 (405)
                      -+.+++++|+++. +|..+.  ++|++|+|++|+|+ .++...+.++++|++|+|++|+|+.+|..              
T Consensus        14 ~~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~--------------   75 (174)
T 2r9u_A           14 QTLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLTAIPTG--------------   75 (174)
T ss_dssp             SSEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTT--------------
T ss_pred             CcEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCcc-ccCHHHhcCCcCCCEEECCCCCCCccChh--------------
Confidence            4678888888865 555543  78888888888887 45444456888888888888888877654              


Q ss_pred             CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCc
Q 036754          119 IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGA  166 (405)
Q Consensus       119 ~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~  166 (405)
                         .|.++++|++|+|++|++++..+..|..+++|+.|++++|++...
T Consensus        76 ---~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           76 ---VFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             ---TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             ---HhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcccc
Confidence               245677888888888888876666688888888888888888754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.53  E-value=1.8e-14  Score=139.99  Aligned_cols=112  Identities=21%  Similarity=0.216  Sum_probs=94.2

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeecc--ccchhHHHHHHHHHhhcCCCCCcceEEeeeecC------Ce
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNE------EF  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  360 (405)
                      .+|...+.||+|+||+||+|.. .+|+.||||++...  .....+.+.+|+.++..++|||||++++++...      ..
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            4577778999999999999984 56899999999754  233456788999999999999999999998654      45


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .|+||||+++ ++.+.+..   .+++.++..++.|+++||+|||+
T Consensus       142 ~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~  182 (464)
T 3ttj_A          142 VYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS  182 (464)
T ss_dssp             EEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHH
Confidence            7999999986 57777643   48999999999999999999994

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.53  E-value=6.7e-15  Score=138.02  Aligned_cols=110  Identities=17%  Similarity=0.218  Sum_probs=92.3

Q ss_pred             ccCCccCcccccCCCceEEEeeC---------CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcce----------
Q 036754          290 YKFSENNLISKGGFGSVYKARLG---------DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIK----------  350 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~----------  350 (405)
                      ++|...+.||+|+||.||+|...         .++.||+|.+...     ..+.+|+.++.+++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            45777789999999999999864         3789999998643     46788999999999999988          


Q ss_pred             -----EEeeeec-CCeeEEEEecCCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          351 -----VISSCSN-EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       351 -----l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                           +++++.. ....++||||+ +|+|.+++... ...+++.++..++.||++||+|||+
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  177 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE  177 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence                 5666665 67889999999 99999999865 2479999999999999999999994

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.52  E-value=1.7e-14  Score=133.68  Aligned_cols=119  Identities=26%  Similarity=0.386  Sum_probs=96.7

Q ss_pred             HhhhccCCccCcccccCCCceEEEee--CCCcEEEEEEeecccc--chhHHHHHHHHHhhcC---CCCCcceEEeeee--
Q 036754          286 CRATYKFSENNLISKGGFGSVYKARL--GDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSI---RHQNLIKVISSCS--  356 (405)
Q Consensus       286 ~~~~~~~~~~~~lg~G~fg~v~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~--  356 (405)
                      .....+|...+.||+|+||.||+|..  .+|+.||+|++.....  .....+.+|+.++..+   +||||+++++++.  
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            34456788889999999999999986  4678999999875432  2234566777776665   8999999999987  


Q ss_pred             ---cCCeeEEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          357 ---NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       357 ---~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                         .....++||||++ |+|.+++.... ..+++..+..++.|+++||+|||.
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  138 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS  138 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence               4567899999998 69999997643 458999999999999999999994

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.52  E-value=7.4e-15  Score=146.86  Aligned_cols=116  Identities=27%  Similarity=0.418  Sum_probs=98.3

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeec------CCee
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSN------EEFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~  361 (405)
                      ++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++.+++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            5678889999999999999985 568999999987542 3345678999999999999999999998765      6678


Q ss_pred             EEEEecCCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+++|+|.+++....  ..+++..+..++.|+++||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs  139 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE  139 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999998643  358899999999999999999994

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.52  E-value=2.8e-14  Score=134.43  Aligned_cols=113  Identities=19%  Similarity=0.225  Sum_probs=96.4

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecC-----CeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE-----EFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~  362 (405)
                      ..|...+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.++.+++||||+++++++...     ...+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            4567778999999999999985 468899999997543 33446788999999999999999999998654     4689


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||++ |+|.+++...  .+++.++..++.|+++||+|||+
T Consensus       107 iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~  146 (364)
T 3qyz_A          107 IVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS  146 (364)
T ss_dssp             EEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999998 5999999764  59999999999999999999994

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.52  E-value=1.6e-14  Score=136.26  Aligned_cols=113  Identities=21%  Similarity=0.259  Sum_probs=88.3

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecC------Ce
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE------EF  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  360 (405)
                      ..|...+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|+.++..++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            4567778999999999999984 578999999986532  23456788999999999999999999998654      56


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++|+||+ +++|.+++..  ..+++..+..++.||++||+|||+
T Consensus       109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~  150 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS  150 (367)
T ss_dssp             CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            79999999 6799998865  369999999999999999999994

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.52  E-value=4.3e-14  Score=133.53  Aligned_cols=112  Identities=21%  Similarity=0.204  Sum_probs=95.2

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC------e
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE------F  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~  360 (405)
                      .+|...+.||+|+||.||+|.. .+++.||||++....  ......+.+|+.++..++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            4567778999999999999985 568899999997532  234567889999999999999999999987654      7


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++||||+++ +|.+++..   .+++.++..++.|+++||+|||+
T Consensus       105 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~  145 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS  145 (371)
T ss_dssp             EEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHH
Confidence            8999999985 78888853   48999999999999999999994

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.50  E-value=9.3e-14  Score=128.80  Aligned_cols=115  Identities=19%  Similarity=0.206  Sum_probs=94.4

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHH-HhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECE-MMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ++|...+.||+|+||.||+|.. .+|+.||||++.... ......+..|+. ++..++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            4566778899999999999996 578999999997643 233445566666 6778899999999999999999999999


Q ss_pred             cCCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++ +|.+++..    ....+++..+..++.|+++||+|||+
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~  143 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE  143 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc
Confidence            9985 88777752    23578999999999999999999994

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.50  E-value=7.8e-14  Score=127.24  Aligned_cols=113  Identities=23%  Similarity=0.376  Sum_probs=95.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeee-ecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC-SNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||.||+|.. .+|+.||+|++....  ....+.+|+.++.+++|++++..++++ ...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence            4677788999999999999995 678999999986543  234678899999999998877766655 557788999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      + +|+|.+++......+++.++..++.|+++||+|||+
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  123 (296)
T 3uzp_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS  123 (296)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9 899999998655679999999999999999999994

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.50  E-value=2.6e-14  Score=137.60  Aligned_cols=113  Identities=19%  Similarity=0.353  Sum_probs=94.0

Q ss_pred             hccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEec
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ..+|...++||+|+||+||.....+|+.||||++.....   ..+.+|+.++.++ +|||||++++++.+....|+||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            345777789999999997655566889999999865332   2346799999999 899999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++ |+|.+++........+.++..++.||++||+|||+
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  136 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS  136 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH
Confidence            97 59999998765556666778899999999999994

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.49  E-value=8.5e-14  Score=128.36  Aligned_cols=116  Identities=16%  Similarity=0.131  Sum_probs=86.3

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc-chh-HHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR-RAF-KSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~-~~~-~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      .++|...+.||+|+||.||+|.. .+|+.||||++..... ... +.+..+..++..++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            34566678899999999999996 4789999999976432 222 33344455678889999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+ ++.+..+.......+++..+..++.|+++||+|||+
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  142 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE  142 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999 445555554434578999999999999999999994

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.49  E-value=5.7e-14  Score=130.42  Aligned_cols=159  Identities=15%  Similarity=0.118  Sum_probs=111.8

Q ss_pred             CCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccc---------------
Q 036754           10 CKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLN---------------   74 (405)
Q Consensus        10 l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~---------------   74 (405)
                      |++|+.|+|.+ .+..+.+.+ |.++. +|+.|++++|.+..+.+..|.++.++..+.++.+...               
T Consensus       100 ~~~L~~l~L~~-~i~~I~~~a-F~~~~-~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~  176 (329)
T 3sb4_A          100 KQTLEKVILSE-KIKNIEDAA-FKGCD-NLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGE  176 (329)
T ss_dssp             CTTCCC-CBCT-TCCEECTTT-TTTCT-TCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESC
T ss_pred             cCCCcEEECCc-cccchhHHH-hhcCc-ccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccc
Confidence            99999999999 899888888 55666 8999999999998888888888888887777663220               


Q ss_pred             -----------cccCcchh---------------------------cCCCCCCeeeCCCCCCCCCchhhhccccCccccC
Q 036754           75 -----------GSISITLG---------------------------SNLASLRKLSLDSNELTSIPLTFWNLKDILYLNF  116 (405)
Q Consensus        75 -----------~~~~~~~~---------------------------~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l  116 (405)
                                 +.++..++                           ..+++|+.|+|++|+++.+|..            
T Consensus       177 ~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~------------  244 (329)
T 3sb4_A          177 PLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDF------------  244 (329)
T ss_dssp             CCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTT------------
T ss_pred             ccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHh------------
Confidence                       01111111                           1278999999999999999875            


Q ss_pred             CCCChhccCCCCCCEEeccCCcccccCCcccccCCCCC-eeecccccccCccchhHHhcccCCccccccCcccCc
Q 036754          117 SVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLK-SLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGE  190 (405)
Q Consensus       117 ~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~  190 (405)
                           .|.++++|+.+++++| +..+.+.+|.++++|+ .+++++ .++...+..|.++++|+.++++.|.++..
T Consensus       245 -----aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I  312 (329)
T 3sb4_A          245 -----TFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTL  312 (329)
T ss_dssp             -----TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEE
T ss_pred             -----hhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCcc
Confidence                 3455666666666666 5555566666666666 666666 55555566666666666666666666543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.49  E-value=1.1e-13  Score=126.19  Aligned_cols=113  Identities=23%  Similarity=0.376  Sum_probs=93.5

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeee-ecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC-SNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||.||+|.. .+++.||||+.....  ....+.+|+.++..++|++++..++++ ...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence            5677788999999999999995 678999999875432  224577899999999988877777665 567788999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      + +|+|.+++......+++.++..++.|+++||+|||+
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  123 (296)
T 4hgt_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS  123 (296)
T ss_dssp             C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9 899999998655679999999999999999999994

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.49  E-value=4.9e-14  Score=133.12  Aligned_cols=112  Identities=21%  Similarity=0.272  Sum_probs=95.1

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCee-----
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFK-----  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-----  361 (405)
                      .+|...+.||+|+||.||+|.. .+|+.||||++....  ......+.+|+.++.+++||||+++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            4566678899999999999985 568999999997543  23356788999999999999999999999876654     


Q ss_pred             -EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 -ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 -~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       ++||||++ |+|.+++..   .+++..+..++.|+++||+|||.
T Consensus       122 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~  162 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHS  162 (371)
T ss_dssp             CEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHH
Confidence             99999998 589888742   48999999999999999999994

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.49  E-value=7.4e-14  Score=133.50  Aligned_cols=108  Identities=20%  Similarity=0.282  Sum_probs=84.3

Q ss_pred             cCcccccCCCceEEEeeC---CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeee--cCCeeEEEEecCC
Q 036754          295 NNLISKGGFGSVYKARLG---DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCS--NEEFKALVLEYMP  369 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~  369 (405)
                      .++||+|+||+||+|...   ++..||+|++....  ....+.+|+.++.+++|||||++++++.  .....++||||++
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence            457999999999999854   57889999986432  2346788999999999999999999985  4678999999997


Q ss_pred             CCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~--------~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      + +|.+++...        ...+++..+..++.||++||+|||+
T Consensus       104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~  146 (405)
T 3rgf_A          104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA  146 (405)
T ss_dssp             E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            5 888877532        1248999999999999999999994

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.49  E-value=1e-13  Score=133.43  Aligned_cols=113  Identities=18%  Similarity=0.234  Sum_probs=94.3

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcC------CCCCcceEEeeeecCCeeEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI------RHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~~l  363 (405)
                      .|...+.||+|+||.||+|.. .+++.||||+++... .....+.+|++++..+      .|+||+++++++...+..++
T Consensus        98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            466678999999999999985 468899999996532 2334566777777665      67799999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||++ |+|.+++.... ..+++..+..++.||++||+|||+
T Consensus       177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  218 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK  218 (429)
T ss_dssp             EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999997 59999987654 459999999999999999999994

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.49  E-value=8.6e-14  Score=129.61  Aligned_cols=112  Identities=16%  Similarity=0.217  Sum_probs=88.3

Q ss_pred             ccCCc-cCcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeec----CCeeEE
Q 036754          290 YKFSE-NNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN----EEFKAL  363 (405)
Q Consensus       290 ~~~~~-~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l  363 (405)
                      ++|.. .++||+|+||.||+|... +|+.||+|++..... ..+   .....+..++|+||+++++++..    ....++
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  103 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-ARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLI  103 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-HHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-HHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence            34555 346999999999999964 689999999865321 111   12233566799999999999875    445899


Q ss_pred             EEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|+|.+++.... ..+++.++..++.|+++||+|||+
T Consensus       104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~  146 (336)
T 3fhr_A          104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS  146 (336)
T ss_dssp             EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999998654 469999999999999999999994

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.48  E-value=5.1e-14  Score=134.01  Aligned_cols=114  Identities=22%  Similarity=0.260  Sum_probs=93.5

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCC--------CCCcceEEeeee----
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR--------HQNLIKVISSCS----  356 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~----  356 (405)
                      ..|...+.||+|+||+||+|.. .+++.||||++... ......+.+|+.++.+++        |+||+++++++.    
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            3566778899999999999984 56889999999643 234567788999998885        788999999887    


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          357 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       357 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .....++||||+ +|++.+++.... ..+++..+..++.||++||+|||+
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~  164 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT  164 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            456789999999 557766665443 569999999999999999999994

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.48  E-value=4.9e-14  Score=132.18  Aligned_cols=112  Identities=21%  Similarity=0.268  Sum_probs=94.4

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCe------
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF------  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------  360 (405)
                      .+|...+.||+|+||.||+|.. .+|+.||||++....  ......+.+|+.++.+++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            4566778899999999999985 568999999996542  2335678899999999999999999999877654      


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++||||++ |+|.+++..   .+++.++..++.||++||+|||+
T Consensus       104 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~  144 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHS  144 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH
Confidence            499999998 588887742   48999999999999999999994

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.48  E-value=6.7e-14  Score=134.40  Aligned_cols=110  Identities=25%  Similarity=0.427  Sum_probs=88.9

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeec----C--CeeEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN----E--EFKAL  363 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~--~~~~l  363 (405)
                      .|...+.||+|+||.||+|+. .+|+.||||++.....    ...+|++++.+++|+|||++++++..    .  ...++
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            466778899999999999996 4689999999864321    23469999999999999999998743    1  23679


Q ss_pred             EEecCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++ ++.+.+..   .+..+++..+..++.||++||+|||+
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~  174 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS  174 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999986 66666542   34579999999999999999999995

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.48  E-value=7.1e-14  Score=134.82  Aligned_cols=108  Identities=21%  Similarity=0.278  Sum_probs=87.1

Q ss_pred             ccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEecCCCCC
Q 036754          294 ENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPHGS  372 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~  372 (405)
                      ..++||+|+||+||.+...+|+.||||++....   ...+.+|+.++.++ +|||||++++++.+.+..++||||+. |+
T Consensus        19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs   94 (434)
T 2rio_A           19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN   94 (434)
T ss_dssp             EEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred             ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence            357899999999987666689999999986532   34567899999876 89999999999999999999999996 69


Q ss_pred             HHHHHhcCCCC------CCHHHHHHHHHHHHHHHhhhcC
Q 036754          373 LEKYLYSSNCI------LDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       373 L~~~l~~~~~~------l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |.+++......      .++..+..++.||++||+|||+
T Consensus        95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  133 (434)
T 2rio_A           95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS  133 (434)
T ss_dssp             HHHHHHTC------------CCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH
Confidence            99999765311      1333457899999999999994

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.48  E-value=2.2e-13  Score=132.70  Aligned_cols=113  Identities=20%  Similarity=0.306  Sum_probs=95.2

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCC-CCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH-QNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||.||+|.. .+++.||||++.....  ...+..|++++..++| +++..+..++...+..++||||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~   84 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL   84 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence            4677789999999999999995 6789999998765432  2357789999999987 5566666667778889999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      + +|+|.+++......+++..+..|+.||++||+|||+
T Consensus        85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~  121 (483)
T 3sv0_A           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS  121 (483)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9 899999998656679999999999999999999994

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.48  E-value=9.1e-14  Score=129.19  Aligned_cols=114  Identities=14%  Similarity=0.262  Sum_probs=96.2

Q ss_pred             ccCCccCcccccCCCceEEEee--CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCC------cceEEeeeecCCee
Q 036754          290 YKFSENNLISKGGFGSVYKARL--GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQN------LIKVISSCSNEEFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~~  361 (405)
                      ++|...+.||+|+||.||+|..  .+++.||||+++.. ......+.+|+.++..++|++      ++++++++...+..
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            3566778899999999999985  46789999998643 233456778888888887664      99999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+ +|+|.+++...+ ..+++.++..++.|+++||+|||.
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  136 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS  136 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH
Confidence            9999999 889999997654 368999999999999999999994

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.48  E-value=4.8e-14  Score=130.41  Aligned_cols=116  Identities=20%  Similarity=0.268  Sum_probs=98.6

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccc------hhHHHHHHHHHhhcCC--CCCcceEEeeeecCC
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRR------AFKSFDIECEMMKSIR--HQNLIKVISSCSNEE  359 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~  359 (405)
                      ..+|...+.||+|+||.||+|.. .+++.||||.+......      ....+.+|+.++.+++  |+||+++++++...+
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~  121 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD  121 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence            45677788999999999999984 57899999999754321      2345677999999986  599999999999999


Q ss_pred             eeEEEEecCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++|+||+.+ |+|.+++...+ .+++..+..++.|+++||+|||+
T Consensus       122 ~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~  167 (320)
T 3a99_A          122 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN  167 (320)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999976 89999997643 68999999999999999999994

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.47  E-value=6e-16  Score=155.34  Aligned_cols=39  Identities=10%  Similarity=-0.055  Sum_probs=17.7

Q ss_pred             CCCCCeeecccccccC-ccchhHHhcccCCccccccCccc
Q 036754          150 LISLKSLNLSKNNLSG-AIPASLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       150 l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~l~l~~n~l~  188 (405)
                      +++|+.|++++|.+++ .++..+..+++|+.|++++|.++
T Consensus       462 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~  501 (592)
T 3ogk_B          462 SPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS  501 (592)
T ss_dssp             CTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred             CccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence            4445555555555443 12223344445555555555443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.47  E-value=1.6e-13  Score=128.83  Aligned_cols=118  Identities=18%  Similarity=0.227  Sum_probs=84.0

Q ss_pred             HHhhhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCe---
Q 036754          285 LCRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEF---  360 (405)
Q Consensus       285 ~~~~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  360 (405)
                      .....++|...+.||+|+||.||+|.. .+|..||||++.... .....+.++++.+..++||||+++++++.....   
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            344556788889999999999999996 568999999986542 233456678888899999999999999865332   


Q ss_pred             ----eEEEEecCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHhhhc
Q 036754          361 ----KALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       361 ----~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                          .++||||+++ ++.+.+..   ....+++..+..++.|++.||+|||
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH  146 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH  146 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh
Confidence                7899999987 55554432   3457899999999999999999999

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.45  E-value=1.5e-13  Score=130.74  Aligned_cols=110  Identities=25%  Similarity=0.398  Sum_probs=87.2

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCC------eeEEE
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE------FKALV  364 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv  364 (405)
                      .|...+.||+|+||+||+|+...+..||+|++......    ..+|+.++..++||||+++++++....      ..++|
T Consensus        41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            46677899999999999999877777999988543221    236899999999999999999985432      37899


Q ss_pred             EecCCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||++++ +.+.+.   .....+++..+..++.|+++||+|||+
T Consensus       117 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~  159 (394)
T 4e7w_A          117 LEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS  159 (394)
T ss_dssp             EECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999875 444332   223579999999999999999999994

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.45  E-value=6.5e-13  Score=124.19  Aligned_cols=85  Identities=18%  Similarity=0.183  Sum_probs=53.6

Q ss_pred             eeeCcCC-cCcccCCchhhhcccccccEEEccc-CcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeee
Q 036754           15 FIDLSNN-PLDSVLPKTFVGNVSHSLEFFVMSY-CNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLS   92 (405)
Q Consensus        15 ~L~Ls~N-~l~~~~~~~f~~~~~~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~   92 (405)
                      .++++++ +|++ +|.  ++.+. +|+.|+|++ |++++..++.|.++++|+.|+|++|+|++ ++...|.+|++|++|+
T Consensus        12 ~v~~~~~n~l~~-ip~--l~~~~-~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~   86 (347)
T 2ifg_A           12 GLRCTRDGALDS-LHH--LPGAE-NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF-VAPDAFHFTPRLSRLN   86 (347)
T ss_dssp             CEECCSSCCCTT-TTT--SCSCS-CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE-ECTTGGGSCSCCCEEE
T ss_pred             EEEcCCCCCCCc-cCC--CCCCC-CeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccce-eCHHHhcCCcCCCEEe
Confidence            4577776 6665 333  34443 677777774 77776666667777777777777777763 4444445677777777


Q ss_pred             CCCCCCCCCchh
Q 036754           93 LDSNELTSIPLT  104 (405)
Q Consensus        93 Ls~N~l~~lp~~  104 (405)
                      |++|+|+.+|..
T Consensus        87 l~~N~l~~~~~~   98 (347)
T 2ifg_A           87 LSFNALESLSWK   98 (347)
T ss_dssp             CCSSCCSCCCST
T ss_pred             CCCCccceeCHH
Confidence            777776666544

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.43  E-value=9.1e-14  Score=131.28  Aligned_cols=114  Identities=11%  Similarity=0.045  Sum_probs=78.4

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc---chhHHHHHHHH---HhhcCCCCCcceEEe-------ee
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR---RAFKSFDIECE---MMKSIRHQNLIKVIS-------SC  355 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~l~~-------~~  355 (405)
                      .+|...+.||+|+||.||+|.. .+|+.||||++.....   .....+.+|+.   .+.. +||||++++.       ++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            3467778999999999999995 4789999999976432   33455677754   5555 7999888553       33


Q ss_pred             ecC-----------------CeeEEEEecCCCCCHHHHHhcCCCCCCHHHH------HHHHHHHHHHHhhhcC
Q 036754          356 SNE-----------------EFKALVLEYMPHGSLEKYLYSSNCILDIFQR------LNIMIDVASALEYLHF  405 (405)
Q Consensus       356 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~------~~i~~~ia~gl~yLH~  405 (405)
                      ...                 ...++||||++ |+|.+++...+..+.+..+      ..++.||++||+|||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~  212 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS  212 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            221                 34799999999 8999999864434566666      7888999999999994

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.42  E-value=2.5e-14  Score=134.83  Aligned_cols=167  Identities=18%  Similarity=0.212  Sum_probs=114.7

Q ss_pred             CCcCCeeeCcCCcCcccCCchhhhc---ccccccEEEcccCcccccCCccc-cCccCCCeeecCCcccccccCcchh---
Q 036754           10 CKCLTFIDLSNNPLDSVLPKTFVGN---VSHSLEFFVMSYCNISGGILEEI-TNLTKLTTIILGGNKLNGSISITLG---   82 (405)
Q Consensus        10 l~~L~~L~Ls~N~l~~~~~~~f~~~---~~~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~---   82 (405)
                      +++|+.|+|++|.++......+...   ...+|+.|+|++|.++......+ ..+++|+.|+|++|.++..-...+.   
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            3578899999999876554442221   11378999999998865433333 4567889999999988633222221   


Q ss_pred             -cCCCCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCccccc----CCcccccCCCCCeee
Q 036754           83 -SNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGS----IPDSFGDLISLKSLN  157 (405)
Q Consensus        83 -~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~  157 (405)
                       ...++|++|+|++|.|+......             ++..+...++|++|+|++|.+...    ++..+...++|++|+
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~-------------l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~  217 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAV-------------LMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELN  217 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHH-------------HHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEE
T ss_pred             HhcCCccceeeCCCCCCChHHHHH-------------HHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEE
Confidence             24678999999999887422110             112344567899999999998743    245567778999999


Q ss_pred             cccccccCc----cchhHHhcccCCccccccCcccC
Q 036754          158 LSKNNLSGA----IPASLEKLLYLKDLNLSFNKLEG  189 (405)
Q Consensus       158 l~~n~l~~~----~~~~~~~l~~L~~l~l~~n~l~~  189 (405)
                      |++|.++..    +...+...++|+.|++++|.|+.
T Consensus       218 Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          218 VAYNGAGDTAALALARAAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             CCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred             CCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence            999999753    33445566899999999998864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.41  E-value=2.1e-13  Score=128.64  Aligned_cols=114  Identities=14%  Similarity=0.231  Sum_probs=94.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCC-----------CCCcceEEeeeec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-----------HQNLIKVISSCSN  357 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~  357 (405)
                      .+|...+.||+|+||.||+|+. .+++.||||++... ......+.+|+.++.+++           |+||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            4566778999999999999995 57899999998643 223456778888888776           8999999999875


Q ss_pred             CC----eeEEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          358 EE----FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       358 ~~----~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+    ..++||||+ +|+|.+++.... ..+++..+..++.||++||+|||+
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~  149 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR  149 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            43    788999999 889999997643 459999999999999999999994

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.41  E-value=5.3e-13  Score=126.51  Aligned_cols=114  Identities=21%  Similarity=0.293  Sum_probs=95.0

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCC-CC-----CcceEEeeeecCCee
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-HQ-----NLIKVISSCSNEEFK  361 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~~  361 (405)
                      .++|...+.||+|+||+||+|.. .+++.||||+++.. ......+..|+.++..++ |+     +++++++++...+..
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  131 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL  131 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence            45677778999999999999985 46889999999643 223456677888877774 44     499999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhc
Q 036754          362 ALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      ++||||++ |+|.+++.... ..+++..+..++.|++.||+|||
T Consensus       132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH  174 (382)
T 2vx3_A          132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA  174 (382)
T ss_dssp             EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHT
T ss_pred             EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhc
Confidence            99999996 59999998654 46899999999999999999999

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.40  E-value=4.5e-13  Score=125.36  Aligned_cols=114  Identities=16%  Similarity=0.233  Sum_probs=94.2

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CC-cEEEEEEeeccccchhHHHHHHHHHhhcCCCCC------cceEEeeeecCCee
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DG-MEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQN------LIKVISSCSNEEFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~~  361 (405)
                      ++|...+.||+|+||+||+|... ++ ..||+|+++.. ......+.+|+.++.+++|++      ++.+.+++...+..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            45667788999999999999853 34 68999999643 233456778999998887766      89999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+ +|++.+++.... ..+++.++..++.||++||+|||+
T Consensus        98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~  141 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE  141 (355)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999 567777776543 569999999999999999999995

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.40  E-value=2.4e-14  Score=143.60  Aligned_cols=188  Identities=16%  Similarity=0.171  Sum_probs=121.9

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhccc-----------------------ccccEEEccc-----------Cc
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVS-----------------------HSLEFFVMSY-----------CN   48 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~-----------------------~~L~~L~L~~-----------n~   48 (405)
                      ++..+..+++|++|+|++|.+++.....+++.++                       ++|+.|++++           |.
T Consensus       285 l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~  364 (592)
T 3ogk_B          285 MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGL  364 (592)
T ss_dssp             GGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCC
T ss_pred             HHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCc
Confidence            3445667778888888888765433322233333                       1445555552           33


Q ss_pred             cccc-CCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCC----CCCCCCCc------hhhhccccCccccCC
Q 036754           49 ISGG-ILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLD----SNELTSIP------LTFWNLKDILYLNFS  117 (405)
Q Consensus        49 l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls----~N~l~~lp------~~~~~l~~L~~l~l~  117 (405)
                      ++.. ++..+..+++|++|+++.|++++..+..+...+++|++|+++    .|.++..|      ..+.++++|+.|+++
T Consensus       365 ~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~  444 (592)
T 3ogk_B          365 VSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFY  444 (592)
T ss_dssp             CCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEE
T ss_pred             cCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEe
Confidence            3321 111233466667777666666655555554457788888885    56777543      235567888888874


Q ss_pred             C----CC----hhc-cCCCCCCEEeccCCcccc-cCCcccccCCCCCeeecccccccCc-cchhHHhcccCCccccccCc
Q 036754          118 V----IP----IEI-GGLPNLEYLFLGYNRLQG-SIPDSFGDLISLKSLNLSKNNLSGA-IPASLEKLLYLKDLNLSFNK  186 (405)
Q Consensus       118 ~----~p----~~~-~~l~~L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~l~l~~n~  186 (405)
                      .    +.    ..+ ..+++|++|++++|.+++ .++..+..+++|+.|++++|.+++. ++..+..+++|+.|++++|+
T Consensus       445 ~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~  524 (592)
T 3ogk_B          445 LRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR  524 (592)
T ss_dssp             CCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred             cCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence            2    11    112 347899999999999875 3455568899999999999998644 44556789999999999999


Q ss_pred             ccCc
Q 036754          187 LEGE  190 (405)
Q Consensus       187 l~~~  190 (405)
                      +++.
T Consensus       525 it~~  528 (592)
T 3ogk_B          525 ASMT  528 (592)
T ss_dssp             CCTT
T ss_pred             CCHH
Confidence            8754

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.38  E-value=3.5e-13  Score=125.97  Aligned_cols=132  Identities=18%  Similarity=0.147  Sum_probs=99.6

Q ss_pred             cEEEcccC-cccccCCccccCccCCCeeecCC-cccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCC
Q 036754           40 EFFVMSYC-NISGGILEEITNLTKLTTIILGG-NKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS  117 (405)
Q Consensus        40 ~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~  117 (405)
                      ..++++++ +++. +|. +..+++|+.|+|++ |+|+ .+|...+.+|++|++|+|++|+|+.+|+.             
T Consensus        11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-------------   74 (347)
T 2ifg_A           11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPD-------------   74 (347)
T ss_dssp             SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTT-------------
T ss_pred             CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCC-CcChhHhccccCCCEEECCCCccceeCHH-------------
Confidence            35688888 8887 666 99999999999996 9998 66766667999999999999999977643             


Q ss_pred             CCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccc-hhHHhcccCCccccccCcccCcCC
Q 036754          118 VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIP-ASLEKLLYLKDLNLSFNKLEGEIP  192 (405)
Q Consensus       118 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~l~l~~n~l~~~~p  192 (405)
                          .|.++++|++|+|++|+|++.++..|..++ |+.|+|.+|.+..... .+|..+.......+..+.+++.-|
T Consensus        75 ----~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~  145 (347)
T 2ifg_A           75 ----AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ  145 (347)
T ss_dssp             ----GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred             ----HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCC
Confidence                456778899999999999977777777666 9999999999975433 344444444444444455554443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.37  E-value=1.5e-14  Score=145.10  Aligned_cols=197  Identities=12%  Similarity=0.082  Sum_probs=98.9

Q ss_pred             CCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccc-cCCccccCccCCCeeec---------CCcccccccC
Q 036754            9 NCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISG-GILEEITNLTKLTTIIL---------GGNKLNGSIS   78 (405)
Q Consensus         9 ~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L---------~~N~l~~~~~   78 (405)
                      .+++|+.|+|++|.+++.....++..++ +|+.|++++| +.. .++.....+++|+.|+|         +.|.+++.-.
T Consensus       287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~-~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l  364 (594)
T 2p1m_B          287 VCSRLTTLNLSYATVQSYDLVKLLCQCP-KLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGL  364 (594)
T ss_dssp             HHTTCCEEECTTCCCCHHHHHHHHTTCT-TCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHH
T ss_pred             hhCCCCEEEccCCCCCHHHHHHHHhcCC-CcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHH
Confidence            4566666666666654433222233444 6666666666 322 12222234566666666         2234432222


Q ss_pred             cchhcCCCCCCeeeCCCCCCCC-Cchhhh-ccccCccccCC--C------CC---------hhccCCCCCCEEeccCCcc
Q 036754           79 ITLGSNLASLRKLSLDSNELTS-IPLTFW-NLKDILYLNFS--V------IP---------IEIGGLPNLEYLFLGYNRL  139 (405)
Q Consensus        79 ~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~-~l~~L~~l~l~--~------~p---------~~~~~l~~L~~L~l~~n~l  139 (405)
                      ..+..++++|++|+++.|+++. .+..+. .+++|+.|+++  .      +.         ..+.++++|++|++++ .+
T Consensus       365 ~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l  443 (594)
T 2p1m_B          365 VSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LL  443 (594)
T ss_dssp             HHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SC
T ss_pred             HHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cc
Confidence            2232346666666666666652 122222 35566666555  1      11         1134556667777755 44


Q ss_pred             cccCCccccc-CCCCCeeecccccccCccchhH-HhcccCCccccccCcccCcCCC--CCccCCCCcccccCC
Q 036754          140 QGSIPDSFGD-LISLKSLNLSKNNLSGAIPASL-EKLLYLKDLNLSFNKLEGEIPR--GGSFGNFSAESFEGN  208 (405)
Q Consensus       140 ~~~~p~~~~~-l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~l~l~~n~l~~~~p~--~~~~~~~~~~~~~~n  208 (405)
                      .+..+..+.. +++|+.|++++|.+++..+..+ ..+++|+.|++++|.+++....  ...+++++.+++.+|
T Consensus       444 ~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~  516 (594)
T 2p1m_B          444 TDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSC  516 (594)
T ss_dssp             CHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESS
T ss_pred             cHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCC
Confidence            4333333433 6667777777776654433333 4566677777777766432211  122455555555554

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.33  E-value=1e-11  Score=118.11  Aligned_cols=170  Identities=13%  Similarity=0.091  Sum_probs=102.0

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      +|.++ +|+.++|.+| +..+...+|.+ +  +|+.+.+.+ .+..+.+..|.++++|+.++|++|+++ .++...|. .
T Consensus       131 aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~--~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~-~  202 (401)
T 4fdw_A          131 AFRNS-QIAKVVLNEG-LKSIGDMAFFN-S--TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFV-Y  202 (401)
T ss_dssp             TTTTC-CCSEEECCTT-CCEECTTTTTT-C--CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTT-T
T ss_pred             hcccC-CccEEEeCCC-ccEECHHhcCC-C--CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEe-e
Confidence            45565 6888887766 77777777544 2  577777775 566666677777788888888777776 66666663 5


Q ss_pred             CCCCeeeCCCCCCCCCch-hhhccccCccccCCC--------------------------C-ChhccCCCCCCEEeccCC
Q 036754           86 ASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSV--------------------------I-PIEIGGLPNLEYLFLGYN  137 (405)
Q Consensus        86 ~~L~~L~Ls~N~l~~lp~-~~~~l~~L~~l~l~~--------------------------~-p~~~~~l~~L~~L~l~~n  137 (405)
                      .+|+.+.|.. +++.++. .|.++.+|+.+.+..                          + ...|.++++|+.+++.+|
T Consensus       203 ~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~l~~I~~~aF~~~~L~~i~lp~~i~~I~~~aF~~c~~L~~l~l~~~  281 (401)
T 4fdw_A          203 AGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPENVSTIGQEAFRESGITTVKLPNGVTNIASRAFYYCPELAEVTTYGS  281 (401)
T ss_dssp             CCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTTCCEECTTTTTTCCCSEEEEETTCCEECTTTTTTCTTCCEEEEESS
T ss_pred             cccCEEEeCC-chheehhhHhhCCCCCCEEecCCCccCccccccccCCccEEEeCCCccEEChhHhhCCCCCCEEEeCCc
Confidence            6777777763 3555543 344555555555432                          1 223455556666666555


Q ss_pred             ccc-----ccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccC
Q 036754          138 RLQ-----GSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFN  185 (405)
Q Consensus       138 ~l~-----~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n  185 (405)
                      .+.     ...+..|.+|++|+.+++.+ .++......|.++.+|+.+.+..|
T Consensus       282 ~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~  333 (401)
T 4fdw_A          282 TFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN  333 (401)
T ss_dssp             CCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT
T ss_pred             cccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc
Confidence            443     24445555666666666653 344444555555666666665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.33  E-value=1.3e-12  Score=129.14  Aligned_cols=101  Identities=13%  Similarity=0.129  Sum_probs=77.5

Q ss_pred             cCcccccCCCceEEEeeCCCcEEEEEEeeccc--------cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          295 NNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--------RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      .+.||+|+||.||+|.. .+..+|+|......        ....+.+.+|++++.+++||||+++..++...+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            46899999999999954 57788998864321        1123458899999999999999977677667788899999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++..         +..++.|+++||+|||+
T Consensus       420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~  449 (540)
T 3en9_A          420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHK  449 (540)
T ss_dssp             CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHH
Confidence            9999999999864         56799999999999994

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.31  E-value=3.5e-12  Score=115.50  Aligned_cols=113  Identities=15%  Similarity=0.112  Sum_probs=83.7

Q ss_pred             HHHHHHhhhccCCccCcccccCCCceEEEeeCCCcEEEEEEeecccc------------------chhHHHHHHHHHhhc
Q 036754          281 SYLELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCR------------------RAFKSFDIECEMMKS  342 (405)
Q Consensus       281 ~~~~~~~~~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~  342 (405)
                      +...+......|...+.||+|+||.||+|...+|+.||+|.++....                  .....+.+|+.++.+
T Consensus        81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~  160 (282)
T 1zar_A           81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK  160 (282)
T ss_dssp             HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence            33344444444556688999999999999997799999999964321                  124568899999999


Q ss_pred             CCCCCcceEEeeeecCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       343 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|   +++.+++.. +..++||||+++|+|.+ +..       .+...++.|+++||+|||.
T Consensus       161 l~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~  211 (282)
T 1zar_A          161 LQG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYH  211 (282)
T ss_dssp             TTT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHH
T ss_pred             ccC---CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHH
Confidence            984   555554433 56699999999999998 522       1244699999999999994

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.29  E-value=5.6e-12  Score=125.27  Aligned_cols=103  Identities=18%  Similarity=0.137  Sum_probs=77.9

Q ss_pred             cccCCCceEEEe-eCCCcEEEEEEeeccc----------cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEEEe
Q 036754          299 SKGGFGSVYKAR-LGDGMEVAVKVFNLQC----------RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       299 g~G~fg~v~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      +.|++|.+..+. ..-|..+|+|++....          ....++|.+|+++|+++ .|+||++++++++++...|||||
T Consensus       243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME  322 (569)
T 4azs_A          243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME  322 (569)
T ss_dssp             C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred             ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence            445555444332 2347889999996531          12346799999999999 79999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |++||+|.+.|...+ .++..   +|+.||++||+|+|.
T Consensus       323 yv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~  357 (569)
T 4azs_A          323 KLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEK  357 (569)
T ss_dssp             CCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHH
T ss_pred             cCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHH
Confidence            999999999998654 56654   488999999999994

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.29  E-value=1.3e-11  Score=117.25  Aligned_cols=172  Identities=16%  Similarity=0.201  Sum_probs=138.8

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      +|.+|++|+.++|++|++..+...+|.  +. +|+.+.|..+ ++.+....|.++++|+.+++.+| ++ .++...|.+ 
T Consensus       175 aF~~c~~L~~l~l~~n~l~~I~~~aF~--~~-~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~-~I~~~aF~~-  247 (401)
T 4fdw_A          175 IFYYCYNLKKADLSKTKITKLPASTFV--YA-GIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VS-TIGQEAFRE-  247 (401)
T ss_dssp             TTTTCTTCCEEECTTSCCSEECTTTTT--TC-CCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CC-EECTTTTTT-
T ss_pred             HhhCcccCCeeecCCCcceEechhhEe--ec-ccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-cc-Ccccccccc-
Confidence            678888999999998888888888754  23 8899988844 77777788889999999999876 55 788888866 


Q ss_pred             CCCCeeeCCCCCCCCCc-hhhhccccCccccCCC----------C-ChhccCCCCCCEEeccCCcccccCCcccccCCCC
Q 036754           86 ASLRKLSLDSNELTSIP-LTFWNLKDILYLNFSV----------I-PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISL  153 (405)
Q Consensus        86 ~~L~~L~Ls~N~l~~lp-~~~~~l~~L~~l~l~~----------~-p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L  153 (405)
                      .+|+.++| .|+++.++ ..|.++.+|+.+.+..          + +..|.++++|+.+++.+ .+.......|.+|++|
T Consensus       248 ~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L  325 (401)
T 4fdw_A          248 SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKV  325 (401)
T ss_dssp             CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSC
T ss_pred             CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCc
Confidence            78999998 56677775 4567888888887643          2 34688999999999994 5777778899999999


Q ss_pred             CeeecccccccCccchhHHhcccCCccccccCccc
Q 036754          154 KSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       154 ~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~  188 (405)
                      +.+.+..| ++...+..|.++ +|+.+++..|.+.
T Consensus       326 ~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~  358 (401)
T 4fdw_A          326 TQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPP  358 (401)
T ss_dssp             CEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCC
T ss_pred             cEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCc
Confidence            99999766 666777889999 9999999998765

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.28  E-value=2.1e-13  Score=136.78  Aligned_cols=180  Identities=17%  Similarity=0.163  Sum_probs=131.8

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEccc---------CcccccCCccc-cCccCCCeeecCCcccccc
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSY---------CNISGGILEEI-TNLTKLTTIILGGNKLNGS   76 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~---------n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~   76 (405)
                      +.++++|+.|++++| +.......+...++ +|+.|+++.         +.++......+ ..+++|+.|+++.|.+++.
T Consensus       310 ~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~-~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~  387 (594)
T 2p1m_B          310 LCQCPKLQRLWVLDY-IEDAGLEVLASTCK-DLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNA  387 (594)
T ss_dssp             HTTCTTCCEEEEEGG-GHHHHHHHHHHHCT-TCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHH
T ss_pred             HhcCCCcCEEeCcCc-cCHHHHHHHHHhCC-CCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHH
Confidence            568999999999998 54332223234455 899999943         45554333333 3489999999999999866


Q ss_pred             cCcchhcCCCCCCeeeCC--C----CCCCCCch------hhhccccCccccCCCC-----ChhccC-CCCCCEEeccCCc
Q 036754           77 ISITLGSNLASLRKLSLD--S----NELTSIPL------TFWNLKDILYLNFSVI-----PIEIGG-LPNLEYLFLGYNR  138 (405)
Q Consensus        77 ~~~~~~~~l~~L~~L~Ls--~----N~l~~lp~------~~~~l~~L~~l~l~~~-----p~~~~~-l~~L~~L~l~~n~  138 (405)
                      ....+...+++|++|+|+  +    |+++..|.      .+..+++|+.|+++..     +..+.. +++|++|++++|.
T Consensus       388 ~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~~l~~~~~~~l~~~~~~L~~L~L~~~~  467 (594)
T 2p1m_B          388 ALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAG  467 (594)
T ss_dssp             HHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHCTTCCEEEEESCC
T ss_pred             HHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecCcccHHHHHHHHHhchhccEeeccCCC
Confidence            566665578999999999  4    67775543      2567789999998761     112333 8899999999999


Q ss_pred             ccccCCccc-ccCCCCCeeecccccccCccch-hHHhcccCCccccccCccc
Q 036754          139 LQGSIPDSF-GDLISLKSLNLSKNNLSGAIPA-SLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       139 l~~~~p~~~-~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~l~l~~n~l~  188 (405)
                      +++..+..+ ..+++|+.|++++|.+++.... ....+++|+.|++++|.++
T Consensus       468 i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~  519 (594)
T 2p1m_B          468 DSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS  519 (594)
T ss_dssp             SSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred             CcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence            876555555 6789999999999999644333 3456899999999999884

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.25  E-value=7.9e-13  Score=124.51  Aligned_cols=149  Identities=19%  Similarity=0.196  Sum_probs=108.0

Q ss_pred             CCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCcccc-----CccCCCeeecCCcccccc----cCcc
Q 036754           10 CKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEIT-----NLTKLTTIILGGNKLNGS----ISIT   80 (405)
Q Consensus        10 l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~~~~   80 (405)
                      .++|+.|+|++|.++......+...+. +|+.|+|++|.++......++     ..++|++|+|++|.|+..    ++..
T Consensus       100 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~-~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~  178 (372)
T 3un9_A          100 RHALDEVNLASCQLDPAGLRTLLPVFL-RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEG  178 (372)
T ss_dssp             SSCEEEEECTTCCCCHHHHHHTHHHHH-TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHH
T ss_pred             CCCceEEEecCCCCCHHHHHHHHHHHH-hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHH
Confidence            479999999999997655555444455 899999999999765444442     457899999999999732    2333


Q ss_pred             hhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCccccc----CCcccccCCCCCee
Q 036754           81 LGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGS----IPDSFGDLISLKSL  156 (405)
Q Consensus        81 ~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L  156 (405)
                      + ..+++|++|+|++|.|+.....  .           ++..+...++|++|+|++|.+...    ++..+...++|++|
T Consensus       179 L-~~~~~L~~L~Ls~N~l~~~g~~--~-----------L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L  244 (372)
T 3un9_A          179 L-AGNTSVTHLSLLHTGLGDEGLE--L-----------LAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELL  244 (372)
T ss_dssp             H-HTCSSCCEEECTTSSCHHHHHH--H-----------HHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEE
T ss_pred             H-hcCCCcCEEeCCCCCCCcHHHH--H-----------HHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEE
Confidence            3 4788999999999998743211  0           112344567899999999999753    33445567999999


Q ss_pred             ecccccccCccchhHHh
Q 036754          157 NLSKNNLSGAIPASLEK  173 (405)
Q Consensus       157 ~l~~n~l~~~~~~~~~~  173 (405)
                      +|++|.++..-...+..
T Consensus       245 ~Ls~N~i~~~g~~~L~~  261 (372)
T 3un9_A          245 HLYFNELSSEGRQVLRD  261 (372)
T ss_dssp             ECTTSSCCHHHHHHHHH
T ss_pred             eccCCCCCHHHHHHHHH
Confidence            99999998654444444

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.05  E-value=1.3e-10  Score=111.06  Aligned_cols=117  Identities=17%  Similarity=0.157  Sum_probs=82.6

Q ss_pred             hhccCCccCcccccCCCceEEEe-eCCCcEEEEEEeecccc---chhHHHHHHHHHhhcCCC-CCcceEEe---------
Q 036754          288 ATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCR---RAFKSFDIECEMMKSIRH-QNLIKVIS---------  353 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~l~~---------  353 (405)
                      .+.+|...+.||+|+||+||+|+ ..+|+.||||++.....   ...+.+.+|+.++..++| +|......         
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            34456677899999999999999 46789999999874332   235678899999999987 32211111         


Q ss_pred             ------------eeec-----CCeeEEEEecCCCCCHHHHHh------cCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          354 ------------SCSN-----EEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       354 ------------~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                                  ++..     ....+++|+++ +|+|.+++.      ..+..++|..+..++.||++||+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  229 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH  229 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence                        1111     12345666654 679999884      223457888999999999999999994

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.00  E-value=8.1e-11  Score=105.10  Aligned_cols=104  Identities=19%  Similarity=0.239  Sum_probs=75.9

Q ss_pred             CccCcccccCCCceEEEee-CCCcE--EEEEEeeccccc------------------------hhHHHHHHHHHhhcCCC
Q 036754          293 SENNLISKGGFGSVYKARL-GDGME--VAVKVFNLQCRR------------------------AFKSFDIECEMMKSIRH  345 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h  345 (405)
                      ...+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+..+.++.|
T Consensus        50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  129 (258)
T 1zth_A           50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE  129 (258)
T ss_dssp             EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence            4457899999999999997 78888  999987543111                        01357889999999988


Q ss_pred             CCc--ceEEeeeecCCeeEEEEecCCC-C----CHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhc
Q 036754          346 QNL--IKVISSCSNEEFKALVLEYMPH-G----SLEKYLYSSNCILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       346 ~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      +++  ..++++    ...+|||||+.+ |    +|.++...    .++.++..++.|+++||+|||
T Consensus       130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH  187 (258)
T 1zth_A          130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLY  187 (258)
T ss_dssp             TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHH
Confidence            864  333332    356899999942 4    67766432    234457789999999999999

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.90  E-value=5.9e-10  Score=104.14  Aligned_cols=170  Identities=16%  Similarity=0.156  Sum_probs=96.0

Q ss_pred             cCCCCCcCCeeeCcCCcCc-----ccC---CchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCccccccc
Q 036754            6 SLSNCKCLTFIDLSNNPLD-----SVL---PKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSI   77 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~-----~~~---~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~   77 (405)
                      ++.++++|+.|.+..+...     ...   -..++..++ +|+.|+|++|.-.. ++. +. +++|+.|+|..|.++...
T Consensus       134 s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P-~L~~L~L~g~~~l~-l~~-~~-~~~L~~L~L~~~~l~~~~  209 (362)
T 2ra8_A          134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMP-LLNNLKIKGTNNLS-IGK-KP-RPNLKSLEIISGGLPDSV  209 (362)
T ss_dssp             THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCT-TCCEEEEECCBTCB-CCS-CB-CTTCSEEEEECSBCCHHH
T ss_pred             hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCC-CCcEEEEeCCCCce-ecc-cc-CCCCcEEEEecCCCChHH
Confidence            3455677888877654321     010   112234444 78888887763111 222 32 677888888777765332


Q ss_pred             Ccchh-cCCCCCCeeeCCC--CCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccc---cCC
Q 036754           78 SITLG-SNLASLRKLSLDS--NELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFG---DLI  151 (405)
Q Consensus        78 ~~~~~-~~l~~L~~L~Ls~--N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~---~l~  151 (405)
                      ...+. ..+++|++|+|+.  |....- ..+..+..+       +  ....+|+|++|++++|.+....+..+.   .++
T Consensus       210 l~~l~~~~lp~L~~L~L~~~~~~~~~~-~~~~~l~~~-------l--~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~  279 (362)
T 2ra8_A          210 VEDILGSDLPNLEKLVLYVGVEDYGFD-GDMNVFRPL-------F--SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP  279 (362)
T ss_dssp             HHHHHHSBCTTCCEEEEECBCGGGTCC-SCGGGTGGG-------S--CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGG
T ss_pred             HHHHHHccCCCCcEEEEeccccccccc-hhHHHHHHH-------H--hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCC
Confidence            22222 2577777777753  211100 000000000       0  012478899999998887643333332   478


Q ss_pred             CCCeeecccccccCc----cchhHHhcccCCccccccCcccC
Q 036754          152 SLKSLNLSKNNLSGA----IPASLEKLLYLKDLNLSFNKLEG  189 (405)
Q Consensus       152 ~L~~L~l~~n~l~~~----~~~~~~~l~~L~~l~l~~n~l~~  189 (405)
                      +|++|+|+.|.+.+.    ++..+..+++|+.|++++|.++.
T Consensus       280 ~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             GCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred             CCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence            899999999988753    33344667889999999888763

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.82  E-value=1.7e-09  Score=101.03  Aligned_cols=106  Identities=13%  Similarity=0.108  Sum_probs=68.8

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeecccc--------------chhHHH--------HHHHHHhhcCCCCCc
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCR--------------RAFKSF--------DIECEMMKSIRHQNL  348 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~e~~~l~~l~h~ni  348 (405)
                      -+.....||+|+||.||+|...+|+.||||+++....              .....+        ..|...+.++.+..+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3566788999999999999988999999998764211              001112        234555555544433


Q ss_pred             ceEEeeeecCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       349 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .....+..  ...+|||||+++++|.+...     .  .....++.|++.||.|||.
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~  223 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAK  223 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHH
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHH
Confidence            21111111  22369999999988876532     1  1245678999999999994

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.76  E-value=2.4e-09  Score=95.10  Aligned_cols=110  Identities=21%  Similarity=0.198  Sum_probs=72.1

Q ss_pred             CCCCCcCCe--eeCcCCcCcccCCch---hhhcccccccEEEcccCcccc--cCCccccCccCCCeeecCCcccccccCc
Q 036754            7 LSNCKCLTF--IDLSNNPLDSVLPKT---FVGNVSHSLEFFVMSYCNISG--GILEEITNLTKLTTIILGGNKLNGSISI   79 (405)
Q Consensus         7 ~~~l~~L~~--L~Ls~N~l~~~~~~~---f~~~~~~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~   79 (405)
                      |...+.|..  ++++.|.... .+..   ...+++ +|+.|+|++|++++  .+|..+..+++|+.|+|++|+|++.-.-
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~-~~~~l~i~~~~l~-~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l  214 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSC-MAATLRIIEENIP-ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSEREL  214 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHH-HHHHHHHHHHHCT-TCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGG
T ss_pred             cCCCcchhhcCccccCCHHHH-HHHHHHHHHhhCC-CCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhh
Confidence            445555655  7778775332 2221   123455 89999999999988  4567788999999999999999843121


Q ss_pred             chhcCCCCCCeeeCCCCCCC-CCch-------hhhccccCccccCCCC
Q 036754           80 TLGSNLASLRKLSLDSNELT-SIPL-------TFWNLKDILYLNFSVI  119 (405)
Q Consensus        80 ~~~~~l~~L~~L~Ls~N~l~-~lp~-------~~~~l~~L~~l~l~~~  119 (405)
                      .-+..+ +|++|+|++|.+. .+|.       .+..+++|+.|+-..+
T Consensus       215 ~~l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LDg~~v  261 (267)
T 3rw6_A          215 DKIKGL-KLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLDGHEL  261 (267)
T ss_dssp             GGGTTS-CCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEESSCBC
T ss_pred             hhcccC-CcceEEccCCcCccccCcchhHHHHHHHHCcccCeECCcCC
Confidence            222234 9999999999997 4552       2344555555554433

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.66  E-value=9.2e-09  Score=96.05  Aligned_cols=160  Identities=19%  Similarity=0.223  Sum_probs=103.7

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCcccc--CccCCCeeecCC--cccccc-----
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEIT--NLTKLTTIILGG--NKLNGS-----   76 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~--N~l~~~-----   76 (405)
                      .+..+++|+.|+|++|.-.. ++.  +. .+ +|+.|+|..|.+.......++  .+++|+.|+|+.  |...+.     
T Consensus       167 ll~~~P~L~~L~L~g~~~l~-l~~--~~-~~-~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~  241 (362)
T 2ra8_A          167 VLDAMPLLNNLKIKGTNNLS-IGK--KP-RP-NLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNV  241 (362)
T ss_dssp             HHHTCTTCCEEEEECCBTCB-CCS--CB-CT-TCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGG
T ss_pred             HHhcCCCCcEEEEeCCCCce-ecc--cc-CC-CCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHH
Confidence            34678999999999884222 232  22 34 899999999988654444444  789999999853  322111     


Q ss_pred             cCcchh-cCCCCCCeeeCCCCCCCC-CchhhhccccCccccCCCCChhccCCCCCCEEeccCCccccc----CCcccccC
Q 036754           77 ISITLG-SNLASLRKLSLDSNELTS-IPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGS----IPDSFGDL  150 (405)
Q Consensus        77 ~~~~~~-~~l~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~----~p~~~~~l  150 (405)
                      +...+. ..+++|++|+|++|.++. .+..+..               ...+++|++|+|+.|.+.+.    ++..+..+
T Consensus       242 l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~---------------a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l  306 (362)
T 2ra8_A          242 FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLE---------------SDILPQLETMDISAGVLTDEGARLLLDHVDKI  306 (362)
T ss_dssp             TGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHH---------------CSSGGGCSEEECCSSCCBHHHHHHHHTTHHHH
T ss_pred             HHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHh---------------CccCCCCCEEECCCCCCChHHHHHHHhhcccC
Confidence            111111 257899999999999872 2222221               12367899999999998763    33344567


Q ss_pred             CCCCeeecccccccCccchhHHhcccCCccccccCc
Q 036754          151 ISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNK  186 (405)
Q Consensus       151 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~  186 (405)
                      ++|+.|++++|.++...-..+...- ...++++.++
T Consensus       307 ~~L~~L~L~~n~i~d~~~~~l~~al-g~~~~~~~~~  341 (362)
T 2ra8_A          307 KHLKFINMKYNYLSDEMKKELQKSL-PMKIDVSDSQ  341 (362)
T ss_dssp             TTCSEEECCSBBCCHHHHHHHHHHC-CSEEECCSBC
T ss_pred             CcceEEECCCCcCCHHHHHHHHHHc-CCEEEecCCc
Confidence            9999999999988744333333311 2456666665

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.62  E-value=3.2e-08  Score=87.82  Aligned_cols=82  Identities=23%  Similarity=0.297  Sum_probs=65.4

Q ss_pred             CCCCcCCeeeCcCCcCcccC--CchhhhcccccccEEEcccCcccccCCccccCcc--CCCeeecCCcccccccCc----
Q 036754            8 SNCKCLTFIDLSNNPLDSVL--PKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT--KLTTIILGGNKLNGSISI----   79 (405)
Q Consensus         8 ~~l~~L~~L~Ls~N~l~~~~--~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~----   79 (405)
                      .++++|+.|+|++|+|+++.  |.. ++.++ +|+.|+|++|++++.  ..+..+.  +|++|+|++|.+.+.+|.    
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~-~~~l~-~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y  242 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSI-VQKAP-NLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTY  242 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTH-HHHST-TCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHH
T ss_pred             hhCCCCCEEECCCCCCCCCccchhH-HhhCC-CCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhH
Confidence            46889999999999999854  444 56676 999999999999875  3444455  999999999999977763    


Q ss_pred             --chhcCCCCCCeeeC
Q 036754           80 --TLGSNLASLRKLSL   93 (405)
Q Consensus        80 --~~~~~l~~L~~L~L   93 (405)
                        .+...+++|+.||=
T Consensus       243 ~~~il~~~P~L~~LDg  258 (267)
T 3rw6_A          243 ISAIRERFPKLLRLDG  258 (267)
T ss_dssp             HHHHHHHCTTCCEESS
T ss_pred             HHHHHHHCcccCeECC
Confidence              34467899998864

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.54  E-value=1.8e-08  Score=85.02  Aligned_cols=91  Identities=19%  Similarity=0.170  Sum_probs=40.9

Q ss_pred             CCCCCcCCeeeCcCC-cCcccCCchh---hhcccccccEEEcccCccccc----CCccccCccCCCeeecCCcccccc--
Q 036754            7 LSNCKCLTFIDLSNN-PLDSVLPKTF---VGNVSHSLEFFVMSYCNISGG----ILEEITNLTKLTTIILGGNKLNGS--   76 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N-~l~~~~~~~f---~~~~~~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~--   76 (405)
                      +...++|+.|+|++| .|.......+   +...+ +|++|+|++|.+...    +...+...++|++|+|++|.|...  
T Consensus        32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~-~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~  110 (185)
T 1io0_A           32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNT-YVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI  110 (185)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCC-SCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCC-CcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence            445566666666666 5543221111   11122 455555555555431    222233344555555555555421  


Q ss_pred             --cCcchhcCCCCCCeeeC--CCCCCC
Q 036754           77 --ISITLGSNLASLRKLSL--DSNELT   99 (405)
Q Consensus        77 --~~~~~~~~l~~L~~L~L--s~N~l~   99 (405)
                        +...+ ...++|++|+|  ++|.|+
T Consensus       111 ~~l~~~L-~~n~~L~~L~L~~~~N~i~  136 (185)
T 1io0_A          111 LALVEAL-QSNTSLIELRIDNQSQPLG  136 (185)
T ss_dssp             HHHHHGG-GGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHH-HhCCCceEEEecCCCCCCC
Confidence              11111 23345555555  445554

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=98.49  E-value=6.9e-07  Score=84.63  Aligned_cols=174  Identities=13%  Similarity=0.159  Sum_probs=93.4

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccc-----------
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLN-----------   74 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-----------   74 (405)
                      +|.+|++|+.+++.++ +..+...+ +.++. +|+.+++..| ++.+....|.++..|+.+.+..+...           
T Consensus       157 aF~~c~~L~~i~l~~~-~~~I~~~~-F~~c~-~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~~~~~~~~l  232 (394)
T 4fs7_A          157 AFATCESLEYVSLPDS-METLHNGL-FSGCG-KLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGDFALSKTGV  232 (394)
T ss_dssp             TTTTCTTCCEEECCTT-CCEECTTT-TTTCT-TCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCCC
T ss_pred             hhcccCCCcEEecCCc-cceecccc-ccCCC-CceEEEcCCC-ceEeCchhhccccccceeecCCCceEeehhhcccCCC
Confidence            5677777777777654 44455555 44444 6777777665 44445556666666666666554321           


Q ss_pred             ---------cccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCC--CC-hhccCCCCCCEEeccCCccccc
Q 036754           75 ---------GSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV--IP-IEIGGLPNLEYLFLGYNRLQGS  142 (405)
Q Consensus        75 ---------~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~--~p-~~~~~l~~L~~L~l~~n~l~~~  142 (405)
                               ..+....+.++..|+.+.+..+..+--...+.....++......  ++ ..+.++.+|+.+.+..+ +...
T Consensus       233 ~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L~~i~l~~~-i~~I  311 (394)
T 4fs7_A          233 KNIIIPDSFTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSLTEVKLLDS-VKFI  311 (394)
T ss_dssp             CEEEECTTCCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEECTTTTTTCTTCCEEEECTT-CCEE
T ss_pred             ceEEECCCceecccccccccccceeEEcCCCcceeeccccccccccceeccCceeeccccccccccccccccccc-ccee
Confidence                     01222223334444444444332211111222233333222211  11 23556677777777654 4445


Q ss_pred             CCcccccCCCCCeeecccccccCccchhHHhcccCCccccccC
Q 036754          143 IPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFN  185 (405)
Q Consensus       143 ~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n  185 (405)
                      ...+|.++++|+.+++.++ ++......|.++.+|+.+.+..+
T Consensus       312 ~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~  353 (394)
T 4fs7_A          312 GEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS  353 (394)
T ss_dssp             CTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred             chhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence            5666777777777777644 55455667777777777777655

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.45  E-value=8.3e-08  Score=80.83  Aligned_cols=61  Identities=25%  Similarity=0.292  Sum_probs=25.5

Q ss_pred             CCCCEEeccCCccccc----CCcccccCCCCCeeec--ccccccCc----cchhHHhcccCCccccccCcc
Q 036754          127 PNLEYLFLGYNRLQGS----IPDSFGDLISLKSLNL--SKNNLSGA----IPASLEKLLYLKDLNLSFNKL  187 (405)
Q Consensus       127 ~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l--~~n~l~~~----~~~~~~~l~~L~~l~l~~n~l  187 (405)
                      ++|++|+|++|.+...    +...+...++|++|++  ++|.+...    +...+...++|++|++++|.+
T Consensus        93 ~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i  163 (185)
T 1io0_A           93 NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  163 (185)
T ss_dssp             SSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             CCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence            3444444444444321    1223333444555555  44544322    112233334455555555544

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=98.35  E-value=3.1e-06  Score=80.13  Aligned_cols=99  Identities=14%  Similarity=0.227  Sum_probs=65.0

Q ss_pred             ccccCccccCCC----C-ChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccc
Q 036754          107 NLKDILYLNFSV----I-PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLN  181 (405)
Q Consensus       107 ~l~~L~~l~l~~----~-p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~  181 (405)
                      +...|+.+.+..    + ...|.++++|+.+.+.. .+.......|.++.+|+.+.+.++ ++......|.++.+|+.+.
T Consensus       263 ~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~~-~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~  340 (394)
T 4gt6_A          263 SCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFSS-RITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIA  340 (394)
T ss_dssp             TCSSCCEEECCTTCCEECTTTTTTCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred             ecccccEEecccccceecCcccccccccccccCCC-cccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEE
Confidence            334555555432    1 23566788899888864 455566777888899999998765 5556667888888899888


Q ss_pred             cccCcccCcCCC--CCccCCCCcccccCCC
Q 036754          182 LSFNKLEGEIPR--GGSFGNFSAESFEGNE  209 (405)
Q Consensus       182 l~~n~l~~~~p~--~~~~~~~~~~~~~~n~  209 (405)
                      +..+ ++ .++.  .....+|+.+.+.++.
T Consensus       341 ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~  368 (394)
T 4gt6_A          341 IPSS-VT-KIPESAFSNCTALNNIEYSGSR  368 (394)
T ss_dssp             ECTT-CC-BCCGGGGTTCTTCCEEEESSCH
T ss_pred             ECcc-cC-EEhHhHhhCCCCCCEEEECCce
Confidence            8655 33 2322  2234566777776654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.29  E-value=3.3e-06  Score=75.00  Aligned_cols=109  Identities=13%  Similarity=0.035  Sum_probs=83.0

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCC-CCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      .++......+.|+.+.||+.... +..+++|............+.+|..++..+. +..+.++++++...+..|+||||+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            34555566778888999998754 6789999986543233446788999998884 677889999998888999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|.++.+.+..      ..+...++.+++++++.||.
T Consensus        93 ~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~  123 (263)
T 3tm0_A           93 DGVLCSEEYED------EQSPEKIIELYAECIRLFHS  123 (263)
T ss_dssp             SSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHH
T ss_pred             CCeehhhccCC------cccHHHHHHHHHHHHHHHhC
Confidence            99998876321      12244688999999999993

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.28  E-value=4.4e-06  Score=78.53  Aligned_cols=155  Identities=17%  Similarity=0.179  Sum_probs=95.4

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNL   85 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l   85 (405)
                      .+..+..+..+.+..+. ....... +..+. +|+.+.+..+ +..+....|.++.+|+.+.+..+ ++ .+....|.++
T Consensus       189 ~~~~~~~~~~~~~~~~~-~~i~~~~-f~~~~-~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~  262 (379)
T 4h09_A          189 SYPAAKTGTEFTIPSTV-KTVTAYG-FSYGK-NLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNC  262 (379)
T ss_dssp             ECCTTCCCSEEECCTTC-CEECTTT-TTTCS-SCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTC
T ss_pred             cccccccccccccccce-eEEeecc-ccccc-ccceeeeccc-eeEEccccccCCccceEEEcCCC-cc-EeCcccccee
Confidence            34455556666555432 2333334 22333 6777776544 44445566777777888877765 44 6666777777


Q ss_pred             CCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccC
Q 036754           86 ASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG  165 (405)
Q Consensus        86 ~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~  165 (405)
                      .+|+.+.+.. .++.++..                 .|.++++|+.+.+.++.++......|.++.+|+.+.+..+ ++.
T Consensus       263 ~~l~~i~l~~-~i~~i~~~-----------------aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~  323 (379)
T 4h09_A          263 TALKTLNFYA-KVKTVPYL-----------------LCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKT  323 (379)
T ss_dssp             TTCCEEEECC-CCSEECTT-----------------TTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCE
T ss_pred             ehhccccccc-cceecccc-----------------ccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccE
Confidence            7787777754 35544433                 3455667777777776666566667777777777777654 554


Q ss_pred             ccchhHHhcccCCccccccC
Q 036754          166 AIPASLEKLLYLKDLNLSFN  185 (405)
Q Consensus       166 ~~~~~~~~l~~L~~l~l~~n  185 (405)
                      .....|.++.+|+.+.+..+
T Consensus       324 I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          324 IQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             ECTTTTTTCTTCCCCCCCTT
T ss_pred             EHHHHhhCCCCCCEEEECCc
Confidence            55566777777777776543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=98.25  E-value=2.8e-06  Score=80.37  Aligned_cols=171  Identities=21%  Similarity=0.179  Sum_probs=117.7

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCc---------------------ccccCCccccCccCCC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCN---------------------ISGGILEEITNLTKLT   64 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~---------------------l~~~~~~~~~~l~~L~   64 (405)
                      +|.++++|+.+++..| +..+...+ +.++. .|+.+.+..+.                     ++.+....|..+.+|+
T Consensus       180 ~F~~c~~L~~i~l~~~-~~~I~~~~-F~~~~-~L~~i~~~~~~~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~  256 (394)
T 4fs7_A          180 LFSGCGKLKSIKLPRN-LKIIRDYC-FAECI-LLENMEFPNSLYYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLE  256 (394)
T ss_dssp             TTTTCTTCCBCCCCTT-CCEECTTT-TTTCT-TCCBCCCCTTCCEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCC
T ss_pred             cccCCCCceEEEcCCC-ceEeCchh-hcccc-ccceeecCCCceEeehhhcccCCCceEEECCCceecccccccccccce
Confidence            4677888888888766 55555555 33333 44444443321                     2223334567788899


Q ss_pred             eeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCC----C-ChhccCCCCCCEEeccCCcc
Q 036754           65 TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV----I-PIEIGGLPNLEYLFLGYNRL  139 (405)
Q Consensus        65 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~----~-p~~~~~l~~L~~L~l~~n~l  139 (405)
                      .+.+..+..  .++...|.++..|+.+.+..+.+.  ...+....+|+.+.+..    + ...|.++.+|+.+++..+ +
T Consensus       257 ~~~~~~~~~--~i~~~~F~~~~~l~~~~~~~~~i~--~~~F~~~~~L~~i~l~~~i~~I~~~aF~~c~~L~~i~lp~~-v  331 (394)
T 4fs7_A          257 SISIQNNKL--RIGGSLFYNCSGLKKVIYGSVIVP--EKTFYGCSSLTEVKLLDSVKFIGEEAFESCTSLVSIDLPYL-V  331 (394)
T ss_dssp             EEEECCTTC--EECSCTTTTCTTCCEEEECSSEEC--TTTTTTCTTCCEEEECTTCCEECTTTTTTCTTCCEECCCTT-C
T ss_pred             eEEcCCCcc--eeeccccccccccceeccCceeec--cccccccccccccccccccceechhhhcCCCCCCEEEeCCc-c
Confidence            999887754  466677778888888887765432  12345566666665432    3 235778899999999765 6


Q ss_pred             cccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccC
Q 036754          140 QGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFN  185 (405)
Q Consensus       140 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n  185 (405)
                      +.....+|.+|++|+.+.+..| ++......|.++.+|+.+++..+
T Consensus       332 ~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          332 EEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             CEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             cEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence            6667788999999999999877 76677788999999999988654

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=98.17  E-value=7.2e-06  Score=77.55  Aligned_cols=150  Identities=12%  Similarity=0.132  Sum_probs=97.8

Q ss_pred             CCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCC
Q 036754           10 CKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLR   89 (405)
Q Consensus        10 l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~   89 (405)
                      ...+..+.+. +.+..+...+ +.++. +|+.+.+.++.. .+-...|.++++|+.+.+. +.++ .++...|.++.+|+
T Consensus       241 ~~~~~~~~ip-~~v~~i~~~a-F~~c~-~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~  314 (394)
T 4gt6_A          241 QREDPAFKIP-NGVARIETHA-FDSCA-YLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLK  314 (394)
T ss_dssp             TCCCSEEECC-TTEEEECTTT-TTTCS-SCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCC
T ss_pred             ccccceEEcC-CcceEcccce-eeecc-cccEEecccccc-eecCcccccccccccccCC-Cccc-ccCceeecCCCCcC
Confidence            3445555554 3455666667 44555 788888876543 4456678888999999996 4465 78888888999999


Q ss_pred             eeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccch
Q 036754           90 KLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPA  169 (405)
Q Consensus        90 ~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~  169 (405)
                      .++|..+ ++.++..                 .|.++.+|+.+.+..+ ++.....+|.+|++|+.+++.++....   .
T Consensus       315 ~i~lp~~-v~~I~~~-----------------aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~  372 (394)
T 4gt6_A          315 SIDIPEG-ITQILDD-----------------AFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---N  372 (394)
T ss_dssp             EEECCTT-CCEECTT-----------------TTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---H
T ss_pred             EEEeCCc-ccEehHh-----------------HhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---h
Confidence            9998754 6666543                 4667788888888655 555666778888888888888875431   3


Q ss_pred             hHHhcccCCccccccCcc
Q 036754          170 SLEKLLYLKDLNLSFNKL  187 (405)
Q Consensus       170 ~~~~l~~L~~l~l~~n~l  187 (405)
                      .+.....|+.+.+..|.+
T Consensus       373 ~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          373 AISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             TCBCCCCC----------
T ss_pred             hhhccCCCCEEEeCCCCE
Confidence            455566777777765544

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.06  E-value=3.1e-05  Score=72.70  Aligned_cols=157  Identities=12%  Similarity=0.062  Sum_probs=95.9

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchh-----------hhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccc
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTF-----------VGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLN   74 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f-----------~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~   74 (405)
                      +|.++.+++.+.+..+.........+           +.... .+..+.+..+ ........+....+|+.+.+..+ +.
T Consensus       153 ~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~i~~~~f~~~~~l~~i~~~~~-~~  229 (379)
T 4h09_A          153 IGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAK-TGTEFTIPST-VKTVTAYGFSYGKNLKKITITSG-VT  229 (379)
T ss_dssp             TTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTC-CCSEEECCTT-CCEECTTTTTTCSSCSEEECCTT-CC
T ss_pred             hhcccccccccccccccceeecccceecccccceeccccccc-cccccccccc-eeEEeecccccccccceeeeccc-ee
Confidence            46677777777776654432221110           00111 3444443332 22234445666777888877665 33


Q ss_pred             cccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCC
Q 036754           75 GSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLK  154 (405)
Q Consensus        75 ~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  154 (405)
                       .++...+.++..|+.+.+..+ ++.++..                 .|.++.+|+.+.+..+ +.......|.++++|+
T Consensus       230 -~i~~~~f~~~~~L~~i~lp~~-v~~I~~~-----------------aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~  289 (379)
T 4h09_A          230 -TLGDGAFYGMKALDEIAIPKN-VTSIGSF-----------------LLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLT  289 (379)
T ss_dssp             -EECTTTTTTCSSCCEEEECTT-CCEECTT-----------------TTTTCTTCCEEEECCC-CSEECTTTTTTCTTCC
T ss_pred             -EEccccccCCccceEEEcCCC-ccEeCcc-----------------ccceeehhcccccccc-ceeccccccccccccc
Confidence             566666667888888877654 5555433                 3455667777777654 4445556778888888


Q ss_pred             eeecccccccCccchhHHhcccCCccccccC
Q 036754          155 SLNLSKNNLSGAIPASLEKLLYLKDLNLSFN  185 (405)
Q Consensus       155 ~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n  185 (405)
                      .+.+.++.++......|.++.+|+.+.+..+
T Consensus       290 ~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~  320 (379)
T 4h09_A          290 KVVMDNSAIETLEPRVFMDCVKLSSVTLPTA  320 (379)
T ss_dssp             EEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred             cccccccccceehhhhhcCCCCCCEEEcCcc
Confidence            8888887777666778888888888887654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.91  E-value=4e-06  Score=69.09  Aligned_cols=81  Identities=16%  Similarity=0.194  Sum_probs=41.3

Q ss_pred             cccEEEcccCcccccCCccccCccCCCeeecCCcc-cccccCcchhcCC----CCCCeeeCCCC-CCCCCc-hhhhcccc
Q 036754           38 SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK-LNGSISITLGSNL----ASLRKLSLDSN-ELTSIP-LTFWNLKD  110 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~l----~~L~~L~Ls~N-~l~~lp-~~~~~l~~  110 (405)
                      .|+.||+++|.++..--..+.++++|+.|+|++|. ++..--..+ +.+    ++|++|+|++| ++|.-- ..+.++++
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L-~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERL-SQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHH-HTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHH-HhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            46666666666654433445566666666666664 442111112 122    35666666665 355211 12345566


Q ss_pred             CccccCCCC
Q 036754          111 ILYLNFSVI  119 (405)
Q Consensus       111 L~~l~l~~~  119 (405)
                      |+.|+++..
T Consensus       141 L~~L~L~~c  149 (176)
T 3e4g_A          141 LKYLFLSDL  149 (176)
T ss_dssp             CCEEEEESC
T ss_pred             CCEEECCCC
Confidence            666665543

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.90  E-value=2.8e-05  Score=68.62  Aligned_cols=95  Identities=16%  Similarity=0.068  Sum_probs=70.9

Q ss_pred             cccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCC--cceEEeeeecCCeeEEEEecCCCCCHHHH
Q 036754          299 SKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQN--LIKVISSCSNEEFKALVLEYMPHGSLEKY  376 (405)
Q Consensus       299 g~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~  376 (405)
                      +.|..+.||+....+|..+++|.....   ....+.+|+..+..+.+.+  +.+++++....+..++||||+++.++.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            456668999998777888999987543   2345678888888886555  456888887777889999999998874  


Q ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          377 LYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       377 l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..    ..+   ...++.++++.|+.||.
T Consensus       104 ~~----~~~---~~~~~~~l~~~l~~lh~  125 (264)
T 1nd4_A          104 SS----HLA---PAEKVSIMADAMRRLHT  125 (264)
T ss_dssp             TS----CCC---HHHHHHHHHHHHHHHTT
T ss_pred             cC----cCC---HhHHHHHHHHHHHHHhC
Confidence            21    122   23678899999999994

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.88  E-value=5e-06  Score=68.52  Aligned_cols=35  Identities=14%  Similarity=0.012  Sum_probs=18.5

Q ss_pred             cCCCeeecCCcccccccCcchhcCCCCCCeeeCCCC
Q 036754           61 TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSN   96 (405)
Q Consensus        61 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N   96 (405)
                      .+|+.|||+++.++..--..+ .++++|++|+|++|
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L-~~~~~L~~L~L~~C   95 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHM-EGLQYVEKIRLCKC   95 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGG-TTCSCCCEEEEESC
T ss_pred             ceEeEEeCcCCCccHHHHHHh-cCCCCCCEEEeCCC
Confidence            356666666666542211222 35666666666665

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.55  E-value=0.0002  Score=66.61  Aligned_cols=107  Identities=11%  Similarity=0.110  Sum_probs=76.9

Q ss_pred             cCcccccCCCceEEEeeCCCcEEEEEEee--ccc-cchhHHHHHHHHHhhcCC--CCCcceEEeeeecC---CeeEEEEe
Q 036754          295 NNLISKGGFGSVYKARLGDGMEVAVKVFN--LQC-RRAFKSFDIECEMMKSIR--HQNLIKVISSCSNE---EFKALVLE  366 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e  366 (405)
                      .+.++.|.++.||+....+ ..+++|+..  ... ......+.+|..++..+.  +..+.++++++.+.   ...|+|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4568899999999988754 577888765  332 122346778999988886  45678888888765   45889999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++..+.+..   -..++..++..++.++++.|+.||.
T Consensus       122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A          122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhC
Confidence            99997775421   1247788889999999999999993

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.47  E-value=0.00018  Score=56.31  Aligned_cols=56  Identities=25%  Similarity=0.273  Sum_probs=47.2

Q ss_pred             CeeeCCCCCCC--CCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccccccc
Q 036754           89 RKLSLDSNELT--SIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLS  164 (405)
Q Consensus        89 ~~L~Ls~N~l~--~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~  164 (405)
                      ..++.++++++  ++|..+.                    ++|++|+|++|.|+...+..|..+++|+.|+|++|++.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--------------------~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--------------------VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--------------------TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--------------------cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            37888899988  8885421                    46899999999999887888999999999999999886

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.43  E-value=0.00019  Score=56.12  Aligned_cols=37  Identities=30%  Similarity=0.424  Sum_probs=20.4

Q ss_pred             CCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCC
Q 036754           62 KLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELT   99 (405)
Q Consensus        62 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~   99 (405)
                      +|+.|+|++|+|+ .+|.+.|..+++|+.|+|++|.+.
T Consensus        32 ~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           32 DTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence            4555555555555 555555555555555555555543

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.04  E-value=0.0002  Score=60.11  Aligned_cols=66  Identities=18%  Similarity=0.233  Sum_probs=29.3

Q ss_pred             CCCCcCCeeeCcCC-cCcccCCchh---hhcccccccEEEcccCccccc----CCccccCccCCCeeecCCcccc
Q 036754            8 SNCKCLTFIDLSNN-PLDSVLPKTF---VGNVSHSLEFFVMSYCNISGG----ILEEITNLTKLTTIILGGNKLN   74 (405)
Q Consensus         8 ~~l~~L~~L~Ls~N-~l~~~~~~~f---~~~~~~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~   74 (405)
                      .+-+.|+.|+|++| .|.......+   +..- ..|+.|+|++|.+...    +-+.+..-+.|+.|+|++|.|.
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N-~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNS-KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT  111 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTC-SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHhhC-CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence            34455666666654 5432211110   1111 1455666666655431    1122233345555555555554

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.69  E-value=0.0006  Score=57.12  Aligned_cols=61  Identities=23%  Similarity=0.301  Sum_probs=26.9

Q ss_pred             cccEEEcccC-cccc----cCCccccCccCCCeeecCCcccccc----cCcchhcCCCCCCeeeCCCCCCC
Q 036754           38 SLEFFVMSYC-NISG----GILEEITNLTKLTTIILGGNKLNGS----ISITLGSNLASLRKLSLDSNELT   99 (405)
Q Consensus        38 ~L~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~~l~~L~~L~Ls~N~l~   99 (405)
                      .|+.|+|++| .+..    .+-+.+..-+.|+.|+|++|.|...    +-..+ ..-+.|++|+|+.|.|+
T Consensus        42 ~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL-~~N~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           42 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELI-ETSPSLRVLNVESNFLT  111 (197)
T ss_dssp             SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHH-HHCSSCCEEECCSSBCC
T ss_pred             CccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHH-hcCCccCeEecCCCcCC
Confidence            4556666553 4432    1222233345555555555555411    11111 12244555555555554

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=96.51  E-value=0.011  Score=53.40  Aligned_cols=102  Identities=7%  Similarity=-0.010  Sum_probs=74.5

Q ss_pred             cCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCC---CcceEEeeee-cCCeeEEEEecCCC
Q 036754          295 NNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQ---NLIKVISSCS-NEEFKALVLEYMPH  370 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  370 (405)
                      ...++.|....||+.    |..+++|.-..  ......+.+|.+++..+.+.   .+.+++.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            345777888888876    56778887422  22345678899999988653   3556666664 34567899999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..+.+....   .++..++..++.++++.|+.||.
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~  129 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSA  129 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhc
Confidence            888764322   36778888999999999999983

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=96.34  E-value=0.0095  Score=53.68  Aligned_cols=102  Identities=17%  Similarity=0.113  Sum_probs=72.2

Q ss_pred             cCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCC-CCC--cceEEeeeecCC---eeEEEEecC
Q 036754          295 NNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-HQN--LIKVISSCSNEE---FKALVLEYM  368 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  368 (405)
                      .+.++.|....||+..    ..+++|.....  .....+.+|.+.+..+. +..  +.++++.....+   ..|+||||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3558899999999753    46788875432  23456788999988773 333  345555443333   458999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|.++......   .++..++..++.++++.++.||.
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~  132 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHS  132 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHc
Confidence            99887654332   47788889999999999999983

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=96.29  E-value=0.027  Score=49.58  Aligned_cols=100  Identities=16%  Similarity=0.031  Sum_probs=71.0

Q ss_pred             ccccCCC-ceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCC-CCCcceEEeeeecCCeeEEEEecCCCCCHH
Q 036754          298 ISKGGFG-SVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEFKALVLEYMPHGSLE  374 (405)
Q Consensus       298 lg~G~fg-~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  374 (405)
                      +..|..| .||+.... ++..+.+|.-...   ....+.+|...+..+. +--+.++++++...+..++|||++++.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            4455555 58987654 4567888876533   3446777888887763 334668888888889999999999998887


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          375 KYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       375 ~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +.....     ......++.++++.|+-||.
T Consensus       109 ~~~~~~-----~~~~~~~~~~l~~~L~~Lh~  134 (272)
T 4gkh_A          109 QVLEEY-----PDSGENIVDALAVFLRRLHS  134 (272)
T ss_dssp             HHHHHC-----GGGHHHHHHHHHHHHHHHHT
T ss_pred             ccccCC-----HHHHHHHHHHHHHHHHHhcC
Confidence            765432     12344577888899988884

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.14  E-value=0.019  Score=51.98  Aligned_cols=93  Identities=15%  Similarity=0.160  Sum_probs=68.0

Q ss_pred             CccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCC---CCCcceEEeeeecCCeeEEEEecCC
Q 036754          293 SENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR---HQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      ...+.++.|.+..+|+... ++..+++|.....   ....+.+|.+.+..+.   ...+.++++++...+..++||||++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3445688999999999876 4667888876533   2456778888887773   3568888888887788999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhc
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      +..+..               ..+.++++.|+-||
T Consensus       115 G~~~~~---------------~~~~~lG~~LA~LH  134 (312)
T 3jr1_A          115 KSKNKQ---------------SSFTIFAEKIAQLH  134 (312)
T ss_dssp             CCCCCT---------------THHHHHHHHHHHHH
T ss_pred             CCCCCc---------------hhHHHHHHHHHHHH
Confidence            865311               23456777777777

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=95.81  E-value=0.0084  Score=55.37  Aligned_cols=110  Identities=11%  Similarity=0.003  Sum_probs=74.0

Q ss_pred             Ccc-cccCCCceEEEeeC-------CCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCC---CCcceEEeeeecC---
Q 036754          296 NLI-SKGGFGSVYKARLG-------DGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRH---QNLIKVISSCSNE---  358 (405)
Q Consensus       296 ~~l-g~G~fg~v~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~---  358 (405)
                      +.+ +.|....+|+....       ++..+++|......   ......+.+|..++..+..   -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78888899987754       25678888765432   1112456778888877742   3567788777654   


Q ss_pred             CeeEEEEecCCCCCHHHHHhc---CC--CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 EFKALVLEYMPHGSLEKYLYS---SN--CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 ~~~~lv~e~~~~g~L~~~l~~---~~--~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ...++||||+++..+.+.+..   ..  ..++..++..++.++++.|+-||.
T Consensus       106 g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~  157 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHS  157 (357)
T ss_dssp             SSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhC
Confidence            356899999998776653210   00  135666777889999999999984

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=94.89  E-value=0.05  Score=50.94  Aligned_cols=76  Identities=16%  Similarity=0.163  Sum_probs=48.5

Q ss_pred             cCcccccCCCceEEEeeC-CCcEEEEEEeecccc-------chhHHHHHHHHHhhcCCC--CC-cceEEeeeecCCeeEE
Q 036754          295 NNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCR-------RAFKSFDIECEMMKSIRH--QN-LIKVISSCSNEEFKAL  363 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l  363 (405)
                      .+.+|.|.++.||++... +++.++||.......       .....+..|.+.+..+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            356899999999999753 467899998653211       123456678888877632  33 3455543  3445689


Q ss_pred             EEecCCCCC
Q 036754          364 VLEYMPHGS  372 (405)
Q Consensus       364 v~e~~~~g~  372 (405)
                      ||||+++..
T Consensus       113 vmE~l~g~~  121 (397)
T 2olc_A          113 VMEDLSHLK  121 (397)
T ss_dssp             EECCCTTSE
T ss_pred             EEEeCCCcc
Confidence            999998643

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=94.56  E-value=0.12  Score=45.87  Aligned_cols=76  Identities=14%  Similarity=0.110  Sum_probs=53.7

Q ss_pred             CccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCC---CCcceEEeeeecCCeeEEEEecCC
Q 036754          293 SENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH---QNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       293 ~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      .....+|.|..+.||+.++.+|+.|.+|+-..........|.+|.+.|..+.-   --+.+++++.    ..++||||++
T Consensus        18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~   93 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVD   93 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCC
T ss_pred             EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeec
Confidence            33456899999999999999999999998654433334457789888887742   2344555442    2478999987


Q ss_pred             CCC
Q 036754          370 HGS  372 (405)
Q Consensus       370 ~g~  372 (405)
                      .+.
T Consensus        94 ~~~   96 (288)
T 3f7w_A           94 ERP   96 (288)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=86.41  E-value=1.5  Score=39.50  Aligned_cols=73  Identities=14%  Similarity=0.199  Sum_probs=39.2

Q ss_pred             CcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCC--CCcceEEe------eeecCCeeEEEEec
Q 036754          296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH--QNLIKVIS------SCSNEEFKALVLEY  367 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~  367 (405)
                      ..++.|..+.||+....+| .+++|......    .....|...+..+..  -.+.+++.      +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3456677889999887555 48899886421    222234444433321  12333332      11235678899999


Q ss_pred             CCCCCH
Q 036754          368 MPHGSL  373 (405)
Q Consensus       368 ~~~g~L  373 (405)
                      ++|.++
T Consensus       113 i~G~~~  118 (346)
T 2q83_A          113 IEGRPF  118 (346)
T ss_dssp             CCCBCC
T ss_pred             ecCccC
Confidence            998654

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.38  E-value=0.083  Score=50.60  Aligned_cols=58  Identities=7%  Similarity=0.026  Sum_probs=16.1

Q ss_pred             CcccccCCCceEEEeeCC-CcEEEE------EEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeee
Q 036754          296 NLISKGGFGSVYKARLGD-GMEVAV------KVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCS  356 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  356 (405)
                      +.+|   ||.||+|.+.. ..+|||      |..+...  .+....|.+|..++...+|+|+++.+++..
T Consensus       148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            4555   99999999743 367888      7665432  233456888999999999999999988654

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=83.43  E-value=2.6  Score=25.26  Aligned_cols=7  Identities=14%  Similarity=0.335  Sum_probs=2.7

Q ss_pred             HHHhhhc
Q 036754          255 ILRYRQR  261 (405)
Q Consensus       255 ~~~~~~~  261 (405)
                      ++++|+|
T Consensus        31 ~~~~RRR   37 (44)
T 2l2t_A           31 AVYVRRK   37 (44)
T ss_dssp             HHHHHTT
T ss_pred             HHHhhhh
Confidence            3333433

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=82.61  E-value=2.8  Score=25.22  Aligned_cols=7  Identities=43%  Similarity=0.335  Sum_probs=2.6

Q ss_pred             HHHhhhc
Q 036754          255 ILRYRQR  261 (405)
Q Consensus       255 ~~~~~~~  261 (405)
                      ++++|+|
T Consensus        32 ~~~~RRr   38 (44)
T 2ks1_B           32 GLFMRRR   38 (44)
T ss_dssp             HHHHHTT
T ss_pred             HHHhhhh
Confidence            3333333

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=80.89  E-value=3.9  Score=38.21  Aligned_cols=101  Identities=10%  Similarity=0.037  Sum_probs=56.1

Q ss_pred             cCcccccCCCceEEEeeCCCcEEEEEEeeccc-----c-c---hhHHHHHHHHHhh-cCCCCCcceEEeeeecCCeeEEE
Q 036754          295 NNLISKGGFGSVYKARLGDGMEVAVKVFNLQC-----R-R---AFKSFDIECEMMK-SIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~-----~-~---~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      .+.+|.|..+.||+... ++..++||......     . .   ....+..|+..+. ......+.+++.+.  .+..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            45688999999999864 46789999542211     0 1   2223444443322 22334566666654  5667899


Q ss_pred             EecC-CCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhc
Q 036754          365 LEYM-PHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLH  404 (405)
Q Consensus       365 ~e~~-~~g-~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH  404 (405)
                      |||+ +++ .+.+.+..... ..     ..+.++++.|+-+|
T Consensus       116 ~e~l~~g~~~l~~~l~~~~~-~~-----~~~~~lg~~La~lH  151 (420)
T 2pyw_A          116 MRYLEPPHIILRKGLIAGIE-YP-----FLADHMSDYMAKTL  151 (420)
T ss_dssp             ECCCCTTCEEHHHHHHHTCC-CT-----THHHHHHHHHHHHH
T ss_pred             EeecCCcchhHHHHHhcCCC-CH-----HHHHHHHHHHHHHH
Confidence            9999 763 34443332211 11     13445555555555

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=80.53  E-value=3.6  Score=38.02  Aligned_cols=96  Identities=17%  Similarity=0.243  Sum_probs=55.1

Q ss_pred             CcccccCCCceEEEeeCC--------CcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCc-ceEEeeeecCCeeEEEEe
Q 036754          296 NLISKGGFGSVYKARLGD--------GMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNL-IKVISSCSNEEFKALVLE  366 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  366 (405)
                      +.+..|-...+|+...++        +..+.+|+.... ......+.+|.+++..+.-..+ .++++++..    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            346667778899988642        467888875332 1234455688888877743333 455655543    39999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++..+..-      .+..   -.+..++|+.|+-||.
T Consensus       131 ~i~G~~l~~~------~l~~---p~~~~~ia~~La~LH~  160 (379)
T 3feg_A          131 YIPSRPLKTQ------ELRE---PVLSAAIATKMAQFHG  160 (379)
T ss_dssp             CCSEEECCGG------GGGC---HHHHHHHHHHHHHHHT
T ss_pred             EecCccCChh------HhCC---HHHHHHHHHHHHHHhC
Confidence            9998554321      1111   2356778888888884

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	405
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-26
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-26
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-25
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-25
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-24
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-24
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-24
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-24
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-24
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-24
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-23
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-23
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-23
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-22
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-21
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-21
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-21
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-21
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-21
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-21
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-21
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-21
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-20
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-20
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-20
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-20
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-20
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-20
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-20
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-19
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-19
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-19
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-19
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-19
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-18
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-18
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-18
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-18
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-18
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-18
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-17
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-17
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-17
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-17
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-16
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-16
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-16
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-16
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-15
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-15
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-15
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-15
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-15
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-14
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-14
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-14
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-14
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-13
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-05
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-13
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-13
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-13
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-12
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-12
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-06
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-11
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-10
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	6e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 3e-26
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 5/122 (4%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R T K  E   +  G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 9   EVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 65

Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 402
           +HQ L+++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + +
Sbjct: 66  QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 403 LH 404
           + 
Sbjct: 125 IE 126

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 7e-26
 Identities = 28/124 (22%), Positives = 57/124 (45%), Gaps = 7/124 (5%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMK 341
           E+        +   I  G FG+VYK +     +VAVK+ N+     +  ++F  E  +++
Sbjct: 4   EIPDGQITVGQ--RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 342 SIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 401
             RH N++  +   +     A+V ++    SL  +L+      ++ + ++I    A  ++
Sbjct: 60  KTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 402 YLHF 405
           YLH 
Sbjct: 119 YLHA 122

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  101 bits (253), Expect = 4e-25
 Identities = 28/140 (20%), Positives = 59/140 (42%), Gaps = 14/140 (10%)

Query: 280 FSYLELCRATYKFSEN---------NLISKGGFGSVYKARL----GDGMEVAVKVFNLQ- 325
           F++ +   A  +F++           +I  G FG V    L       + VA+K      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 326 CRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD 385
             +  + F  E  +M    H N+I +    +      ++ E+M +GSL+ +L  ++    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 386 IFQRLNIMIDVASALEYLHF 405
           + Q + ++  +A+ ++YL  
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD 146

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (251), Expect = 8e-25
 Identities = 25/110 (22%), Positives = 50/110 (45%), Gaps = 1/110 (0%)

Query: 296 NLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISS 354
             +  G FG VYKA+     +  A KV + +     + + +E +++ S  H N++K++ +
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 355 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
              E    +++E+   G+++  +      L   Q   +      AL YLH
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  101 bits (252), Expect = 2e-24
 Identities = 21/109 (19%), Positives = 43/109 (39%), Gaps = 1/109 (0%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
            +  G FG V++      G     K  N        +   E  +M  + H  LI +  + 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            ++    L+LE++  G L   + + +  +   + +N M      L+++H
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.8 bits (248), Expect = 2e-24
 Identities = 28/127 (22%), Positives = 54/127 (42%), Gaps = 6/127 (4%)

Query: 283 LELCRATYKFSENNLISKGGFGSVYKARL---GDGMEVAVKVFNLQCRRAF-KSFDIECE 338
           L L R     ++   +  G FGSV +         ++VA+KV      +A  +    E +
Sbjct: 3   LFLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 339 MMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 398
           +M  + +  ++++I  C  E    LV+E    G L K+L      + +     ++  V+ 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 399 ALEYLHF 405
            ++YL  
Sbjct: 121 GMKYLEE 127

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  100 bits (250), Expect = 3e-24
 Identities = 22/116 (18%), Positives = 45/116 (38%), Gaps = 3/116 (2%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNL 348
           Y   E   +  G FG V++      G   A K          ++   E + M  +RH  L
Sbjct: 28  YDIHE--ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           + +  +  ++    ++ E+M  G L + +   +  +   + +  M  V   L ++H
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.6 bits (245), Expect = 3e-24
 Identities = 29/116 (25%), Positives = 52/116 (44%), Gaps = 3/116 (2%)

Query: 290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLI 349
             F +   +  G FG V   +     +VA+K+   +   +   F  E ++M ++ H+ L+
Sbjct: 6   LTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 405
           ++   C+ +    ++ EYM +G L  YL          Q L +  DV  A+EYL  
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 99.3 bits (247), Expect = 4e-24
 Identities = 29/118 (24%), Positives = 46/118 (38%), Gaps = 5/118 (4%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNL---QCRRAFKSFDIECEMMKSIRHQ 346
            FS+   I  G FG+VY AR + +   VA+K  +    Q    ++    E   ++ +RH 
Sbjct: 16  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 347 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           N I+       E    LV+EY    + +         L   +   +       L YLH
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.6 bits (245), Expect = 9e-24
 Identities = 22/116 (18%), Positives = 51/116 (43%), Gaps = 3/116 (2%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKS-FDIECEMMKSIRHQNL 348
            F + + +  G  G V+K      G+ +A K+ +L+ + A ++    E +++       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +    +  ++   ++ +E+M  GSL++ L  +   +       + I V   L YL 
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR 121

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.6 bits (240), Expect = 2e-23
 Identities = 39/123 (31%), Positives = 54/123 (43%), Gaps = 7/123 (5%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
            L     K  +   I KG FG V       G +VAVK          ++F  E  +M  +
Sbjct: 3   ALNMKELKLLQ--TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQL 57

Query: 344 RHQNLIKVISSCSNEEFK-ALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALE 401
           RH NL++++     E+    +V EYM  GSL  YL S    +L     L   +DV  A+E
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 402 YLH 404
           YL 
Sbjct: 118 YLE 120

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.3 bits (239), Expect = 2e-23
 Identities = 30/115 (26%), Positives = 49/115 (42%), Gaps = 3/115 (2%)

Query: 290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLI 349
             F +   I  G FG V+     +  +VA+K        + + F  E E+M  + H  L+
Sbjct: 7   LTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           ++   C  +    LV E+M HG L  YL +   +      L + +DV   + YL 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.4 bits (237), Expect = 8e-23
 Identities = 31/115 (26%), Positives = 56/115 (48%), Gaps = 3/115 (2%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLI 349
           K++    I +G  G+VY A  +  G EVA++  NLQ +   +    E  +M+  ++ N++
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             + S    +   +V+EY+  GSL   +  +    D  Q   +  +   ALE+LH
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH 133

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.3 bits (231), Expect = 3e-22
 Identities = 26/117 (22%), Positives = 49/117 (41%), Gaps = 7/117 (5%)

Query: 294 ENNLISKGGFGSVYKARL---GDGMEVAVKVFNLQCR--RAFKSFDIECEMMKSIRHQNL 348
           E+  +  G FG+V K           VAVK+   +            E  +M+ + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 405
           +++I  C  E +  LV+E    G L KYL  +   +     + ++  V+  ++YL  
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE 125

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.5 bits (224), Expect = 3e-21
 Identities = 24/119 (20%), Positives = 46/119 (38%), Gaps = 7/119 (5%)

Query: 292 FSEN----NLISKGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDIECEMMKSIRH 345
           F E+      + +G +G V  A        VAVK+ ++ +     ++   E  + K + H
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62

Query: 346 QNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +N++K          + L LEY   G L   +   +  +           + + + YLH
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLH 120

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.5 bits (224), Expect = 3e-21
 Identities = 30/123 (24%), Positives = 56/123 (45%), Gaps = 5/123 (4%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI 343
           E+ R + +      + +G FG V+         VA+K        + ++F  E ++MK +
Sbjct: 13  EIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKL 69

Query: 344 RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF-QRLNIMIDVASALEY 402
           RH+ L+++ +  S E    +V EYM  GSL  +L           Q +++   +AS + Y
Sbjct: 70  RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128

Query: 403 LHF 405
           +  
Sbjct: 129 VER 131

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.5 bits (224), Expect = 4e-21
 Identities = 30/119 (25%), Positives = 51/119 (42%), Gaps = 7/119 (5%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECEMMKSIRH 345
           +KF +  ++ +G F +V  AR L    E A+K+     +           E ++M  + H
Sbjct: 10  FKFGK--ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 346 QNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
              +K+  +  ++E     L Y  +G L KY+       D         ++ SALEYLH
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 125

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.3 bits (223), Expect = 7e-21
 Identities = 28/146 (19%), Positives = 52/146 (35%), Gaps = 27/146 (18%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQCRRAF-KSFDIE 336
           E  R    F +   +  G FG V +A           M VAVK+          ++   E
Sbjct: 19  EFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76

Query: 337 CEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--------------- 380
            +++  +  H N++ ++ +C+      ++ EY  +G L  +L                  
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 381 --NCILDIFQRLNIMIDVASALEYLH 404
                LD+   L+    VA  + +L 
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLA 162

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 89.4 bits (221), Expect = 8e-21
 Identities = 33/123 (26%), Positives = 56/123 (45%), Gaps = 5/123 (4%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKS 342
           E+ R          +  G +G VY+       + VAVK          + F  E  +MK 
Sbjct: 13  EMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKE 69

Query: 343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALE 401
           I+H NL++++  C+ E    ++ E+M +G+L  YL   N   +     L +   ++SA+E
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129

Query: 402 YLH 404
           YL 
Sbjct: 130 YLE 132

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.9 bits (220), Expect = 8e-21
 Identities = 31/118 (26%), Positives = 53/118 (44%), Gaps = 5/118 (4%)

Query: 291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFN---LQCRRAFKSFDIECEMMKSIRHQ 346
            F     + KG FG+VY AR       +A+KV     L+          E E+   +RH 
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 347 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 123

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 89.7 bits (222), Expect = 9e-21
 Identities = 22/117 (18%), Positives = 44/117 (37%), Gaps = 5/117 (4%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAF-KSFDIECEMMKSIRHQN 347
           Y F +  ++  G F  V  A        VA+K    +       S + E  ++  I+H N
Sbjct: 11  YDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           ++ +     +     L+++ +  G L   +              ++  V  A++YLH
Sbjct: 69  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLH 124

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.0 bits (220), Expect = 9e-21
 Identities = 32/122 (26%), Positives = 44/122 (36%), Gaps = 10/122 (8%)

Query: 290 YKFSENNLISKGGFGSVYKARL----GDGMEVAVKVFN---LQCRRAFKSFDIECEMMKS 342
            +  E   +  G FG V +       G  + VAVK      L    A   F  E   M S
Sbjct: 10  LRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 402
           + H+NLI++         K +V E  P GSL   L        +       + VA  + Y
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 403 LH 404
           L 
Sbjct: 127 LE 128

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.7 bits (219), Expect = 2e-20
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 8/111 (7%)

Query: 298 ISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN 357
           I KG FG V++ +   G EVAVK+F+ +  R++   + E      +RH+N++  I++ + 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 358 EEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +        LV +Y  HGSL  YL      + +   + + +  AS L +LH
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLH 117

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.3 bits (218), Expect = 2e-20
 Identities = 27/126 (21%), Positives = 51/126 (40%), Gaps = 8/126 (6%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARL----GDGMEVAVKVFNLQCRRAFKS-FDIECE 338
           E+ R   +      I +G FG V++          + VA+K        + +  F  E  
Sbjct: 3   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60

Query: 339 MMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 398
            M+   H +++K+I   + E    +++E    G L  +L      LD+   +     +++
Sbjct: 61  TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119

Query: 399 ALEYLH 404
           AL YL 
Sbjct: 120 ALAYLE 125

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.6 bits (219), Expect = 3e-20
 Identities = 19/109 (17%), Positives = 47/109 (43%), Gaps = 2/109 (1%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
            + +G FG V++            K   ++          E  ++   RH+N++ +  S 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70

Query: 356 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            + E   ++ E++    + + + +S   L+  + ++ +  V  AL++LH
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 88.3 bits (218), Expect = 6e-20
 Identities = 23/120 (19%), Positives = 46/120 (38%), Gaps = 8/120 (6%)

Query: 292 FSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNL------QCRRAFKSFDIECEMMKSIR 344
           FS + +I +GGFG VY  R    G   A+K  +       Q      +  I   ++ +  
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 345 HQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
              ++ +  +    +  + +L+ M  G L  +L       +         ++   LE++H
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMH 124

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.5 bits (216), Expect = 7e-20
 Identities = 33/151 (21%), Positives = 58/151 (38%), Gaps = 32/151 (21%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQCRRAF-KSFDIE 336
           E  R   +F +  ++  G FG V  A        G  ++VAVK+   +   +  ++   E
Sbjct: 33  EFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 90

Query: 337 CEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-------------- 381
            +MM  +  H+N++ ++ +C+      L+ EY  +G L  YL S                
Sbjct: 91  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150

Query: 382 --------CILDIFQRLNIMIDVASALEYLH 404
                    +L     L     VA  +E+L 
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.2 bits (213), Expect = 8e-20
 Identities = 23/117 (19%), Positives = 42/117 (35%), Gaps = 8/117 (6%)

Query: 296 NLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVI 352
             I  G +G   K R   DG  +  K  +         +    E  +++ ++H N+++  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 353 SSCSNEEFKA--LVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLH 404
               +       +V+EY   G L   +         LD    L +M  +  AL+  H
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.5 bits (216), Expect = 9e-20
 Identities = 28/124 (22%), Positives = 55/124 (44%), Gaps = 13/124 (10%)

Query: 290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNL 348
             +++  +I  G FG VY+A+L   G  VA+K      R      + E ++M+ + H N+
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNI 75

Query: 349 IKVISSC------SNEEFKALVLEYMPHGSLE--KYLYSSNCILDIFQRLNIMIDVASAL 400
           +++           +E +  LVL+Y+P       ++   +   L +      M  +  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 401 EYLH 404
            Y+H
Sbjct: 136 AYIH 139

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 86.0 bits (212), Expect = 1e-19
 Identities = 25/124 (20%), Positives = 52/124 (41%), Gaps = 9/124 (7%)

Query: 289 TYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRR---AFKSFDIECEMMKSIR 344
           + ++    ++  GG   V+ AR L    +VAVKV      R    +  F  E +   ++ 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 345 HQNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 400
           H  ++ V  +   E        +V+EY+   +L   +++    +   + + ++ D   AL
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124

Query: 401 EYLH 404
            + H
Sbjct: 125 NFSH 128

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.7 bits (211), Expect = 2e-19
 Identities = 29/119 (24%), Positives = 54/119 (45%), Gaps = 6/119 (5%)

Query: 292 FSENNLISKGGFGSVYKARLGDG-----MEVAVKVFNLQCR-RAFKSFDIECEMMKSIRH 345
            +   +I  G FG VYK  L        + VA+K        +    F  E  +M    H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 346 QNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            N+I++    S  +   ++ EYM +G+L+K+L   +    + Q + ++  +A+ ++YL 
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.3 bits (208), Expect = 4e-19
 Identities = 31/122 (25%), Positives = 54/122 (44%), Gaps = 10/122 (8%)

Query: 290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQ--CRRAFKSFDIECEMMKSIRHQ 346
            KF  +  I +G F +VYK       +EVA      +   +   + F  E EM+K ++H 
Sbjct: 11  LKF--DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 347 NLIKVISSC----SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 402
           N+++   S       ++   LV E M  G+L+ YL     ++ I    +    +   L++
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQF 127

Query: 403 LH 404
           LH
Sbjct: 128 LH 129

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 84.9 bits (209), Expect = 4e-19
 Identities = 35/155 (22%), Positives = 59/155 (38%), Gaps = 32/155 (20%)

Query: 280 FSYLELCRATYKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQCRRAF-KS 332
              LE  R   ++     I +G FG V++AR            VAVK+   +        
Sbjct: 5   LLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD 62

Query: 333 FDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------- 381
           F  E  +M    + N++K++  C+  +   L+ EYM +G L ++L S +           
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 382 ------------CILDIFQRLNIMIDVASALEYLH 404
                         L   ++L I   VA+ + YL 
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 157

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.8 bits (209), Expect = 5e-19
 Identities = 31/117 (26%), Positives = 49/117 (41%), Gaps = 6/117 (5%)

Query: 295 NNLISKGGFGSVYKARL----GDGMEVAVKVFNLQCRRAF-KSFDIECEMMKSIRHQNLI 349
           N +I +G FG VY   L    G  +  AVK  N          F  E  +MK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 350 KVISSCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 405
            ++  C   E    +VL YM HG L  ++ +      +   +   + VA  +++L  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.3 bits (205), Expect = 2e-18
 Identities = 36/133 (27%), Positives = 60/133 (45%), Gaps = 20/133 (15%)

Query: 292 FSENNLISKGGFGSVYKARL---GDGMEVAVKVFN-LQCRRAFKSFDIECEMMKSI-RHQ 346
               ++I +G FG V KAR+   G  M+ A+K       +   + F  E E++  +  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 347 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLN 391
           N+I ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q L+
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 392 IMIDVASALEYLH 404
              DVA  ++YL 
Sbjct: 132 FAADVARGMDYLS 144

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 82.4 bits (203), Expect = 2e-18
 Identities = 24/125 (19%), Positives = 50/125 (40%), Gaps = 12/125 (9%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDI---------ECEMM 340
            +    ++ +G    V +        E AVK+ ++    +F + ++         E +++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 341 KSIR-HQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 399
           + +  H N+I++  +     F  LV + M  G L  YL +    L   +   IM  +   
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEV 122

Query: 400 LEYLH 404
           +  LH
Sbjct: 123 ICALH 127

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.6 bits (203), Expect = 2e-18
 Identities = 27/137 (19%), Positives = 52/137 (37%), Gaps = 18/137 (13%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNL-QCRRAFKSFDIE 336
           E+ R     S    + +G FG VY+              VA+K  N     R    F  E
Sbjct: 16  EVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73

Query: 337 CEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---------SSNCILDIF 387
             +MK     ++++++   S  +   +++E M  G L+ YL                 + 
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133

Query: 388 QRLNIMIDVASALEYLH 404
           + + +  ++A  + YL+
Sbjct: 134 KMIQMAGEIADGMAYLN 150

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.1 bits (202), Expect = 4e-18
 Identities = 27/120 (22%), Positives = 52/120 (43%), Gaps = 7/120 (5%)

Query: 292 FSENNLISKGGFGSVYKAR-LGDGMEVAVKV-----FNLQCRRAFKSFDIECEMMKSIRH 345
           F +  ++  G FG+VYK   + +G +V + V           +A K    E  +M S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 346 QNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 405
            ++ +++  C     + L+ + MP G L  Y+      +     LN  + +A  + YL  
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.4 bits (200), Expect = 5e-18
 Identities = 34/146 (23%), Positives = 58/146 (39%), Gaps = 27/146 (18%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKARL--------GDGMEVAVKVFNLQ-CRRAFKSFD 334
           EL R      +   + +G FG V  A              +VAVK+       +      
Sbjct: 9   ELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66

Query: 335 IECEMMKSI-RHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------Y 378
            E EMMK I +H+N+I ++ +C+ +    +++EY   G+L +YL               +
Sbjct: 67  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126

Query: 379 SSNCILDIFQRLNIMIDVASALEYLH 404
           +    L     ++    VA  +EYL 
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLA 152

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 81.0 bits (199), Expect = 8e-18
 Identities = 26/116 (22%), Positives = 48/116 (41%), Gaps = 5/116 (4%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNL 348
           Y+      I  G FG +Y    +  G EVA+K+  ++ +       IE ++ K ++    
Sbjct: 9   YRLGR--KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           I  I  C  E    +++  +   SLE      +    +   L +   + S +EY+H
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.7 bits (198), Expect = 1e-17
 Identities = 26/115 (22%), Positives = 52/115 (45%), Gaps = 7/115 (6%)

Query: 296 NLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCR-----RAFKSFDIECEMMKSIRHQNLI 349
           + + +G F +VYKAR       VA+K   L  R        ++   E ++++ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 350 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            ++ +  ++   +LV ++M        +  ++ +L        M+     LEYLH
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.5 bits (198), Expect = 2e-17
 Identities = 17/114 (14%), Positives = 47/114 (41%), Gaps = 10/114 (8%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
           ++  G  G V +        + A+K+    C +A +  ++     ++ +  ++++++   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVEL---HWRASQCPHIVRIVDVY 74

Query: 356 ----SNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLH 404
               +  +   +V+E +  G L   +    +      +   IM  +  A++YLH
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 79.5 bits (195), Expect = 2e-17
 Identities = 26/116 (22%), Positives = 52/116 (44%), Gaps = 3/116 (2%)

Query: 291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNL 348
           K+     I +G +G VYKA+   G   A+K   L+        +   E  ++K ++H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           +K+      ++   LV E++    L+K L      L+     + ++ + + + Y H
Sbjct: 63  VKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.8 bits (196), Expect = 3e-17
 Identities = 23/118 (19%), Positives = 47/118 (39%), Gaps = 6/118 (5%)

Query: 292 FSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECE-MMKSIRHQ 346
           F  + ++ KG FG V+ A         A+K      +      +   +E   +  +  H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 347 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            L  +  +   +E    V+EY+  G L  ++ S +   D+ +      ++   L++LH
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.3 bits (192), Expect = 1e-16
 Identities = 28/138 (20%), Positives = 54/138 (39%), Gaps = 16/138 (11%)

Query: 280 FSYLELCRATYKFSEN----NLISKGGFGSVYKAR-LGDGMEVAVKVFN--LQCRRAFKS 332
           F   E+ +  ++          +  G +G+V  A     G +VA+K      Q     K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 333 FDIECEMMKSIRHQNLIKVISSCSNEEFKA------LVLEYMPHGSLEKYLYSSNCILDI 386
              E  ++K +RH+N+I ++   + +E         LV+ +M  G+    L      L  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGE 120

Query: 387 FQRLNIMIDVASALEYLH 404
            +   ++  +   L Y+H
Sbjct: 121 DRIQFLVYQMLKGLRYIH 138

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.8 bits (188), Expect = 2e-16
 Identities = 26/117 (22%), Positives = 48/117 (41%), Gaps = 3/117 (2%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQN 347
            F +   I +G +G VYKAR    G  VA+K   L         +   E  ++K + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           ++K++     E    LV E++     +    S+   + +    + +  +   L + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.3 bits (187), Expect = 3e-16
 Identities = 26/122 (21%), Positives = 48/122 (39%), Gaps = 10/122 (8%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNL------QCRRAFKSFDIECEMMKS 342
           Y   E   +  G F  V K R    G++ A K          +   + +  + E  ++K 
Sbjct: 12  YDTGE--ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 343 IRHQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 402
           I+H N+I +     N+    L+LE +  G L  +  +    L   +    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYY 128

Query: 403 LH 404
           LH
Sbjct: 129 LH 130

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.7 bits (183), Expect = 8e-16
 Identities = 23/124 (18%), Positives = 43/124 (34%), Gaps = 11/124 (8%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAF------KSFDIECEMMKS 342
           Y+     L+  GGFGSVY    + D + VA+K         +          +E  ++K 
Sbjct: 6   YQVGP--LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 343 IR--HQNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 400
           +      +I+++      +   L+LE            +    L      +    V  A+
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 401 EYLH 404
            + H
Sbjct: 124 RHCH 127

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 75.1 bits (184), Expect = 1e-15
 Identities = 23/113 (20%), Positives = 46/113 (40%), Gaps = 5/113 (4%)

Query: 296 NLISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECEMMKSIRHQNLIKV 351
             +  G FG V+  R   +G   A+KV     +   +  +  + E  M+  + H  +I++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 352 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
             +  + +   ++++Y+  G     L   +             +V  ALEYLH
Sbjct: 70  WGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.8 bits (182), Expect = 1e-15
 Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 7/216 (3%)

Query: 5   SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLT 64
            +++    L ++ +++  +          +   +L     SY  +SG +   I++L  L 
Sbjct: 95  PAIAKLTQLHYLYITHTNVSG--AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152

Query: 65  TIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIG 124
            I   GN+++G+I  + GS       +++  N LT      +   ++ +++ S   +E  
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGD 212

Query: 125 GLPNLEY-----LFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKD 179
                                       G   +L  L+L  N + G +P  L +L +L  
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272

Query: 180 LNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP 215
           LN+SFN L GEIP+GG+   F   ++  N+ LCGSP
Sbjct: 273 LNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.5 bits (182), Expect = 2e-15
 Identities = 20/120 (16%), Positives = 51/120 (42%), Gaps = 8/120 (6%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAF-KSFDIECEMMKSIRHQNL 348
           +++  + I +G +G V  A    + + VA+K  +    + + +    E +++   RH+N+
Sbjct: 9   RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 68

Query: 349 IKVISSCSNEEFKAL----VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           I +         + +    ++ ++    L K L + +  L        +  +   L+Y+H
Sbjct: 69  IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH 126

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.8 bits (180), Expect = 2e-15
 Identities = 27/132 (20%), Positives = 50/132 (37%), Gaps = 12/132 (9%)

Query: 285 LCRATYKFSENNLISKGGFGSVYKAR--LGDGMEVAVKVFNLQCRRAFKSFDIECE---- 338
           LCRA  ++     I +G +G V+KAR     G  VA+K   +Q            E    
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 339 -MMKSIRHQNLIKVISSCSNEEFKA-----LVLEYMPHGSLEKYLYSSNCILDIFQRLNI 392
             +++  H N++++   C+           LV E++               +      ++
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 393 MIDVASALEYLH 404
           M  +   L++LH
Sbjct: 122 MFQLLRGLDFLH 133

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.8 bits (180), Expect = 4e-15
 Identities = 29/136 (21%), Positives = 54/136 (39%), Gaps = 12/136 (8%)

Query: 280 FSYLELCRATYKFSEN----NLISKGGFGSVYKAR-LGDGMEVAVKVFN--LQCRRAFKS 332
           F   EL +  ++  E     + +  G +GSV  A     G+ VAVK  +   Q     K 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 333 FDIECEMMKSIRHQNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQ 388
              E  ++K ++H+N+I ++   +      EF  + L     G+    +      L    
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDH 122

Query: 389 RLNIMIDVASALEYLH 404
              ++  +   L+Y+H
Sbjct: 123 VQFLIYQILRGLKYIH 138

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.2 bits (176), Expect = 9e-15
 Identities = 27/145 (18%), Positives = 48/145 (33%), Gaps = 26/145 (17%)

Query: 284 ELCRATYKFSENNLISKGGFGSVYKAR------LGDGMEVAVKVFNL-QCRRAFKSFDIE 336
           E  R   K  +   + +G FG V +A             VAVK+          ++   E
Sbjct: 9   EFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66

Query: 337 CEMMKSIRHQNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNC------------ 382
            +++  I H   +  +     +    L  ++E+   G+L  YL S               
Sbjct: 67  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126

Query: 383 ---ILDIFQRLNIMIDVASALEYLH 404
               L +   +     VA  +E+L 
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLA 151

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 72.2 bits (176), Expect = 1e-14
 Identities = 21/113 (18%), Positives = 52/113 (46%), Gaps = 11/113 (9%)

Query: 296 NLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-HQNLIKVIS 353
             + +G +  V++A  + +  +V VK+     ++  K    E ++++++R   N+I +  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 97

Query: 354 SCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
              +   +  ALV E++ +   ++   +    L  +     M ++  AL+Y H
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH 146

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.1 bits (173), Expect = 2e-14
 Identities = 22/118 (18%), Positives = 51/118 (43%), Gaps = 4/118 (3%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQN 347
           K+ +   I +G +G+V+KA+       VA+K   L         S   E  ++K ++H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 348 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 405
           ++++     +++   LV E+      + +   +  + D     + +  +   L + H 
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS 119

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.4 bits (174), Expect = 2e-14
 Identities = 29/118 (24%), Positives = 47/118 (39%), Gaps = 5/118 (4%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQ 346
            F    L+ KG FG V   R    G   A+K+   +    +        E  ++++ RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 347 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            L  +  +    +    V+EY   G L  +L S   +    +      ++ SALEYLH
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH 122

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 69.8 bits (170), Expect = 5e-14
 Identities = 20/116 (17%), Positives = 39/116 (33%), Gaps = 5/116 (4%)

Query: 290 YKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNL 348
           YK      I +G FG +++   L +  +VA+K      R        E    K +     
Sbjct: 7   YKVGR--RIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 62

Query: 349 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
           I  +     E    +++  +   SLE  L        +         + + ++ +H
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 69.6 bits (169), Expect = 1e-13
 Identities = 40/185 (21%), Positives = 72/185 (38%), Gaps = 10/185 (5%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           +S ++ L     L  + L+ N L  +     + N    L    ++   IS   L  ++ L
Sbjct: 209 ISDITPLGILTNLDELSLNGNQLKDIGTLASLTN----LTDLDLANNQISN--LAPLSGL 262

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP 120
           TKLT + LG N+++    +   + L +L        +++ I          LY N     
Sbjct: 263 TKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI 322

Query: 121 IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDL 180
             +  L  L+ LF   N++      S  +L ++  L+   N +S   P  L  L  +  L
Sbjct: 323 SPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 378

Query: 181 NLSFN 185
            L+  
Sbjct: 379 GLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 1e-06
 Identities = 38/155 (24%), Positives = 62/155 (40%), Gaps = 30/155 (19%)

Query: 59  NLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYL---- 114
            LT L ++I   N+++    + + +NL    +LSL+ N+L  I  T  +L ++  L    
Sbjct: 195 KLTNLESLIATNNQISDITPLGILTNL---DELSLNGNQLKDIG-TLASLTNLTDLDLAN 250

Query: 115 NFSVIPIEIGGLPNLEYLFLGYNRLQGSIP--------------------DSFGDLISLK 154
           N       + GL  L  L LG N++    P                        +L +L 
Sbjct: 251 NQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLT 310

Query: 155 SLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEG 189
            L L  NN+S   P  +  L  L+ L  + NK+  
Sbjct: 311 YLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 3e-05
 Identities = 18/102 (17%), Positives = 34/102 (33%), Gaps = 24/102 (23%)

Query: 58  TNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFS 117
           T L +    +LG   +  ++S    ++L  +  L  D   + SI                
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKSID--------------- 60

Query: 118 VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLS 159
                +  L NL  +    N+L    P    +L  L  + ++
Sbjct: 61  ----GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN 96

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.2 bits (168), Expect = 1e-13
 Identities = 26/131 (19%), Positives = 54/131 (41%), Gaps = 12/131 (9%)

Query: 285 LCRATYKFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDIECEMMK 341
            C    K+ +   I +G FG V+KAR    G +VA+K   ++        +   E ++++
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64

Query: 342 SIRHQNLIKVISSCSNEEFKA--------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 393
            ++H+N++ +I  C  +            LV ++  H               + +   +M
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVM 123

Query: 394 IDVASALEYLH 404
             + + L Y+H
Sbjct: 124 QMLLNGLYYIH 134

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 68.3 bits (166), Expect = 2e-13
 Identities = 21/118 (17%), Positives = 44/118 (37%), Gaps = 5/118 (4%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDIECEMMKSIRHQ 346
           +F     +  G FG V   +    G   A+K+ +   +   +  +    E  +++++   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 347 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            L+K+  S  +     +V+EY+  G +  +L                  +    EYLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH 158

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.9 bits (165), Expect = 2e-13
 Identities = 25/118 (21%), Positives = 49/118 (41%), Gaps = 10/118 (8%)

Query: 296 NLISKGGFGSVYKARL----GDGMEVAVKVFN----LQCRRAFKSFDIECEMMKSIRHQ- 346
            ++  G +G V+  R       G   A+KV      +Q  +  +    E ++++ IR   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 347 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 404
            L+ +  +   E    L+L+Y+  G L  +L          +    + ++  ALE+LH
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHLH 146

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.7 bits (159), Expect = 2e-12
 Identities = 23/123 (18%), Positives = 47/123 (38%), Gaps = 13/123 (10%)

Query: 291 KFSENNLISKGGFGSVYKAR-LGDGMEVAVKVFN--LQCRRAFKSFDIECEMMKSIRHQN 347
           ++     I  G  G V  A        VA+K  +   Q +   K    E  +MK + H+N
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 348 LIKVISSCSNEEFK------ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 401
           +I +++  + ++         LV+E M     +          D  +   ++  +   ++
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIK 133

Query: 402 YLH 404
           +LH
Sbjct: 134 HLH 136

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 64.3 bits (155), Expect = 3e-12
 Identities = 37/192 (19%), Positives = 67/192 (34%), Gaps = 16/192 (8%)

Query: 8   SNCKC-LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTI 66
             C+C L  +  S+  L+ V       ++        +    I+     +  NL  L T+
Sbjct: 6   FRCQCHLRVVQCSDLGLEKVPK-----DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTL 60

Query: 67  ILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVI------P 120
           IL  NK++          L  L +L L  N+L  +P         L ++ + I       
Sbjct: 61  ILINNKISKISPGAFA-PLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV 119

Query: 121 IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDL 180
                   +  L     +  G    +F  +  L  + ++  N++  IP  L     L +L
Sbjct: 120 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTEL 176

Query: 181 NLSFNKLEGEIP 192
           +L  NK+     
Sbjct: 177 HLDGNKITKVDA 188

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 55.4 bits (132), Expect = 3e-09
 Identities = 51/249 (20%), Positives = 84/249 (33%), Gaps = 28/249 (11%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
              +DL NN +  +    F      +L   ++    IS         L KL  + L  N+
Sbjct: 33  TALLDLQNNKITEIKDGDFKNL--KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 73  LNG--------------------SISITLGSNLASLRKLSLDSNELTS---IPLTFWNLK 109
           L                       +  ++ + L  +  + L +N L S       F  +K
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150

Query: 110 DILYLNFS---VIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGA 166
            + Y+  +   +  I  G  P+L  L L  N++      S   L +L  L LS N++S  
Sbjct: 151 KLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 210

Query: 167 IPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVQPCKTGI 226
              SL    +L++L+L+ NKL                    N +     N    P     
Sbjct: 211 DNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTK 270

Query: 227 HHTSSKNSL 235
             + S  SL
Sbjct: 271 KASYSGVSL 279

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 55.0 bits (131), Expect = 4e-09
 Identities = 38/194 (19%), Positives = 66/194 (34%), Gaps = 18/194 (9%)

Query: 8   SNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTII 67
              K L  + +  N +  V    F G     +     +    SG        + KL+ I 
Sbjct: 97  KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 156

Query: 68  LGGNKLNGSISITLGSNLASLRKLSLDSNELTS-IPLTFWNLKDILYLNFSVIPI----- 121
           +    +    +        SL +L LD N++T     +   L ++  L  S   I     
Sbjct: 157 IADTNI----TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN 212

Query: 122 -EIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG------AIPASLEKL 174
             +   P+L  L L  N+L   +P    D   ++ + L  NN+S         P    K 
Sbjct: 213 GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 271

Query: 175 LYLKDLNLSFNKLE 188
                ++L  N ++
Sbjct: 272 ASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 48.9 bits (115), Expect = 4e-07
 Identities = 28/151 (18%), Positives = 45/151 (29%), Gaps = 4/151 (2%)

Query: 87  SLRKLSLDSNELTSIPLTFWNLKDILYLNF----SVIPIEIGGLPNLEYLFLGYNRLQGS 142
            LR +      L  +P        +L L       +   +   L NL  L L  N++   
Sbjct: 11  HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70

Query: 143 IPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSA 202
            P +F  L+ L+ L LSKN L        + L  L+       K+   +  G +      
Sbjct: 71  SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130

Query: 203 ESFEGNELLCGSPNLQVQPCKTGIHHTSSKN 233
                 +             K      +  N
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 46.2 bits (108), Expect = 4e-06
 Identities = 26/153 (16%), Positives = 53/153 (34%), Gaps = 17/153 (11%)

Query: 8   SNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTII 67
                LT + L  N +  V   +  G   ++L    +S+ +IS      + N   L  + 
Sbjct: 168 GLPPSLTELHLDGNKITKVDAASLKGL--NNLAKLGLSFNSISAVDNGSLANTPHLRELH 225

Query: 68  LGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLP 127
           L  NKL         ++   ++ + L +N +++I    +             P       
Sbjct: 226 LNNNKLVKVPGGL--ADHKYIQVVYLHNNNISAIGSNDFCP-----------PGYNTKKA 272

Query: 128 NLEYLFLGYNRLQGS--IPDSFGDLISLKSLNL 158
           +   + L  N +Q     P +F  +    ++ L
Sbjct: 273 SYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 59.0 bits (142), Expect = 7e-11
 Identities = 12/123 (9%), Positives = 33/123 (26%), Gaps = 22/123 (17%)

Query: 296 NLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK----------SFDIECEMMKSIRH 345
            L+ +G   +V+        E  VK   +      K           F +          
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 346 QNLIKVISSCSNEEF----KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 401
           + L K+      + +     A+++E +               + +     ++  +   + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAK--------ELYRVRVENPDEVLDMILEEVA 117

Query: 402 YLH 404
             +
Sbjct: 118 KFY 120

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 58.9 bits (141), Expect = 3e-10
 Identities = 19/125 (15%), Positives = 46/125 (36%), Gaps = 17/125 (13%)

Query: 297 LISKGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSC 355
            +  G F +V+ A+ + +   VA+K+     +   ++ + E ++++ +   +  K  S  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 356 SNEEFK---------------ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 400
           +N   K                +V E +    L       +  + +     I   +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 401 EYLHF 405
           +Y+H 
Sbjct: 139 DYMHR 143

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.2 bits (131), Expect = 4e-09
 Identities = 36/190 (18%), Positives = 66/190 (34%), Gaps = 14/190 (7%)

Query: 7   LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTI 66
                 L  + L    L  + P  F      +L++  +    +     +   +L  LT +
Sbjct: 101 FHGLGRLHTLHLDRCGLQELGPGLF--RGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158

Query: 67  ILGGNKLNGSISITLGSNLASLRKLSLDSNELTSI-PLTFWNLKDILYLNFS------VI 119
            L GN+++          L SL +L L  N +  + P  F +L  ++ L         + 
Sbjct: 159 FLHGNRISSVPERAF-RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217

Query: 120 PIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKD 179
              +  L  L+YL L  N        +      L+    S + +  ++P  L        
Sbjct: 218 TEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLAGRDL--- 273

Query: 180 LNLSFNKLEG 189
             L+ N L+G
Sbjct: 274 KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.8 bits (117), Expect = 2e-07
 Identities = 43/234 (18%), Positives = 69/234 (29%), Gaps = 33/234 (14%)

Query: 13  LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK 72
              I L  N +  V   +F      +L    +    ++       T L  L  + L  N 
Sbjct: 34  SQRIFLHGNRISHVPAASFRA--CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 73  LNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNF-------SVIPIEIGG 125
              S+       L  L  L LD   L  +    +     L   +       ++       
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 126 LPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLY--------- 176
           L NL +LFL  NR+      +F  L SL  L L +N ++   P +   L           
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211

Query: 177 ---------------LKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP 215
                          L+ L L+ N    +      +          +E+ C  P
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.6 bits (119), Expect = 1e-07
 Identities = 23/93 (24%), Positives = 36/93 (38%), Gaps = 27/93 (29%)

Query: 84  NLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSI 143
              SL +L++ +N+L  +P                        P LE L   +N L   +
Sbjct: 282 LPPSLEELNVSNNKLIELP---------------------ALPPRLERLIASFNHLA-EV 319

Query: 144 PDSFGDLISLKSLNLSKNNLSG--AIPASLEKL 174
           P+      +LK L++  N L     IP S+E L
Sbjct: 320 PELPQ---NLKQLHVEYNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.1 bits (110), Expect = 2e-06
 Identities = 20/67 (29%), Positives = 32/67 (47%), Gaps = 9/67 (13%)

Query: 126 LPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFN 185
            P+LE L +  N+L   +P        L+ L  S N+L+  +P   + L   K L++ +N
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNL---KQLHVEYN 334

Query: 186 KLEGEIP 192
            L  E P
Sbjct: 335 PLR-EFP 340

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.4 bits (108), Expect = 3e-06
 Identities = 21/114 (18%), Positives = 32/114 (28%), Gaps = 27/114 (23%)

Query: 41  FFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTS 100
             +      S  I         L  + +  NKL       L +    L +L    N L  
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-----ELPALPPRLERLIASFNHLAE 318

Query: 101 IPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLK 154
           +P                         NL+ L + YN L+   PD    +  L+
Sbjct: 319 VP---------------------ELPQNLKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 6e-04
 Identities = 18/107 (16%), Positives = 33/107 (30%), Gaps = 36/107 (33%)

Query: 9   NCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIIL 68
               L  +++SNN L                             +      L +L   I 
Sbjct: 282 LPPSLEELNVSNNKLIE---------------------------LPALPPRLERL---IA 311

Query: 69  GGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLN 115
             N L       +     +L++L ++ N L   P    +++D L +N
Sbjct: 312 SFNHLA-----EVPELPQNLKQLHVEYNPLREFPDIPESVED-LRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 37.5 bits (85), Expect = 0.002
 Identities = 23/78 (29%), Positives = 29/78 (37%), Gaps = 7/78 (8%)

Query: 133 FLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIP 192
               N     I        SL+ LN+S N L   +PA   +   L+ L  SFN L  E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320

Query: 193 RGGSFGNFSAESFEGNEL 210
                 N      E N L
Sbjct: 321 --ELPQNLKQLHVEYNPL 336

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.0 bits (111), Expect = 3e-07
 Identities = 26/112 (23%), Positives = 49/112 (43%), Gaps = 5/112 (4%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           L+ L  L     +T +DLS+N L ++ P      ++      V+   + +   ++ + NL
Sbjct: 10  LTVLCHLEQLLLVTHLDLSHNRLRALPP-----ALAALRCLEVLQASDNALENVDGVANL 64

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDIL 112
            +L  ++L  N+L  S +I    +   L  L+L  N L         L ++L
Sbjct: 65  PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.4 bits (99), Expect = 1e-05
 Identities = 29/115 (25%), Positives = 41/115 (35%), Gaps = 10/115 (8%)

Query: 68  LGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVI----PIEI 123
           L    L     +     L  +  L L  N L ++P     L+ +  L  S         +
Sbjct: 5   LAHKDLTVLCHL---EQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGV 61

Query: 124 GGLPNLEYLFLGYNRLQG-SIPDSFGDLISLKSLNLSKNNLSG--AIPASLEKLL 175
             LP L+ L L  NRLQ  +          L  LNL  N+L     I   L ++L
Sbjct: 62  ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.2 bits (88), Expect = 3e-04
 Identities = 27/106 (25%), Positives = 37/106 (34%), Gaps = 5/106 (4%)

Query: 89  RKLSLDSNELTSIPLTFWNLKDILYLNFS--VIPIEIGGLPNLEYLFLG-YNRLQGSIPD 145
           R L L   +LT +      L  + +L+ S   +      L  L  L +   +       D
Sbjct: 1   RVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59

Query: 146 SFGDLISLKSLNLSKNNL-SGAIPASLEKLLYLKDLNLSFNKLEGE 190
              +L  L+ L L  N L   A    L     L  LNL  N L  E
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 5e-07
 Identities = 17/103 (16%), Positives = 30/103 (29%), Gaps = 13/103 (12%)

Query: 63  LTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIE 122
           + ++ +   +L+ +    L   L   + + LD   LT                   I   
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA-------------RCKDISSA 50

Query: 123 IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSG 165
           +   P L  L L  N L           +   S  + K +L  
Sbjct: 51  LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 7e-06
 Identities = 13/71 (18%), Positives = 26/71 (36%), Gaps = 5/71 (7%)

Query: 128 NLEYLFLGYNRLQGS-IPDSFGDLISLKSLNLSKNNLSG----AIPASLEKLLYLKDLNL 182
           +++ L +    L  +   +    L   + + L    L+      I ++L     L +LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 183 SFNKLEGEIPR 193
             N+L      
Sbjct: 63  RSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 8e-06
 Identities = 17/76 (22%), Positives = 27/76 (35%), Gaps = 9/76 (11%)

Query: 127 PNLEYLFLGYNRLQG----SIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLL-----YL 177
             L  L+L    +      S+  +     SL+ L+LS N L  A    L + +      L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 178 KDLNLSFNKLEGEIPR 193
           + L L       E+  
Sbjct: 429 EQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 3e-05
 Identities = 17/101 (16%), Positives = 30/101 (29%), Gaps = 18/101 (17%)

Query: 83  SNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGS 142
              + LR L L   +++                 S +   +    +L  L L  N L  +
Sbjct: 366 QPGSVLRVLWLADCDVSDSSC-------------SSLAATLLANHSLRELDLSNNCLGDA 412

Query: 143 IPDSFGDLI-----SLKSLNLSKNNLSGAIPASLEKLLYLK 178
                 + +      L+ L L     S  +   L+ L   K
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 2e-04
 Identities = 16/106 (15%), Positives = 30/106 (28%), Gaps = 25/106 (23%)

Query: 87  SLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQG----S 142
            ++ L +   EL+                       +  L   + + L    L       
Sbjct: 3   DIQSLDIQCEELSDARW----------------AELLPLLQQCQVVRLDDCGLTEARCKD 46

Query: 143 IPDSFGDLISLKSLNLSKNNLSGAIPASLEKLL-----YLKDLNLS 183
           I  +     +L  LNL  N L       + + L      ++ L+L 
Sbjct: 47  ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.001
 Identities = 13/92 (14%), Positives = 32/92 (34%), Gaps = 9/92 (9%)

Query: 13 LTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEIT----NLTKLTTIIL 68
          +  +D+    L        +  +    +   +  C ++    ++I+        L  + L
Sbjct: 4  IQSLDIQCEELSDARWAELLPLLQQ-CQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 69 GGNKLNG----SISITLGSNLASLRKLSLDSN 96
            N+L       +   L +    ++KLSL + 
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.2 bits (108), Expect = 3e-06
 Identities = 34/209 (16%), Positives = 57/209 (27%), Gaps = 33/209 (15%)

Query: 6   SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTT 65
            +S       ++     L ++ P     ++        +S   +    L  +   T+LT 
Sbjct: 5   EVSKVASHLEVNCDKRNLTALPP-----DLPKDTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 66  IILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNF--------- 116
           + L   +L           L +L         L  +  T   L  +              
Sbjct: 60  LNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 117 ------------------SVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNL 158
                             ++ P  +   P LE L L  N L          L +L +L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 159 SKNNLSGAIPASLEKLLYLKDLNLSFNKL 187
            +N+L   IP        L    L  N  
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (98), Expect = 3e-05
 Identities = 29/116 (25%), Positives = 40/116 (34%), Gaps = 6/116 (5%)

Query: 83  SNLASLRKLSLDSNELTSIP----LTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNR 138
           S      + +LD   L S P         + +      + + I    +P L  L L  NR
Sbjct: 17  SKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNR 76

Query: 139 LQG--SIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIP 192
           L     +        +LK LNLS N L         K L L++L L  N L     
Sbjct: 77  LYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (92), Expect = 1e-04
 Identities = 22/116 (18%), Positives = 43/116 (37%), Gaps = 8/116 (6%)

Query: 83  SNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIE--------IGGLPNLEYLFL 134
                   L+  S+   ++ +   N+ ++L LN S   +         +   PNL+ L L
Sbjct: 39  VAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98

Query: 135 GYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGE 190
             N L+          + L+ L L  N+LS         +  +++      +L+G 
Sbjct: 99  SGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGH 154

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 4e-05
 Identities = 25/183 (13%), Positives = 57/183 (31%), Gaps = 10/183 (5%)

Query: 1   LSFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNL 60
           ++ +  +     L  ++L +N +        +  + +  +   +         +  I  L
Sbjct: 53  VTTIEGVQYLNNLIGLELKDNQIT------DLAPLKNLTKITELELSGNPLKNVSAIAGL 106

Query: 61  TKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIP 120
             + T+ L   ++     +   SNL  L         ++ +          +        
Sbjct: 107 QSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDL 166

Query: 121 IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDL 180
             +  L  L  L    N++    P     L +L  ++L  N +S   P  L     L  +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222

Query: 181 NLS 183
            L+
Sbjct: 223 TLT 225

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (90), Expect = 4e-04
 Identities = 7/42 (16%), Positives = 13/42 (30%), Gaps = 2/42 (4%)

Query: 123 IGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLS 164
             G      L +   R+         +L  L++ +    NL 
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 7e-04
 Identities = 9/44 (20%), Positives = 15/44 (34%)

Query: 143 IPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNK 186
             D F        L++S+  +       LE L  L+  +    K
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (87), Expect = 6e-04
 Identities = 20/86 (23%), Positives = 31/86 (36%), Gaps = 4/86 (4%)

Query: 83  SNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIE----IGGLPNLEYLFLGYNR 138
           +N    R+L L   ++  I      L     ++FS   I        L  L+ L +  NR
Sbjct: 15  TNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNR 74

Query: 139 LQGSIPDSFGDLISLKSLNLSKNNLS 164
           +          L  L  L L+ N+L 
Sbjct: 75  ICRIGEGLDQALPDLTELILTNNSLV 100

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.002
 Identities = 36/204 (17%), Positives = 67/204 (32%), Gaps = 32/204 (15%)

Query: 2   SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLT 61
             + S          +L    +   + +  +    +S++  + +  +I    ++ I  L 
Sbjct: 15  KQIFSDDAFAETIKDNLKKKSVTDAVTQNEL----NSIDQIIANNSDIKS--VQGIQYLP 68

Query: 62  KLTTIILGGNKLNGSISIT----------------------LGSNLASLRKLSLDSNELT 99
            +T + L GNKL     +                           L SL       +++ 
Sbjct: 69  NVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN 128

Query: 100 SIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLS 159
            +          L  N       +  L  L+ L L  N++   +P     L  L++L LS
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 186

Query: 160 KNNLSGAIPASLEKLLYLKDLNLS 183
           KN++S     +L  L  L  L L 
Sbjct: 187 KNHISD--LRALAGLKNLDVLELF 208

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	405
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.95
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.9
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.89
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.88
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.87
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.87
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.86
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.86
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.85
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.85
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.85
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.85
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.85
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.84
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.84
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.84
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.84
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.84
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.83
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.83
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.83
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.83
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.83
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.82
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.82
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.82
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.82
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.82
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.82
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.82
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.82
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.82
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.81
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.8
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.8
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.8
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.8
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.79
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.79
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.79
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.79
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.79
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.78
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.78
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.78
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.78
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.77
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.77
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.77
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.77
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.77
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.76
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.75
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.75
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.75
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.75
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.75
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.74
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.74
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.73
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.72
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.7
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.69
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.69
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.68
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.68
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.68
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.67
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.67
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.67
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.67
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.66
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.66
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.65
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.65
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.64
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.63
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.63
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.61
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.59
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.58
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.57
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.51
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.46
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.46
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.45
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.43
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.4
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.31
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.22
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.18
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.18
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.08
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.07
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.82
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.76
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.66
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.76
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.63
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.17
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.01
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	96.79
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	93.56
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	84.59

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.95  E-value=2.7e-28  Score=223.73  Aligned_cols=211  Identities=29%  Similarity=0.531  Sum_probs=185.5

Q ss_pred             cccccCCCCCcCCeeeCcC-CcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcc
Q 036754            2 SFLSSLSNCKCLTFIDLSN-NPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISIT   80 (405)
Q Consensus         2 ~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~   80 (405)
                      ++|++|+++++|++|||++ |.+.+.+|.. +++++ +|++|+|++|++.+..+..+..+++|+.+++++|.+.+.+|..
T Consensus        67 ~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~-i~~L~-~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~  144 (313)
T d1ogqa_          67 PIPSSLANLPYLNFLYIGGINNLVGPIPPA-IAKLT-QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS  144 (313)
T ss_dssp             ECCGGGGGCTTCSEEEEEEETTEESCCCGG-GGGCT-TCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGG
T ss_pred             CCChHHhcCccccccccccccccccccccc-ccccc-ccchhhhccccccccccccccchhhhcccccccccccccCchh
Confidence            4678999999999999987 8999889988 77877 9999999999999999999999999999999999998888887


Q ss_pred             hhcCCCCCCeeeCCCCCCC-CCchhhhccccC-ccccCCC-----------------------------CChhccCCCCC
Q 036754           81 LGSNLASLRKLSLDSNELT-SIPLTFWNLKDI-LYLNFSV-----------------------------IPIEIGGLPNL  129 (405)
Q Consensus        81 ~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L-~~l~l~~-----------------------------~p~~~~~l~~L  129 (405)
                      + .++++|+.+++++|.++ .+|..+..+..+ +.++++.                             +|..+..++++
T Consensus       145 l-~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l  223 (313)
T d1ogqa_         145 I-SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT  223 (313)
T ss_dssp             G-GGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCC
T ss_pred             h-ccCcccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            7 48999999999999998 788877766654 3333221                             45667788999


Q ss_pred             CEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCC
Q 036754          130 EYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNE  209 (405)
Q Consensus       130 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~  209 (405)
                      +.+++++|.+.+.+| .++.+++|+.|++++|+++|.+|..+.++++|+.|++++|+++|.+|+.+.+.+++.+++.+|+
T Consensus       224 ~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         224 QKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK  302 (313)
T ss_dssp             SEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred             ccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCc
Confidence            999999999987655 6888999999999999999999999999999999999999999999998889999999999999


Q ss_pred             CccCCCC
Q 036754          210 LLCGSPN  216 (405)
Q Consensus       210 ~~c~~~~  216 (405)
                      ..|+.|-
T Consensus       303 ~l~g~pl  309 (313)
T d1ogqa_         303 CLCGSPL  309 (313)
T ss_dssp             EEESTTS
T ss_pred             cccCCCC
Confidence            9999764

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=8.4e-26  Score=201.96  Aligned_cols=200  Identities=24%  Similarity=0.240  Sum_probs=175.7

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCC
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLA   86 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~   86 (405)
                      ..+...+..+|.+++.|+.+ |.. +   +++|+.|+|++|++++..++.|.++++|++|+|++|+|+ .+|..  ..++
T Consensus         6 ~~~~~~~~~v~C~~~~L~~i-P~~-l---p~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~~--~~l~   77 (266)
T d1p9ag_           6 VSKVASHLEVNCDKRNLTAL-PPD-L---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD--GTLP   77 (266)
T ss_dssp             EECSTTCCEEECTTSCCSSC-CSC-C---CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECC--SCCT
T ss_pred             EcccCCCeEEEccCCCCCee-CcC-c---CcCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccccc--cccc
Confidence            34566778889999999875 543 2   358999999999999988889999999999999999998 67653  5799


Q ss_pred             CCCeeeCCCCCCCCCchhhhccccCccccCCC------CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccc
Q 036754           87 SLRKLSLDSNELTSIPLTFWNLKDILYLNFSV------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSK  160 (405)
Q Consensus        87 ~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~------~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~  160 (405)
                      +|++|+|++|+++.+|..+.++++|+.|+++.      .+..+..++++++|++++|.+....+..+..+++|+.+++++
T Consensus        78 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~  157 (266)
T d1p9ag_          78 VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN  157 (266)
T ss_dssp             TCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             cccccccccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccc
Confidence            99999999999999999999999999999875      344567889999999999999988888889999999999999


Q ss_pred             ccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCccCC
Q 036754          161 NNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS  214 (405)
Q Consensus       161 n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~~  214 (405)
                      |++++..+..|..+++|++|++++|.|+..++......+++.+++.||||.|.|
T Consensus       158 N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         158 NNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             SCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             ccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCc
Confidence            999999889999999999999999999965556677889999999999999975

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=1.3e-23  Score=189.40  Aligned_cols=201  Identities=23%  Similarity=0.243  Sum_probs=174.0

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCC-cccccccCcchhcCCCCCC
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGG-NKLNGSISITLGSNLASLR   89 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~l~~L~   89 (405)
                      +++++|+|++|+|+.+.+.+ +.++. +|+.|++++|++..+.+..+..++.++.++... |.++ .++...+.++++|+
T Consensus        32 ~~~~~L~Ls~N~i~~i~~~~-f~~l~-~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~-~l~~~~~~~l~~L~  108 (284)
T d1ozna_          32 AASQRIFLHGNRISHVPAAS-FRACR-NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR-SVDPATFHGLGRLH  108 (284)
T ss_dssp             TTCSEEECTTSCCCEECTTT-TTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCC-CCCTTTTTTCTTCC
T ss_pred             CCCCEEECcCCcCCCCCHHH-hhccc-cccccccccccccccccccccccccccccccccccccc-cccchhhcccccCC
Confidence            46899999999999888777 56666 899999999999999999999999999998764 4554 77777778999999


Q ss_pred             eeeCCCCCCCCCch-hhhccccCccccCCC-----CC-hhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccccc
Q 036754           90 KLSLDSNELTSIPL-TFWNLKDILYLNFSV-----IP-IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN  162 (405)
Q Consensus        90 ~L~Ls~N~l~~lp~-~~~~l~~L~~l~l~~-----~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~  162 (405)
                      +|++++|.+..++. .+....+|+.++++.     +| ..|..+++|++|++++|.+++..+..|.++++|+.+++++|.
T Consensus       109 ~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~  188 (284)
T d1ozna_         109 TLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR  188 (284)
T ss_dssp             EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcc
Confidence            99999999987654 456677888877654     54 467889999999999999998889999999999999999999


Q ss_pred             ccCccchhHHhcccCCccccccCcccCcCCC-CCccCCCCcccccCCCCccCC
Q 036754          163 LSGAIPASLEKLLYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLCGS  214 (405)
Q Consensus       163 l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~~~~~~~~~~~n~~~c~~  214 (405)
                      +++..|..|..+++|+.|++++|.+.+.++. .....++..+++.+|++.|.+
T Consensus       189 l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C  241 (284)
T d1ozna_         189 VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC  241 (284)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred             ccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCc
Confidence            9999999999999999999999999987764 356788999999999999964

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.89  E-value=1.6e-22  Score=184.19  Aligned_cols=201  Identities=21%  Similarity=0.288  Sum_probs=126.5

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchh
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG   82 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   82 (405)
                      +|+.+.  +++++|+|++|+|+.+.+.+ +.+++ +|+.|++++|.+....|..|..+++|++|++++|+++ .+|...+
T Consensus        25 lP~~l~--~~l~~L~Ls~N~i~~l~~~~-f~~l~-~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~   99 (305)
T d1xkua_          25 VPKDLP--PDTALLDLQNNKITEIKDGD-FKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP   99 (305)
T ss_dssp             CCCSCC--TTCCEEECCSSCCCCBCTTT-TTTCT-TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC
T ss_pred             cCCCCC--CCCCEEECcCCcCCCcChhH-hhccc-cccccccccccccccchhhhhCCCccCEecccCCccC-cCccchh
Confidence            455553  67999999999999888777 56666 8999999999999988999999999999999999987 5665432


Q ss_pred             cCCCCCCeeeCCCCCCCCCchh---------------------------hhc---------------------cccCccc
Q 036754           83 SNLASLRKLSLDSNELTSIPLT---------------------------FWN---------------------LKDILYL  114 (405)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~lp~~---------------------------~~~---------------------l~~L~~l  114 (405)
                         ..|+.|++++|.+..++..                           +..                     .++|+.|
T Consensus       100 ---~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~~L  176 (305)
T d1xkua_         100 ---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTEL  176 (305)
T ss_dssp             ---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEE
T ss_pred             ---hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcccCCccCEE
Confidence               3445555555554443321                           111                     2233333


Q ss_pred             cCCC------CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCccc
Q 036754          115 NFSV------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLE  188 (405)
Q Consensus       115 ~l~~------~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~  188 (405)
                      +++.      .+..+.+++.+++|++++|.+.+..+..|.++++|++|+|++|+++ .+|..+..+++|+.|++++|+|+
T Consensus       177 ~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~  255 (305)
T d1xkua_         177 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS  255 (305)
T ss_dssp             ECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred             ECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence            3322      2344555566666666666666555566666666666666666665 33555666666666666666665


Q ss_pred             CcCCCC-------CccCCCCcccccCCCCcc
Q 036754          189 GEIPRG-------GSFGNFSAESFEGNELLC  212 (405)
Q Consensus       189 ~~~p~~-------~~~~~~~~~~~~~n~~~c  212 (405)
                      ......       ....+++.+.+.+||+.+
T Consensus       256 ~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~  286 (305)
T d1xkua_         256 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY  286 (305)
T ss_dssp             CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred             ccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence            432211       122345555566666544

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.88  E-value=6.6e-23  Score=187.46  Aligned_cols=185  Identities=27%  Similarity=0.415  Sum_probs=157.0

Q ss_pred             cccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcch
Q 036754            2 SFLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITL   81 (405)
Q Consensus         2 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~   81 (405)
                      ++|++|+++++|++|+|++|++.+..+.. +..+. +|+.+++++|.+.+.+|..+..+++|+.+++++|.+++.+|..+
T Consensus        92 ~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~-~~~~~-~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~  169 (313)
T d1ogqa_          92 PIPPAIAKLTQLHYLYITHTNVSGAIPDF-LSQIK-TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY  169 (313)
T ss_dssp             CCCGGGGGCTTCSEEEEEEECCEEECCGG-GGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGG
T ss_pred             ccccccccccccchhhhcccccccccccc-ccchh-hhcccccccccccccCchhhccCcccceeecccccccccccccc
Confidence            47889999999999999999999998887 55555 89999999999999999999999999999999999999999888


Q ss_pred             hcCCCC-CCeeeCCCCCCC-CCchhh-----------------------hccccCccccCCC-----CChhccCCCCCCE
Q 036754           82 GSNLAS-LRKLSLDSNELT-SIPLTF-----------------------WNLKDILYLNFSV-----IPIEIGGLPNLEY  131 (405)
Q Consensus        82 ~~~l~~-L~~L~Ls~N~l~-~lp~~~-----------------------~~l~~L~~l~l~~-----~p~~~~~l~~L~~  131 (405)
                      + .+.. ++.+++++|+++ ..|..+                       ..++.++.++++.     .+..++.+++|++
T Consensus       170 ~-~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~  248 (313)
T d1ogqa_         170 G-SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNG  248 (313)
T ss_dssp             G-CCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCE
T ss_pred             c-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            6 5555 488999988887 333333                       2334455555543     4567888999999


Q ss_pred             EeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCc-ccCc
Q 036754          132 LFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNK-LEGE  190 (405)
Q Consensus       132 L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~-l~~~  190 (405)
                      |++++|+++|.+|..|+++++|++|+|++|+++|.+|. +.++++|+.+++++|+ +.|.
T Consensus       249 L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             EECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred             ccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence            99999999999999999999999999999999998885 5789999999999997 5664

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=4.8e-22  Score=177.24  Aligned_cols=178  Identities=26%  Similarity=0.229  Sum_probs=150.6

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchh
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG   82 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   82 (405)
                      +|+.+.  ++|++|||++|+|+++.+.+ +.+++ +|++|+|++|+++...  .++.+++|++|+|++|+++ .++..+ 
T Consensus        25 iP~~lp--~~l~~L~Ls~N~i~~l~~~~-f~~l~-~L~~L~L~~N~l~~l~--~~~~l~~L~~L~Ls~N~l~-~~~~~~-   96 (266)
T d1p9ag_          25 LPPDLP--KDTTILHLSENLLYTFSLAT-LMPYT-RLTQLNLDRAELTKLQ--VDGTLPVLGTLDLSHNQLQ-SLPLLG-   96 (266)
T ss_dssp             CCSCCC--TTCCEEECTTSCCSEEEGGG-GTTCT-TCCEEECTTSCCCEEE--CCSCCTTCCEEECCSSCCS-SCCCCT-
T ss_pred             eCcCcC--cCCCEEECcCCcCCCcCHHH-hhccc-cccccccccccccccc--ccccccccccccccccccc-cccccc-
Confidence            454443  57999999999999987777 56676 9999999999998643  4578999999999999998 555554 


Q ss_pred             cCCCCCCeeeCCCCCCCCCch-hhhccccCccccCCC-----CC-hhccCCCCCCEEeccCCcccccCCcccccCCCCCe
Q 036754           83 SNLASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSV-----IP-IEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKS  155 (405)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~lp~-~~~~l~~L~~l~l~~-----~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  155 (405)
                      .++++|++|++++|.+..++. .+..+.++..|+++.     +| ..+..+++|+++++++|++++..+..|..+++|++
T Consensus        97 ~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~  176 (266)
T d1p9ag_          97 QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT  176 (266)
T ss_dssp             TTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCE
T ss_pred             ccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccce
Confidence            589999999999999997754 456778888887764     44 45677899999999999999888888999999999


Q ss_pred             eecccccccCccchhHHhcccCCccccccCcccC
Q 036754          156 LNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEG  189 (405)
Q Consensus       156 L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~  189 (405)
                      |+|++|+++ .+|..+..+++|+.|++++|++.+
T Consensus       177 L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             EECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             eecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence            999999999 677778889999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=2.4e-22  Score=178.77  Aligned_cols=115  Identities=25%  Similarity=0.376  Sum_probs=103.9

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      .+|...+.||+|+||+||+|...++..||||+++... ...++|.+|++++.+++|||||+++|+|...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4566678899999999999999888899999997543 345679999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++......++|..+..|+.|||+||+|||+
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~  119 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE  119 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc
Confidence            999999998776789999999999999999999994

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=3.9e-22  Score=176.57  Aligned_cols=115  Identities=24%  Similarity=0.382  Sum_probs=104.8

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      ++|...+.||+|+||+||+|+.+++..||||+++.... ...+|.+|+.++++++|||||+++|+|.+.+..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57888899999999999999998888999999976533 35679999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|++..++......+++..+.+++.|||+||+|||+
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~  118 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES  118 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh
Confidence            999999987766679999999999999999999994

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.86  E-value=2.7e-22  Score=181.67  Aligned_cols=115  Identities=23%  Similarity=0.408  Sum_probs=99.3

Q ss_pred             cCCccCcccccCCCceEEEeeC-CC---cEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          291 KFSENNLISKGGFGSVYKARLG-DG---MEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      +|...++||+|+||+||+|... ++   ..||||.+.... ....+.|.+|+.++++++|||||+++|+|...+..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            3445578999999999999863 23   368999886543 345568999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||++|+|.+++......++|.++..++.|||+||+|||+
T Consensus       107 Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~  146 (299)
T d1jpaa_         107 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD  146 (299)
T ss_dssp             ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            9999999999998766679999999999999999999994

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=1.1e-21  Score=176.56  Aligned_cols=206  Identities=26%  Similarity=0.275  Sum_probs=168.8

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEc-ccCcccccCCccccCccCCCeeecCCcccccccCcchhcC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVM-SYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSN   84 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L-~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~   84 (405)
                      +|.++++|++||+++|++..+.+.. +.... .++.+.. ..|.++...+..|.++++|++|++++|.+. .++...+..
T Consensus        51 ~f~~l~~L~~L~ls~n~l~~i~~~~-~~~~~-~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~-~~~~~~~~~  127 (284)
T d1ozna_          51 SFRACRNLTILWLHSNVLARIDAAA-FTGLA-LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRG  127 (284)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTT-TTTCT-TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTT
T ss_pred             Hhhcccccccccccccccccccccc-ccccc-cccccccccccccccccchhhcccccCCEEecCCcccc-cccccccch
Confidence            5899999999999999999988887 45554 6777765 466788888889999999999999999997 566666678


Q ss_pred             CCCCCeeeCCCCCCCCCch-hhhccccCccccCCC------CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeee
Q 036754           85 LASLRKLSLDSNELTSIPL-TFWNLKDILYLNFSV------IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLN  157 (405)
Q Consensus        85 l~~L~~L~Ls~N~l~~lp~-~~~~l~~L~~l~l~~------~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  157 (405)
                      +++|+.+++++|+|+.+|. .+..+..|+.|+++.      .+..+.++++|+++++++|.+.+..|..|..+++|++|+
T Consensus       128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~  207 (284)
T d1ozna_         128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY  207 (284)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence            9999999999999998865 466788899988765      355788999999999999999999999999999999999


Q ss_pred             cccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCccCC
Q 036754          158 LSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS  214 (405)
Q Consensus       158 l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~~  214 (405)
                      +++|.+.+..+..|..+++|+.+++++|++.+..+...-...++......+...|..
T Consensus       208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~  264 (284)
T d1ozna_         208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL  264 (284)
T ss_dssp             CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEE
T ss_pred             ccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCC
Confidence            999999999999999999999999999999875442211112233333445555543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=9e-22  Score=177.00  Aligned_cols=115  Identities=22%  Similarity=0.344  Sum_probs=104.1

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      .|...+.||+|+||+||+|.. .+|..||||++........+.+.+|++++++++|||||++++++.+.+..++||||++
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~   92 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   92 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence            456677899999999999995 5789999999987666667889999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++.+....+++.++..++.||++||+|||+
T Consensus        93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~  128 (288)
T d2jfla1          93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD  128 (288)
T ss_dssp             TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999987655579999999999999999999994

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=3.4e-21  Score=173.43  Aligned_cols=113  Identities=27%  Similarity=0.355  Sum_probs=103.0

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      .|...+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++|||||++++++.+.+..|+||||++
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~  100 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence            577788999999999999984 5799999999987665566789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++.+.  .+++.++..++.||+.||+|||+
T Consensus       101 gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~  134 (293)
T d1yhwa1         101 GGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS  134 (293)
T ss_dssp             TCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999988753  59999999999999999999994

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.85  E-value=1.8e-21  Score=175.03  Aligned_cols=116  Identities=26%  Similarity=0.425  Sum_probs=102.3

Q ss_pred             hccCCccCcccccCCCceEEEeeC-CCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          289 TYKFSENNLISKGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      .++|...+.||+|+||+||+|... +|+.||||+++... ...++|.+|+.++++++|||||+++|+|.+.+..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            345666788999999999999964 58899999987543 3456799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++... ...++|..+..|+.|||+||+|||+
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~  133 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK  133 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999754 3579999999999999999999994

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.85  E-value=7.2e-21  Score=160.92  Aligned_cols=179  Identities=21%  Similarity=0.214  Sum_probs=144.7

Q ss_pred             cCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccc-cCCccccCccCCCeeecCCcccccccCcchhcCCCCCCe
Q 036754           12 CLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISG-GILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRK   90 (405)
Q Consensus        12 ~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~   90 (405)
                      ..+.++.++|+++.++++.     +.++++|+|++|+|++ ..+..|.++++|+.|+|++|.+. .++...+..+++|++
T Consensus         9 ~~~~v~Cs~~~L~~iP~~l-----p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~-~~~~~~~~~~~~L~~   82 (192)
T d1w8aa_           9 EGTTVDCTGRGLKEIPRDI-----PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQE   82 (192)
T ss_dssp             ETTEEECTTSCCSSCCSCC-----CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC-CBCTTTTTTCTTCCE
T ss_pred             cCCEEEEeCCCcCccCCCC-----CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccc-cccccccccccccce
Confidence            3578999999998754432     3589999999999986 45677899999999999999998 566666679999999


Q ss_pred             eeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchh
Q 036754           91 LSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPAS  170 (405)
Q Consensus        91 L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~  170 (405)
                      |+|++|+|+.+|+.                 .|.++++|++|+|++|++++..|+.|..+++|++|+|++|++....+..
T Consensus        83 L~Ls~N~l~~l~~~-----------------~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~  145 (192)
T d1w8aa_          83 LQLGENKIKEISNK-----------------MFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA  145 (192)
T ss_dssp             EECCSCCCCEECSS-----------------SSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH
T ss_pred             eeeccccccccCHH-----------------HHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH
Confidence            99999999988754                 4667899999999999999999999999999999999999998654322


Q ss_pred             HHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCccCCCC
Q 036754          171 LEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN  216 (405)
Q Consensus       171 ~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~  216 (405)
                       .-...++.+.+..|.+++..|..  +......++..|.+.|..++
T Consensus       146 -~~~~~l~~~~l~~~~~~c~~p~~--l~~~~l~~L~~n~l~C~~~~  188 (192)
T d1w8aa_         146 -WFAEWLRKKSLNGGAARCGAPSK--VRDVQIKDLPHSEFKCSSEN  188 (192)
T ss_dssp             -HHHHHHHHHCCSGGGCBBCSSTT--TTTSBGGGSCTTTCCCCCC-
T ss_pred             -HHhhhhhhhcccCCCeEeCCChh--hcCCEeeecCHhhCcCCCCC
Confidence             22234667778888887766643  45666778888988886653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=2.5e-21  Score=173.79  Aligned_cols=115  Identities=21%  Similarity=0.374  Sum_probs=97.9

Q ss_pred             ccCCccCc-ccccCCCceEEEeeC---CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNL-ISKGGFGSVYKARLG---DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~-lg~G~fg~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      +++...+. ||+|+||.||+|...   ++..||||+++... ....++|.+|++++++++|||||+++|+|.+ +..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            34444553 999999999999753   35579999997654 3446789999999999999999999999865 568999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++...+..+++.++..++.|||+||+|||+
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~  127 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE  127 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999987766689999999999999999999994

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=1.3e-21  Score=174.24  Aligned_cols=115  Identities=19%  Similarity=0.230  Sum_probs=99.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      ++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..||||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            4677778999999999999995 578999999997543 33446789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++... ..+++.++..++.||++||+|||+
T Consensus        85 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~  121 (271)
T d1nvra_          85 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHG  121 (271)
T ss_dssp             CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999754 479999999999999999999994

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=3.4e-21  Score=172.21  Aligned_cols=114  Identities=24%  Similarity=0.412  Sum_probs=99.3

Q ss_pred             hccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          289 TYKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      .++|...+.||+|+||+||+|+..  ..||||+++...  ....+.|.+|+.++.+++|||||+++|++.. +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            356777889999999999999864  359999997543  4456789999999999999999999998754 56899999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.++++..+..++|.++..|+.|||+||+|||+
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~  122 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA  122 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            999999999998766679999999999999999999994

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.84  E-value=3.1e-21  Score=178.18  Aligned_cols=116  Identities=17%  Similarity=0.259  Sum_probs=104.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ++|...+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++|||||++++++.+.+..|||||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            3566778899999999999985 578999999997665555677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++......+++.++..|+.||+.||+|||+
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~  142 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE  142 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999997666679999999999999999999994

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=1.8e-21  Score=178.15  Aligned_cols=117  Identities=18%  Similarity=0.215  Sum_probs=104.2

Q ss_pred             hhccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          288 ATYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       288 ~~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ..++|...+.||+|+||+||+|.. .+|+.||+|+++... ......+.+|+.++++++|||||+++++|.+.+..|+||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            346788888999999999999995 578999999997653 334567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++.+.+ .+++..+..++.|+++||+|||+
T Consensus        84 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~  122 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE  122 (322)
T ss_dssp             ECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997654 69999999999999999999994

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=2.9e-21  Score=172.49  Aligned_cols=114  Identities=24%  Similarity=0.391  Sum_probs=98.8

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      ++|...+.||+|+||.||+|...+++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            4566678899999999999999888899999997543 345679999999999999999999998754 56799999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|.+++.... ..++|.++++|+.|||+||+|||+
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~  127 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE  127 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999999876433 358999999999999999999994

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=5.8e-21  Score=169.33  Aligned_cols=115  Identities=26%  Similarity=0.372  Sum_probs=102.0

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.||+|+||+||+|+. .+|+.||+|++.+..   ......+.+|+.++++++|||||++++++.+.+..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            4577778999999999999996 568899999997542   334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+ .+++.++..++.||++||+|||+
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~  124 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS  124 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997644 69999999999999999999994

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.83  E-value=7.3e-21  Score=175.74  Aligned_cols=116  Identities=18%  Similarity=0.249  Sum_probs=104.1

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ++|...+.||+|+||+||+|.. .+|+.||||++..........+.+|+.++++++|||||++++++.+.+..||||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            3467778999999999999985 579999999997655455667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++...+..+++.++..|+.||++||+|||+
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~  145 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE  145 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999887666679999999999999999999994

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=8.2e-21  Score=171.49  Aligned_cols=115  Identities=22%  Similarity=0.324  Sum_probs=101.6

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc------cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC------RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  362 (405)
                      +.|...+.||+|+||+||+|.. .+|+.||||++.+..      ....+.+.+|+.++++++|||||++++++.+.+..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3466778899999999999995 578999999996532      123567899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||||++|+|.+++...+ .+++.++..++.|+++||+|||+
T Consensus        90 iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~  131 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHS  131 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhh
Confidence            9999999999999997654 79999999999999999999994

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.83  E-value=9.3e-21  Score=171.88  Aligned_cols=115  Identities=17%  Similarity=0.250  Sum_probs=97.1

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      +.|...+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+.++++++|||||++++++.+.+..||||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            3466778999999999999985 568999999997543 23345678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++|+|.+++...+ .+++.++..++.||++||+|||+
T Consensus        89 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~  125 (307)
T d1a06a_          89 VSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHD  125 (307)
T ss_dssp             CCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhh
Confidence            99999999997654 79999999999999999999994

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=1.2e-20  Score=168.75  Aligned_cols=108  Identities=23%  Similarity=0.353  Sum_probs=92.3

Q ss_pred             CcccccCCCceEEEeeC---CCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCCC
Q 036754          296 NLISKGGFGSVYKARLG---DGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMPH  370 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  370 (405)
                      +.||+|+||+||+|.+.   .++.||||+++...  ....+.|.+|+.++++++|||||+++|+|.+ +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            56999999999999853   34689999996543  3345679999999999999999999999865 457899999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          371 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       371 g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+|.++++..+ .++|.++..++.|||+||+|||+
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~  125 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEE  125 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHh
Confidence            99999998654 69999999999999999999994

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=1.6e-20  Score=171.57  Aligned_cols=115  Identities=17%  Similarity=0.238  Sum_probs=101.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +.|...+.||+|+||+||+|.. .+|+.||||+++... .....+.+|++++.+++|||||++++++.+.+..|||||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            3456678899999999999985 578899999997543 23456789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++...+..+++.++..|+.||++||+|||+
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~  120 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS  120 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999998766579999999999999999999994

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=6.7e-21  Score=169.58  Aligned_cols=116  Identities=20%  Similarity=0.284  Sum_probs=98.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeec--CCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSN--EEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  364 (405)
                      ++|...+.||+|+||+||+|.. .+|+.||||.+....  ....+.+.+|++++++++|||||++++++.+  .+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5677788999999999999985 578999999997643  3345678999999999999999999998864  4568999


Q ss_pred             EecCCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++...   +..+++..+..++.|+++||+|||+
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~  127 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR  127 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999998642   3579999999999999999999993

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=1.4e-20  Score=167.40  Aligned_cols=111  Identities=26%  Similarity=0.374  Sum_probs=95.7

Q ss_pred             ccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeec----CCeeEEEEe
Q 036754          294 ENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSN----EEFKALVLE  366 (405)
Q Consensus       294 ~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e  366 (405)
                      ..+.||+|+||+||+|.. .++..||+|.+....  ....+.+.+|++++++++|||||++++++..    ....++|||
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE   92 (270)
T d1t4ha_          13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE   92 (270)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence            345799999999999995 468899999987543  3345678999999999999999999999864    356799999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.+++.... .+++..+..++.||++||+|||+
T Consensus        93 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~  130 (270)
T d1t4ha_          93 LMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT  130 (270)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHH
Confidence            999999999997644 69999999999999999999995

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.82  E-value=1.3e-20  Score=170.96  Aligned_cols=114  Identities=25%  Similarity=0.301  Sum_probs=100.1

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      .|+..+.||+|+||+||+|+. .+|+.||||++....   ....+.+.+|+.++.+++|||||++++++.+.+..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            367778899999999999984 578999999997543   2344678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||++|++..++... ..+++.++..++.||++||+|||+
T Consensus        96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~  133 (309)
T d1u5ra_          96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS  133 (309)
T ss_dssp             CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999998776654 479999999999999999999994

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=1.2e-20  Score=169.27  Aligned_cols=114  Identities=26%  Similarity=0.401  Sum_probs=99.7

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYMP  369 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  369 (405)
                      ++|...+.||+|+||.||+|...++..||||+++... ...+.|.+|+.++++++|||||+++|+|. .+..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence            4677778899999999999999888889999996543 34567999999999999999999999985 466899999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          370 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       370 ~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|+|..++.... ..++|.++..|+.|||+||+|||+
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~  131 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER  131 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh
Confidence            999999886532 469999999999999999999994

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=1.4e-20  Score=169.12  Aligned_cols=115  Identities=24%  Similarity=0.330  Sum_probs=102.5

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.||+|+||+||+|.. .+|+.||||++....   ....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5677889999999999999985 578999999997542   334567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+ .+++.++..++.|+++||+|||+
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~  126 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG  126 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhcc
Confidence            9999999999987654 79999999999999999999994

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=5.7e-21  Score=169.31  Aligned_cols=113  Identities=32%  Similarity=0.428  Sum_probs=95.9

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeec-CCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN-EEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  368 (405)
                      ++|...+.||+|+||.||+|.. .|+.||||+++..  ...+.|.+|++++++++|||||+++|+|.. .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            3556678899999999999998 5789999999653  345678999999999999999999999865 45689999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.++++..+ ..++|..+++|+.|||+||+|||+
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~  121 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG  121 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc
Confidence            9999999997543 358999999999999999999994

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=2.3e-20  Score=167.65  Aligned_cols=116  Identities=25%  Similarity=0.434  Sum_probs=101.4

Q ss_pred             ccCCccCcccccCCCceEEEeeCCC-----cEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDG-----MEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      .+|+..++||+|+||.||+|.+...     ..||||+++... .....+|.+|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4567778999999999999986432     479999997543 3345578999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+.+|++.+++......++|.++..++.|||+||+|||+
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~  128 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN  128 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc
Confidence            999999999999988776789999999999999999999994

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.81  E-value=2.1e-20  Score=166.96  Aligned_cols=115  Identities=20%  Similarity=0.278  Sum_probs=100.7

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc---------chhHHHHHHHHHhhcCC-CCCcceEEeeeecC
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR---------RAFKSFDIECEMMKSIR-HQNLIKVISSCSNE  358 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  358 (405)
                      ++|...+.||+|+||+||+|+. .+|+.||||+++....         .....+.+|+.++++++ |||||++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            3566778999999999999985 5789999999975421         12345889999999997 99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          359 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       359 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +..||||||+++|||.++++..+ .+++.++..++.||++||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~  128 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHK  128 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999997654 79999999999999999999994

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.80  E-value=4.8e-19  Score=160.78  Aligned_cols=195  Identities=23%  Similarity=0.222  Sum_probs=148.7

Q ss_pred             cCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCee
Q 036754           12 CLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKL   91 (405)
Q Consensus        12 ~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L   91 (405)
                      .++.+|-++++++.+++ . +   ++++++|+|++|+++...+..|.++++|++|++++|.+. .++...+.++++|++|
T Consensus        11 ~~~~~~C~~~~L~~lP~-~-l---~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~-~i~~~~f~~l~~L~~L   84 (305)
T d1xkua_          11 HLRVVQCSDLGLEKVPK-D-L---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERL   84 (305)
T ss_dssp             ETTEEECTTSCCCSCCC-S-C---CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEE
T ss_pred             cCCEEEecCCCCCccCC-C-C---CCCCCEEECcCCcCCCcChhHhhcccccccccccccccc-ccchhhhhCCCccCEe
Confidence            56789999999987644 3 2   348999999999999977788999999999999999998 6666666799999999


Q ss_pred             eCCCCCCCCCchhhh-ccccCcc---------------------ccCCC--------CChhcc-----------------
Q 036754           92 SLDSNELTSIPLTFW-NLKDILY---------------------LNFSV--------IPIEIG-----------------  124 (405)
Q Consensus        92 ~Ls~N~l~~lp~~~~-~l~~L~~---------------------l~l~~--------~p~~~~-----------------  124 (405)
                      ++++|+++.+|..+. .+..|..                     +....        .+..+.                 
T Consensus        85 ~l~~n~l~~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~  164 (305)
T d1xkua_          85 YLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT  164 (305)
T ss_dssp             ECCSSCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred             cccCCccCcCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc
Confidence            999999999986543 1221110                     00000        011122                 


Q ss_pred             ----CCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCC
Q 036754          125 ----GLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNF  200 (405)
Q Consensus       125 ----~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~  200 (405)
                          .+++|++|++++|...+..+..|..++.++.|++++|.+++..+..+.++++|++|++++|.|+..++....++++
T Consensus       165 l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L  244 (305)
T d1xkua_         165 IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYI  244 (305)
T ss_dssp             CCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSC
T ss_pred             cCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccCC
Confidence                2456677777777777777778888888999999999998888888888999999999999988665556667888


Q ss_pred             CcccccCCCCcc
Q 036754          201 SAESFEGNELLC  212 (405)
Q Consensus       201 ~~~~~~~n~~~c  212 (405)
                      +.+++++|....
T Consensus       245 ~~L~Ls~N~i~~  256 (305)
T d1xkua_         245 QVVYLHNNNISA  256 (305)
T ss_dssp             CEEECCSSCCCC
T ss_pred             CEEECCCCccCc
Confidence            888888887543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.80  E-value=6.8e-20  Score=154.84  Aligned_cols=165  Identities=16%  Similarity=0.180  Sum_probs=132.8

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchh
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLG   82 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   82 (405)
                      +|+.+.  +++++|+|++|+|++..+...++.++ +|+.|+|++|++....++.|..+++|++|+|++|+|+ .+|...|
T Consensus        23 iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~-~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~-~l~~~~F   98 (192)
T d1w8aa_          23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLP-HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMF   98 (192)
T ss_dssp             CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCT-TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCC-EECSSSS
T ss_pred             cCCCCC--CCCCEEEeCCCCCcccccccccCCCc-eEeeeeccccccccccccccccccccceeeecccccc-ccCHHHH
Confidence            454443  58999999999998766555477776 9999999999999999999999999999999999998 7888888


Q ss_pred             cCCCCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccccc
Q 036754           83 SNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN  162 (405)
Q Consensus        83 ~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~  162 (405)
                      .++++|++|+|++|+|+.+|+.                 .|.++++|++|+|++|++....+..+ -...++.+.+..|.
T Consensus        99 ~~l~~L~~L~L~~N~l~~i~~~-----------------~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~  160 (192)
T d1w8aa_          99 LGLHQLKTLNLYDNQISCVMPG-----------------SFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGA  160 (192)
T ss_dssp             TTCTTCCEEECCSSCCCEECTT-----------------SSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGG
T ss_pred             hCCCcccccccCCccccccCHH-----------------HhcCCcccccccccccccccccchHH-HhhhhhhhcccCCC
Confidence            8999999999999999988765                 45678899999999999875433222 22346667788888


Q ss_pred             ccCccchhHHhcccCCccccccCcccCcCC
Q 036754          163 LSGAIPASLEKLLYLKDLNLSFNKLEGEIP  192 (405)
Q Consensus       163 l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p  192 (405)
                      ++...|..   +..++.++++.|.++...+
T Consensus       161 ~~c~~p~~---l~~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         161 ARCGAPSK---VRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             CBBCSSTT---TTTSBGGGSCTTTCCCCCC
T ss_pred             eEeCCChh---hcCCEeeecCHhhCcCCCC
Confidence            87666654   4566778899998876544

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=6.6e-20  Score=166.70  Aligned_cols=116  Identities=31%  Similarity=0.572  Sum_probs=97.2

Q ss_pred             ccCCccCcccccCCCceEEEeeC-CCc--EEEEEEeecc-ccchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG-DGM--EVAVKVFNLQ-CRRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  364 (405)
                      ++|...+.||+|+||.||+|+.. +|.  .||||+++.. .....+.|.+|++++.++ +|||||+++|+|...+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            45666788999999999999864 444  5788887644 344567899999999998 799999999999999999999


Q ss_pred             EecCCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.++++..               ...++|.++.+++.|||+||+|||+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~  145 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ  145 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc
Confidence            9999999999999753               2579999999999999999999994

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.80  E-value=1.1e-19  Score=164.65  Aligned_cols=123  Identities=28%  Similarity=0.395  Sum_probs=105.7

Q ss_pred             HHHHhhhccCCccCcccccCCCceEEEeeC------CCcEEEEEEeecccc-chhHHHHHHHHHhhcCCCCCcceEEeee
Q 036754          283 LELCRATYKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQCR-RAFKSFDIECEMMKSIRHQNLIKVISSC  355 (405)
Q Consensus       283 ~~~~~~~~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~  355 (405)
                      .+++..+++|...+.||+|+||+||+|+..      +++.||||+++.... ...+.|.+|+.++++++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            345556678888999999999999999853      457899999976543 3456799999999999999999999999


Q ss_pred             ecCCeeEEEEecCCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          356 SNEEFKALVLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       356 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ...+..+++|||+++|+|.++++...                       ..++|.+++.|+.|+|+||+|||.
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~  158 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE  158 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc
Confidence            99999999999999999999997432                       248999999999999999999994

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=1.2e-19  Score=166.34  Aligned_cols=115  Identities=24%  Similarity=0.304  Sum_probs=102.8

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...++||+|+||.||+|+. .+|+.||||++++..   ......+.+|+.++++++|||||++++++.+.+..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5677889999999999999995 679999999997542   334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||+
T Consensus        85 ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~  123 (337)
T d1o6la_          85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHS  123 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhh
Confidence            9999999999998654 68999999999999999999994

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.79  E-value=1.8e-19  Score=163.90  Aligned_cols=115  Identities=23%  Similarity=0.282  Sum_probs=102.1

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.||+|+||+||+|+. .+|+.||||+++...   ....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4577788999999999999995 578999999997542   344567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|++..++.... .+++..+..++.||+.||+|||.
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~  122 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHS  122 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhcc
Confidence            9999999999887654 68899999999999999999995

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=1.5e-19  Score=164.71  Aligned_cols=115  Identities=20%  Similarity=0.320  Sum_probs=99.3

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhh-cCCCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMK-SIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      ++|...+.||+|+||+||+|+. .+|+.||||++++..   ......+..|+.++. .++|||||++++++.+.+..|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            4567778999999999999995 578999999997542   334556777877765 68999999999999999999999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|+|.+++.... .+++.++..++.||+.||+|||+
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~  121 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHS  121 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999997654 68999999999999999999994

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=1.3e-19  Score=165.77  Aligned_cols=116  Identities=26%  Similarity=0.434  Sum_probs=96.5

Q ss_pred             ccCCccCcccccCCCceEEEeeCC------CcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCee
Q 036754          290 YKFSENNLISKGGFGSVYKARLGD------GMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  361 (405)
                      ++|...+.||+|+||+||+|+...      ...||||.+.... ......+.+|+.++.++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            567777899999999999998532      2369999986543 34456789999999998 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN----------------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~----------------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+++|+|.++++..+                      ..++|..+..|+.|||+||+|||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~  182 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF  182 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999999997643                      248999999999999999999994

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=2e-19  Score=163.38  Aligned_cols=111  Identities=28%  Similarity=0.458  Sum_probs=96.2

Q ss_pred             cCcccccCCCceEEEeeCCC----cEEEEEEeecc-ccchhHHHHHHHHHhhcCCCCCcceEEeeeec-CCeeEEEEecC
Q 036754          295 NNLISKGGFGSVYKARLGDG----MEVAVKVFNLQ-CRRAFKSFDIECEMMKSIRHQNLIKVISSCSN-EEFKALVLEYM  368 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  368 (405)
                      .++||+|+||+||+|.+..+    ..||||+++.. .....++|.+|++++++++|||||+++|+|.. +...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46799999999999996432    36899999753 34456789999999999999999999999875 56889999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+|.+++......+++..+++++.|+|+||+|||+
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~  148 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS  148 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc
Confidence            9999999998777778899999999999999999994

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=2.7e-19  Score=159.74  Aligned_cols=115  Identities=22%  Similarity=0.310  Sum_probs=98.5

Q ss_pred             ccCCccCcccccCCCceEEEeeCC----CcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARLGD----GMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  364 (405)
                      ++|...+.||+|+||.||+|....    +..||||.++... ......|.+|+.++++++|||||+++|++. .+..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            456677899999999999998532    3568899886543 334567999999999999999999999985 4678999


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |||+++|++.+++......+++.++..++.||++||+|||+
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~  126 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES  126 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc
Confidence            99999999999987766689999999999999999999994

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=1.5e-19  Score=161.15  Aligned_cols=115  Identities=25%  Similarity=0.321  Sum_probs=91.0

Q ss_pred             ccCCccCcccccCCCceEEEeeC--CC--cEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG--DG--MEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  362 (405)
                      ++|+..+.||+|+||.||+|+..  ++  ..||||++....   .+..++|.+|+.++++++|||||+++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            45677788999999999999852  22  478999986542   3345689999999999999999999999965 5678


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|++.+++..+...+++..+++++.|||+||+|||+
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~  129 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES  129 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh
Confidence            9999999999999887665679999999999999999999994

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.78  E-value=1.7e-19  Score=161.38  Aligned_cols=115  Identities=20%  Similarity=0.316  Sum_probs=99.0

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC----ee
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE----FK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~  361 (405)
                      +.|...+.||+|+||+||+|+. .+|+.||||+++...   ......+.+|++++++++|||||++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            3466778999999999999984 679999999997543   233567899999999999999999999887643    47


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+||||+++|+|.+++...+ .+++.++..++.||++||+|||+
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~  129 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ  129 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            89999999999999887654 79999999999999999999994

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=2.4e-19  Score=163.11  Aligned_cols=116  Identities=22%  Similarity=0.364  Sum_probs=100.0

Q ss_pred             ccCCccCcccccCCCceEEEee------CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecCCee
Q 036754          290 YKFSENNLISKGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNEEFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  361 (405)
                      +++...+.||+|+||.||+|++      .+++.||||+++... ......|.+|+.++.++ +|||||+++|+|.+.+..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            4566678899999999999985      245789999997654 33456789999999999 699999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSN-----------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+++|+|.++++...                 ..+++..+.+++.|||+||+|||+
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~  163 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS  163 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999999997542                 258999999999999999999994

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=4.7e-19  Score=161.59  Aligned_cols=115  Identities=24%  Similarity=0.392  Sum_probs=96.5

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCc----EEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGM----EVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKAL  363 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  363 (405)
                      .+|...++||+|+||+||+|.. .+|+    .||+|+++... .+..+.|.+|+.++++++|||||+++|+|.+ +..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence            3577788999999999999985 3443    58899886543 4456789999999999999999999999976 45678


Q ss_pred             EEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||+.+|+|.+++......++|..+.+++.|||+||+|||+
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~  129 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED  129 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            899999999999998877789999999999999999999994

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=4.3e-19  Score=160.49  Aligned_cols=115  Identities=24%  Similarity=0.353  Sum_probs=96.1

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEe
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLE  366 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  366 (405)
                      ++|...+.||+|+||+||+|+. .+|+.||||+++...  ......+.+|++++++++|||||++++++.+.+..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            4677788999999999999995 678999999996543  2335678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHH-hcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l-~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+.++ +.+++ ......+++.++..++.|+++||+|||+
T Consensus        82 ~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~  120 (298)
T d1gz8a_          82 FLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS  120 (298)
T ss_dssp             CCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc
Confidence            99764 44444 3334579999999999999999999994

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=2.9e-19  Score=162.22  Aligned_cols=116  Identities=22%  Similarity=0.366  Sum_probs=99.6

Q ss_pred             ccCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  362 (405)
                      ++|...+.||+|+||+||+|...      +++.||||+++... ......|.+|+.++++++|||||+++|+|...+..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            45667788999999999999853      35789999997543 334567899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++...+         ..++|..+.+++.|+|+||+|||+
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~  151 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA  151 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            9999999999999986421         357999999999999999999994

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=8.5e-19  Score=158.71  Aligned_cols=111  Identities=30%  Similarity=0.423  Sum_probs=91.5

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeecCC----eeEEEEe
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE----FKALVLE  366 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e  366 (405)
                      ++...+.||+|+||.||+|+. +|+.||||+++..... ...+..|+..+.+++|||||+++|+|...+    ..++|||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            345567899999999999997 6889999998654221 222344666677889999999999997643    5789999


Q ss_pred             cCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          367 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       367 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      |+++|+|.++++..  .++|.++.+++.|+|.||+|+|+
T Consensus        82 y~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~  118 (303)
T d1vjya_          82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHM  118 (303)
T ss_dssp             CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHC
T ss_pred             cccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999864  58999999999999999999994

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=2.1e-18  Score=147.70  Aligned_cols=177  Identities=25%  Similarity=0.370  Sum_probs=102.7

Q ss_pred             eeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCC
Q 036754           15 FIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLD   94 (405)
Q Consensus        15 ~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls   94 (405)
                      ..++..+.+.+..+..   .+. +|+.|++++|.++...  .+..+++|++|+|++|+++ .++. + ..+++|++|+++
T Consensus        28 ~~~l~~~~~~~~~~~~---~L~-~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~-~l~~-~-~~l~~L~~L~l~   98 (210)
T d1h6ta2          28 KDNLKKKSVTDAVTQN---ELN-SIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLT-DIKP-L-ANLKNLGWLFLD   98 (210)
T ss_dssp             HHHTTCSCTTSEECHH---HHH-TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCC-CCGG-G-TTCTTCCEEECC
T ss_pred             HHHhCcCccCCccCHH---Hhc-CccEEECcCCCCCCch--hHhhCCCCCEEeCCCcccc-Cccc-c-ccCccccccccc
Confidence            3445555555544422   222 5666666666655422  2555666666666666665 3332 2 356666666666


Q ss_pred             CCCCCCCchhhhccccCccccCCC----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchh
Q 036754           95 SNELTSIPLTFWNLKDILYLNFSV----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPAS  170 (405)
Q Consensus        95 ~N~l~~lp~~~~~l~~L~~l~l~~----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~  170 (405)
                      +|+++.+| .+..+++|+.|+++.    -...+.++++++.++++.|.+.+  +..+..+++|+.+++++|.+++..  .
T Consensus        99 ~n~i~~l~-~l~~l~~L~~L~l~~~~~~~~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~  173 (210)
T d1h6ta2          99 ENKVKDLS-SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--P  173 (210)
T ss_dssp             SSCCCCGG-GGTTCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--G
T ss_pred             cccccccc-cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccc--c
Confidence            66666555 355555566555543    12345566777777777777763  234666777777777777777543  2


Q ss_pred             HHhcccCCccccccCcccCcCCCCCccCCCCccccc
Q 036754          171 LEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFE  206 (405)
Q Consensus       171 ~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~  206 (405)
                      +.++++|+.|++++|+++. +|....+++++.+++.
T Consensus       174 l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         174 LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELF  208 (210)
T ss_dssp             GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEE
T ss_pred             ccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEcc
Confidence            6677777777777777764 3444455566555543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.76  E-value=1.1e-18  Score=161.85  Aligned_cols=115  Identities=19%  Similarity=0.258  Sum_probs=96.9

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHH---HHHHHhhcCCCCCcceEEeeeecCCeeE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFD---IECEMMKSIRHQNLIKVISSCSNEEFKA  362 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~  362 (405)
                      ++|...+.||+|+||.||+|+. .+|+.||||++.+..   ......+.   .|+.+++.++|||||++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            4677788999999999999995 578999999996532   12222333   4467788889999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +||||+++|+|.+++.... .+++.++..++.||+.||+|||+
T Consensus        84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~  125 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHN  125 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999997654 68999999999999999999994

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.75  E-value=1e-18  Score=157.16  Aligned_cols=114  Identities=20%  Similarity=0.280  Sum_probs=99.6

Q ss_pred             cCCccCcccccCCCceEEEeeCCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +|...+.||+|+||+||+|+..+|+.||||+++...  ....+.+.+|+.++++++|||||++++++...+..++++||+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~   82 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence            566778899999999999998899999999996543  333567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++.+..+... .+.+++.++..++.||++||+|||+
T Consensus        83 ~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~  118 (286)
T d1ob3a_          83 DQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHD  118 (286)
T ss_dssp             SEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhcc
Confidence            88766666543 4579999999999999999999994

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.75  E-value=1.5e-18  Score=159.97  Aligned_cols=115  Identities=19%  Similarity=0.251  Sum_probs=102.0

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc---cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  365 (405)
                      ++|...+.||+|+||.||+|.. .+|+.||||++.+..   ....+.+.+|+.++..++|||||++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4577778999999999999985 579999999997532   334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|.+++...+ .+++.++..++.||++||+|||+
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~  159 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS  159 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999997654 69999999999999999999994

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=1e-18  Score=157.98  Aligned_cols=116  Identities=27%  Similarity=0.425  Sum_probs=94.0

Q ss_pred             ccCCccCcccccCCCceEEEeeC--------CCcEEEEEEeecccc-chhHHHHHHHHHhhcC-CCCCcceEEeeeecCC
Q 036754          290 YKFSENNLISKGGFGSVYKARLG--------DGMEVAVKVFNLQCR-RAFKSFDIECEMMKSI-RHQNLIKVISSCSNEE  359 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  359 (405)
                      ++|...+.||+|+||.||+|+..        ++..||||+++.... ....++.+|...+.++ +|||||+++++|.+.+
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            45566788999999999999742        235799999976543 3457788999999888 8999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          360 FKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       360 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ..++||||+++|+|.++++.++               ..+++.+++.++.|||+||+|||+
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~  153 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS  153 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh
Confidence            9999999999999999997543               358999999999999999999994

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=7.9e-18  Score=157.36  Aligned_cols=190  Identities=22%  Similarity=0.321  Sum_probs=156.4

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhc
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGS   83 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~   83 (405)
                      ...+..+++++.+++++|.+++..|..   ..+ +|+.|++++|.++.  ++.+..+++|+.|++++|.+++ ++.  +.
T Consensus       190 ~~~~~~l~~~~~l~l~~n~i~~~~~~~---~~~-~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~-~~~--~~  260 (384)
T d2omza2         190 ISVLAKLTNLESLIATNNQISDITPLG---ILT-NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAP--LS  260 (384)
T ss_dssp             CGGGGGCTTCSEEECCSSCCCCCGGGG---GCT-TCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG--GT
T ss_pred             ccccccccccceeeccCCccCCCCccc---ccC-CCCEEECCCCCCCC--cchhhcccccchhccccCccCC-CCc--cc
Confidence            346778899999999999999876643   334 89999999999986  3468899999999999999984 443  35


Q ss_pred             CCCCCCeeeCCCCCCCCCchhhhccccCccccCCC----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecc
Q 036754           84 NLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLS  159 (405)
Q Consensus        84 ~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~  159 (405)
                      .+++|++|++++|+++.+++ +..+..+..+.+..    -+..+..++++++|++++|++++..  .+..+++|+.|+++
T Consensus       261 ~~~~L~~L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~  337 (384)
T d2omza2         261 GLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFA  337 (384)
T ss_dssp             TCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECC
T ss_pred             ccccCCEeeccCcccCCCCc-cccccccccccccccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECC
Confidence            79999999999999998864 56677777776554    2345778899999999999999653  38899999999999


Q ss_pred             cccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCC
Q 036754          160 KNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGN  208 (405)
Q Consensus       160 ~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n  208 (405)
                      +|++++ ++ .+.++++|+.|++++|++++.+| ...+++++.+++++|
T Consensus       338 ~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         338 NNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             SSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred             CCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence            999985 34 68999999999999999998765 566788888888876

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=4.8e-18  Score=147.30  Aligned_cols=184  Identities=22%  Similarity=0.315  Sum_probs=136.4

Q ss_pred             CCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCC
Q 036754            7 LSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLA   86 (405)
Q Consensus         7 ~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~   86 (405)
                      +..+++|+.|++++|.|+.+ ++  +..++ +|+.|++++|++++..|  +..+++|+++++++|.++ .++. + .+++
T Consensus        37 ~~~l~~L~~L~l~~~~i~~l-~~--l~~l~-~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~~-l-~~l~  107 (227)
T d1h6ua2          37 QADLDGITTLSAFGTGVTTI-EG--VQYLN-NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSA-I-AGLQ  107 (227)
T ss_dssp             HHHHHTCCEEECTTSCCCCC-TT--GGGCT-TCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCGG-G-TTCT
T ss_pred             HHHcCCcCEEECCCCCCCcc-hh--HhcCC-CCcEeecCCceeecccc--cccccccccccccccccc-cccc-c-cccc
Confidence            45677889999999988875 33  55666 89999999998877443  788889999999998887 5553 3 4788


Q ss_pred             CCCeeeCCCCCCCCCchhhhccccCccccCCC----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccccc
Q 036754           87 SLRKLSLDSNELTSIPLTFWNLKDILYLNFSV----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNN  162 (405)
Q Consensus        87 ~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~  162 (405)
                      +|+.+++++|....++. +.....+..+.++.    ....+.++++|++|++++|.+....  .++.+++|+.|++++|+
T Consensus       108 ~L~~l~l~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~  184 (227)
T d1h6ua2         108 SIKTLDLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNK  184 (227)
T ss_dssp             TCCEEECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             cccccccccccccccch-hccccchhhhhchhhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCc
Confidence            99999999888776543 33444555555443    2234677889999999999887432  38889999999999999


Q ss_pred             ccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccc
Q 036754          163 LSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESF  205 (405)
Q Consensus       163 l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~  205 (405)
                      +++. + .+.++++|++|++++|++++.. ....++++..+++
T Consensus       185 l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~-~l~~l~~L~~L~l  224 (227)
T d1h6ua2         185 ISDI-S-PLASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTL  224 (227)
T ss_dssp             CCCC-G-GGGGCTTCCEEECTTSCCCBCG-GGTTCTTCCEEEE
T ss_pred             cCCC-h-hhcCCCCCCEEECcCCcCCCCc-ccccCCCCCEEEe
Confidence            9864 3 3788999999999999988644 3455666666555

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=1.4e-18  Score=147.53  Aligned_cols=174  Identities=24%  Similarity=0.302  Sum_probs=117.6

Q ss_pred             cCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCee
Q 036754           12 CLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKL   91 (405)
Q Consensus        12 ~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L   91 (405)
                      ++..++++.+.+++..+..   .+. +++.|++++|.++..  +.++.+++|++|++++|+++ .++. + .++++|++|
T Consensus        19 ~~i~~~l~~~~~~~~~~~~---~l~-~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~-~~~~-l-~~l~~L~~L   89 (199)
T d2omxa2          19 EKMKTVLGKTNVTDTVSQT---DLD-QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT-DITP-L-KNLTKLVDI   89 (199)
T ss_dssp             HHHHHHTTCSSTTSEECHH---HHT-TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCC-CCGG-G-TTCTTCCEE
T ss_pred             HHHHHHhCCCCCCCccCHH---Hhc-CCCEEECCCCCCCCc--cccccCCCcCcCcccccccc-Cccc-c-cCCcccccc
Confidence            3344566666666654432   333 677777777777652  24666777777777777776 3332 3 467777777


Q ss_pred             eCCCCCCCCCchhhhccccCccccCCC----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCcc
Q 036754           92 SLDSNELTSIPLTFWNLKDILYLNFSV----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAI  167 (405)
Q Consensus        92 ~Ls~N~l~~lp~~~~~l~~L~~l~l~~----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~  167 (405)
                      ++++|.+..+|. +.+++.|+.++++.    ....+..+++|++|++++|.+.. ++ .+..+++|+.|++++|.+++..
T Consensus        90 ~l~~n~~~~~~~-l~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~  166 (199)
T d2omxa2          90 LMNNNQIADITP-LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLK  166 (199)
T ss_dssp             ECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG
T ss_pred             cccccccccccc-cccccccccccccccccccccccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCCc
Confidence            777777776653 56666666666654    22346778899999999998873 33 5888899999999999998643


Q ss_pred             chhHHhcccCCccccccCcccCcCCCCCccCCC
Q 036754          168 PASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNF  200 (405)
Q Consensus       168 ~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~  200 (405)
                        .+.++++|+.|++++|++++ ++....++++
T Consensus       167 --~l~~l~~L~~L~ls~N~i~~-i~~l~~L~~L  196 (199)
T d2omxa2         167 --PLANLTTLERLDISSNKVSD-ISVLAKLTNL  196 (199)
T ss_dssp             --GGTTCTTCCEEECCSSCCCC-CGGGGGCTTC
T ss_pred             --cccCCCCCCEEECCCCCCCC-CccccCCCCC
Confidence              37788999999999998875 3333334433

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=6e-18  Score=143.52  Aligned_cols=159  Identities=26%  Similarity=0.340  Sum_probs=131.6

Q ss_pred             CCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCC
Q 036754            8 SNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLAS   87 (405)
Q Consensus         8 ~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~   87 (405)
                      ..+++|+.|++++|.+..+..   +..++ +|++|++++|++++..|  ++++++|++|++++|.+. .++.  +.++++
T Consensus        37 ~~l~~l~~L~l~~~~i~~l~~---l~~l~-nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~~--l~~l~~  107 (199)
T d2omxa2          37 TDLDQVTTLQADRLGIKSIDG---VEYLN-NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITP--LANLTN  107 (199)
T ss_dssp             HHHTTCCEEECTTSCCCCCTT---GGGCT-TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG--GTTCTT
T ss_pred             HHhcCCCEEECCCCCCCCccc---cccCC-CcCcCccccccccCccc--ccCCcccccccccccccc-cccc--cccccc
Confidence            457899999999999987533   45666 99999999999988543  899999999999999987 5553  358999


Q ss_pred             CCeeeCCCCCCCCCchhhhccccCccccCCC----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccc
Q 036754           88 LRKLSLDSNELTSIPLTFWNLKDILYLNFSV----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNL  163 (405)
Q Consensus        88 L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l  163 (405)
                      |+.|++++|.+..++ .+..+++|+.++++.    ..+.+..+++|++|++++|.+++. + .++++++|++|++++|++
T Consensus       108 L~~L~l~~~~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i  184 (199)
T d2omxa2         108 LTGLTLFNNQITDID-PLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKV  184 (199)
T ss_dssp             CSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred             ccccccccccccccc-ccchhhhhHHhhhhhhhhcccccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCC
Confidence            999999999988765 467889999998875    233688899999999999999854 3 489999999999999999


Q ss_pred             cCccchhHHhcccCCcc
Q 036754          164 SGAIPASLEKLLYLKDL  180 (405)
Q Consensus       164 ~~~~~~~~~~l~~L~~l  180 (405)
                      ++. + .+.++++|+.|
T Consensus       185 ~~i-~-~l~~L~~L~~L  199 (199)
T d2omxa2         185 SDI-S-VLAKLTNLESL  199 (199)
T ss_dssp             CCC-G-GGGGCTTCSEE
T ss_pred             CCC-c-cccCCCCCCcC
Confidence            864 3 47788888765

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=1.8e-18  Score=158.61  Aligned_cols=111  Identities=16%  Similarity=0.217  Sum_probs=93.1

Q ss_pred             ccCCcc-CcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcC-CCCCcceEEeeeec----CCeeE
Q 036754          290 YKFSEN-NLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSI-RHQNLIKVISSCSN----EEFKA  362 (405)
Q Consensus       290 ~~~~~~-~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~~  362 (405)
                      ++|... ++||+|+||+||+|.. .+|+.||||+++..     ..+.+|+.++.++ +|||||++++++.+    ....|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            355544 4699999999999985 67899999998642     3467799887655 89999999998865    45689


Q ss_pred             EEEecCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          363 LVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       363 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +|||||++|||.+++..++ ..+++.++..|+.||++||+|||+
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~  129 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS  129 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999998653 469999999999999999999994

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=1.2e-18  Score=157.64  Aligned_cols=110  Identities=24%  Similarity=0.327  Sum_probs=91.4

Q ss_pred             cCcccccCCCceEEEee-CCCcEEEEEEeecccc-----chhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEecC
Q 036754          295 NNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR-----RAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      .++||+|+||+||+|.. .+|+.||||+++....     ...+.+.+|+.++++++|||||++++++...+..||||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            46799999999999995 5689999999865432     12356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|++..... .+..+++.++..++.||++||+|||+
T Consensus        83 ~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~  118 (299)
T d1ua2a_          83 ETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQ  118 (299)
T ss_dssp             SEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHH
T ss_pred             cchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhc
Confidence            9877666554 34578999999999999999999994

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=2.3e-17  Score=154.07  Aligned_cols=65  Identities=29%  Similarity=0.401  Sum_probs=45.2

Q ss_pred             cccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccc
Q 036754            4 LSSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLN   74 (405)
Q Consensus         4 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~   74 (405)
                      ++.+..+++|++|||++|+|+++.|   +++++ +|++|++++|++.+..  .++.+++|+.|++++|.++
T Consensus        59 l~gl~~L~nL~~L~Ls~N~l~~l~~---l~~L~-~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~  123 (384)
T d2omza2          59 IDGVEYLNNLTQINFSNNQLTDITP---LKNLT-KLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQIT  123 (384)
T ss_dssp             CTTGGGCTTCCEEECCSSCCCCCGG---GTTCT-TCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             ccccccCCCCCEEeCcCCcCCCCcc---ccCCc-cccccccccccccccc--ccccccccccccccccccc
Confidence            3456677888888888888877543   55665 7888888888877643  2666777777777766654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=1.3e-17  Score=142.69  Aligned_cols=162  Identities=24%  Similarity=0.296  Sum_probs=135.2

Q ss_pred             CCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCC
Q 036754            9 NCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASL   88 (405)
Q Consensus         9 ~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L   88 (405)
                      .+.+|+.|++++|.+....+   +..++ +|+.|+|++|++++..  .++.+++|++|++++|+++ .+|. + .++++|
T Consensus        44 ~L~~L~~L~l~~~~i~~l~~---l~~l~-~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~-~l~~-l-~~l~~L  114 (210)
T d1h6ta2          44 ELNSIDQIIANNSDIKSVQG---IQYLP-NVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK-DLSS-L-KDLKKL  114 (210)
T ss_dssp             HHHTCCEEECTTSCCCCCTT---GGGCT-TCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CGGG-G-TTCTTC
T ss_pred             HhcCccEEECcCCCCCCchh---HhhCC-CCCEEeCCCccccCcc--ccccCcccccccccccccc-cccc-c-cccccc
Confidence            47789999999999987654   45666 9999999999998844  3688999999999999998 5663 3 589999


Q ss_pred             CeeeCCCCCCCCCchhhhccccCccccCCC----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccccccc
Q 036754           89 RKLSLDSNELTSIPLTFWNLKDILYLNFSV----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLS  164 (405)
Q Consensus        89 ~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~  164 (405)
                      +.|++++|.+..++ .+..++.++.++++.    -+..+..+++|+++++++|++.+. + .+.++++|+.|++++|.++
T Consensus       115 ~~L~l~~~~~~~~~-~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~  191 (210)
T d1h6ta2         115 KSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHIS  191 (210)
T ss_dssp             CEEECTTSCCCCCG-GGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred             cccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCC
Confidence            99999999998776 467788888887764    234577899999999999999854 3 3889999999999999998


Q ss_pred             CccchhHHhcccCCcccccc
Q 036754          165 GAIPASLEKLLYLKDLNLSF  184 (405)
Q Consensus       165 ~~~~~~~~~l~~L~~l~l~~  184 (405)
                      . +| .+..+++|+.|++++
T Consensus       192 ~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         192 D-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             B-CG-GGTTCTTCSEEEEEE
T ss_pred             C-Ch-hhcCCCCCCEEEccC
Confidence            5 44 588999999999864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=1.2e-17  Score=150.44  Aligned_cols=114  Identities=20%  Similarity=0.263  Sum_probs=100.4

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCCeeEEEEec
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEEFKALVLEY  367 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  367 (405)
                      .|...+.||+|+||+||+|+. .+|+.||||+++...  ......+.+|+.++++++|||||++++++......++|+||
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~   82 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence            466678999999999999995 578999999997543  33457889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          368 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       368 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +.++++..++... +.+++..+..++.|+++||+|||+
T Consensus        83 ~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~  119 (292)
T d1unla_          83 CDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS  119 (292)
T ss_dssp             CSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccc-cccchhHHHHHHHHHHHHHHHhhc
Confidence            9999988887654 478999999999999999999994

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=7.3e-18  Score=150.24  Aligned_cols=114  Identities=20%  Similarity=0.276  Sum_probs=96.7

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeecccc------chhHHHHHHHHHhhcCC--CCCcceEEeeeecCCee
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCR------RAFKSFDIECEMMKSIR--HQNLIKVISSCSNEEFK  361 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~  361 (405)
                      +|...+.||+|+||+||+|.. .+|+.||||++.....      .....+.+|+.++++++  |||||++++++.+.+..
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~   84 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF   84 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence            466778999999999999995 5789999999975421      12244678999999986  89999999999999999


Q ss_pred             EEEEecCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++||||+.+ +++.+++.... .+++.++..++.||++||+|||+
T Consensus        85 ~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~  128 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN  128 (273)
T ss_dssp             EEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999976 68888886543 79999999999999999999994

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.69  E-value=2.6e-17  Score=148.74  Aligned_cols=116  Identities=22%  Similarity=0.373  Sum_probs=93.2

Q ss_pred             ccCCccCcccccCCCceEEEeeC------CCcEEEEEEeeccc-cchhHHHHHHHHHhhcC-CCCCcceEEeeeecC-Ce
Q 036754          290 YKFSENNLISKGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDIECEMMKSI-RHQNLIKVISSCSNE-EF  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~  360 (405)
                      ++|...+.||+|+||.||+|...      +++.||||+++... ....+.+.+|+..+.++ +|+|||.+++++... ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            56777889999999999999842      34689999997543 33456778888888776 689999999987654 56


Q ss_pred             eEEEEecCCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++|||||++|+|.++++..+               ..++|.++..++.|||+||+|||+
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~  152 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS  152 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh
Confidence            899999999999999997532               358999999999999999999994

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.69  E-value=3.3e-17  Score=133.78  Aligned_cols=130  Identities=18%  Similarity=0.216  Sum_probs=89.8

Q ss_pred             ccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcC
Q 036754            5 SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSN   84 (405)
Q Consensus         5 ~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~   84 (405)
                      +.|.++.+|+.|||++|+|+.+ +.. +..+. +|+.|+|++|+++..  +.|..+++|++|++++|+++ .++..++..
T Consensus        12 ~~~~n~~~lr~L~L~~n~I~~i-~~~-~~~l~-~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~   85 (162)
T d1a9na_          12 AQYTNAVRDRELDLRGYKIPVI-ENL-GATLD-QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQA   85 (162)
T ss_dssp             CEEECTTSCEEEECTTSCCCSC-CCG-GGGTT-CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHH
T ss_pred             HhccCcCcCcEEECCCCCCCcc-Ccc-ccccc-cCCEEECCCCCCCcc--CCcccCcchhhhhccccccc-CCCcccccc
Confidence            4566777888888888888776 443 34444 788888888888764  34777888888888888887 666666667


Q ss_pred             CCCCCeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCc----ccccCCCCCeee
Q 036754           85 LASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPD----SFGDLISLKSLN  157 (405)
Q Consensus        85 l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~----~~~~l~~L~~L~  157 (405)
                      +++|++|++++|+|+.++.- .               .+..+++|++|++++|++.. .|.    .+..+++|+.||
T Consensus        86 l~~L~~L~L~~N~i~~~~~l-~---------------~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          86 LPDLTELILTNNSLVELGDL-D---------------PLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CTTCCEEECCSCCCCCGGGG-G---------------GGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred             ccccccceeccccccccccc-c---------------ccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence            88888888888888766531 1               23456777777777777763 332    355666666665

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.68  E-value=2.3e-16  Score=136.56  Aligned_cols=166  Identities=21%  Similarity=0.304  Sum_probs=136.9

Q ss_pred             ccCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcC
Q 036754            5 SSLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSN   84 (405)
Q Consensus         5 ~~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~   84 (405)
                      +.++++++|++|+|++|.+.+..|   +..++ +|+.+++++|.++..  +.+.++++|+.+++++|...+ ++.  +..
T Consensus        57 ~~l~~l~~L~~L~ls~n~i~~~~~---l~~l~-~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~-~~~--~~~  127 (227)
T d1h6ua2          57 EGVQYLNNLIGLELKDNQITDLAP---LKNLT-KITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP--LAG  127 (227)
T ss_dssp             TTGGGCTTCCEEECCSSCCCCCGG---GTTCC-SCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG--GTT
T ss_pred             hhHhcCCCCcEeecCCceeecccc---ccccc-ccccccccccccccc--ccccccccccccccccccccc-cch--hcc
Confidence            568899999999999999988765   55666 999999999998753  358899999999999999873 332  247


Q ss_pred             CCCCCeeeCCCCCCCCCchhhhccccCccccCCC----CChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccc
Q 036754           85 LASLRKLSLDSNELTSIPLTFWNLKDILYLNFSV----IPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSK  160 (405)
Q Consensus        85 l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~----~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~  160 (405)
                      .+.+..++++++.+...+ .+.+.++|+.|+++.    -...+.++++|++|++++|++.+ ++ .+..+++|++|++++
T Consensus       128 ~~~~~~l~~~~~~~~~~~-~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~  204 (227)
T d1h6ua2         128 LSNLQVLYLDLNQITNIS-PLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKN  204 (227)
T ss_dssp             CTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTT
T ss_pred             ccchhhhhchhhhhchhh-hhccccccccccccccccccchhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcC
Confidence            889999999999988654 366778888888775    23458899999999999999985 44 388999999999999


Q ss_pred             ccccCccchhHHhcccCCcccccc
Q 036754          161 NNLSGAIPASLEKLLYLKDLNLSF  184 (405)
Q Consensus       161 n~l~~~~~~~~~~l~~L~~l~l~~  184 (405)
                      |++++..|  +.++++|+.|++++
T Consensus       205 N~lt~i~~--l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         205 NQISDVSP--LANTSNLFIVTLTN  226 (227)
T ss_dssp             SCCCBCGG--GTTCTTCCEEEEEE
T ss_pred             CcCCCCcc--cccCCCCCEEEeeC
Confidence            99996543  78999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.68  E-value=2.7e-17  Score=151.91  Aligned_cols=111  Identities=25%  Similarity=0.403  Sum_probs=89.0

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEEeeeec------CCeeEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVISSCSN------EEFKAL  363 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~l  363 (405)
                      +|...++||+|+||+||+|+. .+|+.||||++.....    ...+|++++++++|+|||++++++..      ....+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            466778899999999999995 5789999999965432    22369999999999999999998853      235789


Q ss_pred             EEecCCCCCHHHHHh--cCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          364 VLEYMPHGSLEKYLY--SSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       364 v~e~~~~g~L~~~l~--~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||||+++|.+.....  .....+++.++..++.||++||+|||+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~  140 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS  140 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            999998764333322  234579999999999999999999995

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.68  E-value=1.4e-16  Score=139.22  Aligned_cols=178  Identities=19%  Similarity=0.122  Sum_probs=133.3

Q ss_pred             CcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCccccc-CCccccCccCCCeeecCC-cccccccCcchhcCCCCC
Q 036754           11 KCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGG-ILEEITNLTKLTTIILGG-NKLNGSISITLGSNLASL   88 (405)
Q Consensus        11 ~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~l~~L   88 (405)
                      +++++|||++|+|..+.+.+ +.+++ +|++|++++|.+... .+..|..+++++.|++.. |++. .++...+.++++|
T Consensus        29 ~~l~~L~Ls~n~i~~l~~~~-f~~l~-~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~-~~~~~~~~~l~~L  105 (242)
T d1xwdc1          29 RNAIELRFVLTKLRVIQKGA-FSGFG-DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNL  105 (242)
T ss_dssp             SCCSEEEEESCCCCEECTTT-TTTCT-TCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCC-EECTTSEECCTTC
T ss_pred             CCCCEEECcCCcCCccChhH-hhccc-hhhhhhhccccccceeecccccccccccccccccccccc-ccccccccccccc
Confidence            47999999999999888777 55666 999999999998764 456789999999998764 6776 5666666799999


Q ss_pred             CeeeCCCCCCCCCch--hhhccccCccccCCC-----C-ChhccCC-CCCCEEeccCCcccccCCcccccCCCCCe-eec
Q 036754           89 RKLSLDSNELTSIPL--TFWNLKDILYLNFSV-----I-PIEIGGL-PNLEYLFLGYNRLQGSIPDSFGDLISLKS-LNL  158 (405)
Q Consensus        89 ~~L~Ls~N~l~~lp~--~~~~l~~L~~l~l~~-----~-p~~~~~l-~~L~~L~l~~n~l~~~~p~~~~~l~~L~~-L~l  158 (405)
                      ++|++++|+++..|.  .+..+..+..+....     + +..+.++ ..++.|++++|+++...+..|. .+++.. +++
T Consensus       106 ~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l  184 (242)
T d1xwdc1         106 QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLS  184 (242)
T ss_dssp             CEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECT
T ss_pred             cccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccccccccc-chhhhccccc
Confidence            999999999987654  223344444333221     2 2344444 3788899999999865555554 455444 467


Q ss_pred             ccccccCccchhHHhcccCCccccccCcccCcCC
Q 036754          159 SKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIP  192 (405)
Q Consensus       159 ~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p  192 (405)
                      ++|.++...+..|.++++|+.|++++|+++..++
T Consensus       185 ~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~  218 (242)
T d1xwdc1         185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPS  218 (242)
T ss_dssp             TCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCS
T ss_pred             cccccccccHHHhcCCCCCCEEECCCCcCCccCH
Confidence            8888987777788999999999999999985544

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.67  E-value=5.9e-17  Score=148.35  Aligned_cols=109  Identities=19%  Similarity=0.307  Sum_probs=93.8

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCC-CCCcceEEeeeec--CCeeEEEE
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-HQNLIKVISSCSN--EEFKALVL  365 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  365 (405)
                      ++|...+.||+|+||+||+|+. .+|+.||||+++..   ..+.+.+|+.++.+++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            4577788999999999999995 67899999998643   3456788999999995 9999999999874  45689999


Q ss_pred             ecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          366 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       366 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ||+++|+|....    +.+++.++..++.||++||+|||+
T Consensus       112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~  147 (328)
T d3bqca1         112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS  147 (328)
T ss_dssp             ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhh
Confidence            999999987764    358999999999999999999994

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.67  E-value=4.4e-17  Score=150.36  Aligned_cols=113  Identities=22%  Similarity=0.289  Sum_probs=89.2

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC------e
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE------F  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~  360 (405)
                      +.|...+.||+|+||+||+|.. .+|+.||||+++...  ....+.+.+|+.++++++|||||+++++|...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            4566778899999999999995 579999999997542  334567889999999999999999999987654      4


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .++||||+ +++|..+.+..  .+++..+..++.||+.||+|||+
T Consensus        98 ~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~  139 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHA  139 (346)
T ss_dssp             CEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHh
Confidence            69999999 45788877653  59999999999999999999994

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.67  E-value=5.8e-17  Score=149.34  Aligned_cols=113  Identities=18%  Similarity=0.223  Sum_probs=91.5

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc-cchhHHHHHHHHHhhcCCCCCcceEEeeeecCC----eeEEE
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDIECEMMKSIRHQNLIKVISSCSNEE----FKALV  364 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv  364 (405)
                      .|...+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+.++.+++|||||++++++....    ..+++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence            466778999999999999984 689999999997543 334567899999999999999999999986543    23445


Q ss_pred             EecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          365 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       365 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++|+.+|||.+++...  .+++..+..++.|+++||+|||+
T Consensus        89 ~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~  127 (345)
T d1pmea_          89 VTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS  127 (345)
T ss_dssp             EEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            5667799999999764  59999999999999999999994

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.67  E-value=5.6e-17  Score=149.78  Aligned_cols=114  Identities=18%  Similarity=0.241  Sum_probs=95.6

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeecC-----Cee
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSNE-----EFK  361 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  361 (405)
                      +.|...+.||+|+||+||+|.. .+|+.||||+++...  ....+.+.+|+.++++++|||+|++++++...     ...
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            4567778999999999999984 679999999997543  23445788999999999999999999988642     344


Q ss_pred             EEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          362 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       362 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +++++|+.+|+|.+++..+  .+++.++..++.||+.||+|||+
T Consensus        98 ~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~  139 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHS  139 (348)
T ss_dssp             CEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHh
Confidence            6777888999999999653  59999999999999999999994

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.66  E-value=4.5e-16  Score=120.87  Aligned_cols=81  Identities=17%  Similarity=0.251  Sum_probs=40.4

Q ss_pred             CeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeC
Q 036754           14 TFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSL   93 (405)
Q Consensus        14 ~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L   93 (405)
                      +.|||++|+|+.. +.  ++.+. +|++|++++|+++. +|+.++.+++|++|++++|.|+ .+|. + ..+++|++|++
T Consensus         1 R~L~Ls~n~l~~l-~~--l~~l~-~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~-~l~~-~-~~l~~L~~L~l   72 (124)
T d1dcea3           1 RVLHLAHKDLTVL-CH--LEQLL-LVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-V-ANLPRLQELLL   72 (124)
T ss_dssp             SEEECTTSCCSSC-CC--GGGGT-TCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCC-CCGG-G-TTCSSCCEEEC
T ss_pred             CEEEcCCCCCCCC-cc--cccCC-CCCEEECCCCccCc-chhhhhhhhccccccccccccc-ccCc-c-ccccccCeEEC
Confidence            3456666666543 22  33443 55555555555543 3444555555555555555554 3332 2 34555555555


Q ss_pred             CCCCCCCCc
Q 036754           94 DSNELTSIP  102 (405)
Q Consensus        94 s~N~l~~lp  102 (405)
                      ++|+|+.+|
T Consensus        73 ~~N~i~~~~   81 (124)
T d1dcea3          73 CNNRLQQSA   81 (124)
T ss_dssp             CSSCCCSSS
T ss_pred             CCCccCCCC
Confidence            555555443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.66  E-value=5.2e-17  Score=147.97  Aligned_cols=115  Identities=22%  Similarity=0.287  Sum_probs=98.8

Q ss_pred             ccCCccCcccccCCCceEEEee----CCCcEEEEEEeeccc----cchhHHHHHHHHHhhcCCC-CCcceEEeeeecCCe
Q 036754          290 YKFSENNLISKGGFGSVYKARL----GDGMEVAVKVFNLQC----RRAFKSFDIECEMMKSIRH-QNLIKVISSCSNEEF  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  360 (405)
                      ++|...+.||+|+||+||+|..    .+|+.||||+++...    ....+.+.+|+.++.+++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            4577788999999999999974    247899999986432    2345667889999999977 899999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .+++|||+.+|+|.+++...+ .+.......++.|++.||+|||+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~  147 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHK  147 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhc
Confidence            999999999999999997654 57788889999999999999994

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=8e-17  Score=145.94  Aligned_cols=120  Identities=23%  Similarity=0.324  Sum_probs=95.2

Q ss_pred             HhhhccCCccCcccccCCCceEEEee-CC-CcEEEEEEeeccc--cchhHHHHHHHHHhhcC---CCCCcceEEeeeec-
Q 036754          286 CRATYKFSENNLISKGGFGSVYKARL-GD-GMEVAVKVFNLQC--RRAFKSFDIECEMMKSI---RHQNLIKVISSCSN-  357 (405)
Q Consensus       286 ~~~~~~~~~~~~lg~G~fg~v~~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-  357 (405)
                      ++..++|...+.||+|+||+||+|.. .+ ++.||||+++...  ......+.+|+.+++.+   +|||||++++++.. 
T Consensus         3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            44556788889999999999999985 34 5679999997543  22334566777776655   89999999998853 


Q ss_pred             ----CCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          358 ----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       358 ----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                          ....+++|||+++|++..........+++.....++.|+++||+|||+
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~  134 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS  134 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence                346789999999987766665555679999999999999999999994

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=1.4e-16  Score=145.11  Aligned_cols=116  Identities=22%  Similarity=0.319  Sum_probs=93.3

Q ss_pred             hccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeec--------
Q 036754          289 TYKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSN--------  357 (405)
Q Consensus       289 ~~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  357 (405)
                      .++|+..+.||+|+||+||+|+. .+|+.||||++....  ......+.+|+.++++++|+|++++++.+..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            45677788999999999999995 578999999986542  3345678899999999999999999998755        


Q ss_pred             CCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          358 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       358 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ....++||||++++.+.... .....++......++.|+++||+|||.
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~  135 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHR  135 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhcc
Confidence            34578999999987665544 334578999999999999999999994

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=1.3e-16  Score=147.53  Aligned_cols=112  Identities=21%  Similarity=0.203  Sum_probs=91.0

Q ss_pred             ccCCccCcccccCCCceEEEee-CCCcEEEEEEeeccc--cchhHHHHHHHHHhhcCCCCCcceEEeeeec------CCe
Q 036754          290 YKFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDIECEMMKSIRHQNLIKVISSCSN------EEF  360 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  360 (405)
                      +.|...++||+|+||+||+|.. .+|+.||||++....  ......+.+|+.++++++|||||++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            3467778999999999999995 579999999997543  2334578899999999999999999999864      367


Q ss_pred             eEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          361 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       361 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      .|+||||+.+| +.+.+.   ..+++.++..++.||+.||+|||+
T Consensus        97 ~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~  137 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHS  137 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhhh
Confidence            89999999765 445443   358999999999999999999994

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.63  E-value=1.2e-15  Score=118.32  Aligned_cols=118  Identities=25%  Similarity=0.274  Sum_probs=97.2

Q ss_pred             cEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccCCCC
Q 036754           40 EFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNFSVI  119 (405)
Q Consensus        40 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~  119 (405)
                      +.|+|++|+++.. + .+..+++|++|++++|+|+ .+|..+ ..+++|+.|++++|+|+.+|.                
T Consensus         1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~-~~l~~L~~L~l~~N~i~~l~~----------------   60 (124)
T d1dcea3           1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPAL-AALRCLEVLQASDNALENVDG----------------   60 (124)
T ss_dssp             SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGG-GGCTTCCEEECCSSCCCCCGG----------------
T ss_pred             CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhh-hhhhcccccccccccccccCc----------------
Confidence            5799999999864 3 4899999999999999998 788776 589999999999999998762                


Q ss_pred             ChhccCCCCCCEEeccCCcccccC-CcccccCCCCCeeecccccccCc---cchhHHhcccCCcc
Q 036754          120 PIEIGGLPNLEYLFLGYNRLQGSI-PDSFGDLISLKSLNLSKNNLSGA---IPASLEKLLYLKDL  180 (405)
Q Consensus       120 p~~~~~l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~n~l~~~---~~~~~~~l~~L~~l  180 (405)
                         +..+++|++|++++|++.... ...+..+++|+.|++++|+++..   .......+++|+.+
T Consensus        61 ---~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          61 ---VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             ---GTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             ---cccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence               356789999999999998543 25688999999999999999743   23445567777654

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.63  E-value=3.8e-16  Score=127.33  Aligned_cols=127  Identities=20%  Similarity=0.159  Sum_probs=100.7

Q ss_pred             cccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCcc
Q 036754           34 NVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILY  113 (405)
Q Consensus        34 ~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~  113 (405)
                      +.. .+++|+|++|+|+.+ ++.+..+++|+.|+|++|+|+ .++.  +..+++|++|++++|+++.+|..+        
T Consensus        16 n~~-~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~-~l~~--~~~l~~L~~L~ls~N~i~~l~~~~--------   82 (162)
T d1a9na_          16 NAV-RDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-KLDG--FPLLRRLKTLLVNNNRICRIGEGL--------   82 (162)
T ss_dssp             CTT-SCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-EECC--CCCCSSCCEEECCSSCCCEECSCH--------
T ss_pred             CcC-cCcEEECCCCCCCcc-CccccccccCCEEECCCCCCC-ccCC--cccCcchhhhhcccccccCCCccc--------
Confidence            444 789999999999875 666788999999999999998 6653  368999999999999999887543        


Q ss_pred             ccCCCCChhccCCCCCCEEeccCCcccccCC-cccccCCCCCeeecccccccCcc---chhHHhcccCCcccc
Q 036754          114 LNFSVIPIEIGGLPNLEYLFLGYNRLQGSIP-DSFGDLISLKSLNLSKNNLSGAI---PASLEKLLYLKDLNL  182 (405)
Q Consensus       114 l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~---~~~~~~l~~L~~l~l  182 (405)
                               +..+++|++|++++|++..... ..+..+++|++|++++|+++...   +..+..+++|+.||.
T Consensus        83 ---------~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~  146 (162)
T d1a9na_          83 ---------DQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF  146 (162)
T ss_dssp             ---------HHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred             ---------cccccccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence                     2346889999999999874322 46788999999999999987443   235778888888873

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.61  E-value=1.1e-15  Score=137.42  Aligned_cols=112  Identities=15%  Similarity=0.166  Sum_probs=96.2

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCC-CCcceEEeeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH-QNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      +|...+.||+|+||+||+|+. .+|+.||||++....  ....+.+|++.+..++| +|++.+++++......++||||+
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            466678899999999999995 578999999885432  23456778888888865 89999999999999999999998


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                       +|+|.+++...+..+++.++..++.|++.||+|||+
T Consensus        84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~  119 (293)
T d1csna_          84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE  119 (293)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH
Confidence             679999998766679999999999999999999995

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=1.1e-15  Score=133.36  Aligned_cols=178  Identities=18%  Similarity=0.132  Sum_probs=135.5

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEccc-CcccccCCccccCccCCCeeecCCcccccccCcchhcC
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSY-CNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSN   84 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~   84 (405)
                      +|.++++|++|+|++|.+...++...+..++ +++.+.+.. |++....+..|.++++|+.|++++|.+....+......
T Consensus        48 ~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~-~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~  126 (242)
T d1xwdc1          48 AFSGFGDLEKIEISQNDVLEVIEADVFSNLP-KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS  126 (242)
T ss_dssp             TTTTCTTCCEEEEESCTTCCEECSSSEESCT-TCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCB
T ss_pred             Hhhccchhhhhhhccccccceeecccccccc-ccccccccccccccccccccccccccccccccchhhhccccccccccc
Confidence            5899999999999999998765543355665 889998764 67888888899999999999999999973333333445


Q ss_pred             CCCCCeeeCCCCCCCCCchh-hhccc-cCccccCCC-----CChhccCCCCCCEE-eccCCcccccCCcccccCCCCCee
Q 036754           85 LASLRKLSLDSNELTSIPLT-FWNLK-DILYLNFSV-----IPIEIGGLPNLEYL-FLGYNRLQGSIPDSFGDLISLKSL  156 (405)
Q Consensus        85 l~~L~~L~Ls~N~l~~lp~~-~~~l~-~L~~l~l~~-----~p~~~~~l~~L~~L-~l~~n~l~~~~p~~~~~l~~L~~L  156 (405)
                      +..|..+..+++++..++.. +.++. .++.+++..     ++....+.+++..+ ++++|.++...+..|.++++|+.|
T Consensus       127 l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L  206 (242)
T d1xwdc1         127 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL  206 (242)
T ss_dssp             SSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEE
T ss_pred             ccccccccccccccccccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEE
Confidence            67777778888888877643 34443 566665543     55555566666555 578888986666779999999999


Q ss_pred             ecccccccCccchhHHhcccCCcccccc
Q 036754          157 NLSKNNLSGAIPASLEKLLYLKDLNLSF  184 (405)
Q Consensus       157 ~l~~n~l~~~~~~~~~~l~~L~~l~l~~  184 (405)
                      ++++|+++...+..|.+++.|+.+++.+
T Consensus       207 ~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         207 DISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             ECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             ECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            9999999977777888888888877643

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.58  E-value=4.1e-15  Score=134.04  Aligned_cols=112  Identities=22%  Similarity=0.343  Sum_probs=91.0

Q ss_pred             cCCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCCCCCcceEE-eeeecCCeeEEEEecC
Q 036754          291 KFSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRHQNLIKVI-SSCSNEEFKALVLEYM  368 (405)
Q Consensus       291 ~~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~-~~~~~~~~~~lv~e~~  368 (405)
                      .|...+.||+|+||.||+|+. .+|+.||||++....  ...++.+|+++++.++|+|+|..+ ++....+..++||||+
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~   85 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   85 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence            366678899999999999985 578999999986543  234578899999999877765554 4556778889999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      . |++.+.+......+++..+..++.|+++||+|||+
T Consensus        86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  121 (299)
T d1ckia_          86 G-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS  121 (299)
T ss_dssp             C-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             C-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH
Confidence            5 57777776656689999999999999999999994

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=9.8e-16  Score=137.06  Aligned_cols=177  Identities=21%  Similarity=0.187  Sum_probs=133.0

Q ss_pred             CCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCc-ccccccCcchhcCCC
Q 036754            8 SNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGN-KLNGSISITLGSNLA   86 (405)
Q Consensus         8 ~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~l~   86 (405)
                      ....+|++|||++|.+.......++..++ +|++|+|++|.++...+..++.+++|++|+|++| .++..--..+..+++
T Consensus        43 ~~~~~L~~LdLs~~~i~~~~l~~l~~~c~-~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~  121 (284)
T d2astb2          43 FSPFRVQHMDLSNSVIEVSTLHGILSQCS-KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS  121 (284)
T ss_dssp             CCCBCCCEEECTTCEECHHHHHHHHTTBC-CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCT
T ss_pred             ccCCCCCEEECCCCccCHHHHHHHHHhCC-CcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHH
Confidence            35678999999999887654444466776 9999999999998877888889999999999996 455221123345789


Q ss_pred             CCCeeeCCCC-CCC--CCchhhhc-cccCccccCCCCC---------hhccCCCCCCEEeccCCc-ccccCCcccccCCC
Q 036754           87 SLRKLSLDSN-ELT--SIPLTFWN-LKDILYLNFSVIP---------IEIGGLPNLEYLFLGYNR-LQGSIPDSFGDLIS  152 (405)
Q Consensus        87 ~L~~L~Ls~N-~l~--~lp~~~~~-l~~L~~l~l~~~p---------~~~~~l~~L~~L~l~~n~-l~~~~p~~~~~l~~  152 (405)
                      +|++|+++++ +++  .++..+.. .+.|+.|+++...         ....++++|++|++++|. +++.....+..+++
T Consensus       122 ~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~  201 (284)
T d2astb2         122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY  201 (284)
T ss_dssp             TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred             hccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCc
Confidence            9999999996 565  23333433 3578888876522         123568899999999864 66666777888999


Q ss_pred             CCeeecccc-cccCccchhHHhcccCCccccccC
Q 036754          153 LKSLNLSKN-NLSGAIPASLEKLLYLKDLNLSFN  185 (405)
Q Consensus       153 L~~L~l~~n-~l~~~~~~~~~~l~~L~~l~l~~n  185 (405)
                      |++|+++++ .+++.....+.++++|+.|+++++
T Consensus       202 L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         202 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             CCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             CCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            999999994 677666667888899999999876

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.51  E-value=3e-16  Score=132.45  Aligned_cols=145  Identities=21%  Similarity=0.292  Sum_probs=100.9

Q ss_pred             CcCCeeeCcCC--cCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCcchhcCCCCC
Q 036754           11 KCLTFIDLSNN--PLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASL   88 (405)
Q Consensus        11 ~~L~~L~Ls~N--~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L   88 (405)
                      ..++.++++++  .+. ..|.+ ++.+. +|+.|+|++|+++.. + .+..+++|++|+|++|.|+ .+|... ..+++|
T Consensus        23 ~~~~~~~l~~~~~~i~-~l~~s-l~~L~-~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~-~~~~~L   95 (198)
T d1m9la_          23 TEAEKVELHGMIPPIE-KMDAT-LSTLK-ACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLD-AVADTL   95 (198)
T ss_dssp             TTCSCEECCBCCTTCC-CCHHH-HHHTT-TCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHH-HHHHHC
T ss_pred             cccceeeeecccCchh-hhhhH-Hhccc-ccceeECcccCCCCc-c-cccCCccccChhhcccccc-cccccc-cccccc
Confidence            34556666654  222 23344 55665 899999999998864 3 5888899999999999987 676433 356789


Q ss_pred             CeeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCC-cccccCCCCCeeecccccccCcc
Q 036754           89 RKLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIP-DSFGDLISLKSLNLSKNNLSGAI  167 (405)
Q Consensus        89 ~~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~  167 (405)
                      ++|++++|+++.++. +                  ..+++|++|++++|+++.... ..+..+++|+.|++++|++....
T Consensus        96 ~~L~l~~N~i~~l~~-~------------------~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~  156 (198)
T d1m9la_          96 EELWISYNQIASLSG-I------------------EKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY  156 (198)
T ss_dssp             CEEECSEEECCCHHH-H------------------HHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHH
T ss_pred             ccccccccccccccc-c------------------cccccccccccccchhccccccccccCCCccceeecCCCccccCc
Confidence            999999999887642 2                  234567888888888874322 45778888888888888876443


Q ss_pred             ch----------hHHhcccCCccc
Q 036754          168 PA----------SLEKLLYLKDLN  181 (405)
Q Consensus       168 ~~----------~~~~l~~L~~l~  181 (405)
                      +.          .+..+++|+.||
T Consensus       157 ~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         157 KENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             CTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             ccccchhhHHHHHHHHCCCcCEeC
Confidence            32          256788888876

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.46  E-value=6e-13  Score=121.88  Aligned_cols=56  Identities=36%  Similarity=0.321  Sum_probs=39.6

Q ss_pred             CCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCCCCccCCCCcccccCCCCcc
Q 036754          150 LISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC  212 (405)
Q Consensus       150 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~~~~~~~~~~~~~~~n~~~c  212 (405)
                      +++|++|++++|+++. +|..   +++|+.|++++|+|+. +|..  ..+++.+++++|+...
T Consensus       283 ~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~L~~-l~~~--~~~L~~L~L~~N~L~~  338 (353)
T d1jl5a_         283 PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPEL--PQNLKQLHVEYNPLRE  338 (353)
T ss_dssp             CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCSS
T ss_pred             CCCCCEEECCCCccCc-cccc---cCCCCEEECCCCcCCc-cccc--cCCCCEEECcCCcCCC
Confidence            3578888888888874 4543   5678888888888874 4432  4567888888887643

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=1.4e-13  Score=111.07  Aligned_cols=91  Identities=13%  Similarity=0.088  Sum_probs=45.8

Q ss_pred             CCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccCc-ccccCCccccCccCCCeeecCCcccccccCcchhcCCCC
Q 036754            9 NCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCN-ISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLAS   87 (405)
Q Consensus         9 ~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~   87 (405)
                      .+...+.++.+++++...+ .. +..++ +|+.|++++|+ ++.+.++.|.++++|+.|+|++|+|+ .++...|.++++
T Consensus         6 ~c~~~~~l~c~~~~~~~~p-~~-l~~l~-~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~i~~~~f~~l~~   81 (156)
T d2ifga3           6 CPHGSSGLRCTRDGALDSL-HH-LPGAE-NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR   81 (156)
T ss_dssp             CCSSSSCEECCSSCCCTTT-TT-SCSCS-CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC-EECTTGGGSCSC
T ss_pred             CcCCCCeEEecCCCCccCc-cc-ccCcc-ccCeeecCCCccccccCchhhccccccCcceeeccccC-Cccccccccccc
Confidence            3444555666666555432 22 22233 55555554432 55544455555555555555555554 444444445555


Q ss_pred             CCeeeCCCCCCCCCch
Q 036754           88 LRKLSLDSNELTSIPL  103 (405)
Q Consensus        88 L~~L~Ls~N~l~~lp~  103 (405)
                      |++|+|++|+|+++|.
T Consensus        82 L~~L~Ls~N~l~~l~~   97 (156)
T d2ifga3          82 LSRLNLSFNALESLSW   97 (156)
T ss_dssp             CCEEECCSSCCSCCCS
T ss_pred             ccceeccCCCCcccCh
Confidence            5555555555555443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.45  E-value=2e-15  Score=127.35  Aligned_cols=132  Identities=26%  Similarity=0.300  Sum_probs=89.2

Q ss_pred             cccEEEcccCc--ccccCCccccCccCCCeeecCCcccccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCcccc
Q 036754           38 SLEFFVMSYCN--ISGGILEEITNLTKLTTIILGGNKLNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLN  115 (405)
Q Consensus        38 ~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~  115 (405)
                      .++.+++..+.  +. .++..+..+++|+.|+|++|+|+ .++ .+ .++++|++|+|++|+|+.+|.....        
T Consensus        24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l-~~l~~L~~L~Ls~N~i~~i~~~~~~--------   91 (198)
T d1m9la_          24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SL-SGMENLRILSLGRNLIKKIENLDAV--------   91 (198)
T ss_dssp             TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CH-HHHTTCCEEECCEEEECSCSSHHHH--------
T ss_pred             ccceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cc-cCCccccChhhcccccccccccccc--------
Confidence            34455554432  21 24456777888888888888887 565 33 4788888888888888777643221        


Q ss_pred             CCCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccc-hhHHhcccCCccccccCcccCcCCC
Q 036754          116 FSVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIP-ASLEKLLYLKDLNLSFNKLEGEIPR  193 (405)
Q Consensus       116 l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~l~l~~n~l~~~~p~  193 (405)
                                +++|++|++++|.++. + +.+..+++|+.|++++|+++.... ..+..+++|+.|++++|++....+.
T Consensus        92 ----------~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  158 (198)
T d1m9la_          92 ----------ADTLEELWISYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             ----------HHHCCEEECSEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred             ----------cccccccccccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccccCccc
Confidence                      2457788888888774 3 347777888888888888875432 4577788888888888877655443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.43  E-value=5.5e-13  Score=107.50  Aligned_cols=107  Identities=21%  Similarity=0.216  Sum_probs=79.0

Q ss_pred             cccEEEcccCcccccCCccccCccCCCeeecCCcc-cccccCcchhcCCCCCCeeeCCCCCCCCCchhhhccccCccccC
Q 036754           38 SLEFFVMSYCNISGGILEEITNLTKLTTIILGGNK-LNGSISITLGSNLASLRKLSLDSNELTSIPLTFWNLKDILYLNF  116 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~l~l  116 (405)
                      ..+.++.+++.+.. .|..+..+++|+.|++++|+ ++ .++...|.++++|+.|+|++|+|+.+++.            
T Consensus         9 ~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~------------   74 (156)
T d2ifga3           9 GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPD------------   74 (156)
T ss_dssp             SSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTT------------
T ss_pred             CCCeEEecCCCCcc-CcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccc------------
Confidence            35567777777765 56667778888888887664 66 77777777888888888888888877543            


Q ss_pred             CCCChhccCCCCCCEEeccCCcccccCCcccccCCCCCeeeccccccc
Q 036754          117 SVIPIEIGGLPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLS  164 (405)
Q Consensus       117 ~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~  164 (405)
                           .|.++++|++|+|++|+++...++.|.. ..|+.|+|++|++.
T Consensus        75 -----~f~~l~~L~~L~Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~  116 (156)
T d2ifga3          75 -----AFHFTPRLSRLNLSFNALESLSWKTVQG-LSLQELVLSGNPLH  116 (156)
T ss_dssp             -----GGGSCSCCCEEECCSSCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred             -----cccccccccceeccCCCCcccChhhhcc-ccccccccCCCccc
Confidence                 3556778888888888888555555544 46888888888875

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.40  E-value=2.3e-12  Score=117.91  Aligned_cols=59  Identities=32%  Similarity=0.433  Sum_probs=48.1

Q ss_pred             CCCCCEEeccCCcccccCCcccccCCCCCeeecccccccCccchhHHhcccCCccccccCcccCcCCC
Q 036754          126 LPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGEIPR  193 (405)
Q Consensus       126 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~p~  193 (405)
                      +++|++|++++|+++ .+|..   +++|+.|++++|+++. +|..   +.+|++|++++|+++. +|.
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~~-l~~~---~~~L~~L~L~~N~L~~-lp~  341 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAE-VPEL---PQNLKQLHVEYNPLRE-FPD  341 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCC
T ss_pred             CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCCc-cccc---cCCCCEEECcCCcCCC-CCc
Confidence            578999999999998 56653   5789999999999984 5543   5689999999999984 443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.31  E-value=1.4e-12  Score=116.15  Aligned_cols=180  Identities=18%  Similarity=0.208  Sum_probs=127.2

Q ss_pred             cCCCCCcCCeeeCcCCcCcccCCchhhhcccccccEEEcccC-ccccc-CCccccCccCCCeeecCCc-ccccc-cCcch
Q 036754            6 SLSNCKCLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYC-NISGG-ILEEITNLTKLTTIILGGN-KLNGS-ISITL   81 (405)
Q Consensus         6 ~~~~l~~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~   81 (405)
                      .+.++++|++|+|++|.+++..+.. ++.++ +|+.|++++| .++.. +.....++++|++|+++++ .++.. +...+
T Consensus        66 l~~~c~~L~~L~L~~~~l~~~~~~~-l~~~~-~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~  143 (284)
T d2astb2          66 ILSQCSKLQNLSLEGLRLSDPIVNT-LAKNS-NLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV  143 (284)
T ss_dssp             HHTTBCCCSEEECTTCBCCHHHHHH-HTTCT-TCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH
T ss_pred             HHHhCCCcccccccccCCCcHHHHH-HhcCC-CCcCccccccccccccccchhhHHHHhccccccccccccccccchhhh
Confidence            4678999999999999998776666 56666 8999999996 45532 2233467899999999996 45422 23333


Q ss_pred             hcCCCCCCeeeCCCC--CCC--CCchhhhccccCccccCCC-------CChhccCCCCCCEEeccCC-cccccCCccccc
Q 036754           82 GSNLASLRKLSLDSN--ELT--SIPLTFWNLKDILYLNFSV-------IPIEIGGLPNLEYLFLGYN-RLQGSIPDSFGD  149 (405)
Q Consensus        82 ~~~l~~L~~L~Ls~N--~l~--~lp~~~~~l~~L~~l~l~~-------~p~~~~~l~~L~~L~l~~n-~l~~~~p~~~~~  149 (405)
                      ....++|+.|+++++  .++  .+.....++++|+.|+++.       .+..+..+++|++|++++| .++......+++
T Consensus       144 ~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~  223 (284)
T d2astb2         144 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE  223 (284)
T ss_dssp             HHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGG
T ss_pred             cccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhc
Confidence            345689999999975  455  3444456788999999875       2335778899999999995 576666667889


Q ss_pred             CCCCCeeecccccccCccchhHHhcccCCccccccCcccCc
Q 036754          150 LISLKSLNLSKNNLSGAIPASLEKLLYLKDLNLSFNKLEGE  190 (405)
Q Consensus       150 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~  190 (405)
                      +++|+.|+++++--.+..+.....   +..|.+..+.++..
T Consensus       224 ~~~L~~L~l~~~~~d~~l~~l~~~---lp~L~i~~~~ls~~  261 (284)
T d2astb2         224 IPTLKTLQVFGIVPDGTLQLLKEA---LPHLQINCSHFTTI  261 (284)
T ss_dssp             CTTCCEEECTTSSCTTCHHHHHHH---STTSEESCCCSCCT
T ss_pred             CCCCCEEeeeCCCCHHHHHHHHHh---CccccccCccCCCC
Confidence            999999999988222222222233   44455666666644

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.22  E-value=5.4e-12  Score=116.39  Aligned_cols=113  Identities=13%  Similarity=0.179  Sum_probs=84.8

Q ss_pred             CCccCcccccCCCceEEEee-CCCcEEEEEEeeccccchhHHHHHHHHHhhcCC-----------CCCcceEEeeeec--
Q 036754          292 FSENNLISKGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-----------HQNLIKVISSCSN--  357 (405)
Q Consensus       292 ~~~~~~lg~G~fg~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~--  357 (405)
                      |...+.||+|+||+||+|+. .+|+.||||+++... .....+.+|+.++.+++           |+|||++++++..  
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            56678999999999999995 679999999997542 22345677888777664           5789999988754  


Q ss_pred             CCeeEEEEecCCCCCH-HHHHh-cCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          358 EEFKALVLEYMPHGSL-EKYLY-SSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       358 ~~~~~lv~e~~~~g~L-~~~l~-~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ....+++++++..++. ..... .....+++..+..++.||++||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~  143 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR  143 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh
Confidence            4566777777665443 22222 233578899999999999999999994

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.18  E-value=5.2e-12  Score=115.65  Aligned_cols=205  Identities=18%  Similarity=0.170  Sum_probs=134.9

Q ss_pred             ccCCCCCcCCeeeCcCCcCcccCCc---hh------hhcccccccEEEcccCccccc----CCccccCccCCCeeecCCc
Q 036754            5 SSLSNCKCLTFIDLSNNPLDSVLPK---TF------VGNVSHSLEFFVMSYCNISGG----ILEEITNLTKLTTIILGGN   71 (405)
Q Consensus         5 ~~~~~l~~L~~L~Ls~N~l~~~~~~---~f------~~~~~~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N   71 (405)
                      +.+...++|+.|+++++......+.   .+      +..++ +|+.|+|++|.+...    +...+...++|+.|++++|
T Consensus        53 ~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~-~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n  131 (344)
T d2ca6a1          53 ENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCP-KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN  131 (344)
T ss_dssp             HTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCT-TCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSS
T ss_pred             HHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCC-Ccccccccccccccccccchhhhhcccccchheecccc
Confidence            4567788899999988765433221   10      22333 799999999988653    3334456788999999998


Q ss_pred             ccccccCcc------------hhcCCCCCCeeeCCCCCCCC-----CchhhhccccCccccCCCC-----------Chhc
Q 036754           72 KLNGSISIT------------LGSNLASLRKLSLDSNELTS-----IPLTFWNLKDILYLNFSVI-----------PIEI  123 (405)
Q Consensus        72 ~l~~~~~~~------------~~~~l~~L~~L~Ls~N~l~~-----lp~~~~~l~~L~~l~l~~~-----------p~~~  123 (405)
                      .+...-...            .....+.|+.|++++|+++.     +...+.....|+.++++..           ...+
T Consensus       132 ~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l  211 (344)
T d2ca6a1         132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGL  211 (344)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTG
T ss_pred             cccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhh
Confidence            874210000            11356788899999988872     2333455667888877651           1235


Q ss_pred             cCCCCCCEEeccCCccccc----CCcccccCCCCCeeecccccccCccchhH----Hh--cccCCccccccCcccCcC--
Q 036754          124 GGLPNLEYLFLGYNRLQGS----IPDSFGDLISLKSLNLSKNNLSGAIPASL----EK--LLYLKDLNLSFNKLEGEI--  191 (405)
Q Consensus       124 ~~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~n~l~~~~~~~~----~~--l~~L~~l~l~~n~l~~~~--  191 (405)
                      ..+++|+.|++++|.+...    +...+..+++|++|++++|.+++.-...+    ..  ...|++|++++|.++..-  
T Consensus       212 ~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~  291 (344)
T d2ca6a1         212 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR  291 (344)
T ss_dssp             GGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHH
T ss_pred             cchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHH
Confidence            6678999999999987532    33456788999999999999875433333    22  356999999999886421  


Q ss_pred             --CCC--CccCCCCcccccCCCC
Q 036754          192 --PRG--GSFGNFSAESFEGNEL  210 (405)
Q Consensus       192 --p~~--~~~~~~~~~~~~~n~~  210 (405)
                        ...  ...+++..+++++|.+
T Consensus       292 ~l~~~l~~~~~~L~~L~l~~N~~  314 (344)
T d2ca6a1         292 TLKTVIDEKMPDLLFLELNGNRF  314 (344)
T ss_dssp             HHHHHHHHHCTTCCEEECTTSBS
T ss_pred             HHHHHHHccCCCCCEEECCCCcC
Confidence              111  1245678888888875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.18  E-value=1.8e-11  Score=102.14  Aligned_cols=99  Identities=14%  Similarity=0.150  Sum_probs=74.5

Q ss_pred             cCcccccCCCceEEEeeCCCcEEEEEEeecccc------------------chhHHHHHHHHHhhcCCCCCcceEEeeee
Q 036754          295 NNLISKGGFGSVYKARLGDGMEVAVKVFNLQCR------------------RAFKSFDIECEMMKSIRHQNLIKVISSCS  356 (405)
Q Consensus       295 ~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~~~~  356 (405)
                      .+.||+|+||.||+|...+|+.||||+++....                  ........|...+.++.|.+++..+++..
T Consensus         5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~   84 (191)
T d1zara2           5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG   84 (191)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET
T ss_pred             CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC
Confidence            568999999999999988999999998753211                  01123456788899999999998876532


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          357 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       357 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                          .+++|||++++.+.+        +++....+++.|+++|++|||.
T Consensus        85 ----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~  121 (191)
T d1zara2          85 ----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYH  121 (191)
T ss_dssp             ----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHH
T ss_pred             ----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhh
Confidence                369999999865433        2333456789999999999994

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.08  E-value=3e-11  Score=110.50  Aligned_cols=205  Identities=18%  Similarity=0.131  Sum_probs=140.7

Q ss_pred             ccccCCCCCcCCeeeCcCCcCcccCCchh---hhcccccccEEEcccCccccc---CC-------ccccCccCCCeeecC
Q 036754            3 FLSSLSNCKCLTFIDLSNNPLDSVLPKTF---VGNVSHSLEFFVMSYCNISGG---IL-------EEITNLTKLTTIILG   69 (405)
Q Consensus         3 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~f---~~~~~~~L~~L~L~~n~l~~~---~~-------~~~~~l~~L~~L~L~   69 (405)
                      +..++...++|+.|+|++|.+.......+   +...+ +|+.|+++++.....   .+       ..+...++|+.|+|+
T Consensus        23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~-~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~  101 (344)
T d2ca6a1          23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK-DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  101 (344)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCT-TCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCC-CCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence            45567778999999999999866544332   23334 899999998765321   12       234567899999999


Q ss_pred             Ccccccc----cCcchhcCCCCCCeeeCCCCCCCCC-----chhh---------hccccCccccCCC----------CCh
Q 036754           70 GNKLNGS----ISITLGSNLASLRKLSLDSNELTSI-----PLTF---------WNLKDILYLNFSV----------IPI  121 (405)
Q Consensus        70 ~N~l~~~----~~~~~~~~l~~L~~L~Ls~N~l~~l-----p~~~---------~~l~~L~~l~l~~----------~p~  121 (405)
                      +|.+...    +...+ ...++|++|++++|.++.-     ...+         ...+.|+.+.++.          +..
T Consensus       102 ~n~i~~~~~~~l~~~l-~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~  180 (344)
T d2ca6a1         102 DNAFGPTAQEPLIDFL-SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK  180 (344)
T ss_dssp             SCCCCTTTHHHHHHHH-HHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHH
T ss_pred             ccccccccccchhhhh-cccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccc
Confidence            9998632    22222 3678999999999998621     0111         2344566666654          222


Q ss_pred             hccCCCCCCEEeccCCccccc-----CCcccccCCCCCeeecccccccCc----cchhHHhcccCCccccccCcccCcCC
Q 036754          122 EIGGLPNLEYLFLGYNRLQGS-----IPDSFGDLISLKSLNLSKNNLSGA----IPASLEKLLYLKDLNLSFNKLEGEIP  192 (405)
Q Consensus       122 ~~~~l~~L~~L~l~~n~l~~~-----~p~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~l~l~~n~l~~~~p  192 (405)
                      .+...+.|++|++++|.+...     +...+..+++|+.|++++|.++..    +...+...++|++|++++|.+++.-.
T Consensus       181 ~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~  260 (344)
T d2ca6a1         181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA  260 (344)
T ss_dssp             HHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHH
T ss_pred             hhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhh
Confidence            345678999999999998632     334467789999999999998633    33456788899999999999875311


Q ss_pred             C-------CCccCCCCcccccCCC
Q 036754          193 R-------GGSFGNFSAESFEGNE  209 (405)
Q Consensus       193 ~-------~~~~~~~~~~~~~~n~  209 (405)
                      .       ......+..+++++|.
T Consensus       261 ~~l~~~l~~~~~~~L~~L~ls~N~  284 (344)
T d2ca6a1         261 AAVVDAFSKLENIGLQTLRLQYNE  284 (344)
T ss_dssp             HHHHHHHHTCSSCCCCEEECCSSC
T ss_pred             HHHHHHhhhccCCCCCEEECCCCc
Confidence            1       1223567788888875

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.07  E-value=1.7e-11  Score=115.92  Aligned_cols=84  Identities=18%  Similarity=0.072  Sum_probs=53.6

Q ss_pred             CCCCEEeccCCcccccCCcc----cccCCCCCeeecccccccCcc----chhHH-hcccCCccccccCcccCc----CCC
Q 036754          127 PNLEYLFLGYNRLQGSIPDS----FGDLISLKSLNLSKNNLSGAI----PASLE-KLLYLKDLNLSFNKLEGE----IPR  193 (405)
Q Consensus       127 ~~L~~L~l~~n~l~~~~p~~----~~~l~~L~~L~l~~n~l~~~~----~~~~~-~l~~L~~l~l~~n~l~~~----~p~  193 (405)
                      ..|+.+++++|.+.......    +...++|++|+|++|.++..-    ...+. ..+.|+.|++++|.++..    +++
T Consensus       312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~  391 (460)
T d1z7xw1         312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA  391 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence            45777777777665432222    334568999999999986432    22222 345699999999998742    111


Q ss_pred             -CCccCCCCcccccCCCC
Q 036754          194 -GGSFGNFSAESFEGNEL  210 (405)
Q Consensus       194 -~~~~~~~~~~~~~~n~~  210 (405)
                       ....++++.+++++|+.
T Consensus       392 ~l~~~~~L~~L~Ls~N~i  409 (460)
T d1z7xw1         392 TLLANHSLRELDLSNNCL  409 (460)
T ss_dssp             HHHHCCCCCEEECCSSSC
T ss_pred             HHhcCCCCCEEECCCCcC
Confidence             12346788888888865

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.82  E-value=4.4e-10  Score=90.74  Aligned_cols=39  Identities=33%  Similarity=0.268  Sum_probs=16.6

Q ss_pred             CCCCCEEeccCCcccccCCcccccCCCCCeeeccccccc
Q 036754          126 LPNLEYLFLGYNRLQGSIPDSFGDLISLKSLNLSKNNLS  164 (405)
Q Consensus       126 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~  164 (405)
                      +++|+.|++++|.++...+-.+.....|+.|++++|++.
T Consensus        90 l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          90 APNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             STTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             CCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence            344444444444444322222222334455555555544

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.76  E-value=7e-10  Score=89.49  Aligned_cols=121  Identities=21%  Similarity=0.114  Sum_probs=73.5

Q ss_pred             cCCeeeCcCCcCcccCCchhhhcccccccEEEcccCcccccCCccccCccCCCeeecCCcccccccCc--chhcCCCCCC
Q 036754           12 CLTFIDLSNNPLDSVLPKTFVGNVSHSLEFFVMSYCNISGGILEEITNLTKLTTIILGGNKLNGSISI--TLGSNLASLR   89 (405)
Q Consensus        12 ~L~~L~Ls~N~l~~~~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~~l~~L~   89 (405)
                      ..+.||++++......     ..+. .+..++..++.. ..++..+..+++|++|+|++|+|+ .++.  ..+..+++|+
T Consensus        23 ~~~~Ldls~l~~~~~l-----~~~~-~~~~l~~~~~~~-~~l~~~~~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~   94 (162)
T d1koha1          23 SQQALDLKGLRSDPDL-----VAQN-IDVVLNRRSSMA-ATLRIIEENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLK   94 (162)
T ss_dssp             SSCCBCCCCCSSCTTT-----TTTT-CCCCTTSHHHHH-HHHHHHHHHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCC
T ss_pred             hhCeeecccCCCCchh-----hhcc-chhhcchhhhHh-hhhHHHHHhCCCCCEeeCCCcccc-CCchhHHHHhhCCccc
Confidence            4566777766542211     1111 334444444433 234445567888999999999887 4432  3345788899


Q ss_pred             eeeCCCCCCCCCchhhhccccCccccCCCCChhccCCCCCCEEeccCCcccccCCcc-------cccCCCCCeee
Q 036754           90 KLSLDSNELTSIPLTFWNLKDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGSIPDS-------FGDLISLKSLN  157 (405)
Q Consensus        90 ~L~Ls~N~l~~lp~~~~~l~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-------~~~l~~L~~L~  157 (405)
                      .|+|++|+|+++++- .                +....+|+.|++++|++.......       +..+|+|+.||
T Consensus        95 ~L~Ls~N~i~~l~~l-~----------------~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          95 ILNLSGNELKSEREL-D----------------KIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             CCCCTTSCCCCGGGH-H----------------HHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             ccccccCccccchhh-h----------------hhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            999999998877652 1                112346788889999887544322       34566676654

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.66  E-value=2.4e-09  Score=100.76  Aligned_cols=86  Identities=21%  Similarity=0.080  Sum_probs=51.6

Q ss_pred             CCCCCCEEeccCCccccc----CCcccc-cCCCCCeeecccccccCc----cchhHHhcccCCccccccCcccCcCCC--
Q 036754          125 GLPNLEYLFLGYNRLQGS----IPDSFG-DLISLKSLNLSKNNLSGA----IPASLEKLLYLKDLNLSFNKLEGEIPR--  193 (405)
Q Consensus       125 ~l~~L~~L~l~~n~l~~~----~p~~~~-~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~l~l~~n~l~~~~p~--  193 (405)
                      ..++|++|+|++|++...    ++..+. ..+.|++|++++|.++..    +...+...++|++|++++|+++.....  
T Consensus       338 ~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l  417 (460)
T d1z7xw1         338 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL  417 (460)
T ss_dssp             HCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHH
T ss_pred             cccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHH
Confidence            456788888888877532    222232 346688888888887632    334556667888888888887642111  


Q ss_pred             ---C-CccCCCCcccccCCCC
Q 036754          194 ---G-GSFGNFSAESFEGNEL  210 (405)
Q Consensus       194 ---~-~~~~~~~~~~~~~n~~  210 (405)
                         . .....++.+.+.+|.+
T Consensus       418 ~~~l~~~~~~L~~l~l~~~~~  438 (460)
T d1z7xw1         418 VESVRQPGCLLEQLVLYDIYW  438 (460)
T ss_dssp             HHHHTSTTCCCCEEECTTCCC
T ss_pred             HHHHHhCCCccCEEECCCCCC
Confidence               0 1122456666666654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.76  E-value=4.8e-06  Score=66.62  Aligned_cols=93  Identities=16%  Similarity=0.177  Sum_probs=53.0

Q ss_pred             CCCCcCCeeeCcCC-cCcccCCchh---hhcccccccEEEcccCcccccC----CccccCccCCCeeecCCcccccccCc
Q 036754            8 SNCKCLTFIDLSNN-PLDSVLPKTF---VGNVSHSLEFFVMSYCNISGGI----LEEITNLTKLTTIILGGNKLNGSISI   79 (405)
Q Consensus         8 ~~l~~L~~L~Ls~N-~l~~~~~~~f---~~~~~~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~   79 (405)
                      .+.++|+.|+|+++ .++...-..+   +.... +|+.|+|++|.+....    ...+...+.|+.|+|++|.++..--.
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~-~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~   90 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSK-HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA   90 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCS-CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCC-ccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH
Confidence            45688888888874 4543211111   22222 6788888888775422    22344456778888888877632111


Q ss_pred             ch---hcCCCCCCeeeCCCCCCCCC
Q 036754           80 TL---GSNLASLRKLSLDSNELTSI  101 (405)
Q Consensus        80 ~~---~~~l~~L~~L~Ls~N~l~~l  101 (405)
                      .+   ...-++|++|+|++|.+..+
T Consensus        91 ~l~~aL~~n~sL~~L~l~~n~~~~~  115 (167)
T d1pgva_          91 RLLRSTLVTQSIVEFKADNQRQSVL  115 (167)
T ss_dssp             HHHHHTTTTCCCSEEECCCCSSCCC
T ss_pred             HHHHHHHhCCcCCEEECCCCcCCCc
Confidence            11   13446677777777766554

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.63  E-value=1.7e-05  Score=63.26  Aligned_cols=111  Identities=17%  Similarity=0.098  Sum_probs=61.4

Q ss_pred             cccEEEcccC-ccccc----CCccccCccCCCeeecCCcccccccCcc---hhcCCCCCCeeeCCCCCCCCCc-hhhhcc
Q 036754           38 SLEFFVMSYC-NISGG----ILEEITNLTKLTTIILGGNKLNGSISIT---LGSNLASLRKLSLDSNELTSIP-LTFWNL  108 (405)
Q Consensus        38 ~L~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~---~~~~l~~L~~L~Ls~N~l~~lp-~~~~~l  108 (405)
                      +|+.|+|+++ .++..    +-..+...++|+.|+|++|.+...-...   .....+.|++|+|++|.++.-. ..+.. 
T Consensus        16 ~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~-   94 (167)
T d1pgva_          16 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR-   94 (167)
T ss_dssp             SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH-
T ss_pred             CCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH-
Confidence            7888888764 35431    2223455677888888888775221111   1234567888888888776311 11111 


Q ss_pred             ccCccccCCCCChhccCCCCCCEEeccCCccccc-------CCcccccCCCCCeeeccccc
Q 036754          109 KDILYLNFSVIPIEIGGLPNLEYLFLGYNRLQGS-------IPDSFGDLISLKSLNLSKNN  162 (405)
Q Consensus       109 ~~L~~l~l~~~p~~~~~l~~L~~L~l~~n~l~~~-------~p~~~~~l~~L~~L~l~~n~  162 (405)
                                   .+...+.|++|++++|.+...       +...+...++|+.|+++.+.
T Consensus        95 -------------aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          95 -------------STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             -------------HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             -------------HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence                         233446677777777754421       12223345666666665543

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.17  E-value=5.9e-05  Score=59.92  Aligned_cols=62  Identities=19%  Similarity=0.241  Sum_probs=29.9

Q ss_pred             cccEEEccc-Cccccc----CCccccCccCCCeeecCCcccccccCcc---hhcCCCCCCeeeCCCCCCC
Q 036754           38 SLEFFVMSY-CNISGG----ILEEITNLTKLTTIILGGNKLNGSISIT---LGSNLASLRKLSLDSNELT   99 (405)
Q Consensus        38 ~L~~L~L~~-n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~---~~~~l~~L~~L~Ls~N~l~   99 (405)
                      +|+.|+|++ +.++..    +-..+...++|+.|+|++|.++..--..   .+...++|+.|++++|.++
T Consensus        18 ~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          18 DLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             TCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             CCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            566666665 334321    1122334556666666666654221111   1123455666666665554

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.01  E-value=0.00013  Score=57.80  Aligned_cols=37  Identities=11%  Similarity=0.105  Sum_probs=16.9

Q ss_pred             cccEEEcccCccccc----CCccccCccCCCeeecCCcccc
Q 036754           38 SLEFFVMSYCNISGG----ILEEITNLTKLTTIILGGNKLN   74 (405)
Q Consensus        38 ~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~   74 (405)
                      +|+.|+|++|.++..    +-..+...+.++.+++++|.+.
T Consensus        47 ~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          47 YVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             SCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             ccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            455555555554331    1112233445555555555543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=96.79  E-value=0.0026  Score=53.79  Aligned_cols=109  Identities=13%  Similarity=0.057  Sum_probs=71.4

Q ss_pred             ccCCccCcccccCCCceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCC-CCCcceEEeeeecCCeeEEEEecC
Q 036754          290 YKFSENNLISKGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIR-HQNLIKVISSCSNEEFKALVLEYM  368 (405)
Q Consensus       290 ~~~~~~~~lg~G~fg~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  368 (405)
                      ..+...+..+.++.+.||+... ++..+.+|............+.+|...+..+. +--+.+++++....+..++||+++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l   92 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             hceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence            3343333323334468998765 45567788776554444455677887776653 434667788888888999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          369 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       369 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      ++.++.+.....   .   ....++.++++.++-||.
T Consensus        93 ~G~~~~~~~~~~---~---~~~~~~~~l~~~l~~lH~  123 (263)
T d1j7la_          93 DGVLCSEEYEDE---Q---SPEKIIELYAECIRLFHS  123 (263)
T ss_dssp             SSEEHHHHTTTC---S---CHHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccc---c---cHHHHHHHHHHHHHHHhc
Confidence            998887654321   1   234467788888888884

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=93.56  E-value=0.19  Score=41.31  Aligned_cols=96  Identities=16%  Similarity=0.087  Sum_probs=61.7

Q ss_pred             ccccCC-CceEEEeeCCCcEEEEEEeeccccchhHHHHHHHHHhhcCCC--CCcceEEeeeecCCeeEEEEecCCCCCHH
Q 036754          298 ISKGGF-GSVYKARLGDGMEVAVKVFNLQCRRAFKSFDIECEMMKSIRH--QNLIKVISSCSNEEFKALVLEYMPHGSLE  374 (405)
Q Consensus       298 lg~G~f-g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~  374 (405)
                      +..|.. +.||+....++..+.+|......   ...+..|...+..+..  --+.+++++....+..++||||+++.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            344443 57899888777778888765432   2345566766665533  33566787777788899999999886543


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHhhhcC
Q 036754          375 KYLYSSNCILDIFQRLNIMIDVASALEYLHF  405 (405)
Q Consensus       375 ~~l~~~~~~l~~~~~~~i~~~ia~gl~yLH~  405 (405)
                      +.      ...   ....+.++++.|+-||.
T Consensus        95 ~~------~~~---~~~~~~~l~~~la~LH~  116 (255)
T d1nd4a_          95 SS------HLA---PAEKVSIMADAMRRLHT  116 (255)
T ss_dssp             TS------CCC---HHHHHHHHHHHHHHHTT
T ss_pred             cc------ccc---HHHHHHHHHHHHHHHcc
Confidence            31      122   22345567777777773

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=84.59  E-value=1.2  Score=39.08  Aligned_cols=82  Identities=18%  Similarity=0.189  Sum_probs=48.7

Q ss_pred             CcccccCCCceEEEeeCC-CcEEEEEEeeccc-------cchhHHHHHHHHHhhcCC-C--CCcceEEeeeecCCeeEEE
Q 036754          296 NLISKGGFGSVYKARLGD-GMEVAVKVFNLQC-------RRAFKSFDIECEMMKSIR-H--QNLIKVISSCSNEEFKALV  364 (405)
Q Consensus       296 ~~lg~G~fg~v~~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  364 (405)
                      +.+|.|....||+.+..+ ++.++||.-....       .....+...|.+.+..+. +  ..+.+++.+  +++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            357999999999998654 5788999754311       112233455776666542 2  345555544  34566799


Q ss_pred             EecCCCCCH-HHHHhc
Q 036754          365 LEYMPHGSL-EKYLYS  379 (405)
Q Consensus       365 ~e~~~~g~L-~~~l~~  379 (405)
                      |||+++..+ ...+..
T Consensus       110 mE~L~~~~~~~~~l~~  125 (392)
T d2pula1         110 MEDLSHLKIARKGLIE  125 (392)
T ss_dssp             ECCCTTSEEHHHHHHH
T ss_pred             EeccCCcccchhhhcc
Confidence            999987543 334433